data_2pni_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2pni _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.115 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -139.4 159.1 42.95 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.506 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -142.68 125.15 15.68 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.1 -1.863 . . . . 0.0 107.601 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -89.61 118.46 29.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.629 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.63 152.48 0.33 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.927 0.767 . . . . 0.0 112.788 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -113.29 -44.81 3.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.512 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.34 151.99 41.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.06 0.85 . . . . 0.0 110.799 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.01 116.37 7.76 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.257 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -117.99 138.1 52.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.125 0.891 . . . . 0.0 108.895 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.02 146.4 25.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.297 0.998 . . . . 0.0 109.921 174.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 164.53 14.94 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.176 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.62 -25.24 0.77 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.074 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -108.03 149.68 28.12 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.101 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.56 -12.25 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.531 170.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -81.76 -40.27 22.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 123.903 0.752 . . . . 0.0 111.187 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.77 156.22 19.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.114 0.884 . . . . 0.0 111.265 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.41 174.43 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.666 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -75.05 131.47 40.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.766 -174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.0 mt -121.56 127.46 50.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.587 1.179 . . . . 0.0 109.179 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.74 -173.62 2.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.268 0.98 . . . . 0.0 108.904 -175.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.414 ' C ' ' H ' ' A' ' 28' ' ' ASP . 3.1 mp -83.12 156.53 23.23 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.423 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.12 0.03 1.0 Allowed Glycine 0 N--CA 1.5 2.955 0 O-C-N 123.872 0.732 . . . . 0.0 113.201 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -65.69 106.29 1.45 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 mt -90.64 132.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.743 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.5 mp -108.52 151.52 25.98 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.064 -1.88 . . . . 0.0 109.013 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.8 m -129.43 147.43 51.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 123.842 0.714 . . . . 0.0 109.845 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.59 -147.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 123.807 0.692 . . . . 0.0 109.265 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 O-C-N 123.419 0.449 . . . . 0.0 110.033 178.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.244 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -86.96 -37.86 17.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -102.31 102.97 27.94 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.999 0.812 . . . . 0.0 111.325 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -68.6 -17.99 42.92 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.641 2.227 . . . . 0.0 114.092 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.53 -31.67 68.14 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.657 0.598 . . . . 0.0 112.246 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.32 -21.89 21.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.831 0.707 . . . . 0.0 111.376 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.12 146.91 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -91.56 1.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -90.19 131.04 36.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.425 -1.388 . . . . 0.0 109.032 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -108.46 126.82 53.32 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.94 124.23 46.33 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.77 -166.18 16.67 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -140.17 150.19 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.23 99.87 7.93 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.274 -177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.81 -21.49 66.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.3 m -46.05 -37.42 6.7 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.812 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.61 2.46 6.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.849 1.343 . . . . 0.0 108.877 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.64 36.87 73.33 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.614 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -109.51 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.51 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 156.05 40.99 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.767 0.794 . . . . 0.0 111.699 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.66 -153.05 23.3 Favored Glycine 0 N--CA 1.489 2.197 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.032 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.71 153.94 24.57 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.6 p90 -151.36 140.77 13.95 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.912 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.15 150.39 87.74 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.53 1.486 . . . . 0.0 110.708 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.29 48.72 4.08 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 t -141.21 16.39 2.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.105 0.532 . . . . 0.0 111.616 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -136.05 -4.08 2.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 123.751 0.657 . . . . 0.0 111.847 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.98 -169.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 123.932 0.77 . . . . 0.0 109.13 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.71 113.58 5.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.582 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 25.2 t80 -48.27 142.97 4.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.442 171.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 pt -122.24 -53.5 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 123.926 0.766 . . . . 0.0 111.688 176.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.84 146.63 15.79 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.478 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.582 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-N 113.311 -1.444 . . . . 0.0 109.988 177.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.151 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -125.09 161.29 27.11 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.563 1.164 . . . . 0.0 113.673 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -139.3 154.68 47.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.167 -2.288 . . . . 0.0 106.711 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 -123.33 121.54 36.08 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.93 145.75 12.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.266 0.979 . . . . 0.0 111.433 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tp -107.4 -41.36 5.1 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.839 -176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.93 152.55 43.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.264 0.977 . . . . 0.0 110.242 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.21 123.04 18.49 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.577 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -123.09 136.8 54.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.504 1.127 . . . . 0.0 109.076 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -94.61 151.7 19.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 124.294 0.996 . . . . 0.0 109.32 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.49 131.39 35.55 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 123.921 0.763 . . . . 0.0 110.311 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -110.1 -11.22 14.63 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 124.183 0.927 . . . . 0.0 110.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -120.6 146.26 46.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.327 1.017 . . . . 0.0 109.424 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.38 -19.12 63.08 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.758 172.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.3 -19.81 38.7 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.099 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.38 164.67 12.01 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 123.874 0.734 . . . . 0.0 110.757 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 pt -124.58 168.86 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.556 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.52 136.24 40.6 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.494 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.7 mt -125.94 135.16 51.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.206 0.941 . . . . 0.0 110.674 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -175.86 3.95 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.43 -173.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mt -84.74 158.31 20.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 123.534 0.521 . . . . 0.0 110.781 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.0 -6.15 1.06 Allowed Glycine 0 N--CA 1.503 3.157 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.676 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.97 110.57 11.71 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -176.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.2 mt -93.96 138.65 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.856 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.75 148.32 27.6 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.702 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 m -126.7 147.34 49.96 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 124.033 0.833 . . . . 0.0 109.177 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.37 -154.99 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.52 172.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 121.253 0.549 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.463 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -176.9 -22.85 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.31 80.63 29.02 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 123.885 0.741 . . . . 0.0 109.113 177.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.15 -22.51 40.27 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.872 2.381 . . . . 0.0 111.938 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -50.16 -41.41 49.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.766 1.292 . . . . 0.0 112.238 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -93.63 -29.32 15.51 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 123.87 0.731 . . . . 0.0 111.463 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.8 mt -64.72 146.33 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.739 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.37 -96.5 1.07 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -98.32 128.58 44.81 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.246 -0.977 . . . . 0.0 110.35 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.5 mp -107.18 136.26 47.31 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -104.97 125.7 51.24 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.04 -164.67 13.55 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -137.27 147.04 45.43 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.131 -0.534 . . . . 0.0 110.749 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -101.1 100.31 10.87 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.9 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -54.51 -39.26 67.43 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 123.743 0.652 . . . . 0.0 111.97 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 96.9 m -52.22 -42.03 63.23 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 124.222 0.951 . . . . 0.0 112.142 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 p -105.28 0.35 27.05 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.343 1.027 . . . . 0.0 110.598 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.96 24.04 13.09 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 124.155 0.91 . . . . 0.0 112.667 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.53 166.48 12.5 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -174.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.7 ttm-85 -148.1 125.64 11.72 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.33 -162.83 26.66 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.978 -1.106 . . . . 0.0 111.173 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.93 153.79 21.48 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.696 -0.752 . . . . 0.0 109.15 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 34.9 p90 -151.24 147.83 21.28 Favored Pre-proline 0 N--CA 1.493 1.695 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.684 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.19 156.28 60.28 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.424 2.083 . . . . 0.0 112.0 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.01 44.2 1.84 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.6 t -134.43 -17.31 2.04 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.656 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.78 0.87 39.59 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.265 0.978 . . . . 0.0 111.696 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.92 -179.0 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 123.756 0.66 . . . . 0.0 109.459 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -149.18 106.53 3.62 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.046 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.463 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 77.6 t80 -43.65 128.44 5.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.097 169.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 pt -126.2 -58.26 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 124.019 0.824 . . . . 0.0 111.419 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.63 156.38 20.99 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -162.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.914 0.864 . . . . 0.0 112.152 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -128.44 162.07 28.02 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.234 1.016 . . . . 0.0 112.488 -175.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.42 165.32 27.76 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 112.416 -2.174 . . . . 0.0 107.835 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -128.03 115.13 18.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.949 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.48 116.4 3.07 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 123.889 0.743 . . . . 0.0 111.175 173.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tp -76.91 -33.1 57.78 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.949 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -141.25 143.02 33.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 124.296 0.997 . . . . 0.0 109.853 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.18 104.3 0.57 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.083 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -101.21 130.57 47.35 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -89.48 163.77 15.1 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 138.64 31.25 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -131.31 -19.33 2.79 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.74 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -123.64 151.26 43.22 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.864 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -63.19 -20.26 65.26 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.286 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -26.97 21.18 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.725 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.39 153.42 20.87 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.376 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.22 -173.67 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 124.511 1.132 . . . . 0.0 111.097 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.47 120.53 28.87 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 112.533 -2.121 . . . . 0.0 107.678 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 mt -117.37 119.99 36.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.159 0.912 . . . . 0.0 108.916 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.95 -170.36 1.78 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 124.561 1.163 . . . . 0.0 109.523 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 28' ' ' ASP . 14.1 mt -84.99 156.1 21.29 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.478 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.99 9.16 2.68 Favored Glycine 0 N--CA 1.502 3.085 0 O-C-N 124.101 0.875 . . . . 0.0 113.074 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 26' ' ' LEU . 3.4 m-20 -71.45 125.17 26.33 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mp -96.37 146.91 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 124.198 0.936 . . . . 0.0 109.021 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 mp -115.46 161.53 18.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 112.442 -2.163 . . . . 0.0 110.911 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.6 m -131.31 153.95 49.05 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.748 1.28 . . . . 0.0 108.329 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.432 ' CG1' ' H ' ' A' ' 33' ' ' ASN . 2.1 t -130.03 -150.5 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.432 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 123.583 0.552 . . . . 0.0 110.889 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 121.167 0.508 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.48 0.57 0.2 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.006 -173.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -128.93 69.7 80.83 Favored Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 123.606 0.566 . . . . 0.0 111.266 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.93 -4.87 4.04 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.639 2.226 . . . . 0.0 113.67 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.51 -45.5 53.46 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 123.732 0.645 . . . . 0.0 110.756 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -92.47 -28.94 16.51 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 124.057 0.848 . . . . 0.0 111.141 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.7 mt -65.02 143.37 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 123.766 0.666 . . . . 0.0 109.741 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.42 -99.91 1.05 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -89.62 144.59 25.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.492 0.76 . . . . 0.0 110.467 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.2 mp -122.5 130.1 52.69 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.329 170.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.27 121.69 33.24 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.38 177.7 25.48 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 120.048 -1.072 . . . . 0.0 113.008 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.69 123.63 45.99 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 113.559 -1.32 . . . . 0.0 109.226 174.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -89.47 80.78 6.67 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.42 1.105 . . . . 0.0 108.506 170.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -49.48 -24.95 2.28 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.961 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.1 m -53.13 -41.55 65.18 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.19 0.931 . . . . 0.0 112.075 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.8 p -119.41 6.3 11.13 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.428 1.08 . . . . 0.0 109.161 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.87 60.12 8.57 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 124.283 0.989 . . . . 0.0 111.12 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -139.74 160.67 39.35 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.406 0.709 . . . . 0.0 109.999 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -116.25 140.28 49.48 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.96 -155.5 17.34 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.343 -1.408 . . . . 0.0 111.994 164.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.22 166.43 10.64 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.695 -1.252 . . . . 0.0 110.151 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.9 p90 -161.89 145.59 9.43 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.889 170.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.24 154.12 75.39 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.233 1.955 . . . . 0.0 113.169 173.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.21 -16.82 63.91 Favored Glycine 0 N--CA 1.499 2.873 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.265 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.4 p -75.8 -14.11 60.3 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 122.245 0.218 . . . . 0.0 111.522 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.28 3.61 35.64 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 123.998 0.811 . . . . 0.0 111.658 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.89 -178.6 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 123.878 0.736 . . . . 0.0 109.237 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -147.79 111.35 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.453 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 41.3 t80 -51.28 140.92 15.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 123.753 0.658 . . . . 0.0 109.603 174.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.99 -56.47 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 124.431 1.082 . . . . 0.0 110.472 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.04 147.74 17.17 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.705 -1.236 . . . . 0.0 111.151 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.453 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-N 112.856 -1.672 . . . . 0.0 109.128 173.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.512 2.652 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -128.98 168.49 15.94 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.376 1.084 . . . . 0.0 111.705 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -143.51 123.15 13.29 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 112.275 -2.239 . . . . 0.0 105.563 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -89.39 122.04 32.23 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.76 146.28 10.77 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 123.642 0.589 . . . . 0.0 110.734 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 tp -114.92 -28.79 6.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 124.115 0.884 . . . . 0.0 110.43 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 156.77 48.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 123.954 0.784 . . . . 0.0 110.831 -174.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.39 103.57 16.24 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.596 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -110.55 133.26 53.46 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -89.43 158.69 17.63 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 139.68 30.24 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.591 -0.843 . . . . 0.0 110.173 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -128.99 -13.6 4.54 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.192 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.78 140.87 36.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 124.217 0.948 . . . . 0.0 109.322 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.84 -21.84 3.22 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.379 -1.282 . . . . 0.0 114.044 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -59.48 -57.76 11.58 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.799 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -83.29 174.05 11.06 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.053 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.0 pt -129.48 177.05 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 124.267 0.979 . . . . 0.0 111.674 175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.83 136.75 47.14 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.473 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 mt -126.38 133.19 51.38 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 123.973 0.795 . . . . 0.0 111.159 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.26 170.65 15.88 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.343 1.027 . . . . 0.0 110.695 -176.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 28' ' ' ASP . 2.0 mt -66.8 151.09 48.15 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 123.481 0.488 . . . . 0.0 110.413 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.9 -9.83 3.51 Favored Glycine 0 N--CA 1.501 2.976 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.036 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 26' ' ' LEU . 15.7 t70 -74.86 108.05 7.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.8 152.34 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 115.437 -0.802 . . . . 0.0 108.882 176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.2 mp -129.19 127.54 41.54 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.6 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.9 m -107.23 140.28 40.35 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.394 1.058 . . . . 0.0 108.961 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.5 -136.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 124.443 1.089 . . . . 0.0 108.725 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 123.871 0.732 . . . . 0.0 109.441 -176.853 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.511 2.598 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.18 10.25 20.07 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.472 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -129.0 77.46 77.9 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.25 -18.22 50.93 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.411 2.074 . . . . 0.0 112.828 170.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -53.42 -41.47 66.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.125 0.891 . . . . 0.0 111.901 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.61 -26.36 20.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.053 0.846 . . . . 0.0 110.689 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.3 mt -79.97 139.17 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 123.961 0.788 . . . . 0.0 109.287 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -93.06 1.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -95.92 120.25 35.87 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 113.708 -1.246 . . . . 0.0 109.169 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.9 mp -96.76 136.26 37.56 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 170.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -98.63 123.44 42.82 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.33 -178.39 27.84 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -133.8 144.12 48.8 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.762 0.33 . . . . 0.0 111.18 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.24 98.52 8.65 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.166 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -57.75 -29.21 64.6 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.343 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.0 m -53.05 -43.51 66.72 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 123.905 0.753 . . . . 0.0 112.143 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 p -102.64 -4.1 25.66 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 124.274 0.984 . . . . 0.0 110.187 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.14 28.4 61.29 Favored Glycine 0 N--CA 1.493 2.435 0 O-C-N 124.149 0.906 . . . . 0.0 111.926 -172.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -104.17 155.72 18.48 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -143.11 137.57 29.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.065 0.853 . . . . 0.0 110.186 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.32 -155.06 21.73 Favored Glycine 0 N--CA 1.492 2.399 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.429 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.81 153.26 22.74 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.233 -0.983 . . . . 0.0 108.866 -174.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 32.9 p90 -147.95 148.86 31.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.799 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.14 158.12 41.08 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.985 1.79 . . . . 0.0 111.92 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.99 53.6 0.63 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -151.38 -15.89 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.049 0.499 . . . . 0.0 112.108 174.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -94.87 -4.81 46.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 123.977 0.798 . . . . 0.0 112.324 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.4 m -109.64 -166.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 123.954 0.784 . . . . 0.0 109.253 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.28 113.15 5.11 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -48.75 128.34 15.27 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.783 165.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 pt -114.7 -84.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 124.36 1.038 . . . . 0.0 110.4 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.83 161.13 13.1 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -171.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.068 0 CA-C-O 121.939 0.876 . . . . 0.0 112.635 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -126.16 163.26 23.51 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.21 0.943 . . . . 0.0 111.363 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -139.1 160.12 40.55 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.543 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -126.63 118.72 25.38 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -174.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.83 130.77 38.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.857 0.723 . . . . 0.0 110.73 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -85.38 -45.89 11.46 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.226 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -143.23 156.67 44.8 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.395 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.17 111.68 1.82 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.442 173.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -120.93 133.39 55.28 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.973 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -90.1 161.75 15.64 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -89.68 147.55 23.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.839 0.712 . . . . 0.0 111.548 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -117.62 -4.53 11.22 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.3 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -146.57 148.84 32.55 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -52.68 -22.59 5.32 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.076 172.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -69.66 -45.56 68.13 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.235 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.38 158.18 16.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 123.965 0.791 . . . . 0.0 109.005 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 pt -115.16 170.68 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 124.185 0.928 . . . . 0.0 111.792 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.71 136.61 38.2 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.257 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.5 mt -125.46 133.37 52.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.345 1.028 . . . . 0.0 109.917 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.57 -167.88 1.59 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.686 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 28' ' ' ASP . 68.1 mt -89.22 157.98 18.04 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.627 176.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 58.7 1.71 0.92 Allowed Glycine 0 N--CA 1.505 3.244 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.39 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -76.28 108.54 9.29 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.77 -0.715 . . . . 0.0 110.972 -173.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tp -90.51 149.65 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.033 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mp -119.07 151.85 37.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.3 m -132.89 146.52 51.87 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.015 0.822 . . . . 0.0 109.627 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.95 -157.39 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.782 174.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 121.084 0.469 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -164.35 -11.35 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.361 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -122.25 82.39 45.39 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 124.502 1.126 . . . . 0.0 109.344 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -52.8 -20.0 12.02 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.589 2.193 . . . . 0.0 112.054 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.77 -43.17 80.55 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.936 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.01 -29.11 18.64 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 123.632 0.582 . . . . 0.0 111.485 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 mt -66.25 145.4 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.49 -73.29 1.27 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -127.95 133.75 49.25 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.561 -1.82 . . . . 0.0 107.932 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HG ' ' CZ ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -127.2 144.46 51.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.176 0.922 . . . . 0.0 109.172 174.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.47 145.58 25.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.633 1.208 . . . . 0.0 107.839 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.81 179.7 42.6 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 173.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -128.91 142.12 51.05 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.886 -0.657 . . . . 0.0 109.808 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' HB ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -114.03 82.73 1.75 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 125.176 1.547 . . . . 0.0 109.528 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -27.1 49.28 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.776 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.434 ' HB ' ' ND2' ' A' ' 60' ' ' ASN . 31.0 m -52.12 -42.68 63.5 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 123.924 0.765 . . . . 0.0 111.562 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -109.12 -3.51 17.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.799 1.312 . . . . 0.0 109.758 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.77 65.7 2.91 Favored Glycine 0 N--CA 1.493 2.447 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.049 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -137.23 162.05 34.54 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.314 0.655 . . . . 0.0 110.247 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -148.15 131.04 16.14 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.383 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.46 -163.42 36.59 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.506 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -102.87 152.44 21.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.487 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 41.2 p90 -148.02 152.27 39.72 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.413 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -66.6 151.23 83.24 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.071 1.847 . . . . 0.0 112.24 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.36 19.79 29.94 Favored Glycine 0 N--CA 1.496 2.697 0 O-C-N 124.093 0.871 . . . . 0.0 112.006 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.419 ' H ' ' HG1' ' A' ' 72' ' ' THR . 0.8 OUTLIER -109.83 -35.18 6.24 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.311 0.577 . . . . 0.0 110.911 -178.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -90.21 8.37 33.45 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.479 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.2 m -125.87 179.42 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 123.628 0.58 . . . . 0.0 110.263 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -150.06 106.41 3.49 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.713 0.768 . . . . 0.0 110.262 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.448 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 80.0 t80 -44.64 126.16 5.34 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.244 -1.343 . . . . 0.0 111.253 167.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.413 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -115.13 -62.25 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 123.969 0.793 . . . . 0.0 110.889 -177.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -139.94 161.5 26.32 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -161.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 . . . . . 0 N--CA 1.486 1.362 0 CA-C-N 113.583 -1.308 . . . . 0.0 109.139 -171.555 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.02 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -134.11 158.92 42.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.006 0.817 . . . . 0.0 111.589 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -138.58 138.62 38.1 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.811 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -94.47 121.88 36.46 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.115 0.884 . . . . 0.0 109.894 171.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.84 119.87 6.94 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.848 167.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.02 -57.89 3.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.603 0.564 . . . . 0.0 109.889 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.97 156.98 25.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.38 1.05 . . . . 0.0 109.919 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.92 134.3 51.74 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.985 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -132.71 128.47 37.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 124.361 1.038 . . . . 0.0 110.208 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -89.58 168.25 12.3 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.662 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 145.95 25.06 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.311 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.87 -3.62 8.65 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.481 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -143.42 145.05 32.31 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.024 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.47 -15.14 2.42 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 114.981 -1.008 . . . . 0.0 113.29 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -74.64 -46.47 37.99 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.558 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 152.31 22.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.083 0.864 . . . . 0.0 109.893 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.59 -170.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 124.472 1.108 . . . . 0.0 109.577 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -95.19 106.34 18.35 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.52 -1.673 . . . . 0.0 108.715 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 1.8 mm? -88.98 143.14 27.06 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.646 172.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.52 -173.19 3.28 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.21 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mt -78.25 150.92 33.32 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.019 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.07 -3.47 1.61 Allowed Glycine 0 N--CA 1.506 3.347 0 O-C-N 123.413 0.446 . . . . 0.0 113.588 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.26 116.48 8.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 123.928 0.428 . . . . 0.0 109.95 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 mt -102.3 139.12 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.768 0.794 . . . . 0.0 110.019 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.44 HD21 ' CE2' ' A' ' 69' ' ' PHE . 10.2 mp -117.67 162.19 18.45 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 112.909 -1.951 . . . . 0.0 109.454 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.85 147.68 49.95 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 124.036 0.835 . . . . 0.0 108.833 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.7 -169.24 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 123.53 0.519 . . . . 0.0 109.829 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 . . . . . 0 N--CA 1.496 1.829 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.285 178.327 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.368 0.604 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.07 1.2 28.75 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.91 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -124.77 79.39 63.66 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.51 -31.08 80.39 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.814 1.676 . . . . 0.0 111.404 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.93 -39.25 39.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.538 1.149 . . . . 0.0 112.129 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -90.0 -31.95 16.98 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.126 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.7 mt -65.93 151.74 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 123.852 0.72 . . . . 0.0 110.452 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.5 -102.78 1.08 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -91.0 140.3 29.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.417 0.716 . . . . 0.0 110.885 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.495 HD11 ' CE2' ' A' ' 69' ' ' PHE . 97.9 mt -107.05 135.69 48.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.19 124.15 48.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 124.195 0.934 . . . . 0.0 108.778 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.27 -170.63 33.22 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.317 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -94.72 146.47 24.15 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.24 -0.98 . . . . 0.0 110.082 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.87 64.63 0.81 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.042 -1.436 . . . . 0.0 108.693 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -56.93 -23.9 48.6 Favored 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.755 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.6 m -53.44 -34.73 58.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.849 0.718 . . . . 0.0 111.594 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -108.89 -5.17 16.28 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.771 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.2 40.67 49.28 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -143.59 176.38 9.25 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -147.25 147.35 30.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 123.924 0.765 . . . . 0.0 109.168 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.87 -153.67 13.64 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.269 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.2 149.71 29.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.495 ' CE2' HD11 ' A' ' 56' ' ' LEU . 7.4 p90 -151.2 142.82 15.65 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.258 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.12 157.98 15.93 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.459 2.106 . . . . 0.0 112.874 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.2 28.57 14.04 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 124.39 1.056 . . . . 0.0 113.508 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.9 t -133.81 -3.03 2.91 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 117.202 0.501 . . . . 0.0 110.725 -170.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -121.33 -6.43 9.34 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 123.918 0.761 . . . . 0.0 111.275 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.48 178.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 124.139 0.899 . . . . 0.0 109.508 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -149.34 104.85 3.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.462 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 28.5 t80 -47.05 142.93 3.3 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.636 172.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -122.97 -51.71 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 124.313 1.008 . . . . 0.0 111.958 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.33 146.41 13.9 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.978 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.462 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 20.0 ptt-85 . . . . . 0 N--CA 1.496 1.866 0 CA-C-N 113.485 -1.357 . . . . 0.0 111.102 179.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.19 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -128.74 160.85 31.24 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.406 1.098 . . . . 0.0 112.394 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -148.93 118.92 7.14 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 112.542 -2.117 . . . . 0.0 105.288 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.01 124.21 38.93 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.37 114.25 1.74 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.005 0.816 . . . . 0.0 110.429 174.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 tp -78.5 -31.87 47.9 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.366 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.74 144.14 37.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.436 1.085 . . . . 0.0 108.889 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -64.3 108.65 1.65 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.159 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -113.75 136.99 52.25 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -89.7 -178.5 5.54 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -89.93 122.56 33.07 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.327 171.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -90.06 -7.77 53.07 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.945 0.778 . . . . 0.0 110.727 172.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -144.73 150.65 37.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 124.028 0.83 . . . . 0.0 109.648 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.62 -15.65 3.18 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.18 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.48 -41.29 27.8 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.931 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.33 168.24 18.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 123.691 0.619 . . . . 0.0 111.428 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.56 -164.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 124.144 0.902 . . . . 0.0 109.827 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -100.43 108.04 19.93 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.683 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.63 123.08 35.66 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 113.529 -1.668 . . . . 0.0 109.71 173.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.03 167.32 11.88 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.687 170.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mt -53.8 150.4 7.51 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.024 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.06 -14.05 3.03 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 114.969 -1.014 . . . . 0.0 114.345 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.87 117.35 6.25 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tp -94.73 148.65 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 123.915 0.759 . . . . 0.0 109.152 171.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.3 mp -121.98 135.27 54.84 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.5 m -122.04 140.2 52.78 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 124.143 0.902 . . . . 0.0 108.687 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.63 -175.45 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.973 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 121.459 0.647 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.6 -6.35 53.45 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.909 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.53 86.97 35.51 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.68 -6.1 10.03 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.721 2.281 . . . . 0.0 113.75 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -65.97 -35.8 81.59 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.485 0.491 . . . . 0.0 111.947 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -89.2 -28.16 20.16 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 123.678 0.611 . . . . 0.0 110.537 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.0 mt -80.3 141.3 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.8 -84.46 1.34 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -91.49 125.15 36.14 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 113.032 -1.584 . . . . 0.0 110.16 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.3 mp -102.68 131.17 49.66 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 168.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.96 122.31 40.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 168.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.89 -175.31 22.7 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.973 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -120.28 133.53 55.45 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.816 -0.692 . . . . 0.0 110.182 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -99.18 82.83 2.77 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 124.501 1.126 . . . . 0.0 109.132 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -48.05 -28.51 2.88 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.274 172.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 m -55.93 -49.16 74.25 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.022 0.826 . . . . 0.0 111.075 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.441 ' H ' ' HG1' ' A' ' 63' ' ' THR . 13.5 p -95.3 0.01 53.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.306 1.004 . . . . 0.0 110.303 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.95 45.56 96.34 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.455 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.85 174.39 10.7 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.358 0.681 . . . . 0.0 109.933 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -145.0 144.24 30.93 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.91 -175.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.28 -158.16 20.44 Favored Glycine 0 N--CA 1.493 2.484 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.749 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.15 168.96 8.99 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.736 -1.232 . . . . 0.0 110.289 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 17.7 p90 -164.16 144.7 6.6 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.912 170.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.8 160.47 40.62 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 121.975 1.783 . . . . 0.0 112.109 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.64 54.65 1.24 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.2 t -137.37 -29.84 0.87 Allowed 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -91.58 -6.05 53.01 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.396 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.19 167.69 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.599 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -139.06 127.05 22.33 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -49.86 144.07 6.89 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.403 167.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.77 -54.99 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 124.026 0.828 . . . . 0.0 111.107 175.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.86 152.76 23.68 Favored Glycine 0 N--CA 1.496 2.668 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.353 -165.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 O-C-N 124.486 0.756 . . . . 0.0 111.759 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.51 2.571 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -150.0 162.0 41.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.184 0.992 . . . . 0.0 111.815 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -131.8 140.0 49.06 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.126 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -90.97 124.51 35.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.79 0.681 . . . . 0.0 110.084 161.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.43 121.55 9.23 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.809 0.693 . . . . 0.0 111.258 165.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.35 -67.98 0.82 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.228 0.955 . . . . 0.0 109.627 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -94.59 137.26 33.92 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.367 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -68.55 91.2 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 124.13 0.894 . . . . 0.0 110.515 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -92.98 133.05 36.51 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.954 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -90.31 163.15 14.85 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.365 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -89.0 115.97 26.95 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.437 0.637 . . . . 0.0 111.611 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -89.08 -14.44 36.3 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.942 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.54 155.49 43.7 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.843 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -63.37 -26.21 68.65 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.852 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.08 -28.4 69.05 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.511 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.25 152.35 25.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.54 1.15 . . . . 0.0 110.812 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 pt -113.03 176.12 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.002 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -69.96 137.4 51.44 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.084 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.6 mt -126.99 90.41 3.15 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.5 166.3 10.53 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.751 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 28' ' ' ASP . 2.9 mt -64.92 162.13 17.05 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.28 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.41 -11.33 13.25 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.498 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 26' ' ' LEU . 1.3 m-20 -95.69 133.7 39.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.398 0.705 . . . . 0.0 109.587 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.65 143.73 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.963 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.2 mp -106.32 139.51 40.7 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.67 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.2 m -112.1 144.82 40.83 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 123.871 0.732 . . . . 0.0 110.508 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.68 173.51 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 123.951 0.782 . . . . 0.0 110.686 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 t30 . . . . . 0 N--CA 1.502 2.128 0 CA-C-N 114.409 -1.269 . . . . 0.0 114.106 175.869 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.504 2.272 0 CA-C-O 122.61 1.195 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.87 -7.77 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 113.208 -1.815 . . . . 0.0 111.221 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -124.26 75.2 60.48 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 124.113 0.883 . . . . 0.0 111.388 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.2 -11.54 10.74 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.221 1.947 . . . . 0.0 113.56 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -65.95 -40.64 91.51 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.089 0.868 . . . . 0.0 111.543 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -91.38 -21.33 21.05 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 123.769 0.668 . . . . 0.0 112.002 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.4 mt -82.77 145.83 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.29 -88.16 1.24 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -89.76 145.26 25.32 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 113.608 -1.296 . . . . 0.0 109.9 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.2 mp -124.04 125.46 44.57 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.405 166.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.94 119.28 32.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 123.891 0.744 . . . . 0.0 109.079 168.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.13 -165.31 10.62 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 171.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.8 134.99 34.15 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -96.77 76.08 2.77 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -43.16 -33.23 0.86 Allowed 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 113.97 -1.468 . . . . 0.0 112.929 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.5 m -55.21 -49.59 71.56 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 124.208 0.943 . . . . 0.0 111.336 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.4 p -93.37 -4.34 51.67 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.148 0.905 . . . . 0.0 110.888 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.85 60.07 8.67 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 123.884 0.74 . . . . 0.0 111.329 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.58 154.56 45.51 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.343 0.672 . . . . 0.0 109.314 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -127.87 135.21 49.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.328 1.017 . . . . 0.0 108.446 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.92 -168.68 39.12 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.18 -1.486 . . . . 0.0 112.69 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -108.02 165.76 11.23 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.149 -1.525 . . . . 0.0 109.181 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.6 p90 -160.03 143.23 10.23 Favored Pre-proline 0 N--CA 1.494 1.725 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.379 175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.76 155.54 68.69 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.967 1.778 . . . . 0.0 110.937 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.05 49.64 3.58 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.0 t -129.97 -28.84 2.14 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -96.82 13.53 28.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 124.193 0.933 . . . . 0.0 111.537 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.28 178.71 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 114.67 -1.15 . . . . 0.0 107.926 -170.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -150.63 116.63 5.59 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -51.58 127.3 19.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 123.856 0.722 . . . . 0.0 109.883 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.66 -55.99 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 124.598 1.187 . . . . 0.0 109.757 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.95 161.83 35.37 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 118.643 -1.741 . . . . 0.0 112.237 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-N 112.117 -2.042 . . . . 0.0 110.486 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.509 2.504 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -128.03 163.12 25.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 124.641 1.213 . . . . 0.0 111.839 -168.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -140.59 124.22 17.05 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 112.3 -2.227 . . . . 0.0 105.68 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -91.89 124.66 36.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.1 118.5 5.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 124.162 0.914 . . . . 0.0 110.692 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -60.75 2.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 124.02 0.825 . . . . 0.0 109.213 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.31 168.94 9.31 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.309 1.006 . . . . 0.0 110.228 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.7 123.88 30.88 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.349 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -121.97 138.91 54.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.45 172.52 8.94 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.421 ' H ' ' CD ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -89.74 144.52 25.9 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.136 172.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -134.44 -9.54 2.51 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.683 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -141.0 146.65 37.54 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.997 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.8 -17.58 9.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.461 1.101 . . . . 0.0 113.318 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -71.34 -51.07 26.29 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.383 -1.281 . . . . 0.0 111.693 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.41 153.31 21.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.135 0.897 . . . . 0.0 109.606 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pt -114.39 174.59 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 124.378 1.049 . . . . 0.0 110.93 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.75 130.17 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.719 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.66 124.33 44.96 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.579 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 172.75 11.61 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.835 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.95 150.56 48.45 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.028 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.66 -10.27 18.82 Favored Glycine 0 N--CA 1.5 2.909 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.431 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.02 110.14 1.49 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 tp -90.2 155.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mp -129.23 143.69 50.95 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.184 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.8 m -128.18 143.0 51.01 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.08 -125.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.435 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 CA-C-N 118.234 0.47 . . . . 0.0 111.136 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.512 2.629 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -162.56 -6.1 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.04 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -128.13 76.25 78.0 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 123.917 0.761 . . . . 0.0 110.048 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.93 -16.07 19.2 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.294 1.996 . . . . 0.0 113.514 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -59.7 -47.04 87.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 123.926 0.766 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -89.72 -31.61 17.38 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 123.957 0.785 . . . . 0.0 110.033 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.1 mt -66.49 143.63 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 123.803 0.689 . . . . 0.0 109.643 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.45 -97.78 1.07 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -93.48 135.99 34.19 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.239 -0.981 . . . . 0.0 109.834 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.4 mp -117.58 147.68 42.6 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.796 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.29 130.32 56.47 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.349 1.03 . . . . 0.0 108.223 176.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.44 169.96 36.34 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.55 -1.309 . . . . 0.0 112.999 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -90.73 141.1 29.15 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.17 -1.015 . . . . 0.0 109.102 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -105.49 72.56 0.98 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.442 1.089 . . . . 0.0 109.933 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -44.3 -33.78 1.72 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.291 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 m -51.72 -47.73 63.87 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 124.115 0.884 . . . . 0.0 111.975 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.8 -4.66 23.3 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.849 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.48 47.67 85.18 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -119.05 178.34 4.54 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.154 -1.023 . . . . 0.0 109.61 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -150.12 136.47 18.89 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.56 -153.89 13.54 Favored Glycine 0 N--CA 1.5 2.928 0 C-N-CA 118.916 -1.611 . . . . 0.0 113.538 165.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.79 158.29 17.1 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -172.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.5 p90 -159.53 143.84 11.06 Favored Pre-proline 0 N--CA 1.489 1.5 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.788 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.59 154.32 71.78 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.941 1.761 . . . . 0.0 111.539 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.69 19.53 19.75 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 124.128 0.893 . . . . 0.0 112.648 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.54 -32.4 7.71 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.268 0.556 . . . . 0.0 111.237 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -89.62 -0.31 57.43 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.064 -175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.23 -178.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 124.194 0.934 . . . . 0.0 109.283 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -146.61 122.0 10.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 45.1 t80 -55.0 120.98 7.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 124.034 0.834 . . . . 0.0 108.98 168.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -90.85 -54.98 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.372 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -169.9 157.76 29.47 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.391 -1.385 . . . . 0.0 111.507 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.949 0 CA-C-N 114.52 -0.84 . . . . 0.0 111.608 171.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.184 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -120.14 159.93 23.9 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.754 0.788 . . . . 0.0 112.593 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -140.13 132.04 27.66 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.235 -1.802 . . . . 0.0 107.433 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -89.76 123.77 34.05 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 170.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.59 126.74 14.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.508 1.13 . . . . 0.0 111.752 164.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 tp -80.45 -36.55 33.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.099 0.874 . . . . 0.0 110.121 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -145.49 165.1 29.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.185 0.928 . . . . 0.0 110.795 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.03 121.16 23.13 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.393 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -128.47 128.48 44.46 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.227 0.954 . . . . 0.0 109.423 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.32 159.51 15.23 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.604 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.34 150.21 22.67 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 123.772 0.67 . . . . 0.0 109.928 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -123.73 -9.79 7.83 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.021 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -139.62 153.35 47.33 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.904 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.91 -11.21 7.2 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.392 -1.276 . . . . 0.0 113.355 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -80.45 -35.02 35.5 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.374 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -98.6 177.61 5.26 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 124.158 0.911 . . . . 0.0 111.039 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 pt -141.23 172.75 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.086 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.83 128.76 33.79 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.979 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.3 mt -127.78 140.39 52.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.971 0.794 . . . . 0.0 109.998 -173.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.27 -173.5 3.68 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.078 -176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 28' ' ' ASP . 4.3 mt -75.52 152.48 37.81 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.663 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.36 -7.87 1.72 Allowed Glycine 0 N--CA 1.498 2.82 0 CA-C-N 114.97 -1.014 . . . . 0.0 114.006 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 26' ' ' LEU . 1.2 m-20 -60.82 106.52 0.58 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 mt -98.77 126.88 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 172.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.63 158.07 16.96 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 112.56 -2.109 . . . . 0.0 108.539 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 m -134.42 147.09 50.38 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -172.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.1 -166.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 m120 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.998 0.904 . . . . 0.0 111.681 173.233 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.18 11.3 1.93 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.291 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.15 76.68 78.82 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 123.604 0.565 . . . . 0.0 109.532 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.26 -16.88 56.69 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.119 1.879 . . . . 0.0 112.731 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -67.09 -37.3 83.7 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 123.896 0.747 . . . . 0.0 110.945 -172.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.81 -33.79 16.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 124.184 0.928 . . . . 0.0 110.104 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.9 mt -64.97 149.1 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 124.152 0.908 . . . . 0.0 109.823 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.43 -103.86 1.09 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -89.88 137.5 32.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 124.632 0.842 . . . . 0.0 110.348 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.45 HD11 ' CE2' ' A' ' 69' ' ' PHE . 64.7 mt -106.4 131.65 53.35 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 113.934 -1.484 . . . . 0.0 107.721 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.77 117.44 34.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.009 0.818 . . . . 0.0 109.483 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.91 172.58 35.11 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.299 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.84 149.3 22.01 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.477 -0.861 . . . . 0.0 109.997 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -124.42 61.1 1.14 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.89 -22.68 5.79 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.064 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -53.01 -50.48 64.14 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.001 0.813 . . . . 0.0 111.084 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.42 ' H ' ' HG1' ' A' ' 63' ' ' THR . 5.4 p -94.2 3.28 55.47 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.476 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.51 29.42 74.77 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -123.9 173.89 7.91 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -150.45 147.48 27.59 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.79 -154.78 19.44 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.092 171.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.37 155.11 16.87 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.661 -0.769 . . . . 0.0 109.364 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.45 ' CE2' HD11 ' A' ' 56' ' ' LEU . 11.8 p90 -157.25 142.34 12.28 Favored Pre-proline 0 N--CA 1.498 1.952 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.846 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.69 151.09 49.35 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.253 1.969 . . . . 0.0 111.899 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.25 -4.39 77.62 Favored Glycine 0 N--CA 1.498 2.817 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.436 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.3 t -104.19 1.36 30.56 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 116.801 0.3 . . . . 0.0 111.345 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.35 -9.46 16.76 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 123.747 0.655 . . . . 0.0 111.988 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 m -119.3 -172.12 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 124.134 0.896 . . . . 0.0 108.983 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -150.13 124.47 9.55 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -49.78 131.57 22.03 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 124.116 0.885 . . . . 0.0 109.913 168.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.74 -53.68 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 124.359 1.037 . . . . 0.0 109.393 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.73 171.18 40.11 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-N 114.52 -0.84 . . . . 0.0 109.368 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.405 ' CZ ' ' O ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.193 0 CA-C-O 121.466 0.651 . . . . 0.0 111.481 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -133.09 166.08 23.26 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.393 -169.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -139.92 141.39 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -105.66 120.52 41.88 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.341 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.78 114.91 1.57 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.312 1.007 . . . . 0.0 111.596 168.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -63.54 1.36 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.301 176.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -103.62 143.19 33.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.05 0.844 . . . . 0.0 110.26 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.43 118.65 9.7 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 124.4 1.062 . . . . 0.0 111.164 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -129.42 128.32 42.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 124.564 1.165 . . . . 0.0 108.999 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -89.57 171.42 9.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -89.01 136.17 33.16 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -124.68 -7.66 7.38 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.719 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.65 142.81 50.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 124.258 0.974 . . . . 0.0 109.246 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -10.35 1.78 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.537 172.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.53 -37.5 13.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.053 0.845 . . . . 0.0 111.204 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -86.98 145.43 26.51 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 123.833 0.708 . . . . 0.0 110.471 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pt -99.58 -179.88 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 124.067 0.854 . . . . 0.0 111.8 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -79.73 138.9 37.45 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.207 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -126.95 130.03 49.3 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.652 -1.613 . . . . 0.0 108.408 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.25 33.31 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.28 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -53.84 149.27 8.97 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.01 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.84 -14.4 10.47 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.375 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.54 117.79 9.23 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.68 148.99 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 123.947 0.779 . . . . 0.0 109.431 167.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.6 mp -121.95 154.35 37.29 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.8 m -137.26 145.16 43.21 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 123.471 0.482 . . . . 0.0 109.951 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -122.14 -145.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 124.269 0.981 . . . . 0.0 108.487 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.405 ' O ' ' CZ ' ' A' ' 6' ' ' TYR . 5.0 m-80 . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 120.665 0.269 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.59 5.1 39.07 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.826 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -126.98 76.47 75.89 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 123.767 0.667 . . . . 0.0 109.395 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.25 -3.84 6.88 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.329 2.02 . . . . 0.0 113.732 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -71.36 -43.31 67.16 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.806 0.691 . . . . 0.0 110.985 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.68 -24.68 21.54 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.391 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.74 143.02 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.56 -91.0 1.21 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -94.81 123.43 38.26 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.767 -1.217 . . . . 0.0 110.455 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.4 mp -95.63 172.68 7.91 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.756 171.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.17 107.44 4.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -175.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.53 -176.78 23.84 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.513 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . 0.402 ' CZ ' ' HD2' ' A' ' 66' ' ' ARG . 6.8 m-85 -106.81 153.27 22.72 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.295 -0.953 . . . . 0.0 110.234 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -123.99 60.77 1.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.849 -1.523 . . . . 0.0 107.486 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -42.86 -36.33 1.46 Allowed 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.954 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 p -49.55 -54.58 17.29 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.514 1.134 . . . . 0.0 113.756 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -93.76 3.21 55.78 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.627 0.58 . . . . 0.0 111.29 172.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.23 17.46 56.05 Favored Glycine 0 N--CA 1.496 2.668 0 O-C-N 123.845 0.715 . . . . 0.0 112.227 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.5 167.94 10.84 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.402 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 4.3 ptm180 -150.24 148.82 29.35 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.229 0.538 . . . . 0.0 110.246 175.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.2 -156.41 28.0 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.243 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.93 160.89 15.41 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -169.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 27.8 p90 -159.87 149.93 15.0 Favored Pre-proline 0 N--CA 1.498 1.933 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.499 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.75 146.17 87.9 Favored 'Trans proline' 0 N--CA 1.487 1.103 0 C-N-CA 122.064 1.843 . . . . 0.0 112.03 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.59 7.18 82.55 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 123.83 0.706 . . . . 0.0 112.297 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -23.95 15.57 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 176.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -89.83 -9.62 48.43 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.376 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 m -122.95 -178.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 124.491 1.12 . . . . 0.0 108.334 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -149.61 120.57 7.67 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -48.73 127.62 14.01 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 165.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -94.27 -62.39 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 124.225 0.953 . . . . 0.0 109.442 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.16 158.02 28.81 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -165.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 CA-C-N 114.206 -0.997 . . . . 0.0 110.726 169.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -133.1 162.9 30.49 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 124.301 1.001 . . . . 0.0 111.992 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -143.76 135.97 26.75 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.294 -1.776 . . . . 0.0 107.082 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.73 125.17 49.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 124.276 0.985 . . . . 0.0 108.862 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.5 149.64 5.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 123.879 0.737 . . . . 0.0 110.873 168.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 tp -121.48 -25.58 5.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 123.974 0.796 . . . . 0.0 111.075 -175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.04 146.78 27.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.038 0.836 . . . . 0.0 110.294 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.39 118.55 6.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.507 1.13 . . . . 0.0 110.55 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -120.6 135.98 54.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 124.778 1.299 . . . . 0.0 108.82 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -89.81 157.03 18.11 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.406 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -88.58 149.82 23.38 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.84 -19.56 2.6 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.312 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.23 147.25 35.41 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.163 -1.381 . . . . 0.0 110.051 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.81 -21.33 64.32 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.158 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.16 -12.28 57.1 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.69 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.97 147.79 30.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 124.091 0.87 . . . . 0.0 110.849 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.22 -175.26 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.483 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -88.73 129.15 35.6 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.445 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.5 mt -114.02 135.95 53.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.016 0.822 . . . . 0.0 111.007 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.49 -173.91 3.2 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.089 -176.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 28' ' ' ASP . 6.7 mt -84.92 158.06 20.67 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.687 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.64 -5.27 2.45 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.137 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -68.86 147.41 51.76 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.075 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 tt -132.57 150.14 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 124.101 0.876 . . . . 0.0 111.358 172.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mp -121.77 152.83 39.04 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.149 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.3 m -135.04 149.35 50.11 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.914 0.759 . . . . 0.0 110.449 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.3 t -127.67 -153.99 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 123.959 0.787 . . . . 0.0 109.002 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.423 -179.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 121.247 0.546 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.74 -4.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.855 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -126.86 79.27 72.65 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 123.942 0.776 . . . . 0.0 110.499 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.82 -7.96 5.2 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.237 1.958 . . . . 0.0 113.514 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -48.56 45.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.2 -23.21 21.34 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 123.822 0.701 . . . . 0.0 111.024 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.78 143.37 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.26 -99.68 1.04 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -89.99 133.49 34.78 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.376 -0.912 . . . . 0.0 110.343 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -109.28 156.47 19.91 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.414 171.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.08 124.65 31.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.32 -179.24 29.47 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.073 -1.06 . . . . 0.0 111.498 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -95.85 126.7 41.28 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.52 -1.34 . . . . 0.0 109.483 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -90.3 85.02 6.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 124.459 1.099 . . . . 0.0 109.896 173.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -47.48 -32.87 5.61 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.952 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -55.88 -47.01 78.15 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.298 0.999 . . . . 0.0 111.423 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -105.03 5.38 32.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.228 0.955 . . . . 0.0 109.651 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.66 53.72 37.34 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 124.292 0.995 . . . . 0.0 111.42 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -138.93 173.21 11.8 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -172.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -129.11 118.87 23.18 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.45 -171.05 23.83 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 118.953 -1.594 . . . . 0.0 113.224 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -103.25 162.16 13.21 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 113.646 -1.277 . . . . 0.0 109.603 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -159.66 140.86 9.3 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.215 176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.61 152.44 74.63 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.647 1.564 . . . . 0.0 110.406 176.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.75 26.11 2.83 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.984 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.467 ' HG1' ' H ' ' A' ' 73' ' ' TYR . 7.5 p -96.57 -51.91 4.14 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.276 0.56 . . . . 0.0 111.729 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . 0.467 ' H ' ' HG1' ' A' ' 72' ' ' THR . 22.9 m-85 -90.48 25.65 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.156 -1.383 . . . . 0.0 110.847 -170.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.47 158.7 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -172.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -138.07 112.48 8.73 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -46.77 116.48 1.34 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.448 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.83 -56.98 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.522 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.49 175.85 38.88 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.459 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-N 113.973 -1.114 . . . . 0.0 110.383 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.228 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -128.87 164.1 23.83 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.785 0.803 . . . . 0.0 112.737 -171.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -139.03 133.46 31.69 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 113.414 -1.721 . . . . 0.0 107.926 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -90.65 113.49 25.55 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.37 128.2 30.62 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.136 167.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.01 -71.01 0.75 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.036 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -90.34 145.99 24.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 123.86 0.725 . . . . 0.0 110.045 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.97 125.07 23.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.126 0.891 . . . . 0.0 110.52 177.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -127.84 133.15 49.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.41 1.069 . . . . 0.0 109.374 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -90.01 160.94 16.1 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.346 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 160.83 16.73 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 123.952 0.783 . . . . 0.0 110.224 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.64 -50.43 4.06 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.899 0.857 . . . . 0.0 110.5 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.439 ' HG3' ' H ' ' A' ' 20' ' ' GLU . 6.8 ptp180 -150.27 -166.04 2.44 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 112.82 -1.991 . . . . 0.0 110.437 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -61.5 2.87 0.15 Allowed 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . 0.439 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 28.5 tt0 -85.07 -36.99 20.83 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 123.246 0.341 . . . . 0.0 110.38 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.13 163.77 18.92 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.669 -174.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.25 -175.93 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 124.515 1.134 . . . . 0.0 110.294 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -83.6 129.09 34.96 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 112.612 -2.085 . . . . 0.0 107.474 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.4 mt -122.75 133.19 54.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.167 0.917 . . . . 0.0 110.415 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.22 171.32 14.33 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.053 -174.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.437 ' CD1' ' H ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -72.7 151.22 42.31 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.401 -172.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.89 -12.93 15.25 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.111 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 26' ' ' LEU . 2.9 m-20 -69.89 141.73 53.1 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.048 0.499 . . . . 0.0 110.206 173.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 mt -117.1 141.32 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 124.512 1.133 . . . . 0.0 110.01 172.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.43 150.15 27.09 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 112.748 -2.024 . . . . 0.0 109.233 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.4 m -128.22 138.98 52.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.19 0.931 . . . . 0.0 110.753 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 t -107.76 -155.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 124.367 1.042 . . . . 0.0 108.887 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 . . . . . 0 N--CA 1.488 1.449 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.57 173.97 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 122.109 0.957 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.04 -18.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.38 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -116.25 87.32 19.47 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 124.234 0.959 . . . . 0.0 108.996 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.77 -6.23 3.22 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.535 2.157 . . . . 0.0 113.407 173.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.87 -39.48 87.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 123.651 0.594 . . . . 0.0 111.062 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -90.31 -19.87 23.57 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.127 0.892 . . . . 0.0 110.057 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mt -96.04 129.73 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 123.914 0.759 . . . . 0.0 109.782 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.62 -78.69 1.33 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -90.96 133.16 35.5 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.273 -1.464 . . . . 0.0 110.252 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.3 mp -120.75 125.44 47.63 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 172.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -90.0 120.32 31.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 123.926 0.766 . . . . 0.0 109.559 168.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.91 -163.68 9.6 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.386 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -139.99 123.52 17.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.59 88.45 7.42 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.32 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -53.93 -38.17 64.61 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.199 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -52.02 -47.29 65.08 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.252 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.403 ' H ' ' HG1' ' A' ' 63' ' ' THR . 30.1 p -91.28 -4.82 55.54 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 123.992 0.808 . . . . 0.0 109.836 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.45 36.08 62.81 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 124.325 1.015 . . . . 0.0 111.836 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -135.98 134.37 38.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.231 0.606 . . . . 0.0 110.227 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -89.55 155.45 19.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.341 1.026 . . . . 0.0 109.115 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.86 -161.49 35.2 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.132 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.06 166.33 12.12 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 113.891 -1.154 . . . . 0.0 109.228 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.1 p90 -162.58 140.04 6.27 Favored Pre-proline 0 N--CA 1.496 1.847 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.311 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.14 166.86 13.6 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.875 1.716 . . . . 0.0 112.027 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.15 48.05 1.03 Allowed Glycine 0 N--CA 1.496 2.644 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.599 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -138.39 -28.15 0.85 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.19 0.582 . . . . 0.0 112.507 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -90.92 1.62 56.87 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.319 1.012 . . . . 0.0 110.976 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.49 -174.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 124.293 0.996 . . . . 0.0 108.924 -176.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.39 127.97 11.55 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.621 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.485 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 22.5 t80 -60.56 133.5 56.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.685 176.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.08 -60.57 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 124.339 1.025 . . . . 0.0 110.361 176.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.92 148.0 15.91 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -163.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.485 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-N 112.803 -1.698 . . . . 0.0 109.734 173.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -100.29 157.59 16.49 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.523 0.677 . . . . 0.0 110.859 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -143.99 124.97 14.35 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -90.6 120.9 32.06 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.67 121.12 6.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 123.974 0.796 . . . . 0.0 110.773 168.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.14 -46.42 42.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.018 0.824 . . . . 0.0 109.558 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.84 174.75 10.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.36 1.038 . . . . 0.0 110.152 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.25 133.33 35.99 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.089 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 16' ' ' LYS . 8.9 t80 -120.81 108.5 14.03 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 79.29 2.32 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.938 -171.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 31.3 mmtm -142.53 170.7 15.21 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.487 1.136 . . . . 0.0 111.44 170.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -151.45 60.98 0.89 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.804 -166.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -89.67 159.26 17.21 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -60.84 -17.06 47.73 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.133 0.492 . . . . 0.0 111.156 -176.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -105.12 -29.33 10.45 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.555 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -99.92 165.52 11.51 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 123.652 0.595 . . . . 0.0 111.311 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 pt -138.61 173.37 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.083 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -79.51 131.4 36.03 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.11 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 mt -128.87 137.28 51.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.728 1.267 . . . . 0.0 109.429 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 -179.62 5.55 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.2 mt -63.27 151.1 41.54 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.577 171.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.47 -10.55 6.37 Favored Glycine 0 N--CA 1.496 2.683 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.611 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.17 116.5 4.61 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.142 177.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.6 144.04 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.389 0.614 . . . . 0.0 109.418 174.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 mp -125.22 153.65 42.81 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.063 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.4 m -137.14 132.36 33.89 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.8 t -105.98 168.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m120 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 123.902 0.751 . . . . 0.0 112.874 176.231 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.504 2.248 0 CA-C-O 121.522 0.677 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.36 -5.11 0.23 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.503 -173.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -119.16 85.23 29.53 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 124.471 1.107 . . . . 0.0 109.138 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.14 -2.26 5.51 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.151 2.567 . . . . 0.0 113.687 169.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -73.37 -15.83 61.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 123.684 0.615 . . . . 0.0 111.928 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -125.06 -33.86 2.84 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 123.602 0.564 . . . . 0.0 111.194 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.33 146.26 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 123.92 0.763 . . . . 0.0 110.433 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.28 -94.64 1.1 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -95.43 136.29 35.99 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.286 -0.957 . . . . 0.0 110.584 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.4 mp -115.96 138.23 51.39 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.207 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -107.96 118.83 37.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.89 165.91 30.28 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.453 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.2 143.25 26.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.039 0.494 . . . . 0.0 110.182 176.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -116.09 68.48 0.73 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.135 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -47.05 -31.71 3.51 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 114.123 -1.399 . . . . 0.0 114.088 172.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.9 m -50.37 -49.03 55.45 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.531 1.144 . . . . 0.0 111.187 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.9 p -98.03 -2.74 39.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.25 0.969 . . . . 0.0 110.55 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.62 32.27 81.02 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -122.95 176.35 6.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 124.461 0.742 . . . . 0.0 109.244 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -145.69 145.32 30.84 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.03 0.831 . . . . 0.0 109.114 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.28 -156.19 22.86 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.036 -1.554 . . . . 0.0 113.264 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.74 153.91 19.38 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 35.6 p90 -155.18 141.55 13.14 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 123.619 0.575 . . . . 0.0 109.673 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.82 142.02 67.86 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.828 1.685 . . . . 0.0 111.088 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.67 -22.86 78.76 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 124.012 0.82 . . . . 0.0 111.874 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.4 p -72.45 -6.37 43.15 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.035 -0.082 . . . . 0.0 111.025 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -109.73 -6.35 15.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 123.979 0.799 . . . . 0.0 111.785 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.37 -177.21 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 123.933 0.771 . . . . 0.0 109.028 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.6 123.18 11.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 124.348 1.03 . . . . 0.0 108.948 175.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -56.26 127.16 29.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.355 1.034 . . . . 0.0 109.572 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.46 -55.08 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 123.874 0.734 . . . . 0.0 110.897 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -146.97 161.23 28.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 107.139 -2.385 . . . . 0.0 107.139 -164.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 C-N-CA 119.228 -0.989 . . . . 0.0 112.278 169.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -133.8 155.88 49.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 123.885 0.741 . . . . 0.0 110.216 -166.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -140.39 125.71 18.81 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.619 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -90.89 126.31 36.01 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.75 126.26 23.36 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.705 0.628 . . . . 0.0 111.317 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.24 -35.77 18.33 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.178 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 146.19 38.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.81 0.694 . . . . 0.0 110.224 -175.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.55 120.91 13.76 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.307 172.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -125.79 132.42 52.28 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.082 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -90.16 157.14 17.88 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.94 137.36 32.39 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.788 0.68 . . . . 0.0 109.727 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -119.9 -2.51 10.3 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.69 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 141.7 49.48 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.145 0.903 . . . . 0.0 109.729 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.44 -17.27 62.51 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.923 171.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.53 -31.22 21.39 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.637 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.68 144.58 27.74 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 123.641 0.588 . . . . 0.0 109.49 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pt -104.67 171.75 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 124.3 1.0 . . . . 0.0 111.332 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.24 149.34 47.56 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.77 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.1 mt -135.04 142.15 46.31 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.124 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.1 170.08 17.4 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 28' ' ' ASP . 1.6 mt -70.89 153.5 42.65 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.05 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.41 -7.75 1.27 Allowed Glycine 0 N--CA 1.505 3.234 0 O-C-N 123.537 0.523 . . . . 0.0 113.331 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 26' ' ' LEU . 26.0 t70 -68.95 109.12 3.78 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.526 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -89.04 149.9 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mp -130.62 157.2 43.38 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 124.509 1.131 . . . . 0.0 111.041 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -136.83 141.5 42.86 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 123.782 0.676 . . . . 0.0 110.949 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.403 ' CG1' ' H ' ' A' ' 33' ' ' ASN . 2.3 t -116.4 -147.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.403 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 120.844 0.354 . . . . 0.0 110.735 -175.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.511 2.607 0 CA-C-O 121.858 0.837 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.0 -12.21 0.1 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.031 -173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -120.23 81.5 29.46 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 123.873 0.733 . . . . 0.0 110.198 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.88 -26.63 68.25 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.216 1.944 . . . . 0.0 112.368 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -47.27 -47.04 25.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.883 1.364 . . . . 0.0 111.501 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.63 -37.06 13.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.383 1.052 . . . . 0.0 110.597 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.9 mt -60.5 143.19 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 123.624 0.578 . . . . 0.0 110.081 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.46 -79.48 1.33 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -169.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -115.09 129.87 56.79 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 112.694 -1.753 . . . . 0.0 109.189 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.443 ' HG ' ' CZ ' ' A' ' 69' ' ' PHE . 1.0 OUTLIER -130.19 143.64 50.9 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.92 173.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -90.05 145.05 25.36 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.713 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.97 160.03 30.07 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -113.66 125.35 54.05 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -101.79 88.09 3.3 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.231 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -47.85 -36.85 12.66 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 113.608 -1.633 . . . . 0.0 111.977 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -42.39 98.59 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -90.74 0.81 57.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 123.793 0.683 . . . . 0.0 109.432 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.01 22.87 13.76 Favored Glycine 0 N--CA 1.497 2.72 0 O-C-N 124.459 1.099 . . . . 0.0 112.315 -168.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -121.74 155.67 34.75 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.76 150.54 47.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.621 1.201 . . . . 0.0 109.698 -174.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.78 -159.15 30.45 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.011 -1.09 . . . . 0.0 111.216 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.07 144.33 44.77 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -165.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.443 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 33.4 p90 -145.29 151.8 48.74 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 124.375 1.047 . . . . 0.0 108.914 -174.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -66.06 165.74 23.09 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.094 1.863 . . . . 0.0 111.779 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.15 60.4 0.4 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -147.71 -24.91 0.37 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -102.18 15.29 29.57 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 124.08 0.863 . . . . 0.0 111.264 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.5 177.81 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.014 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -148.26 116.3 6.44 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.527 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 15.5 t80 -47.81 143.34 4.1 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.757 165.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.53 -49.1 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 124.371 1.044 . . . . 0.0 111.752 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.84 150.21 22.25 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.333 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.527 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 1.1 ppt_? . . . . . 0 N--CA 1.499 1.995 0 CA-C-N 113.833 -1.183 . . . . 0.0 111.97 179.055 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.431 ' HH ' ' ND2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.232 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -123.51 157.94 32.44 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.05 0.929 . . . . 0.0 113.313 -173.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -140.43 121.35 14.55 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 112.397 -2.183 . . . . 0.0 107.486 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.2 ttt-85 -89.82 125.14 35.21 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.17 127.49 32.09 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 124.275 0.985 . . . . 0.0 110.742 171.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tp -92.52 -68.43 0.8 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.074 0.859 . . . . 0.0 109.527 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -98.2 144.52 27.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.028 0.83 . . . . 0.0 109.713 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -62.05 129.31 40.25 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.659 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -129.92 133.43 46.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.551 1.157 . . . . 0.0 108.846 175.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -90.01 154.33 19.9 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.971 0.794 . . . . 0.0 109.951 171.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.62 142.08 28.01 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.929 -177.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -89.4 -30.42 18.37 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.682 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -150.35 176.93 10.45 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.49 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.46 -18.39 28.27 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.661 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -69.1 -34.46 75.13 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.137 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.65 153.24 22.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.381 1.051 . . . . 0.0 109.406 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 pt -111.39 173.07 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 124.471 1.107 . . . . 0.0 110.534 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.57 132.91 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.186 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.8 mt -121.34 127.02 50.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 124.55 1.156 . . . . 0.0 109.866 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.443 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -132.83 172.7 12.23 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.302 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.07 150.98 44.3 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.156 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.05 -13.86 8.65 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.991 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.19 118.28 6.17 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.19 151.09 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.714 0.769 . . . . 0.0 109.295 170.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 mp -127.71 150.84 49.6 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.388 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.3 m -132.4 146.99 52.36 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 123.822 0.701 . . . . 0.0 109.443 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.37 -147.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.431 ' ND2' ' HH ' ' A' ' 6' ' ' TYR . 9.9 p-10 . . . . . 0 N--CA 1.493 1.694 0 O-C-N 123.768 0.668 . . . . 0.0 111.773 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.503 2.206 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.87 -22.33 0.07 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.023 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -116.29 81.97 11.25 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 124.23 0.956 . . . . 0.0 110.753 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.92 -8.76 6.48 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.373 2.049 . . . . 0.0 113.264 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -70.0 -37.78 75.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.85 0.719 . . . . 0.0 111.329 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -89.68 -27.82 19.86 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 123.933 0.771 . . . . 0.0 110.779 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.7 mt -76.68 140.78 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 123.923 0.764 . . . . 0.0 109.07 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.71 -91.76 1.2 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -175.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -98.18 123.27 42.16 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.701 -1.25 . . . . 0.0 109.503 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.6 mp -99.95 164.27 12.08 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.256 174.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.438 HD21 ' N ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -137.4 126.69 24.74 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . 0.438 ' N ' HD21 ' A' ' 57' ' ' ASN . . . -156.36 175.82 33.92 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.247 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -99.59 125.17 45.35 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.87 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -89.63 84.27 6.33 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.22 0.95 . . . . 0.0 109.872 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -56.94 -34.82 68.39 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.116 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.4 m -54.57 -38.63 66.9 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.03 0.831 . . . . 0.0 111.87 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.422 ' H ' ' HG1' ' A' ' 63' ' ' THR . 40.1 p -99.77 -4.36 30.79 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.808 0.693 . . . . 0.0 111.564 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.92 29.84 76.42 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -136.35 170.41 16.08 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -136.51 150.7 48.8 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.08 0.863 . . . . 0.0 109.251 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.65 -163.69 31.16 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.819 -1.182 . . . . 0.0 111.808 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.95 153.48 22.49 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.513 -0.843 . . . . 0.0 109.552 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.4 p90 -150.89 146.67 19.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.285 -176.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -66.59 150.08 83.98 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 121.787 1.658 . . . . 0.0 110.431 175.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.25 23.59 11.33 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 124.078 0.861 . . . . 0.0 111.971 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.41 ' H ' ' HG1' ' A' ' 72' ' ' THR . 0.6 OUTLIER -106.98 -34.67 7.12 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.052 0.453 . . . . 0.0 111.23 177.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -89.92 14.91 10.93 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.193 -174.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.26 171.69 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.218 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -145.9 123.2 11.58 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.48 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 41.8 t80 -48.97 149.06 2.0 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.974 0.796 . . . . 0.0 109.677 170.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.79 -54.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 124.015 0.822 . . . . 0.0 111.336 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.92 146.23 15.43 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.802 -168.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.48 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-N 113.138 -1.531 . . . . 0.0 110.839 178.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.006 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -145.38 165.57 28.09 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 122.437 1.113 . . . . 0.0 113.121 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -142.91 151.55 41.12 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 112.285 -2.234 . . . . 0.0 107.064 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -119.1 115.47 24.34 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.34 121.21 7.15 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.484 171.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tp -93.79 -43.4 8.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.508 1.13 . . . . 0.0 110.235 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.43 143.54 45.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.578 1.174 . . . . 0.0 110.342 -177.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.88 117.47 20.0 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.304 -1.317 . . . . 0.0 109.787 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -120.58 131.24 54.56 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -89.1 156.24 18.95 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.652 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -89.19 132.73 34.72 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.622 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -112.51 -13.9 13.29 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.138 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 -129.42 149.33 51.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 124.417 1.073 . . . . 0.0 110.387 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.07 -12.59 61.82 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.878 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -80.09 -19.78 46.64 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.116 0.885 . . . . 0.0 111.514 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.55 159.71 16.85 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.012 0.82 . . . . 0.0 111.497 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 pt -110.63 176.59 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.844 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -73.16 139.88 46.66 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.897 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 mt -127.52 127.64 44.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.192 0.933 . . . . 0.0 110.566 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.95 -176.61 4.86 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.92 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -61.64 152.98 29.27 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.807 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.14 -11.57 4.8 Favored Glycine 0 N--CA 1.499 2.836 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.801 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.17 95.51 0.18 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -91.2 133.25 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.796 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.3 mp -112.83 146.45 38.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 112.494 -2.139 . . . . 0.0 108.756 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 m -132.14 155.79 47.53 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.29 169.8 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -170.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.776 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 N--CA 1.502 2.15 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.18 -4.83 19.11 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 174.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 79.12 46.49 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.15 -19.22 65.84 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 122.072 1.848 . . . . 0.0 112.365 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -57.62 -40.49 79.29 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.151 0.907 . . . . 0.0 112.549 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -89.9 -27.41 19.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 123.757 0.661 . . . . 0.0 109.961 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.9 mt -70.58 148.32 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.492 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.52 -94.82 1.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -89.78 144.68 25.77 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.203 -0.998 . . . . 0.0 110.256 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.474 HD11 ' CE2' ' A' ' 69' ' ' PHE . 55.0 mt -117.76 133.22 56.16 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.029 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.8 117.89 34.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.146 0.904 . . . . 0.0 109.463 175.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.87 175.76 35.06 Favored Glycine 0 N--CA 1.496 2.671 0 O-C-N 124.181 0.925 . . . . 0.0 112.015 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -94.71 150.03 20.63 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.108 -1.046 . . . . 0.0 109.987 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.4 64.13 1.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.372 -1.286 . . . . 0.0 107.959 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.01 -25.48 30.38 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.696 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.5 m -51.75 -49.35 62.76 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 124.351 1.032 . . . . 0.0 110.914 175.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -94.61 -3.74 49.04 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 124.331 1.019 . . . . 0.0 111.722 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.06 42.38 77.34 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -141.68 178.38 7.51 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.345 -0.927 . . . . 0.0 108.801 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -147.19 151.69 37.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.97 -153.21 13.32 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 118.895 -1.622 . . . . 0.0 112.38 167.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -104.51 148.78 26.09 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.474 ' CE2' HD11 ' A' ' 56' ' ' LEU . 17.0 p90 -153.47 140.29 12.91 Favored Pre-proline 0 N--CA 1.494 1.763 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.423 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.31 160.74 15.61 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.905 1.737 . . . . 0.0 111.949 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.12 35.38 4.6 Favored Glycine 0 N--CA 1.498 2.788 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.177 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.56 -30.52 1.87 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -90.24 13.93 13.99 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.926 0.766 . . . . 0.0 110.874 -173.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.08 176.2 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 124.57 1.168 . . . . 0.0 107.918 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -144.77 113.76 6.88 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -45.17 139.4 3.38 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.959 0.787 . . . . 0.0 110.196 168.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.465 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.8 pt -137.02 -66.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 124.597 1.186 . . . . 0.0 109.892 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.465 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -98.22 157.89 20.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 -171.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 O-C-N 124.587 0.816 . . . . 0.0 111.485 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -125.65 161.99 26.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 124.192 0.932 . . . . 0.0 111.591 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -138.44 159.57 41.74 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.821 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -120.2 116.27 25.28 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.54 111.55 0.66 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.896 0.748 . . . . 0.0 110.498 170.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -51.37 40.86 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.639 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.38 151.48 49.3 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.511 1.132 . . . . 0.0 109.874 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -57.31 129.23 40.86 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.692 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -130.31 129.71 43.56 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.178 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -89.29 155.7 19.21 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.779 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 146.53 24.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.811 0.694 . . . . 0.0 109.388 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -131.78 -7.12 3.59 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.911 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.03 150.55 50.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 124.163 0.914 . . . . 0.0 109.404 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -65.45 -16.97 64.18 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.707 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -78.58 -25.51 45.31 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.728 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.86 154.91 19.43 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.3 1.0 . . . . 0.0 111.174 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 pt -119.13 177.35 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.775 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.87 135.46 38.85 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.826 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.9 mt -128.31 135.04 49.06 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 124.294 0.996 . . . . 0.0 110.188 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.51 -174.47 3.65 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.742 -173.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 28' ' ' ASP . 1.8 mp -81.99 154.05 25.9 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.207 -176.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.85 -6.36 2.04 Favored Glycine 0 N--CA 1.502 3.04 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.673 -176.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 26' ' ' LEU . 1.4 m-20 -65.93 116.99 7.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.19 138.89 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 124.287 0.992 . . . . 0.0 109.868 173.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.74 158.95 18.08 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.903 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.8 m -130.58 151.2 51.3 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 123.804 0.69 . . . . 0.0 109.495 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.424 ' CG1' ' H ' ' A' ' 33' ' ' ASN . 2.1 t -119.85 -141.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.424 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 35.7 m120 . . . . . 0 N--CA 1.486 1.375 0 O-C-N 124.11 0.881 . . . . 0.0 109.227 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 121.554 0.692 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.96 18.38 13.45 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.78 -172.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -130.33 73.14 81.55 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 123.899 0.749 . . . . 0.0 110.309 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.85 -4.96 4.04 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.56 2.174 . . . . 0.0 113.536 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.83 -39.42 69.77 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.62 0.575 . . . . 0.0 110.895 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.8 -33.05 16.67 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.094 0.871 . . . . 0.0 109.793 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 mt -77.37 125.5 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.54 -78.62 1.32 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -92.56 120.47 33.04 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 113.335 -1.433 . . . . 0.0 110.006 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 mp -105.9 123.78 48.52 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.088 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.98 122.41 35.31 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 168.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.68 171.34 32.45 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.015 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.02 150.28 21.07 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.25 -0.975 . . . . 0.0 109.871 176.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -120.14 77.21 1.23 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.102 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -52.94 -36.13 59.42 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.942 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -53.28 -50.38 64.98 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.264 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.0 p -89.54 4.74 48.3 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.574 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.45 35.21 50.49 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 124.383 1.052 . . . . 0.0 111.483 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -138.65 -175.85 4.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 154.2 37.46 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.384 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.42 -162.82 34.03 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.774 -1.203 . . . . 0.0 112.55 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.82 161.24 13.84 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.079 -1.06 . . . . 0.0 109.711 176.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -162.1 142.18 7.65 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.434 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.71 155.33 64.03 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 121.547 1.498 . . . . 0.0 111.89 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.46 -12.43 64.93 Favored Glycine 0 N--CA 1.5 2.937 0 O-C-N 123.915 0.759 . . . . 0.0 112.494 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.51 3.62 18.14 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.507 0.323 . . . . 0.0 110.823 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -121.1 -2.16 9.7 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.165 0.916 . . . . 0.0 110.572 -176.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 m -128.08 -177.64 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 124.175 0.922 . . . . 0.0 110.067 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -150.16 113.78 4.99 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.846 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.458 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 28.4 t80 -46.95 142.59 3.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 123.551 0.532 . . . . 0.0 110.388 172.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 pt -118.6 -55.37 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 123.948 0.78 . . . . 0.0 110.409 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.26 147.16 15.73 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.023 -1.084 . . . . 0.0 110.695 -165.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.458 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-N 112.904 -1.648 . . . . 0.0 110.019 176.266 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.505 2.324 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -147.59 165.26 30.91 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.27 1.033 . . . . 0.0 112.698 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -146.19 148.66 32.76 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 112.404 -2.18 . . . . 0.0 106.896 -174.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -117.64 113.8 22.45 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.82 103.95 0.07 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.401 1.063 . . . . 0.0 110.723 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.33 -31.48 69.96 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.824 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.93 141.9 38.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.133 0.895 . . . . 0.0 109.845 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.67 112.87 5.03 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.396 174.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -113.5 133.12 55.4 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -89.89 156.52 18.41 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.322 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -88.84 147.17 24.54 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.927 -175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -122.67 -7.03 8.57 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.299 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -139.01 159.25 42.59 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.731 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.9 -21.16 66.43 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.364 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.99 -23.35 33.36 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.907 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -94.77 146.21 24.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.263 0.977 . . . . 0.0 109.979 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -111.98 176.69 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 124.775 1.297 . . . . 0.0 110.3 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -86.2 106.22 17.14 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.683 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.56 125.37 35.6 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.46 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.78 -173.12 2.18 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.728 1.267 . . . . 0.0 109.256 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.6 mt -74.13 145.72 44.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.69 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.47 10.88 4.63 Favored Glycine 0 N--CA 1.503 3.119 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.206 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.18 127.17 30.58 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.297 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mp -104.56 142.84 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 CA-C-O 121.307 0.575 . . . . 0.0 109.46 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.456 HD21 ' CE1' ' A' ' 69' ' ' PHE . 7.4 mp -126.82 150.37 49.21 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.028 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.2 m -128.84 149.62 50.67 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 123.956 0.785 . . . . 0.0 110.62 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.63 -156.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 O-C-N 123.551 0.532 . . . . 0.0 109.728 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.483 ' H ' HD21 ' A' ' 33' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 171.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.21 -2.84 26.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.532 1.145 . . . . 0.0 111.859 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -119.96 79.15 24.84 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 123.97 0.794 . . . . 0.0 111.283 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.83 -13.7 23.68 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.784 1.656 . . . . 0.0 112.744 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -64.11 -38.1 89.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.093 0.871 . . . . 0.0 111.488 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -90.12 -28.09 19.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.931 0.769 . . . . 0.0 110.912 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 mt -74.09 141.47 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 123.866 0.729 . . . . 0.0 109.577 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.43 -92.82 1.15 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -93.23 120.39 33.47 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.603 -1.299 . . . . 0.0 109.679 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.0 mp -100.44 125.38 46.73 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.604 171.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -95.99 118.23 32.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.739 0.65 . . . . 0.0 109.729 171.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.01 -179.36 18.95 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -124.42 125.19 43.87 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -96.42 91.99 6.09 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.434 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -52.41 -35.04 50.99 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.021 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.7 m -51.25 -36.98 44.59 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.514 1.134 . . . . 0.0 112.096 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 64.5 p -115.74 2.6 13.7 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.952 0.782 . . . . 0.0 110.064 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.9 18.69 57.58 Favored Glycine 0 N--CA 1.493 2.483 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.746 -174.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -110.02 153.65 24.3 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' CD ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -137.74 146.72 44.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.665 1.228 . . . . 0.0 109.479 -175.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.89 -163.04 31.07 Favored Glycine 0 N--CA 1.491 2.314 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.18 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.3 151.15 26.96 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.066 -1.067 . . . . 0.0 109.587 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 26.7 p90 -147.68 144.38 19.17 Favored Pre-proline 0 N--CA 1.493 1.715 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.365 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.29 153.83 71.84 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.745 1.63 . . . . 0.0 111.34 174.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.27 53.17 2.47 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.3 t -134.46 -23.25 1.66 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -105.15 26.75 8.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.141 0.901 . . . . 0.0 110.63 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.46 166.85 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.595 -173.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -144.91 118.8 9.3 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.103 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -48.46 130.62 16.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.05 0.844 . . . . 0.0 110.464 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.469 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.2 pt -135.87 -62.39 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 123.907 0.754 . . . . 0.0 111.426 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.469 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -93.81 159.68 23.91 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 -176.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 124.758 0.917 . . . . 0.0 110.478 -178.292 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.115 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -139.4 159.1 42.95 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.506 -173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -142.68 125.15 15.68 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.1 -1.863 . . . . 0.0 107.601 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -89.61 118.46 29.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.629 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.63 152.48 0.33 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.927 0.767 . . . . 0.0 112.788 170.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -113.29 -44.81 3.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.512 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.34 151.99 41.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.06 0.85 . . . . 0.0 110.799 -175.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.01 116.37 7.76 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.257 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -117.99 138.1 52.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.125 0.891 . . . . 0.0 108.895 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.02 146.4 25.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.297 0.998 . . . . 0.0 109.921 174.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 164.53 14.94 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.176 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.62 -25.24 0.77 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.074 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -108.03 149.68 28.12 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.101 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.56 -12.25 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.531 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -81.76 -40.27 22.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 123.903 0.752 . . . . 0.0 111.187 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.77 156.22 19.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.114 0.884 . . . . 0.0 111.265 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.41 174.43 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.666 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -75.05 131.47 40.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.766 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.0 mt -121.56 127.46 50.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.587 1.179 . . . . 0.0 109.179 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.74 -173.62 2.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.268 0.98 . . . . 0.0 108.904 -175.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.414 ' C ' ' H ' ' A' ' 28' ' ' ASP . 3.1 mp -83.12 156.53 23.23 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.423 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.12 0.03 1.0 Allowed Glycine 0 N--CA 1.5 2.955 0 O-C-N 123.872 0.732 . . . . 0.0 113.201 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -65.69 106.29 1.45 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 mt -90.64 132.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.743 174.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.5 mp -108.52 151.52 25.98 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.064 -1.88 . . . . 0.0 109.013 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.8 m -129.43 147.43 51.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 123.842 0.714 . . . . 0.0 109.845 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.59 -147.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 123.807 0.692 . . . . 0.0 109.265 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 O-C-N 123.419 0.449 . . . . 0.0 110.033 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.244 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -86.96 -37.86 17.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -102.31 102.97 27.94 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.999 0.812 . . . . 0.0 111.325 174.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -68.6 -17.99 42.92 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.641 2.227 . . . . 0.0 114.092 167.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.53 -31.67 68.14 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.657 0.598 . . . . 0.0 112.246 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.32 -21.89 21.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.831 0.707 . . . . 0.0 111.376 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.12 146.91 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -91.56 1.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -90.19 131.04 36.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.425 -1.388 . . . . 0.0 109.032 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -108.46 126.82 53.32 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.94 124.23 46.33 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.77 -166.18 16.67 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -140.17 150.19 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.23 99.87 7.93 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.274 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.81 -21.49 66.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.3 m -46.05 -37.42 6.7 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.812 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.61 2.46 6.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.849 1.343 . . . . 0.0 108.877 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.64 36.87 73.33 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.614 -176.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -109.51 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.51 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 156.05 40.99 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.767 0.794 . . . . 0.0 111.699 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.66 -153.05 23.3 Favored Glycine 0 N--CA 1.489 2.197 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.032 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.71 153.94 24.57 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -173.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.6 p90 -151.36 140.77 13.95 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.912 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.15 150.39 87.74 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.53 1.486 . . . . 0.0 110.708 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.29 48.72 4.08 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 t -141.21 16.39 2.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.105 0.532 . . . . 0.0 111.616 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -136.05 -4.08 2.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 123.751 0.657 . . . . 0.0 111.847 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.98 -169.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 123.932 0.77 . . . . 0.0 109.13 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.71 113.58 5.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 172.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.582 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 25.2 t80 -48.27 142.97 4.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.442 171.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 pt -122.24 -53.5 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 123.926 0.766 . . . . 0.0 111.688 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.84 146.63 15.79 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.478 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.582 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-N 113.311 -1.444 . . . . 0.0 109.988 177.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -133.01 165.3 25.04 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.145 0.974 . . . . 0.0 111.857 -177.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -136.64 128.42 29.05 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.883 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -89.31 114.69 26.11 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.89 122.53 4.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.362 1.039 . . . . 0.0 111.99 171.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.27 -41.37 34.19 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.677 -178.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.11 160.62 39.53 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 124.21 0.944 . . . . 0.0 110.376 -177.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.47 127.8 33.76 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.496 173.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -126.56 130.48 50.63 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.367 1.042 . . . . 0.0 109.042 173.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -90.29 153.88 20.13 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 169.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.62 171.9 9.34 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.101 0.876 . . . . 0.0 109.864 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.44 -10.01 1.24 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.094 177.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -132.84 154.58 50.19 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.357 -176.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.2 -19.15 62.83 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.55 174.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -71.89 -31.17 66.15 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.045 176.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.77 152.06 23.02 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 124.23 0.956 . . . . 0.0 110.317 -177.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pt -115.46 173.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.834 176.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -74.22 134.05 42.7 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.265 -1.788 . . . . 0.0 108.866 -176.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.4 mt -126.63 136.63 52.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.279 0.987 . . . . 0.0 110.026 -177.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 173.08 11.9 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.699 -173.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -67.55 158.02 32.99 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.228 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.3 -10.0 1.49 Allowed Glycine 0 N--CA 1.5 2.909 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.886 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.32 133.15 50.79 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.17 116.23 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.47 129.94 45.69 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 -168.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.2 m -103.91 146.97 27.89 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 124.006 0.816 . . . . 0.0 110.619 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.431 ' CG1' ' H ' ' A' ' 33' ' ' ASN . 2.1 t -121.03 -149.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 124.52 1.138 . . . . 0.0 108.365 179.435 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.431 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 4.2 m-80 . . . . . 0 N--CA 1.496 1.832 0 O-C-N 123.409 0.443 . . . . 0.0 111.228 176.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.507 2.404 0 CA-C-O 121.909 0.861 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -158.95 -22.75 0.07 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.35 -173.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 84.99 37.78 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 124.006 0.816 . . . . 0.0 109.395 175.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -56.28 -23.0 43.59 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.444 2.096 . . . . 0.0 111.997 173.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.42 -45.63 76.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.657 1.223 . . . . 0.0 110.837 -175.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.01 -26.52 20.29 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 124.113 0.883 . . . . 0.0 111.102 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.66 153.73 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 123.72 0.638 . . . . 0.0 109.857 176.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.17 -101.42 1.03 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 178.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -92.18 147.25 23.08 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.497 -0.851 . . . . 0.0 110.382 -177.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.468 HD11 ' CE2' ' A' ' 69' ' ' PHE . 67.4 mt -117.46 120.22 37.46 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 113.831 -1.531 . . . . 0.0 107.829 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.25 123.16 42.19 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 124.221 0.951 . . . . 0.0 109.732 173.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.07 -173.19 31.49 Favored Glycine 0 N--CA 1.499 2.871 0 O-C-N 124.066 0.853 . . . . 0.0 111.71 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.73 128.7 49.96 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.025 -174.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -94.06 62.19 3.03 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 124.445 1.09 . . . . 0.0 109.625 175.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -42.71 -33.9 0.81 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 114.467 -1.242 . . . . 0.0 114.179 173.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.9 p -55.08 -50.26 69.6 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 123.598 0.561 . . . . 0.0 112.028 177.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -89.83 1.89 55.62 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.059 0.85 . . . . 0.0 111.06 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.99 33.25 86.75 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -131.44 165.32 23.79 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -150.43 156.04 40.71 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 123.571 0.545 . . . . 0.0 110.551 177.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.68 -154.14 20.32 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.457 176.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.04 150.78 26.71 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.468 ' CE2' HD11 ' A' ' 56' ' ' LEU . 12.8 p90 -154.95 139.43 11.66 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 124.171 0.919 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.95 161.17 19.59 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.126 1.884 . . . . 0.0 112.86 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.08 22.28 32.71 Favored Glycine 0 N--CA 1.495 2.593 0 O-C-N 124.206 0.941 . . . . 0.0 111.871 -176.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.42 -47.4 4.69 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 117.444 0.622 . . . . 0.0 112.65 -174.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -94.02 40.34 1.08 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.499 -171.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.39 152.05 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.484 -174.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -131.96 111.82 11.87 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.431 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 75.8 t80 -54.78 122.57 11.03 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.306 174.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -94.42 -49.6 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 124.113 0.883 . . . . 0.0 110.783 -176.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.97 -168.45 41.55 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.912 -1.137 . . . . 0.0 112.696 175.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 CA-C-N 113.41 -1.395 . . . . 0.0 109.973 175.837 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.261 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -128.9 164.03 23.99 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 122.849 1.309 . . . . 0.0 113.832 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -141.12 154.7 46.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 111.398 -2.637 . . . . 0.0 107.338 -174.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -125.73 121.21 32.74 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.54 126.06 16.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 124.121 0.888 . . . . 0.0 110.935 168.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.38 -33.12 23.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.874 0.734 . . . . 0.0 111.017 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.88 157.59 44.26 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.928 0.767 . . . . 0.0 110.346 -174.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.89 116.95 19.53 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.26 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -121.19 133.78 55.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.449 1.093 . . . . 0.0 108.725 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.6 164.57 14.7 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -89.06 142.36 27.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.616 0.572 . . . . 0.0 109.803 -177.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.44 -12.45 5.0 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.96 177.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.91 143.12 51.37 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.336 178.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.98 -34.54 76.34 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.083 -178.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.69 -35.41 80.69 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.404 177.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -88.35 162.09 16.75 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.177 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.64 174.83 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.278 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.79 148.56 42.38 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.936 -177.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.8 mt -133.24 141.28 47.95 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.093 0.87 . . . . 0.0 110.538 178.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.78 165.67 26.82 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.532 -171.31 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 28' ' ' ASP . 7.7 mt -65.74 151.69 46.02 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.336 174.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.32 -9.4 4.33 Favored Glycine 0 N--CA 1.501 2.995 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.03 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 26' ' ' LEU . 50.4 t0 -69.02 132.46 46.68 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mt -121.05 138.74 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 124.343 1.027 . . . . 0.0 108.629 176.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.48 150.21 27.06 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 112.972 -1.922 . . . . 0.0 108.138 178.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 m -127.5 153.81 45.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.632 0.583 . . . . 0.0 109.992 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.29 175.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -176.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.794 0.807 . . . . 0.0 110.338 -178.15 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.71 23.32 9.54 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.393 -169.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.68 68.65 81.85 Favored Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.674 -176.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -59.23 -23.91 71.7 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.46 2.107 . . . . 0.0 111.73 174.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -59.31 -49.17 78.84 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.285 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -90.09 -35.19 15.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 123.832 0.708 . . . . 0.0 110.909 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.4 mt -64.1 129.86 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 123.943 0.777 . . . . 0.0 109.64 172.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.46 -87.41 1.27 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -175.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -98.23 124.87 43.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.609 -1.296 . . . . 0.0 108.144 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.407 ' HG ' ' CZ ' ' A' ' 69' ' ' PHE . 1.4 pt? -132.65 144.67 50.5 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 173.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -92.87 147.84 22.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.594 1.184 . . . . 0.0 108.867 -176.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.86 154.13 25.25 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 175.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.46 122.49 32.7 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.062 -1.069 . . . . 0.0 108.487 176.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -96.47 69.66 2.61 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.977 0.894 . . . . 0.0 111.168 177.005 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -52.31 -26.76 12.96 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 113.754 -1.567 . . . . 0.0 112.458 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.4 p -51.67 -51.72 53.64 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.037 0.836 . . . . 0.0 112.782 174.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.6 p -91.6 2.28 56.56 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.228 176.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.86 30.37 77.81 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -129.34 178.32 6.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 124.506 0.768 . . . . 0.0 109.508 -178.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -144.51 147.66 33.52 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.17 -163.01 28.54 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 118.79 -1.671 . . . . 0.0 113.847 166.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.69 152.74 19.32 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 113.17 -1.515 . . . . 0.0 108.98 -178.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.407 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 24.4 p90 -154.36 152.74 26.88 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 123.654 0.596 . . . . 0.0 109.803 175.215 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -65.66 165.25 23.67 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 122.32 2.013 . . . . 0.0 112.007 176.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.55 -2.35 67.71 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 123.987 0.804 . . . . 0.0 111.57 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -96.34 -34.13 11.69 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.507 0.67 . . . . 0.0 109.833 -166.689 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -90.95 6.11 45.99 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.567 -1.652 . . . . 0.0 111.529 -174.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.34 -177.75 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 124.208 0.942 . . . . 0.0 109.046 -178.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.34 115.95 5.51 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -49.4 128.91 18.03 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 166.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.67 -54.72 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 124.131 0.894 . . . . 0.0 109.721 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.94 171.92 36.36 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.681 -1.724 . . . . 0.0 110.502 -170.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.395 0 CA-C-N 113.732 -1.234 . . . . 0.0 109.404 168.673 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.171 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -136.73 162.01 34.38 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.848 0.833 . . . . 0.0 110.991 -169.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -129.64 170.75 13.4 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.587 -1.642 . . . . 0.0 107.341 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -133.89 116.65 15.87 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.14 112.03 0.98 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.301 1.0 . . . . 0.0 110.013 174.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.4 tp -70.07 -38.49 75.75 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.514 -177.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.61 170.83 15.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 124.582 1.176 . . . . 0.0 109.981 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.22 123.2 28.27 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.529 175.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -118.83 134.25 55.29 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -89.74 159.12 17.23 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.047 175.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -88.3 141.09 28.83 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -176.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -121.32 -8.65 9.16 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.644 178.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -136.67 146.62 46.14 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -60.41 -31.01 69.98 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.166 174.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.58 -32.75 73.8 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.3 178.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.36 161.1 14.53 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.304 1.002 . . . . 0.0 110.107 177.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 pt -116.94 174.86 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 124.349 1.031 . . . . 0.0 111.545 176.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.52 141.95 46.73 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.125 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -131.38 135.17 46.98 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.968 0.792 . . . . 0.0 111.534 178.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.31 176.52 8.62 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 28' ' ' ASP . 1.7 mp -72.47 154.53 40.81 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.937 -177.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.69 -5.57 2.33 Favored Glycine 0 N--CA 1.5 2.931 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.896 -176.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -64.64 101.13 0.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.233 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.95 135.96 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 124.274 0.984 . . . . 0.0 110.099 173.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -111.2 157.03 20.56 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.968 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.5 m -133.37 150.8 51.81 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.768 0.668 . . . . 0.0 110.407 -176.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.411 ' CG1' ' H ' ' A' ' 33' ' ' ASN . 1.4 t -128.31 -151.93 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 123.841 0.713 . . . . 0.0 109.151 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.411 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 1.8 m-80 . . . . . 0 N--CA 1.493 1.717 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.869 178.059 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.45 -0.84 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.596 178.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -123.0 77.78 50.81 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 123.93 0.769 . . . . 0.0 109.557 -176.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.43 -18.83 15.73 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.888 2.392 . . . . 0.0 112.7 175.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -53.97 -42.62 69.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.087 0.867 . . . . 0.0 111.806 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -89.8 -29.6 18.53 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.1 0.875 . . . . 0.0 110.926 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 mt -73.54 136.7 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.82 -87.08 1.31 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -172.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -102.75 131.22 49.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.309 -1.445 . . . . 0.0 109.051 -178.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -114.5 138.31 50.76 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.233 173.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -108.29 124.33 50.15 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 173.221 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -151.14 176.87 29.46 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 120.079 -1.058 . . . . 0.0 112.006 177.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -110.52 131.24 55.22 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.149 -1.025 . . . . 0.0 109.275 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -103.43 102.82 12.75 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.682 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.11 -36.31 72.72 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.284 177.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.4 m -56.63 -28.49 60.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.494 1.121 . . . . 0.0 111.996 -177.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -116.9 -2.96 11.69 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.645 -176.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.15 19.81 32.95 Favored Glycine 0 N--CA 1.497 2.748 0 O-C-N 124.405 1.066 . . . . 0.0 111.37 -172.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.98 165.78 13.31 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -172.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.16 149.8 40.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.006 0.816 . . . . 0.0 109.68 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.72 -145.19 6.66 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.456 173.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.39 153.67 30.62 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.145 -1.027 . . . . 0.0 108.29 -173.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 31.1 p90 -157.01 143.55 13.26 Favored Pre-proline 0 N--CA 1.493 1.699 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.751 178.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.08 157.87 46.86 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 122.111 1.874 . . . . 0.0 112.043 176.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.94 43.62 1.92 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -134.0 -26.38 1.52 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 178.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -93.21 2.4 56.67 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.463 -177.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.42 -176.44 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 124.306 1.004 . . . . 0.0 109.227 -177.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -150.27 115.15 5.31 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -48.36 122.26 5.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.142 0.901 . . . . 0.0 109.343 171.138 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.97 -51.1 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.039 177.485 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -166.16 159.84 33.21 Favored Glycine 0 N--CA 1.485 1.911 0 C-N-CA 118.814 -1.66 . . . . 0.0 110.688 -178.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.413 ' CD ' ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.473 0 CA-C-N 111.866 -2.167 . . . . 0.0 105.957 173.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.104 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -144.43 159.56 42.53 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 117.413 -1.715 . . . . 0.0 113.67 -174.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -146.31 143.96 29.49 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 112.345 -2.207 . . . . 0.0 107.439 -172.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -118.57 112.96 20.55 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -174.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.17 121.67 3.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.302 1.001 . . . . 0.0 109.983 175.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -68.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.205 176.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.41 171.79 7.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.382 1.052 . . . . 0.0 109.924 -177.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.43 121.12 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.38 175.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -124.87 129.33 50.19 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -89.82 -170.33 2.77 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -88.33 144.89 26.13 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.039 175.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.39 -15.7 9.06 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.802 173.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.18 147.48 27.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.553 1.158 . . . . 0.0 108.796 -178.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.11 -11.31 0.67 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.033 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -81.37 -44.68 17.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 124.212 0.945 . . . . 0.0 111.261 177.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.75 165.47 18.85 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.855 0.722 . . . . 0.0 109.334 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 177.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 122.507 1.146 . . . . 0.0 110.85 177.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -82.23 113.11 19.83 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 111.927 -2.397 . . . . 0.0 106.781 -178.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.6 mt -103.76 143.19 33.13 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.422 0.629 . . . . 0.0 111.769 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 172.15 15.72 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.271 -176.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 28' ' ' ASP . 6.5 mp -64.84 155.75 33.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.016 -177.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.19 -12.96 2.89 Favored Glycine 0 N--CA 1.504 3.187 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.476 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 26' ' ' LEU . 9.4 t70 -76.58 113.89 14.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.205 0.591 . . . . 0.0 109.609 -175.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.91 149.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.246 0.546 . . . . 0.0 109.885 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.1 mp -124.47 145.91 49.25 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.228 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 m -127.1 125.63 41.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.165 0.916 . . . . 0.0 109.616 -177.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.4 t -95.85 -124.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -171.127 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.506 2.338 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 -11.89 55.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 82.37 48.52 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 124.219 0.949 . . . . 0.0 108.587 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.23 -10.68 26.77 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.118 1.879 . . . . 0.0 113.021 173.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.89 -36.73 79.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.719 0.637 . . . . 0.0 111.608 -176.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -91.4 -29.98 16.76 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.279 -176.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -71.6 149.82 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.222 177.07 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.4 -95.31 1.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -98.8 126.22 44.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.826 0.956 . . . . 0.0 110.061 -175.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.7 mp -98.29 145.09 27.01 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.429 174.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.432 HD22 ' CG ' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -104.54 125.92 51.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.2 0.937 . . . . 0.0 108.664 169.879 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.7 160.39 27.95 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.382 173.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.76 122.24 31.97 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.124 -1.038 . . . . 0.0 109.7 172.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -92.44 64.76 4.37 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.674 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -52.61 -31.2 35.27 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.006 -178.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.6 p -53.89 -48.28 70.27 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.116 0.885 . . . . 0.0 111.49 179.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -89.74 -5.47 56.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.03 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.44 24.98 64.26 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 177.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -129.28 179.34 5.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.506 0.768 . . . . 0.0 109.144 -175.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -147.14 151.67 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.453 179.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.68 -161.08 33.2 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.2 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.432 ' CG ' HD22 ' A' ' 57' ' ' ASN . 1.9 m-20 -111.96 162.18 15.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -170.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.4 p90 -160.65 148.47 12.69 Favored Pre-proline 0 N--CA 1.496 1.845 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.12 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.85 150.03 89.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.698 1.598 . . . . 0.0 111.209 177.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.04 48.09 2.22 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 175.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -146.71 8.16 0.98 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.819 0.364 . . . . 0.0 111.565 174.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.05 9.34 9.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.967 0.792 . . . . 0.0 111.473 -178.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 -171.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 124.016 0.823 . . . . 0.0 109.702 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -150.15 102.36 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.179 175.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -41.99 136.32 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.496 170.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.463 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.3 pt -139.57 -67.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 124.005 0.816 . . . . 0.0 110.604 -177.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.463 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -89.86 159.02 27.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -173.01 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? . . . . . 0 N--CA 1.489 1.49 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.88 -168.007 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.104 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -144.43 159.56 42.53 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 117.413 -1.715 . . . . 0.0 113.67 -174.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -146.31 143.96 29.49 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 112.345 -2.207 . . . . 0.0 107.439 -172.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -118.57 112.96 20.55 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -174.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.17 121.67 3.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.302 1.001 . . . . 0.0 109.983 175.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -68.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.205 176.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.41 171.79 7.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.382 1.052 . . . . 0.0 109.924 -177.012 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.43 121.12 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.38 175.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -124.87 129.33 50.19 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -89.82 -170.33 2.77 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -88.33 144.89 26.13 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.039 175.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.39 -15.7 9.06 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.802 173.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.18 147.48 27.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.553 1.158 . . . . 0.0 108.796 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.11 -11.31 0.67 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -81.37 -44.68 17.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 124.212 0.945 . . . . 0.0 111.261 177.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.75 165.47 18.85 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.855 0.722 . . . . 0.0 109.334 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 177.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 122.507 1.146 . . . . 0.0 110.85 177.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -82.23 113.11 19.83 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 111.927 -2.397 . . . . 0.0 106.781 -178.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.6 mt -103.76 143.19 33.13 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.422 0.629 . . . . 0.0 111.769 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 172.15 15.72 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.271 -176.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 28' ' ' ASP . 6.5 mp -64.84 155.75 33.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.016 -177.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.19 -12.96 2.89 Favored Glycine 0 N--CA 1.504 3.187 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.476 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 26' ' ' LEU . 9.4 t70 -76.58 113.89 14.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.205 0.591 . . . . 0.0 109.609 -175.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.91 149.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.246 0.546 . . . . 0.0 109.885 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.1 mp -124.47 145.91 49.25 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.228 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 m -127.1 125.63 41.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.165 0.916 . . . . 0.0 109.616 -177.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.4 t -95.85 -124.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -171.127 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.506 2.338 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 -11.89 55.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 82.37 48.52 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 124.219 0.949 . . . . 0.0 108.587 -177.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.23 -10.68 26.77 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.118 1.879 . . . . 0.0 113.021 173.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.89 -36.73 79.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.719 0.637 . . . . 0.0 111.608 -176.037 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -91.4 -29.98 16.76 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.279 -176.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -71.6 149.82 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.222 177.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.4 -95.31 1.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 177.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -98.8 126.22 44.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.826 0.956 . . . . 0.0 110.061 -175.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.7 mp -98.29 145.09 27.01 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.429 174.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.432 HD22 ' CG ' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -104.54 125.92 51.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.2 0.937 . . . . 0.0 108.664 169.879 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.7 160.39 27.95 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.382 173.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.76 122.24 31.97 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.124 -1.038 . . . . 0.0 109.7 172.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -92.44 64.76 4.37 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.674 176.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -52.61 -31.2 35.27 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.006 -178.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.6 p -53.89 -48.28 70.27 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.116 0.885 . . . . 0.0 111.49 179.142 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -89.74 -5.47 56.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.03 177.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.44 24.98 64.26 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 177.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -129.28 179.34 5.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.506 0.768 . . . . 0.0 109.144 -175.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -147.14 151.67 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.453 179.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.68 -161.08 33.2 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.2 176.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.432 ' CG ' HD22 ' A' ' 57' ' ' ASN . 1.9 m-20 -111.96 162.18 15.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -170.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.4 p90 -160.65 148.47 12.69 Favored Pre-proline 0 N--CA 1.496 1.845 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.12 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.85 150.03 89.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.698 1.598 . . . . 0.0 111.209 177.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.04 48.09 2.22 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -146.71 8.16 0.98 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.819 0.364 . . . . 0.0 111.565 174.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.05 9.34 9.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.967 0.792 . . . . 0.0 111.473 -178.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 -171.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 124.016 0.823 . . . . 0.0 109.702 -173.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -150.15 102.36 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.179 175.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -41.99 136.32 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.496 170.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.463 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.3 pt -139.57 -67.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 124.005 0.816 . . . . 0.0 110.604 -177.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.463 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -89.86 159.02 27.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -173.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? . . . . . 0 N--CA 1.489 1.49 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.88 -168.007 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.377 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 . . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -133.38 160.31 37.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 124.038 0.836 . . . . 0.0 111.602 -177.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -138.35 162.04 35.4 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.078 -1.874 . . . . 0.0 108.05 -177.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -125.87 112.9 16.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.293 0.996 . . . . 0.0 108.738 -179.35 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.41 108.93 0.43 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.321 170.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.68 -14.41 32.3 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.15 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.38 141.46 41.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.308 1.005 . . . . 0.0 110.544 -179.176 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.59 115.32 17.26 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.182 171.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -125.96 136.15 52.67 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 124.323 1.015 . . . . 0.0 109.101 176.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -89.79 163.3 15.11 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -89.02 140.6 29.27 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.851 0.719 . . . . 0.0 109.514 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -89.74 -25.34 21.2 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.994 -179.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -150.2 162.22 40.88 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.363 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -52.52 -14.89 0.55 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.137 -1.392 . . . . 0.0 114.609 173.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -75.94 -42.8 47.63 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 123.61 0.569 . . . . 0.0 110.767 177.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.35 146.48 24.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.02 0.825 . . . . 0.0 110.161 177.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -99.03 173.14 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.058 175.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.36 140.6 37.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.644 -177.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -125.86 138.91 53.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.497 1.123 . . . . 0.0 109.277 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.04 -155.14 0.67 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.043 -171.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 28' ' ' ASP . 8.8 mt -106.4 144.29 33.29 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.706 0.629 . . . . 0.0 111.12 175.099 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.09 6.6 5.71 Favored Glycine 0 N--CA 1.503 3.11 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.667 178.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 26' ' ' LEU . 1.1 m-20 -68.89 144.25 54.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 123.93 0.429 . . . . 0.0 110.498 173.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mp -108.9 146.79 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 124.569 1.168 . . . . 0.0 107.933 -177.761 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -128.57 129.04 45.4 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.747 172.021 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 97.0 m -106.5 152.32 23.82 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 124.269 0.981 . . . . 0.0 109.273 -178.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.67 -173.45 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 124.079 0.862 . . . . 0.0 109.115 -179.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.7 -178.388 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.503 2.193 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.99 -14.15 16.06 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.288 -178.444 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -112.04 94.46 25.48 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 124.197 0.936 . . . . 0.0 108.942 173.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.67 -20.9 53.03 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.266 1.977 . . . . 0.0 112.768 166.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -59.16 -36.6 75.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.898 0.749 . . . . 0.0 111.951 -175.014 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.75 -31.83 17.26 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 123.856 0.723 . . . . 0.0 109.241 -176.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.73 146.17 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 124.123 0.889 . . . . 0.0 110.144 175.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.84 -99.69 1.1 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -89.79 131.94 35.48 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.416 -0.892 . . . . 0.0 110.01 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.541 HD11 ' CE2' ' A' ' 69' ' ' PHE . 95.7 mt -102.04 156.26 17.65 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -134.21 121.5 21.44 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.9 -162.38 17.1 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -176.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.73 130.01 31.38 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -172.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -93.63 68.1 3.98 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.182 -1.826 . . . . 0.0 108.856 174.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -43.05 -29.54 0.36 Allowed 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 114.538 -1.21 . . . . 0.0 114.023 175.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' THR . . . . . 0.416 ' HG1' ' H ' ' A' ' 63' ' ' THR . 82.8 p -45.85 -51.02 13.67 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.426 1.079 . . . . 0.0 112.328 178.11 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' THR . . . . . 0.416 ' H ' ' HG1' ' A' ' 62' ' ' THR . 1.6 p -106.44 0.26 24.65 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.986 174.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.43 37.81 53.22 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 175.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -109.3 135.75 49.87 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -120.99 125.36 47.17 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 123.811 0.694 . . . . 0.0 110.469 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.77 -147.21 8.0 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 119.521 -1.323 . . . . 0.0 114.094 176.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.19 164.39 12.91 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 113.782 -1.209 . . . . 0.0 108.898 -177.01 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.541 ' CE2' HD11 ' A' ' 56' ' ' LEU . 7.4 p90 -163.83 140.87 5.54 Favored Pre-proline 0 N--CA 1.494 1.728 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.614 175.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.7 155.96 40.1 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.389 2.06 . . . . 0.0 112.305 -177.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.414 ' HA2' HD13 ' A' ' 56' ' ' LEU . . . -95.86 47.95 1.83 Allowed Glycine 0 N--CA 1.497 2.704 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.704 179.547 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.5 t -147.27 -22.85 0.39 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -89.89 -12.26 39.48 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 123.973 0.795 . . . . 0.0 110.488 -178.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.4 m -105.67 -173.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.291 -176.022 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.29 114.32 5.09 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.706 175.433 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' TYR . . . . . 0.539 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 18.7 t80 -55.69 124.95 19.13 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.932 177.066 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -98.97 -52.9 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 123.934 0.771 . . . . 0.0 110.421 178.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.1 163.64 32.92 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.643 -175.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' ARG . . . . . 0.539 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-N 113.588 -1.306 . . . . 0.0 110.808 163.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 1.1 p 60.95 154.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 124.837 0.963 . . . . 0.0 113.049 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.0 mtt -104.82 9.49 34.84 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.172 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 p -146.37 172.61 13.24 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 120.97 0.414 . . . . 0.0 111.358 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.58 172.28 12.31 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.292 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -92.87 -71.19 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.724 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.47 -134.6 10.74 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 124.64 1.213 . . . . 0.0 110.153 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -97.73 161.53 13.71 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -139.4 159.1 42.95 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.506 -173.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -142.68 125.15 15.68 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.1 -1.863 . . . . 0.0 107.601 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -89.61 118.46 29.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.629 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.63 152.48 0.33 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.927 0.767 . . . . 0.0 112.788 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -113.29 -44.81 3.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.512 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.34 151.99 41.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.06 0.85 . . . . 0.0 110.799 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.01 116.37 7.76 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.257 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -117.99 138.1 52.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.125 0.891 . . . . 0.0 108.895 178.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.02 146.4 25.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.297 0.998 . . . . 0.0 109.921 174.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 164.53 14.94 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.176 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.62 -25.24 0.77 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.074 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -108.03 149.68 28.12 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.101 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.56 -12.25 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.531 170.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -81.76 -40.27 22.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 123.903 0.752 . . . . 0.0 111.187 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.77 156.22 19.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.114 0.884 . . . . 0.0 111.265 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.41 174.43 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.666 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -75.05 131.47 40.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.766 -174.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.0 mt -121.56 127.46 50.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.587 1.179 . . . . 0.0 109.179 -177.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.74 -173.62 2.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.268 0.98 . . . . 0.0 108.904 -175.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' C ' ' H ' ' A' ' 28' ' ' ASP . 3.1 mp -83.12 156.53 23.23 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.423 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.12 0.03 1.0 Allowed Glycine 0 N--CA 1.5 2.955 0 O-C-N 123.872 0.732 . . . . 0.0 113.201 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -65.69 106.29 1.45 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.579 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 mt -90.64 132.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.743 174.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.5 mp -108.52 151.52 25.98 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.064 -1.88 . . . . 0.0 109.013 179.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.8 m -129.43 147.43 51.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 123.842 0.714 . . . . 0.0 109.845 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.59 -147.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 123.807 0.692 . . . . 0.0 109.265 -178.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.77 158.12 15.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 123.419 0.449 . . . . 0.0 110.033 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -85.41 -27.27 25.89 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.033 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.48 32.99 0.41 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -152.29 49.08 0.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.413 ' C ' ' H ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -60.0 -30.78 69.37 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.094 171.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.5 t -46.02 -8.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 114.195 -1.366 . . . . 0.0 114.351 167.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 37' ' ' LEU . . . -32.6 -36.46 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.273 0.983 . . . . 0.0 112.283 169.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.4 mt -92.72 -34.71 13.82 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.457 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.05 9.96 4.93 Favored Glycine 0 N--CA 1.499 2.838 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.361 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.11 167.18 22.33 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.968 -0.616 . . . . 0.0 110.213 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.38 6.81 0.67 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.841 0.829 . . . . 0.0 112.392 172.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -177.19 106.65 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.356 -1.747 . . . . 0.0 108.08 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.25 -6.02 0.32 Allowed Glycine 0 N--CA 1.497 2.728 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 46.15 91.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.064 0.935 . . . . 0.0 111.246 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.61 -14.14 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 113.407 -1.724 . . . . 0.0 113.349 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -86.96 -37.86 17.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -102.31 102.97 27.94 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.999 0.812 . . . . 0.0 111.325 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -68.6 -17.99 42.92 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.641 2.227 . . . . 0.0 114.092 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.53 -31.67 68.14 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.657 0.598 . . . . 0.0 112.246 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.32 -21.89 21.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.831 0.707 . . . . 0.0 111.376 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.12 146.91 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -91.56 1.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -90.19 131.04 36.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.425 -1.388 . . . . 0.0 109.032 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -108.46 126.82 53.32 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.506 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.94 124.23 46.33 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.77 -166.18 16.67 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -140.17 150.19 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.23 99.87 7.93 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.274 -177.124 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.81 -21.49 66.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.3 m -46.05 -37.42 6.7 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.812 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.61 2.46 6.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.849 1.343 . . . . 0.0 108.877 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.64 36.87 73.33 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.614 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -109.51 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.51 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 156.05 40.99 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.767 0.794 . . . . 0.0 111.699 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.66 -153.05 23.3 Favored Glycine 0 N--CA 1.489 2.197 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.032 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.71 153.94 24.57 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.6 p90 -151.36 140.77 13.95 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.912 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.15 150.39 87.74 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.53 1.486 . . . . 0.0 110.708 175.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.29 48.72 4.08 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 t -141.21 16.39 2.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.105 0.532 . . . . 0.0 111.616 -179.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -136.05 -4.08 2.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 123.751 0.657 . . . . 0.0 111.847 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.98 -169.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 123.932 0.77 . . . . 0.0 109.13 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.71 113.58 5.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.582 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 25.2 t80 -48.27 142.97 4.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.442 171.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 pt -122.24 -53.5 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 123.926 0.766 . . . . 0.0 111.688 176.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.84 146.63 15.79 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.478 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.582 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -130.15 119.58 23.21 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.311 -1.444 . . . . 0.0 109.988 177.633 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -177.84 162.32 1.69 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.383 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -66.91 84.82 0.12 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.978 171.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.4 mt -89.92 130.01 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.659 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.77 161.45 46.19 Favored Pre-proline 0 N--CA 1.5 2.059 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.032 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.185 0 C-N-CA 121.739 1.626 . . . . 0.0 111.566 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 60.1 m -58.41 -19.34 35.32 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 26.0 tpp 64.46 43.91 4.35 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.663 0.744 . . . . 0.0 110.678 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.38 170.12 22.09 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.891 -173.033 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.74 153.74 43.23 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.554 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -99.55 40.15 1.25 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.187 0.994 . . . . 0.0 110.584 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.69 -162.99 29.25 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.648 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.33 145.9 24.26 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.44 -0.88 . . . . 0.0 109.621 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -125.09 161.29 27.11 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.563 1.164 . . . . 0.0 113.673 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -139.3 154.68 47.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.167 -2.288 . . . . 0.0 106.711 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 -123.33 121.54 36.08 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.93 145.75 12.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.266 0.979 . . . . 0.0 111.433 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tp -107.4 -41.36 5.1 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.839 -176.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.93 152.55 43.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.264 0.977 . . . . 0.0 110.242 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.21 123.04 18.49 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.577 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -123.09 136.8 54.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.504 1.127 . . . . 0.0 109.076 174.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -94.61 151.7 19.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 124.294 0.996 . . . . 0.0 109.32 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.49 131.39 35.55 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 123.921 0.763 . . . . 0.0 110.311 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -110.1 -11.22 14.63 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 124.183 0.927 . . . . 0.0 110.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -120.6 146.26 46.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.327 1.017 . . . . 0.0 109.424 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.38 -19.12 63.08 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.758 172.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.3 -19.81 38.7 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.099 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.38 164.67 12.01 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 123.874 0.734 . . . . 0.0 110.757 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 pt -124.58 168.86 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.556 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.52 136.24 40.6 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.494 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 90.7 mt -125.94 135.16 51.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.206 0.941 . . . . 0.0 110.674 -177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -175.86 3.95 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.43 -173.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mt -84.74 158.31 20.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 123.534 0.521 . . . . 0.0 110.781 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.0 -6.15 1.06 Allowed Glycine 0 N--CA 1.503 3.157 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.676 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.97 110.57 11.71 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -176.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 4.2 mt -93.96 138.65 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.856 176.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.8 mp -105.75 148.32 27.6 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.702 178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 m -126.7 147.34 49.96 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 124.033 0.833 . . . . 0.0 109.177 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -120.37 -154.99 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.26 -179.43 7.41 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.52 172.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.2 -37.67 3.03 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.299 -1.773 . . . . 0.0 110.259 -164.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.47 41.94 0.58 Allowed Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 p -150.88 69.69 0.97 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mt -51.77 -22.62 3.75 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 111.792 -2.458 . . . . 0.0 113.705 170.003 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 t -61.33 -9.66 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.351 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.67 -25.56 1.84 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.557 166.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 20.9 mt -118.16 -7.37 10.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 123.953 0.783 . . . . 0.0 109.42 -176.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.84 25.6 69.09 Favored Glycine 0 N--CA 1.494 2.518 0 O-C-N 124.253 0.971 . . . . 0.0 112.108 -171.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -91.49 153.08 20.04 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.846 -176.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 t -149.71 34.25 0.69 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.139 0.899 . . . . 0.0 110.588 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.5 -55.68 2.68 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.748 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.16 9.83 56.63 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 124.628 1.205 . . . . 0.0 112.127 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.03 -72.15 0.18 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.372 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 49.8 62.54 2.59 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 123.843 0.714 . . . . 0.0 109.993 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.463 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -176.9 -22.85 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.31 80.63 29.02 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 123.885 0.741 . . . . 0.0 109.113 177.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.15 -22.51 40.27 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.872 2.381 . . . . 0.0 111.938 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -50.16 -41.41 49.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.766 1.292 . . . . 0.0 112.238 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -93.63 -29.32 15.51 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 123.87 0.731 . . . . 0.0 111.463 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.8 mt -64.72 146.33 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.739 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.37 -96.5 1.07 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -98.32 128.58 44.81 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.246 -0.977 . . . . 0.0 110.35 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.49 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.5 mp -107.18 136.26 47.31 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -104.97 125.7 51.24 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.04 -164.67 13.55 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -137.27 147.04 45.43 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.131 -0.534 . . . . 0.0 110.749 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -101.1 100.31 10.87 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.9 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -54.51 -39.26 67.43 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 123.743 0.652 . . . . 0.0 111.97 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 96.9 m -52.22 -42.03 63.23 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 124.222 0.951 . . . . 0.0 112.142 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 p -105.28 0.35 27.05 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.343 1.027 . . . . 0.0 110.598 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.96 24.04 13.09 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 124.155 0.91 . . . . 0.0 112.667 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.53 166.48 12.5 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -174.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.7 ttm-85 -148.1 125.64 11.72 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.33 -162.83 26.66 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.978 -1.106 . . . . 0.0 111.173 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.93 153.79 21.48 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.696 -0.752 . . . . 0.0 109.15 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.49 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 34.9 p90 -151.24 147.83 21.28 Favored Pre-proline 0 N--CA 1.493 1.695 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.684 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.19 156.28 60.28 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.424 2.083 . . . . 0.0 112.0 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.01 44.2 1.84 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.6 t -134.43 -17.31 2.04 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.656 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.78 0.87 39.59 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.265 0.978 . . . . 0.0 111.696 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.92 -179.0 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 123.756 0.66 . . . . 0.0 109.459 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -149.18 106.53 3.62 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.046 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.463 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 77.6 t80 -43.65 128.44 5.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.097 169.294 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 pt -126.2 -58.26 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 124.019 0.824 . . . . 0.0 111.419 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.63 156.38 20.99 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -162.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.23 154.34 36.64 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.914 0.864 . . . . 0.0 112.152 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -62.69 177.15 0.57 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 113.065 -1.88 . . . . 0.0 113.093 160.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -81.61 28.31 0.41 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.466 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.7 tt -90.82 -5.15 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.766 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.1 t -138.25 72.47 45.44 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 123.939 0.774 . . . . 0.0 109.752 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.489 1.262 0 C-N-CA 122.369 2.046 . . . . 0.0 112.205 171.288 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 11.0 p -157.7 117.59 3.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 123.786 0.345 . . . . 0.0 110.13 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 1.6 mpp? -100.91 156.33 17.44 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 123.925 0.766 . . . . 0.0 109.252 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.77 170.33 0.08 Allowed 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -172.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . 0.511 ' H ' ' HZ3' ' A' ' 80' ' ' LYS . . . -165.28 135.92 3.82 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.02 177.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -94.43 92.01 6.93 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.618 0.723 . . . . 0.0 110.003 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 147.78 -169.27 28.62 Favored Glycine 0 N--CA 1.498 2.77 0 CA-C-N 113.974 -1.467 . . . . 0.0 112.076 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.42 149.58 21.23 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 114.311 -0.944 . . . . 0.0 108.663 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 6.4 mt-30 -128.44 162.07 28.02 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.234 1.016 . . . . 0.0 112.488 -175.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.42 165.32 27.76 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 112.416 -2.174 . . . . 0.0 107.835 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -128.03 115.13 18.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.949 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.48 116.4 3.07 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 123.889 0.743 . . . . 0.0 111.175 173.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tp -76.91 -33.1 57.78 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.949 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -141.25 143.02 33.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 124.296 0.997 . . . . 0.0 109.853 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.18 104.3 0.57 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.083 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 76.2 t80 -101.21 130.57 47.35 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -89.48 163.77 15.1 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 138.64 31.25 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -131.31 -19.33 2.79 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.74 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -123.64 151.26 43.22 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.864 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -63.19 -20.26 65.26 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.286 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -26.97 21.18 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.725 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.39 153.42 20.87 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.376 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -121.22 -173.67 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 124.511 1.132 . . . . 0.0 111.097 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -87.47 120.53 28.87 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 112.533 -2.121 . . . . 0.0 107.678 -174.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.2 mt -117.37 119.99 36.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.159 0.912 . . . . 0.0 108.916 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.95 -170.36 1.78 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 124.561 1.163 . . . . 0.0 109.523 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 28' ' ' ASP . 14.1 mt -84.99 156.1 21.29 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.478 178.169 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.99 9.16 2.68 Favored Glycine 0 N--CA 1.502 3.085 0 O-C-N 124.101 0.875 . . . . 0.0 113.074 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 26' ' ' LEU . 3.4 m-20 -71.45 125.17 26.33 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.358 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mp -96.37 146.91 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 124.198 0.936 . . . . 0.0 109.021 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.3 mp -115.46 161.53 18.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 112.442 -2.163 . . . . 0.0 110.911 174.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.6 m -131.31 153.95 49.05 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.748 1.28 . . . . 0.0 108.329 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.432 ' CG1' ' H ' ' A' ' 33' ' ' ASN . 2.1 t -130.03 -150.5 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.432 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 0.5 OUTLIER -80.07 178.07 8.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.583 0.552 . . . . 0.0 110.889 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 pttp -120.95 -34.03 3.62 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.077 -171.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.12 34.6 0.78 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -150.07 58.56 0.97 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -61.49 -18.94 61.29 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 113.08 -1.873 . . . . 0.0 113.565 165.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.8 t -56.85 -9.25 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-N 115.305 -0.861 . . . . 0.0 113.084 167.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.99 -35.35 0.36 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.908 1.38 . . . . 0.0 111.57 171.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.2 mp -111.52 -15.23 13.56 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.339 1.025 . . . . 0.0 111.916 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.71 31.19 13.27 Favored Glycine 0 N--CA 1.502 3.055 0 O-C-N 124.167 0.917 . . . . 0.0 112.301 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.76 148.8 15.72 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 113.942 -1.129 . . . . 0.0 113.013 174.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -139.67 37.84 2.01 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.78 -172.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.07 -50.58 0.26 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.34 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.74 88.07 0.11 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -130.11 -60.93 1.0 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -173.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 47.68 40.5 12.08 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 124.642 1.214 . . . . 0.0 111.915 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.48 0.57 0.2 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.006 -173.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -128.93 69.7 80.83 Favored Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 123.606 0.566 . . . . 0.0 111.266 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.93 -4.87 4.04 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.639 2.226 . . . . 0.0 113.67 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.51 -45.5 53.46 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 123.732 0.645 . . . . 0.0 110.756 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -92.47 -28.94 16.51 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 124.057 0.848 . . . . 0.0 111.141 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.7 mt -65.02 143.37 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 123.766 0.666 . . . . 0.0 109.741 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.42 -99.91 1.05 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -89.62 144.59 25.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.492 0.76 . . . . 0.0 110.467 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.2 mp -122.5 130.1 52.69 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.329 170.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -91.27 121.69 33.24 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.38 177.7 25.48 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 120.048 -1.072 . . . . 0.0 113.008 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.69 123.63 45.99 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 113.559 -1.32 . . . . 0.0 109.226 174.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -89.47 80.78 6.67 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.42 1.105 . . . . 0.0 108.506 170.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -49.48 -24.95 2.28 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.961 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 18.1 m -53.13 -41.55 65.18 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.19 0.931 . . . . 0.0 112.075 -176.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.8 p -119.41 6.3 11.13 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.428 1.08 . . . . 0.0 109.161 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.87 60.12 8.57 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 124.283 0.989 . . . . 0.0 111.12 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -139.74 160.67 39.35 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.406 0.709 . . . . 0.0 109.999 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -116.25 140.28 49.48 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.96 -155.5 17.34 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.343 -1.408 . . . . 0.0 111.994 164.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.22 166.43 10.64 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.695 -1.252 . . . . 0.0 110.151 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.9 p90 -161.89 145.59 9.43 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.889 170.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.24 154.12 75.39 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.233 1.955 . . . . 0.0 113.169 173.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.21 -16.82 63.91 Favored Glycine 0 N--CA 1.499 2.873 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.265 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.4 p -75.8 -14.11 60.3 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 122.245 0.218 . . . . 0.0 111.522 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.28 3.61 35.64 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 123.998 0.811 . . . . 0.0 111.658 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.89 -178.6 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 123.878 0.736 . . . . 0.0 109.237 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -147.79 111.35 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.453 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 41.3 t80 -51.28 140.92 15.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 123.753 0.658 . . . . 0.0 109.603 174.115 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -118.99 -56.47 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 124.431 1.082 . . . . 0.0 110.472 177.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.04 147.74 17.17 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.705 -1.236 . . . . 0.0 111.151 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.453 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -130.96 125.0 32.24 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 112.856 -1.672 . . . . 0.0 109.128 173.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.511 ' HZ3' ' H ' ' A' ' 3' ' ' ALA . 71.7 mttt -78.12 138.16 38.58 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.446 173.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -73.69 77.38 1.54 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.714 1.259 . . . . 0.0 109.893 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 43.5 mt -94.63 91.28 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.361 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.72 159.41 48.71 Favored Pre-proline 0 N--CA 1.505 2.288 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.072 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 C-N-CA 121.825 1.683 . . . . 0.0 111.206 178.487 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 CA-C-O 121.479 0.489 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 5.3 p -171.74 129.09 0.65 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.019 -1.091 . . . . 0.0 109.454 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 1.7 mmt -56.31 -38.41 71.25 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 124.039 0.837 . . . . 0.0 111.116 174.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -84.47 -170.39 3.08 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.992 0.808 . . . . 0.0 110.677 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.33 150.64 45.61 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.968 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -143.15 91.82 2.32 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.447 173.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -120.08 165.25 13.62 Favored Glycine 0 N--CA 1.497 2.743 0 O-C-N 124.662 1.226 . . . . 0.0 111.3 -178.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.92 152.05 51.95 Favored 'General case' 0 N--CA 1.512 2.652 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 -152.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -128.98 168.49 15.94 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.376 1.084 . . . . 0.0 111.705 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -143.51 123.15 13.29 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 112.275 -2.239 . . . . 0.0 105.563 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -89.39 122.04 32.23 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.76 146.28 10.77 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 123.642 0.589 . . . . 0.0 110.734 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 tp -114.92 -28.79 6.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 124.115 0.884 . . . . 0.0 110.43 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 156.77 48.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 123.954 0.784 . . . . 0.0 110.831 -174.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.39 103.57 16.24 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.596 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.4 t80 -110.55 133.26 53.46 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -89.43 158.69 17.63 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 139.68 30.24 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.591 -0.843 . . . . 0.0 110.173 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -128.99 -13.6 4.54 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.192 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.78 140.87 36.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 124.217 0.948 . . . . 0.0 109.322 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.84 -21.84 3.22 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.379 -1.282 . . . . 0.0 114.044 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -59.48 -57.76 11.58 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.799 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -83.29 174.05 11.06 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.053 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.0 pt -129.48 177.05 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 124.267 0.979 . . . . 0.0 111.674 175.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.83 136.75 47.14 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.473 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 15.5 mt -126.38 133.19 51.38 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 123.973 0.795 . . . . 0.0 111.159 179.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -145.26 170.65 15.88 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.343 1.027 . . . . 0.0 110.695 -176.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 28' ' ' ASP . 2.0 mt -66.8 151.09 48.15 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 123.481 0.488 . . . . 0.0 110.413 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.9 -9.83 3.51 Favored Glycine 0 N--CA 1.501 2.976 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.036 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 26' ' ' LEU . 15.7 t70 -74.86 108.05 7.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.8 152.34 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 115.437 -0.802 . . . . 0.0 108.882 176.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.2 mp -129.19 127.54 41.54 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.6 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.9 m -107.23 140.28 40.35 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.394 1.058 . . . . 0.0 108.961 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.5 -136.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 124.443 1.089 . . . . 0.0 108.725 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -109.27 -157.52 0.62 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 123.871 0.732 . . . . 0.0 109.441 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -137.61 -0.69 2.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 124.663 1.227 . . . . 0.0 111.051 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.69 -50.68 63.31 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 153.65 -53.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 126.061 1.683 . . . . 0.0 106.626 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -176.97 -21.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.535 -1.666 . . . . 0.0 111.487 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.2 t -65.1 -17.83 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 CA-C-O 121.174 0.511 . . . . 0.0 111.422 173.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.35 -27.86 4.4 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.307 167.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.3 mp -105.1 -13.18 15.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.127 0.892 . . . . 0.0 111.269 177.063 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.4 27.21 8.77 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 124.195 0.935 . . . . 0.0 111.377 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -95.34 168.59 10.63 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.34 -0.93 . . . . 0.0 111.956 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -147.69 112.13 5.27 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 113.72 -1.582 . . . . 0.0 107.301 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.1 t70 43.27 90.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.618 1.199 . . . . 0.0 113.751 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.69 -7.41 1.86 Allowed Glycine 0 N--CA 1.495 2.621 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.759 -171.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 51.77 98.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.043 0.937 . . . . 0.0 110.123 -170.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.92 -24.63 0.43 Allowed 'General case' 0 N--CA 1.511 2.598 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 175.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.18 10.25 20.07 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.472 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -129.0 77.46 77.9 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.25 -18.22 50.93 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.411 2.074 . . . . 0.0 112.828 170.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -53.42 -41.47 66.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.125 0.891 . . . . 0.0 111.901 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.61 -26.36 20.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.053 0.846 . . . . 0.0 110.689 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.3 mt -79.97 139.17 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 123.961 0.788 . . . . 0.0 109.287 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -93.06 1.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -95.92 120.25 35.87 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 113.708 -1.246 . . . . 0.0 109.169 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.486 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.9 mp -96.76 136.26 37.56 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 170.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -98.63 123.44 42.82 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.33 -178.39 27.84 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -133.8 144.12 48.8 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.762 0.33 . . . . 0.0 111.18 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.24 98.52 8.65 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.166 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -57.75 -29.21 64.6 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.343 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.0 m -53.05 -43.51 66.72 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 123.905 0.753 . . . . 0.0 112.143 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 22.3 p -102.64 -4.1 25.66 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 124.274 0.984 . . . . 0.0 110.187 178.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.14 28.4 61.29 Favored Glycine 0 N--CA 1.493 2.435 0 O-C-N 124.149 0.906 . . . . 0.0 111.926 -172.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -104.17 155.72 18.48 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -143.11 137.57 29.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.065 0.853 . . . . 0.0 110.186 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.32 -155.06 21.73 Favored Glycine 0 N--CA 1.492 2.399 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.429 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.81 153.26 22.74 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.233 -0.983 . . . . 0.0 108.866 -174.32 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.486 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 32.9 p90 -147.95 148.86 31.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.799 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.14 158.12 41.08 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.985 1.79 . . . . 0.0 111.92 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.99 53.6 0.63 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -151.38 -15.89 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.049 0.499 . . . . 0.0 112.108 174.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -94.87 -4.81 46.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 123.977 0.798 . . . . 0.0 112.324 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.4 m -109.64 -166.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 123.954 0.784 . . . . 0.0 109.253 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.28 113.15 5.11 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -48.75 128.34 15.27 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.783 165.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 pt -114.7 -84.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 124.36 1.038 . . . . 0.0 110.4 178.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.83 161.13 13.1 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -171.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.69 22.03 14.45 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.939 0.876 . . . . 0.0 112.635 -177.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.18 27.99 0.11 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 123.194 1.473 . . . . 0.0 109.273 -174.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.5 17.46 2.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 112.041 -2.345 . . . . 0.0 112.318 175.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -89.25 134.31 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 152.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.07 166.37 15.34 Favored Pre-proline 0 N--CA 1.511 2.596 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.067 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.493 1.456 0 C-N-CA 122.043 1.828 . . . . 0.0 112.337 175.112 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 CA-C-O 119.935 -0.37 . . . . 0.0 112.916 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 8.1 t -82.35 -27.59 32.09 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.845 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 0.0 OUTLIER 72.47 -31.07 0.22 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 124.551 1.157 . . . . 0.0 113.145 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.3 t -155.36 141.74 18.62 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.98 112.48 10.15 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.366 -0.933 . . . . 0.0 109.249 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -131.24 96.86 4.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.601 164.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.91 -146.87 0.04 OUTLIER Glycine 0 N--CA 1.494 2.552 0 CA-C-N 113.244 -1.798 . . . . 0.0 112.832 167.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.88 150.76 20.38 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -174.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -126.16 163.26 23.51 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.21 0.943 . . . . 0.0 111.363 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -139.1 160.12 40.55 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.543 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -126.63 118.72 25.38 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -174.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.83 130.77 38.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.857 0.723 . . . . 0.0 110.73 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -85.38 -45.89 11.46 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.226 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -143.23 156.67 44.8 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.395 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.17 111.68 1.82 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.442 173.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.3 t80 -120.93 133.39 55.28 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.973 177.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -90.1 161.75 15.64 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -89.68 147.55 23.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.839 0.712 . . . . 0.0 111.548 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -117.62 -4.53 11.22 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.3 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -146.57 148.84 32.55 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -52.68 -22.59 5.32 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.076 172.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -69.66 -45.56 68.13 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.235 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.38 158.18 16.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 123.965 0.791 . . . . 0.0 109.005 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 pt -115.16 170.68 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 124.185 0.928 . . . . 0.0 111.792 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.71 136.61 38.2 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.257 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.5 mt -125.46 133.37 52.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.345 1.028 . . . . 0.0 109.917 -177.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.57 -167.88 1.59 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.686 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.403 ' C ' ' H ' ' A' ' 28' ' ' ASP . 68.1 mt -89.22 157.98 18.04 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.627 176.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 58.7 1.71 0.92 Allowed Glycine 0 N--CA 1.505 3.244 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.39 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.403 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.3 OUTLIER -76.28 108.54 9.29 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.77 -0.715 . . . . 0.0 110.972 -173.446 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.4 tp -90.51 149.65 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.033 -177.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mp -119.07 151.85 37.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.3 m -132.89 146.52 51.87 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.015 0.822 . . . . 0.0 109.627 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 t -128.95 -157.39 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.31 179.39 4.57 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.782 174.368 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -114.96 -38.88 3.79 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.909 -172.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.57 41.72 0.74 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -175.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.0 t -147.62 69.66 1.15 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.12 -19.34 1.1 Allowed 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.243 -2.253 . . . . 0.0 111.788 167.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.78 -17.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 123.797 0.686 . . . . 0.0 111.687 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.29 -20.82 4.66 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 123.947 0.779 . . . . 0.0 112.63 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 42.3 mt -129.37 5.39 5.21 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.21 30.07 72.9 Favored Glycine 0 N--CA 1.497 2.708 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.04 -170.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.81 169.01 16.59 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.325 -0.938 . . . . 0.0 109.86 -170.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.3 p -137.59 -157.07 0.74 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.99 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.66 93.8 0.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.24 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -125.17 -109.17 1.75 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -154.53 -38.64 0.09 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.354 0.679 . . . . 0.0 110.263 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 54.27 57.32 5.98 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 124.301 1.001 . . . . 0.0 110.452 -177.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.448 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -164.35 -11.35 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.361 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -122.25 82.39 45.39 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 124.502 1.126 . . . . 0.0 109.344 177.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -52.8 -20.0 12.02 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.589 2.193 . . . . 0.0 112.054 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.77 -43.17 80.55 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.936 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.01 -29.11 18.64 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 123.632 0.582 . . . . 0.0 111.485 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 mt -66.25 145.4 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.49 -73.29 1.27 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -127.95 133.75 49.25 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.561 -1.82 . . . . 0.0 107.932 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.487 ' HG ' ' CZ ' ' A' ' 69' ' ' PHE . 0.4 OUTLIER -127.2 144.46 51.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.176 0.922 . . . . 0.0 109.172 174.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.47 145.58 25.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.633 1.208 . . . . 0.0 107.839 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.81 179.7 42.6 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 173.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -128.91 142.12 51.05 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.886 -0.657 . . . . 0.0 109.808 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.434 ' ND2' ' HB ' ' A' ' 62' ' ' THR . 0.2 OUTLIER -114.03 82.73 1.75 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 125.176 1.547 . . . . 0.0 109.528 178.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -27.1 49.28 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.776 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.434 ' HB ' ' ND2' ' A' ' 60' ' ' ASN . 31.0 m -52.12 -42.68 63.5 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 123.924 0.765 . . . . 0.0 111.562 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -109.12 -3.51 17.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.799 1.312 . . . . 0.0 109.758 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.77 65.7 2.91 Favored Glycine 0 N--CA 1.493 2.447 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.049 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -137.23 162.05 34.54 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.314 0.655 . . . . 0.0 110.247 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -148.15 131.04 16.14 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.383 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.46 -163.42 36.59 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.506 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -102.87 152.44 21.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.487 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 41.2 p90 -148.02 152.27 39.72 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.413 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -66.6 151.23 83.24 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.071 1.847 . . . . 0.0 112.24 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.36 19.79 29.94 Favored Glycine 0 N--CA 1.496 2.697 0 O-C-N 124.093 0.871 . . . . 0.0 112.006 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.419 ' H ' ' HG1' ' A' ' 72' ' ' THR . 0.8 OUTLIER -109.83 -35.18 6.24 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.311 0.577 . . . . 0.0 110.911 -178.1 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -90.21 8.37 33.45 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.479 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.2 m -125.87 179.42 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 123.628 0.58 . . . . 0.0 110.263 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -150.06 106.41 3.49 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.713 0.768 . . . . 0.0 110.262 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.448 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 80.0 t80 -44.64 126.16 5.34 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.244 -1.343 . . . . 0.0 111.253 167.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.413 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -115.13 -62.25 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 123.969 0.793 . . . . 0.0 110.889 -177.881 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.413 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -139.94 161.5 26.32 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -161.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -160.75 105.47 1.4 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.583 -1.308 . . . . 0.0 109.139 -171.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -72.34 89.51 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -53.96 106.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.34 -2.209 . . . . 0.0 109.012 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.84 15.06 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.052 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.28 150.92 32.82 Favored Pre-proline 0 N--CA 1.492 1.646 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.878 175.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 C-N-CA 121.982 1.788 . . . . 0.0 112.068 172.464 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.1 OUTLIER -64.05 135.15 56.17 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.202 -0.499 . . . . 0.0 110.745 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.7 mmm -52.96 -27.51 19.38 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 124.278 0.986 . . . . 0.0 111.749 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.6 p -157.65 140.66 15.12 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.113 0.883 . . . . 0.0 108.935 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.51 179.2 1.06 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.687 0.617 . . . . 0.0 111.526 171.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.64 -28.48 21.6 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.613 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.23 -133.2 37.98 Favored Glycine 0 N--CA 1.495 2.593 0 O-C-N 124.528 1.143 . . . . 0.0 112.753 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.65 159.25 15.04 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.433 -0.883 . . . . 0.0 109.699 168.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -134.11 158.92 42.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.006 0.817 . . . . 0.0 111.589 -178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -138.58 138.62 38.1 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.811 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -94.47 121.88 36.46 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.115 0.884 . . . . 0.0 109.894 171.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.84 119.87 6.94 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.848 167.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.02 -57.89 3.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.603 0.564 . . . . 0.0 109.889 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.97 156.98 25.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.38 1.05 . . . . 0.0 109.919 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.92 134.3 51.74 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.985 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -132.71 128.47 37.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 124.361 1.038 . . . . 0.0 110.208 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -89.58 168.25 12.3 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.662 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 145.95 25.06 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.311 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.87 -3.62 8.65 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.481 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -143.42 145.05 32.31 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.024 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.47 -15.14 2.42 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 114.981 -1.008 . . . . 0.0 113.29 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -74.64 -46.47 37.99 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.558 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 152.31 22.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.083 0.864 . . . . 0.0 109.893 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.59 -170.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 124.472 1.108 . . . . 0.0 109.577 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -95.19 106.34 18.35 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.52 -1.673 . . . . 0.0 108.715 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.508 ' N ' ' CD2' ' A' ' 24' ' ' LEU . 1.8 mm? -88.98 143.14 27.06 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.646 172.657 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.52 -173.19 3.28 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.21 -179.289 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mt -78.25 150.92 33.32 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.019 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.07 -3.47 1.61 Allowed Glycine 0 N--CA 1.506 3.347 0 O-C-N 123.413 0.446 . . . . 0.0 113.588 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.26 116.48 8.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 123.928 0.428 . . . . 0.0 109.95 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 mt -102.3 139.12 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.768 0.794 . . . . 0.0 110.019 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.44 HD21 ' CE2' ' A' ' 69' ' ' PHE . 10.2 mp -117.67 162.19 18.45 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 112.909 -1.951 . . . . 0.0 109.454 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.85 147.68 49.95 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 124.036 0.835 . . . . 0.0 108.833 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -121.7 -169.24 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 123.53 0.519 . . . . 0.0 109.829 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.6 m-80 -99.88 136.66 39.47 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.285 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 -38.82 8.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.706 1.254 . . . . 0.0 110.783 177.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.25 -5.74 86.97 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 m -158.47 38.59 0.24 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.72 -31.21 64.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.726 172.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.8 t -50.3 -8.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-N 114.192 -1.367 . . . . 0.0 113.944 170.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.4 -37.22 0.08 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.792 170.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 11.2 mp -96.41 -26.04 15.48 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.864 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.75 17.65 9.57 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 124.68 1.238 . . . . 0.0 110.978 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.29 173.82 5.36 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.57 -0.815 . . . . 0.0 112.207 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.5 m -140.81 -166.08 2.07 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.253 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.27 86.01 0.16 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.07 0.856 . . . . 0.0 109.866 174.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.9 -113.26 2.31 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -157.62 87.25 0.95 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.03 -19.37 65.83 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.438 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.07 1.2 28.75 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.91 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -124.77 79.39 63.66 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.51 -31.08 80.39 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.814 1.676 . . . . 0.0 111.404 175.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.93 -39.25 39.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.538 1.149 . . . . 0.0 112.129 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -90.0 -31.95 16.98 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.126 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 61.7 mt -65.93 151.74 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 123.852 0.72 . . . . 0.0 110.452 176.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.5 -102.78 1.08 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -91.0 140.3 29.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.417 0.716 . . . . 0.0 110.885 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.495 HD11 ' CE2' ' A' ' 69' ' ' PHE . 97.9 mt -107.05 135.69 48.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.19 124.15 48.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 124.195 0.934 . . . . 0.0 108.778 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.27 -170.63 33.22 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.317 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -94.72 146.47 24.15 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.24 -0.98 . . . . 0.0 110.082 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.87 64.63 0.81 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.042 -1.436 . . . . 0.0 108.693 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -56.93 -23.9 48.6 Favored 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.755 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.6 m -53.44 -34.73 58.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.849 0.718 . . . . 0.0 111.594 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 39.1 p -108.89 -5.17 16.28 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.771 177.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.2 40.67 49.28 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -143.59 176.38 9.25 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -147.25 147.35 30.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 123.924 0.765 . . . . 0.0 109.168 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.87 -153.67 13.64 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.269 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.2 149.71 29.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.495 ' CE2' HD11 ' A' ' 56' ' ' LEU . 7.4 p90 -151.2 142.82 15.65 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.258 178.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.12 157.98 15.93 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.459 2.106 . . . . 0.0 112.874 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.2 28.57 14.04 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 124.39 1.056 . . . . 0.0 113.508 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.9 t -133.81 -3.03 2.91 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 117.202 0.501 . . . . 0.0 110.725 -170.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.7 p90 -121.33 -6.43 9.34 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 123.918 0.761 . . . . 0.0 111.275 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -97.48 178.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 124.139 0.899 . . . . 0.0 109.508 -179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -149.34 104.85 3.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.462 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 28.5 t80 -47.05 142.93 3.3 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.636 172.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -122.97 -51.71 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 124.313 1.008 . . . . 0.0 111.958 -179.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.33 146.41 13.9 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.978 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.462 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 20.0 ptt-85 -127.69 123.23 34.98 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.485 -1.357 . . . . 0.0 111.102 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 16.3 mttp -112.03 45.28 1.28 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.766 177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.25 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.049 175.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.0 tp -148.02 107.52 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-O 122.3 1.048 . . . . 0.0 113.189 -174.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.537 ' H ' ' HG ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -91.55 -47.99 0.34 Allowed Pre-proline 0 N--CA 1.498 1.955 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.098 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 83' ' ' SER . 1.5 Cg_endo . . . . . 0 N--CA 1.486 1.072 0 CA-C-O 116.385 -1.589 . . . . 0.0 111.074 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 15.7 m -149.43 -16.98 0.28 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.122 0.542 . . . . 0.0 110.91 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 4.6 mmt -86.95 -30.83 21.02 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.643 0.589 . . . . 0.0 110.659 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 t -89.45 114.74 26.26 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 123.796 0.685 . . . . 0.0 110.589 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -170.17 32.95 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.859 0.724 . . . . 0.0 111.981 -178.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -67.3 84.33 0.15 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.304 1.05 . . . . 0.0 111.28 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.83 -162.09 27.76 Favored Glycine 0 N--CA 1.496 2.661 0 CA-C-N 112.566 -2.106 . . . . 0.0 110.125 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -98.51 152.34 19.65 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -172.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -128.74 160.85 31.24 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.406 1.098 . . . . 0.0 112.394 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -148.93 118.92 7.14 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 112.542 -2.117 . . . . 0.0 105.288 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.01 124.21 38.93 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.37 114.25 1.74 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.005 0.816 . . . . 0.0 110.429 174.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 tp -78.5 -31.87 47.9 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.366 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.74 144.14 37.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.436 1.085 . . . . 0.0 108.889 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -64.3 108.65 1.65 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.159 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -113.75 136.99 52.25 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -89.7 -178.5 5.54 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -89.93 122.56 33.07 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.327 171.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -90.06 -7.77 53.07 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.945 0.778 . . . . 0.0 110.727 172.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -144.73 150.65 37.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 124.028 0.83 . . . . 0.0 109.648 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.62 -15.65 3.18 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.18 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.48 -41.29 27.8 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.931 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.33 168.24 18.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 123.691 0.619 . . . . 0.0 111.428 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.56 -164.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 124.144 0.902 . . . . 0.0 109.827 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -100.43 108.04 19.93 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.683 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 5.3 mp -92.63 123.08 35.66 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 113.529 -1.668 . . . . 0.0 109.71 173.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.03 167.32 11.88 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.687 170.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mt -53.8 150.4 7.51 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.024 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.06 -14.05 3.03 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 114.969 -1.014 . . . . 0.0 114.345 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.87 117.35 6.25 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tp -94.73 148.65 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 123.915 0.759 . . . . 0.0 109.152 171.147 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.3 mp -121.98 135.27 54.84 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.5 m -122.04 140.2 52.78 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 124.143 0.902 . . . . 0.0 108.687 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.63 -175.45 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.42 176.11 7.08 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.973 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -78.23 -20.95 50.71 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.357 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.17 33.31 2.1 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -175.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.7 1.2 5.62 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.689 -0.755 . . . . 0.0 112.229 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 mt -63.94 -42.65 97.28 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.1 t -81.44 -8.87 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.11 -177.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.51 -37.86 0.52 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.094 0.871 . . . . 0.0 109.571 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tp -97.57 -49.84 4.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.199 -1.819 . . . . 0.0 107.897 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.66 39.87 0.75 Allowed Glycine 0 N--CA 1.493 2.483 0 CA-C-N 111.781 -2.463 . . . . 0.0 113.362 -165.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -58.96 167.17 1.71 Allowed 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 166.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.7 p -136.88 29.41 2.85 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.453 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.58 -160.53 1.06 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.596 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.82 3.84 0.35 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -167.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.3 55.31 2.52 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 122.037 0.922 . . . . 0.0 109.466 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.08 -23.91 66.61 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.038 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.6 -6.35 53.45 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.909 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.53 86.97 35.51 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.68 -6.1 10.03 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.721 2.281 . . . . 0.0 113.75 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -65.97 -35.8 81.59 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.485 0.491 . . . . 0.0 111.947 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -89.2 -28.16 20.16 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 123.678 0.611 . . . . 0.0 110.537 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.0 mt -80.3 141.3 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.8 -84.46 1.34 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -91.49 125.15 36.14 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 113.032 -1.584 . . . . 0.0 110.16 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.427 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.3 mp -102.68 131.17 49.66 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 168.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.96 122.31 40.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 168.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.89 -175.31 22.7 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.973 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -120.28 133.53 55.45 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.816 -0.692 . . . . 0.0 110.182 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -99.18 82.83 2.77 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 124.501 1.126 . . . . 0.0 109.132 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -48.05 -28.51 2.88 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.274 172.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 m -55.93 -49.16 74.25 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.022 0.826 . . . . 0.0 111.075 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.441 ' H ' ' HG1' ' A' ' 63' ' ' THR . 13.5 p -95.3 0.01 53.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.306 1.004 . . . . 0.0 110.303 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.95 45.56 96.34 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.455 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.85 174.39 10.7 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.358 0.681 . . . . 0.0 109.933 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -145.0 144.24 30.93 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.91 -175.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.28 -158.16 20.44 Favored Glycine 0 N--CA 1.493 2.484 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.749 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.15 168.96 8.99 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.736 -1.232 . . . . 0.0 110.289 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.427 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 17.7 p90 -164.16 144.7 6.6 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.912 170.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.8 160.47 40.62 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 121.975 1.783 . . . . 0.0 112.109 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.64 54.65 1.24 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.2 t -137.37 -29.84 0.87 Allowed 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -91.58 -6.05 53.01 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.396 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.19 167.69 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.599 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -139.06 127.05 22.33 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -49.86 144.07 6.89 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.403 167.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.77 -54.99 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 124.026 0.828 . . . . 0.0 111.107 175.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.86 152.76 23.68 Favored Glycine 0 N--CA 1.496 2.668 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.353 -165.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.3 149.48 37.89 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 124.486 0.756 . . . . 0.0 111.759 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -124.07 42.79 3.16 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.211 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -40.46 110.62 0.16 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 113.593 -1.64 . . . . 0.0 112.159 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.0 tp -133.06 95.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.165 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.486 ' H ' ' HG ' ' A' ' 83' ' ' SER . 0.0 OUTLIER -99.42 160.92 26.26 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.538 177.488 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.49 1.292 0 C-N-CA 122.124 1.883 . . . . 0.0 112.766 174.626 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.743 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.0 OUTLIER -155.4 147.06 23.11 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 7.8 ttt -154.46 -46.68 0.09 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.8 m -139.95 80.2 1.75 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.457 1.098 . . . . 0.0 109.437 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.68 153.23 20.76 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.349 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -154.3 83.45 1.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 124.209 0.943 . . . . 0.0 109.94 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 99.44 141.7 12.47 Favored Glycine 0 N--CA 1.495 2.569 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.046 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.52 -178.3 4.72 Favored 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -167.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -150.0 162.0 41.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.184 0.992 . . . . 0.0 111.815 -176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -131.8 140.0 49.06 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.126 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -90.97 124.51 35.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.79 0.681 . . . . 0.0 110.084 161.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.43 121.55 9.23 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.809 0.693 . . . . 0.0 111.258 165.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.35 -67.98 0.82 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.228 0.955 . . . . 0.0 109.627 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -94.59 137.26 33.92 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.367 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -68.55 91.2 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 124.13 0.894 . . . . 0.0 110.515 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -92.98 133.05 36.51 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.954 177.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -90.31 163.15 14.85 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.365 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -89.0 115.97 26.95 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.437 0.637 . . . . 0.0 111.611 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -89.08 -14.44 36.3 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.942 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.54 155.49 43.7 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.843 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -63.37 -26.21 68.65 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.852 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.08 -28.4 69.05 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.511 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.25 152.35 25.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.54 1.15 . . . . 0.0 110.812 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 pt -113.03 176.12 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.002 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -69.96 137.4 51.44 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.084 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 67.6 mt -126.99 90.41 3.15 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.5 166.3 10.53 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.751 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.417 ' C ' ' H ' ' A' ' 28' ' ' ASP . 2.9 mt -64.92 162.13 17.05 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.28 -175.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.41 -11.33 13.25 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.498 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.417 ' H ' ' C ' ' A' ' 26' ' ' LEU . 1.3 m-20 -95.69 133.7 39.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.398 0.705 . . . . 0.0 109.587 -179.724 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.65 143.73 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.963 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.2 mp -106.32 139.51 40.7 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.67 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.2 m -112.1 144.82 40.83 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 123.871 0.732 . . . . 0.0 110.508 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.68 173.51 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 123.951 0.782 . . . . 0.0 110.686 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.405 ' N ' ' HB2' ' A' ' 36' ' ' SER . 3.7 t30 -80.77 171.34 15.14 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-N 114.409 -1.269 . . . . 0.0 114.106 175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -73.82 -10.44 59.67 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.683 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.67 28.66 2.16 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.405 ' HB2' ' N ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -71.69 -9.19 57.9 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.41 -0.895 . . . . 0.0 111.449 -179.276 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -75.1 -37.87 61.35 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 175.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.5 t -77.01 -9.37 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 113.77 -1.559 . . . . 0.0 114.656 176.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -40.1 -31.98 0.15 Allowed 'General case' 0 N--CA 1.506 2.372 0 O-C-N 124.173 0.92 . . . . 0.0 111.677 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.2 mt -94.6 17.27 13.61 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.122 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.64 35.26 51.6 Favored Glycine 0 N--CA 1.498 2.786 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.573 -161.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.67 174.14 1.91 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.508 -0.846 . . . . 0.0 112.866 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.533 ' HG ' ' N ' ' A' ' 44' ' ' ASP . 2.2 t -100.35 160.15 14.57 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.459 171.23 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.533 ' N ' ' HG ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -48.74 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.63 170.055 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -102.76 -108.2 3.21 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -163.17 -6.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.692 0.878 . . . . 0.0 112.009 -174.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 34.76 61.99 0.55 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 124.666 1.229 . . . . 0.0 113.856 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.87 -7.77 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 113.208 -1.815 . . . . 0.0 111.221 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -124.26 75.2 60.48 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 124.113 0.883 . . . . 0.0 111.388 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.2 -11.54 10.74 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.221 1.947 . . . . 0.0 113.56 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -65.95 -40.64 91.51 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.089 0.868 . . . . 0.0 111.543 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -91.38 -21.33 21.05 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 123.769 0.668 . . . . 0.0 112.002 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.4 mt -82.77 145.83 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.29 -88.16 1.24 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -89.76 145.26 25.32 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 113.608 -1.296 . . . . 0.0 109.9 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.437 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.2 mp -124.04 125.46 44.57 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.405 166.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.94 119.28 32.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 123.891 0.744 . . . . 0.0 109.079 168.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.13 -165.31 10.62 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 171.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.8 134.99 34.15 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -96.77 76.08 2.77 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -43.16 -33.23 0.86 Allowed 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 113.97 -1.468 . . . . 0.0 112.929 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.5 m -55.21 -49.59 71.56 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 124.208 0.943 . . . . 0.0 111.336 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.4 p -93.37 -4.34 51.67 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.148 0.905 . . . . 0.0 110.888 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.85 60.07 8.67 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 123.884 0.74 . . . . 0.0 111.329 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.58 154.56 45.51 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.343 0.672 . . . . 0.0 109.314 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -127.87 135.21 49.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.328 1.017 . . . . 0.0 108.446 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.92 -168.68 39.12 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.18 -1.486 . . . . 0.0 112.69 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -108.02 165.76 11.23 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.149 -1.525 . . . . 0.0 109.181 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.437 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.6 p90 -160.03 143.23 10.23 Favored Pre-proline 0 N--CA 1.494 1.725 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.379 175.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.76 155.54 68.69 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.967 1.778 . . . . 0.0 110.937 172.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.05 49.64 3.58 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 8.0 t -129.97 -28.84 2.14 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -96.82 13.53 28.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 124.193 0.933 . . . . 0.0 111.537 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.28 178.71 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 114.67 -1.15 . . . . 0.0 107.926 -170.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -150.63 116.63 5.59 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -51.58 127.3 19.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 123.856 0.722 . . . . 0.0 109.883 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.66 -55.99 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 124.598 1.187 . . . . 0.0 109.757 177.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.95 161.83 35.37 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 118.643 -1.741 . . . . 0.0 112.237 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.57 42.56 1.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 112.117 -2.042 . . . . 0.0 110.486 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -64.68 98.48 0.27 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.202 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.98 103.94 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.788 171.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.8 tp -89.44 95.78 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 CA-C-O 122.377 1.084 . . . . 0.0 110.154 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.98 160.5 37.53 Favored Pre-proline 0 N--CA 1.503 2.215 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.127 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.492 1.396 0 C-N-CA 122.46 2.107 . . . . 0.0 112.652 177.881 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.1 OUTLIER -98.79 -62.46 1.23 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -175.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 14.1 mmt -71.83 -7.52 48.81 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.073 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.2 p -69.06 -167.43 0.11 Allowed 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.72 141.15 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -125.49 79.38 1.81 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -172.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -131.82 162.05 23.8 Favored Glycine 0 N--CA 1.504 3.177 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.61 -175.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -137.02 145.31 43.94 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -143.622 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -128.03 163.12 25.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 124.641 1.213 . . . . 0.0 111.839 -168.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -140.59 124.22 17.05 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 112.3 -2.227 . . . . 0.0 105.68 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -91.89 124.66 36.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.1 118.5 5.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 124.162 0.914 . . . . 0.0 110.692 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -60.75 2.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 124.02 0.825 . . . . 0.0 109.213 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.31 168.94 9.31 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.309 1.006 . . . . 0.0 110.228 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.7 123.88 30.88 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.349 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -121.97 138.91 54.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.45 172.52 8.94 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' H ' ' CD ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -89.74 144.52 25.9 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.136 172.841 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -134.44 -9.54 2.51 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.683 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -141.0 146.65 37.54 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.997 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.8 -17.58 9.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.461 1.101 . . . . 0.0 113.318 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -71.34 -51.07 26.29 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.383 -1.281 . . . . 0.0 111.693 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.41 153.31 21.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.135 0.897 . . . . 0.0 109.606 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pt -114.39 174.59 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 124.378 1.049 . . . . 0.0 110.93 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.75 130.17 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.719 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.66 124.33 44.96 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.579 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 172.75 11.61 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.835 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.95 150.56 48.45 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.028 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.66 -10.27 18.82 Favored Glycine 0 N--CA 1.5 2.909 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.431 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.02 110.14 1.49 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 tp -90.2 155.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.8 mp -129.23 143.69 50.95 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.184 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.8 m -128.18 143.0 51.01 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.08 -125.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.546 HD21 ' H ' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -118.94 -173.79 2.57 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.234 0.47 . . . . 0.0 111.136 -170.742 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.546 ' H ' HD21 ' A' ' 33' ' ' ASN . 2.0 mttp -112.85 -45.49 3.19 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 123.869 0.73 . . . . 0.0 112.07 -170.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.25 35.91 0.88 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 m -142.35 63.56 1.4 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mt -55.86 -24.99 40.23 Favored 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.092 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.4 t -57.18 -9.8 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -26.9 2.09 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.943 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.1 mt -117.44 -6.71 11.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.118 0.886 . . . . 0.0 110.252 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 22.53 59.69 Favored Glycine 0 N--CA 1.498 2.797 0 O-C-N 123.954 0.784 . . . . 0.0 112.143 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -80.86 146.93 30.63 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.412 -0.894 . . . . 0.0 111.829 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -150.18 38.0 0.71 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.768 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -119.27 -56.35 2.08 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.274 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.39 58.01 0.78 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -94.04 -77.35 0.46 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 112.085 -2.057 . . . . 0.0 109.501 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 35.23 38.46 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -162.56 -6.1 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.04 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -128.13 76.25 78.0 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 123.917 0.761 . . . . 0.0 110.048 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.93 -16.07 19.2 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.294 1.996 . . . . 0.0 113.514 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -59.7 -47.04 87.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 123.926 0.766 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -89.72 -31.61 17.38 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 123.957 0.785 . . . . 0.0 110.033 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.1 mt -66.49 143.63 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 123.803 0.689 . . . . 0.0 109.643 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.45 -97.78 1.07 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -93.48 135.99 34.19 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.239 -0.981 . . . . 0.0 109.834 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.466 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.4 mp -117.58 147.68 42.6 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.796 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.29 130.32 56.47 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.349 1.03 . . . . 0.0 108.223 176.464 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.44 169.96 36.34 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.55 -1.309 . . . . 0.0 112.999 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -90.73 141.1 29.15 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.17 -1.015 . . . . 0.0 109.102 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -105.49 72.56 0.98 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.442 1.089 . . . . 0.0 109.933 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -44.3 -33.78 1.72 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.291 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 m -51.72 -47.73 63.87 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 124.115 0.884 . . . . 0.0 111.975 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.8 -4.66 23.3 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.849 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.48 47.67 85.18 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -119.05 178.34 4.54 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.154 -1.023 . . . . 0.0 109.61 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -150.12 136.47 18.89 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.56 -153.89 13.54 Favored Glycine 0 N--CA 1.5 2.928 0 C-N-CA 118.916 -1.611 . . . . 0.0 113.538 165.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.79 158.29 17.1 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -172.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.466 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.5 p90 -159.53 143.84 11.06 Favored Pre-proline 0 N--CA 1.489 1.5 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.788 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.59 154.32 71.78 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.941 1.761 . . . . 0.0 111.539 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.69 19.53 19.75 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 124.128 0.893 . . . . 0.0 112.648 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.54 -32.4 7.71 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.268 0.556 . . . . 0.0 111.237 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -89.62 -0.31 57.43 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.064 -175.321 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.23 -178.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 124.194 0.934 . . . . 0.0 109.283 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -146.61 122.0 10.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.421 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 45.1 t80 -55.0 120.98 7.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 124.034 0.834 . . . . 0.0 108.98 168.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -90.85 -54.98 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.372 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -169.9 157.76 29.47 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.391 -1.385 . . . . 0.0 111.507 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.405 ' NH2' ' HZ3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -85.8 164.4 17.57 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.52 -0.84 . . . . 0.0 111.608 171.89 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.405 ' HZ3' ' NH2' ' A' ' 79' ' ' ARG . 15.4 mttp 64.89 22.85 12.55 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 122.702 1.239 . . . . 0.0 110.297 174.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 19.21 8.81 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.212 -2.267 . . . . 0.0 112.932 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.7 tt -88.48 82.98 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 CA-C-O 123.063 1.411 . . . . 0.0 112.396 156.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.2 p -150.31 69.58 8.92 Favored Pre-proline 0 N--CA 1.498 1.956 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.459 167.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.22 0 C-N-CA 121.931 1.754 . . . . 0.0 111.695 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' A GLY . . . . . 0.437 ' H1 ' ' H ' ' A' ' 1' B SER . . . . . . . . 0 N--CA 1.494 2.519 0 CA-C-O 119.937 -0.369 . . . . 0.0 112.811 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' B SER . . . . . 0.437 ' H ' ' H1 ' ' A' ' 1' A GLY . 20.5 t -86.4 -6.35 58.95 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.663 0.272 . . . . 0.0 111.428 179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 4.8 mmt -63.36 -72.84 0.13 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 123.665 0.603 . . . . 0.0 110.816 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.52 144.86 0.4 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 123.927 0.767 . . . . 0.0 110.244 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.02 -167.86 1.96 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.649 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -146.04 13.51 1.29 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 123.645 0.59 . . . . 0.0 112.091 -179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.12 -131.45 37.45 Favored Glycine 0 N--CA 1.496 2.649 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.271 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -104.24 144.14 32.0 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 114.194 -1.003 . . . . 0.0 108.671 170.704 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -120.14 159.93 23.9 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.754 0.788 . . . . 0.0 112.593 -179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -140.13 132.04 27.66 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.235 -1.802 . . . . 0.0 107.433 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -89.76 123.77 34.05 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 170.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.59 126.74 14.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.508 1.13 . . . . 0.0 111.752 164.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 tp -80.45 -36.55 33.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.099 0.874 . . . . 0.0 110.121 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -145.49 165.1 29.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.185 0.928 . . . . 0.0 110.795 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.03 121.16 23.13 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.393 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -128.47 128.48 44.46 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.227 0.954 . . . . 0.0 109.423 178.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.32 159.51 15.23 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.604 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.34 150.21 22.67 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 123.772 0.67 . . . . 0.0 109.928 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -123.73 -9.79 7.83 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.021 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -139.62 153.35 47.33 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.904 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.91 -11.21 7.2 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.392 -1.276 . . . . 0.0 113.355 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -80.45 -35.02 35.5 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.374 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -98.6 177.61 5.26 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 124.158 0.911 . . . . 0.0 111.039 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 pt -141.23 172.75 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.086 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.83 128.76 33.79 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.979 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.3 mt -127.78 140.39 52.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.971 0.794 . . . . 0.0 109.998 -173.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -140.27 -173.5 3.68 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.078 -176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 28' ' ' ASP . 4.3 mt -75.52 152.48 37.81 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.663 177.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.36 -7.87 1.72 Allowed Glycine 0 N--CA 1.498 2.82 0 CA-C-N 114.97 -1.014 . . . . 0.0 114.006 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 26' ' ' LEU . 1.2 m-20 -60.82 106.52 0.58 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 mt -98.77 126.88 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 172.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.63 158.07 16.96 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 112.56 -2.109 . . . . 0.0 108.539 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 m -134.42 147.09 50.38 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -172.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -120.1 -166.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 5.0 m120 -85.19 153.61 22.53 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.998 0.904 . . . . 0.0 111.681 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -54.95 2.81 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 112.993 -1.912 . . . . 0.0 107.625 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -100.96 10.46 58.61 Favored Glycine 0 N--CA 1.494 2.533 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.733 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.6 t -155.15 39.89 0.42 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -172.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.4 -32.78 71.65 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.204 170.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 2.9 t -52.25 -8.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 113.765 -1.561 . . . . 0.0 113.25 173.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -29.61 -41.01 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 124.927 1.291 . . . . 0.0 111.813 169.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mt -86.62 -40.45 15.14 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 112.829 -1.987 . . . . 0.0 111.468 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.48 17.16 5.31 Favored Glycine 0 N--CA 1.494 2.543 0 CA-C-N 113.039 -1.891 . . . . 0.0 110.241 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -67.95 175.18 3.22 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.725 -0.738 . . . . 0.0 111.844 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.58 150.92 30.68 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.46 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -53.05 110.0 0.48 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.385 1.053 . . . . 0.0 111.125 171.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.71 -108.04 0.83 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -153.91 91.08 1.42 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -54.75 -13.72 1.13 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.835 -1.53 . . . . 0.0 113.124 171.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.18 11.3 1.93 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.291 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.15 76.68 78.82 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 123.604 0.565 . . . . 0.0 109.532 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.26 -16.88 56.69 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.119 1.879 . . . . 0.0 112.731 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -67.09 -37.3 83.7 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 123.896 0.747 . . . . 0.0 110.945 -172.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.81 -33.79 16.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 124.184 0.928 . . . . 0.0 110.104 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.9 mt -64.97 149.1 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 124.152 0.908 . . . . 0.0 109.823 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.43 -103.86 1.09 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -89.88 137.5 32.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 124.632 0.842 . . . . 0.0 110.348 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.45 HD11 ' CE2' ' A' ' 69' ' ' PHE . 64.7 mt -106.4 131.65 53.35 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 113.934 -1.484 . . . . 0.0 107.721 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -104.77 117.44 34.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.009 0.818 . . . . 0.0 109.483 175.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.91 172.58 35.11 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.299 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.84 149.3 22.01 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.477 -0.861 . . . . 0.0 109.997 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -124.42 61.1 1.14 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.89 -22.68 5.79 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.064 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -53.01 -50.48 64.14 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.001 0.813 . . . . 0.0 111.084 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.42 ' H ' ' HG1' ' A' ' 63' ' ' THR . 5.4 p -94.2 3.28 55.47 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.476 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.51 29.42 74.77 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -123.9 173.89 7.91 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -150.45 147.48 27.59 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.79 -154.78 19.44 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.092 171.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.37 155.11 16.87 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.661 -0.769 . . . . 0.0 109.364 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.45 ' CE2' HD11 ' A' ' 56' ' ' LEU . 11.8 p90 -157.25 142.34 12.28 Favored Pre-proline 0 N--CA 1.498 1.952 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.846 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.69 151.09 49.35 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.253 1.969 . . . . 0.0 111.899 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.25 -4.39 77.62 Favored Glycine 0 N--CA 1.498 2.817 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.436 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.3 t -104.19 1.36 30.56 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 116.801 0.3 . . . . 0.0 111.345 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.35 -9.46 16.76 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 123.747 0.655 . . . . 0.0 111.988 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 m -119.3 -172.12 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 124.134 0.896 . . . . 0.0 108.983 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -150.13 124.47 9.55 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -49.78 131.57 22.03 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 124.116 0.885 . . . . 0.0 109.913 168.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -108.74 -53.68 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 124.359 1.037 . . . . 0.0 109.393 175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.73 171.18 40.11 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.97 161.44 40.49 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.52 -0.84 . . . . 0.0 109.368 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -104.7 130.23 52.78 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.922 164.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -78.76 90.27 4.64 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 112.7 -2.045 . . . . 0.0 108.846 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 tt -145.88 65.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.786 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -142.77 67.92 18.84 Favored Pre-proline 0 N--CA 1.495 1.789 0 CA-C-N 113.519 -1.673 . . . . 0.0 109.838 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.258 0 CA-C-O 116.217 -1.659 . . . . 0.0 111.807 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 68.5 m -57.02 139.33 52.56 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.281 0.636 . . . . 0.0 112.603 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 61.6 mtt -76.12 -19.64 58.33 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.792 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t -138.55 175.45 9.55 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.865 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.59 177.27 4.63 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.612 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.74 -67.85 0.78 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 168.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 33.47 146.11 0.0 OUTLIER Glycine 0 N--CA 1.512 3.728 0 N-CA-C 119.086 2.395 . . . . 0.0 119.086 -173.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.405 ' CZ ' ' O ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -150.97 149.39 29.54 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.466 0.651 . . . . 0.0 111.481 -167.609 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -133.09 166.08 23.26 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.393 -169.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -139.92 141.39 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -105.66 120.52 41.88 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.341 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.78 114.91 1.57 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.312 1.007 . . . . 0.0 111.596 168.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -63.54 1.36 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.301 176.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -103.62 143.19 33.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.05 0.844 . . . . 0.0 110.26 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.43 118.65 9.7 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 124.4 1.062 . . . . 0.0 111.164 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -129.42 128.32 42.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 124.564 1.165 . . . . 0.0 108.999 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -89.57 171.42 9.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -89.01 136.17 33.16 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -124.68 -7.66 7.38 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.719 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.65 142.81 50.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 124.258 0.974 . . . . 0.0 109.246 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -10.35 1.78 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.537 172.476 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.53 -37.5 13.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.053 0.845 . . . . 0.0 111.204 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -86.98 145.43 26.51 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 123.833 0.708 . . . . 0.0 110.471 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pt -99.58 -179.88 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 124.067 0.854 . . . . 0.0 111.8 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -79.73 138.9 37.45 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.207 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -126.95 130.03 49.3 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.652 -1.613 . . . . 0.0 108.408 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.25 33.31 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.28 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -53.84 149.27 8.97 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.01 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.84 -14.4 10.47 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.375 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.54 117.79 9.23 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.68 148.99 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 123.947 0.779 . . . . 0.0 109.431 167.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.6 mp -121.95 154.35 37.29 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.8 m -137.26 145.16 43.21 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 123.471 0.482 . . . . 0.0 109.951 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 t -122.14 -145.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 124.269 0.981 . . . . 0.0 108.487 179.194 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.405 ' O ' ' CZ ' ' A' ' 6' ' ' TYR . 5.0 m-80 -103.64 -167.87 1.43 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.7 pttt -123.14 -52.7 1.85 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.07 0.857 . . . . 0.0 110.649 -169.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.08 27.31 5.64 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.6 t -146.38 61.32 1.23 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -62.04 -6.62 3.06 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 112.539 -2.118 . . . . 0.0 113.639 164.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -64.03 -12.63 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 169.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.48 -24.08 0.76 Allowed 'General case' 0 N--CA 1.508 2.436 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.851 163.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.411 ' CD2' ' H ' ' A' ' 57' ' ' ASN . 4.7 mt -111.42 -20.62 12.16 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.44 -177.007 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.01 11.01 29.02 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 124.999 1.437 . . . . 0.0 112.412 -172.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -88.69 162.79 16.09 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 123.842 0.377 . . . . 0.0 110.637 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -150.42 36.8 0.66 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 123.734 0.647 . . . . 0.0 111.465 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -144.88 -96.66 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.743 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.12 76.38 0.03 OUTLIER Glycine 0 N--CA 1.494 2.511 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.005 -173.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -147.14 31.18 0.93 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 112.741 -1.73 . . . . 0.0 110.143 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -77.87 13.07 1.47 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.038 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.59 5.1 39.07 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.826 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -126.98 76.47 75.89 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 123.767 0.667 . . . . 0.0 109.395 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.25 -3.84 6.88 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.329 2.02 . . . . 0.0 113.732 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -71.36 -43.31 67.16 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.806 0.691 . . . . 0.0 110.985 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.68 -24.68 21.54 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.391 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.74 143.02 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.56 -91.0 1.21 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -94.81 123.43 38.26 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.767 -1.217 . . . . 0.0 110.455 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.4 mp -95.63 172.68 7.91 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.756 171.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.411 ' H ' ' CD2' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -145.17 107.44 4.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -175.414 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.53 -176.78 23.84 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.513 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . 0.402 ' CZ ' ' HD2' ' A' ' 66' ' ' ARG . 6.8 m-85 -106.81 153.27 22.72 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.295 -0.953 . . . . 0.0 110.234 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 8.5 t-20 -123.99 60.77 1.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.849 -1.523 . . . . 0.0 107.486 -177.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -42.86 -36.33 1.46 Allowed 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.954 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 p -49.55 -54.58 17.29 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.514 1.134 . . . . 0.0 113.756 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -93.76 3.21 55.78 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.627 0.58 . . . . 0.0 111.29 172.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.23 17.46 56.05 Favored Glycine 0 N--CA 1.496 2.668 0 O-C-N 123.845 0.715 . . . . 0.0 112.227 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.5 167.94 10.84 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.402 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 4.3 ptm180 -150.24 148.82 29.35 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.229 0.538 . . . . 0.0 110.246 175.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.2 -156.41 28.0 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.243 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.93 160.89 15.41 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -169.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 27.8 p90 -159.87 149.93 15.0 Favored Pre-proline 0 N--CA 1.498 1.933 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.499 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.75 146.17 87.9 Favored 'Trans proline' 0 N--CA 1.487 1.103 0 C-N-CA 122.064 1.843 . . . . 0.0 112.03 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.59 7.18 82.55 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 123.83 0.706 . . . . 0.0 112.297 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -23.95 15.57 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 176.179 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -89.83 -9.62 48.43 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.376 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 m -122.95 -178.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 124.491 1.12 . . . . 0.0 108.334 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -149.61 120.57 7.67 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -48.73 127.62 14.01 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 165.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -94.27 -62.39 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 124.225 0.953 . . . . 0.0 109.442 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.16 158.02 28.81 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -165.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.44 49.71 1.73 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.206 -0.997 . . . . 0.0 110.726 169.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -64.65 101.18 0.44 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.834 170.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -36.56 137.07 0.31 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 113.789 -1.551 . . . . 0.0 112.923 171.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.0 tt -88.53 126.65 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.78 1.276 . . . . 0.0 112.033 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.05 162.22 38.46 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.004 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.489 1.224 0 CA-C-O 116.034 -1.736 . . . . 0.0 112.324 177.086 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 88.2 p -154.09 141.94 20.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 124.085 0.521 . . . . 0.0 110.194 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 1.0 OUTLIER -76.93 -31.61 56.77 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.0 0.813 . . . . 0.0 110.142 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.59 -169.07 2.01 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.375 1.047 . . . . 0.0 109.829 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.97 109.44 2.02 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.764 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -132.65 -13.8 2.9 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.99 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.03 -156.13 22.22 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 124.268 0.98 . . . . 0.0 111.308 -169.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.24 153.61 19.16 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -175.072 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -133.1 162.9 30.49 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 124.301 1.001 . . . . 0.0 111.992 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -143.76 135.97 26.75 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.294 -1.776 . . . . 0.0 107.082 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.73 125.17 49.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 124.276 0.985 . . . . 0.0 108.862 178.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.5 149.64 5.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 123.879 0.737 . . . . 0.0 110.873 168.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 tp -121.48 -25.58 5.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 123.974 0.796 . . . . 0.0 111.075 -175.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.04 146.78 27.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.038 0.836 . . . . 0.0 110.294 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.39 118.55 6.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.507 1.13 . . . . 0.0 110.55 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 2.9 t80 -120.6 135.98 54.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 124.778 1.299 . . . . 0.0 108.82 174.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -89.81 157.03 18.11 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.406 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -88.58 149.82 23.38 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.84 -19.56 2.6 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.312 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.23 147.25 35.41 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.163 -1.381 . . . . 0.0 110.051 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.81 -21.33 64.32 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.158 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.16 -12.28 57.1 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.69 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.97 147.79 30.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 124.091 0.87 . . . . 0.0 110.849 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.22 -175.26 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.483 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -88.73 129.15 35.6 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.445 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 71.5 mt -114.02 135.95 53.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.016 0.822 . . . . 0.0 111.007 -179.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.49 -173.91 3.2 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.089 -176.083 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.41 ' C ' ' H ' ' A' ' 28' ' ' ASP . 6.7 mt -84.92 158.06 20.67 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.687 178.859 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.64 -5.27 2.45 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.137 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.41 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.7 OUTLIER -68.86 147.41 51.76 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.075 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 6.0 tt -132.57 150.14 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 124.101 0.876 . . . . 0.0 111.358 172.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.7 mp -121.77 152.83 39.04 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.149 -176.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.3 m -135.04 149.35 50.11 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.914 0.759 . . . . 0.0 110.449 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.3 t -127.67 -153.99 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 123.959 0.787 . . . . 0.0 109.002 -179.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.74 178.46 8.15 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.423 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.6 11.4 9.84 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.424 -173.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.04 25.08 0.03 OUTLIER Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.7 m -141.57 65.82 1.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -55.95 -12.53 1.44 Allowed 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 113.179 -1.828 . . . . 0.0 113.638 168.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.4 t -61.97 -11.07 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 171.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.26 -32.69 7.59 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.219 168.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 10.1 mp -109.47 -6.36 15.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 124.115 0.884 . . . . 0.0 110.763 178.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.5 26.32 51.43 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.854 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.37 155.74 36.15 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.238 -0.981 . . . . 0.0 111.749 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.5 m -90.11 -140.2 0.15 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.138 -1.392 . . . . 0.0 107.558 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -33.73 -66.13 0.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.824 1.327 . . . . 0.0 112.306 171.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.28 86.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 170.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -62.05 -12.97 21.74 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 114.572 -0.814 . . . . 0.0 110.113 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 47.51 62.83 2.24 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 124.236 0.96 . . . . 0.0 111.607 174.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.74 -4.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.855 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -126.86 79.27 72.65 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 123.942 0.776 . . . . 0.0 110.499 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.82 -7.96 5.2 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.237 1.958 . . . . 0.0 113.514 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -48.56 45.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.2 -23.21 21.34 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 123.822 0.701 . . . . 0.0 111.024 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.78 143.37 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.26 -99.68 1.04 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -89.99 133.49 34.78 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.376 -0.912 . . . . 0.0 110.343 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -109.28 156.47 19.91 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.414 171.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.08 124.65 31.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.32 -179.24 29.47 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.073 -1.06 . . . . 0.0 111.498 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -95.85 126.7 41.28 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.52 -1.34 . . . . 0.0 109.483 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -90.3 85.02 6.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 124.459 1.099 . . . . 0.0 109.896 173.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -47.48 -32.87 5.61 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.952 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -55.88 -47.01 78.15 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.298 0.999 . . . . 0.0 111.423 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -105.03 5.38 32.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.228 0.955 . . . . 0.0 109.651 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.66 53.72 37.34 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 124.292 0.995 . . . . 0.0 111.42 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -138.93 173.21 11.8 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -172.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -129.11 118.87 23.18 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.45 -171.05 23.83 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 118.953 -1.594 . . . . 0.0 113.224 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -103.25 162.16 13.21 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 113.646 -1.277 . . . . 0.0 109.603 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 13.0 p90 -159.66 140.86 9.3 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.215 176.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.61 152.44 74.63 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.647 1.564 . . . . 0.0 110.406 176.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.75 26.11 2.83 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.984 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.467 ' HG1' ' H ' ' A' ' 73' ' ' TYR . 7.5 p -96.57 -51.91 4.14 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.276 0.56 . . . . 0.0 111.729 -176.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . 0.467 ' H ' ' HG1' ' A' ' 72' ' ' THR . 22.9 m-85 -90.48 25.65 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.156 -1.383 . . . . 0.0 110.847 -170.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.47 158.7 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -172.651 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -138.07 112.48 8.73 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -46.77 116.48 1.34 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.448 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -91.83 -56.98 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.522 178.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.49 175.85 38.88 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.459 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.92 136.57 17.99 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.973 -1.114 . . . . 0.0 110.383 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.26 53.08 1.34 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.444 174.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -49.24 124.01 8.34 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.969 -1.923 . . . . 0.0 109.54 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.6 tp -141.33 147.58 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 124.597 1.185 . . . . 0.0 110.161 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.87 162.54 35.37 Favored Pre-proline 0 N--CA 1.504 2.248 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.372 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.488 1.182 0 CA-C-O 116.644 -1.482 . . . . 0.0 111.108 175.886 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.5 OUTLIER -150.7 -16.93 0.23 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.003 -0.598 . . . . 0.0 110.092 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 75.1 mtp -61.62 -31.58 71.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.871 0.732 . . . . 0.0 111.039 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.2 m -65.41 144.96 56.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 123.845 0.716 . . . . 0.0 111.438 174.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.31 -178.27 2.89 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.948 176.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.96 -23.75 48.36 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.574 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.6 -157.35 29.58 Favored Glycine 0 N--CA 1.493 2.493 0 O-C-N 123.935 0.772 . . . . 0.0 111.208 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 143.92 31.06 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 114.228 -0.986 . . . . 0.0 109.165 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -128.87 164.1 23.83 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.785 0.803 . . . . 0.0 112.737 -171.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -139.03 133.46 31.69 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 113.414 -1.721 . . . . 0.0 107.926 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -90.65 113.49 25.55 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.37 128.2 30.62 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.136 167.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.01 -71.01 0.75 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.036 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -90.34 145.99 24.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 123.86 0.725 . . . . 0.0 110.045 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.97 125.07 23.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.126 0.891 . . . . 0.0 110.52 177.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -127.84 133.15 49.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.41 1.069 . . . . 0.0 109.374 175.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -90.01 160.94 16.1 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.346 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 160.83 16.73 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 123.952 0.783 . . . . 0.0 110.224 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.64 -50.43 4.06 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.899 0.857 . . . . 0.0 110.5 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.439 ' HG3' ' H ' ' A' ' 20' ' ' GLU . 6.8 ptp180 -150.27 -166.04 2.44 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 112.82 -1.991 . . . . 0.0 110.437 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -61.5 2.87 0.15 Allowed 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . 0.439 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 28.5 tt0 -85.07 -36.99 20.83 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 123.246 0.341 . . . . 0.0 110.38 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.13 163.77 18.92 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.669 -174.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.25 -175.93 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 124.515 1.134 . . . . 0.0 110.294 177.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -83.6 129.09 34.96 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 112.612 -2.085 . . . . 0.0 107.474 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 82.4 mt -122.75 133.19 54.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.167 0.917 . . . . 0.0 110.415 -175.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.22 171.32 14.33 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.053 -174.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.437 ' CD1' ' H ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -72.7 151.22 42.31 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.401 -172.207 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.89 -12.93 15.25 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.111 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 26' ' ' LEU . 2.9 m-20 -69.89 141.73 53.1 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.048 0.499 . . . . 0.0 110.206 173.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 mt -117.1 141.32 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 124.512 1.133 . . . . 0.0 110.01 172.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.6 mp -107.43 150.15 27.09 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 112.748 -2.024 . . . . 0.0 109.233 177.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.4 m -128.22 138.98 52.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.19 0.931 . . . . 0.0 110.753 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 t -107.76 -155.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 124.367 1.042 . . . . 0.0 108.887 178.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -82.61 174.73 10.76 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.57 173.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -114.3 -26.49 7.98 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.563 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.84 56.46 0.42 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 t -158.52 57.64 0.45 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 171.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -52.01 -26.29 10.4 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 113.185 -1.825 . . . . 0.0 112.052 166.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.4 t -57.6 -8.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 124.426 1.079 . . . . 0.0 112.944 175.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -34.52 -39.5 0.09 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.989 1.431 . . . . 0.0 110.618 170.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.7 mt -123.81 0.39 8.63 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.653 -1.612 . . . . 0.0 113.991 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.85 34.9 52.05 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.15 162.41 7.41 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 113.213 -1.494 . . . . 0.0 112.117 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.5 p -119.97 176.09 5.59 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.827 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.5 t70 52.65 -88.22 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 124.783 1.302 . . . . 0.0 111.194 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.87 91.83 1.73 Allowed Glycine 0 N--CA 1.494 2.516 0 O-C-N 123.757 0.661 . . . . 0.0 111.628 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.33 -62.05 1.41 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.686 -1.257 . . . . 0.0 108.857 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 51.74 82.94 0.06 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 124.592 1.183 . . . . 0.0 112.259 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.04 -18.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.38 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -116.25 87.32 19.47 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 124.234 0.959 . . . . 0.0 108.996 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.77 -6.23 3.22 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.535 2.157 . . . . 0.0 113.407 173.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.87 -39.48 87.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 123.651 0.594 . . . . 0.0 111.062 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -90.31 -19.87 23.57 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.127 0.892 . . . . 0.0 110.057 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mt -96.04 129.73 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 123.914 0.759 . . . . 0.0 109.782 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.62 -78.69 1.33 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -90.96 133.16 35.5 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.273 -1.464 . . . . 0.0 110.252 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.3 mp -120.75 125.44 47.63 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 172.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -90.0 120.32 31.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 123.926 0.766 . . . . 0.0 109.559 168.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.91 -163.68 9.6 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.386 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -139.99 123.52 17.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.59 88.45 7.42 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.32 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -53.93 -38.17 64.61 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.199 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -52.02 -47.29 65.08 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.252 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.403 ' H ' ' HG1' ' A' ' 63' ' ' THR . 30.1 p -91.28 -4.82 55.54 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 123.992 0.808 . . . . 0.0 109.836 177.585 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.45 36.08 62.81 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 124.325 1.015 . . . . 0.0 111.836 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -135.98 134.37 38.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.231 0.606 . . . . 0.0 110.227 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -89.55 155.45 19.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.341 1.026 . . . . 0.0 109.115 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.86 -161.49 35.2 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.132 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.06 166.33 12.12 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 113.891 -1.154 . . . . 0.0 109.228 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.1 p90 -162.58 140.04 6.27 Favored Pre-proline 0 N--CA 1.496 1.847 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.311 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -63.14 166.86 13.6 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.875 1.716 . . . . 0.0 112.027 173.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.15 48.05 1.03 Allowed Glycine 0 N--CA 1.496 2.644 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.599 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.0 t -138.39 -28.15 0.85 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.19 0.582 . . . . 0.0 112.507 -177.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -90.92 1.62 56.87 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.319 1.012 . . . . 0.0 110.976 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.49 -174.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 124.293 0.996 . . . . 0.0 108.924 -176.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.39 127.97 11.55 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.621 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.485 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 22.5 t80 -60.56 133.5 56.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.685 176.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.08 -60.57 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 124.339 1.025 . . . . 0.0 110.361 176.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.92 148.0 15.91 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -163.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.485 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -129.15 128.84 44.25 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 112.803 -1.698 . . . . 0.0 109.734 173.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.24 28.12 0.86 Allowed 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 121.749 0.785 . . . . 0.0 111.68 176.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 37.8 mtpt 47.79 -173.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 113.349 -1.751 . . . . 0.0 113.064 -169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.6 mt -89.47 -8.25 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.327 172.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.08 164.53 43.28 Favored Pre-proline 0 N--CA 1.505 2.299 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 N--CA 1.488 1.148 0 C-N-CA 121.902 1.734 . . . . 0.0 112.931 169.907 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 50.6 m -146.63 108.79 4.43 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.214 -0.993 . . . . 0.0 108.765 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 1.1 tpt -164.22 132.05 3.41 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t 58.84 -165.95 0.18 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 123.826 0.704 . . . . 0.0 112.695 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.24 99.78 0.2 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.107 0.479 . . . . 0.0 110.626 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.28 82.96 5.94 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.754 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.7 -134.33 0.01 OUTLIER Glycine 0 N--CA 1.5 2.942 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.282 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.81 126.5 35.71 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -100.29 157.59 16.49 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.523 0.677 . . . . 0.0 110.859 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -143.99 124.97 14.35 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -90.6 120.9 32.06 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.67 121.12 6.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 123.974 0.796 . . . . 0.0 110.773 168.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -74.14 -46.42 42.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.018 0.824 . . . . 0.0 109.558 176.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.84 174.75 10.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.36 1.038 . . . . 0.0 110.152 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.25 133.33 35.99 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.089 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.507 ' CZ ' ' HB2' ' A' ' 16' ' ' LYS . 8.9 t80 -120.81 108.5 14.03 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 79.29 2.32 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.938 -171.765 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.507 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 31.3 mmtm -142.53 170.7 15.21 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.487 1.136 . . . . 0.0 111.44 170.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -151.45 60.98 0.89 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.804 -166.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -89.67 159.26 17.21 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -60.84 -17.06 47.73 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.133 0.492 . . . . 0.0 111.156 -176.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -105.12 -29.33 10.45 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.555 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -99.92 165.52 11.51 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 123.652 0.595 . . . . 0.0 111.311 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 pt -138.61 173.37 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.083 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -79.51 131.4 36.03 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.11 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 20.6 mt -128.87 137.28 51.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.728 1.267 . . . . 0.0 109.429 -175.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 -179.62 5.55 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.2 mt -63.27 151.1 41.54 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.577 171.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.47 -10.55 6.37 Favored Glycine 0 N--CA 1.496 2.683 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.611 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.17 116.5 4.61 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.142 177.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -97.6 144.04 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.389 0.614 . . . . 0.0 109.418 174.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 9.1 mp -125.22 153.65 42.81 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.063 -179.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.4 m -137.14 132.36 33.89 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 90.8 t -105.98 168.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -58.1 172.18 0.46 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.902 0.751 . . . . 0.0 112.874 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 pttm -135.84 95.4 3.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 124.441 2.067 . . . . 0.0 110.026 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.86 -13.7 45.61 Favored Glycine 0 N--CA 1.504 3.194 0 CA-C-N 111.978 -2.374 . . . . 0.0 111.143 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -111.47 50.96 0.8 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 pp -58.42 -17.32 19.64 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 113.985 -1.462 . . . . 0.0 113.327 161.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.7 t -55.6 -8.83 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 167.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -34.92 -38.48 0.08 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 124.421 1.075 . . . . 0.0 111.537 166.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.6 mt -124.82 -7.34 7.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 113.104 -1.862 . . . . 0.0 111.637 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.22 34.26 10.89 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -72.72 161.74 30.37 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.932 -1.134 . . . . 0.0 112.175 177.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -112.51 -168.73 1.36 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.182 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.72 82.56 2.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 123.879 0.737 . . . . 0.0 110.339 169.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.43 -107.79 2.4 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 173.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -140.98 -40.48 0.4 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.786 0.933 . . . . 0.0 108.628 -173.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 56.85 38.29 29.35 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.645 1.216 . . . . 0.0 111.345 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.36 -5.11 0.23 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.503 -173.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -119.16 85.23 29.53 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 124.471 1.107 . . . . 0.0 109.138 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.14 -2.26 5.51 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.151 2.567 . . . . 0.0 113.687 169.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -73.37 -15.83 61.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 123.684 0.615 . . . . 0.0 111.928 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -125.06 -33.86 2.84 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 123.602 0.564 . . . . 0.0 111.194 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.33 146.26 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 123.92 0.763 . . . . 0.0 110.433 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.28 -94.64 1.1 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -95.43 136.29 35.99 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.286 -0.957 . . . . 0.0 110.584 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.424 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.4 mp -115.96 138.23 51.39 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.207 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -107.96 118.83 37.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.89 165.91 30.28 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.453 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.2 143.25 26.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.039 0.494 . . . . 0.0 110.182 176.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -116.09 68.48 0.73 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.135 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -47.05 -31.71 3.51 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 114.123 -1.399 . . . . 0.0 114.088 172.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.9 m -50.37 -49.03 55.45 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.531 1.144 . . . . 0.0 111.187 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.9 p -98.03 -2.74 39.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.25 0.969 . . . . 0.0 110.55 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.62 32.27 81.02 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -122.95 176.35 6.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 124.461 0.742 . . . . 0.0 109.244 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -145.69 145.32 30.84 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.03 0.831 . . . . 0.0 109.114 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.28 -156.19 22.86 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.036 -1.554 . . . . 0.0 113.264 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.74 153.91 19.38 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 35.6 p90 -155.18 141.55 13.14 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 123.619 0.575 . . . . 0.0 109.673 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.82 142.02 67.86 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.828 1.685 . . . . 0.0 111.088 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.67 -22.86 78.76 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 124.012 0.82 . . . . 0.0 111.874 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.4 p -72.45 -6.37 43.15 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.035 -0.082 . . . . 0.0 111.025 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -109.73 -6.35 15.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 123.979 0.799 . . . . 0.0 111.785 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.37 -177.21 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 123.933 0.771 . . . . 0.0 109.028 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -146.6 123.18 11.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 124.348 1.03 . . . . 0.0 108.948 175.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -56.26 127.16 29.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.355 1.034 . . . . 0.0 109.572 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.46 -55.08 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 123.874 0.734 . . . . 0.0 110.897 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -146.97 161.23 28.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 107.139 -2.385 . . . . 0.0 107.139 -164.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.43 -175.96 5.63 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.228 -0.989 . . . . 0.0 112.278 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.03 94.25 2.68 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 113.549 -1.66 . . . . 0.0 107.619 158.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -44.6 144.66 1.04 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 112.475 -2.148 . . . . 0.0 110.875 171.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.439 ' CD1' ' H ' ' A' ' 82' ' ' ILE . 0.1 OUTLIER -90.95 178.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 123.847 0.717 . . . . 0.0 109.112 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.44 163.38 33.74 Favored Pre-proline 0 N--CA 1.509 2.499 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.716 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 N--CA 1.488 1.187 0 C-N-CA 121.709 1.606 . . . . 0.0 112.612 176.457 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.6 OUTLIER -170.34 -4.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 124.082 0.519 . . . . 0.0 110.801 -175.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 0.0 OUTLIER -154.11 88.47 1.24 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.536 0.684 . . . . 0.0 110.596 -177.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t 60.34 -175.06 0.11 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.256 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.2 106.47 5.87 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.335 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -99.13 79.38 2.33 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.175 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.28 170.06 30.25 Favored Glycine 0 N--CA 1.498 2.832 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.502 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.6 146.01 24.86 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -171.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -133.8 155.88 49.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 123.885 0.741 . . . . 0.0 110.216 -166.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -140.39 125.71 18.81 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.619 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -90.89 126.31 36.01 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.75 126.26 23.36 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.705 0.628 . . . . 0.0 111.317 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.24 -35.77 18.33 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.178 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 146.19 38.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.81 0.694 . . . . 0.0 110.224 -175.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.55 120.91 13.76 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.307 172.378 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.0 t80 -125.79 132.42 52.28 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.082 174.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -90.16 157.14 17.88 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.94 137.36 32.39 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.788 0.68 . . . . 0.0 109.727 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -119.9 -2.51 10.3 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.69 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 141.7 49.48 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.145 0.903 . . . . 0.0 109.729 177.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.44 -17.27 62.51 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.923 171.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.53 -31.22 21.39 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.637 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.68 144.58 27.74 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 123.641 0.588 . . . . 0.0 109.49 179.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pt -104.67 171.75 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 124.3 1.0 . . . . 0.0 111.332 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.24 149.34 47.56 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.77 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 96.1 mt -135.04 142.15 46.31 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.124 -179.534 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.1 170.08 17.4 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.439 ' C ' ' H ' ' A' ' 28' ' ' ASP . 1.6 mt -70.89 153.5 42.65 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.05 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.41 -7.75 1.27 Allowed Glycine 0 N--CA 1.505 3.234 0 O-C-N 123.537 0.523 . . . . 0.0 113.331 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.439 ' H ' ' C ' ' A' ' 26' ' ' LEU . 26.0 t70 -68.95 109.12 3.78 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.526 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -89.04 149.9 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -176.018 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.1 mp -130.62 157.2 43.38 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 124.509 1.131 . . . . 0.0 111.041 174.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -136.83 141.5 42.86 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 123.782 0.676 . . . . 0.0 110.949 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' CG1' ' H ' ' A' ' 33' ' ' ASN . 2.3 t -116.4 -147.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.403 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -90.2 175.82 6.99 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.844 0.354 . . . . 0.0 110.735 -175.85 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -100.67 -29.62 12.2 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.859 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.36 49.87 0.2 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 t -149.93 64.86 0.98 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mt -53.02 -30.33 34.86 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 112.253 -2.249 . . . . 0.0 112.671 169.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.05 -8.86 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.481 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -33.95 0.06 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 124.243 0.964 . . . . 0.0 112.311 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.7 mt -115.32 -16.59 11.46 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.778 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.99 14.57 33.47 Favored Glycine 0 N--CA 1.498 2.82 0 O-C-N 124.404 1.065 . . . . 0.0 112.167 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -74.99 161.45 29.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.134 0.549 . . . . 0.0 111.106 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -149.36 33.93 0.72 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.033 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.38 -154.32 0.5 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.473 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.93 29.94 0.43 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -91.53 -79.85 0.36 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 114.445 -0.877 . . . . 0.0 111.458 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 58.27 39.21 25.87 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 121.858 0.837 . . . . 0.0 111.79 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.0 -12.21 0.1 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.031 -173.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -120.23 81.5 29.46 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 123.873 0.733 . . . . 0.0 110.198 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.88 -26.63 68.25 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.216 1.944 . . . . 0.0 112.368 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -47.27 -47.04 25.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.883 1.364 . . . . 0.0 111.501 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.63 -37.06 13.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.383 1.052 . . . . 0.0 110.597 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.9 mt -60.5 143.19 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 123.624 0.578 . . . . 0.0 110.081 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.46 -79.48 1.33 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -169.228 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -115.09 129.87 56.79 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 112.694 -1.753 . . . . 0.0 109.189 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.443 ' HG ' ' CZ ' ' A' ' 69' ' ' PHE . 1.0 OUTLIER -130.19 143.64 50.9 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.92 173.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -90.05 145.05 25.36 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.713 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.97 160.03 30.07 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -113.66 125.35 54.05 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -101.79 88.09 3.3 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.231 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -47.85 -36.85 12.66 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 113.608 -1.633 . . . . 0.0 111.977 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -42.39 98.59 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.233 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -90.74 0.81 57.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 123.793 0.683 . . . . 0.0 109.432 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.01 22.87 13.76 Favored Glycine 0 N--CA 1.497 2.72 0 O-C-N 124.459 1.099 . . . . 0.0 112.315 -168.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -121.74 155.67 34.75 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -137.76 150.54 47.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.621 1.201 . . . . 0.0 109.698 -174.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.78 -159.15 30.45 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.011 -1.09 . . . . 0.0 111.216 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.07 144.33 44.77 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -165.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.443 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 33.4 p90 -145.29 151.8 48.74 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 124.375 1.047 . . . . 0.0 108.914 -174.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -66.06 165.74 23.09 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.094 1.863 . . . . 0.0 111.779 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.15 60.4 0.4 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -147.71 -24.91 0.37 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -102.18 15.29 29.57 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 124.08 0.863 . . . . 0.0 111.264 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.5 177.81 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.014 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -148.26 116.3 6.44 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.527 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 15.5 t80 -47.81 143.34 4.1 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.757 165.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.53 -49.1 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 124.371 1.044 . . . . 0.0 111.752 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.84 150.21 22.25 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.333 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.527 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 1.1 ppt_? -124.18 132.93 53.66 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 113.833 -1.183 . . . . 0.0 111.97 179.055 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -124.52 40.34 3.76 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.351 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -71.01 -23.36 62.16 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.679 166.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.4 tt -129.37 142.07 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.694 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.415 ' H ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -149.62 -59.94 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 117.722 -1.132 . . . . 0.0 111.161 175.562 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.415 ' HD2' ' H ' ' A' ' 83' ' ' SER . 1.1 Cg_endo . . . . . 0 N--CA 1.49 1.287 0 CA-C-O 116.152 -1.687 . . . . 0.0 112.34 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 1.2 m 60.95 -170.81 0.15 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 124.189 0.582 . . . . 0.0 112.254 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 0.0 OUTLIER -154.63 -19.59 0.12 Allowed 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.535 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 p -68.09 160.65 28.51 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 123.373 0.42 . . . . 0.0 111.704 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.37 119.33 5.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.491 1.119 . . . . 0.0 111.861 175.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -138.69 50.4 1.86 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 113.681 -1.599 . . . . 0.0 108.959 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.37 -168.37 36.4 Favored Glycine 0 N--CA 1.496 2.698 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.681 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.431 ' HH ' ' ND2' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -89.73 145.72 25.0 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.977 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -123.51 157.94 32.44 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.05 0.929 . . . . 0.0 113.313 -173.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -140.43 121.35 14.55 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 112.397 -2.183 . . . . 0.0 107.486 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.2 ttt-85 -89.82 125.14 35.21 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.17 127.49 32.09 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 124.275 0.985 . . . . 0.0 110.742 171.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tp -92.52 -68.43 0.8 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.074 0.859 . . . . 0.0 109.527 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -98.2 144.52 27.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.028 0.83 . . . . 0.0 109.713 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -62.05 129.31 40.25 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.659 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 19.8 t80 -129.92 133.43 46.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.551 1.157 . . . . 0.0 108.846 175.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -90.01 154.33 19.9 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.971 0.794 . . . . 0.0 109.951 171.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.62 142.08 28.01 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.929 -177.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -89.4 -30.42 18.37 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.682 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -150.35 176.93 10.45 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.49 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.46 -18.39 28.27 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.661 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -69.1 -34.46 75.13 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.137 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.65 153.24 22.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.381 1.051 . . . . 0.0 109.406 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 pt -111.39 173.07 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 124.471 1.107 . . . . 0.0 110.534 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.57 132.91 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.186 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.8 mt -121.34 127.02 50.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 124.55 1.156 . . . . 0.0 109.866 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.443 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -132.83 172.7 12.23 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.302 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.07 150.98 44.3 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.156 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.05 -13.86 8.65 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.991 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.19 118.28 6.17 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tp -96.19 151.09 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.714 0.769 . . . . 0.0 109.295 170.851 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 7.4 mp -127.71 150.84 49.6 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.388 177.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.3 m -132.4 146.99 52.36 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 123.822 0.701 . . . . 0.0 109.443 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.4 t -121.37 -147.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.603 HD21 ' H ' ' A' ' 36' ' ' SER . 9.9 p-10 -83.06 -170.68 3.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 123.768 0.668 . . . . 0.0 111.773 176.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 -28.12 0.97 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.693 -170.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.98 27.54 0.21 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.603 ' H ' HD21 ' A' ' 33' ' ' ASN . 69.1 m -141.56 62.54 1.45 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 mt -50.92 -23.37 2.8 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.161 172.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.8 t -63.19 -12.97 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 124.014 0.821 . . . . 0.0 112.331 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.66 -29.47 7.41 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.456 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.7 mt -106.86 8.95 30.97 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 123.975 0.797 . . . . 0.0 109.754 -173.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.22 21.29 63.93 Favored Glycine 0 N--CA 1.496 2.654 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.316 -170.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.46 150.55 29.67 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.943 -0.628 . . . . 0.0 110.987 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -140.25 38.11 1.91 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 124.453 1.096 . . . . 0.0 108.975 -176.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -143.95 -63.84 0.38 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.807 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.14 100.45 0.6 Allowed Glycine 0 N--CA 1.494 2.504 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.375 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -118.93 -46.02 2.55 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.881 -1.16 . . . . 0.0 108.422 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 23.33 54.57 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 125.774 1.922 . . . . 0.0 115.78 -172.742 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.87 -22.33 0.07 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.023 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -116.29 81.97 11.25 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 124.23 0.956 . . . . 0.0 110.753 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.92 -8.76 6.48 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.373 2.049 . . . . 0.0 113.264 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -70.0 -37.78 75.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.85 0.719 . . . . 0.0 111.329 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -89.68 -27.82 19.86 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 123.933 0.771 . . . . 0.0 110.779 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.7 mt -76.68 140.78 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 123.923 0.764 . . . . 0.0 109.07 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.71 -91.76 1.2 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -175.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -98.18 123.27 42.16 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.701 -1.25 . . . . 0.0 109.503 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.417 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.6 mp -99.95 164.27 12.08 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.256 174.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.438 HD21 ' N ' ' A' ' 58' ' ' GLY . 0.4 OUTLIER -137.4 126.69 24.74 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.693 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.438 ' N ' HD21 ' A' ' 57' ' ' ASN . . . -156.36 175.82 33.92 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.247 -178.314 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -99.59 125.17 45.35 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.87 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -89.63 84.27 6.33 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.22 0.95 . . . . 0.0 109.872 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -56.94 -34.82 68.39 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.116 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.4 m -54.57 -38.63 66.9 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.03 0.831 . . . . 0.0 111.87 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.422 ' H ' ' HG1' ' A' ' 63' ' ' THR . 40.1 p -99.77 -4.36 30.79 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.808 0.693 . . . . 0.0 111.564 177.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.92 29.84 76.42 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -136.35 170.41 16.08 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -136.51 150.7 48.8 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.08 0.863 . . . . 0.0 109.251 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.65 -163.69 31.16 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.819 -1.182 . . . . 0.0 111.808 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.95 153.48 22.49 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.513 -0.843 . . . . 0.0 109.552 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.417 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.4 p90 -150.89 146.67 19.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.285 -176.329 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -66.59 150.08 83.98 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 121.787 1.658 . . . . 0.0 110.431 175.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.25 23.59 11.33 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 124.078 0.861 . . . . 0.0 111.971 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.41 ' H ' ' HG1' ' A' ' 72' ' ' THR . 0.6 OUTLIER -106.98 -34.67 7.12 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.052 0.453 . . . . 0.0 111.23 177.957 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -89.92 14.91 10.93 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.193 -174.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.26 171.69 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.218 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -145.9 123.2 11.58 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.48 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 41.8 t80 -48.97 149.06 2.0 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.974 0.796 . . . . 0.0 109.677 170.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.79 -54.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 124.015 0.822 . . . . 0.0 111.336 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.92 146.23 15.43 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.802 -168.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.48 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -129.63 145.19 51.52 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.138 -1.531 . . . . 0.0 110.839 178.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.72 80.7 1.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.52 171.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.68 127.75 18.9 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 112.659 -2.064 . . . . 0.0 111.411 167.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -89.71 -8.72 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.247 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.5 t -119.9 85.81 35.04 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 123.796 0.685 . . . . 0.0 109.774 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 C--N 1.315 -1.203 0 CA-C-O 115.789 -1.838 . . . . 0.0 112.473 170.318 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.411 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.9 OUTLIER -172.41 -51.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.078 -0.561 . . . . 0.0 109.626 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.1 ptp -57.34 121.33 9.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.31 1.006 . . . . 0.0 111.79 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.21 136.36 33.21 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.13 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.53 122.81 19.79 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.916 0.76 . . . . 0.0 110.634 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -94.8 91.72 6.61 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.111 0.958 . . . . 0.0 109.838 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.12 -127.93 6.23 Favored Glycine 0 N--CA 1.493 2.437 0 CA-C-N 112.875 -1.966 . . . . 0.0 109.046 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.05 177.76 5.31 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -174.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -145.38 165.57 28.09 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 122.437 1.113 . . . . 0.0 113.121 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -142.91 151.55 41.12 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 112.285 -2.234 . . . . 0.0 107.064 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -119.1 115.47 24.34 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.34 121.21 7.15 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.484 171.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tp -93.79 -43.4 8.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.508 1.13 . . . . 0.0 110.235 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.43 143.54 45.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.578 1.174 . . . . 0.0 110.342 -177.083 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.88 117.47 20.0 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.304 -1.317 . . . . 0.0 109.787 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -120.58 131.24 54.56 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -89.1 156.24 18.95 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.652 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -89.19 132.73 34.72 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.622 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -112.51 -13.9 13.29 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.138 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 -129.42 149.33 51.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 124.417 1.073 . . . . 0.0 110.387 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.07 -12.59 61.82 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.878 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -80.09 -19.78 46.64 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.116 0.885 . . . . 0.0 111.514 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.55 159.71 16.85 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.012 0.82 . . . . 0.0 111.497 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 pt -110.63 176.59 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.844 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -73.16 139.88 46.66 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.897 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 16.1 mt -127.52 127.64 44.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.192 0.933 . . . . 0.0 110.566 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.95 -176.61 4.86 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.92 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -61.64 152.98 29.27 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.807 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.14 -11.57 4.8 Favored Glycine 0 N--CA 1.499 2.836 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.801 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -65.17 95.51 0.18 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -91.2 133.25 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.796 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.3 mp -112.83 146.45 38.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 112.494 -2.139 . . . . 0.0 108.756 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 m -132.14 155.79 47.53 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.428 HG13 ' OG ' ' A' ' 36' ' ' SER . 0.0 OUTLIER -138.29 169.8 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -170.283 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.14 154.22 42.41 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.776 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -60.73 -27.72 68.13 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.977 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.03 31.56 5.08 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.428 ' OG ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -63.68 -16.71 61.74 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.713 174.913 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -57.07 -34.59 68.43 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 117.993 -1.483 . . . . 0.0 108.243 175.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.36 -9.16 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.82 -36.73 1.57 Allowed 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.32 0.581 . . . . 0.0 110.709 170.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.8 mt -108.52 -15.9 14.33 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 113.987 -1.461 . . . . 0.0 109.507 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.41 38.2 29.44 Favored Glycine 0 N--CA 1.491 2.328 0 O-C-N 124.52 1.137 . . . . 0.0 112.772 -171.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -58.97 163.65 3.38 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 114.502 -0.849 . . . . 0.0 112.327 176.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.1 m -124.66 34.31 5.03 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.534 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.1 -165.28 1.01 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.72 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.21 12.05 0.07 OUTLIER Glycine 0 N--CA 1.493 2.495 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.8 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.29 79.32 1.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.49 1.138 . . . . 0.0 109.908 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.37 -4.9 2.07 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 113.996 -1.457 . . . . 0.0 112.591 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.18 -4.83 19.11 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 174.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 79.12 46.49 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.15 -19.22 65.84 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 122.072 1.848 . . . . 0.0 112.365 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -57.62 -40.49 79.29 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.151 0.907 . . . . 0.0 112.549 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -89.9 -27.41 19.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 123.757 0.661 . . . . 0.0 109.961 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.9 mt -70.58 148.32 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.492 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.52 -94.82 1.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -89.78 144.68 25.77 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.203 -0.998 . . . . 0.0 110.256 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.474 HD11 ' CE2' ' A' ' 69' ' ' PHE . 55.0 mt -117.76 133.22 56.16 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.029 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.8 117.89 34.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.146 0.904 . . . . 0.0 109.463 175.488 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.87 175.76 35.06 Favored Glycine 0 N--CA 1.496 2.671 0 O-C-N 124.181 0.925 . . . . 0.0 112.015 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -94.71 150.03 20.63 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.108 -1.046 . . . . 0.0 109.987 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.4 64.13 1.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.372 -1.286 . . . . 0.0 107.959 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.01 -25.48 30.38 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.696 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 62.5 m -51.75 -49.35 62.76 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 124.351 1.032 . . . . 0.0 110.914 175.029 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -94.61 -3.74 49.04 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 124.331 1.019 . . . . 0.0 111.722 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.06 42.38 77.34 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -141.68 178.38 7.51 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.345 -0.927 . . . . 0.0 108.801 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -147.19 151.69 37.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.97 -153.21 13.32 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 118.895 -1.622 . . . . 0.0 112.38 167.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -104.51 148.78 26.09 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.474 ' CE2' HD11 ' A' ' 56' ' ' LEU . 17.0 p90 -153.47 140.29 12.91 Favored Pre-proline 0 N--CA 1.494 1.763 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.423 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.31 160.74 15.61 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.905 1.737 . . . . 0.0 111.949 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.12 35.38 4.6 Favored Glycine 0 N--CA 1.498 2.788 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.177 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -130.56 -30.52 1.87 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 18.0 m-30 -90.24 13.93 13.99 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.926 0.766 . . . . 0.0 110.874 -173.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.08 176.2 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 124.57 1.168 . . . . 0.0 107.918 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -144.77 113.76 6.88 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -45.17 139.4 3.38 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.959 0.787 . . . . 0.0 110.196 168.469 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.465 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.8 pt -137.02 -66.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 124.597 1.186 . . . . 0.0 109.892 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -98.22 157.89 20.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 -171.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.43 169.49 8.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.587 0.816 . . . . 0.0 111.485 168.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.424 ' C ' ' H ' ' A' ' 82' ' ' ILE . 10.4 ptmt -58.82 -154.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.255 -1.338 . . . . 0.0 113.117 160.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -67.97 13.56 0.08 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.277 -177.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.424 ' H ' ' C ' ' A' ' 80' ' ' LYS . 48.2 mt -89.07 139.42 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.21 167.26 11.2 Favored Pre-proline 0 N--CA 1.501 2.092 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.972 178.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.485 0.984 0 CA-C-O 116.692 -1.462 . . . . 0.0 110.929 168.164 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 36.0 t -158.89 119.82 3.3 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.033 -0.584 . . . . 0.0 109.857 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 8.8 ttt 55.08 28.13 10.43 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 124.178 0.924 . . . . 0.0 111.252 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -92.72 166.06 12.64 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.866 -177.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.54 93.5 1.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.178 -176.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -75.64 -27.99 58.62 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.009 -177.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.67 -169.22 26.36 Favored Glycine 0 N--CA 1.495 2.577 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.619 172.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.04 150.46 20.15 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 113.583 -1.308 . . . . 0.0 108.031 -177.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -125.65 161.99 26.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 124.192 0.932 . . . . 0.0 111.591 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -138.44 159.57 41.74 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.821 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -120.2 116.27 25.28 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.54 111.55 0.66 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.896 0.748 . . . . 0.0 110.498 170.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -51.37 40.86 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.639 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.38 151.48 49.3 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.511 1.132 . . . . 0.0 109.874 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -57.31 129.23 40.86 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.692 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.8 t80 -130.31 129.71 43.56 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.178 175.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -89.29 155.7 19.21 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.779 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 146.53 24.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.811 0.694 . . . . 0.0 109.388 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -131.78 -7.12 3.59 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.911 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.03 150.55 50.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 124.163 0.914 . . . . 0.0 109.404 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -65.45 -16.97 64.18 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.707 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -78.58 -25.51 45.31 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.728 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.86 154.91 19.43 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.3 1.0 . . . . 0.0 111.174 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 pt -119.13 177.35 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.775 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.87 135.46 38.85 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.826 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 64.9 mt -128.31 135.04 49.06 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 124.294 0.996 . . . . 0.0 110.188 -177.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.51 -174.47 3.65 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.742 -173.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.418 ' C ' ' H ' ' A' ' 28' ' ' ASP . 1.8 mp -81.99 154.05 25.9 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.207 -176.037 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.85 -6.36 2.04 Favored Glycine 0 N--CA 1.502 3.04 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.673 -176.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' H ' ' C ' ' A' ' 26' ' ' LEU . 1.4 m-20 -65.93 116.99 7.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 mt -104.19 138.89 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 124.287 0.992 . . . . 0.0 109.868 173.112 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.0 mp -110.74 158.95 18.08 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.903 -179.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.8 m -130.58 151.2 51.3 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 123.804 0.69 . . . . 0.0 109.495 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.424 ' CG1' ' H ' ' A' ' 33' ' ' ASN . 2.1 t -119.85 -141.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.424 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 35.7 m120 -124.71 174.13 8.09 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 124.11 0.881 . . . . 0.0 109.227 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -89.17 0.74 56.5 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.297 169.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.81 -16.62 7.87 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 123.8 0.688 . . . . 0.0 113.397 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 p 74.1 42.03 0.37 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 123.4 1.571 . . . . 0.0 110.482 166.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 45.2 mt 78.95 -16.88 0.63 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 110.551 -3.022 . . . . 0.0 110.194 177.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.86 -22.42 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 CA-C-O 121.873 0.844 . . . . 0.0 111.084 172.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.17 -22.58 4.42 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.632 -1.622 . . . . 0.0 113.204 166.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.9 mt -110.35 -9.19 14.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 123.992 0.807 . . . . 0.0 110.018 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.2 14.57 50.96 Favored Glycine 0 N--CA 1.497 2.733 0 O-C-N 124.145 0.903 . . . . 0.0 112.714 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.2 168.12 13.51 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.041 0.495 . . . . 0.0 111.11 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.0 m -147.5 66.67 1.12 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.249 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -163.67 -155.35 0.31 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.074 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.2 26.37 2.17 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -85.69 46.77 1.35 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.999 -1.1 . . . . 0.0 110.145 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -66.81 -26.88 67.15 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.819 -177.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.96 18.38 13.45 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.78 -172.719 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -130.33 73.14 81.55 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 123.899 0.749 . . . . 0.0 110.309 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -60.85 -4.96 4.04 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.56 2.174 . . . . 0.0 113.536 174.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.83 -39.42 69.77 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.62 0.575 . . . . 0.0 110.895 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.8 -33.05 16.67 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.094 0.871 . . . . 0.0 109.793 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 mt -77.37 125.5 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.54 -78.62 1.32 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -92.56 120.47 33.04 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 113.335 -1.433 . . . . 0.0 110.006 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.2 mp -105.9 123.78 48.52 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.088 172.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.98 122.41 35.31 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 168.438 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.68 171.34 32.45 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.015 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.02 150.28 21.07 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.25 -0.975 . . . . 0.0 109.871 176.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -120.14 77.21 1.23 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.102 174.089 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -52.94 -36.13 59.42 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.942 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -53.28 -50.38 64.98 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.264 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.0 p -89.54 4.74 48.3 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.574 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.45 35.21 50.49 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 124.383 1.052 . . . . 0.0 111.483 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -138.65 -175.85 4.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 154.2 37.46 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.384 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.42 -162.82 34.03 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.774 -1.203 . . . . 0.0 112.55 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.82 161.24 13.84 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.079 -1.06 . . . . 0.0 109.711 176.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 34.4 p90 -162.1 142.18 7.65 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.434 175.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.71 155.33 64.03 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 121.547 1.498 . . . . 0.0 111.89 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.46 -12.43 64.93 Favored Glycine 0 N--CA 1.5 2.937 0 O-C-N 123.915 0.759 . . . . 0.0 112.494 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.51 3.62 18.14 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.507 0.323 . . . . 0.0 110.823 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -121.1 -2.16 9.7 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.165 0.916 . . . . 0.0 110.572 -176.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 m -128.08 -177.64 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 124.175 0.922 . . . . 0.0 110.067 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -150.16 113.78 4.99 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.846 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.458 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 28.4 t80 -46.95 142.59 3.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 123.551 0.532 . . . . 0.0 110.388 172.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 pt -118.6 -55.37 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 123.948 0.78 . . . . 0.0 110.409 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.26 147.16 15.73 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.023 -1.084 . . . . 0.0 110.695 -165.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.458 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -127.06 128.79 46.84 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 112.904 -1.648 . . . . 0.0 110.019 176.266 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -68.06 159.72 30.28 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.338 174.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -79.46 68.8 5.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.045 0.84 . . . . 0.0 109.98 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.4 mt -140.54 1.36 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.907 178.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.412 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -90.65 -50.46 0.34 Allowed Pre-proline 0 N--CA 1.498 1.964 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.513 170.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 83' ' ' SER . 1.7 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 CA-C-O 116.153 -1.686 . . . . 0.0 111.244 -174.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 4.5 t 60.74 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.214 -0.993 . . . . 0.0 112.168 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 25.8 mtt -141.42 -46.92 0.38 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.478 -175.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.34 139.11 1.66 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.451 0.469 . . . . 0.0 110.299 -177.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.03 117.46 15.84 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.33 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -88.93 -42.53 11.76 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.89 -177.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.78 -144.66 34.21 Favored Glycine 0 N--CA 1.495 2.614 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.176 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -89.82 168.75 11.83 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 124.239 0.611 . . . . 0.0 109.694 158.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -147.59 165.26 30.91 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.27 1.033 . . . . 0.0 112.698 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -146.19 148.66 32.76 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 112.404 -2.18 . . . . 0.0 106.896 -174.579 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -117.64 113.8 22.45 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.82 103.95 0.07 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.401 1.063 . . . . 0.0 110.723 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.33 -31.48 69.96 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.824 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.93 141.9 38.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.133 0.895 . . . . 0.0 109.845 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.67 112.87 5.03 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.396 174.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -113.5 133.12 55.4 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -89.89 156.52 18.41 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.322 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -88.84 147.17 24.54 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.927 -175.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -122.67 -7.03 8.57 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.299 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -139.01 159.25 42.59 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.731 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.9 -21.16 66.43 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.364 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.99 -23.35 33.36 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.907 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -94.77 146.21 24.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.263 0.977 . . . . 0.0 109.979 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -111.98 176.69 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 124.775 1.297 . . . . 0.0 110.3 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -86.2 106.22 17.14 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.683 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.56 125.37 35.6 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.46 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.78 -173.12 2.18 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.728 1.267 . . . . 0.0 109.256 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.6 mt -74.13 145.72 44.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.69 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.47 10.88 4.63 Favored Glycine 0 N--CA 1.503 3.119 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.206 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.18 127.17 30.58 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.297 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mp -104.56 142.84 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 CA-C-O 121.307 0.575 . . . . 0.0 109.46 -178.609 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.456 HD21 ' CE1' ' A' ' 69' ' ' PHE . 7.4 mp -126.82 150.37 49.21 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.028 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.2 m -128.84 149.62 50.67 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 123.956 0.785 . . . . 0.0 110.62 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -120.63 -156.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 O-C-N 123.551 0.532 . . . . 0.0 109.728 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.483 ' H ' HD21 ' A' ' 33' ' ' ASN . 0.9 OUTLIER -63.01 -157.21 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 171.034 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -138.17 -19.8 1.11 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.03 33.71 0.09 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.5 p -145.81 64.15 1.24 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 113.767 -1.216 . . . . 0.0 108.351 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 mt -50.49 -26.32 5.02 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 112.92 -1.945 . . . . 0.0 113.438 169.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.95 -9.25 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.037 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -45.07 -30.48 1.1 Allowed 'General case' 0 N--CA 1.503 2.204 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.178 169.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.4 mt -117.86 -7.31 10.95 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.012 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.93 18.85 57.33 Favored Glycine 0 N--CA 1.495 2.624 0 O-C-N 123.952 0.782 . . . . 0.0 111.352 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -91.29 167.67 12.14 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.585 -0.808 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 m -109.08 170.31 8.13 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.299 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.52 155.11 20.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.753 175.74 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.13 2.38 31.58 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 124.288 0.992 . . . . 0.0 111.89 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -138.78 2.79 2.21 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 123.981 0.46 . . . . 0.0 111.943 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.36 -17.96 15.04 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 124.127 0.892 . . . . 0.0 112.462 174.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.21 -2.84 26.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.532 1.145 . . . . 0.0 111.859 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -119.96 79.15 24.84 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 123.97 0.794 . . . . 0.0 111.283 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.83 -13.7 23.68 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.784 1.656 . . . . 0.0 112.744 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -64.11 -38.1 89.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.093 0.871 . . . . 0.0 111.488 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -90.12 -28.09 19.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.931 0.769 . . . . 0.0 110.912 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 mt -74.09 141.47 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 123.866 0.729 . . . . 0.0 109.577 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.43 -92.82 1.15 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -93.23 120.39 33.47 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.603 -1.299 . . . . 0.0 109.679 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.0 mp -100.44 125.38 46.73 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.604 171.213 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -95.99 118.23 32.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.739 0.65 . . . . 0.0 109.729 171.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.01 -179.36 18.95 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -124.42 125.19 43.87 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -96.42 91.99 6.09 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.434 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -52.41 -35.04 50.99 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.021 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.7 m -51.25 -36.98 44.59 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.514 1.134 . . . . 0.0 112.096 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 64.5 p -115.74 2.6 13.7 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.952 0.782 . . . . 0.0 110.064 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.9 18.69 57.58 Favored Glycine 0 N--CA 1.493 2.483 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.746 -174.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -110.02 153.65 24.3 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' CD ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -137.74 146.72 44.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.665 1.228 . . . . 0.0 109.479 -175.78 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.89 -163.04 31.07 Favored Glycine 0 N--CA 1.491 2.314 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.18 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.3 151.15 26.96 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.066 -1.067 . . . . 0.0 109.587 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 26.7 p90 -147.68 144.38 19.17 Favored Pre-proline 0 N--CA 1.493 1.715 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.365 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.29 153.83 71.84 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.745 1.63 . . . . 0.0 111.34 174.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.27 53.17 2.47 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.3 t -134.46 -23.25 1.66 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -105.15 26.75 8.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.141 0.901 . . . . 0.0 110.63 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.46 166.85 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.595 -173.252 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -144.91 118.8 9.3 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.103 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -48.46 130.62 16.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.05 0.844 . . . . 0.0 110.464 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.469 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.2 pt -135.87 -62.39 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 123.907 0.754 . . . . 0.0 111.426 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.469 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -93.81 159.68 23.91 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 -176.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -127.06 160.33 31.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.758 0.917 . . . . 0.0 110.478 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -27.13 147.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 125.223 1.577 . . . . 0.0 114.555 166.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 18.4 mttm -63.2 -12.68 30.08 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.893 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 18.3 mt -99.98 141.45 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 124.166 0.916 . . . . 0.0 108.949 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.76 163.99 41.51 Favored Pre-proline 0 N--CA 1.497 1.917 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.879 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.218 0 CA-C-O 116.404 -1.582 . . . . 0.0 111.744 177.126 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 1.1 p 60.95 154.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 124.837 0.963 . . . . 0.0 113.049 -171.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.0 mtt -104.82 9.49 34.84 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.172 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 p -146.37 172.61 13.24 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 120.97 0.414 . . . . 0.0 111.358 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.58 172.28 12.31 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.292 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -92.87 -71.19 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.724 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.47 -134.6 10.74 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 124.64 1.213 . . . . 0.0 110.153 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -97.73 161.53 13.71 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -139.4 159.1 42.95 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.506 -173.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -142.68 125.15 15.68 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.1 -1.863 . . . . 0.0 107.601 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -89.61 118.46 29.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.629 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.63 152.48 0.33 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.927 0.767 . . . . 0.0 112.788 170.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -113.29 -44.81 3.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.512 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.34 151.99 41.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.06 0.85 . . . . 0.0 110.799 -175.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.01 116.37 7.76 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.257 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -117.99 138.1 52.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.125 0.891 . . . . 0.0 108.895 178.406 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.02 146.4 25.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.297 0.998 . . . . 0.0 109.921 174.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 164.53 14.94 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.176 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.62 -25.24 0.77 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.074 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -108.03 149.68 28.12 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.101 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.56 -12.25 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.531 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -81.76 -40.27 22.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 123.903 0.752 . . . . 0.0 111.187 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.77 156.22 19.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.114 0.884 . . . . 0.0 111.265 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.41 174.43 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.666 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -75.05 131.47 40.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.766 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 97.0 mt -121.56 127.46 50.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.587 1.179 . . . . 0.0 109.179 -177.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.74 -173.62 2.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.268 0.98 . . . . 0.0 108.904 -175.672 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.414 ' C ' ' H ' ' A' ' 28' ' ' ASP . 3.1 mp -83.12 156.53 23.23 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.423 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.12 0.03 1.0 Allowed Glycine 0 N--CA 1.5 2.955 0 O-C-N 123.872 0.732 . . . . 0.0 113.201 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.414 ' H ' ' C ' ' A' ' 26' ' ' LEU . 0.6 OUTLIER -65.69 106.29 1.45 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.579 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 5.6 mt -90.64 132.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.743 174.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.5 mp -108.52 151.52 25.98 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.064 -1.88 . . . . 0.0 109.013 179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.8 m -129.43 147.43 51.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 123.842 0.714 . . . . 0.0 109.845 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -119.59 -147.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 123.807 0.692 . . . . 0.0 109.265 -178.199 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -97.77 158.12 15.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 123.419 0.449 . . . . 0.0 110.033 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -85.41 -27.27 25.89 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.033 -173.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.48 32.99 0.41 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -175.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -152.29 49.08 0.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.413 ' C ' ' H ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -60.0 -30.78 69.37 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.094 171.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.5 t -46.02 -8.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 114.195 -1.366 . . . . 0.0 114.351 167.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.413 ' H ' ' C ' ' A' ' 37' ' ' LEU . . . -32.6 -36.46 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.273 0.983 . . . . 0.0 112.283 169.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.4 mt -92.72 -34.71 13.82 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.457 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.05 9.96 4.93 Favored Glycine 0 N--CA 1.499 2.838 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.361 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.11 167.18 22.33 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.968 -0.616 . . . . 0.0 110.213 -174.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.38 6.81 0.67 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.841 0.829 . . . . 0.0 112.392 172.34 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -177.19 106.65 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.356 -1.747 . . . . 0.0 108.08 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.25 -6.02 0.32 Allowed Glycine 0 N--CA 1.497 2.728 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 46.15 91.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.064 0.935 . . . . 0.0 111.246 -172.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.61 -14.14 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 113.407 -1.724 . . . . 0.0 113.349 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.421 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -86.96 -37.86 17.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -102.31 102.97 27.94 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.999 0.812 . . . . 0.0 111.325 174.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -68.6 -17.99 42.92 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.641 2.227 . . . . 0.0 114.092 167.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.53 -31.67 68.14 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.657 0.598 . . . . 0.0 112.246 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.32 -21.89 21.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.831 0.707 . . . . 0.0 111.376 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.12 146.91 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -91.56 1.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -90.19 131.04 36.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.425 -1.388 . . . . 0.0 109.032 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.429 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -108.46 126.82 53.32 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.506 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.94 124.23 46.33 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.77 -166.18 16.67 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -140.17 150.19 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -114.23 99.87 7.93 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.274 -177.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.81 -21.49 66.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.3 m -46.05 -37.42 6.7 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.812 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.61 2.46 6.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.849 1.343 . . . . 0.0 108.877 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.64 36.87 73.33 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.614 -176.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -109.51 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.51 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 156.05 40.99 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.767 0.794 . . . . 0.0 111.699 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.66 -153.05 23.3 Favored Glycine 0 N--CA 1.489 2.197 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.032 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.71 153.94 24.57 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -173.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.429 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.6 p90 -151.36 140.77 13.95 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.912 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -65.15 150.39 87.74 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.53 1.486 . . . . 0.0 110.708 175.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.29 48.72 4.08 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.6 t -141.21 16.39 2.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.105 0.532 . . . . 0.0 111.616 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -136.05 -4.08 2.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 123.751 0.657 . . . . 0.0 111.847 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.98 -169.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 123.932 0.77 . . . . 0.0 109.13 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.71 113.58 5.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 172.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.582 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 25.2 t80 -48.27 142.97 4.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.442 171.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.5 pt -122.24 -53.5 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 123.926 0.766 . . . . 0.0 111.688 176.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.84 146.63 15.79 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.478 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.582 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.0 OUTLIER -130.15 119.58 23.21 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.311 -1.444 . . . . 0.0 109.988 177.633 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -177.84 162.32 1.69 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.383 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -66.91 84.82 0.12 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.978 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.4 mt -89.92 130.01 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.659 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.77 161.45 46.19 Favored Pre-proline 0 N--CA 1.5 2.059 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.032 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.185 0 C-N-CA 121.739 1.626 . . . . 0.0 111.566 175.93 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 29.7 m -58.79 -21.48 56.19 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 174.476 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 5.5 ttm -60.16 133.25 55.91 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 123.619 0.574 . . . . 0.0 111.574 174.312 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.36 109.18 0.17 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 124.513 1.133 . . . . 0.0 108.766 -178.263 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.78 -160.91 0.21 Allowed 'General case' 0 N--CA 1.504 2.235 0 O-C-N 123.987 0.804 . . . . 0.0 112.806 -179.276 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -128.12 -68.24 0.78 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.455 176.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.98 -135.09 8.68 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -177.558 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.9 158.32 15.48 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.872 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.6 mt-30 -133.01 165.3 25.04 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.145 0.974 . . . . 0.0 111.857 -177.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -136.64 128.42 29.05 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.883 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -89.31 114.69 26.11 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.627 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.89 122.53 4.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.362 1.039 . . . . 0.0 111.99 171.288 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.27 -41.37 34.19 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.677 -178.365 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.11 160.62 39.53 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 124.21 0.944 . . . . 0.0 110.376 -177.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.47 127.8 33.76 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.496 173.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -126.56 130.48 50.63 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.367 1.042 . . . . 0.0 109.042 173.34 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -90.29 153.88 20.13 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 169.349 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.62 171.9 9.34 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.101 0.876 . . . . 0.0 109.864 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.44 -10.01 1.24 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.094 177.222 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -132.84 154.58 50.19 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.357 -176.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.2 -19.15 62.83 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.55 174.382 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -71.89 -31.17 66.15 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.045 176.492 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.77 152.06 23.02 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 124.23 0.956 . . . . 0.0 110.317 -177.721 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pt -115.46 173.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.834 176.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -74.22 134.05 42.7 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.265 -1.788 . . . . 0.0 108.866 -176.387 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 87.4 mt -126.63 136.63 52.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.279 0.987 . . . . 0.0 110.026 -177.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 173.08 11.9 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.699 -173.976 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -67.55 158.02 32.99 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.228 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.3 -10.0 1.49 Allowed Glycine 0 N--CA 1.5 2.909 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.886 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.32 133.15 50.79 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.17 116.23 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.47 129.94 45.69 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 -168.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.2 m -103.91 146.97 27.89 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 124.006 0.816 . . . . 0.0 110.619 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.431 ' CG1' ' H ' ' A' ' 33' ' ' ASN . 2.1 t -121.03 -149.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 124.52 1.138 . . . . 0.0 108.365 179.435 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.431 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 4.2 m-80 -82.74 175.91 9.75 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.409 0.443 . . . . 0.0 111.228 176.836 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -112.32 -28.86 7.75 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.616 1.198 . . . . 0.0 110.883 -175.385 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.89 40.29 0.39 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -177.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 t -147.2 66.7 1.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.932 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -52.4 -26.1 11.65 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 112.202 -2.272 . . . . 0.0 112.457 170.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.5 t -66.17 -9.26 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 123.949 0.781 . . . . 0.0 112.705 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -46.96 -34.85 5.9 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 124.378 1.049 . . . . 0.0 111.578 167.885 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mp -104.03 -4.93 22.67 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 124.108 0.88 . . . . 0.0 111.161 -178.719 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.49 16.41 71.18 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 123.963 0.79 . . . . 0.0 112.452 -174.615 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -77.18 146.58 36.97 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.058 -0.571 . . . . 0.0 111.391 -177.747 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.8 m -138.42 33.92 2.28 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 124.093 0.871 . . . . 0.0 109.62 -174.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -123.88 -92.59 0.52 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.379 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.24 14.9 0.12 Allowed Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.466 -166.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -61.36 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 O-C-N 123.964 0.449 . . . . 0.0 110.719 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 45.71 39.41 5.09 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.909 0.861 . . . . 0.0 112.908 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.431 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -158.95 -22.75 0.07 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.35 -173.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 84.99 37.78 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 124.006 0.816 . . . . 0.0 109.395 175.61 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -56.28 -23.0 43.59 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.444 2.096 . . . . 0.0 111.997 173.257 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.42 -45.63 76.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.657 1.223 . . . . 0.0 110.837 -175.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.01 -26.52 20.29 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 124.113 0.883 . . . . 0.0 111.102 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 62.4 mt -64.66 153.73 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 123.72 0.638 . . . . 0.0 109.857 176.635 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.17 -101.42 1.03 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 178.668 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -92.18 147.25 23.08 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.497 -0.851 . . . . 0.0 110.382 -177.609 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.468 HD11 ' CE2' ' A' ' 69' ' ' PHE . 67.4 mt -117.46 120.22 37.46 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 113.831 -1.531 . . . . 0.0 107.829 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.25 123.16 42.19 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 124.221 0.951 . . . . 0.0 109.732 173.613 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.07 -173.19 31.49 Favored Glycine 0 N--CA 1.499 2.871 0 O-C-N 124.066 0.853 . . . . 0.0 111.71 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.73 128.7 49.96 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.025 -174.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -94.06 62.19 3.03 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 124.445 1.09 . . . . 0.0 109.625 175.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -42.71 -33.9 0.81 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 114.467 -1.242 . . . . 0.0 114.179 173.155 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.9 p -55.08 -50.26 69.6 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 123.598 0.561 . . . . 0.0 112.028 177.218 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -89.83 1.89 55.62 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.059 0.85 . . . . 0.0 111.06 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.99 33.25 86.75 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -131.44 165.32 23.79 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -150.43 156.04 40.71 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 123.571 0.545 . . . . 0.0 110.551 177.163 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.68 -154.14 20.32 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.457 176.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.04 150.78 26.71 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.468 ' CE2' HD11 ' A' ' 56' ' ' LEU . 12.8 p90 -154.95 139.43 11.66 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 124.171 0.919 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.95 161.17 19.59 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.126 1.884 . . . . 0.0 112.86 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.08 22.28 32.71 Favored Glycine 0 N--CA 1.495 2.593 0 O-C-N 124.206 0.941 . . . . 0.0 111.871 -176.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.42 -47.4 4.69 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 117.444 0.622 . . . . 0.0 112.65 -174.737 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -94.02 40.34 1.08 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.499 -171.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.39 152.05 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.484 -174.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -131.96 111.82 11.87 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.431 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 75.8 t80 -54.78 122.57 11.03 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.306 174.779 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -94.42 -49.6 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 124.113 0.883 . . . . 0.0 110.783 -176.905 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.97 -168.45 41.55 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.912 -1.137 . . . . 0.0 112.696 175.235 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 140.3 51.85 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 113.41 -1.395 . . . . 0.0 109.973 175.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -114.54 37.79 3.3 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.685 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -131.95 -72.05 0.54 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.122 177.439 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.8 tp -89.7 100.97 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.777 -171.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.411 ' H ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -150.09 -57.12 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.08 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.174 -176.73 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.411 ' HD2' ' H ' ' A' ' 83' ' ' SER . 1.1 Cg_endo . . . . . 0 N--CA 1.489 1.223 0 CA-C-O 116.36 -1.6 . . . . 0.0 111.08 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 33.7 t -61.69 -49.38 76.71 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.682 -0.759 . . . . 0.0 111.31 175.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 0.0 OUTLIER 64.24 149.69 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 O-C-N 124.152 0.908 . . . . 0.0 112.13 -173.095 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.414 ' H ' ' HG ' ' A' ' 2' ' ' SER . 0.0 OUTLIER -54.51 143.7 23.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.544 173.008 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.14 -140.63 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.284 -1.326 . . . . 0.0 109.304 -176.482 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -126.3 39.53 3.92 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 122.022 0.915 . . . . 0.0 111.66 -174.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.84 -144.64 7.74 Favored Glycine 0 N--CA 1.495 2.594 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.501 176.684 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.34 150.81 21.18 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -174.66 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -128.9 164.03 23.99 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 122.849 1.309 . . . . 0.0 113.832 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -141.12 154.7 46.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 111.398 -2.637 . . . . 0.0 107.338 -174.654 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -125.73 121.21 32.74 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.54 126.06 16.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 124.121 0.888 . . . . 0.0 110.935 168.771 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.38 -33.12 23.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.874 0.734 . . . . 0.0 111.017 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.88 157.59 44.26 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.928 0.767 . . . . 0.0 110.346 -174.514 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.89 116.95 19.53 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.26 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 5.3 t80 -121.19 133.78 55.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.449 1.093 . . . . 0.0 108.725 179.181 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.6 164.57 14.7 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.495 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -89.06 142.36 27.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.616 0.572 . . . . 0.0 109.803 -177.443 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.44 -12.45 5.0 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.96 177.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.91 143.12 51.37 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.336 178.546 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.98 -34.54 76.34 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.083 -178.846 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.69 -35.41 80.69 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.404 177.467 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -88.35 162.09 16.75 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.177 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.64 174.83 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.278 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.79 148.56 42.38 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.936 -177.147 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.8 mt -133.24 141.28 47.95 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.093 0.87 . . . . 0.0 110.538 178.043 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.78 165.67 26.82 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.532 -171.31 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.427 ' C ' ' H ' ' A' ' 28' ' ' ASP . 7.7 mt -65.74 151.69 46.02 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.336 174.842 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.32 -9.4 4.33 Favored Glycine 0 N--CA 1.501 2.995 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.03 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.427 ' H ' ' C ' ' A' ' 26' ' ' LEU . 50.4 t0 -69.02 132.46 46.68 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.439 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mt -121.05 138.74 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 124.343 1.027 . . . . 0.0 108.629 176.158 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.9 mp -107.48 150.21 27.06 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 112.972 -1.922 . . . . 0.0 108.138 178.683 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 m -127.5 153.81 45.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.632 0.583 . . . . 0.0 109.992 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -131.29 175.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -176.508 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.482 ' CB ' ' HB3' ' A' ' 36' ' ' SER . 1.8 t-20 -72.39 164.0 27.07 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.794 0.807 . . . . 0.0 110.338 -178.15 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -61.87 -20.45 63.72 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.514 174.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.29 31.06 1.57 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 -175.427 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.482 ' HB3' ' CB ' ' A' ' 33' ' ' ASN . 7.7 p -73.63 8.07 2.08 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 178.807 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.78 -42.22 88.49 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 117.834 -1.546 . . . . 0.0 110.0 160.455 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.7 t -82.0 -9.49 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.967 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.74 -37.17 1.67 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 123.933 0.771 . . . . 0.0 110.281 170.341 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mt -115.45 -0.4 13.12 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.609 -174.184 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.65 33.63 86.66 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 123.819 0.699 . . . . 0.0 113.143 -172.445 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.36 150.12 40.46 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 114.5 -0.85 . . . . 0.0 111.273 -173.68 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -89.4 -152.39 0.24 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.377 175.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -40.63 132.6 2.14 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 167.23 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 165.49 103.9 0.17 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -168.79 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.73 -0.81 0.49 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 124.656 0.856 . . . . 0.0 112.211 174.684 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 70.94 4.63 5.15 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.909 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.71 23.32 9.54 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.393 -169.64 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.68 68.65 81.85 Favored Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.674 -176.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -59.23 -23.91 71.7 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.46 2.107 . . . . 0.0 111.73 174.24 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -59.31 -49.17 78.84 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.285 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -90.09 -35.19 15.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 123.832 0.708 . . . . 0.0 110.909 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.4 mt -64.1 129.86 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 123.943 0.777 . . . . 0.0 109.64 172.122 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.46 -87.41 1.27 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -175.85 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -98.23 124.87 43.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.609 -1.296 . . . . 0.0 108.144 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.407 ' HG ' ' CZ ' ' A' ' 69' ' ' PHE . 1.4 pt? -132.65 144.67 50.5 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 173.686 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -92.87 147.84 22.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.594 1.184 . . . . 0.0 108.867 -176.066 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.86 154.13 25.25 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 175.604 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.46 122.49 32.7 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.062 -1.069 . . . . 0.0 108.487 176.376 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -96.47 69.66 2.61 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.977 0.894 . . . . 0.0 111.168 177.005 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -52.31 -26.76 12.96 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 113.754 -1.567 . . . . 0.0 112.458 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.4 p -51.67 -51.72 53.64 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.037 0.836 . . . . 0.0 112.782 174.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.6 p -91.6 2.28 56.56 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.228 176.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.86 30.37 77.81 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.615 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -129.34 178.32 6.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 124.506 0.768 . . . . 0.0 109.508 -178.44 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -144.51 147.66 33.52 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.506 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.17 -163.01 28.54 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 118.79 -1.671 . . . . 0.0 113.847 166.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.69 152.74 19.32 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 113.17 -1.515 . . . . 0.0 108.98 -178.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.407 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 24.4 p90 -154.36 152.74 26.88 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 123.654 0.596 . . . . 0.0 109.803 175.215 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -65.66 165.25 23.67 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 122.32 2.013 . . . . 0.0 112.007 176.494 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.55 -2.35 67.71 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 123.987 0.804 . . . . 0.0 111.57 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -96.34 -34.13 11.69 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.507 0.67 . . . . 0.0 109.833 -166.689 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -90.95 6.11 45.99 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.567 -1.652 . . . . 0.0 111.529 -174.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.34 -177.75 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 124.208 0.942 . . . . 0.0 109.046 -178.429 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.34 115.95 5.51 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -49.4 128.91 18.03 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 166.182 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.67 -54.72 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 124.131 0.894 . . . . 0.0 109.721 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.94 171.92 36.36 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.681 -1.724 . . . . 0.0 110.502 -170.484 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.37 146.27 27.41 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.732 -1.234 . . . . 0.0 109.404 168.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -78.15 100.92 6.79 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.065 166.505 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.23 95.33 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.464 176.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.98 140.94 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.921 177.165 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.55 163.15 45.21 Favored Pre-proline 0 N--CA 1.498 1.963 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.754 -177.517 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 C-N-CA 121.887 1.725 . . . . 0.0 112.301 176.285 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.9 OUTLIER -75.02 136.21 41.25 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 124.128 0.546 . . . . 0.0 110.895 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.2 ptp -87.76 60.72 6.08 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.936 0.874 . . . . 0.0 110.868 -176.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -165.23 142.95 6.03 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.986 -172.676 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.77 -1.29 0.09 Allowed 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.394 177.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.22 82.34 0.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 124.485 1.116 . . . . 0.0 108.772 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -141.8 -151.31 5.51 Favored Glycine 0 N--CA 1.497 2.717 0 CA-C-N 112.528 -2.124 . . . . 0.0 111.083 -178.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.72 154.96 17.59 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -136.73 162.01 34.38 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.848 0.833 . . . . 0.0 110.991 -169.31 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -129.64 170.75 13.4 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.587 -1.642 . . . . 0.0 107.341 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -133.89 116.65 15.87 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.477 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.14 112.03 0.98 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.301 1.0 . . . . 0.0 110.013 174.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.4 tp -70.07 -38.49 75.75 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.514 -177.594 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.61 170.83 15.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 124.582 1.176 . . . . 0.0 109.981 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.22 123.2 28.27 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.529 175.199 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -118.83 134.25 55.29 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.678 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -89.74 159.12 17.23 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.047 175.635 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -88.3 141.09 28.83 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -176.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -121.32 -8.65 9.16 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.644 178.224 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -136.67 146.62 46.14 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.611 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -60.41 -31.01 69.98 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.166 174.549 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.58 -32.75 73.8 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.3 178.431 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.36 161.1 14.53 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.304 1.002 . . . . 0.0 110.107 177.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 pt -116.94 174.86 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 124.349 1.031 . . . . 0.0 111.545 176.298 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.52 141.95 46.73 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.125 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 18.0 mt -131.38 135.17 46.98 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.968 0.792 . . . . 0.0 111.534 178.279 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.31 176.52 8.62 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.247 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.4 ' C ' ' H ' ' A' ' 28' ' ' ASP . 1.7 mp -72.47 154.53 40.81 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.937 -177.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.69 -5.57 2.33 Favored Glycine 0 N--CA 1.5 2.931 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.896 -176.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.4 ' H ' ' C ' ' A' ' 26' ' ' LEU . 1.0 OUTLIER -64.64 101.13 0.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.233 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.95 135.96 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 124.274 0.984 . . . . 0.0 110.099 173.118 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -111.2 157.03 20.56 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.968 -178.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.5 m -133.37 150.8 51.81 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.768 0.668 . . . . 0.0 110.407 -176.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.411 ' CG1' ' H ' ' A' ' 33' ' ' ASN . 1.4 t -128.31 -151.93 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 123.841 0.713 . . . . 0.0 109.151 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.411 ' H ' ' CG1' ' A' ' 32' ' ' VAL . 1.8 m-80 -87.18 -173.66 4.52 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.869 178.059 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -133.76 -41.05 0.85 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.504 -173.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.28 22.84 3.52 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 t -143.14 61.02 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 mt -51.72 -18.73 1.31 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 112.717 -2.038 . . . . 0.0 113.206 167.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.0 -23.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 124.488 1.117 . . . . 0.0 113.563 176.851 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -40.7 -28.59 0.08 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 112.516 -2.129 . . . . 0.0 112.316 168.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.452 HD23 ' H ' ' A' ' 57' ' ' ASN . 26.0 mt -125.96 -7.61 6.63 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.518 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.44 36.45 30.22 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -178.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.79 176.48 5.15 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 112.731 -1.734 . . . . 0.0 109.675 -172.451 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.4 t -132.52 142.02 49.01 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.623 175.965 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.04 117.73 4.29 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.023 173.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.76 -43.55 0.06 OUTLIER Glycine 0 N--CA 1.494 2.511 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.613 -179.205 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -150.13 69.12 1.0 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.38 -1.41 . . . . 0.0 108.509 -167.72 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -100.54 56.99 0.91 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.606 172.619 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.45 -0.84 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.596 178.568 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -123.0 77.78 50.81 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 123.93 0.769 . . . . 0.0 109.557 -176.834 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.43 -18.83 15.73 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.888 2.392 . . . . 0.0 112.7 175.583 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -53.97 -42.62 69.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.087 0.867 . . . . 0.0 111.806 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -89.8 -29.6 18.53 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.1 0.875 . . . . 0.0 110.926 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 mt -73.54 136.7 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.82 -87.08 1.31 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -172.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -102.75 131.22 49.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.309 -1.445 . . . . 0.0 109.051 -178.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -114.5 138.31 50.76 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.233 173.958 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.452 ' H ' HD23 ' A' ' 40' ' ' LEU . 1.2 m120 -108.29 124.33 50.15 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 173.221 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -151.14 176.87 29.46 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 120.079 -1.058 . . . . 0.0 112.006 177.829 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -110.52 131.24 55.22 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.149 -1.025 . . . . 0.0 109.275 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -103.43 102.82 12.75 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.682 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.11 -36.31 72.72 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.284 177.775 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.4 m -56.63 -28.49 60.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.494 1.121 . . . . 0.0 111.996 -177.502 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -116.9 -2.96 11.69 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.645 -176.602 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.15 19.81 32.95 Favored Glycine 0 N--CA 1.497 2.748 0 O-C-N 124.405 1.066 . . . . 0.0 111.37 -172.751 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.98 165.78 13.31 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -172.088 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.16 149.8 40.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.006 0.816 . . . . 0.0 109.68 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.72 -145.19 6.66 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.456 173.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.39 153.67 30.62 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.145 -1.027 . . . . 0.0 108.29 -173.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.476 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 31.1 p90 -157.01 143.55 13.26 Favored Pre-proline 0 N--CA 1.493 1.699 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.751 178.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.08 157.87 46.86 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 122.111 1.874 . . . . 0.0 112.043 176.064 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.94 43.62 1.92 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.92 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -134.0 -26.38 1.52 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 178.066 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -93.21 2.4 56.67 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.463 -177.945 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.42 -176.44 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 124.306 1.004 . . . . 0.0 109.227 -177.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -150.27 115.15 5.31 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.716 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -48.36 122.26 5.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.142 0.901 . . . . 0.0 109.343 171.138 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.97 -51.1 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.039 177.485 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -166.16 159.84 33.21 Favored Glycine 0 N--CA 1.485 1.911 0 C-N-CA 118.814 -1.66 . . . . 0.0 110.688 -178.868 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.413 ' CD ' ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -129.54 124.55 34.17 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.866 -2.167 . . . . 0.0 105.957 173.962 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -57.53 141.47 47.69 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.25 169.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.91 109.16 0.29 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.118 0.886 . . . . 0.0 110.649 171.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.66 -6.92 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.129 173.54 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.32 157.5 47.48 Favored Pre-proline 0 N--CA 1.503 2.207 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -175.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.491 1.338 0 C-N-CA 122.314 2.01 . . . . 0.0 111.732 -179.513 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 55.3 p -65.82 -37.6 86.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.451 178.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 19.3 mmt -73.25 110.39 7.5 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.833 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.48 169.13 23.64 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.37 -175.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.82 95.55 9.91 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.781 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.22 21.96 3.46 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.03 -178.808 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.93 -160.71 0.1 OUTLIER Glycine 0 N--CA 1.495 2.589 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.547 167.619 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -89.44 177.75 6.49 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -163.494 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -144.43 159.56 42.53 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 117.413 -1.715 . . . . 0.0 113.67 -174.535 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -146.31 143.96 29.49 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 112.345 -2.207 . . . . 0.0 107.439 -172.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -118.57 112.96 20.55 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -174.606 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.17 121.67 3.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.302 1.001 . . . . 0.0 109.983 175.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -68.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.205 176.791 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.41 171.79 7.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.382 1.052 . . . . 0.0 109.924 -177.012 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.43 121.12 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.38 175.539 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -124.87 129.33 50.19 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -89.82 -170.33 2.77 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -88.33 144.89 26.13 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.039 175.221 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.39 -15.7 9.06 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.802 173.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.18 147.48 27.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.553 1.158 . . . . 0.0 108.796 -178.601 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.11 -11.31 0.67 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.033 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -81.37 -44.68 17.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 124.212 0.945 . . . . 0.0 111.261 177.661 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.75 165.47 18.85 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.855 0.722 . . . . 0.0 109.334 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 177.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 122.507 1.146 . . . . 0.0 110.85 177.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -82.23 113.11 19.83 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 111.927 -2.397 . . . . 0.0 106.781 -178.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.6 mt -103.76 143.19 33.13 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.422 0.629 . . . . 0.0 111.769 179.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 172.15 15.72 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.271 -176.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 28' ' ' ASP . 6.5 mp -64.84 155.75 33.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.016 -177.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.19 -12.96 2.89 Favored Glycine 0 N--CA 1.504 3.187 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.476 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 26' ' ' LEU . 9.4 t70 -76.58 113.89 14.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.205 0.591 . . . . 0.0 109.609 -175.737 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.91 149.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.246 0.546 . . . . 0.0 109.885 179.658 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.1 mp -124.47 145.91 49.25 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.228 179.622 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 m -127.1 125.63 41.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.165 0.916 . . . . 0.0 109.616 -177.351 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.4 t -95.85 -124.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -140.03 -173.84 3.76 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -171.127 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 pttm -116.13 5.55 13.8 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.436 173.272 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.19 -12.25 11.49 Favored Glycine 0 N--CA 1.495 2.599 0 CA-C-O 118.941 -0.922 . . . . 0.0 112.88 178.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p 77.45 41.96 0.13 Allowed 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.463 1.125 . . . . 0.0 109.811 165.793 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mt 81.45 -15.31 0.73 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 111.554 -2.566 . . . . 0.0 110.337 177.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.91 -20.3 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.543 169.66 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.51 -22.1 19.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.533 167.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mt -114.46 0.52 14.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.052 0.845 . . . . 0.0 110.939 -179.047 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.6 16.67 80.56 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.842 -170.149 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -91.59 155.08 18.62 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 97.6 p -137.74 7.48 2.75 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.022 0.915 . . . . 0.0 113.235 176.207 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -176.31 104.07 0.07 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.944 -1.935 . . . . 0.0 107.256 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.15 -14.47 0.03 OUTLIER Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.561 170.443 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.02 99.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.682 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.52 -17.62 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 168.867 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 -11.89 55.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.1 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 82.37 48.52 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 124.219 0.949 . . . . 0.0 108.587 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.23 -10.68 26.77 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.118 1.879 . . . . 0.0 113.021 173.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.89 -36.73 79.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.719 0.637 . . . . 0.0 111.608 -176.037 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -91.4 -29.98 16.76 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.279 -176.217 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -71.6 149.82 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.222 177.07 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.4 -95.31 1.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -98.8 126.22 44.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.826 0.956 . . . . 0.0 110.061 -175.836 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.7 mp -98.29 145.09 27.01 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.429 174.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.432 HD22 ' CG ' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -104.54 125.92 51.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.2 0.937 . . . . 0.0 108.664 169.879 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.7 160.39 27.95 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.382 173.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.76 122.24 31.97 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.124 -1.038 . . . . 0.0 109.7 172.458 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -92.44 64.76 4.37 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.674 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -52.61 -31.2 35.27 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.006 -178.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.6 p -53.89 -48.28 70.27 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.116 0.885 . . . . 0.0 111.49 179.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -89.74 -5.47 56.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.03 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.44 24.98 64.26 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 177.773 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -129.28 179.34 5.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.506 0.768 . . . . 0.0 109.144 -175.407 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -147.14 151.67 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.453 179.012 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.68 -161.08 33.2 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.2 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.432 ' CG ' HD22 ' A' ' 57' ' ' ASN . 1.9 m-20 -111.96 162.18 15.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -170.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.4 p90 -160.65 148.47 12.69 Favored Pre-proline 0 N--CA 1.496 1.845 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.12 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.85 150.03 89.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.698 1.598 . . . . 0.0 111.209 177.568 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.04 48.09 2.22 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 175.23 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -146.71 8.16 0.98 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.819 0.364 . . . . 0.0 111.565 174.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.05 9.34 9.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.967 0.792 . . . . 0.0 111.473 -178.603 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 -171.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 124.016 0.823 . . . . 0.0 109.702 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -150.15 102.36 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.179 175.014 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -41.99 136.32 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.496 170.214 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.463 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.3 pt -139.57 -67.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 124.005 0.816 . . . . 0.0 110.604 -177.741 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.463 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -89.86 159.02 27.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -173.01 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -171.18 133.0 0.84 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.88 -168.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.1 mttm 54.23 112.63 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 112.097 -2.32 . . . . 0.0 113.229 169.402 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp 43.11 37.9 1.35 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.761 -175.644 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.99 123.65 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 118.424 -1.31 . . . . 0.0 109.527 -171.769 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.16 163.95 23.18 Favored Pre-proline 0 N--CA 1.503 2.177 0 CA-C-N 112.849 -1.978 . . . . 0.0 108.919 -171.775 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 C-N-CA 121.779 1.653 . . . . 0.0 111.918 175.731 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 55.3 p -65.82 -37.6 86.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.451 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 19.3 mmt -73.25 110.39 7.5 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.833 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.48 169.13 23.64 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.37 -175.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.82 95.55 9.91 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.781 -177.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.22 21.96 3.46 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.03 -178.808 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.93 -160.71 0.1 OUTLIER Glycine 0 N--CA 1.495 2.589 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.547 167.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -89.44 177.75 6.49 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -163.494 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -144.43 159.56 42.53 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 117.413 -1.715 . . . . 0.0 113.67 -174.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -146.31 143.96 29.49 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 112.345 -2.207 . . . . 0.0 107.439 -172.406 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -118.57 112.96 20.55 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -174.606 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.17 121.67 3.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.302 1.001 . . . . 0.0 109.983 175.071 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.8 -68.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.205 176.791 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.41 171.79 7.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.382 1.052 . . . . 0.0 109.924 -177.012 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.43 121.12 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.38 175.539 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -124.87 129.33 50.19 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.237 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -89.82 -170.33 2.77 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -88.33 144.89 26.13 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.039 175.221 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.39 -15.7 9.06 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.802 173.987 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -150.18 147.48 27.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.553 1.158 . . . . 0.0 108.796 -178.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.11 -11.31 0.67 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.033 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -81.37 -44.68 17.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 124.212 0.945 . . . . 0.0 111.261 177.661 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.75 165.47 18.85 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.855 0.722 . . . . 0.0 109.334 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 177.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 122.507 1.146 . . . . 0.0 110.85 177.707 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -82.23 113.11 19.83 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 111.927 -2.397 . . . . 0.0 106.781 -178.323 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.6 mt -103.76 143.19 33.13 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.422 0.629 . . . . 0.0 111.769 179.288 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 172.15 15.72 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.271 -176.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.405 ' C ' ' H ' ' A' ' 28' ' ' ASP . 6.5 mp -64.84 155.75 33.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.016 -177.457 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.19 -12.96 2.89 Favored Glycine 0 N--CA 1.504 3.187 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.476 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.405 ' H ' ' C ' ' A' ' 26' ' ' LEU . 9.4 t70 -76.58 113.89 14.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.205 0.591 . . . . 0.0 109.609 -175.737 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -96.91 149.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.246 0.546 . . . . 0.0 109.885 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.1 mp -124.47 145.91 49.25 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.228 179.622 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 m -127.1 125.63 41.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.165 0.916 . . . . 0.0 109.616 -177.351 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 6.4 t -95.85 -124.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.951 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 74.9 m-80 -140.03 -173.84 3.76 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -171.127 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 pttm -116.13 5.55 13.8 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.436 173.272 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.19 -12.25 11.49 Favored Glycine 0 N--CA 1.495 2.599 0 CA-C-O 118.941 -0.922 . . . . 0.0 112.88 178.198 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p 77.45 41.96 0.13 Allowed 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.463 1.125 . . . . 0.0 109.811 165.793 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mt 81.45 -15.31 0.73 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 111.554 -2.566 . . . . 0.0 110.337 177.081 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.91 -20.3 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.543 169.66 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.51 -22.1 19.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.533 167.26 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 9.3 mt -114.46 0.52 14.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.052 0.845 . . . . 0.0 110.939 -179.047 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.6 16.67 80.56 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.842 -170.149 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -91.59 155.08 18.62 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 97.6 p -137.74 7.48 2.75 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.022 0.915 . . . . 0.0 113.235 176.207 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -176.31 104.07 0.07 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.944 -1.935 . . . . 0.0 107.256 -175.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.15 -14.47 0.03 OUTLIER Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.561 170.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.02 99.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.682 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.52 -17.62 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 168.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 -11.89 55.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.1 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 82.37 48.52 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 124.219 0.949 . . . . 0.0 108.587 -177.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.23 -10.68 26.77 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.118 1.879 . . . . 0.0 113.021 173.596 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.89 -36.73 79.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.719 0.637 . . . . 0.0 111.608 -176.037 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -91.4 -29.98 16.76 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.279 -176.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -71.6 149.82 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.222 177.07 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.4 -95.31 1.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 177.232 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -98.8 126.22 44.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.826 0.956 . . . . 0.0 110.061 -175.836 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.7 mp -98.29 145.09 27.01 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.429 174.252 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.432 HD22 ' CG ' ' A' ' 68' ' ' ASP . 0.9 OUTLIER -104.54 125.92 51.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.2 0.937 . . . . 0.0 108.664 169.879 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.7 160.39 27.95 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.382 173.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.76 122.24 31.97 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.124 -1.038 . . . . 0.0 109.7 172.458 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -92.44 64.76 4.37 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.674 176.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -52.61 -31.2 35.27 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.006 -178.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 37.6 p -53.89 -48.28 70.27 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.116 0.885 . . . . 0.0 111.49 179.142 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -89.74 -5.47 56.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.03 177.163 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.44 24.98 64.26 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 177.773 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -129.28 179.34 5.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.506 0.768 . . . . 0.0 109.144 -175.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -147.14 151.67 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.453 179.012 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.68 -161.08 33.2 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.2 176.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.432 ' CG ' HD22 ' A' ' 57' ' ' ASN . 1.9 m-20 -111.96 162.18 15.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -170.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.4 p90 -160.65 148.47 12.69 Favored Pre-proline 0 N--CA 1.496 1.845 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.12 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.85 150.03 89.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.698 1.598 . . . . 0.0 111.209 177.568 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.04 48.09 2.22 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -146.71 8.16 0.98 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.819 0.364 . . . . 0.0 111.565 174.842 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.05 9.34 9.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.967 0.792 . . . . 0.0 111.473 -178.603 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 -171.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 124.016 0.823 . . . . 0.0 109.702 -173.043 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 10.0 tt0 -150.15 102.36 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.179 175.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -41.99 136.32 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.496 170.214 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.463 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.3 pt -139.57 -67.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 124.005 0.816 . . . . 0.0 110.604 -177.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.463 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -89.86 159.02 27.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -173.01 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -171.18 133.0 0.84 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.88 -168.007 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.1 mttm 54.23 112.63 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 112.097 -2.32 . . . . 0.0 113.229 169.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp 43.11 37.9 1.35 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.761 -175.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -88.99 123.65 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 118.424 -1.31 . . . . 0.0 109.527 -171.769 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.16 163.95 23.18 Favored Pre-proline 0 N--CA 1.503 2.177 0 CA-C-N 112.849 -1.978 . . . . 0.0 108.919 -171.775 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 C-N-CA 121.779 1.653 . . . . 0.0 111.918 175.731 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' B SER . . . . . . . . . . . . . 5.4 t -155.81 146.31 21.88 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.017 0.481 . . . . 0.0 110.084 -179.011 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' C MET . . . . . . . . . . . . . 11.6 tpt 55.97 79.44 0.17 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 124.216 0.947 . . . . 0.0 111.572 176.309 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 p -157.65 74.16 0.73 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.886 -175.173 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.4 107.18 14.87 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.17 176.024 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -89.75 -12.86 38.11 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.818 177.685 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.95 -112.6 0.27 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 177.69 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' TYR . . . . . 0.408 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -111.19 159.68 17.65 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.831 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -133.38 160.31 37.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 124.038 0.836 . . . . 0.0 111.602 -177.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -138.35 162.04 35.4 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.078 -1.874 . . . . 0.0 108.05 -177.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -125.87 112.9 16.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.293 0.996 . . . . 0.0 108.738 -179.35 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.41 108.93 0.43 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.321 170.315 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.68 -14.41 32.3 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.15 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.38 141.46 41.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.308 1.005 . . . . 0.0 110.544 -179.176 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.59 115.32 17.26 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.182 171.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -125.96 136.15 52.67 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 124.323 1.015 . . . . 0.0 109.101 176.909 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -89.79 163.3 15.11 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -89.02 140.6 29.27 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.851 0.719 . . . . 0.0 109.514 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -89.74 -25.34 21.2 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.994 -179.356 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -150.2 162.22 40.88 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.363 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -52.52 -14.89 0.55 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.137 -1.392 . . . . 0.0 114.609 173.893 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -75.94 -42.8 47.63 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 123.61 0.569 . . . . 0.0 110.767 177.822 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.35 146.48 24.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.02 0.825 . . . . 0.0 110.161 177.418 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -99.03 173.14 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.058 175.832 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.36 140.6 37.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.644 -177.176 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -125.86 138.91 53.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.497 1.123 . . . . 0.0 109.277 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.04 -155.14 0.67 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.043 -171.911 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.411 ' C ' ' H ' ' A' ' 28' ' ' ASP . 8.8 mt -106.4 144.29 33.29 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.706 0.629 . . . . 0.0 111.12 175.099 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.09 6.6 5.71 Favored Glycine 0 N--CA 1.503 3.11 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.667 178.322 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.411 ' H ' ' C ' ' A' ' 26' ' ' LEU . 1.1 m-20 -68.89 144.25 54.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 123.93 0.429 . . . . 0.0 110.498 173.728 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mp -108.9 146.79 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 124.569 1.168 . . . . 0.0 107.933 -177.761 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 6.4 mp -128.57 129.04 45.4 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.747 172.021 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 97.0 m -106.5 152.32 23.82 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 124.269 0.981 . . . . 0.0 109.273 -178.919 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -131.67 -173.45 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 124.079 0.862 . . . . 0.0 109.115 -179.133 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -80.76 160.82 24.78 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.7 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -55.41 -33.03 63.17 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.57 175.899 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -127.65 40.99 1.65 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 106.389 -2.685 . . . . 0.0 106.389 -177.202 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -16.6 41.23 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.575 -1.312 . . . . 0.0 111.811 -177.983 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 mt -57.12 -47.72 80.42 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.451 -0.9 . . . . 0.0 108.765 172.238 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.6 t -74.02 -10.66 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.499 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.89 -30.08 9.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.106 0.879 . . . . 0.0 110.158 176.122 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -103.57 -36.94 7.75 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.765 -179.526 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.84 18.66 3.17 Favored Glycine 0 N--CA 1.493 2.479 0 O-C-N 125.755 1.909 . . . . 0.0 113.279 -174.699 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -69.05 174.94 4.07 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.334 0.588 . . . . 0.0 111.637 176.001 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.5 p -123.29 -178.05 3.88 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.884 176.56 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -56.36 104.12 0.13 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.434 1.084 . . . . 0.0 111.331 174.67 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.88 -110.11 0.94 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -178.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . 0.479 ' C ' ' H ' ' A' ' 48' ' ' ALA . 1.3 pt20 -155.73 89.11 1.15 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.622 1.201 . . . . 0.0 109.865 -172.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.6 16.73 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.578 172.59 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 46' ' ' GLN . . . -103.99 -14.15 16.06 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.288 -178.444 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -112.04 94.46 25.48 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 124.197 0.936 . . . . 0.0 108.942 173.961 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.67 -20.9 53.03 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.266 1.977 . . . . 0.0 112.768 166.937 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -59.16 -36.6 75.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.898 0.749 . . . . 0.0 111.951 -175.014 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.75 -31.83 17.26 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 123.856 0.723 . . . . 0.0 109.241 -176.612 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.73 146.17 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 124.123 0.889 . . . . 0.0 110.144 175.324 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.84 -99.69 1.1 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.978 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -89.79 131.94 35.48 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.416 -0.892 . . . . 0.0 110.01 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.541 HD11 ' CE2' ' A' ' 69' ' ' PHE . 95.7 mt -102.04 156.26 17.65 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -134.21 121.5 21.44 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.9 -162.38 17.1 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -176.773 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.73 130.01 31.38 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -172.821 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -93.63 68.1 3.98 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.182 -1.826 . . . . 0.0 108.856 174.346 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -43.05 -29.54 0.36 Allowed 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 114.538 -1.21 . . . . 0.0 114.023 175.709 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' THR . . . . . 0.416 ' HG1' ' H ' ' A' ' 63' ' ' THR . 82.8 p -45.85 -51.02 13.67 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.426 1.079 . . . . 0.0 112.328 178.11 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' THR . . . . . 0.416 ' H ' ' HG1' ' A' ' 62' ' ' THR . 1.6 p -106.44 0.26 24.65 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.986 174.982 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.43 37.81 53.22 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 175.333 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -109.3 135.75 49.87 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.227 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -120.99 125.36 47.17 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 123.811 0.694 . . . . 0.0 110.469 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.77 -147.21 8.0 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 119.521 -1.323 . . . . 0.0 114.094 176.777 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.19 164.39 12.91 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 113.782 -1.209 . . . . 0.0 108.898 -177.01 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.541 ' CE2' HD11 ' A' ' 56' ' ' LEU . 7.4 p90 -163.83 140.87 5.54 Favored Pre-proline 0 N--CA 1.494 1.728 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.614 175.726 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -59.7 155.96 40.1 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.389 2.06 . . . . 0.0 112.305 -177.694 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.414 ' HA2' HD13 ' A' ' 56' ' ' LEU . . . -95.86 47.95 1.83 Allowed Glycine 0 N--CA 1.497 2.704 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.704 179.547 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.5 t -147.27 -22.85 0.39 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 179.222 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.7 m-30 -89.89 -12.26 39.48 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 123.973 0.795 . . . . 0.0 110.488 -178.261 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.4 m -105.67 -173.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.291 -176.022 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.29 114.32 5.09 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.706 175.433 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' TYR . . . . . 0.539 ' HH ' ' N ' ' A' ' 79' ' ' ARG . 18.7 t80 -55.69 124.95 19.13 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.932 177.066 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -98.97 -52.9 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 123.934 0.771 . . . . 0.0 110.421 178.731 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.1 163.64 32.92 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.643 -175.545 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' ARG . . . . . 0.539 ' N ' ' HH ' ' A' ' 76' ' ' TYR . 0.1 OUTLIER -123.56 150.29 44.23 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.588 -1.306 . . . . 0.0 110.808 163.884 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -162.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.95 172.341 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -86.9 70.92 10.36 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 173.422 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.8 tt -89.82 138.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 121.728 0.775 . . . . 0.0 112.564 162.455 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.34 164.91 22.09 Favored Pre-proline 0 N--CA 1.502 2.136 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.417 -178.398 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.487 1.124 0 C-N-CA 122.015 1.81 . . . . 0.0 112.319 170.804 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.115 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.531 ' HB3' HD11 ' A' ' 77' ' ' ILE . 30.1 mt-30 -139.4 159.1 42.95 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.506 -173.432 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -142.68 125.15 15.68 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.1 -1.863 . . . . 0.0 107.601 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -89.61 118.46 29.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.629 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.63 152.48 0.33 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.927 0.767 . . . . 0.0 112.788 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -113.29 -44.81 3.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.512 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.34 151.99 41.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.06 0.85 . . . . 0.0 110.799 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.01 116.37 7.76 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.257 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.2 t80 -117.99 138.1 52.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.125 0.891 . . . . 0.0 108.895 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.02 146.4 25.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.297 0.998 . . . . 0.0 109.921 174.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 164.53 14.94 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.176 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.62 -25.24 0.77 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.074 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -108.03 149.68 28.12 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.101 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.56 -12.25 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.531 170.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -81.76 -40.27 22.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 123.903 0.752 . . . . 0.0 111.187 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.77 156.22 19.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.114 0.884 . . . . 0.0 111.265 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.41 174.43 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.666 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -75.05 131.47 40.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.766 -174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 14' ' ' TYR . 97.0 mt -121.56 127.46 50.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.587 1.179 . . . . 0.0 109.179 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.74 -173.62 2.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.268 0.98 . . . . 0.0 108.904 -175.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 26' ' ' LEU . 3.1 mp -83.12 156.53 23.23 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.423 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.12 0.03 1.0 Allowed Glycine 0 N--CA 1.5 2.955 0 O-C-N 123.872 0.732 . . . . 0.0 113.201 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.69 106.29 1.45 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 30' ' ' LEU . 5.6 mt -90.64 132.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.743 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.634 HD11 HD22 ' A' ' 60' ' ' ASN . 10.5 mp -108.52 151.52 25.98 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.064 -1.88 . . . . 0.0 109.013 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.8 m -129.43 147.43 51.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 123.842 0.714 . . . . 0.0 109.845 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.431 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -119.59 -147.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 123.807 0.692 . . . . 0.0 109.265 -178.199 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.431 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 O-C-N 123.419 0.449 . . . . 0.0 110.033 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.244 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -86.96 -37.86 17.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -102.31 102.97 27.94 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.999 0.812 . . . . 0.0 111.325 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -68.6 -17.99 42.92 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.641 2.227 . . . . 0.0 114.092 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.53 -31.67 68.14 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.657 0.598 . . . . 0.0 112.246 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.32 -21.89 21.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.831 0.707 . . . . 0.0 111.376 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.12 146.91 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -91.56 1.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -90.19 131.04 36.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.425 -1.388 . . . . 0.0 109.032 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -108.46 126.82 53.32 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -100.94 124.23 46.33 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.77 -166.18 16.67 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -140.17 150.19 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.634 HD22 HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -114.23 99.87 7.93 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.274 -177.124 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.81 -21.49 66.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.3 m -46.05 -37.42 6.7 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.812 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.61 2.46 6.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.849 1.343 . . . . 0.0 108.877 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.64 36.87 73.33 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.614 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -109.51 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.51 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 156.05 40.99 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.767 0.794 . . . . 0.0 111.699 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.66 -153.05 23.3 Favored Glycine 0 N--CA 1.489 2.197 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.032 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.71 153.94 24.57 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.6 p90 -151.36 140.77 13.95 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.912 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HB2' HG22 ' A' ' 72' ' ' THR . 1.3 Cg_endo -65.15 150.39 87.74 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.53 1.486 . . . . 0.0 110.708 175.672 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.29 48.72 4.08 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 70' ' ' PRO . 7.6 t -141.21 16.39 2.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.105 0.532 . . . . 0.0 111.616 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -136.05 -4.08 2.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 123.751 0.657 . . . . 0.0 111.847 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.98 -169.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 123.932 0.77 . . . . 0.0 109.13 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.71 113.58 5.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 25.2 t80 -48.27 142.97 4.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.442 171.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.5 pt -122.24 -53.5 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 123.926 0.766 . . . . 0.0 111.688 176.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.84 146.63 15.79 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.478 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-N 113.311 -1.444 . . . . 0.0 109.988 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.151 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -125.09 161.29 27.11 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.563 1.164 . . . . 0.0 113.673 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -139.3 154.68 47.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.167 -2.288 . . . . 0.0 106.711 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 -123.33 121.54 36.08 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.93 145.75 12.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.266 0.979 . . . . 0.0 111.433 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tp -107.4 -41.36 5.1 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.839 -176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.93 152.55 43.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.264 0.977 . . . . 0.0 110.242 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.21 123.04 18.49 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.577 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.419 ' CD1' HD12 ' A' ' 24' ' ' LEU . 4.0 t80 -123.09 136.8 54.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.504 1.127 . . . . 0.0 109.076 174.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -94.61 151.7 19.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 124.294 0.996 . . . . 0.0 109.32 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.49 131.39 35.55 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 123.921 0.763 . . . . 0.0 110.311 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -110.1 -11.22 14.63 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 124.183 0.927 . . . . 0.0 110.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -120.6 146.26 46.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.327 1.017 . . . . 0.0 109.424 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.38 -19.12 63.08 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.758 172.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.3 -19.81 38.7 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.099 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.38 164.67 12.01 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 123.874 0.734 . . . . 0.0 110.757 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 pt -124.58 168.86 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.556 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.52 136.24 40.6 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.494 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.419 HD12 ' CD1' ' A' ' 14' ' ' TYR . 90.7 mt -125.94 135.16 51.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.206 0.941 . . . . 0.0 110.674 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -175.86 3.95 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.43 -173.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mt -84.74 158.31 20.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 123.534 0.521 . . . . 0.0 110.781 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.0 -6.15 1.06 Allowed Glycine 0 N--CA 1.503 3.157 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.676 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.97 110.57 11.71 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -176.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.441 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.2 mt -93.96 138.65 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.856 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 30' ' ' LEU . 9.8 mp -105.75 148.32 27.6 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.702 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 m -126.7 147.34 49.96 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 124.033 0.833 . . . . 0.0 109.177 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -120.37 -154.99 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.454 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.52 172.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 121.253 0.549 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -176.9 -22.85 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.31 80.63 29.02 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 123.885 0.741 . . . . 0.0 109.113 177.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.15 -22.51 40.27 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.872 2.381 . . . . 0.0 111.938 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -50.16 -41.41 49.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.766 1.292 . . . . 0.0 112.238 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -93.63 -29.32 15.51 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 123.87 0.731 . . . . 0.0 111.463 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.8 mt -64.72 146.33 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.739 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.37 -96.5 1.07 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -98.32 128.58 44.81 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.246 -0.977 . . . . 0.0 110.35 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.5 mp -107.18 136.26 47.31 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.1 t30 -104.97 125.7 51.24 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.04 -164.67 13.55 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -137.27 147.04 45.43 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.131 -0.534 . . . . 0.0 110.749 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -101.1 100.31 10.87 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.9 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -54.51 -39.26 67.43 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 123.743 0.652 . . . . 0.0 111.97 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 96.9 m -52.22 -42.03 63.23 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 124.222 0.951 . . . . 0.0 112.142 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 p -105.28 0.35 27.05 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.343 1.027 . . . . 0.0 110.598 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.96 24.04 13.09 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 124.155 0.91 . . . . 0.0 112.667 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.53 166.48 12.5 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -174.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.7 ttm-85 -148.1 125.64 11.72 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.33 -162.83 26.66 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.978 -1.106 . . . . 0.0 111.173 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.93 153.79 21.48 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.696 -0.752 . . . . 0.0 109.15 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 34.9 p90 -151.24 147.83 21.28 Favored Pre-proline 0 N--CA 1.493 1.695 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.684 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.19 156.28 60.28 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.424 2.083 . . . . 0.0 112.0 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.01 44.2 1.84 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.6 t -134.43 -17.31 2.04 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.656 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.78 0.87 39.59 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.265 0.978 . . . . 0.0 111.696 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.92 -179.0 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 123.756 0.66 . . . . 0.0 109.459 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -149.18 106.53 3.62 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.046 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.475 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 77.6 t80 -43.65 128.44 5.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.097 169.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 pt -126.2 -58.26 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 124.019 0.824 . . . . 0.0 111.419 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.63 156.38 20.99 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -162.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.914 0.864 . . . . 0.0 112.152 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.432 ' HB3' HD11 ' A' ' 77' ' ' ILE . 6.4 mt-30 -128.44 162.07 28.02 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.234 1.016 . . . . 0.0 112.488 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.42 165.32 27.76 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 112.416 -2.174 . . . . 0.0 107.835 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -128.03 115.13 18.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.949 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.48 116.4 3.07 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 123.889 0.743 . . . . 0.0 111.175 173.249 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tp -76.91 -33.1 57.78 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.949 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -141.25 143.02 33.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 124.296 0.997 . . . . 0.0 109.853 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.18 104.3 0.57 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.083 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.408 ' HD2' HD12 ' A' ' 24' ' ' LEU . 76.2 t80 -101.21 130.57 47.35 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -89.48 163.77 15.1 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 138.64 31.25 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -131.31 -19.33 2.79 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.74 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -123.64 151.26 43.22 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.864 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -63.19 -20.26 65.26 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.286 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -26.97 21.18 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.725 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.39 153.42 20.87 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.376 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -121.22 -173.67 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 124.511 1.132 . . . . 0.0 111.097 -179.199 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASP . . . . . 0.412 ' H ' HG22 ' A' ' 22' ' ' ILE . 3.5 m-20 -87.47 120.53 28.87 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 112.533 -2.121 . . . . 0.0 107.678 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.408 HD12 ' HD2' ' A' ' 14' ' ' TYR . 5.2 mt -117.37 119.99 36.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.159 0.912 . . . . 0.0 108.916 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.95 -170.36 1.78 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 124.561 1.163 . . . . 0.0 109.523 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.1 mt -84.99 156.1 21.29 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.478 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.99 9.16 2.68 Favored Glycine 0 N--CA 1.502 3.085 0 O-C-N 124.101 0.875 . . . . 0.0 113.074 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' CG ' HG21 ' A' ' 62' ' ' THR . 3.4 m-20 -71.45 125.17 26.33 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.358 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mp -96.37 146.91 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 124.198 0.936 . . . . 0.0 109.021 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.599 HD23 ' CE1' ' A' ' 69' ' ' PHE . 7.3 mp -115.46 161.53 18.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 112.442 -2.163 . . . . 0.0 110.911 174.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.6 m -131.31 153.95 49.05 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.748 1.28 . . . . 0.0 108.329 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.658 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.1 t -130.03 -150.5 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.658 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 123.583 0.552 . . . . 0.0 110.889 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 121.167 0.508 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.48 0.57 0.2 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.006 -173.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -128.93 69.7 80.83 Favored Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 123.606 0.566 . . . . 0.0 111.266 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.93 -4.87 4.04 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.639 2.226 . . . . 0.0 113.67 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.51 -45.5 53.46 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 123.732 0.645 . . . . 0.0 110.756 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -92.47 -28.94 16.51 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 124.057 0.848 . . . . 0.0 111.141 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.7 mt -65.02 143.37 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 123.766 0.666 . . . . 0.0 109.741 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.42 -99.91 1.05 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -89.62 144.59 25.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.492 0.76 . . . . 0.0 110.467 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.2 mp -122.5 130.1 52.69 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.329 170.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.516 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -91.27 121.69 33.24 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.03 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.38 177.7 25.48 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 120.048 -1.072 . . . . 0.0 113.008 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.69 123.63 45.99 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 113.559 -1.32 . . . . 0.0 109.226 174.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.433 HD21 HD11 ' A' ' 30' ' ' LEU . 29.5 t-20 -89.47 80.78 6.67 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.42 1.105 . . . . 0.0 108.506 170.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -49.48 -24.95 2.28 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.961 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.429 HG21 ' CG ' ' A' ' 28' ' ' ASP . 18.1 m -53.13 -41.55 65.18 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.19 0.931 . . . . 0.0 112.075 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.8 p -119.41 6.3 11.13 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.428 1.08 . . . . 0.0 109.161 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.87 60.12 8.57 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 124.283 0.989 . . . . 0.0 111.12 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -139.74 160.67 39.35 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.406 0.709 . . . . 0.0 109.999 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -116.25 140.28 49.48 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.96 -155.5 17.34 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.343 -1.408 . . . . 0.0 111.994 164.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.22 166.43 10.64 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.695 -1.252 . . . . 0.0 110.151 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.599 ' CE1' HD23 ' A' ' 30' ' ' LEU . 21.9 p90 -161.89 145.59 9.43 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.889 170.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.24 154.12 75.39 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.233 1.955 . . . . 0.0 113.169 173.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.21 -16.82 63.91 Favored Glycine 0 N--CA 1.499 2.873 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.265 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.4 p -75.8 -14.11 60.3 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 122.245 0.218 . . . . 0.0 111.522 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.28 3.61 35.64 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 123.998 0.811 . . . . 0.0 111.658 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.89 -178.6 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 123.878 0.736 . . . . 0.0 109.237 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -147.79 111.35 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -51.28 140.92 15.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 123.753 0.658 . . . . 0.0 109.603 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.1 pt -118.99 -56.47 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 124.431 1.082 . . . . 0.0 110.472 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.04 147.74 17.17 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.705 -1.236 . . . . 0.0 111.151 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-N 112.856 -1.672 . . . . 0.0 109.128 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.512 2.652 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.586 ' HB3' HD11 ' A' ' 77' ' ' ILE . 26.1 mt-30 -128.98 168.49 15.94 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.376 1.084 . . . . 0.0 111.705 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -143.51 123.15 13.29 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 112.275 -2.239 . . . . 0.0 105.563 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -89.39 122.04 32.23 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.76 146.28 10.77 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 123.642 0.589 . . . . 0.0 110.734 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 tp -114.92 -28.79 6.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 124.115 0.884 . . . . 0.0 110.43 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 156.77 48.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 123.954 0.784 . . . . 0.0 110.831 -174.315 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.39 103.57 16.24 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.596 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.549 ' HD2' HD12 ' A' ' 24' ' ' LEU . 10.4 t80 -110.55 133.26 53.46 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -89.43 158.69 17.63 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 139.68 30.24 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.591 -0.843 . . . . 0.0 110.173 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -128.99 -13.6 4.54 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.192 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.78 140.87 36.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 124.217 0.948 . . . . 0.0 109.322 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.84 -21.84 3.22 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.379 -1.282 . . . . 0.0 114.044 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -59.48 -57.76 11.58 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.799 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -83.29 174.05 11.06 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.053 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.0 pt -129.48 177.05 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 124.267 0.979 . . . . 0.0 111.674 175.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.83 136.75 47.14 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.473 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.549 HD12 ' HD2' ' A' ' 14' ' ' TYR . 15.5 mt -126.38 133.19 51.38 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 123.973 0.795 . . . . 0.0 111.159 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.485 ' NE2' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -145.26 170.65 15.88 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.343 1.027 . . . . 0.0 110.695 -176.367 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mt -66.8 151.09 48.15 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 123.481 0.488 . . . . 0.0 110.413 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.9 -9.83 3.51 Favored Glycine 0 N--CA 1.501 2.976 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.036 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.86 108.05 7.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.539 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -89.8 152.34 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 115.437 -0.802 . . . . 0.0 108.882 176.81 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.539 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.2 mp -129.19 127.54 41.54 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.6 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.9 m -107.23 140.28 40.35 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.394 1.058 . . . . 0.0 108.961 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.5 -136.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 124.443 1.089 . . . . 0.0 108.725 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 123.871 0.732 . . . . 0.0 109.441 -176.853 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.511 2.598 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.18 10.25 20.07 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.472 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -129.0 77.46 77.9 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.25 -18.22 50.93 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.411 2.074 . . . . 0.0 112.828 170.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -53.42 -41.47 66.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.125 0.891 . . . . 0.0 111.901 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.61 -26.36 20.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.053 0.846 . . . . 0.0 110.689 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.3 mt -79.97 139.17 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 123.961 0.788 . . . . 0.0 109.287 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -93.06 1.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -95.92 120.25 35.87 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 113.708 -1.246 . . . . 0.0 109.169 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.9 mp -96.76 136.26 37.56 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 170.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -98.63 123.44 42.82 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.33 -178.39 27.84 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -133.8 144.12 48.8 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.762 0.33 . . . . 0.0 111.18 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.24 98.52 8.65 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.166 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -57.75 -29.21 64.6 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.343 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.0 m -53.05 -43.51 66.72 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 123.905 0.753 . . . . 0.0 112.143 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.485 HG21 ' NE2' ' A' ' 25' ' ' HIS . 22.3 p -102.64 -4.1 25.66 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 124.274 0.984 . . . . 0.0 110.187 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.14 28.4 61.29 Favored Glycine 0 N--CA 1.493 2.435 0 O-C-N 124.149 0.906 . . . . 0.0 111.926 -172.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -104.17 155.72 18.48 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -143.11 137.57 29.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.065 0.853 . . . . 0.0 110.186 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.32 -155.06 21.73 Favored Glycine 0 N--CA 1.492 2.399 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.429 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.81 153.26 22.74 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.233 -0.983 . . . . 0.0 108.866 -174.32 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 32.9 p90 -147.95 148.86 31.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.799 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.14 158.12 41.08 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.985 1.79 . . . . 0.0 111.92 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.99 53.6 0.63 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -151.38 -15.89 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.049 0.499 . . . . 0.0 112.108 174.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -94.87 -4.81 46.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 123.977 0.798 . . . . 0.0 112.324 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.4 m -109.64 -166.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 123.954 0.784 . . . . 0.0 109.253 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.28 113.15 5.11 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -48.75 128.34 15.27 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.783 165.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.5 pt -114.7 -84.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 124.36 1.038 . . . . 0.0 110.4 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.83 161.13 13.1 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -171.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.068 0 CA-C-O 121.939 0.876 . . . . 0.0 112.635 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -126.16 163.26 23.51 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.21 0.943 . . . . 0.0 111.363 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -139.1 160.12 40.55 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.543 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -126.63 118.72 25.38 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -174.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.83 130.77 38.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.857 0.723 . . . . 0.0 110.73 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -85.38 -45.89 11.46 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.226 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -143.23 156.67 44.8 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.395 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.17 111.68 1.82 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.442 173.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.466 ' CD2' HD12 ' A' ' 24' ' ' LEU . 6.3 t80 -120.93 133.39 55.28 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.973 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -90.1 161.75 15.64 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -89.68 147.55 23.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.839 0.712 . . . . 0.0 111.548 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -117.62 -4.53 11.22 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.3 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -146.57 148.84 32.55 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -52.68 -22.59 5.32 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.076 172.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -69.66 -45.56 68.13 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.235 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.38 158.18 16.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 123.965 0.791 . . . . 0.0 109.005 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 pt -115.16 170.68 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 124.185 0.928 . . . . 0.0 111.792 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.71 136.61 38.2 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.257 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.466 HD12 ' CD2' ' A' ' 14' ' ' TYR . 88.5 mt -125.46 133.37 52.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.345 1.028 . . . . 0.0 109.917 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.57 -167.88 1.59 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.686 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -89.22 157.98 18.04 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.627 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 58.7 1.71 0.92 Allowed Glycine 0 N--CA 1.505 3.244 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.39 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.28 108.54 9.29 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.77 -0.715 . . . . 0.0 110.972 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.525 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.4 tp -90.51 149.65 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.033 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 29' ' ' ILE . 10.0 mp -119.07 151.85 37.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.3 m -132.89 146.52 51.87 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.015 0.822 . . . . 0.0 109.627 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.5 t -128.95 -157.39 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.644 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.782 174.368 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 121.084 0.469 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -164.35 -11.35 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.361 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' H ' ' H ' ' A' ' 48' ' ' ALA . 18.9 mttp -122.25 82.39 45.39 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 124.502 1.126 . . . . 0.0 109.344 177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -52.8 -20.0 12.02 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.589 2.193 . . . . 0.0 112.054 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.77 -43.17 80.55 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.936 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.01 -29.11 18.64 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 123.632 0.582 . . . . 0.0 111.485 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 mt -66.25 145.4 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.49 -73.29 1.27 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -127.95 133.75 49.25 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.561 -1.82 . . . . 0.0 107.932 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.66 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -127.2 144.46 51.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.176 0.922 . . . . 0.0 109.172 174.459 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -89.47 145.58 25.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.633 1.208 . . . . 0.0 107.839 -179.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.81 179.7 42.6 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 173.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -128.91 142.12 51.05 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.886 -0.657 . . . . 0.0 109.808 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.03 82.73 1.75 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 125.176 1.547 . . . . 0.0 109.528 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -27.1 49.28 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.776 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.0 m -52.12 -42.68 63.5 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 123.924 0.765 . . . . 0.0 111.562 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -109.12 -3.51 17.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.799 1.312 . . . . 0.0 109.758 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.77 65.7 2.91 Favored Glycine 0 N--CA 1.493 2.447 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.049 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -137.23 162.05 34.54 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.314 0.655 . . . . 0.0 110.247 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -148.15 131.04 16.14 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.383 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.46 -163.42 36.59 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.506 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -102.87 152.44 21.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.488 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 41.2 p90 -148.02 152.27 39.72 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.413 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -66.6 151.23 83.24 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.071 1.847 . . . . 0.0 112.24 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.36 19.79 29.94 Favored Glycine 0 N--CA 1.496 2.697 0 O-C-N 124.093 0.871 . . . . 0.0 112.006 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.83 -35.18 6.24 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.311 0.577 . . . . 0.0 110.911 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -90.21 8.37 33.45 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.479 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.2 m -125.87 179.42 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 123.628 0.58 . . . . 0.0 110.263 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -150.06 106.41 3.49 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.713 0.768 . . . . 0.0 110.262 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 80.0 t80 -44.64 126.16 5.34 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.244 -1.343 . . . . 0.0 111.253 167.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.407 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -115.13 -62.25 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 123.969 0.793 . . . . 0.0 110.889 -177.881 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.407 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -139.94 161.5 26.32 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -161.167 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 . . . . . 0 N--CA 1.486 1.362 0 CA-C-N 113.583 -1.308 . . . . 0.0 109.139 -171.555 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.02 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.509 ' HB3' HD11 ' A' ' 77' ' ' ILE . 30.9 mt-30 -134.11 158.92 42.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.006 0.817 . . . . 0.0 111.589 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -138.58 138.62 38.1 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.811 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -94.47 121.88 36.46 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.115 0.884 . . . . 0.0 109.894 171.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.84 119.87 6.94 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.848 167.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.02 -57.89 3.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.603 0.564 . . . . 0.0 109.889 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.97 156.98 25.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.38 1.05 . . . . 0.0 109.919 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.92 134.3 51.74 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.985 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -132.71 128.47 37.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 124.361 1.038 . . . . 0.0 110.208 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -89.58 168.25 12.3 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.662 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 145.95 25.06 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.311 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.87 -3.62 8.65 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.481 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -143.42 145.05 32.31 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.024 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.47 -15.14 2.42 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 114.981 -1.008 . . . . 0.0 113.29 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -74.64 -46.47 37.99 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.558 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 152.31 22.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.083 0.864 . . . . 0.0 109.893 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.59 -170.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 124.472 1.108 . . . . 0.0 109.577 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -95.19 106.34 18.35 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.52 -1.673 . . . . 0.0 108.715 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 24' ' ' LEU . 1.8 mm? -88.98 143.14 27.06 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.646 172.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.422 ' NE2' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -135.52 -173.19 3.28 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.21 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mt -78.25 150.92 33.32 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.019 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.07 -3.47 1.61 Allowed Glycine 0 N--CA 1.506 3.347 0 O-C-N 123.413 0.446 . . . . 0.0 113.588 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.26 116.48 8.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 123.928 0.428 . . . . 0.0 109.95 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.502 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.0 mt -102.3 139.12 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.768 0.794 . . . . 0.0 110.019 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.502 HD12 ' C ' ' A' ' 29' ' ' ILE . 10.2 mp -117.67 162.19 18.45 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 112.909 -1.951 . . . . 0.0 109.454 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.85 147.68 49.95 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 124.036 0.835 . . . . 0.0 108.833 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -121.7 -169.24 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 123.53 0.519 . . . . 0.0 109.829 178.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.503 ' H ' HG12 ' A' ' 32' ' ' VAL . 7.0 m120 . . . . . 0 N--CA 1.496 1.829 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.285 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.368 0.604 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.07 1.2 28.75 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.91 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -124.77 79.39 63.66 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 53' ' ' ILE . 1.5 Cg_endo -62.51 -31.08 80.39 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.814 1.676 . . . . 0.0 111.404 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.93 -39.25 39.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.538 1.149 . . . . 0.0 112.129 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -90.0 -31.95 16.98 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.126 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 50' ' ' PRO . 61.7 mt -65.93 151.74 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 123.852 0.72 . . . . 0.0 110.452 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.5 -102.78 1.08 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -91.0 140.3 29.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.417 0.716 . . . . 0.0 110.885 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.9 mt -107.05 135.69 48.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.19 124.15 48.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 124.195 0.934 . . . . 0.0 108.778 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.27 -170.63 33.22 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.317 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -94.72 146.47 24.15 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.24 -0.98 . . . . 0.0 110.082 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.481 ' ND2' HD11 ' A' ' 30' ' ' LEU . 18.1 t-20 -119.87 64.63 0.81 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.042 -1.436 . . . . 0.0 108.693 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -56.93 -23.9 48.6 Favored 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.755 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.6 m -53.44 -34.73 58.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.849 0.718 . . . . 0.0 111.594 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.422 HG21 ' NE2' ' A' ' 25' ' ' HIS . 39.1 p -108.89 -5.17 16.28 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.771 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.2 40.67 49.28 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -143.59 176.38 9.25 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -147.25 147.35 30.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 123.924 0.765 . . . . 0.0 109.168 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.87 -153.67 13.64 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.269 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.2 149.71 29.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -151.2 142.82 15.65 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.258 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.12 157.98 15.93 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.459 2.106 . . . . 0.0 112.874 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.2 28.57 14.04 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 124.39 1.056 . . . . 0.0 113.508 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.9 t -133.81 -3.03 2.91 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 117.202 0.501 . . . . 0.0 110.725 -170.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.504 ' OH ' HD12 ' A' ' 24' ' ' LEU . 1.7 p90 -121.33 -6.43 9.34 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 123.918 0.761 . . . . 0.0 111.275 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.486 HG13 ' CE1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -97.48 178.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 124.139 0.899 . . . . 0.0 109.508 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -149.34 104.85 3.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -47.05 142.93 3.3 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.636 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.7 pt -122.97 -51.71 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 124.313 1.008 . . . . 0.0 111.958 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.33 146.41 13.9 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.978 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 . . . . . 0 N--CA 1.496 1.866 0 CA-C-N 113.485 -1.357 . . . . 0.0 111.102 179.401 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.19 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -128.74 160.85 31.24 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.406 1.098 . . . . 0.0 112.394 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -148.93 118.92 7.14 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 112.542 -2.117 . . . . 0.0 105.288 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.01 124.21 38.93 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.37 114.25 1.74 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.005 0.816 . . . . 0.0 110.429 174.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 tp -78.5 -31.87 47.9 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.366 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.74 144.14 37.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.436 1.085 . . . . 0.0 108.889 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -64.3 108.65 1.65 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.159 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.44 ' CD2' HD13 ' A' ' 24' ' ' LEU . 17.8 t80 -113.75 136.99 52.25 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -89.7 -178.5 5.54 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -89.93 122.56 33.07 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.327 171.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -90.06 -7.77 53.07 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.945 0.778 . . . . 0.0 110.727 172.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -144.73 150.65 37.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 124.028 0.83 . . . . 0.0 109.648 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.62 -15.65 3.18 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.18 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.48 -41.29 27.8 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.931 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.33 168.24 18.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 123.691 0.619 . . . . 0.0 111.428 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.56 -164.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 124.144 0.902 . . . . 0.0 109.827 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -100.43 108.04 19.93 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.683 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 24' ' ' LEU . 5.3 mp -92.63 123.08 35.66 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 113.529 -1.668 . . . . 0.0 109.71 173.282 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.03 167.32 11.88 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.687 170.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mt -53.8 150.4 7.51 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.024 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.06 -14.05 3.03 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 114.969 -1.014 . . . . 0.0 114.345 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.87 117.35 6.25 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tp -94.73 148.65 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 123.915 0.759 . . . . 0.0 109.152 171.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.567 HD23 ' CE1' ' A' ' 69' ' ' PHE . 8.3 mp -121.98 135.27 54.84 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.5 m -122.04 140.2 52.78 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 124.143 0.902 . . . . 0.0 108.687 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.63 -175.45 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.973 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 121.459 0.647 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.6 -6.35 53.45 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.909 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.53 86.97 35.51 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.68 -6.1 10.03 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.721 2.281 . . . . 0.0 113.75 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -65.97 -35.8 81.59 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.485 0.491 . . . . 0.0 111.947 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -89.2 -28.16 20.16 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 123.678 0.611 . . . . 0.0 110.537 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.0 mt -80.3 141.3 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.8 -84.46 1.34 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -91.49 125.15 36.14 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 113.032 -1.584 . . . . 0.0 110.16 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.3 mp -102.68 131.17 49.66 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 168.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.96 122.31 40.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 168.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.89 -175.31 22.7 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.973 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -120.28 133.53 55.45 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.816 -0.692 . . . . 0.0 110.182 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -99.18 82.83 2.77 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 124.501 1.126 . . . . 0.0 109.132 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -48.05 -28.51 2.88 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.274 172.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 m -55.93 -49.16 74.25 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.022 0.826 . . . . 0.0 111.075 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 p -95.3 0.01 53.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.306 1.004 . . . . 0.0 110.303 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.95 45.56 96.34 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.455 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.85 174.39 10.7 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.358 0.681 . . . . 0.0 109.933 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -145.0 144.24 30.93 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.91 -175.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.28 -158.16 20.44 Favored Glycine 0 N--CA 1.493 2.484 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.749 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.15 168.96 8.99 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.736 -1.232 . . . . 0.0 110.289 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.567 ' CE1' HD23 ' A' ' 30' ' ' LEU . 17.7 p90 -164.16 144.7 6.6 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.912 170.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.8 160.47 40.62 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 121.975 1.783 . . . . 0.0 112.109 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.64 54.65 1.24 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.2 t -137.37 -29.84 0.87 Allowed 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -91.58 -6.05 53.01 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.396 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.19 167.69 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.599 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -139.06 127.05 22.33 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -49.86 144.07 6.89 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.403 167.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.77 -54.99 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 124.026 0.828 . . . . 0.0 111.107 175.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.86 152.76 23.68 Favored Glycine 0 N--CA 1.496 2.668 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.353 -165.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 O-C-N 124.486 0.756 . . . . 0.0 111.759 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.51 2.571 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.513 ' HB3' HD11 ' A' ' 77' ' ' ILE . 23.6 mt-30 -150.0 162.0 41.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.184 0.992 . . . . 0.0 111.815 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -131.8 140.0 49.06 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.126 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -90.97 124.51 35.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.79 0.681 . . . . 0.0 110.084 161.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.43 121.55 9.23 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.809 0.693 . . . . 0.0 111.258 165.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.35 -67.98 0.82 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.228 0.955 . . . . 0.0 109.627 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -94.59 137.26 33.92 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.367 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -68.55 91.2 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 124.13 0.894 . . . . 0.0 110.515 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.442 ' CD2' HD12 ' A' ' 24' ' ' LEU . 9.1 t80 -92.98 133.05 36.51 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.954 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -90.31 163.15 14.85 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.365 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -89.0 115.97 26.95 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.437 0.637 . . . . 0.0 111.611 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -89.08 -14.44 36.3 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.942 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.54 155.49 43.7 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.843 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -63.37 -26.21 68.65 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.852 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.08 -28.4 69.05 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.511 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.25 152.35 25.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.54 1.15 . . . . 0.0 110.812 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 pt -113.03 176.12 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.002 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -69.96 137.4 51.44 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.084 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 14' ' ' TYR . 67.6 mt -126.99 90.41 3.15 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.5 166.3 10.53 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.751 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mt -64.92 162.13 17.05 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.28 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.41 -11.33 13.25 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.498 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.69 133.7 39.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.398 0.705 . . . . 0.0 109.587 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.65 143.73 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.963 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.2 mp -106.32 139.51 40.7 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.67 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.2 m -112.1 144.82 40.83 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 123.871 0.732 . . . . 0.0 110.508 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.68 173.51 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 123.951 0.782 . . . . 0.0 110.686 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 t30 . . . . . 0 N--CA 1.502 2.128 0 CA-C-N 114.409 -1.269 . . . . 0.0 114.106 175.869 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.504 2.272 0 CA-C-O 122.61 1.195 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.87 -7.77 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 113.208 -1.815 . . . . 0.0 111.221 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -124.26 75.2 60.48 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 124.113 0.883 . . . . 0.0 111.388 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.2 -11.54 10.74 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.221 1.947 . . . . 0.0 113.56 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -65.95 -40.64 91.51 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.089 0.868 . . . . 0.0 111.543 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -91.38 -21.33 21.05 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 123.769 0.668 . . . . 0.0 112.002 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.4 mt -82.77 145.83 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.29 -88.16 1.24 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -89.76 145.26 25.32 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 113.608 -1.296 . . . . 0.0 109.9 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.2 mp -124.04 125.46 44.57 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.405 166.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -93.94 119.28 32.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 123.891 0.744 . . . . 0.0 109.079 168.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.13 -165.31 10.62 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 171.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.8 134.99 34.15 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -96.77 76.08 2.77 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -43.16 -33.23 0.86 Allowed 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 113.97 -1.468 . . . . 0.0 112.929 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.5 m -55.21 -49.59 71.56 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 124.208 0.943 . . . . 0.0 111.336 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.4 p -93.37 -4.34 51.67 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.148 0.905 . . . . 0.0 110.888 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.85 60.07 8.67 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 123.884 0.74 . . . . 0.0 111.329 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.58 154.56 45.51 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.343 0.672 . . . . 0.0 109.314 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -127.87 135.21 49.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.328 1.017 . . . . 0.0 108.446 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.92 -168.68 39.12 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.18 -1.486 . . . . 0.0 112.69 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -108.02 165.76 11.23 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.149 -1.525 . . . . 0.0 109.181 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.6 p90 -160.03 143.23 10.23 Favored Pre-proline 0 N--CA 1.494 1.725 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.379 175.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HB2' HG22 ' A' ' 72' ' ' THR . 2.5 Cg_endo -65.76 155.54 68.69 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.967 1.778 . . . . 0.0 110.937 172.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.05 49.64 3.58 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 70' ' ' PRO . 8.0 t -129.97 -28.84 2.14 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -96.82 13.53 28.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 124.193 0.933 . . . . 0.0 111.537 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.28 178.71 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 114.67 -1.15 . . . . 0.0 107.926 -170.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -150.63 116.63 5.59 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -51.58 127.3 19.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 123.856 0.722 . . . . 0.0 109.883 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.0 OUTLIER -101.66 -55.99 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 124.598 1.187 . . . . 0.0 109.757 177.579 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.95 161.83 35.37 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 118.643 -1.741 . . . . 0.0 112.237 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-N 112.117 -2.042 . . . . 0.0 110.486 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.509 2.504 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -128.03 163.12 25.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 124.641 1.213 . . . . 0.0 111.839 -168.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -140.59 124.22 17.05 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 112.3 -2.227 . . . . 0.0 105.68 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -91.89 124.66 36.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.1 118.5 5.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 124.162 0.914 . . . . 0.0 110.692 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -60.75 2.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 124.02 0.825 . . . . 0.0 109.213 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.31 168.94 9.31 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.309 1.006 . . . . 0.0 110.228 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.7 123.88 30.88 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.349 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -121.97 138.91 54.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.45 172.52 8.94 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.515 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -89.74 144.52 25.9 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.136 172.841 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -134.44 -9.54 2.51 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.683 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -141.0 146.65 37.54 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.997 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.8 -17.58 9.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.461 1.101 . . . . 0.0 113.318 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -71.34 -51.07 26.29 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.383 -1.281 . . . . 0.0 111.693 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.41 153.31 21.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.135 0.897 . . . . 0.0 109.606 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pt -114.39 174.59 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 124.378 1.049 . . . . 0.0 110.93 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.75 130.17 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.719 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.66 124.33 44.96 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.579 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 172.75 11.61 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.835 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.95 150.56 48.45 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.028 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.66 -10.27 18.82 Favored Glycine 0 N--CA 1.5 2.909 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.431 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.02 110.14 1.49 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.538 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 tp -90.2 155.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.8 mp -129.23 143.69 50.95 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.184 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.8 m -128.18 143.0 51.01 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.08 -125.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.435 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 CA-C-N 118.234 0.47 . . . . 0.0 111.136 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.512 2.629 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -162.56 -6.1 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.04 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -128.13 76.25 78.0 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 123.917 0.761 . . . . 0.0 110.048 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.93 -16.07 19.2 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.294 1.996 . . . . 0.0 113.514 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -59.7 -47.04 87.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 123.926 0.766 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -89.72 -31.61 17.38 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 123.957 0.785 . . . . 0.0 110.033 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.1 mt -66.49 143.63 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 123.803 0.689 . . . . 0.0 109.643 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.45 -97.78 1.07 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -93.48 135.99 34.19 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.239 -0.981 . . . . 0.0 109.834 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.4 mp -117.58 147.68 42.6 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.796 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -117.29 130.32 56.47 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.349 1.03 . . . . 0.0 108.223 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.44 169.96 36.34 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.55 -1.309 . . . . 0.0 112.999 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -90.73 141.1 29.15 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.17 -1.015 . . . . 0.0 109.102 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -105.49 72.56 0.98 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.442 1.089 . . . . 0.0 109.933 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -44.3 -33.78 1.72 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.291 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 m -51.72 -47.73 63.87 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 124.115 0.884 . . . . 0.0 111.975 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.8 -4.66 23.3 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.849 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.48 47.67 85.18 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -119.05 178.34 4.54 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.154 -1.023 . . . . 0.0 109.61 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -150.12 136.47 18.89 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.56 -153.89 13.54 Favored Glycine 0 N--CA 1.5 2.928 0 C-N-CA 118.916 -1.611 . . . . 0.0 113.538 165.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.79 158.29 17.1 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -172.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.5 p90 -159.53 143.84 11.06 Favored Pre-proline 0 N--CA 1.489 1.5 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.788 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.59 154.32 71.78 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.941 1.761 . . . . 0.0 111.539 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.69 19.53 19.75 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 124.128 0.893 . . . . 0.0 112.648 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.54 -32.4 7.71 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.268 0.556 . . . . 0.0 111.237 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -89.62 -0.31 57.43 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.064 -175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.23 -178.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 124.194 0.934 . . . . 0.0 109.283 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -146.61 122.0 10.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.435 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 45.1 t80 -55.0 120.98 7.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 124.034 0.834 . . . . 0.0 108.98 168.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -90.85 -54.98 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.372 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -169.9 157.76 29.47 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.391 -1.385 . . . . 0.0 111.507 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.949 0 CA-C-N 114.52 -0.84 . . . . 0.0 111.608 171.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.184 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.613 ' HB3' HD11 ' A' ' 77' ' ' ILE . 53.2 mt-30 -120.14 159.93 23.9 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.754 0.788 . . . . 0.0 112.593 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -140.13 132.04 27.66 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.235 -1.802 . . . . 0.0 107.433 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -89.76 123.77 34.05 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 170.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.59 126.74 14.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.508 1.13 . . . . 0.0 111.752 164.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 tp -80.45 -36.55 33.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.099 0.874 . . . . 0.0 110.121 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -145.49 165.1 29.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.185 0.928 . . . . 0.0 110.795 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.03 121.16 23.13 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.393 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.403 ' CD2' HD12 ' A' ' 24' ' ' LEU . 27.9 t80 -128.47 128.48 44.46 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.227 0.954 . . . . 0.0 109.423 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.32 159.51 15.23 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.604 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.34 150.21 22.67 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 123.772 0.67 . . . . 0.0 109.928 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -123.73 -9.79 7.83 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.021 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -139.62 153.35 47.33 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.904 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.91 -11.21 7.2 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.392 -1.276 . . . . 0.0 113.355 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -80.45 -35.02 35.5 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.374 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -98.6 177.61 5.26 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 124.158 0.911 . . . . 0.0 111.039 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 pt -141.23 172.75 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.086 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.83 128.76 33.79 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.979 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.403 HD12 ' CD2' ' A' ' 14' ' ' TYR . 85.3 mt -127.78 140.39 52.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.971 0.794 . . . . 0.0 109.998 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.483 ' NE2' HG21 ' A' ' 63' ' ' THR . 0.2 OUTLIER -140.27 -173.5 3.68 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.078 -176.822 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -75.52 152.48 37.81 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.663 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.36 -7.87 1.72 Allowed Glycine 0 N--CA 1.498 2.82 0 CA-C-N 114.97 -1.014 . . . . 0.0 114.006 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.82 106.52 0.58 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 mt -98.77 126.88 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 172.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.63 158.07 16.96 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 112.56 -2.109 . . . . 0.0 108.539 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 m -134.42 147.09 50.38 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -172.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.3 OUTLIER -120.1 -166.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.492 ' H ' HG12 ' A' ' 32' ' ' VAL . 5.0 m120 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.998 0.904 . . . . 0.0 111.681 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.18 11.3 1.93 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.291 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.15 76.68 78.82 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 123.604 0.565 . . . . 0.0 109.532 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.26 -16.88 56.69 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.119 1.879 . . . . 0.0 112.731 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -67.09 -37.3 83.7 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 123.896 0.747 . . . . 0.0 110.945 -172.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.81 -33.79 16.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 124.184 0.928 . . . . 0.0 110.104 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.9 mt -64.97 149.1 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 124.152 0.908 . . . . 0.0 109.823 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.43 -103.86 1.09 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -89.88 137.5 32.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 124.632 0.842 . . . . 0.0 110.348 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 64.7 mt -106.4 131.65 53.35 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 113.934 -1.484 . . . . 0.0 107.721 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -104.77 117.44 34.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.009 0.818 . . . . 0.0 109.483 175.22 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.91 172.58 35.11 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.299 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.84 149.3 22.01 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.477 -0.861 . . . . 0.0 109.997 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -124.42 61.1 1.14 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.89 -22.68 5.79 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.064 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -53.01 -50.48 64.14 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.001 0.813 . . . . 0.0 111.084 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.483 HG21 ' NE2' ' A' ' 25' ' ' HIS . 5.4 p -94.2 3.28 55.47 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.476 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.51 29.42 74.77 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -123.9 173.89 7.91 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -150.45 147.48 27.59 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.79 -154.78 19.44 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.092 171.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.37 155.11 16.87 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.661 -0.769 . . . . 0.0 109.364 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 56' ' ' LEU . 11.8 p90 -157.25 142.34 12.28 Favored Pre-proline 0 N--CA 1.498 1.952 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.846 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.69 151.09 49.35 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.253 1.969 . . . . 0.0 111.899 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.25 -4.39 77.62 Favored Glycine 0 N--CA 1.498 2.817 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.436 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.3 t -104.19 1.36 30.56 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 116.801 0.3 . . . . 0.0 111.345 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.35 -9.46 16.76 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 123.747 0.655 . . . . 0.0 111.988 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 m -119.3 -172.12 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 124.134 0.896 . . . . 0.0 108.983 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -150.13 124.47 9.55 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -49.78 131.57 22.03 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 124.116 0.885 . . . . 0.0 109.913 168.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.613 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.2 pt -108.74 -53.68 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 124.359 1.037 . . . . 0.0 109.393 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.73 171.18 40.11 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-N 114.52 -0.84 . . . . 0.0 109.368 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.405 ' CZ ' ' O ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.193 0 CA-C-O 121.466 0.651 . . . . 0.0 111.481 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -133.09 166.08 23.26 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.393 -169.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -139.92 141.39 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -105.66 120.52 41.88 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.341 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.78 114.91 1.57 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.312 1.007 . . . . 0.0 111.596 168.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -63.54 1.36 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.301 176.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -103.62 143.19 33.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.05 0.844 . . . . 0.0 110.26 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.43 118.65 9.7 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 124.4 1.062 . . . . 0.0 111.164 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -129.42 128.32 42.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 124.564 1.165 . . . . 0.0 108.999 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -89.57 171.42 9.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -89.01 136.17 33.16 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -124.68 -7.66 7.38 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.719 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.65 142.81 50.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 124.258 0.974 . . . . 0.0 109.246 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -10.35 1.78 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.537 172.476 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.53 -37.5 13.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.053 0.845 . . . . 0.0 111.204 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -86.98 145.43 26.51 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 123.833 0.708 . . . . 0.0 110.471 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pt -99.58 -179.88 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 124.067 0.854 . . . . 0.0 111.8 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -79.73 138.9 37.45 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.207 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -126.95 130.03 49.3 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.652 -1.613 . . . . 0.0 108.408 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.25 33.31 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.28 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -53.84 149.27 8.97 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.01 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.84 -14.4 10.47 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.375 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.54 117.79 9.23 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.456 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -101.68 148.99 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 123.947 0.779 . . . . 0.0 109.431 167.408 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.463 HD11 ' ND2' ' A' ' 60' ' ' ASN . 10.6 mp -121.95 154.35 37.29 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.8 m -137.26 145.16 43.21 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 123.471 0.482 . . . . 0.0 109.951 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.477 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.0 t -122.14 -145.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 124.269 0.981 . . . . 0.0 108.487 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' H ' HG12 ' A' ' 32' ' ' VAL . 5.0 m-80 . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 120.665 0.269 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.59 5.1 39.07 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.826 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -126.98 76.47 75.89 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 123.767 0.667 . . . . 0.0 109.395 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.25 -3.84 6.88 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.329 2.02 . . . . 0.0 113.732 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -71.36 -43.31 67.16 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.806 0.691 . . . . 0.0 110.985 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.68 -24.68 21.54 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.391 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.74 143.02 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.56 -91.0 1.21 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -94.81 123.43 38.26 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.767 -1.217 . . . . 0.0 110.455 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.4 mp -95.63 172.68 7.91 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.756 171.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.17 107.44 4.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -175.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.53 -176.78 23.84 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.513 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 66' ' ' ARG . 6.8 m-85 -106.81 153.27 22.72 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.295 -0.953 . . . . 0.0 110.234 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.463 ' ND2' HD11 ' A' ' 30' ' ' LEU . 8.5 t-20 -123.99 60.77 1.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.849 -1.523 . . . . 0.0 107.486 -177.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -42.86 -36.33 1.46 Allowed 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.954 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 p -49.55 -54.58 17.29 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.514 1.134 . . . . 0.0 113.756 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -93.76 3.21 55.78 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.627 0.58 . . . . 0.0 111.29 172.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.23 17.46 56.05 Favored Glycine 0 N--CA 1.496 2.668 0 O-C-N 123.845 0.715 . . . . 0.0 112.227 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.5 167.94 10.84 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 4.3 ptm180 -150.24 148.82 29.35 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.229 0.538 . . . . 0.0 110.246 175.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.2 -156.41 28.0 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.243 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.93 160.89 15.41 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -169.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 27.8 p90 -159.87 149.93 15.0 Favored Pre-proline 0 N--CA 1.498 1.933 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.499 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.75 146.17 87.9 Favored 'Trans proline' 0 N--CA 1.487 1.103 0 C-N-CA 122.064 1.843 . . . . 0.0 112.03 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.59 7.18 82.55 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 123.83 0.706 . . . . 0.0 112.297 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -23.95 15.57 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 176.179 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -89.83 -9.62 48.43 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.376 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 m -122.95 -178.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 124.491 1.12 . . . . 0.0 108.334 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -149.61 120.57 7.67 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -48.73 127.62 14.01 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 165.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -94.27 -62.39 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 124.225 0.953 . . . . 0.0 109.442 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.16 158.02 28.81 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -165.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 CA-C-N 114.206 -0.997 . . . . 0.0 110.726 169.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -133.1 162.9 30.49 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 124.301 1.001 . . . . 0.0 111.992 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -143.76 135.97 26.75 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.294 -1.776 . . . . 0.0 107.082 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HE ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -102.73 125.17 49.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 124.276 0.985 . . . . 0.0 108.862 178.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.5 149.64 5.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 123.879 0.737 . . . . 0.0 110.873 168.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 tp -121.48 -25.58 5.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 123.974 0.796 . . . . 0.0 111.075 -175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.04 146.78 27.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.038 0.836 . . . . 0.0 110.294 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.39 118.55 6.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.507 1.13 . . . . 0.0 110.55 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.416 ' CD1' HD12 ' A' ' 24' ' ' LEU . 2.9 t80 -120.6 135.98 54.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 124.778 1.299 . . . . 0.0 108.82 174.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -89.81 157.03 18.11 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.406 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -88.58 149.82 23.38 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.84 -19.56 2.6 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.312 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.23 147.25 35.41 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.163 -1.381 . . . . 0.0 110.051 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.81 -21.33 64.32 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.158 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.16 -12.28 57.1 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.69 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.97 147.79 30.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 124.091 0.87 . . . . 0.0 110.849 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.22 -175.26 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.483 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -88.73 129.15 35.6 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.445 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 14' ' ' TYR . 71.5 mt -114.02 135.95 53.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.016 0.822 . . . . 0.0 111.007 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.49 -173.91 3.2 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.089 -176.083 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -84.92 158.06 20.67 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.687 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.64 -5.27 2.45 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.137 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.86 147.41 51.76 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.476 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.0 tt -132.57 150.14 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 124.101 0.876 . . . . 0.0 111.358 172.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.668 HD11 HD22 ' A' ' 60' ' ' ASN . 9.7 mp -121.77 152.83 39.04 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.149 -176.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.3 m -135.04 149.35 50.11 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.914 0.759 . . . . 0.0 110.449 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.3 t -127.67 -153.99 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 123.959 0.787 . . . . 0.0 109.002 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.578 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.423 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 121.247 0.546 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.74 -4.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.855 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -126.86 79.27 72.65 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 123.942 0.776 . . . . 0.0 110.499 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.82 -7.96 5.2 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.237 1.958 . . . . 0.0 113.514 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -48.56 45.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.2 -23.21 21.34 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 123.822 0.701 . . . . 0.0 111.024 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.78 143.37 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.26 -99.68 1.04 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -89.99 133.49 34.78 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.376 -0.912 . . . . 0.0 110.343 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -109.28 156.47 19.91 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.414 171.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 34.9 t-20 -131.08 124.65 31.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.32 -179.24 29.47 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.073 -1.06 . . . . 0.0 111.498 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -95.85 126.7 41.28 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.52 -1.34 . . . . 0.0 109.483 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.668 HD22 HD11 ' A' ' 30' ' ' LEU . 23.2 t-20 -90.3 85.02 6.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 124.459 1.099 . . . . 0.0 109.896 173.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -47.48 -32.87 5.61 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.952 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -55.88 -47.01 78.15 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.298 0.999 . . . . 0.0 111.423 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -105.03 5.38 32.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.228 0.955 . . . . 0.0 109.651 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.66 53.72 37.34 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 124.292 0.995 . . . . 0.0 111.42 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -138.93 173.21 11.8 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -172.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -129.11 118.87 23.18 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.45 -171.05 23.83 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 118.953 -1.594 . . . . 0.0 113.224 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -103.25 162.16 13.21 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 113.646 -1.277 . . . . 0.0 109.603 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CE1' HD23 ' A' ' 30' ' ' LEU . 13.0 p90 -159.66 140.86 9.3 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.215 176.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.61 152.44 74.63 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.647 1.564 . . . . 0.0 110.406 176.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.75 26.11 2.83 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.984 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 p -96.57 -51.91 4.14 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.276 0.56 . . . . 0.0 111.729 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -90.48 25.65 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.156 -1.383 . . . . 0.0 110.847 -170.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.47 158.7 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -172.651 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -138.07 112.48 8.73 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -46.77 116.48 1.34 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.448 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.58 HD13 ' HE ' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -91.83 -56.98 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.522 178.769 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.49 175.85 38.88 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.459 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-N 113.973 -1.114 . . . . 0.0 110.383 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.228 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -128.87 164.1 23.83 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.785 0.803 . . . . 0.0 112.737 -171.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -139.03 133.46 31.69 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 113.414 -1.721 . . . . 0.0 107.926 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -90.65 113.49 25.55 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.37 128.2 30.62 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.136 167.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.01 -71.01 0.75 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.036 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -90.34 145.99 24.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 123.86 0.725 . . . . 0.0 110.045 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.97 125.07 23.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.126 0.891 . . . . 0.0 110.52 177.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.518 ' CD2' HD12 ' A' ' 24' ' ' LEU . 16.5 t80 -127.84 133.15 49.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.41 1.069 . . . . 0.0 109.374 175.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -90.01 160.94 16.1 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.346 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 160.83 16.73 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 123.952 0.783 . . . . 0.0 110.224 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.64 -50.43 4.06 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.899 0.857 . . . . 0.0 110.5 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.518 ' HG3' ' H ' ' A' ' 20' ' ' GLU . 6.8 ptp180 -150.27 -166.04 2.44 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 112.82 -1.991 . . . . 0.0 110.437 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -61.5 2.87 0.15 Allowed 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.518 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 28.5 tt0 -85.07 -36.99 20.83 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 123.246 0.341 . . . . 0.0 110.38 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.13 163.77 18.92 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.669 -174.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.597 HD12 ' H ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -120.25 -175.93 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 124.515 1.134 . . . . 0.0 110.294 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -83.6 129.09 34.96 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 112.612 -2.085 . . . . 0.0 107.474 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.518 HD12 ' CD2' ' A' ' 14' ' ' TYR . 82.4 mt -122.75 133.19 54.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.167 0.917 . . . . 0.0 110.415 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.22 171.32 14.33 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.053 -174.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -72.7 151.22 42.31 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.401 -172.207 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.89 -12.93 15.25 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.111 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.89 141.73 53.1 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.048 0.499 . . . . 0.0 110.206 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 mt -117.1 141.32 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 124.512 1.133 . . . . 0.0 110.01 172.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 30' ' ' LEU . 8.6 mp -107.43 150.15 27.09 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 112.748 -2.024 . . . . 0.0 109.233 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.4 m -128.22 138.98 52.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.19 0.931 . . . . 0.0 110.753 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.5 t -107.76 -155.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 124.367 1.042 . . . . 0.0 108.887 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.629 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.5 t-20 . . . . . 0 N--CA 1.488 1.449 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.57 173.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 122.109 0.957 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.04 -18.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.38 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -116.25 87.32 19.47 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 124.234 0.959 . . . . 0.0 108.996 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.77 -6.23 3.22 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.535 2.157 . . . . 0.0 113.407 173.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.87 -39.48 87.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 123.651 0.594 . . . . 0.0 111.062 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -90.31 -19.87 23.57 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.127 0.892 . . . . 0.0 110.057 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mt -96.04 129.73 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 123.914 0.759 . . . . 0.0 109.782 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.62 -78.69 1.33 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -90.96 133.16 35.5 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.273 -1.464 . . . . 0.0 110.252 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.3 mp -120.75 125.44 47.63 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 172.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.414 ' O ' HG13 ' A' ' 32' ' ' VAL . 65.9 t30 -90.0 120.32 31.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 123.926 0.766 . . . . 0.0 109.559 168.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.91 -163.68 9.6 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.386 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -139.99 123.52 17.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.59 88.45 7.42 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.32 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -53.93 -38.17 64.61 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.199 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -52.02 -47.29 65.08 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.252 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -91.28 -4.82 55.54 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 123.992 0.808 . . . . 0.0 109.836 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.45 36.08 62.81 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 124.325 1.015 . . . . 0.0 111.836 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -135.98 134.37 38.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.231 0.606 . . . . 0.0 110.227 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -89.55 155.45 19.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.341 1.026 . . . . 0.0 109.115 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.86 -161.49 35.2 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.132 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.06 166.33 12.12 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 113.891 -1.154 . . . . 0.0 109.228 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.1 p90 -162.58 140.04 6.27 Favored Pre-proline 0 N--CA 1.496 1.847 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.311 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.458 ' HB2' HG22 ' A' ' 72' ' ' THR . 2.5 Cg_endo -63.14 166.86 13.6 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.875 1.716 . . . . 0.0 112.027 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.15 48.05 1.03 Allowed Glycine 0 N--CA 1.496 2.644 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.599 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.474 HG23 ' CD2' ' A' ' 73' ' ' TYR . 5.0 t -138.39 -28.15 0.85 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.19 0.582 . . . . 0.0 112.507 -177.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.474 ' CD2' HG23 ' A' ' 72' ' ' THR . 68.5 m-85 -90.92 1.62 56.87 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.319 1.012 . . . . 0.0 110.976 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.49 -174.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 124.293 0.996 . . . . 0.0 108.924 -176.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.39 127.97 11.55 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.621 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -60.56 133.5 56.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.685 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.08 -60.57 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 124.339 1.025 . . . . 0.0 110.361 176.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.92 148.0 15.91 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -163.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-N 112.803 -1.698 . . . . 0.0 109.734 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 42.8 mt-30 -100.29 157.59 16.49 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.523 0.677 . . . . 0.0 110.859 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -143.99 124.97 14.35 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -90.6 120.9 32.06 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.67 121.12 6.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 123.974 0.796 . . . . 0.0 110.773 168.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -74.14 -46.42 42.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.018 0.824 . . . . 0.0 109.558 176.48 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.84 174.75 10.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.36 1.038 . . . . 0.0 110.152 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.25 133.33 35.99 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.089 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 16' ' ' LYS . 8.9 t80 -120.81 108.5 14.03 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 79.29 2.32 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.938 -171.765 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 31.3 mmtm -142.53 170.7 15.21 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.487 1.136 . . . . 0.0 111.44 170.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -151.45 60.98 0.89 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.804 -166.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -89.67 159.26 17.21 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -60.84 -17.06 47.73 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.133 0.492 . . . . 0.0 111.156 -176.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -105.12 -29.33 10.45 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.555 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -99.92 165.52 11.51 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 123.652 0.595 . . . . 0.0 111.311 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 pt -138.61 173.37 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.083 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -79.51 131.4 36.03 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.11 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 14' ' ' TYR . 20.6 mt -128.87 137.28 51.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.728 1.267 . . . . 0.0 109.429 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 -179.62 5.55 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.2 mt -63.27 151.1 41.54 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.577 171.011 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.47 -10.55 6.37 Favored Glycine 0 N--CA 1.496 2.683 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.611 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.17 116.5 4.61 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.142 177.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.522 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -97.6 144.04 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.389 0.614 . . . . 0.0 109.418 174.895 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 29' ' ' ILE . 9.1 mp -125.22 153.65 42.81 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.063 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.4 m -137.14 132.36 33.89 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 33' ' ' ASN . 90.8 t -105.98 168.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 32' ' ' VAL . 8.6 m120 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 123.902 0.751 . . . . 0.0 112.874 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.504 2.248 0 CA-C-O 121.522 0.677 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.36 -5.11 0.23 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.503 -173.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -119.16 85.23 29.53 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 124.471 1.107 . . . . 0.0 109.138 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.14 -2.26 5.51 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.151 2.567 . . . . 0.0 113.687 169.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -73.37 -15.83 61.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 123.684 0.615 . . . . 0.0 111.928 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -125.06 -33.86 2.84 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 123.602 0.564 . . . . 0.0 111.194 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.33 146.26 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 123.92 0.763 . . . . 0.0 110.433 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.28 -94.64 1.1 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -95.43 136.29 35.99 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.286 -0.957 . . . . 0.0 110.584 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.4 mp -115.96 138.23 51.39 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.207 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -107.96 118.83 37.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.89 165.91 30.28 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.453 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.2 143.25 26.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.039 0.494 . . . . 0.0 110.182 176.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -116.09 68.48 0.73 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.135 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -47.05 -31.71 3.51 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 114.123 -1.399 . . . . 0.0 114.088 172.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.9 m -50.37 -49.03 55.45 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.531 1.144 . . . . 0.0 111.187 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.9 p -98.03 -2.74 39.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.25 0.969 . . . . 0.0 110.55 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.62 32.27 81.02 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -122.95 176.35 6.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 124.461 0.742 . . . . 0.0 109.244 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -145.69 145.32 30.84 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.03 0.831 . . . . 0.0 109.114 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.28 -156.19 22.86 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.036 -1.554 . . . . 0.0 113.264 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.74 153.91 19.38 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 35.6 p90 -155.18 141.55 13.14 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 123.619 0.575 . . . . 0.0 109.673 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.82 142.02 67.86 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.828 1.685 . . . . 0.0 111.088 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.67 -22.86 78.76 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 124.012 0.82 . . . . 0.0 111.874 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.4 p -72.45 -6.37 43.15 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.035 -0.082 . . . . 0.0 111.025 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -109.73 -6.35 15.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 123.979 0.799 . . . . 0.0 111.785 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.37 -177.21 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 123.933 0.771 . . . . 0.0 109.028 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HB2' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -146.6 123.18 11.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 124.348 1.03 . . . . 0.0 108.948 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -56.26 127.16 29.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.355 1.034 . . . . 0.0 109.572 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.46 -55.08 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 123.874 0.734 . . . . 0.0 110.897 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -146.97 161.23 28.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 107.139 -2.385 . . . . 0.0 107.139 -164.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 C-N-CA 119.228 -0.989 . . . . 0.0 112.278 169.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -133.8 155.88 49.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 123.885 0.741 . . . . 0.0 110.216 -166.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -140.39 125.71 18.81 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.619 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -90.89 126.31 36.01 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.75 126.26 23.36 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.705 0.628 . . . . 0.0 111.317 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.24 -35.77 18.33 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.178 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 146.19 38.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.81 0.694 . . . . 0.0 110.224 -175.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.55 120.91 13.76 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.307 172.378 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.486 ' CD2' HD12 ' A' ' 24' ' ' LEU . 10.0 t80 -125.79 132.42 52.28 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.082 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -90.16 157.14 17.88 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.94 137.36 32.39 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.788 0.68 . . . . 0.0 109.727 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -119.9 -2.51 10.3 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.69 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HB3' ' H ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -120.02 141.7 49.48 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.145 0.903 . . . . 0.0 109.729 177.207 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.44 -17.27 62.51 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.923 171.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.53 -31.22 21.39 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.637 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . 0.425 ' H ' ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -85.68 144.58 27.74 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 123.641 0.588 . . . . 0.0 109.49 179.322 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pt -104.67 171.75 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 124.3 1.0 . . . . 0.0 111.332 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.24 149.34 47.56 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.77 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.486 HD12 ' CD2' ' A' ' 14' ' ' TYR . 96.1 mt -135.04 142.15 46.31 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.124 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.1 170.08 17.4 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 28' ' ' ASP . 1.6 mt -70.89 153.5 42.65 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.05 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.41 -7.75 1.27 Allowed Glycine 0 N--CA 1.505 3.234 0 O-C-N 123.537 0.523 . . . . 0.0 113.331 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 26' ' ' LEU . 26.0 t70 -68.95 109.12 3.78 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.526 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.702 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -89.04 149.9 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -176.018 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.702 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.1 mp -130.62 157.2 43.38 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 124.509 1.131 . . . . 0.0 111.041 174.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -136.83 141.5 42.86 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 123.782 0.676 . . . . 0.0 110.949 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.3 t -116.4 -147.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.597 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 120.844 0.354 . . . . 0.0 110.735 -175.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.511 2.607 0 CA-C-O 121.858 0.837 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.0 -12.21 0.1 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.031 -173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -120.23 81.5 29.46 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 123.873 0.733 . . . . 0.0 110.198 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.88 -26.63 68.25 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.216 1.944 . . . . 0.0 112.368 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -47.27 -47.04 25.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.883 1.364 . . . . 0.0 111.501 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.63 -37.06 13.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.383 1.052 . . . . 0.0 110.597 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.9 mt -60.5 143.19 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 123.624 0.578 . . . . 0.0 110.081 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.46 -79.48 1.33 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -169.228 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -115.09 129.87 56.79 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 112.694 -1.753 . . . . 0.0 109.189 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.605 ' N ' HD23 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -130.19 143.64 50.9 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.92 173.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -90.05 145.05 25.36 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.713 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.97 160.03 30.07 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -113.66 125.35 54.05 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -101.79 88.09 3.3 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.231 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -47.85 -36.85 12.66 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 113.608 -1.633 . . . . 0.0 111.977 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -42.39 98.59 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -90.74 0.81 57.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 123.793 0.683 . . . . 0.0 109.432 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.01 22.87 13.76 Favored Glycine 0 N--CA 1.497 2.72 0 O-C-N 124.459 1.099 . . . . 0.0 112.315 -168.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -121.74 155.67 34.75 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -137.76 150.54 47.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.621 1.201 . . . . 0.0 109.698 -174.391 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.78 -159.15 30.45 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.011 -1.09 . . . . 0.0 111.216 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.07 144.33 44.77 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -165.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.446 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 33.4 p90 -145.29 151.8 48.74 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 124.375 1.047 . . . . 0.0 108.914 -174.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -66.06 165.74 23.09 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.094 1.863 . . . . 0.0 111.779 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.15 60.4 0.4 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -147.71 -24.91 0.37 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -102.18 15.29 29.57 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 124.08 0.863 . . . . 0.0 111.264 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.5 177.81 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.014 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -148.26 116.3 6.44 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -47.81 143.34 4.1 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.757 165.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.53 -49.1 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 124.371 1.044 . . . . 0.0 111.752 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.84 150.21 22.25 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.333 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? . . . . . 0 N--CA 1.499 1.995 0 CA-C-N 113.833 -1.183 . . . . 0.0 111.97 179.055 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.232 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -123.51 157.94 32.44 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.05 0.929 . . . . 0.0 113.313 -173.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -140.43 121.35 14.55 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 112.397 -2.183 . . . . 0.0 107.486 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.2 ttt-85 -89.82 125.14 35.21 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.17 127.49 32.09 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 124.275 0.985 . . . . 0.0 110.742 171.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tp -92.52 -68.43 0.8 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.074 0.859 . . . . 0.0 109.527 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -98.2 144.52 27.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.028 0.83 . . . . 0.0 109.713 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -62.05 129.31 40.25 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.659 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.447 ' CD2' HD12 ' A' ' 24' ' ' LEU . 19.8 t80 -129.92 133.43 46.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.551 1.157 . . . . 0.0 108.846 175.823 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -90.01 154.33 19.9 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.971 0.794 . . . . 0.0 109.951 171.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.62 142.08 28.01 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.929 -177.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -89.4 -30.42 18.37 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.682 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -150.35 176.93 10.45 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.49 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.46 -18.39 28.27 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.661 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -69.1 -34.46 75.13 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.137 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.65 153.24 22.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.381 1.051 . . . . 0.0 109.406 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 pt -111.39 173.07 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 124.471 1.107 . . . . 0.0 110.534 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.57 132.91 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.186 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.447 HD12 ' CD2' ' A' ' 14' ' ' TYR . 89.8 mt -121.34 127.02 50.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 124.55 1.156 . . . . 0.0 109.866 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.443 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -132.83 172.7 12.23 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.302 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.07 150.98 44.3 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.156 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.05 -13.86 8.65 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.991 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.19 118.28 6.17 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.568 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.1 tp -96.19 151.09 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.714 0.769 . . . . 0.0 109.295 170.851 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.4 mp -127.71 150.84 49.6 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.388 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.3 m -132.4 146.99 52.36 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 123.822 0.701 . . . . 0.0 109.443 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.4 t -121.37 -147.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.516 ' H ' HG12 ' A' ' 32' ' ' VAL . 9.9 p-10 . . . . . 0 N--CA 1.493 1.694 0 O-C-N 123.768 0.668 . . . . 0.0 111.773 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.503 2.206 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.87 -22.33 0.07 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.023 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -116.29 81.97 11.25 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 124.23 0.956 . . . . 0.0 110.753 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.92 -8.76 6.48 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.373 2.049 . . . . 0.0 113.264 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -70.0 -37.78 75.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.85 0.719 . . . . 0.0 111.329 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -89.68 -27.82 19.86 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 123.933 0.771 . . . . 0.0 110.779 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.7 mt -76.68 140.78 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 123.923 0.764 . . . . 0.0 109.07 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.71 -91.76 1.2 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -175.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -98.18 123.27 42.16 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.701 -1.25 . . . . 0.0 109.503 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.6 mp -99.95 164.27 12.08 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.256 174.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -137.4 126.69 24.74 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.36 175.82 33.92 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.247 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -99.59 125.17 45.35 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.87 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -89.63 84.27 6.33 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.22 0.95 . . . . 0.0 109.872 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -56.94 -34.82 68.39 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.116 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.4 m -54.57 -38.63 66.9 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.03 0.831 . . . . 0.0 111.87 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.1 p -99.77 -4.36 30.79 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.808 0.693 . . . . 0.0 111.564 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.92 29.84 76.42 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -136.35 170.41 16.08 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -136.51 150.7 48.8 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.08 0.863 . . . . 0.0 109.251 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.65 -163.69 31.16 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.819 -1.182 . . . . 0.0 111.808 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.95 153.48 22.49 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.513 -0.843 . . . . 0.0 109.552 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.4 p90 -150.89 146.67 19.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.285 -176.329 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -66.59 150.08 83.98 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 121.787 1.658 . . . . 0.0 110.431 175.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.25 23.59 11.33 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 124.078 0.861 . . . . 0.0 111.971 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.98 -34.67 7.12 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.052 0.453 . . . . 0.0 111.23 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -89.92 14.91 10.93 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.193 -174.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.26 171.69 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.218 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -145.9 123.2 11.58 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -48.97 149.06 2.0 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.974 0.796 . . . . 0.0 109.677 170.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.79 -54.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 124.015 0.822 . . . . 0.0 111.336 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.92 146.23 15.43 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.802 -168.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-N 113.138 -1.531 . . . . 0.0 110.839 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.006 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -145.38 165.57 28.09 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 122.437 1.113 . . . . 0.0 113.121 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -142.91 151.55 41.12 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 112.285 -2.234 . . . . 0.0 107.064 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -119.1 115.47 24.34 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.34 121.21 7.15 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.484 171.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tp -93.79 -43.4 8.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.508 1.13 . . . . 0.0 110.235 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.43 143.54 45.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.578 1.174 . . . . 0.0 110.342 -177.083 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.88 117.47 20.0 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.304 -1.317 . . . . 0.0 109.787 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.494 ' HD2' HD12 ' A' ' 24' ' ' LEU . 16.8 t80 -120.58 131.24 54.56 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -89.1 156.24 18.95 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.652 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -89.19 132.73 34.72 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.622 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -112.51 -13.9 13.29 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.138 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 -129.42 149.33 51.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 124.417 1.073 . . . . 0.0 110.387 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.07 -12.59 61.82 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.878 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -80.09 -19.78 46.64 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.116 0.885 . . . . 0.0 111.514 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.55 159.71 16.85 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.012 0.82 . . . . 0.0 111.497 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 pt -110.63 176.59 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.844 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -73.16 139.88 46.66 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.897 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.494 HD12 ' HD2' ' A' ' 14' ' ' TYR . 16.1 mt -127.52 127.64 44.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.192 0.933 . . . . 0.0 110.566 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.95 -176.61 4.86 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.92 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -61.64 152.98 29.27 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.807 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.14 -11.57 4.8 Favored Glycine 0 N--CA 1.499 2.836 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.801 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' HG21 ' A' ' 62' ' ' THR . 1.1 m-20 -65.17 95.51 0.18 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -91.2 133.25 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.796 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.3 mp -112.83 146.45 38.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 112.494 -2.139 . . . . 0.0 108.756 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 m -132.14 155.79 47.53 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -138.29 169.8 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -170.283 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.776 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 N--CA 1.502 2.15 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.18 -4.83 19.11 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 174.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 79.12 46.49 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.15 -19.22 65.84 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 122.072 1.848 . . . . 0.0 112.365 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -57.62 -40.49 79.29 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.151 0.907 . . . . 0.0 112.549 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -89.9 -27.41 19.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 123.757 0.661 . . . . 0.0 109.961 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.9 mt -70.58 148.32 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.492 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.52 -94.82 1.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -89.78 144.68 25.77 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.203 -0.998 . . . . 0.0 110.256 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 55.0 mt -117.76 133.22 56.16 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.029 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -111.8 117.89 34.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.146 0.904 . . . . 0.0 109.463 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.87 175.76 35.06 Favored Glycine 0 N--CA 1.496 2.671 0 O-C-N 124.181 0.925 . . . . 0.0 112.015 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -94.71 150.03 20.63 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.108 -1.046 . . . . 0.0 109.987 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.4 64.13 1.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.372 -1.286 . . . . 0.0 107.959 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.01 -25.48 30.38 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.696 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 28' ' ' ASP . 62.5 m -51.75 -49.35 62.76 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 124.351 1.032 . . . . 0.0 110.914 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -94.61 -3.74 49.04 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 124.331 1.019 . . . . 0.0 111.722 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.06 42.38 77.34 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -141.68 178.38 7.51 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.345 -0.927 . . . . 0.0 108.801 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -147.19 151.69 37.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.97 -153.21 13.32 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 118.895 -1.622 . . . . 0.0 112.38 167.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -104.51 148.78 26.09 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 56' ' ' LEU . 17.0 p90 -153.47 140.29 12.91 Favored Pre-proline 0 N--CA 1.494 1.763 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.423 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.31 160.74 15.61 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.905 1.737 . . . . 0.0 111.949 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.12 35.38 4.6 Favored Glycine 0 N--CA 1.498 2.788 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.177 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.448 HG23 ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.56 -30.52 1.87 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.562 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.448 ' CD1' HG23 ' A' ' 72' ' ' THR . 18.0 m-30 -90.24 13.93 13.99 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.926 0.766 . . . . 0.0 110.874 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.08 176.2 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 124.57 1.168 . . . . 0.0 107.918 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -144.77 113.76 6.88 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -45.17 139.4 3.38 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.959 0.787 . . . . 0.0 110.196 168.469 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.487 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.8 pt -137.02 -66.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 124.597 1.186 . . . . 0.0 109.892 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.487 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -98.22 157.89 20.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 -171.148 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 O-C-N 124.587 0.816 . . . . 0.0 111.485 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -125.65 161.99 26.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 124.192 0.932 . . . . 0.0 111.591 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -138.44 159.57 41.74 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.821 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -120.2 116.27 25.28 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.54 111.55 0.66 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.896 0.748 . . . . 0.0 110.498 170.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -51.37 40.86 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.639 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.38 151.48 49.3 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.511 1.132 . . . . 0.0 109.874 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -57.31 129.23 40.86 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.692 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.489 ' CD2' HD12 ' A' ' 24' ' ' LEU . 16.8 t80 -130.31 129.71 43.56 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.178 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -89.29 155.7 19.21 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.779 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 146.53 24.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.811 0.694 . . . . 0.0 109.388 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -131.78 -7.12 3.59 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.911 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.03 150.55 50.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 124.163 0.914 . . . . 0.0 109.404 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -65.45 -16.97 64.18 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.707 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -78.58 -25.51 45.31 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.728 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.86 154.91 19.43 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.3 1.0 . . . . 0.0 111.174 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 pt -119.13 177.35 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.775 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.87 135.46 38.85 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.826 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.489 HD12 ' CD2' ' A' ' 14' ' ' TYR . 64.9 mt -128.31 135.04 49.06 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 124.294 0.996 . . . . 0.0 110.188 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.51 -174.47 3.65 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.742 -173.058 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.99 154.05 25.9 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.207 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.85 -6.36 2.04 Favored Glycine 0 N--CA 1.502 3.04 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.673 -176.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.93 116.99 7.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.5 mt -104.19 138.89 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 124.287 0.992 . . . . 0.0 109.868 173.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.543 HD11 ' ND2' ' A' ' 60' ' ' ASN . 11.0 mp -110.74 158.95 18.08 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.903 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.8 m -130.58 151.2 51.3 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 123.804 0.69 . . . . 0.0 109.495 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.1 t -119.85 -141.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.531 ' H ' HG12 ' A' ' 32' ' ' VAL . 35.7 m120 . . . . . 0 N--CA 1.486 1.375 0 O-C-N 124.11 0.881 . . . . 0.0 109.227 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 121.554 0.692 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.96 18.38 13.45 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.78 -172.719 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -130.33 73.14 81.55 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 123.899 0.749 . . . . 0.0 110.309 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HG3' ' H ' ' A' ' 76' ' ' TYR . 3.6 Cg_exo -60.85 -4.96 4.04 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.56 2.174 . . . . 0.0 113.536 174.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.83 -39.42 69.77 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.62 0.575 . . . . 0.0 110.895 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.8 -33.05 16.67 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.094 0.871 . . . . 0.0 109.793 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 mt -77.37 125.5 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.54 -78.62 1.32 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -92.56 120.47 33.04 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 113.335 -1.433 . . . . 0.0 110.006 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 2.2 mp -105.9 123.78 48.52 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.088 172.862 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.98 122.41 35.31 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 168.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.68 171.34 32.45 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.015 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.02 150.28 21.07 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.25 -0.975 . . . . 0.0 109.871 176.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.543 ' ND2' HD11 ' A' ' 30' ' ' LEU . 4.4 m120 -120.14 77.21 1.23 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.102 174.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -52.94 -36.13 59.42 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.942 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -53.28 -50.38 64.98 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.264 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.0 p -89.54 4.74 48.3 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.574 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.45 35.21 50.49 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 124.383 1.052 . . . . 0.0 111.483 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -138.65 -175.85 4.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 154.2 37.46 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.384 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.42 -162.82 34.03 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.774 -1.203 . . . . 0.0 112.55 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.82 161.24 13.84 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.079 -1.06 . . . . 0.0 109.711 176.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.481 ' CE1' HD23 ' A' ' 30' ' ' LEU . 34.4 p90 -162.1 142.18 7.65 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.434 175.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.71 155.33 64.03 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 121.547 1.498 . . . . 0.0 111.89 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.46 -12.43 64.93 Favored Glycine 0 N--CA 1.5 2.937 0 O-C-N 123.915 0.759 . . . . 0.0 112.494 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.51 3.62 18.14 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.507 0.323 . . . . 0.0 110.823 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -121.1 -2.16 9.7 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.165 0.916 . . . . 0.0 110.572 -176.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 m -128.08 -177.64 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 124.175 0.922 . . . . 0.0 110.067 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -150.16 113.78 4.99 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.846 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.409 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 28.4 t80 -46.95 142.59 3.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 123.551 0.532 . . . . 0.0 110.388 172.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 pt -118.6 -55.37 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 123.948 0.78 . . . . 0.0 110.409 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.26 147.16 15.73 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.023 -1.084 . . . . 0.0 110.695 -165.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-N 112.904 -1.648 . . . . 0.0 110.019 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.505 2.324 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -147.59 165.26 30.91 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.27 1.033 . . . . 0.0 112.698 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -146.19 148.66 32.76 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 112.404 -2.18 . . . . 0.0 106.896 -174.579 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -117.64 113.8 22.45 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.82 103.95 0.07 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.401 1.063 . . . . 0.0 110.723 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.33 -31.48 69.96 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.824 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.93 141.9 38.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.133 0.895 . . . . 0.0 109.845 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.67 112.87 5.03 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.396 174.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -113.5 133.12 55.4 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -89.89 156.52 18.41 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.322 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -88.84 147.17 24.54 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.927 -175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -122.67 -7.03 8.57 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.299 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -139.01 159.25 42.59 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.731 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.9 -21.16 66.43 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.364 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.99 -23.35 33.36 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.907 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -94.77 146.21 24.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.263 0.977 . . . . 0.0 109.979 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -111.98 176.69 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 124.775 1.297 . . . . 0.0 110.3 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -86.2 106.22 17.14 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.683 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.56 125.37 35.6 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.46 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.78 -173.12 2.18 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.728 1.267 . . . . 0.0 109.256 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.6 mt -74.13 145.72 44.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.69 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.47 10.88 4.63 Favored Glycine 0 N--CA 1.503 3.119 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.206 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.18 127.17 30.58 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.297 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.71 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 mp -104.56 142.84 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 CA-C-O 121.307 0.575 . . . . 0.0 109.46 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.71 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.4 mp -126.82 150.37 49.21 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.028 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.2 m -128.84 149.62 50.67 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 123.956 0.785 . . . . 0.0 110.62 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -120.63 -156.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 O-C-N 123.551 0.532 . . . . 0.0 109.728 179.148 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.483 ' H ' HG12 ' A' ' 32' ' ' VAL . 13.5 p-10 . . . . . 0 N--CA 1.502 2.129 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 171.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.21 -2.84 26.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.532 1.145 . . . . 0.0 111.859 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -119.96 79.15 24.84 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 123.97 0.794 . . . . 0.0 111.283 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.83 -13.7 23.68 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.784 1.656 . . . . 0.0 112.744 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -64.11 -38.1 89.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.093 0.871 . . . . 0.0 111.488 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -90.12 -28.09 19.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.931 0.769 . . . . 0.0 110.912 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 mt -74.09 141.47 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 123.866 0.729 . . . . 0.0 109.577 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.43 -92.82 1.15 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -93.23 120.39 33.47 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.603 -1.299 . . . . 0.0 109.679 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.0 mp -100.44 125.38 46.73 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.604 171.213 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -95.99 118.23 32.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.739 0.65 . . . . 0.0 109.729 171.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.01 -179.36 18.95 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -124.42 125.19 43.87 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -96.42 91.99 6.09 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.434 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -52.41 -35.04 50.99 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.021 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.7 m -51.25 -36.98 44.59 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.514 1.134 . . . . 0.0 112.096 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 64.5 p -115.74 2.6 13.7 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.952 0.782 . . . . 0.0 110.064 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.9 18.69 57.58 Favored Glycine 0 N--CA 1.493 2.483 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.746 -174.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -110.02 153.65 24.3 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' CD ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -137.74 146.72 44.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.665 1.228 . . . . 0.0 109.479 -175.78 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.89 -163.04 31.07 Favored Glycine 0 N--CA 1.491 2.314 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.18 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.3 151.15 26.96 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.066 -1.067 . . . . 0.0 109.587 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 26.7 p90 -147.68 144.38 19.17 Favored Pre-proline 0 N--CA 1.493 1.715 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.365 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.29 153.83 71.84 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.745 1.63 . . . . 0.0 111.34 174.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.27 53.17 2.47 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.3 t -134.46 -23.25 1.66 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -105.15 26.75 8.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.141 0.901 . . . . 0.0 110.63 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.46 166.85 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.595 -173.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -144.91 118.8 9.3 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.103 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -48.46 130.62 16.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.05 0.844 . . . . 0.0 110.464 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.491 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.2 pt -135.87 -62.39 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 123.907 0.754 . . . . 0.0 111.426 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.491 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -93.81 159.68 23.91 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 -176.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 124.758 0.917 . . . . 0.0 110.478 -178.292 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.115 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.531 ' HB3' HD11 ' A' ' 77' ' ' ILE . 30.1 mt-30 -139.4 159.1 42.95 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.506 -173.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -142.68 125.15 15.68 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.1 -1.863 . . . . 0.0 107.601 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -89.61 118.46 29.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.629 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.63 152.48 0.33 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.927 0.767 . . . . 0.0 112.788 170.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -113.29 -44.81 3.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.512 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.34 151.99 41.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.06 0.85 . . . . 0.0 110.799 -175.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.01 116.37 7.76 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.257 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.2 t80 -117.99 138.1 52.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.125 0.891 . . . . 0.0 108.895 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.02 146.4 25.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.297 0.998 . . . . 0.0 109.921 174.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 164.53 14.94 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.176 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.62 -25.24 0.77 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.074 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -108.03 149.68 28.12 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.101 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.56 -12.25 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.531 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -81.76 -40.27 22.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 123.903 0.752 . . . . 0.0 111.187 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.77 156.22 19.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.114 0.884 . . . . 0.0 111.265 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.41 174.43 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.666 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -75.05 131.47 40.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.766 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 14' ' ' TYR . 97.0 mt -121.56 127.46 50.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.587 1.179 . . . . 0.0 109.179 -177.148 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.74 -173.62 2.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.268 0.98 . . . . 0.0 108.904 -175.672 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 26' ' ' LEU . 3.1 mp -83.12 156.53 23.23 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.423 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.12 0.03 1.0 Allowed Glycine 0 N--CA 1.5 2.955 0 O-C-N 123.872 0.732 . . . . 0.0 113.201 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.69 106.29 1.45 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 30' ' ' LEU . 5.6 mt -90.64 132.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.743 174.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.634 HD11 HD22 ' A' ' 60' ' ' ASN . 10.5 mp -108.52 151.52 25.98 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.064 -1.88 . . . . 0.0 109.013 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.8 m -129.43 147.43 51.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 123.842 0.714 . . . . 0.0 109.845 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.431 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -119.59 -147.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 123.807 0.692 . . . . 0.0 109.265 -178.199 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.431 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 O-C-N 123.419 0.449 . . . . 0.0 110.033 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.244 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -86.96 -37.86 17.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -102.31 102.97 27.94 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.999 0.812 . . . . 0.0 111.325 174.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -68.6 -17.99 42.92 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.641 2.227 . . . . 0.0 114.092 167.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.53 -31.67 68.14 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.657 0.598 . . . . 0.0 112.246 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.32 -21.89 21.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.831 0.707 . . . . 0.0 111.376 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.12 146.91 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -91.56 1.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -90.19 131.04 36.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.425 -1.388 . . . . 0.0 109.032 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -108.46 126.82 53.32 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.506 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -100.94 124.23 46.33 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.77 -166.18 16.67 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -140.17 150.19 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.634 HD22 HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -114.23 99.87 7.93 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.274 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.81 -21.49 66.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.3 m -46.05 -37.42 6.7 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.812 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.61 2.46 6.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.849 1.343 . . . . 0.0 108.877 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.64 36.87 73.33 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.614 -176.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -109.51 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.51 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 156.05 40.99 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.767 0.794 . . . . 0.0 111.699 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.66 -153.05 23.3 Favored Glycine 0 N--CA 1.489 2.197 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.032 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.71 153.94 24.57 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -173.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.6 p90 -151.36 140.77 13.95 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.912 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HB2' HG22 ' A' ' 72' ' ' THR . 1.3 Cg_endo -65.15 150.39 87.74 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.53 1.486 . . . . 0.0 110.708 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.29 48.72 4.08 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 70' ' ' PRO . 7.6 t -141.21 16.39 2.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.105 0.532 . . . . 0.0 111.616 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -136.05 -4.08 2.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 123.751 0.657 . . . . 0.0 111.847 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.98 -169.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 123.932 0.77 . . . . 0.0 109.13 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.71 113.58 5.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 172.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 25.2 t80 -48.27 142.97 4.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.442 171.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.5 pt -122.24 -53.5 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 123.926 0.766 . . . . 0.0 111.688 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.84 146.63 15.79 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.478 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-N 113.311 -1.444 . . . . 0.0 109.988 177.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.685 ' HB3' HD11 ' A' ' 77' ' ' ILE . 4.6 mt-30 -133.01 165.3 25.04 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.145 0.974 . . . . 0.0 111.857 -177.712 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -136.64 128.42 29.05 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.883 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -89.31 114.69 26.11 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.627 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.89 122.53 4.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.362 1.039 . . . . 0.0 111.99 171.288 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.27 -41.37 34.19 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.677 -178.365 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.11 160.62 39.53 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 124.21 0.944 . . . . 0.0 110.376 -177.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.47 127.8 33.76 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.496 173.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.457 ' CD2' HD12 ' A' ' 24' ' ' LEU . 16.4 t80 -126.56 130.48 50.63 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.367 1.042 . . . . 0.0 109.042 173.34 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -90.29 153.88 20.13 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 169.349 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.62 171.9 9.34 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.101 0.876 . . . . 0.0 109.864 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.44 -10.01 1.24 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.094 177.222 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -132.84 154.58 50.19 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.357 -176.331 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.2 -19.15 62.83 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.55 174.382 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -71.89 -31.17 66.15 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.045 176.492 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.77 152.06 23.02 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 124.23 0.956 . . . . 0.0 110.317 -177.721 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pt -115.46 173.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.834 176.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -74.22 134.05 42.7 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.265 -1.788 . . . . 0.0 108.866 -176.387 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.457 HD12 ' CD2' ' A' ' 14' ' ' TYR . 87.4 mt -126.63 136.63 52.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.279 0.987 . . . . 0.0 110.026 -177.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 173.08 11.9 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.699 -173.976 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -67.55 158.02 32.99 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.228 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.3 -10.0 1.49 Allowed Glycine 0 N--CA 1.5 2.909 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.886 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.32 133.15 50.79 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.174 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.17 116.23 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.47 129.94 45.69 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 -168.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.2 m -103.91 146.97 27.89 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 124.006 0.816 . . . . 0.0 110.619 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.1 t -121.03 -149.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 124.52 1.138 . . . . 0.0 108.365 179.435 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.631 ' H ' HG12 ' A' ' 32' ' ' VAL . 4.2 m-80 . . . . . 0 N--CA 1.496 1.832 0 O-C-N 123.409 0.443 . . . . 0.0 111.228 176.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.507 2.404 0 CA-C-O 121.909 0.861 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -158.95 -22.75 0.07 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.35 -173.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 84.99 37.78 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 124.006 0.816 . . . . 0.0 109.395 175.61 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.555 ' HA ' HD12 ' A' ' 53' ' ' ILE . 5.0 Cg_exo -56.28 -23.0 43.59 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.444 2.096 . . . . 0.0 111.997 173.257 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.42 -45.63 76.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.657 1.223 . . . . 0.0 110.837 -175.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.01 -26.52 20.29 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 124.113 0.883 . . . . 0.0 111.102 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' A' ' 50' ' ' PRO . 62.4 mt -64.66 153.73 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 123.72 0.638 . . . . 0.0 109.857 176.635 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.17 -101.42 1.03 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 178.668 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -92.18 147.25 23.08 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.497 -0.851 . . . . 0.0 110.382 -177.609 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 67.4 mt -117.46 120.22 37.46 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 113.831 -1.531 . . . . 0.0 107.829 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.25 123.16 42.19 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 124.221 0.951 . . . . 0.0 109.732 173.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.07 -173.19 31.49 Favored Glycine 0 N--CA 1.499 2.871 0 O-C-N 124.066 0.853 . . . . 0.0 111.71 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.73 128.7 49.96 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.025 -174.337 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -94.06 62.19 3.03 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 124.445 1.09 . . . . 0.0 109.625 175.353 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -42.71 -33.9 0.81 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 114.467 -1.242 . . . . 0.0 114.179 173.155 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.9 p -55.08 -50.26 69.6 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 123.598 0.561 . . . . 0.0 112.028 177.218 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -89.83 1.89 55.62 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.059 0.85 . . . . 0.0 111.06 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.99 33.25 86.75 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -131.44 165.32 23.79 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -150.43 156.04 40.71 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 123.571 0.545 . . . . 0.0 110.551 177.163 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.68 -154.14 20.32 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.457 176.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.04 150.78 26.71 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 56' ' ' LEU . 12.8 p90 -154.95 139.43 11.66 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 124.171 0.919 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.95 161.17 19.59 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.126 1.884 . . . . 0.0 112.86 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.08 22.28 32.71 Favored Glycine 0 N--CA 1.495 2.593 0 O-C-N 124.206 0.941 . . . . 0.0 111.871 -176.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.42 -47.4 4.69 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 117.444 0.622 . . . . 0.0 112.65 -174.737 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -94.02 40.34 1.08 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.499 -171.463 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.39 152.05 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.484 -174.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -131.96 111.82 11.87 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.432 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 75.8 t80 -54.78 122.57 11.03 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.306 174.779 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.685 HD11 ' HB3' ' A' ' 7' ' ' GLN . 0.9 OUTLIER -94.42 -49.6 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 124.113 0.883 . . . . 0.0 110.783 -176.905 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.97 -168.45 41.55 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.912 -1.137 . . . . 0.0 112.696 175.235 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 CA-C-N 113.41 -1.395 . . . . 0.0 109.973 175.837 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.261 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -128.9 164.03 23.99 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 122.849 1.309 . . . . 0.0 113.832 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -141.12 154.7 46.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 111.398 -2.637 . . . . 0.0 107.338 -174.654 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -125.73 121.21 32.74 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.54 126.06 16.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 124.121 0.888 . . . . 0.0 110.935 168.771 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.38 -33.12 23.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.874 0.734 . . . . 0.0 111.017 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.88 157.59 44.26 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.928 0.767 . . . . 0.0 110.346 -174.514 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.89 116.95 19.53 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.26 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' CD2' HD12 ' A' ' 24' ' ' LEU . 5.3 t80 -121.19 133.78 55.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.449 1.093 . . . . 0.0 108.725 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.6 164.57 14.7 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.495 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -89.06 142.36 27.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.616 0.572 . . . . 0.0 109.803 -177.443 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.44 -12.45 5.0 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.96 177.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.91 143.12 51.37 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.336 178.546 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.98 -34.54 76.34 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.083 -178.846 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.69 -35.41 80.69 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.404 177.467 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -88.35 162.09 16.75 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.177 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.64 174.83 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.278 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.79 148.56 42.38 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.936 -177.147 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 14' ' ' TYR . 92.8 mt -133.24 141.28 47.95 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.093 0.87 . . . . 0.0 110.538 178.043 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.78 165.67 26.82 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.532 -171.31 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.7 mt -65.74 151.69 46.02 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.336 174.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.32 -9.4 4.33 Favored Glycine 0 N--CA 1.501 2.995 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.03 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -69.02 132.46 46.68 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.439 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mt -121.05 138.74 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 124.343 1.027 . . . . 0.0 108.629 176.158 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.438 HD23 ' CE1' ' A' ' 69' ' ' PHE . 10.9 mp -107.48 150.21 27.06 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 112.972 -1.922 . . . . 0.0 108.138 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 m -127.5 153.81 45.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.632 0.583 . . . . 0.0 109.992 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -131.29 175.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -176.508 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.794 0.807 . . . . 0.0 110.338 -178.15 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.71 23.32 9.54 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.393 -169.64 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.68 68.65 81.85 Favored Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.674 -176.138 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HG3' ' H ' ' A' ' 76' ' ' TYR . 5.5 Cg_exo -59.23 -23.91 71.7 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.46 2.107 . . . . 0.0 111.73 174.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -59.31 -49.17 78.84 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.285 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -90.09 -35.19 15.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 123.832 0.708 . . . . 0.0 110.909 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.4 mt -64.1 129.86 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 123.943 0.777 . . . . 0.0 109.64 172.122 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.46 -87.41 1.27 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -175.85 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -98.23 124.87 43.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.609 -1.296 . . . . 0.0 108.144 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.582 ' H ' HD23 ' A' ' 56' ' ' LEU . 1.4 pt? -132.65 144.67 50.5 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 173.686 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -92.87 147.84 22.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.594 1.184 . . . . 0.0 108.867 -176.066 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.86 154.13 25.25 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 175.604 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.46 122.49 32.7 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.062 -1.069 . . . . 0.0 108.487 176.376 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -96.47 69.66 2.61 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.977 0.894 . . . . 0.0 111.168 177.005 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -52.31 -26.76 12.96 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 113.754 -1.567 . . . . 0.0 112.458 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.4 p -51.67 -51.72 53.64 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.037 0.836 . . . . 0.0 112.782 174.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.6 p -91.6 2.28 56.56 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.228 176.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.86 30.37 77.81 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.615 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -129.34 178.32 6.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 124.506 0.768 . . . . 0.0 109.508 -178.44 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -144.51 147.66 33.52 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.506 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.17 -163.01 28.54 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 118.79 -1.671 . . . . 0.0 113.847 166.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.69 152.74 19.32 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 113.17 -1.515 . . . . 0.0 108.98 -178.192 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.438 ' CE1' HD23 ' A' ' 30' ' ' LEU . 24.4 p90 -154.36 152.74 26.88 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 123.654 0.596 . . . . 0.0 109.803 175.215 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -65.66 165.25 23.67 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 122.32 2.013 . . . . 0.0 112.007 176.494 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.55 -2.35 67.71 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 123.987 0.804 . . . . 0.0 111.57 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -96.34 -34.13 11.69 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.507 0.67 . . . . 0.0 109.833 -166.689 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -90.95 6.11 45.99 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.567 -1.652 . . . . 0.0 111.529 -174.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.34 -177.75 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 124.208 0.942 . . . . 0.0 109.046 -178.429 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.34 115.95 5.51 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.576 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' TYR . . . . . 0.404 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 32.2 t80 -49.4 128.91 18.03 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 166.182 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.67 -54.72 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 124.131 0.894 . . . . 0.0 109.721 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.94 171.92 36.36 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.681 -1.724 . . . . 0.0 110.502 -170.484 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.395 0 CA-C-N 113.732 -1.234 . . . . 0.0 109.404 168.673 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.171 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -136.73 162.01 34.38 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.848 0.833 . . . . 0.0 110.991 -169.31 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -129.64 170.75 13.4 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.587 -1.642 . . . . 0.0 107.341 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -133.89 116.65 15.87 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.477 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.14 112.03 0.98 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.301 1.0 . . . . 0.0 110.013 174.52 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.4 tp -70.07 -38.49 75.75 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.514 -177.594 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.61 170.83 15.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 124.582 1.176 . . . . 0.0 109.981 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.22 123.2 28.27 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.529 175.199 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CD2' HD12 ' A' ' 24' ' ' LEU . 8.5 t80 -118.83 134.25 55.29 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -89.74 159.12 17.23 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.047 175.635 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -88.3 141.09 28.83 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -176.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -121.32 -8.65 9.16 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.644 178.224 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -136.67 146.62 46.14 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.611 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -60.41 -31.01 69.98 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.166 174.549 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.58 -32.75 73.8 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.3 178.431 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.36 161.1 14.53 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.304 1.002 . . . . 0.0 110.107 177.942 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 pt -116.94 174.86 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 124.349 1.031 . . . . 0.0 111.545 176.298 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.52 141.95 46.73 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.125 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.5 HD12 ' CD2' ' A' ' 14' ' ' TYR . 18.0 mt -131.38 135.17 46.98 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.968 0.792 . . . . 0.0 111.534 178.279 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.31 176.52 8.62 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.247 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mp -72.47 154.53 40.81 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.937 -177.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.69 -5.57 2.33 Favored Glycine 0 N--CA 1.5 2.931 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.896 -176.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.64 101.13 0.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.233 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.95 135.96 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 124.274 0.984 . . . . 0.0 110.099 173.118 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 69' ' ' PHE . 11.1 mp -111.2 157.03 20.56 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.968 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.5 m -133.37 150.8 51.81 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.768 0.668 . . . . 0.0 110.407 -176.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.4 t -128.31 -151.93 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 123.841 0.713 . . . . 0.0 109.151 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.588 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.8 m-80 . . . . . 0 N--CA 1.493 1.717 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.869 178.059 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.45 -0.84 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.596 178.568 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -123.0 77.78 50.81 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 123.93 0.769 . . . . 0.0 109.557 -176.834 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.43 -18.83 15.73 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.888 2.392 . . . . 0.0 112.7 175.583 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -53.97 -42.62 69.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.087 0.867 . . . . 0.0 111.806 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -89.8 -29.6 18.53 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.1 0.875 . . . . 0.0 110.926 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 mt -73.54 136.7 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.82 -87.08 1.31 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -172.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -102.75 131.22 49.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.309 -1.445 . . . . 0.0 109.051 -178.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -114.5 138.31 50.76 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.233 173.958 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -108.29 124.33 50.15 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 173.221 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -151.14 176.87 29.46 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 120.079 -1.058 . . . . 0.0 112.006 177.829 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -110.52 131.24 55.22 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.149 -1.025 . . . . 0.0 109.275 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -103.43 102.82 12.75 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.682 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.11 -36.31 72.72 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.284 177.775 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.4 m -56.63 -28.49 60.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.494 1.121 . . . . 0.0 111.996 -177.502 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -116.9 -2.96 11.69 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.645 -176.602 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.15 19.81 32.95 Favored Glycine 0 N--CA 1.497 2.748 0 O-C-N 124.405 1.066 . . . . 0.0 111.37 -172.751 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.98 165.78 13.31 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -172.088 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.16 149.8 40.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.006 0.816 . . . . 0.0 109.68 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.72 -145.19 6.66 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.456 173.569 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.39 153.67 30.62 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.145 -1.027 . . . . 0.0 108.29 -173.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 31.1 p90 -157.01 143.55 13.26 Favored Pre-proline 0 N--CA 1.493 1.699 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.751 178.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.08 157.87 46.86 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 122.111 1.874 . . . . 0.0 112.043 176.064 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.94 43.62 1.92 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.92 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -134.0 -26.38 1.52 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 178.066 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -93.21 2.4 56.67 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.463 -177.945 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.42 -176.44 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 124.306 1.004 . . . . 0.0 109.227 -177.468 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -150.27 115.15 5.31 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.716 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -48.36 122.26 5.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.142 0.901 . . . . 0.0 109.343 171.138 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.97 -51.1 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.039 177.485 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -166.16 159.84 33.21 Favored Glycine 0 N--CA 1.485 1.911 0 C-N-CA 118.814 -1.66 . . . . 0.0 110.688 -178.868 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.478 ' H ' ' CD ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.473 0 CA-C-N 111.866 -2.167 . . . . 0.0 105.957 173.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.104 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -144.43 159.56 42.53 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 117.413 -1.715 . . . . 0.0 113.67 -174.535 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -146.31 143.96 29.49 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 112.345 -2.207 . . . . 0.0 107.439 -172.406 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -118.57 112.96 20.55 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -174.606 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.17 121.67 3.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.302 1.001 . . . . 0.0 109.983 175.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -79.8 -68.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.205 176.791 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.41 171.79 7.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.382 1.052 . . . . 0.0 109.924 -177.012 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.43 121.12 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.38 175.539 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD2' HD12 ' A' ' 24' ' ' LEU . 12.9 t80 -124.87 129.33 50.19 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.237 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -89.82 -170.33 2.77 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -88.33 144.89 26.13 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.039 175.221 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.39 -15.7 9.06 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.802 173.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -150.18 147.48 27.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.553 1.158 . . . . 0.0 108.796 -178.601 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.11 -11.31 0.67 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.033 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 18' ' ' ARG . 1.3 mm-40 -81.37 -44.68 17.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 124.212 0.945 . . . . 0.0 111.261 177.661 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.75 165.47 18.85 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.855 0.722 . . . . 0.0 109.334 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 177.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 122.507 1.146 . . . . 0.0 110.85 177.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -82.23 113.11 19.83 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 111.927 -2.397 . . . . 0.0 106.781 -178.323 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' A' ' 14' ' ' TYR . 61.6 mt -103.76 143.19 33.13 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.422 0.629 . . . . 0.0 111.769 179.288 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 172.15 15.72 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.271 -176.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.613 HD12 ' H ' ' A' ' 26' ' ' LEU . 6.5 mp -64.84 155.75 33.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.016 -177.457 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.19 -12.96 2.89 Favored Glycine 0 N--CA 1.504 3.187 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.476 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -76.58 113.89 14.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.205 0.591 . . . . 0.0 109.609 -175.737 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -96.91 149.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.246 0.546 . . . . 0.0 109.885 179.658 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.518 HD23 ' CE1' ' A' ' 69' ' ' PHE . 10.1 mp -124.47 145.91 49.25 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.228 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 m -127.1 125.63 41.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.165 0.916 . . . . 0.0 109.616 -177.351 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 33' ' ' ASN . 6.4 t -95.85 -124.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.951 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.411 ' N ' HG12 ' A' ' 32' ' ' VAL . 74.9 m-80 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -171.127 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.506 2.338 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 -11.89 55.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.1 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 82.37 48.52 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 124.219 0.949 . . . . 0.0 108.587 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.23 -10.68 26.77 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.118 1.879 . . . . 0.0 113.021 173.596 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.89 -36.73 79.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.719 0.637 . . . . 0.0 111.608 -176.037 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -91.4 -29.98 16.76 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.279 -176.217 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -71.6 149.82 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.222 177.07 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.4 -95.31 1.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -98.8 126.22 44.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.826 0.956 . . . . 0.0 110.061 -175.836 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.7 mp -98.29 145.09 27.01 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.429 174.252 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -104.54 125.92 51.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.2 0.937 . . . . 0.0 108.664 169.879 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.7 160.39 27.95 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.382 173.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.76 122.24 31.97 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.124 -1.038 . . . . 0.0 109.7 172.458 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -92.44 64.76 4.37 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.674 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -52.61 -31.2 35.27 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.006 -178.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.445 HG21 ' H ' ' A' ' 29' ' ' ILE . 37.6 p -53.89 -48.28 70.27 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.116 0.885 . . . . 0.0 111.49 179.142 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -89.74 -5.47 56.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.03 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.44 24.98 64.26 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 177.773 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -129.28 179.34 5.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.506 0.768 . . . . 0.0 109.144 -175.407 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -147.14 151.67 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.453 179.012 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.68 -161.08 33.2 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.2 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.96 162.18 15.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -170.866 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.518 ' CE1' HD23 ' A' ' 30' ' ' LEU . 23.4 p90 -160.65 148.47 12.69 Favored Pre-proline 0 N--CA 1.496 1.845 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.12 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.85 150.03 89.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.698 1.598 . . . . 0.0 111.209 177.568 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.04 48.09 2.22 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 175.23 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -146.71 8.16 0.98 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.819 0.364 . . . . 0.0 111.565 174.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.05 9.34 9.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.967 0.792 . . . . 0.0 111.473 -178.603 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 -171.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 124.016 0.823 . . . . 0.0 109.702 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HB2' HD23 ' A' ' 11' ' ' LEU . 10.0 tt0 -150.15 102.36 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.179 175.014 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -41.99 136.32 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.496 170.214 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.3 pt -139.57 -67.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 124.005 0.816 . . . . 0.0 110.604 -177.741 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.486 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -89.86 159.02 27.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -173.01 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? . . . . . 0 N--CA 1.489 1.49 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.88 -168.007 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.104 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -144.43 159.56 42.53 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 117.413 -1.715 . . . . 0.0 113.67 -174.535 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -146.31 143.96 29.49 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 112.345 -2.207 . . . . 0.0 107.439 -172.406 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -118.57 112.96 20.55 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -174.606 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.17 121.67 3.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.302 1.001 . . . . 0.0 109.983 175.071 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -79.8 -68.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.205 176.791 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.41 171.79 7.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.382 1.052 . . . . 0.0 109.924 -177.012 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.43 121.12 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.38 175.539 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD2' HD12 ' A' ' 24' ' ' LEU . 12.9 t80 -124.87 129.33 50.19 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.237 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -89.82 -170.33 2.77 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.69 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -88.33 144.89 26.13 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.039 175.221 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.39 -15.7 9.06 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.802 173.987 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -150.18 147.48 27.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.553 1.158 . . . . 0.0 108.796 -178.601 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.11 -11.31 0.67 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.033 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 18' ' ' ARG . 1.3 mm-40 -81.37 -44.68 17.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 124.212 0.945 . . . . 0.0 111.261 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.75 165.47 18.85 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.855 0.722 . . . . 0.0 109.334 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 177.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 122.507 1.146 . . . . 0.0 110.85 177.707 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -82.23 113.11 19.83 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 111.927 -2.397 . . . . 0.0 106.781 -178.323 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' A' ' 14' ' ' TYR . 61.6 mt -103.76 143.19 33.13 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.422 0.629 . . . . 0.0 111.769 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 172.15 15.72 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.271 -176.884 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.613 HD12 ' H ' ' A' ' 26' ' ' LEU . 6.5 mp -64.84 155.75 33.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.016 -177.457 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.19 -12.96 2.89 Favored Glycine 0 N--CA 1.504 3.187 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.476 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -76.58 113.89 14.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.205 0.591 . . . . 0.0 109.609 -175.737 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -96.91 149.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.246 0.546 . . . . 0.0 109.885 179.658 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.518 HD23 ' CE1' ' A' ' 69' ' ' PHE . 10.1 mp -124.47 145.91 49.25 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.228 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 m -127.1 125.63 41.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.165 0.916 . . . . 0.0 109.616 -177.351 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 33' ' ' ASN . 6.4 t -95.85 -124.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.951 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.411 ' N ' HG12 ' A' ' 32' ' ' VAL . 74.9 m-80 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -171.127 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.506 2.338 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 -11.89 55.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.1 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 82.37 48.52 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 124.219 0.949 . . . . 0.0 108.587 -177.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.23 -10.68 26.77 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.118 1.879 . . . . 0.0 113.021 173.596 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.89 -36.73 79.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.719 0.637 . . . . 0.0 111.608 -176.037 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -91.4 -29.98 16.76 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.279 -176.217 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -71.6 149.82 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.222 177.07 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.4 -95.31 1.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 177.232 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -98.8 126.22 44.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.826 0.956 . . . . 0.0 110.061 -175.836 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.7 mp -98.29 145.09 27.01 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.429 174.252 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -104.54 125.92 51.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.2 0.937 . . . . 0.0 108.664 169.879 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.7 160.39 27.95 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.382 173.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.76 122.24 31.97 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.124 -1.038 . . . . 0.0 109.7 172.458 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -92.44 64.76 4.37 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.674 176.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -52.61 -31.2 35.27 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.006 -178.012 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.445 HG21 ' H ' ' A' ' 29' ' ' ILE . 37.6 p -53.89 -48.28 70.27 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.116 0.885 . . . . 0.0 111.49 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -89.74 -5.47 56.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.03 177.163 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.44 24.98 64.26 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 177.773 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -129.28 179.34 5.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.506 0.768 . . . . 0.0 109.144 -175.407 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -147.14 151.67 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.453 179.012 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.68 -161.08 33.2 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.2 176.8 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.96 162.18 15.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -170.866 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' PHE . . . . . 0.518 ' CE1' HD23 ' A' ' 30' ' ' LEU . 23.4 p90 -160.65 148.47 12.69 Favored Pre-proline 0 N--CA 1.496 1.845 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.12 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.85 150.03 89.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.698 1.598 . . . . 0.0 111.209 177.568 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.04 48.09 2.22 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -146.71 8.16 0.98 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.819 0.364 . . . . 0.0 111.565 174.842 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.05 9.34 9.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.967 0.792 . . . . 0.0 111.473 -178.603 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 -171.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 124.016 0.823 . . . . 0.0 109.702 -173.043 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HB2' HD23 ' A' ' 11' ' ' LEU . 10.0 tt0 -150.15 102.36 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.179 175.014 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -41.99 136.32 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.496 170.214 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.3 pt -139.57 -67.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 124.005 0.816 . . . . 0.0 110.604 -177.741 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.486 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -89.86 159.02 27.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -173.01 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? . . . . . 0 N--CA 1.489 1.49 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.88 -168.007 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 6' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.377 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.547 ' HB3' HD11 ' A' ' 77' ' ' ILE . 70.0 mt-30 -133.38 160.31 37.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 124.038 0.836 . . . . 0.0 111.602 -177.996 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -138.35 162.04 35.4 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.078 -1.874 . . . . 0.0 108.05 -177.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -125.87 112.9 16.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.293 0.996 . . . . 0.0 108.738 -179.35 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.41 108.93 0.43 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.321 170.315 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.68 -14.41 32.3 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.15 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.38 141.46 41.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.308 1.005 . . . . 0.0 110.544 -179.176 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.59 115.32 17.26 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.182 171.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -125.96 136.15 52.67 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 124.323 1.015 . . . . 0.0 109.101 176.909 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -89.79 163.3 15.11 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.074 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -89.02 140.6 29.27 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.851 0.719 . . . . 0.0 109.514 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -89.74 -25.34 21.2 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.994 -179.356 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -150.2 162.22 40.88 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.363 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -52.52 -14.89 0.55 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.137 -1.392 . . . . 0.0 114.609 173.893 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -75.94 -42.8 47.63 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 123.61 0.569 . . . . 0.0 110.767 177.822 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.35 146.48 24.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.02 0.825 . . . . 0.0 110.161 177.418 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -99.03 173.14 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.058 175.832 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.36 140.6 37.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.644 -177.176 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -125.86 138.91 53.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.497 1.123 . . . . 0.0 109.277 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.04 -155.14 0.67 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.043 -171.911 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.8 mt -106.4 144.29 33.29 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.706 0.629 . . . . 0.0 111.12 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.09 6.6 5.71 Favored Glycine 0 N--CA 1.503 3.11 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.667 178.322 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.89 144.25 54.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 123.93 0.429 . . . . 0.0 110.498 173.728 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.618 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.3 mp -108.9 146.79 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 124.569 1.168 . . . . 0.0 107.933 -177.761 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.618 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.4 mp -128.57 129.04 45.4 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.747 172.021 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 97.0 m -106.5 152.32 23.82 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 124.269 0.981 . . . . 0.0 109.273 -178.919 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -131.67 -173.45 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 124.079 0.862 . . . . 0.0 109.115 -179.133 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.7 -178.388 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.503 2.193 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.99 -14.15 16.06 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.288 -178.444 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -112.04 94.46 25.48 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 124.197 0.936 . . . . 0.0 108.942 173.961 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.67 -20.9 53.03 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.266 1.977 . . . . 0.0 112.768 166.937 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -59.16 -36.6 75.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.898 0.749 . . . . 0.0 111.951 -175.014 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.75 -31.83 17.26 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 123.856 0.723 . . . . 0.0 109.241 -176.612 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.73 146.17 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 124.123 0.889 . . . . 0.0 110.144 175.324 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.84 -99.69 1.1 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.978 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -89.79 131.94 35.48 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.416 -0.892 . . . . 0.0 110.01 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -102.04 156.26 17.65 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.855 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -134.21 121.5 21.44 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.549 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.9 -162.38 17.1 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -176.773 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.73 130.01 31.38 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -172.821 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -93.63 68.1 3.98 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.182 -1.826 . . . . 0.0 108.856 174.346 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -43.05 -29.54 0.36 Allowed 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 114.538 -1.21 . . . . 0.0 114.023 175.709 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.489 HG21 ' H ' ' A' ' 29' ' ' ILE . 82.8 p -45.85 -51.02 13.67 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.426 1.079 . . . . 0.0 112.328 178.11 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -106.44 0.26 24.65 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.986 174.982 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.43 37.81 53.22 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 175.333 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -109.3 135.75 49.87 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.227 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -120.99 125.36 47.17 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 123.811 0.694 . . . . 0.0 110.469 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.77 -147.21 8.0 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 119.521 -1.323 . . . . 0.0 114.094 176.777 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.19 164.39 12.91 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 113.782 -1.209 . . . . 0.0 108.898 -177.01 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -163.83 140.87 5.54 Favored Pre-proline 0 N--CA 1.494 1.728 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.614 175.726 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' PRO . . . . . 0.408 ' HB2' HG22 ' A' ' 72' ' ' THR . 2.4 Cg_endo -59.7 155.96 40.1 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.389 2.06 . . . . 0.0 112.305 -177.694 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.86 47.95 1.83 Allowed Glycine 0 N--CA 1.497 2.704 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.704 179.547 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.689 HG23 ' CD1' ' A' ' 73' ' ' TYR . 5.5 t -147.27 -22.85 0.39 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 179.222 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' TYR . . . . . 0.689 ' CD1' HG23 ' A' ' 72' ' ' THR . 10.7 m-30 -89.89 -12.26 39.48 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 123.973 0.795 . . . . 0.0 110.488 -178.261 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.4 m -105.67 -173.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.291 -176.022 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.29 114.32 5.09 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.706 175.433 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -55.69 124.95 19.13 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.932 177.066 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.2 pt -98.97 -52.9 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 123.934 0.771 . . . . 0.0 110.421 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.1 163.64 32.92 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.643 -175.545 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 79' ' ' ARG . . . . . 0.548 ' HD2' ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-N 113.588 -1.306 . . . . 0.0 110.808 163.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 1.1 p 60.95 154.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 124.837 0.963 . . . . 0.0 113.049 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.0 mtt -104.82 9.49 34.84 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.172 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 p -146.37 172.61 13.24 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 120.97 0.414 . . . . 0.0 111.358 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.58 172.28 12.31 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.292 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -92.87 -71.19 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.724 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.47 -134.6 10.74 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 124.64 1.213 . . . . 0.0 110.153 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -97.73 161.53 13.71 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.531 ' HB3' HD11 ' A' ' 77' ' ' ILE . 30.1 mt-30 -139.4 159.1 42.95 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.506 -173.432 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -142.68 125.15 15.68 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.1 -1.863 . . . . 0.0 107.601 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -89.61 118.46 29.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.629 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.63 152.48 0.33 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.927 0.767 . . . . 0.0 112.788 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -113.29 -44.81 3.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.512 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.34 151.99 41.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.06 0.85 . . . . 0.0 110.799 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.01 116.37 7.76 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.257 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.2 t80 -117.99 138.1 52.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.125 0.891 . . . . 0.0 108.895 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.02 146.4 25.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.297 0.998 . . . . 0.0 109.921 174.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 164.53 14.94 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.176 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.62 -25.24 0.77 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.074 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -108.03 149.68 28.12 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.101 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.56 -12.25 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.531 170.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -81.76 -40.27 22.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 123.903 0.752 . . . . 0.0 111.187 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.77 156.22 19.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.114 0.884 . . . . 0.0 111.265 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.41 174.43 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.666 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -75.05 131.47 40.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.766 -174.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 14' ' ' TYR . 97.0 mt -121.56 127.46 50.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.587 1.179 . . . . 0.0 109.179 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.74 -173.62 2.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.268 0.98 . . . . 0.0 108.904 -175.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 26' ' ' LEU . 3.1 mp -83.12 156.53 23.23 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.423 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.12 0.03 1.0 Allowed Glycine 0 N--CA 1.5 2.955 0 O-C-N 123.872 0.732 . . . . 0.0 113.201 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.69 106.29 1.45 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 30' ' ' LEU . 5.6 mt -90.64 132.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.743 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.634 HD11 HD22 ' A' ' 60' ' ' ASN . 10.5 mp -108.52 151.52 25.98 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.064 -1.88 . . . . 0.0 109.013 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.8 m -129.43 147.43 51.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 123.842 0.714 . . . . 0.0 109.845 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.431 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -119.59 -147.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 123.807 0.692 . . . . 0.0 109.265 -178.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.431 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -97.77 158.12 15.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 123.419 0.449 . . . . 0.0 110.033 178.061 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -85.41 -27.27 25.89 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.033 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.48 32.99 0.41 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -152.29 49.08 0.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -60.0 -30.78 69.37 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.094 171.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 38' ' ' VAL . 14.5 t -46.02 -8.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 114.195 -1.366 . . . . 0.0 114.351 167.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -32.6 -36.46 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.273 0.983 . . . . 0.0 112.283 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.4 mt -92.72 -34.71 13.82 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.457 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.05 9.96 4.93 Favored Glycine 0 N--CA 1.499 2.838 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.361 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.11 167.18 22.33 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.968 -0.616 . . . . 0.0 110.213 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.38 6.81 0.67 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.841 0.829 . . . . 0.0 112.392 172.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -177.19 106.65 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.356 -1.747 . . . . 0.0 108.08 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.25 -6.02 0.32 Allowed Glycine 0 N--CA 1.497 2.728 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 46.15 91.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.064 0.935 . . . . 0.0 111.246 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.61 -14.14 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 113.407 -1.724 . . . . 0.0 113.349 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -86.96 -37.86 17.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -102.31 102.97 27.94 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.999 0.812 . . . . 0.0 111.325 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -68.6 -17.99 42.92 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.641 2.227 . . . . 0.0 114.092 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.53 -31.67 68.14 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.657 0.598 . . . . 0.0 112.246 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.32 -21.89 21.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.831 0.707 . . . . 0.0 111.376 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.12 146.91 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -91.56 1.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -90.19 131.04 36.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.425 -1.388 . . . . 0.0 109.032 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -108.46 126.82 53.32 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -100.94 124.23 46.33 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.77 -166.18 16.67 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -140.17 150.19 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.634 HD22 HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -114.23 99.87 7.93 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.274 -177.124 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.81 -21.49 66.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.3 m -46.05 -37.42 6.7 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.812 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.61 2.46 6.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.849 1.343 . . . . 0.0 108.877 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.64 36.87 73.33 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.614 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -109.51 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.51 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 156.05 40.99 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.767 0.794 . . . . 0.0 111.699 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.66 -153.05 23.3 Favored Glycine 0 N--CA 1.489 2.197 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.032 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.71 153.94 24.57 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.6 p90 -151.36 140.77 13.95 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.912 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HB2' HG22 ' A' ' 72' ' ' THR . 1.3 Cg_endo -65.15 150.39 87.74 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.53 1.486 . . . . 0.0 110.708 175.672 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.29 48.72 4.08 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 70' ' ' PRO . 7.6 t -141.21 16.39 2.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.105 0.532 . . . . 0.0 111.616 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -136.05 -4.08 2.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 123.751 0.657 . . . . 0.0 111.847 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.98 -169.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 123.932 0.77 . . . . 0.0 109.13 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.71 113.58 5.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 25.2 t80 -48.27 142.97 4.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.442 171.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.5 pt -122.24 -53.5 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 123.926 0.766 . . . . 0.0 111.688 176.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.84 146.63 15.79 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.478 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 119.58 23.21 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.311 -1.444 . . . . 0.0 109.988 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -177.84 162.32 1.69 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.383 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -66.91 84.82 0.12 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.978 171.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.4 mt -89.92 130.01 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.659 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.77 161.45 46.19 Favored Pre-proline 0 N--CA 1.5 2.059 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.032 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.185 0 C-N-CA 121.739 1.626 . . . . 0.0 111.566 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 60.1 m -58.41 -19.34 35.32 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 26.0 tpp 64.46 43.91 4.35 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.663 0.744 . . . . 0.0 110.678 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.38 170.12 22.09 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.891 -173.033 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.74 153.74 43.23 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.554 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -99.55 40.15 1.25 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.187 0.994 . . . . 0.0 110.584 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.69 -162.99 29.25 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.648 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.33 145.9 24.26 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.44 -0.88 . . . . 0.0 109.621 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 80.6 mt-30 -125.09 161.29 27.11 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.563 1.164 . . . . 0.0 113.673 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -139.3 154.68 47.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.167 -2.288 . . . . 0.0 106.711 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 -123.33 121.54 36.08 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.93 145.75 12.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.266 0.979 . . . . 0.0 111.433 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tp -107.4 -41.36 5.1 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.839 -176.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.93 152.55 43.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.264 0.977 . . . . 0.0 110.242 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.21 123.04 18.49 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.577 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.419 ' CD1' HD12 ' A' ' 24' ' ' LEU . 4.0 t80 -123.09 136.8 54.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.504 1.127 . . . . 0.0 109.076 174.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -94.61 151.7 19.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 124.294 0.996 . . . . 0.0 109.32 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.49 131.39 35.55 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 123.921 0.763 . . . . 0.0 110.311 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -110.1 -11.22 14.63 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 124.183 0.927 . . . . 0.0 110.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -120.6 146.26 46.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.327 1.017 . . . . 0.0 109.424 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.38 -19.12 63.08 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.758 172.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.3 -19.81 38.7 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.099 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.38 164.67 12.01 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 123.874 0.734 . . . . 0.0 110.757 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 pt -124.58 168.86 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.556 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.52 136.24 40.6 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.494 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.419 HD12 ' CD1' ' A' ' 14' ' ' TYR . 90.7 mt -125.94 135.16 51.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.206 0.941 . . . . 0.0 110.674 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -175.86 3.95 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.43 -173.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mt -84.74 158.31 20.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 123.534 0.521 . . . . 0.0 110.781 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.0 -6.15 1.06 Allowed Glycine 0 N--CA 1.503 3.157 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.676 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.97 110.57 11.71 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -176.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.441 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.2 mt -93.96 138.65 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.856 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 30' ' ' LEU . 9.8 mp -105.75 148.32 27.6 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.702 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 m -126.7 147.34 49.96 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 124.033 0.833 . . . . 0.0 109.177 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -120.37 -154.99 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.286 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.454 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -82.26 -179.43 7.41 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.52 172.122 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.2 -37.67 3.03 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.299 -1.773 . . . . 0.0 110.259 -164.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.47 41.94 0.58 Allowed Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 p -150.88 69.69 0.97 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mt -51.77 -22.62 3.75 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 111.792 -2.458 . . . . 0.0 113.705 170.003 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 t -61.33 -9.66 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.351 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.67 -25.56 1.84 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.557 166.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.423 HD21 ' H ' ' A' ' 57' ' ' ASN . 20.9 mt -118.16 -7.37 10.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 123.953 0.783 . . . . 0.0 109.42 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.84 25.6 69.09 Favored Glycine 0 N--CA 1.494 2.518 0 O-C-N 124.253 0.971 . . . . 0.0 112.108 -171.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -91.49 153.08 20.04 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.846 -176.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 t -149.71 34.25 0.69 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.139 0.899 . . . . 0.0 110.588 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.5 -55.68 2.68 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.748 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.16 9.83 56.63 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 124.628 1.205 . . . . 0.0 112.127 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.407 HE22 ' CD ' ' A' ' 52' ' ' GLU . 4.3 tt0 -67.03 -72.15 0.18 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.372 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 49.8 62.54 2.59 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 123.843 0.714 . . . . 0.0 109.993 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -176.9 -22.85 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.31 80.63 29.02 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 123.885 0.741 . . . . 0.0 109.113 177.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.15 -22.51 40.27 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.872 2.381 . . . . 0.0 111.938 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -50.16 -41.41 49.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.766 1.292 . . . . 0.0 112.238 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.407 ' CD ' HE22 ' A' ' 46' ' ' GLN . 4.7 pt-20 -93.63 -29.32 15.51 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 123.87 0.731 . . . . 0.0 111.463 178.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.8 mt -64.72 146.33 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.739 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.37 -96.5 1.07 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -98.32 128.58 44.81 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.246 -0.977 . . . . 0.0 110.35 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.5 mp -107.18 136.26 47.31 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.423 ' H ' HD21 ' A' ' 40' ' ' LEU . 56.1 t30 -104.97 125.7 51.24 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.04 -164.67 13.55 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -137.27 147.04 45.43 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.131 -0.534 . . . . 0.0 110.749 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -101.1 100.31 10.87 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.9 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -54.51 -39.26 67.43 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 123.743 0.652 . . . . 0.0 111.97 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 96.9 m -52.22 -42.03 63.23 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 124.222 0.951 . . . . 0.0 112.142 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 p -105.28 0.35 27.05 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.343 1.027 . . . . 0.0 110.598 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.96 24.04 13.09 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 124.155 0.91 . . . . 0.0 112.667 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.53 166.48 12.5 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -174.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.7 ttm-85 -148.1 125.64 11.72 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.33 -162.83 26.66 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.978 -1.106 . . . . 0.0 111.173 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.93 153.79 21.48 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.696 -0.752 . . . . 0.0 109.15 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 34.9 p90 -151.24 147.83 21.28 Favored Pre-proline 0 N--CA 1.493 1.695 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.684 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.19 156.28 60.28 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.424 2.083 . . . . 0.0 112.0 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.01 44.2 1.84 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.6 t -134.43 -17.31 2.04 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.656 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.78 0.87 39.59 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.265 0.978 . . . . 0.0 111.696 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.92 -179.0 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 123.756 0.66 . . . . 0.0 109.459 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -149.18 106.53 3.62 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.046 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.475 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 77.6 t80 -43.65 128.44 5.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.097 169.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 pt -126.2 -58.26 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 124.019 0.824 . . . . 0.0 111.419 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.63 156.38 20.99 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -162.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.23 154.34 36.64 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.914 0.864 . . . . 0.0 112.152 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -62.69 177.15 0.57 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 113.065 -1.88 . . . . 0.0 113.093 160.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -81.61 28.31 0.41 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.466 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.7 tt -90.82 -5.15 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.766 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.1 t -138.25 72.47 45.44 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 123.939 0.774 . . . . 0.0 109.752 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.489 1.262 0 C-N-CA 122.369 2.046 . . . . 0.0 112.205 171.288 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 11.0 p -157.7 117.59 3.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 123.786 0.345 . . . . 0.0 110.13 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 1.6 mpp? -100.91 156.33 17.44 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 123.925 0.766 . . . . 0.0 109.252 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.77 170.33 0.08 Allowed 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -172.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.28 135.92 3.82 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.02 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -94.43 92.01 6.93 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.618 0.723 . . . . 0.0 110.003 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 147.78 -169.27 28.62 Favored Glycine 0 N--CA 1.498 2.77 0 CA-C-N 113.974 -1.467 . . . . 0.0 112.076 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.42 149.58 21.23 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 114.311 -0.944 . . . . 0.0 108.663 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.432 ' HB3' HD11 ' A' ' 77' ' ' ILE . 6.4 mt-30 -128.44 162.07 28.02 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.234 1.016 . . . . 0.0 112.488 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.42 165.32 27.76 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 112.416 -2.174 . . . . 0.0 107.835 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -128.03 115.13 18.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.949 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.48 116.4 3.07 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 123.889 0.743 . . . . 0.0 111.175 173.249 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tp -76.91 -33.1 57.78 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.949 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -141.25 143.02 33.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 124.296 0.997 . . . . 0.0 109.853 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.18 104.3 0.57 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.083 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.408 ' HD2' HD12 ' A' ' 24' ' ' LEU . 76.2 t80 -101.21 130.57 47.35 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -89.48 163.77 15.1 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 138.64 31.25 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -131.31 -19.33 2.79 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.74 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -123.64 151.26 43.22 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.864 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -63.19 -20.26 65.26 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.286 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -26.97 21.18 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.725 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.39 153.42 20.87 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.376 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -121.22 -173.67 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 124.511 1.132 . . . . 0.0 111.097 -179.199 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASP . . . . . 0.412 ' H ' HG22 ' A' ' 22' ' ' ILE . 3.5 m-20 -87.47 120.53 28.87 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 112.533 -2.121 . . . . 0.0 107.678 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.408 HD12 ' HD2' ' A' ' 14' ' ' TYR . 5.2 mt -117.37 119.99 36.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.159 0.912 . . . . 0.0 108.916 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.95 -170.36 1.78 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 124.561 1.163 . . . . 0.0 109.523 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.1 mt -84.99 156.1 21.29 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.478 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.99 9.16 2.68 Favored Glycine 0 N--CA 1.502 3.085 0 O-C-N 124.101 0.875 . . . . 0.0 113.074 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' CG ' HG21 ' A' ' 62' ' ' THR . 3.4 m-20 -71.45 125.17 26.33 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.358 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mp -96.37 146.91 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 124.198 0.936 . . . . 0.0 109.021 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.599 HD23 ' CE1' ' A' ' 69' ' ' PHE . 7.3 mp -115.46 161.53 18.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 112.442 -2.163 . . . . 0.0 110.911 174.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.6 m -131.31 153.95 49.05 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.748 1.28 . . . . 0.0 108.329 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.658 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.1 t -130.03 -150.5 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.658 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -80.07 178.07 8.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.583 0.552 . . . . 0.0 110.889 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 82' ' ' ILE . 7.9 pttp -120.95 -34.03 3.62 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.077 -171.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.12 34.6 0.78 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -150.07 58.56 0.97 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.483 ' C ' HD12 ' A' ' 37' ' ' LEU . 4.5 pp -61.49 -18.94 61.29 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 113.08 -1.873 . . . . 0.0 113.565 165.184 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.447 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.8 t -56.85 -9.25 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-N 115.305 -0.861 . . . . 0.0 113.084 167.049 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.99 -35.35 0.36 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.908 1.38 . . . . 0.0 111.57 171.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.2 mp -111.52 -15.23 13.56 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.339 1.025 . . . . 0.0 111.916 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.71 31.19 13.27 Favored Glycine 0 N--CA 1.502 3.055 0 O-C-N 124.167 0.917 . . . . 0.0 112.301 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.76 148.8 15.72 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 113.942 -1.129 . . . . 0.0 113.013 174.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -139.67 37.84 2.01 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.78 -172.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.07 -50.58 0.26 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.34 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.74 88.07 0.11 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -130.11 -60.93 1.0 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -173.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 47.68 40.5 12.08 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 124.642 1.214 . . . . 0.0 111.915 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.48 0.57 0.2 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.006 -173.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -128.93 69.7 80.83 Favored Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 123.606 0.566 . . . . 0.0 111.266 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.93 -4.87 4.04 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.639 2.226 . . . . 0.0 113.67 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.51 -45.5 53.46 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 123.732 0.645 . . . . 0.0 110.756 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -92.47 -28.94 16.51 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 124.057 0.848 . . . . 0.0 111.141 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.7 mt -65.02 143.37 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 123.766 0.666 . . . . 0.0 109.741 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.42 -99.91 1.05 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -89.62 144.59 25.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.492 0.76 . . . . 0.0 110.467 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.2 mp -122.5 130.1 52.69 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.329 170.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.516 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -91.27 121.69 33.24 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.03 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.38 177.7 25.48 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 120.048 -1.072 . . . . 0.0 113.008 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.69 123.63 45.99 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 113.559 -1.32 . . . . 0.0 109.226 174.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.433 HD21 HD11 ' A' ' 30' ' ' LEU . 29.5 t-20 -89.47 80.78 6.67 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.42 1.105 . . . . 0.0 108.506 170.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -49.48 -24.95 2.28 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.961 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.429 HG21 ' CG ' ' A' ' 28' ' ' ASP . 18.1 m -53.13 -41.55 65.18 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.19 0.931 . . . . 0.0 112.075 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.8 p -119.41 6.3 11.13 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.428 1.08 . . . . 0.0 109.161 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.87 60.12 8.57 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 124.283 0.989 . . . . 0.0 111.12 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -139.74 160.67 39.35 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.406 0.709 . . . . 0.0 109.999 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -116.25 140.28 49.48 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.96 -155.5 17.34 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.343 -1.408 . . . . 0.0 111.994 164.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.22 166.43 10.64 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.695 -1.252 . . . . 0.0 110.151 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.599 ' CE1' HD23 ' A' ' 30' ' ' LEU . 21.9 p90 -161.89 145.59 9.43 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.889 170.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.24 154.12 75.39 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.233 1.955 . . . . 0.0 113.169 173.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.21 -16.82 63.91 Favored Glycine 0 N--CA 1.499 2.873 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.265 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.4 p -75.8 -14.11 60.3 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 122.245 0.218 . . . . 0.0 111.522 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.28 3.61 35.64 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 123.998 0.811 . . . . 0.0 111.658 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.89 -178.6 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 123.878 0.736 . . . . 0.0 109.237 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -147.79 111.35 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -51.28 140.92 15.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 123.753 0.658 . . . . 0.0 109.603 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.1 pt -118.99 -56.47 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 124.431 1.082 . . . . 0.0 110.472 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.04 147.74 17.17 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.705 -1.236 . . . . 0.0 111.151 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 125.0 32.24 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 112.856 -1.672 . . . . 0.0 109.128 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -78.12 138.16 38.58 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.446 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -73.69 77.38 1.54 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.714 1.259 . . . . 0.0 109.893 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.451 HG21 ' HB2' ' A' ' 34' ' ' LYS . 43.5 mt -94.63 91.28 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.361 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.72 159.41 48.71 Favored Pre-proline 0 N--CA 1.505 2.288 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.072 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 C-N-CA 121.825 1.683 . . . . 0.0 111.206 178.487 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 CA-C-O 121.479 0.489 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 5.3 p -171.74 129.09 0.65 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.019 -1.091 . . . . 0.0 109.454 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 1.7 mmt -56.31 -38.41 71.25 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 124.039 0.837 . . . . 0.0 111.116 174.175 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -84.47 -170.39 3.08 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.992 0.808 . . . . 0.0 110.677 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.33 150.64 45.61 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.968 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -143.15 91.82 2.32 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.447 173.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 82' ' ' ILE . . . -120.08 165.25 13.62 Favored Glycine 0 N--CA 1.497 2.743 0 O-C-N 124.662 1.226 . . . . 0.0 111.3 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.92 152.05 51.95 Favored 'General case' 0 N--CA 1.512 2.652 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 -152.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.586 ' HB3' HD11 ' A' ' 77' ' ' ILE . 26.1 mt-30 -128.98 168.49 15.94 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.376 1.084 . . . . 0.0 111.705 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -143.51 123.15 13.29 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 112.275 -2.239 . . . . 0.0 105.563 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -89.39 122.04 32.23 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.76 146.28 10.77 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 123.642 0.589 . . . . 0.0 110.734 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 tp -114.92 -28.79 6.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 124.115 0.884 . . . . 0.0 110.43 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 156.77 48.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 123.954 0.784 . . . . 0.0 110.831 -174.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.39 103.57 16.24 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.596 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.549 ' HD2' HD12 ' A' ' 24' ' ' LEU . 10.4 t80 -110.55 133.26 53.46 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -89.43 158.69 17.63 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 139.68 30.24 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.591 -0.843 . . . . 0.0 110.173 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -128.99 -13.6 4.54 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.192 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.78 140.87 36.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 124.217 0.948 . . . . 0.0 109.322 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.84 -21.84 3.22 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.379 -1.282 . . . . 0.0 114.044 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -59.48 -57.76 11.58 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.799 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -83.29 174.05 11.06 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.053 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.0 pt -129.48 177.05 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 124.267 0.979 . . . . 0.0 111.674 175.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.83 136.75 47.14 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.473 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.549 HD12 ' HD2' ' A' ' 14' ' ' TYR . 15.5 mt -126.38 133.19 51.38 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 123.973 0.795 . . . . 0.0 111.159 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.485 ' NE2' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -145.26 170.65 15.88 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.343 1.027 . . . . 0.0 110.695 -176.367 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mt -66.8 151.09 48.15 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 123.481 0.488 . . . . 0.0 110.413 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.9 -9.83 3.51 Favored Glycine 0 N--CA 1.501 2.976 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.036 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.86 108.05 7.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.539 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -89.8 152.34 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 115.437 -0.802 . . . . 0.0 108.882 176.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.539 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.2 mp -129.19 127.54 41.54 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.6 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.9 m -107.23 140.28 40.35 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.394 1.058 . . . . 0.0 108.961 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.5 -136.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 124.443 1.089 . . . . 0.0 108.725 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -109.27 -157.52 0.62 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 123.871 0.732 . . . . 0.0 109.441 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -137.61 -0.69 2.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 124.663 1.227 . . . . 0.0 111.051 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.69 -50.68 63.31 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 153.65 -53.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 126.061 1.683 . . . . 0.0 106.626 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -176.97 -21.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.535 -1.666 . . . . 0.0 111.487 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.572 ' N ' HD12 ' A' ' 37' ' ' LEU . 5.2 t -65.1 -17.83 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 CA-C-O 121.174 0.511 . . . . 0.0 111.422 173.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.426 ' C ' HD12 ' A' ' 40' ' ' LEU . . . -49.35 -27.86 4.4 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.307 167.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.426 HD12 ' C ' ' A' ' 39' ' ' ALA . 10.3 mp -105.1 -13.18 15.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.127 0.892 . . . . 0.0 111.269 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.4 27.21 8.77 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 124.195 0.935 . . . . 0.0 111.377 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.414 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 4.7 m-85 -95.34 168.59 10.63 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.34 -0.93 . . . . 0.0 111.956 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -147.69 112.13 5.27 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 113.72 -1.582 . . . . 0.0 107.301 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.1 t70 43.27 90.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.618 1.199 . . . . 0.0 113.751 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.69 -7.41 1.86 Allowed Glycine 0 N--CA 1.495 2.621 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.759 -171.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 51.77 98.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.043 0.937 . . . . 0.0 110.123 -170.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.92 -24.63 0.43 Allowed 'General case' 0 N--CA 1.511 2.598 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 175.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.18 10.25 20.07 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.472 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -129.0 77.46 77.9 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.25 -18.22 50.93 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.411 2.074 . . . . 0.0 112.828 170.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -53.42 -41.47 66.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.125 0.891 . . . . 0.0 111.901 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.61 -26.36 20.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.053 0.846 . . . . 0.0 110.689 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.414 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 22.3 mt -79.97 139.17 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 123.961 0.788 . . . . 0.0 109.287 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -93.06 1.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -95.92 120.25 35.87 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 113.708 -1.246 . . . . 0.0 109.169 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.9 mp -96.76 136.26 37.56 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 170.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 61.1 t30 -98.63 123.44 42.82 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.33 -178.39 27.84 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -133.8 144.12 48.8 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.762 0.33 . . . . 0.0 111.18 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -102.24 98.52 8.65 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.166 175.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -57.75 -29.21 64.6 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.343 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.0 m -53.05 -43.51 66.72 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 123.905 0.753 . . . . 0.0 112.143 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.485 HG21 ' NE2' ' A' ' 25' ' ' HIS . 22.3 p -102.64 -4.1 25.66 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 124.274 0.984 . . . . 0.0 110.187 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.14 28.4 61.29 Favored Glycine 0 N--CA 1.493 2.435 0 O-C-N 124.149 0.906 . . . . 0.0 111.926 -172.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -104.17 155.72 18.48 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -143.11 137.57 29.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.065 0.853 . . . . 0.0 110.186 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.32 -155.06 21.73 Favored Glycine 0 N--CA 1.492 2.399 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.429 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.81 153.26 22.74 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.233 -0.983 . . . . 0.0 108.866 -174.32 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 32.9 p90 -147.95 148.86 31.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.799 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.14 158.12 41.08 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.985 1.79 . . . . 0.0 111.92 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.99 53.6 0.63 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -151.38 -15.89 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.049 0.499 . . . . 0.0 112.108 174.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -94.87 -4.81 46.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 123.977 0.798 . . . . 0.0 112.324 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.4 m -109.64 -166.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 123.954 0.784 . . . . 0.0 109.253 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.28 113.15 5.11 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -48.75 128.34 15.27 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.783 165.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.5 pt -114.7 -84.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 124.36 1.038 . . . . 0.0 110.4 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.83 161.13 13.1 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -171.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.69 22.03 14.45 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.939 0.876 . . . . 0.0 112.635 -177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.18 27.99 0.11 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 123.194 1.473 . . . . 0.0 109.273 -174.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.5 17.46 2.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 112.041 -2.345 . . . . 0.0 112.318 175.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 5' ' ' GLY . 0.9 OUTLIER -89.25 134.31 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 152.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.07 166.37 15.34 Favored Pre-proline 0 N--CA 1.511 2.596 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.067 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.493 1.456 0 C-N-CA 122.043 1.828 . . . . 0.0 112.337 175.112 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 CA-C-O 119.935 -0.37 . . . . 0.0 112.916 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 8.1 t -82.35 -27.59 32.09 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.845 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 0.0 OUTLIER 72.47 -31.07 0.22 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 124.551 1.157 . . . . 0.0 113.145 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.3 t -155.36 141.74 18.62 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.98 112.48 10.15 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.366 -0.933 . . . . 0.0 109.249 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -131.24 96.86 4.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.601 164.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.91 -146.87 0.04 OUTLIER Glycine 0 N--CA 1.494 2.552 0 CA-C-N 113.244 -1.798 . . . . 0.0 112.832 167.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.88 150.76 20.38 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -174.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -126.16 163.26 23.51 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.21 0.943 . . . . 0.0 111.363 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -139.1 160.12 40.55 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.543 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -126.63 118.72 25.38 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -174.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.83 130.77 38.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.857 0.723 . . . . 0.0 110.73 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -85.38 -45.89 11.46 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.226 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -143.23 156.67 44.8 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.395 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.17 111.68 1.82 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.442 173.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' CD2' HD12 ' A' ' 24' ' ' LEU . 6.3 t80 -120.93 133.39 55.28 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.973 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -90.1 161.75 15.64 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -89.68 147.55 23.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.839 0.712 . . . . 0.0 111.548 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -117.62 -4.53 11.22 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.3 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -146.57 148.84 32.55 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -52.68 -22.59 5.32 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.076 172.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -69.66 -45.56 68.13 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.235 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.38 158.18 16.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 123.965 0.791 . . . . 0.0 109.005 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 pt -115.16 170.68 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 124.185 0.928 . . . . 0.0 111.792 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.71 136.61 38.2 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.257 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.466 HD12 ' CD2' ' A' ' 14' ' ' TYR . 88.5 mt -125.46 133.37 52.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.345 1.028 . . . . 0.0 109.917 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.57 -167.88 1.59 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.686 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -89.22 157.98 18.04 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.627 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 58.7 1.71 0.92 Allowed Glycine 0 N--CA 1.505 3.244 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.39 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.28 108.54 9.29 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.77 -0.715 . . . . 0.0 110.972 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.525 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.4 tp -90.51 149.65 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.033 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 29' ' ' ILE . 10.0 mp -119.07 151.85 37.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.3 m -132.89 146.52 51.87 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.015 0.822 . . . . 0.0 109.627 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.5 t -128.95 -157.39 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.644 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -74.31 179.39 4.57 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.782 174.368 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -114.96 -38.88 3.79 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.909 -172.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.57 41.72 0.74 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -175.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.0 t -147.62 69.66 1.15 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.12 -19.34 1.1 Allowed 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.243 -2.253 . . . . 0.0 111.788 167.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.78 -17.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 123.797 0.686 . . . . 0.0 111.687 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.29 -20.82 4.66 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 123.947 0.779 . . . . 0.0 112.63 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 57' ' ' ASN . 42.3 mt -129.37 5.39 5.21 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.21 30.07 72.9 Favored Glycine 0 N--CA 1.497 2.708 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.04 -170.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.81 169.01 16.59 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.325 -0.938 . . . . 0.0 109.86 -170.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.3 p -137.59 -157.07 0.74 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.99 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.66 93.8 0.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.24 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -125.17 -109.17 1.75 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -154.53 -38.64 0.09 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.354 0.679 . . . . 0.0 110.263 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 54.27 57.32 5.98 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 124.301 1.001 . . . . 0.0 110.452 -177.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -164.35 -11.35 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.361 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' H ' ' H ' ' A' ' 48' ' ' ALA . 18.9 mttp -122.25 82.39 45.39 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 124.502 1.126 . . . . 0.0 109.344 177.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -52.8 -20.0 12.02 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.589 2.193 . . . . 0.0 112.054 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.77 -43.17 80.55 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.936 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.01 -29.11 18.64 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 123.632 0.582 . . . . 0.0 111.485 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 mt -66.25 145.4 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.49 -73.29 1.27 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -127.95 133.75 49.25 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.561 -1.82 . . . . 0.0 107.932 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.66 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -127.2 144.46 51.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.176 0.922 . . . . 0.0 109.172 174.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.514 ' H ' HD22 ' A' ' 40' ' ' LEU . 5.2 t-20 -89.47 145.58 25.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.633 1.208 . . . . 0.0 107.839 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.81 179.7 42.6 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 173.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -128.91 142.12 51.05 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.886 -0.657 . . . . 0.0 109.808 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.03 82.73 1.75 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 125.176 1.547 . . . . 0.0 109.528 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -27.1 49.28 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.776 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.0 m -52.12 -42.68 63.5 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 123.924 0.765 . . . . 0.0 111.562 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -109.12 -3.51 17.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.799 1.312 . . . . 0.0 109.758 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.77 65.7 2.91 Favored Glycine 0 N--CA 1.493 2.447 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.049 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -137.23 162.05 34.54 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.314 0.655 . . . . 0.0 110.247 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -148.15 131.04 16.14 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.383 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.46 -163.42 36.59 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.506 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -102.87 152.44 21.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.488 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 41.2 p90 -148.02 152.27 39.72 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.413 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -66.6 151.23 83.24 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.071 1.847 . . . . 0.0 112.24 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.36 19.79 29.94 Favored Glycine 0 N--CA 1.496 2.697 0 O-C-N 124.093 0.871 . . . . 0.0 112.006 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.83 -35.18 6.24 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.311 0.577 . . . . 0.0 110.911 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -90.21 8.37 33.45 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.479 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.2 m -125.87 179.42 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 123.628 0.58 . . . . 0.0 110.263 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -150.06 106.41 3.49 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.713 0.768 . . . . 0.0 110.262 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 80.0 t80 -44.64 126.16 5.34 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.244 -1.343 . . . . 0.0 111.253 167.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.407 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -115.13 -62.25 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 123.969 0.793 . . . . 0.0 110.889 -177.881 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.407 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -139.94 161.5 26.32 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -161.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -160.75 105.47 1.4 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.583 -1.308 . . . . 0.0 109.139 -171.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -72.34 89.51 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -53.96 106.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.34 -2.209 . . . . 0.0 109.012 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.84 15.06 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.052 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.28 150.92 32.82 Favored Pre-proline 0 N--CA 1.492 1.646 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.878 175.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 C-N-CA 121.982 1.788 . . . . 0.0 112.068 172.464 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.1 OUTLIER -64.05 135.15 56.17 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.202 -0.499 . . . . 0.0 110.745 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.7 mmm -52.96 -27.51 19.38 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 124.278 0.986 . . . . 0.0 111.749 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.6 p -157.65 140.66 15.12 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.113 0.883 . . . . 0.0 108.935 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.51 179.2 1.06 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.687 0.617 . . . . 0.0 111.526 171.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.64 -28.48 21.6 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.613 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.23 -133.2 37.98 Favored Glycine 0 N--CA 1.495 2.593 0 O-C-N 124.528 1.143 . . . . 0.0 112.753 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.65 159.25 15.04 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.433 -0.883 . . . . 0.0 109.699 168.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.509 ' HB3' HD11 ' A' ' 77' ' ' ILE . 30.9 mt-30 -134.11 158.92 42.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.006 0.817 . . . . 0.0 111.589 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -138.58 138.62 38.1 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.811 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -94.47 121.88 36.46 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.115 0.884 . . . . 0.0 109.894 171.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.84 119.87 6.94 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.848 167.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.02 -57.89 3.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.603 0.564 . . . . 0.0 109.889 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.97 156.98 25.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.38 1.05 . . . . 0.0 109.919 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.92 134.3 51.74 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.985 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -132.71 128.47 37.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 124.361 1.038 . . . . 0.0 110.208 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -89.58 168.25 12.3 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.662 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 145.95 25.06 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.311 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.87 -3.62 8.65 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.481 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -143.42 145.05 32.31 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.024 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.47 -15.14 2.42 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 114.981 -1.008 . . . . 0.0 113.29 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -74.64 -46.47 37.99 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.558 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 152.31 22.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.083 0.864 . . . . 0.0 109.893 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.59 -170.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 124.472 1.108 . . . . 0.0 109.577 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -95.19 106.34 18.35 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.52 -1.673 . . . . 0.0 108.715 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 24' ' ' LEU . 1.8 mm? -88.98 143.14 27.06 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.646 172.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.422 ' NE2' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -135.52 -173.19 3.28 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.21 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mt -78.25 150.92 33.32 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.019 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.07 -3.47 1.61 Allowed Glycine 0 N--CA 1.506 3.347 0 O-C-N 123.413 0.446 . . . . 0.0 113.588 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.26 116.48 8.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 123.928 0.428 . . . . 0.0 109.95 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.502 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.0 mt -102.3 139.12 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.768 0.794 . . . . 0.0 110.019 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.502 HD12 ' C ' ' A' ' 29' ' ' ILE . 10.2 mp -117.67 162.19 18.45 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 112.909 -1.951 . . . . 0.0 109.454 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.85 147.68 49.95 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 124.036 0.835 . . . . 0.0 108.833 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -121.7 -169.24 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 123.53 0.519 . . . . 0.0 109.829 178.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.503 ' H ' HG12 ' A' ' 32' ' ' VAL . 7.0 m120 -99.88 136.66 39.47 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.285 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 -38.82 8.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.706 1.254 . . . . 0.0 110.783 177.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.25 -5.74 86.97 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 m -158.47 38.59 0.24 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.62 ' C ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -56.72 -31.21 64.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.726 172.21 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.8 t -50.3 -8.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-N 114.192 -1.367 . . . . 0.0 113.944 170.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.4 -37.22 0.08 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.792 170.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 40' ' ' LEU . 11.2 mp -96.41 -26.04 15.48 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.864 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.75 17.65 9.57 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 124.68 1.238 . . . . 0.0 110.978 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.29 173.82 5.36 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.57 -0.815 . . . . 0.0 112.207 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.5 m -140.81 -166.08 2.07 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.253 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.27 86.01 0.16 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.07 0.856 . . . . 0.0 109.866 174.703 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.9 -113.26 2.31 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -157.62 87.25 0.95 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.03 -19.37 65.83 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.438 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.07 1.2 28.75 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.91 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -124.77 79.39 63.66 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 53' ' ' ILE . 1.5 Cg_endo -62.51 -31.08 80.39 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.814 1.676 . . . . 0.0 111.404 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.93 -39.25 39.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.538 1.149 . . . . 0.0 112.129 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -90.0 -31.95 16.98 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.126 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 50' ' ' PRO . 61.7 mt -65.93 151.74 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 123.852 0.72 . . . . 0.0 110.452 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.5 -102.78 1.08 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -91.0 140.3 29.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.417 0.716 . . . . 0.0 110.885 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.9 mt -107.05 135.69 48.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.19 124.15 48.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 124.195 0.934 . . . . 0.0 108.778 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.27 -170.63 33.22 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.317 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -94.72 146.47 24.15 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.24 -0.98 . . . . 0.0 110.082 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.481 ' ND2' HD11 ' A' ' 30' ' ' LEU . 18.1 t-20 -119.87 64.63 0.81 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.042 -1.436 . . . . 0.0 108.693 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -56.93 -23.9 48.6 Favored 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.755 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.6 m -53.44 -34.73 58.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.849 0.718 . . . . 0.0 111.594 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.422 HG21 ' NE2' ' A' ' 25' ' ' HIS . 39.1 p -108.89 -5.17 16.28 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.771 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.2 40.67 49.28 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -143.59 176.38 9.25 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -147.25 147.35 30.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 123.924 0.765 . . . . 0.0 109.168 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.87 -153.67 13.64 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.269 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.2 149.71 29.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -151.2 142.82 15.65 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.258 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.12 157.98 15.93 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.459 2.106 . . . . 0.0 112.874 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.2 28.57 14.04 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 124.39 1.056 . . . . 0.0 113.508 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.9 t -133.81 -3.03 2.91 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 117.202 0.501 . . . . 0.0 110.725 -170.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.504 ' OH ' HD12 ' A' ' 24' ' ' LEU . 1.7 p90 -121.33 -6.43 9.34 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 123.918 0.761 . . . . 0.0 111.275 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.486 HG13 ' CE1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -97.48 178.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 124.139 0.899 . . . . 0.0 109.508 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -149.34 104.85 3.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -47.05 142.93 3.3 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.636 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.7 pt -122.97 -51.71 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 124.313 1.008 . . . . 0.0 111.958 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.33 146.41 13.9 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.978 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -127.69 123.23 34.98 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.485 -1.357 . . . . 0.0 111.102 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' O ' HG22 ' A' ' 82' ' ' ILE . 16.3 mttp -112.03 45.28 1.28 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.766 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.43 ' HG3' ' H ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -45.25 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.049 175.919 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 82' ' ' ILE . 3.0 tp -148.02 107.52 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-O 122.3 1.048 . . . . 0.0 113.189 -174.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.401 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -91.55 -47.99 0.34 Allowed Pre-proline 0 N--CA 1.498 1.955 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.098 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 83' ' ' SER . 1.5 Cg_endo . . . . . 0 N--CA 1.486 1.072 0 CA-C-O 116.385 -1.589 . . . . 0.0 111.074 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 15.7 m -149.43 -16.98 0.28 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.122 0.542 . . . . 0.0 110.91 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 4.6 mmt -86.95 -30.83 21.02 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.643 0.589 . . . . 0.0 110.659 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 t -89.45 114.74 26.26 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 123.796 0.685 . . . . 0.0 110.589 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . 0.434 ' HB3' ' CE ' ' A' ' 80' ' ' LYS . . . -170.17 32.95 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.859 0.724 . . . . 0.0 111.981 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -67.3 84.33 0.15 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.304 1.05 . . . . 0.0 111.28 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.83 -162.09 27.76 Favored Glycine 0 N--CA 1.496 2.661 0 CA-C-N 112.566 -2.106 . . . . 0.0 110.125 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -98.51 152.34 19.65 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -172.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -128.74 160.85 31.24 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.406 1.098 . . . . 0.0 112.394 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -148.93 118.92 7.14 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 112.542 -2.117 . . . . 0.0 105.288 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.01 124.21 38.93 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.37 114.25 1.74 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.005 0.816 . . . . 0.0 110.429 174.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 tp -78.5 -31.87 47.9 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.366 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.74 144.14 37.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.436 1.085 . . . . 0.0 108.889 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -64.3 108.65 1.65 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.159 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.44 ' CD2' HD13 ' A' ' 24' ' ' LEU . 17.8 t80 -113.75 136.99 52.25 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -89.7 -178.5 5.54 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -89.93 122.56 33.07 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.327 171.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -90.06 -7.77 53.07 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.945 0.778 . . . . 0.0 110.727 172.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -144.73 150.65 37.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 124.028 0.83 . . . . 0.0 109.648 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.62 -15.65 3.18 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.18 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.48 -41.29 27.8 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.931 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.33 168.24 18.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 123.691 0.619 . . . . 0.0 111.428 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.56 -164.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 124.144 0.902 . . . . 0.0 109.827 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -100.43 108.04 19.93 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.683 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 24' ' ' LEU . 5.3 mp -92.63 123.08 35.66 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 113.529 -1.668 . . . . 0.0 109.71 173.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.03 167.32 11.88 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.687 170.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mt -53.8 150.4 7.51 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.024 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.06 -14.05 3.03 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 114.969 -1.014 . . . . 0.0 114.345 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.87 117.35 6.25 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tp -94.73 148.65 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 123.915 0.759 . . . . 0.0 109.152 171.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.567 HD23 ' CE1' ' A' ' 69' ' ' PHE . 8.3 mp -121.98 135.27 54.84 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.5 m -122.04 140.2 52.78 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 124.143 0.902 . . . . 0.0 108.687 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.63 -175.45 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.42 176.11 7.08 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.973 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -78.23 -20.95 50.71 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.357 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.17 33.31 2.1 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -175.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.7 1.2 5.62 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.689 -0.755 . . . . 0.0 112.229 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 mt -63.94 -42.65 97.28 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 38' ' ' VAL . 21.1 t -81.44 -8.87 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.11 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.51 -37.86 0.52 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.094 0.871 . . . . 0.0 109.571 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tp -97.57 -49.84 4.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.199 -1.819 . . . . 0.0 107.897 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.66 39.87 0.75 Allowed Glycine 0 N--CA 1.493 2.483 0 CA-C-N 111.781 -2.463 . . . . 0.0 113.362 -165.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -58.96 167.17 1.71 Allowed 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 166.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.7 p -136.88 29.41 2.85 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.453 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.58 -160.53 1.06 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.596 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.82 3.84 0.35 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -167.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -92.3 55.31 2.52 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 122.037 0.922 . . . . 0.0 109.466 -174.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.08 -23.91 66.61 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.038 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.6 -6.35 53.45 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.909 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.53 86.97 35.51 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.68 -6.1 10.03 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.721 2.281 . . . . 0.0 113.75 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -65.97 -35.8 81.59 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.485 0.491 . . . . 0.0 111.947 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -89.2 -28.16 20.16 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 123.678 0.611 . . . . 0.0 110.537 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.0 mt -80.3 141.3 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.8 -84.46 1.34 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -91.49 125.15 36.14 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 113.032 -1.584 . . . . 0.0 110.16 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.3 mp -102.68 131.17 49.66 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 168.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.96 122.31 40.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 168.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.89 -175.31 22.7 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.973 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -120.28 133.53 55.45 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.816 -0.692 . . . . 0.0 110.182 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -99.18 82.83 2.77 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 124.501 1.126 . . . . 0.0 109.132 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -48.05 -28.51 2.88 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.274 172.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 m -55.93 -49.16 74.25 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.022 0.826 . . . . 0.0 111.075 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 p -95.3 0.01 53.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.306 1.004 . . . . 0.0 110.303 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.95 45.56 96.34 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.455 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.85 174.39 10.7 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.358 0.681 . . . . 0.0 109.933 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -145.0 144.24 30.93 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.91 -175.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.28 -158.16 20.44 Favored Glycine 0 N--CA 1.493 2.484 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.749 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.15 168.96 8.99 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.736 -1.232 . . . . 0.0 110.289 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.567 ' CE1' HD23 ' A' ' 30' ' ' LEU . 17.7 p90 -164.16 144.7 6.6 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.912 170.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.8 160.47 40.62 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 121.975 1.783 . . . . 0.0 112.109 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.64 54.65 1.24 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.2 t -137.37 -29.84 0.87 Allowed 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -91.58 -6.05 53.01 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.396 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.19 167.69 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.599 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -139.06 127.05 22.33 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -49.86 144.07 6.89 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.403 167.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.77 -54.99 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 124.026 0.828 . . . . 0.0 111.107 175.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.86 152.76 23.68 Favored Glycine 0 N--CA 1.496 2.668 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.353 -165.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.3 149.48 37.89 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 124.486 0.756 . . . . 0.0 111.759 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.434 ' CE ' ' HB3' ' A' ' 3' ' ' ALA . 1.0 OUTLIER -124.07 42.79 3.16 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.211 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -40.46 110.62 0.16 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 113.593 -1.64 . . . . 0.0 112.159 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.0 tp -133.06 95.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.165 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.42 160.92 26.26 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.538 177.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.49 1.292 0 C-N-CA 122.124 1.883 . . . . 0.0 112.766 174.626 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.743 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.0 OUTLIER -155.4 147.06 23.11 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 7.8 ttt -154.46 -46.68 0.09 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.8 m -139.95 80.2 1.75 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.457 1.098 . . . . 0.0 109.437 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.68 153.23 20.76 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.349 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -154.3 83.45 1.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 124.209 0.943 . . . . 0.0 109.94 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.428 ' HA3' HG22 ' A' ' 82' ' ' ILE . . . 99.44 141.7 12.47 Favored Glycine 0 N--CA 1.495 2.569 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.046 175.488 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.52 -178.3 4.72 Favored 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -167.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.513 ' HB3' HD11 ' A' ' 77' ' ' ILE . 23.6 mt-30 -150.0 162.0 41.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.184 0.992 . . . . 0.0 111.815 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -131.8 140.0 49.06 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.126 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -90.97 124.51 35.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.79 0.681 . . . . 0.0 110.084 161.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.43 121.55 9.23 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.809 0.693 . . . . 0.0 111.258 165.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.35 -67.98 0.82 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.228 0.955 . . . . 0.0 109.627 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -94.59 137.26 33.92 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.367 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -68.55 91.2 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 124.13 0.894 . . . . 0.0 110.515 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.442 ' CD2' HD12 ' A' ' 24' ' ' LEU . 9.1 t80 -92.98 133.05 36.51 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.954 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -90.31 163.15 14.85 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.365 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -89.0 115.97 26.95 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.437 0.637 . . . . 0.0 111.611 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -89.08 -14.44 36.3 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.942 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.54 155.49 43.7 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.843 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -63.37 -26.21 68.65 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.852 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.08 -28.4 69.05 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.511 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.25 152.35 25.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.54 1.15 . . . . 0.0 110.812 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 pt -113.03 176.12 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.002 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -69.96 137.4 51.44 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.084 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 14' ' ' TYR . 67.6 mt -126.99 90.41 3.15 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.5 166.3 10.53 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.751 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mt -64.92 162.13 17.05 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.28 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.41 -11.33 13.25 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.498 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.69 133.7 39.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.398 0.705 . . . . 0.0 109.587 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.65 143.73 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.963 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.2 mp -106.32 139.51 40.7 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.67 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.42 ' CG2' HG21 ' A' ' 82' ' ' ILE . 23.2 m -112.1 144.82 40.83 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 123.871 0.732 . . . . 0.0 110.508 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.68 173.51 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 123.951 0.782 . . . . 0.0 110.686 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.433 ' H ' ' CB ' ' A' ' 36' ' ' SER . 3.7 t30 -80.77 171.34 15.14 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-N 114.409 -1.269 . . . . 0.0 114.106 175.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -73.82 -10.44 59.67 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.683 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.67 28.66 2.16 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.433 ' CB ' ' H ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -71.69 -9.19 57.9 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.41 -0.895 . . . . 0.0 111.449 -179.276 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -75.1 -37.87 61.35 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 175.843 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 38' ' ' VAL . 9.5 t -77.01 -9.37 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 113.77 -1.559 . . . . 0.0 114.656 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -40.1 -31.98 0.15 Allowed 'General case' 0 N--CA 1.506 2.372 0 O-C-N 124.173 0.92 . . . . 0.0 111.677 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.2 mt -94.6 17.27 13.61 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.122 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.64 35.26 51.6 Favored Glycine 0 N--CA 1.498 2.786 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.573 -161.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.67 174.14 1.91 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.508 -0.846 . . . . 0.0 112.866 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 t -100.35 160.15 14.57 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.459 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.74 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.63 170.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -102.76 -108.2 3.21 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -163.17 -6.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.692 0.878 . . . . 0.0 112.009 -174.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 34.76 61.99 0.55 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 124.666 1.229 . . . . 0.0 113.856 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.87 -7.77 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 113.208 -1.815 . . . . 0.0 111.221 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -124.26 75.2 60.48 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 124.113 0.883 . . . . 0.0 111.388 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.2 -11.54 10.74 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.221 1.947 . . . . 0.0 113.56 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -65.95 -40.64 91.51 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.089 0.868 . . . . 0.0 111.543 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -91.38 -21.33 21.05 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 123.769 0.668 . . . . 0.0 112.002 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.4 mt -82.77 145.83 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.29 -88.16 1.24 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -89.76 145.26 25.32 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 113.608 -1.296 . . . . 0.0 109.9 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.2 mp -124.04 125.46 44.57 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.405 166.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 31.1 t-20 -93.94 119.28 32.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 123.891 0.744 . . . . 0.0 109.079 168.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.13 -165.31 10.62 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 171.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.8 134.99 34.15 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -96.77 76.08 2.77 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -43.16 -33.23 0.86 Allowed 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 113.97 -1.468 . . . . 0.0 112.929 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.5 m -55.21 -49.59 71.56 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 124.208 0.943 . . . . 0.0 111.336 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.4 p -93.37 -4.34 51.67 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.148 0.905 . . . . 0.0 110.888 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.85 60.07 8.67 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 123.884 0.74 . . . . 0.0 111.329 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.58 154.56 45.51 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.343 0.672 . . . . 0.0 109.314 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -127.87 135.21 49.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.328 1.017 . . . . 0.0 108.446 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.92 -168.68 39.12 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.18 -1.486 . . . . 0.0 112.69 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -108.02 165.76 11.23 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.149 -1.525 . . . . 0.0 109.181 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.6 p90 -160.03 143.23 10.23 Favored Pre-proline 0 N--CA 1.494 1.725 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.379 175.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HB2' HG22 ' A' ' 72' ' ' THR . 2.5 Cg_endo -65.76 155.54 68.69 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.967 1.778 . . . . 0.0 110.937 172.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.05 49.64 3.58 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 70' ' ' PRO . 8.0 t -129.97 -28.84 2.14 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -96.82 13.53 28.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 124.193 0.933 . . . . 0.0 111.537 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.28 178.71 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 114.67 -1.15 . . . . 0.0 107.926 -170.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -150.63 116.63 5.59 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -51.58 127.3 19.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 123.856 0.722 . . . . 0.0 109.883 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.0 OUTLIER -101.66 -55.99 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 124.598 1.187 . . . . 0.0 109.757 177.579 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.95 161.83 35.37 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 118.643 -1.741 . . . . 0.0 112.237 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.57 42.56 1.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 112.117 -2.042 . . . . 0.0 110.486 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -64.68 98.48 0.27 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.202 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.98 103.94 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.788 171.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.428 HG22 ' HA3' ' A' ' 5' ' ' GLY . 8.8 tp -89.44 95.78 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 CA-C-O 122.377 1.084 . . . . 0.0 110.154 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.98 160.5 37.53 Favored Pre-proline 0 N--CA 1.503 2.215 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.127 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.492 1.396 0 C-N-CA 122.46 2.107 . . . . 0.0 112.652 177.881 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.1 OUTLIER -98.79 -62.46 1.23 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -175.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 14.1 mmt -71.83 -7.52 48.81 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.073 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.2 p -69.06 -167.43 0.11 Allowed 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.72 141.15 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -125.49 79.38 1.81 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -172.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.432 ' H ' HG22 ' A' ' 82' ' ' ILE . . . -131.82 162.05 23.8 Favored Glycine 0 N--CA 1.504 3.177 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.61 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -137.02 145.31 43.94 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -143.622 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 70.3 mt-30 -128.03 163.12 25.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 124.641 1.213 . . . . 0.0 111.839 -168.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -140.59 124.22 17.05 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 112.3 -2.227 . . . . 0.0 105.68 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -91.89 124.66 36.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.1 118.5 5.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 124.162 0.914 . . . . 0.0 110.692 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -60.75 2.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 124.02 0.825 . . . . 0.0 109.213 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.31 168.94 9.31 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.309 1.006 . . . . 0.0 110.228 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.7 123.88 30.88 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.349 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -121.97 138.91 54.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.45 172.52 8.94 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.515 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -89.74 144.52 25.9 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.136 172.841 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -134.44 -9.54 2.51 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.683 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -141.0 146.65 37.54 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.997 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.8 -17.58 9.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.461 1.101 . . . . 0.0 113.318 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -71.34 -51.07 26.29 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.383 -1.281 . . . . 0.0 111.693 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.41 153.31 21.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.135 0.897 . . . . 0.0 109.606 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pt -114.39 174.59 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 124.378 1.049 . . . . 0.0 110.93 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.75 130.17 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.719 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.66 124.33 44.96 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.579 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 172.75 11.61 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.835 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.95 150.56 48.45 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.028 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.66 -10.27 18.82 Favored Glycine 0 N--CA 1.5 2.909 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.431 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.02 110.14 1.49 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.538 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 tp -90.2 155.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.8 mp -129.23 143.69 50.95 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.184 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.8 m -128.18 143.0 51.01 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.08 -125.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.435 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 0.5 OUTLIER -118.94 -173.79 2.57 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.234 0.47 . . . . 0.0 111.136 -170.742 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 mttp -112.85 -45.49 3.19 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 123.869 0.73 . . . . 0.0 112.07 -170.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.25 35.91 0.88 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 m -142.35 63.56 1.4 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mt -55.86 -24.99 40.23 Favored 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.092 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.4 t -57.18 -9.8 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -26.9 2.09 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.943 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.1 mt -117.44 -6.71 11.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.118 0.886 . . . . 0.0 110.252 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 22.53 59.69 Favored Glycine 0 N--CA 1.498 2.797 0 O-C-N 123.954 0.784 . . . . 0.0 112.143 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -80.86 146.93 30.63 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.412 -0.894 . . . . 0.0 111.829 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -150.18 38.0 0.71 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.768 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -119.27 -56.35 2.08 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.274 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.39 58.01 0.78 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -94.04 -77.35 0.46 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 112.085 -2.057 . . . . 0.0 109.501 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 35.23 38.46 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -162.56 -6.1 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.04 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -128.13 76.25 78.0 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 123.917 0.761 . . . . 0.0 110.048 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.93 -16.07 19.2 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.294 1.996 . . . . 0.0 113.514 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -59.7 -47.04 87.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 123.926 0.766 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -89.72 -31.61 17.38 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 123.957 0.785 . . . . 0.0 110.033 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.1 mt -66.49 143.63 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 123.803 0.689 . . . . 0.0 109.643 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.45 -97.78 1.07 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -93.48 135.99 34.19 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.239 -0.981 . . . . 0.0 109.834 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.4 mp -117.58 147.68 42.6 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.796 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -117.29 130.32 56.47 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.349 1.03 . . . . 0.0 108.223 176.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.44 169.96 36.34 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.55 -1.309 . . . . 0.0 112.999 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -90.73 141.1 29.15 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.17 -1.015 . . . . 0.0 109.102 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -105.49 72.56 0.98 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.442 1.089 . . . . 0.0 109.933 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -44.3 -33.78 1.72 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.291 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 m -51.72 -47.73 63.87 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 124.115 0.884 . . . . 0.0 111.975 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.8 -4.66 23.3 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.849 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.48 47.67 85.18 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -119.05 178.34 4.54 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.154 -1.023 . . . . 0.0 109.61 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -150.12 136.47 18.89 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.56 -153.89 13.54 Favored Glycine 0 N--CA 1.5 2.928 0 C-N-CA 118.916 -1.611 . . . . 0.0 113.538 165.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.79 158.29 17.1 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -172.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.5 p90 -159.53 143.84 11.06 Favored Pre-proline 0 N--CA 1.489 1.5 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.788 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.59 154.32 71.78 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.941 1.761 . . . . 0.0 111.539 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.69 19.53 19.75 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 124.128 0.893 . . . . 0.0 112.648 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.54 -32.4 7.71 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.268 0.556 . . . . 0.0 111.237 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -89.62 -0.31 57.43 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.064 -175.321 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.23 -178.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 124.194 0.934 . . . . 0.0 109.283 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -146.61 122.0 10.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.435 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 45.1 t80 -55.0 120.98 7.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 124.034 0.834 . . . . 0.0 108.98 168.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -90.85 -54.98 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.372 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -169.9 157.76 29.47 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.391 -1.385 . . . . 0.0 111.507 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.8 164.4 17.57 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.52 -0.84 . . . . 0.0 111.608 171.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.4 mttp 64.89 22.85 12.55 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 122.702 1.239 . . . . 0.0 110.297 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 19.21 8.81 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.212 -2.267 . . . . 0.0 112.932 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 82' ' ' ILE . 4.7 tt -88.48 82.98 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 CA-C-O 123.063 1.411 . . . . 0.0 112.396 156.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.2 p -150.31 69.58 8.92 Favored Pre-proline 0 N--CA 1.498 1.956 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.459 167.471 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.22 0 C-N-CA 121.931 1.754 . . . . 0.0 111.695 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.519 0 CA-C-O 119.937 -0.369 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 20.5 t -86.4 -6.35 58.95 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.663 0.272 . . . . 0.0 111.428 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 4.8 mmt -63.36 -72.84 0.13 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 123.665 0.603 . . . . 0.0 110.816 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.52 144.86 0.4 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 123.927 0.767 . . . . 0.0 110.244 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.02 -167.86 1.96 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.649 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.522 ' O ' HG23 ' A' ' 31' ' ' THR . 5.9 pt-20 -146.04 13.51 1.29 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 123.645 0.59 . . . . 0.0 112.091 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.12 -131.45 37.45 Favored Glycine 0 N--CA 1.496 2.649 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.271 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -104.24 144.14 32.0 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 114.194 -1.003 . . . . 0.0 108.671 170.704 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.613 ' HB3' HD11 ' A' ' 77' ' ' ILE . 53.2 mt-30 -120.14 159.93 23.9 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.754 0.788 . . . . 0.0 112.593 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -140.13 132.04 27.66 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.235 -1.802 . . . . 0.0 107.433 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -89.76 123.77 34.05 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 170.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.59 126.74 14.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.508 1.13 . . . . 0.0 111.752 164.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 tp -80.45 -36.55 33.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.099 0.874 . . . . 0.0 110.121 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -145.49 165.1 29.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.185 0.928 . . . . 0.0 110.795 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.03 121.16 23.13 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.393 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.403 ' CD2' HD12 ' A' ' 24' ' ' LEU . 27.9 t80 -128.47 128.48 44.46 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.227 0.954 . . . . 0.0 109.423 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.32 159.51 15.23 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.604 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.34 150.21 22.67 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 123.772 0.67 . . . . 0.0 109.928 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -123.73 -9.79 7.83 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.021 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -139.62 153.35 47.33 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.904 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.91 -11.21 7.2 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.392 -1.276 . . . . 0.0 113.355 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -80.45 -35.02 35.5 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.374 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -98.6 177.61 5.26 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 124.158 0.911 . . . . 0.0 111.039 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 pt -141.23 172.75 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.086 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.83 128.76 33.79 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.979 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.403 HD12 ' CD2' ' A' ' 14' ' ' TYR . 85.3 mt -127.78 140.39 52.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.971 0.794 . . . . 0.0 109.998 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.483 ' NE2' HG21 ' A' ' 63' ' ' THR . 0.2 OUTLIER -140.27 -173.5 3.68 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.078 -176.822 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -75.52 152.48 37.81 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.663 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.36 -7.87 1.72 Allowed Glycine 0 N--CA 1.498 2.82 0 CA-C-N 114.97 -1.014 . . . . 0.0 114.006 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.82 106.52 0.58 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 mt -98.77 126.88 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 172.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.63 158.07 16.96 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 112.56 -2.109 . . . . 0.0 108.539 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 4' ' ' GLU . 1.1 m -134.42 147.09 50.38 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -172.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.3 OUTLIER -120.1 -166.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.492 ' H ' HG12 ' A' ' 32' ' ' VAL . 5.0 m120 -85.19 153.61 22.53 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.998 0.904 . . . . 0.0 111.681 173.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -54.95 2.81 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 112.993 -1.912 . . . . 0.0 107.625 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -100.96 10.46 58.61 Favored Glycine 0 N--CA 1.494 2.533 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.733 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.6 t -155.15 39.89 0.42 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -172.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -60.4 -32.78 71.65 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.204 170.153 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 38' ' ' VAL . 2.9 t -52.25 -8.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 113.765 -1.561 . . . . 0.0 113.25 173.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -29.61 -41.01 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 124.927 1.291 . . . . 0.0 111.813 169.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mt -86.62 -40.45 15.14 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 112.829 -1.987 . . . . 0.0 111.468 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.48 17.16 5.31 Favored Glycine 0 N--CA 1.494 2.543 0 CA-C-N 113.039 -1.891 . . . . 0.0 110.241 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -67.95 175.18 3.22 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.725 -0.738 . . . . 0.0 111.844 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.58 150.92 30.68 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.46 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -53.05 110.0 0.48 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.385 1.053 . . . . 0.0 111.125 171.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.71 -108.04 0.83 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -153.91 91.08 1.42 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -54.75 -13.72 1.13 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.835 -1.53 . . . . 0.0 113.124 171.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.18 11.3 1.93 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.291 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.15 76.68 78.82 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 123.604 0.565 . . . . 0.0 109.532 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.26 -16.88 56.69 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.119 1.879 . . . . 0.0 112.731 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -67.09 -37.3 83.7 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 123.896 0.747 . . . . 0.0 110.945 -172.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.81 -33.79 16.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 124.184 0.928 . . . . 0.0 110.104 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.9 mt -64.97 149.1 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 124.152 0.908 . . . . 0.0 109.823 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.43 -103.86 1.09 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -89.88 137.5 32.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 124.632 0.842 . . . . 0.0 110.348 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 64.7 mt -106.4 131.65 53.35 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 113.934 -1.484 . . . . 0.0 107.721 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -104.77 117.44 34.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.009 0.818 . . . . 0.0 109.483 175.22 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.91 172.58 35.11 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.299 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.84 149.3 22.01 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.477 -0.861 . . . . 0.0 109.997 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -124.42 61.1 1.14 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.89 -22.68 5.79 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.064 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -53.01 -50.48 64.14 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.001 0.813 . . . . 0.0 111.084 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.483 HG21 ' NE2' ' A' ' 25' ' ' HIS . 5.4 p -94.2 3.28 55.47 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.476 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.51 29.42 74.77 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -123.9 173.89 7.91 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -150.45 147.48 27.59 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.79 -154.78 19.44 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.092 171.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.37 155.11 16.87 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.661 -0.769 . . . . 0.0 109.364 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 56' ' ' LEU . 11.8 p90 -157.25 142.34 12.28 Favored Pre-proline 0 N--CA 1.498 1.952 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.846 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.69 151.09 49.35 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.253 1.969 . . . . 0.0 111.899 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.25 -4.39 77.62 Favored Glycine 0 N--CA 1.498 2.817 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.436 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.3 t -104.19 1.36 30.56 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 116.801 0.3 . . . . 0.0 111.345 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.35 -9.46 16.76 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 123.747 0.655 . . . . 0.0 111.988 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 m -119.3 -172.12 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 124.134 0.896 . . . . 0.0 108.983 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -150.13 124.47 9.55 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -49.78 131.57 22.03 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 124.116 0.885 . . . . 0.0 109.913 168.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.613 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.2 pt -108.74 -53.68 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 124.359 1.037 . . . . 0.0 109.393 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.73 171.18 40.11 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.97 161.44 40.49 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.52 -0.84 . . . . 0.0 109.368 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -104.7 130.23 52.78 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.922 164.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -78.76 90.27 4.64 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 112.7 -2.045 . . . . 0.0 108.846 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 tt -145.88 65.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.786 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -142.77 67.92 18.84 Favored Pre-proline 0 N--CA 1.495 1.789 0 CA-C-N 113.519 -1.673 . . . . 0.0 109.838 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.258 0 CA-C-O 116.217 -1.659 . . . . 0.0 111.807 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 68.5 m -57.02 139.33 52.56 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.281 0.636 . . . . 0.0 112.603 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 61.6 mtt -76.12 -19.64 58.33 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.792 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t -138.55 175.45 9.55 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.865 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.59 177.27 4.63 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.612 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.74 -67.85 0.78 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 168.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 34' ' ' LYS . . . 33.47 146.11 0.0 OUTLIER Glycine 0 N--CA 1.512 3.728 0 N-CA-C 119.086 2.395 . . . . 0.0 119.086 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.405 ' CZ ' ' O ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -150.97 149.39 29.54 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.466 0.651 . . . . 0.0 111.481 -167.609 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -133.09 166.08 23.26 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.393 -169.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -139.92 141.39 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -105.66 120.52 41.88 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.341 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.78 114.91 1.57 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.312 1.007 . . . . 0.0 111.596 168.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -63.54 1.36 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.301 176.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -103.62 143.19 33.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.05 0.844 . . . . 0.0 110.26 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.43 118.65 9.7 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 124.4 1.062 . . . . 0.0 111.164 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -129.42 128.32 42.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 124.564 1.165 . . . . 0.0 108.999 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -89.57 171.42 9.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -89.01 136.17 33.16 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -124.68 -7.66 7.38 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.719 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.65 142.81 50.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 124.258 0.974 . . . . 0.0 109.246 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -10.35 1.78 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.537 172.476 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.53 -37.5 13.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.053 0.845 . . . . 0.0 111.204 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -86.98 145.43 26.51 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 123.833 0.708 . . . . 0.0 110.471 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pt -99.58 -179.88 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 124.067 0.854 . . . . 0.0 111.8 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -79.73 138.9 37.45 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.207 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -126.95 130.03 49.3 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.652 -1.613 . . . . 0.0 108.408 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.25 33.31 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.28 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -53.84 149.27 8.97 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.01 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.84 -14.4 10.47 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.375 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.54 117.79 9.23 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.456 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -101.68 148.99 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 123.947 0.779 . . . . 0.0 109.431 167.408 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.463 HD11 ' ND2' ' A' ' 60' ' ' ASN . 10.6 mp -121.95 154.35 37.29 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.8 m -137.26 145.16 43.21 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 123.471 0.482 . . . . 0.0 109.951 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.477 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.0 t -122.14 -145.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 124.269 0.981 . . . . 0.0 108.487 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' H ' HG12 ' A' ' 32' ' ' VAL . 5.0 m-80 -103.64 -167.87 1.43 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.403 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 4.7 pttt -123.14 -52.7 1.85 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.07 0.857 . . . . 0.0 110.649 -169.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.08 27.31 5.64 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.6 t -146.38 61.32 1.23 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -62.04 -6.62 3.06 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 112.539 -2.118 . . . . 0.0 113.639 164.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -64.03 -12.63 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 169.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.48 -24.08 0.76 Allowed 'General case' 0 N--CA 1.508 2.436 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.851 163.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD2' ' H ' ' A' ' 57' ' ' ASN . 4.7 mt -111.42 -20.62 12.16 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.44 -177.007 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.01 11.01 29.02 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 124.999 1.437 . . . . 0.0 112.412 -172.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -88.69 162.79 16.09 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 123.842 0.377 . . . . 0.0 110.637 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -150.42 36.8 0.66 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 123.734 0.647 . . . . 0.0 111.465 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -144.88 -96.66 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.743 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.12 76.38 0.03 OUTLIER Glycine 0 N--CA 1.494 2.511 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.005 -173.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -147.14 31.18 0.93 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 112.741 -1.73 . . . . 0.0 110.143 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -77.87 13.07 1.47 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.038 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.59 5.1 39.07 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.826 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -126.98 76.47 75.89 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 123.767 0.667 . . . . 0.0 109.395 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.25 -3.84 6.88 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.329 2.02 . . . . 0.0 113.732 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -71.36 -43.31 67.16 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.806 0.691 . . . . 0.0 110.985 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.68 -24.68 21.54 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.391 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.74 143.02 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.56 -91.0 1.21 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -94.81 123.43 38.26 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.767 -1.217 . . . . 0.0 110.455 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.4 mp -95.63 172.68 7.91 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.756 171.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.442 ' H ' ' CD2' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -145.17 107.44 4.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -175.414 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.53 -176.78 23.84 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.513 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 66' ' ' ARG . 6.8 m-85 -106.81 153.27 22.72 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.295 -0.953 . . . . 0.0 110.234 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.463 ' ND2' HD11 ' A' ' 30' ' ' LEU . 8.5 t-20 -123.99 60.77 1.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.849 -1.523 . . . . 0.0 107.486 -177.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -42.86 -36.33 1.46 Allowed 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.954 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 p -49.55 -54.58 17.29 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.514 1.134 . . . . 0.0 113.756 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -93.76 3.21 55.78 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.627 0.58 . . . . 0.0 111.29 172.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.23 17.46 56.05 Favored Glycine 0 N--CA 1.496 2.668 0 O-C-N 123.845 0.715 . . . . 0.0 112.227 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.5 167.94 10.84 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 4.3 ptm180 -150.24 148.82 29.35 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.229 0.538 . . . . 0.0 110.246 175.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.2 -156.41 28.0 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.243 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.93 160.89 15.41 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -169.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 27.8 p90 -159.87 149.93 15.0 Favored Pre-proline 0 N--CA 1.498 1.933 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.499 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.75 146.17 87.9 Favored 'Trans proline' 0 N--CA 1.487 1.103 0 C-N-CA 122.064 1.843 . . . . 0.0 112.03 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.59 7.18 82.55 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 123.83 0.706 . . . . 0.0 112.297 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -23.95 15.57 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 176.179 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -89.83 -9.62 48.43 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.376 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 m -122.95 -178.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 124.491 1.12 . . . . 0.0 108.334 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -149.61 120.57 7.67 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -48.73 127.62 14.01 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 165.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -94.27 -62.39 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 124.225 0.953 . . . . 0.0 109.442 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.16 158.02 28.81 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -165.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.44 49.71 1.73 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.206 -0.997 . . . . 0.0 110.726 169.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -64.65 101.18 0.44 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.834 170.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -36.56 137.07 0.31 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 113.789 -1.551 . . . . 0.0 112.923 171.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.0 tt -88.53 126.65 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.78 1.276 . . . . 0.0 112.033 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.05 162.22 38.46 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.004 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.489 1.224 0 CA-C-O 116.034 -1.736 . . . . 0.0 112.324 177.086 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 88.2 p -154.09 141.94 20.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 124.085 0.521 . . . . 0.0 110.194 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 1.0 OUTLIER -76.93 -31.61 56.77 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.0 0.813 . . . . 0.0 110.142 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.59 -169.07 2.01 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.375 1.047 . . . . 0.0 109.829 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.97 109.44 2.02 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.764 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -132.65 -13.8 2.9 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.99 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.03 -156.13 22.22 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 124.268 0.98 . . . . 0.0 111.308 -169.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.24 153.61 19.16 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -175.072 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -133.1 162.9 30.49 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 124.301 1.001 . . . . 0.0 111.992 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -143.76 135.97 26.75 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.294 -1.776 . . . . 0.0 107.082 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HE ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -102.73 125.17 49.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 124.276 0.985 . . . . 0.0 108.862 178.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.5 149.64 5.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 123.879 0.737 . . . . 0.0 110.873 168.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 tp -121.48 -25.58 5.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 123.974 0.796 . . . . 0.0 111.075 -175.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.04 146.78 27.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.038 0.836 . . . . 0.0 110.294 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.39 118.55 6.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.507 1.13 . . . . 0.0 110.55 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.416 ' CD1' HD12 ' A' ' 24' ' ' LEU . 2.9 t80 -120.6 135.98 54.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 124.778 1.299 . . . . 0.0 108.82 174.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -89.81 157.03 18.11 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.406 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -88.58 149.82 23.38 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.84 -19.56 2.6 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.312 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.23 147.25 35.41 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.163 -1.381 . . . . 0.0 110.051 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.81 -21.33 64.32 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.158 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.16 -12.28 57.1 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.69 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.97 147.79 30.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 124.091 0.87 . . . . 0.0 110.849 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.22 -175.26 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.483 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -88.73 129.15 35.6 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.445 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 14' ' ' TYR . 71.5 mt -114.02 135.95 53.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.016 0.822 . . . . 0.0 111.007 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.49 -173.91 3.2 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.089 -176.083 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -84.92 158.06 20.67 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.687 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.64 -5.27 2.45 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.137 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.86 147.41 51.76 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.476 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.0 tt -132.57 150.14 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 124.101 0.876 . . . . 0.0 111.358 172.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.668 HD11 HD22 ' A' ' 60' ' ' ASN . 9.7 mp -121.77 152.83 39.04 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.149 -176.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.3 m -135.04 149.35 50.11 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.914 0.759 . . . . 0.0 110.449 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.3 t -127.67 -153.99 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 123.959 0.787 . . . . 0.0 109.002 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.578 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -79.74 178.46 8.15 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.423 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -122.6 11.4 9.84 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.424 -173.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.04 25.08 0.03 OUTLIER Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.7 m -141.57 65.82 1.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 38' ' ' VAL . 1.1 pp -55.95 -12.53 1.44 Allowed 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 113.179 -1.828 . . . . 0.0 113.638 168.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.538 ' N ' HD12 ' A' ' 37' ' ' LEU . 5.4 t -61.97 -11.07 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 171.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.518 ' C ' HD12 ' A' ' 40' ' ' LEU . . . -48.26 -32.69 7.59 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.219 168.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 39' ' ' ALA . 10.1 mp -109.47 -6.36 15.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 124.115 0.884 . . . . 0.0 110.763 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.5 26.32 51.43 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.854 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.37 155.74 36.15 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.238 -0.981 . . . . 0.0 111.749 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.5 m -90.11 -140.2 0.15 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.138 -1.392 . . . . 0.0 107.558 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -33.73 -66.13 0.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.824 1.327 . . . . 0.0 112.306 171.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.28 86.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 170.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -62.05 -12.97 21.74 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 114.572 -0.814 . . . . 0.0 110.113 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' OE1' HD23 ' A' ' 37' ' ' LEU . 16.1 mt-10 47.51 62.83 2.24 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 124.236 0.96 . . . . 0.0 111.607 174.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.74 -4.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.855 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -126.86 79.27 72.65 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 123.942 0.776 . . . . 0.0 110.499 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.82 -7.96 5.2 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.237 1.958 . . . . 0.0 113.514 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -48.56 45.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.2 -23.21 21.34 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 123.822 0.701 . . . . 0.0 111.024 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.78 143.37 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.26 -99.68 1.04 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -89.99 133.49 34.78 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.376 -0.912 . . . . 0.0 110.343 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -109.28 156.47 19.91 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.414 171.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.433 ' H ' HD21 ' A' ' 40' ' ' LEU . 34.9 t-20 -131.08 124.65 31.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.32 -179.24 29.47 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.073 -1.06 . . . . 0.0 111.498 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -95.85 126.7 41.28 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.52 -1.34 . . . . 0.0 109.483 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.668 HD22 HD11 ' A' ' 30' ' ' LEU . 23.2 t-20 -90.3 85.02 6.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 124.459 1.099 . . . . 0.0 109.896 173.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -47.48 -32.87 5.61 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.952 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -55.88 -47.01 78.15 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.298 0.999 . . . . 0.0 111.423 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -105.03 5.38 32.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.228 0.955 . . . . 0.0 109.651 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.66 53.72 37.34 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 124.292 0.995 . . . . 0.0 111.42 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -138.93 173.21 11.8 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -172.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -129.11 118.87 23.18 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.45 -171.05 23.83 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 118.953 -1.594 . . . . 0.0 113.224 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -103.25 162.16 13.21 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 113.646 -1.277 . . . . 0.0 109.603 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CE1' HD23 ' A' ' 30' ' ' LEU . 13.0 p90 -159.66 140.86 9.3 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.215 176.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.61 152.44 74.63 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.647 1.564 . . . . 0.0 110.406 176.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.75 26.11 2.83 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.984 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 p -96.57 -51.91 4.14 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.276 0.56 . . . . 0.0 111.729 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -90.48 25.65 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.156 -1.383 . . . . 0.0 110.847 -170.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.47 158.7 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -172.651 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -138.07 112.48 8.73 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -46.77 116.48 1.34 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.448 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.58 HD13 ' HE ' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -91.83 -56.98 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.522 178.769 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.49 175.85 38.88 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.459 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.92 136.57 17.99 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.973 -1.114 . . . . 0.0 110.383 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.26 53.08 1.34 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.444 174.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -49.24 124.01 8.34 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.969 -1.923 . . . . 0.0 109.54 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.6 tp -141.33 147.58 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 124.597 1.185 . . . . 0.0 110.161 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.87 162.54 35.37 Favored Pre-proline 0 N--CA 1.504 2.248 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.372 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.488 1.182 0 CA-C-O 116.644 -1.482 . . . . 0.0 111.108 175.886 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.5 OUTLIER -150.7 -16.93 0.23 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.003 -0.598 . . . . 0.0 110.092 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 75.1 mtp -61.62 -31.58 71.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.871 0.732 . . . . 0.0 111.039 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.408 ' HA ' HE22 ' A' ' 7' ' ' GLN . 49.2 m -65.41 144.96 56.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 123.845 0.716 . . . . 0.0 111.438 174.207 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.31 -178.27 2.89 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.948 176.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.96 -23.75 48.36 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.574 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.6 -157.35 29.58 Favored Glycine 0 N--CA 1.493 2.493 0 O-C-N 123.935 0.772 . . . . 0.0 111.208 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 143.92 31.06 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 114.228 -0.986 . . . . 0.0 109.165 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.408 HE22 ' HA ' ' A' ' 2' ' ' SER . 5.5 mt-30 -128.87 164.1 23.83 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.785 0.803 . . . . 0.0 112.737 -171.034 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -139.03 133.46 31.69 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 113.414 -1.721 . . . . 0.0 107.926 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -90.65 113.49 25.55 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.37 128.2 30.62 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.136 167.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.01 -71.01 0.75 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.036 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -90.34 145.99 24.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 123.86 0.725 . . . . 0.0 110.045 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.97 125.07 23.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.126 0.891 . . . . 0.0 110.52 177.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.518 ' CD2' HD12 ' A' ' 24' ' ' LEU . 16.5 t80 -127.84 133.15 49.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.41 1.069 . . . . 0.0 109.374 175.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -90.01 160.94 16.1 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.346 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 160.83 16.73 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 123.952 0.783 . . . . 0.0 110.224 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.64 -50.43 4.06 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.899 0.857 . . . . 0.0 110.5 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.518 ' HG3' ' H ' ' A' ' 20' ' ' GLU . 6.8 ptp180 -150.27 -166.04 2.44 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 112.82 -1.991 . . . . 0.0 110.437 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -61.5 2.87 0.15 Allowed 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.518 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 28.5 tt0 -85.07 -36.99 20.83 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 123.246 0.341 . . . . 0.0 110.38 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.13 163.77 18.92 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.669 -174.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.597 HD12 ' H ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -120.25 -175.93 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 124.515 1.134 . . . . 0.0 110.294 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -83.6 129.09 34.96 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 112.612 -2.085 . . . . 0.0 107.474 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.518 HD12 ' CD2' ' A' ' 14' ' ' TYR . 82.4 mt -122.75 133.19 54.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.167 0.917 . . . . 0.0 110.415 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.22 171.32 14.33 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.053 -174.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -72.7 151.22 42.31 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.401 -172.207 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.89 -12.93 15.25 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.111 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.89 141.73 53.1 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.048 0.499 . . . . 0.0 110.206 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 mt -117.1 141.32 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 124.512 1.133 . . . . 0.0 110.01 172.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 30' ' ' LEU . 8.6 mp -107.43 150.15 27.09 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 112.748 -2.024 . . . . 0.0 109.233 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.4 m -128.22 138.98 52.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.19 0.931 . . . . 0.0 110.753 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.5 t -107.76 -155.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 124.367 1.042 . . . . 0.0 108.887 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.629 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.5 t-20 -82.61 174.73 10.76 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.57 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -114.3 -26.49 7.98 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.563 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.84 56.46 0.42 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 t -158.52 57.64 0.45 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 171.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -52.01 -26.29 10.4 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 113.185 -1.825 . . . . 0.0 112.052 166.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.439 ' H ' HG23 ' A' ' 38' ' ' VAL . 3.4 t -57.6 -8.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 124.426 1.079 . . . . 0.0 112.944 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -34.52 -39.5 0.09 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.989 1.431 . . . . 0.0 110.618 170.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 40' ' ' LEU . 19.7 mt -123.81 0.39 8.63 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.653 -1.612 . . . . 0.0 113.991 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.85 34.9 52.05 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.15 162.41 7.41 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 113.213 -1.494 . . . . 0.0 112.117 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.5 p -119.97 176.09 5.59 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.827 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.5 t70 52.65 -88.22 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 124.783 1.302 . . . . 0.0 111.194 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.87 91.83 1.73 Allowed Glycine 0 N--CA 1.494 2.516 0 O-C-N 123.757 0.661 . . . . 0.0 111.628 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.33 -62.05 1.41 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.686 -1.257 . . . . 0.0 108.857 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 51.74 82.94 0.06 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 124.592 1.183 . . . . 0.0 112.259 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.04 -18.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.38 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -116.25 87.32 19.47 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 124.234 0.959 . . . . 0.0 108.996 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.77 -6.23 3.22 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.535 2.157 . . . . 0.0 113.407 173.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.87 -39.48 87.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 123.651 0.594 . . . . 0.0 111.062 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -90.31 -19.87 23.57 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.127 0.892 . . . . 0.0 110.057 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mt -96.04 129.73 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 123.914 0.759 . . . . 0.0 109.782 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.62 -78.69 1.33 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -90.96 133.16 35.5 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.273 -1.464 . . . . 0.0 110.252 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.3 mp -120.75 125.44 47.63 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 172.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.414 ' O ' HG13 ' A' ' 32' ' ' VAL . 65.9 t30 -90.0 120.32 31.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 123.926 0.766 . . . . 0.0 109.559 168.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.91 -163.68 9.6 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.386 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -139.99 123.52 17.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.59 88.45 7.42 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.32 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -53.93 -38.17 64.61 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.199 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -52.02 -47.29 65.08 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.252 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -91.28 -4.82 55.54 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 123.992 0.808 . . . . 0.0 109.836 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.45 36.08 62.81 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 124.325 1.015 . . . . 0.0 111.836 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -135.98 134.37 38.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.231 0.606 . . . . 0.0 110.227 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -89.55 155.45 19.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.341 1.026 . . . . 0.0 109.115 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.86 -161.49 35.2 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.132 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.06 166.33 12.12 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 113.891 -1.154 . . . . 0.0 109.228 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.1 p90 -162.58 140.04 6.27 Favored Pre-proline 0 N--CA 1.496 1.847 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.311 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.458 ' HB2' HG22 ' A' ' 72' ' ' THR . 2.5 Cg_endo -63.14 166.86 13.6 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.875 1.716 . . . . 0.0 112.027 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.15 48.05 1.03 Allowed Glycine 0 N--CA 1.496 2.644 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.599 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.474 HG23 ' CD2' ' A' ' 73' ' ' TYR . 5.0 t -138.39 -28.15 0.85 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.19 0.582 . . . . 0.0 112.507 -177.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.474 ' CD2' HG23 ' A' ' 72' ' ' THR . 68.5 m-85 -90.92 1.62 56.87 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.319 1.012 . . . . 0.0 110.976 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.49 -174.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 124.293 0.996 . . . . 0.0 108.924 -176.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.39 127.97 11.55 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.621 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -60.56 133.5 56.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.685 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.08 -60.57 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 124.339 1.025 . . . . 0.0 110.361 176.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.92 148.0 15.91 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -163.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.436 ' HG2' ' H ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -129.15 128.84 44.25 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 112.803 -1.698 . . . . 0.0 109.734 173.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.24 28.12 0.86 Allowed 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 121.749 0.785 . . . . 0.0 111.68 176.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' H ' ' HG2' ' A' ' 79' ' ' ARG . 37.8 mtpt 47.79 -173.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 113.349 -1.751 . . . . 0.0 113.064 -169.649 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.6 mt -89.47 -8.25 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.327 172.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.08 164.53 43.28 Favored Pre-proline 0 N--CA 1.505 2.299 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 N--CA 1.488 1.148 0 C-N-CA 121.902 1.734 . . . . 0.0 112.931 169.907 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 50.6 m -146.63 108.79 4.43 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.214 -0.993 . . . . 0.0 108.765 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 1.1 tpt -164.22 132.05 3.41 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t 58.84 -165.95 0.18 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 123.826 0.704 . . . . 0.0 112.695 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.24 99.78 0.2 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.107 0.479 . . . . 0.0 110.626 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.28 82.96 5.94 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.754 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.7 -134.33 0.01 OUTLIER Glycine 0 N--CA 1.5 2.942 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.282 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.81 126.5 35.71 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -100.29 157.59 16.49 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.523 0.677 . . . . 0.0 110.859 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -143.99 124.97 14.35 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -90.6 120.9 32.06 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.67 121.12 6.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 123.974 0.796 . . . . 0.0 110.773 168.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -74.14 -46.42 42.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.018 0.824 . . . . 0.0 109.558 176.48 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.84 174.75 10.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.36 1.038 . . . . 0.0 110.152 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.25 133.33 35.99 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.089 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 16' ' ' LYS . 8.9 t80 -120.81 108.5 14.03 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 79.29 2.32 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.938 -171.765 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 31.3 mmtm -142.53 170.7 15.21 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.487 1.136 . . . . 0.0 111.44 170.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -151.45 60.98 0.89 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.804 -166.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -89.67 159.26 17.21 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -60.84 -17.06 47.73 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.133 0.492 . . . . 0.0 111.156 -176.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -105.12 -29.33 10.45 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.555 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -99.92 165.52 11.51 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 123.652 0.595 . . . . 0.0 111.311 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 pt -138.61 173.37 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.083 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -79.51 131.4 36.03 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.11 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 14' ' ' TYR . 20.6 mt -128.87 137.28 51.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.728 1.267 . . . . 0.0 109.429 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 -179.62 5.55 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.2 mt -63.27 151.1 41.54 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.577 171.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.47 -10.55 6.37 Favored Glycine 0 N--CA 1.496 2.683 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.611 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.17 116.5 4.61 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.142 177.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.522 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -97.6 144.04 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.389 0.614 . . . . 0.0 109.418 174.895 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 29' ' ' ILE . 9.1 mp -125.22 153.65 42.81 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.063 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.4 m -137.14 132.36 33.89 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 33' ' ' ASN . 90.8 t -105.98 168.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 32' ' ' VAL . 8.6 m120 -58.1 172.18 0.46 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.902 0.751 . . . . 0.0 112.874 176.231 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 pttm -135.84 95.4 3.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 124.441 2.067 . . . . 0.0 110.026 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.86 -13.7 45.61 Favored Glycine 0 N--CA 1.504 3.194 0 CA-C-N 111.978 -2.374 . . . . 0.0 111.143 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -111.47 50.96 0.8 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 38' ' ' VAL . 1.2 pp -58.42 -17.32 19.64 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 113.985 -1.462 . . . . 0.0 113.327 161.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.551 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.7 t -55.6 -8.83 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 167.119 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -34.92 -38.48 0.08 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 124.421 1.075 . . . . 0.0 111.537 166.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.6 mt -124.82 -7.34 7.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 113.104 -1.862 . . . . 0.0 111.637 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.22 34.26 10.89 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -72.72 161.74 30.37 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.932 -1.134 . . . . 0.0 112.175 177.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -112.51 -168.73 1.36 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.182 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.72 82.56 2.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 123.879 0.737 . . . . 0.0 110.339 169.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.43 -107.79 2.4 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 173.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -140.98 -40.48 0.4 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.786 0.933 . . . . 0.0 108.628 -173.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 56.85 38.29 29.35 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.645 1.216 . . . . 0.0 111.345 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.36 -5.11 0.23 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.503 -173.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -119.16 85.23 29.53 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 124.471 1.107 . . . . 0.0 109.138 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.14 -2.26 5.51 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.151 2.567 . . . . 0.0 113.687 169.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -73.37 -15.83 61.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 123.684 0.615 . . . . 0.0 111.928 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -125.06 -33.86 2.84 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 123.602 0.564 . . . . 0.0 111.194 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.33 146.26 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 123.92 0.763 . . . . 0.0 110.433 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.28 -94.64 1.1 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -95.43 136.29 35.99 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.286 -0.957 . . . . 0.0 110.584 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.4 mp -115.96 138.23 51.39 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.207 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 30.0 m-20 -107.96 118.83 37.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.89 165.91 30.28 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.453 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.2 143.25 26.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.039 0.494 . . . . 0.0 110.182 176.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -116.09 68.48 0.73 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.135 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -47.05 -31.71 3.51 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 114.123 -1.399 . . . . 0.0 114.088 172.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.9 m -50.37 -49.03 55.45 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.531 1.144 . . . . 0.0 111.187 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.9 p -98.03 -2.74 39.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.25 0.969 . . . . 0.0 110.55 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.62 32.27 81.02 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -122.95 176.35 6.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 124.461 0.742 . . . . 0.0 109.244 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -145.69 145.32 30.84 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.03 0.831 . . . . 0.0 109.114 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.28 -156.19 22.86 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.036 -1.554 . . . . 0.0 113.264 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.74 153.91 19.38 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 35.6 p90 -155.18 141.55 13.14 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 123.619 0.575 . . . . 0.0 109.673 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.82 142.02 67.86 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.828 1.685 . . . . 0.0 111.088 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.67 -22.86 78.76 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 124.012 0.82 . . . . 0.0 111.874 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.4 p -72.45 -6.37 43.15 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.035 -0.082 . . . . 0.0 111.025 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -109.73 -6.35 15.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 123.979 0.799 . . . . 0.0 111.785 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.37 -177.21 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 123.933 0.771 . . . . 0.0 109.028 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HB2' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -146.6 123.18 11.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 124.348 1.03 . . . . 0.0 108.948 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -56.26 127.16 29.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.355 1.034 . . . . 0.0 109.572 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.46 -55.08 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 123.874 0.734 . . . . 0.0 110.897 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -146.97 161.23 28.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 107.139 -2.385 . . . . 0.0 107.139 -164.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.43 -175.96 5.63 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.228 -0.989 . . . . 0.0 112.278 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.03 94.25 2.68 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 113.549 -1.66 . . . . 0.0 107.619 158.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -44.6 144.66 1.04 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 112.475 -2.148 . . . . 0.0 110.875 171.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.821 ' H ' HD12 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -90.95 178.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 123.847 0.717 . . . . 0.0 109.112 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.44 163.38 33.74 Favored Pre-proline 0 N--CA 1.509 2.499 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.716 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 N--CA 1.488 1.187 0 C-N-CA 121.709 1.606 . . . . 0.0 112.612 176.457 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' B SER . . . . . 0.408 ' H ' ' H ' ' A' ' 1' C MET . 0.6 OUTLIER -170.34 -4.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 124.082 0.519 . . . . 0.0 110.801 -175.337 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 1' C MET . . . . . 0.408 ' H ' ' H ' ' A' ' 1' B SER . 0.0 OUTLIER -154.11 88.47 1.24 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.536 0.684 . . . . 0.0 110.596 -177.135 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t 60.34 -175.06 0.11 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.256 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.2 106.47 5.87 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.335 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -99.13 79.38 2.33 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.175 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.28 170.06 30.25 Favored Glycine 0 N--CA 1.498 2.832 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.502 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.6 146.01 24.86 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -171.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -133.8 155.88 49.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 123.885 0.741 . . . . 0.0 110.216 -166.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -140.39 125.71 18.81 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.619 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -90.89 126.31 36.01 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.75 126.26 23.36 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.705 0.628 . . . . 0.0 111.317 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.24 -35.77 18.33 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.178 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 146.19 38.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.81 0.694 . . . . 0.0 110.224 -175.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.55 120.91 13.76 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.307 172.378 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.486 ' CD2' HD12 ' A' ' 24' ' ' LEU . 10.0 t80 -125.79 132.42 52.28 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.082 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -90.16 157.14 17.88 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.94 137.36 32.39 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.788 0.68 . . . . 0.0 109.727 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -119.9 -2.51 10.3 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.69 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HB3' ' H ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -120.02 141.7 49.48 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.145 0.903 . . . . 0.0 109.729 177.207 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.44 -17.27 62.51 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.923 171.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.53 -31.22 21.39 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.637 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . 0.425 ' H ' ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -85.68 144.58 27.74 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 123.641 0.588 . . . . 0.0 109.49 179.322 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pt -104.67 171.75 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 124.3 1.0 . . . . 0.0 111.332 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.24 149.34 47.56 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.77 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.486 HD12 ' CD2' ' A' ' 14' ' ' TYR . 96.1 mt -135.04 142.15 46.31 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.124 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.1 170.08 17.4 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 28' ' ' ASP . 1.6 mt -70.89 153.5 42.65 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.05 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.41 -7.75 1.27 Allowed Glycine 0 N--CA 1.505 3.234 0 O-C-N 123.537 0.523 . . . . 0.0 113.331 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 26' ' ' LEU . 26.0 t70 -68.95 109.12 3.78 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.526 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.702 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -89.04 149.9 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -176.018 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.702 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.1 mp -130.62 157.2 43.38 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 124.509 1.131 . . . . 0.0 111.041 174.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -136.83 141.5 42.86 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 123.782 0.676 . . . . 0.0 110.949 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.3 t -116.4 -147.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.597 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.7 OUTLIER -90.2 175.82 6.99 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.844 0.354 . . . . 0.0 110.735 -175.85 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -100.67 -29.62 12.2 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.859 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.36 49.87 0.2 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 t -149.93 64.86 0.98 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mt -53.02 -30.33 34.86 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 112.253 -2.249 . . . . 0.0 112.671 169.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.05 -8.86 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.481 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -33.95 0.06 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 124.243 0.964 . . . . 0.0 112.311 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.7 mt -115.32 -16.59 11.46 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.778 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.99 14.57 33.47 Favored Glycine 0 N--CA 1.498 2.82 0 O-C-N 124.404 1.065 . . . . 0.0 112.167 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -74.99 161.45 29.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.134 0.549 . . . . 0.0 111.106 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -149.36 33.93 0.72 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.033 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.38 -154.32 0.5 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.473 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.93 29.94 0.43 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -91.53 -79.85 0.36 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 114.445 -0.877 . . . . 0.0 111.458 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 58.27 39.21 25.87 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 121.858 0.837 . . . . 0.0 111.79 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.0 -12.21 0.1 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.031 -173.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -120.23 81.5 29.46 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 123.873 0.733 . . . . 0.0 110.198 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.88 -26.63 68.25 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.216 1.944 . . . . 0.0 112.368 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -47.27 -47.04 25.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.883 1.364 . . . . 0.0 111.501 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.63 -37.06 13.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.383 1.052 . . . . 0.0 110.597 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.9 mt -60.5 143.19 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 123.624 0.578 . . . . 0.0 110.081 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.46 -79.48 1.33 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -169.228 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -115.09 129.87 56.79 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 112.694 -1.753 . . . . 0.0 109.189 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.605 ' N ' HD23 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -130.19 143.64 50.9 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.92 173.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 17.0 t30 -90.05 145.05 25.36 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.713 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.97 160.03 30.07 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -113.66 125.35 54.05 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 -101.79 88.09 3.3 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.231 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -47.85 -36.85 12.66 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 113.608 -1.633 . . . . 0.0 111.977 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -42.39 98.59 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -90.74 0.81 57.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 123.793 0.683 . . . . 0.0 109.432 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.01 22.87 13.76 Favored Glycine 0 N--CA 1.497 2.72 0 O-C-N 124.459 1.099 . . . . 0.0 112.315 -168.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -121.74 155.67 34.75 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -137.76 150.54 47.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.621 1.201 . . . . 0.0 109.698 -174.391 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.78 -159.15 30.45 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.011 -1.09 . . . . 0.0 111.216 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.07 144.33 44.77 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -165.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.446 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 33.4 p90 -145.29 151.8 48.74 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 124.375 1.047 . . . . 0.0 108.914 -174.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -66.06 165.74 23.09 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.094 1.863 . . . . 0.0 111.779 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.15 60.4 0.4 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -147.71 -24.91 0.37 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -102.18 15.29 29.57 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 124.08 0.863 . . . . 0.0 111.264 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.5 177.81 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.014 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -148.26 116.3 6.44 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -47.81 143.34 4.1 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.757 165.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.53 -49.1 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 124.371 1.044 . . . . 0.0 111.752 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.84 150.21 22.25 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.333 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -124.18 132.93 53.66 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 113.833 -1.183 . . . . 0.0 111.97 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -124.52 40.34 3.76 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.351 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -71.01 -23.36 62.16 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.679 166.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.4 tt -129.37 142.07 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.694 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.511 ' H ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -149.62 -59.94 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 117.722 -1.132 . . . . 0.0 111.161 175.562 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.511 ' HD2' ' H ' ' A' ' 83' ' ' SER . 1.1 Cg_endo . . . . . 0 N--CA 1.49 1.287 0 CA-C-O 116.152 -1.687 . . . . 0.0 112.34 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 1.2 m 60.95 -170.81 0.15 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 124.189 0.582 . . . . 0.0 112.254 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 0.0 OUTLIER -154.63 -19.59 0.12 Allowed 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.535 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 p -68.09 160.65 28.51 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 123.373 0.42 . . . . 0.0 111.704 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.37 119.33 5.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.491 1.119 . . . . 0.0 111.861 175.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -138.69 50.4 1.86 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 113.681 -1.599 . . . . 0.0 108.959 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.37 -168.37 36.4 Favored Glycine 0 N--CA 1.496 2.698 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.681 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.73 145.72 25.0 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 84.6 mt-30 -123.51 157.94 32.44 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.05 0.929 . . . . 0.0 113.313 -173.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -140.43 121.35 14.55 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 112.397 -2.183 . . . . 0.0 107.486 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.2 ttt-85 -89.82 125.14 35.21 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.17 127.49 32.09 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 124.275 0.985 . . . . 0.0 110.742 171.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tp -92.52 -68.43 0.8 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.074 0.859 . . . . 0.0 109.527 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -98.2 144.52 27.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.028 0.83 . . . . 0.0 109.713 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -62.05 129.31 40.25 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.659 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.447 ' CD2' HD12 ' A' ' 24' ' ' LEU . 19.8 t80 -129.92 133.43 46.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.551 1.157 . . . . 0.0 108.846 175.823 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -90.01 154.33 19.9 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.971 0.794 . . . . 0.0 109.951 171.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.62 142.08 28.01 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.929 -177.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -89.4 -30.42 18.37 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.682 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -150.35 176.93 10.45 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.49 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.46 -18.39 28.27 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.661 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -69.1 -34.46 75.13 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.137 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.65 153.24 22.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.381 1.051 . . . . 0.0 109.406 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 pt -111.39 173.07 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 124.471 1.107 . . . . 0.0 110.534 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.57 132.91 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.186 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.447 HD12 ' CD2' ' A' ' 14' ' ' TYR . 89.8 mt -121.34 127.02 50.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 124.55 1.156 . . . . 0.0 109.866 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.443 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -132.83 172.7 12.23 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.302 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.07 150.98 44.3 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.156 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.05 -13.86 8.65 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.991 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.19 118.28 6.17 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.568 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.1 tp -96.19 151.09 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.714 0.769 . . . . 0.0 109.295 170.851 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.4 mp -127.71 150.84 49.6 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.388 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.3 m -132.4 146.99 52.36 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 123.822 0.701 . . . . 0.0 109.443 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.4 t -121.37 -147.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.53 HD21 ' H ' ' A' ' 33' ' ' ASN . 2.2 p30 -83.06 -170.68 3.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 123.768 0.668 . . . . 0.0 111.773 176.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 -28.12 0.97 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.693 -170.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.98 27.54 0.21 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 69.1 m -141.56 62.54 1.45 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.443 HD11 ' OE1' ' A' ' 47' ' ' GLU . 3.3 mt -50.92 -23.37 2.8 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.161 172.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.8 t -63.19 -12.97 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 124.014 0.821 . . . . 0.0 112.331 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.66 -29.47 7.41 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.456 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.7 mt -106.86 8.95 30.97 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 123.975 0.797 . . . . 0.0 109.754 -173.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.22 21.29 63.93 Favored Glycine 0 N--CA 1.496 2.654 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.316 -170.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.46 150.55 29.67 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.943 -0.628 . . . . 0.0 110.987 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -140.25 38.11 1.91 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 124.453 1.096 . . . . 0.0 108.975 -176.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -143.95 -63.84 0.38 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.807 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.14 100.45 0.6 Allowed Glycine 0 N--CA 1.494 2.504 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.375 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -118.93 -46.02 2.55 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.881 -1.16 . . . . 0.0 108.422 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' OE1' HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER 23.33 54.57 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 125.774 1.922 . . . . 0.0 115.78 -172.742 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.87 -22.33 0.07 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.023 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -116.29 81.97 11.25 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 124.23 0.956 . . . . 0.0 110.753 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.92 -8.76 6.48 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.373 2.049 . . . . 0.0 113.264 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -70.0 -37.78 75.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.85 0.719 . . . . 0.0 111.329 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -89.68 -27.82 19.86 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 123.933 0.771 . . . . 0.0 110.779 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.7 mt -76.68 140.78 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 123.923 0.764 . . . . 0.0 109.07 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.71 -91.76 1.2 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -175.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -98.18 123.27 42.16 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.701 -1.25 . . . . 0.0 109.503 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.6 mp -99.95 164.27 12.08 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.256 174.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 43.4 t-20 -137.4 126.69 24.74 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.36 175.82 33.92 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.247 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -99.59 125.17 45.35 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.87 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -89.63 84.27 6.33 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.22 0.95 . . . . 0.0 109.872 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -56.94 -34.82 68.39 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.116 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.4 m -54.57 -38.63 66.9 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.03 0.831 . . . . 0.0 111.87 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.1 p -99.77 -4.36 30.79 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.808 0.693 . . . . 0.0 111.564 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.92 29.84 76.42 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -136.35 170.41 16.08 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -136.51 150.7 48.8 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.08 0.863 . . . . 0.0 109.251 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.65 -163.69 31.16 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.819 -1.182 . . . . 0.0 111.808 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.95 153.48 22.49 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.513 -0.843 . . . . 0.0 109.552 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.4 p90 -150.89 146.67 19.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.285 -176.329 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -66.59 150.08 83.98 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 121.787 1.658 . . . . 0.0 110.431 175.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.25 23.59 11.33 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 124.078 0.861 . . . . 0.0 111.971 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.98 -34.67 7.12 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.052 0.453 . . . . 0.0 111.23 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -89.92 14.91 10.93 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.193 -174.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.26 171.69 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.218 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -145.9 123.2 11.58 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -48.97 149.06 2.0 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.974 0.796 . . . . 0.0 109.677 170.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.79 -54.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 124.015 0.822 . . . . 0.0 111.336 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.92 146.23 15.43 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.802 -168.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.63 145.19 51.52 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.138 -1.531 . . . . 0.0 110.839 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.72 80.7 1.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.52 171.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.68 127.75 18.9 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 112.659 -2.064 . . . . 0.0 111.411 167.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -89.71 -8.72 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.247 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.5 t -119.9 85.81 35.04 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 123.796 0.685 . . . . 0.0 109.774 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 C--N 1.315 -1.203 0 CA-C-O 115.789 -1.838 . . . . 0.0 112.473 170.318 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.411 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.9 OUTLIER -172.41 -51.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.078 -0.561 . . . . 0.0 109.626 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.1 ptp -57.34 121.33 9.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.31 1.006 . . . . 0.0 111.79 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.21 136.36 33.21 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.13 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.53 122.81 19.79 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.916 0.76 . . . . 0.0 110.634 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -94.8 91.72 6.61 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.111 0.958 . . . . 0.0 109.838 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.12 -127.93 6.23 Favored Glycine 0 N--CA 1.493 2.437 0 CA-C-N 112.875 -1.966 . . . . 0.0 109.046 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -98.05 177.76 5.31 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -174.566 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -145.38 165.57 28.09 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 122.437 1.113 . . . . 0.0 113.121 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -142.91 151.55 41.12 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 112.285 -2.234 . . . . 0.0 107.064 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -119.1 115.47 24.34 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.34 121.21 7.15 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.484 171.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tp -93.79 -43.4 8.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.508 1.13 . . . . 0.0 110.235 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.43 143.54 45.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.578 1.174 . . . . 0.0 110.342 -177.083 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.88 117.47 20.0 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.304 -1.317 . . . . 0.0 109.787 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.494 ' HD2' HD12 ' A' ' 24' ' ' LEU . 16.8 t80 -120.58 131.24 54.56 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -89.1 156.24 18.95 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.652 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -89.19 132.73 34.72 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.622 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -112.51 -13.9 13.29 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.138 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 -129.42 149.33 51.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 124.417 1.073 . . . . 0.0 110.387 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.07 -12.59 61.82 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.878 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -80.09 -19.78 46.64 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.116 0.885 . . . . 0.0 111.514 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.55 159.71 16.85 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.012 0.82 . . . . 0.0 111.497 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 pt -110.63 176.59 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.844 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -73.16 139.88 46.66 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.897 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.494 HD12 ' HD2' ' A' ' 14' ' ' TYR . 16.1 mt -127.52 127.64 44.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.192 0.933 . . . . 0.0 110.566 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.95 -176.61 4.86 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.92 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -61.64 152.98 29.27 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.807 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.14 -11.57 4.8 Favored Glycine 0 N--CA 1.499 2.836 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.801 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' HG21 ' A' ' 62' ' ' THR . 1.1 m-20 -65.17 95.51 0.18 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -91.2 133.25 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.796 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.3 mp -112.83 146.45 38.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 112.494 -2.139 . . . . 0.0 108.756 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 m -132.14 155.79 47.53 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -138.29 169.8 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -170.283 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.14 154.22 42.41 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.776 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -60.73 -27.72 68.13 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.977 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.03 31.56 5.08 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -16.71 61.74 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.713 174.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 2.0 mt -57.07 -34.59 68.43 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 117.993 -1.483 . . . . 0.0 108.243 175.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.36 -9.16 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.82 -36.73 1.57 Allowed 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.32 0.581 . . . . 0.0 110.709 170.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.8 mt -108.52 -15.9 14.33 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 113.987 -1.461 . . . . 0.0 109.507 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.41 38.2 29.44 Favored Glycine 0 N--CA 1.491 2.328 0 O-C-N 124.52 1.137 . . . . 0.0 112.772 -171.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -58.97 163.65 3.38 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 114.502 -0.849 . . . . 0.0 112.327 176.008 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.1 m -124.66 34.31 5.03 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.534 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.1 -165.28 1.01 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.72 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.21 12.05 0.07 OUTLIER Glycine 0 N--CA 1.493 2.495 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.8 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.29 79.32 1.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.49 1.138 . . . . 0.0 109.908 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.37 -4.9 2.07 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 113.996 -1.457 . . . . 0.0 112.591 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.18 -4.83 19.11 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 174.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 79.12 46.49 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.15 -19.22 65.84 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 122.072 1.848 . . . . 0.0 112.365 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -57.62 -40.49 79.29 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.151 0.907 . . . . 0.0 112.549 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -89.9 -27.41 19.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 123.757 0.661 . . . . 0.0 109.961 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.9 mt -70.58 148.32 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.492 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.52 -94.82 1.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -89.78 144.68 25.77 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.203 -0.998 . . . . 0.0 110.256 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 55.0 mt -117.76 133.22 56.16 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.029 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -111.8 117.89 34.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.146 0.904 . . . . 0.0 109.463 175.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.87 175.76 35.06 Favored Glycine 0 N--CA 1.496 2.671 0 O-C-N 124.181 0.925 . . . . 0.0 112.015 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -94.71 150.03 20.63 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.108 -1.046 . . . . 0.0 109.987 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.4 64.13 1.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.372 -1.286 . . . . 0.0 107.959 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.01 -25.48 30.38 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.696 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 28' ' ' ASP . 62.5 m -51.75 -49.35 62.76 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 124.351 1.032 . . . . 0.0 110.914 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -94.61 -3.74 49.04 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 124.331 1.019 . . . . 0.0 111.722 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.06 42.38 77.34 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -141.68 178.38 7.51 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.345 -0.927 . . . . 0.0 108.801 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -147.19 151.69 37.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.97 -153.21 13.32 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 118.895 -1.622 . . . . 0.0 112.38 167.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -104.51 148.78 26.09 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 56' ' ' LEU . 17.0 p90 -153.47 140.29 12.91 Favored Pre-proline 0 N--CA 1.494 1.763 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.423 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.31 160.74 15.61 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.905 1.737 . . . . 0.0 111.949 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.12 35.38 4.6 Favored Glycine 0 N--CA 1.498 2.788 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.177 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.448 HG23 ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.56 -30.52 1.87 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.562 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.448 ' CD1' HG23 ' A' ' 72' ' ' THR . 18.0 m-30 -90.24 13.93 13.99 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.926 0.766 . . . . 0.0 110.874 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.08 176.2 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 124.57 1.168 . . . . 0.0 107.918 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -144.77 113.76 6.88 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -45.17 139.4 3.38 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.959 0.787 . . . . 0.0 110.196 168.469 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.487 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.8 pt -137.02 -66.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 124.597 1.186 . . . . 0.0 109.892 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.487 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -98.22 157.89 20.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 -171.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.43 169.49 8.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.587 0.816 . . . . 0.0 111.485 168.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -58.82 -154.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.255 -1.338 . . . . 0.0 113.117 160.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -67.97 13.56 0.08 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.277 -177.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.07 139.42 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.21 167.26 11.2 Favored Pre-proline 0 N--CA 1.501 2.092 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.972 178.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.485 0.984 0 CA-C-O 116.692 -1.462 . . . . 0.0 110.929 168.164 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 36.0 t -158.89 119.82 3.3 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.033 -0.584 . . . . 0.0 109.857 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 8.8 ttt 55.08 28.13 10.43 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 124.178 0.924 . . . . 0.0 111.252 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -92.72 166.06 12.64 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.866 -177.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.54 93.5 1.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.178 -176.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.415 ' O ' HD12 ' A' ' 82' ' ' ILE . 4.2 mm-40 -75.64 -27.99 58.62 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.009 -177.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.67 -169.22 26.36 Favored Glycine 0 N--CA 1.495 2.577 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.619 172.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.04 150.46 20.15 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 113.583 -1.308 . . . . 0.0 108.031 -177.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -125.65 161.99 26.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 124.192 0.932 . . . . 0.0 111.591 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -138.44 159.57 41.74 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.821 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -120.2 116.27 25.28 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.54 111.55 0.66 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.896 0.748 . . . . 0.0 110.498 170.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -51.37 40.86 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.639 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.38 151.48 49.3 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.511 1.132 . . . . 0.0 109.874 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -57.31 129.23 40.86 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.692 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.489 ' CD2' HD12 ' A' ' 24' ' ' LEU . 16.8 t80 -130.31 129.71 43.56 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.178 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -89.29 155.7 19.21 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.779 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 146.53 24.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.811 0.694 . . . . 0.0 109.388 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -131.78 -7.12 3.59 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.911 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.03 150.55 50.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 124.163 0.914 . . . . 0.0 109.404 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -65.45 -16.97 64.18 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.707 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -78.58 -25.51 45.31 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.728 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.86 154.91 19.43 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.3 1.0 . . . . 0.0 111.174 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 pt -119.13 177.35 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.775 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.87 135.46 38.85 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.826 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.489 HD12 ' CD2' ' A' ' 14' ' ' TYR . 64.9 mt -128.31 135.04 49.06 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 124.294 0.996 . . . . 0.0 110.188 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.51 -174.47 3.65 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.742 -173.058 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.99 154.05 25.9 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.207 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.85 -6.36 2.04 Favored Glycine 0 N--CA 1.502 3.04 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.673 -176.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.93 116.99 7.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.5 mt -104.19 138.89 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 124.287 0.992 . . . . 0.0 109.868 173.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.543 HD11 ' ND2' ' A' ' 60' ' ' ASN . 11.0 mp -110.74 158.95 18.08 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.903 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.8 m -130.58 151.2 51.3 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 123.804 0.69 . . . . 0.0 109.495 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.1 t -119.85 -141.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.531 ' H ' HG12 ' A' ' 32' ' ' VAL . 35.7 m120 -124.71 174.13 8.09 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 124.11 0.881 . . . . 0.0 109.227 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -89.17 0.74 56.5 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.297 169.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.81 -16.62 7.87 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 123.8 0.688 . . . . 0.0 113.397 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 p 74.1 42.03 0.37 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 123.4 1.571 . . . . 0.0 110.482 166.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.461 HD21 ' HG2' ' A' ' 47' ' ' GLU . 45.2 mt 78.95 -16.88 0.63 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 110.551 -3.022 . . . . 0.0 110.194 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.86 -22.42 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 CA-C-O 121.873 0.844 . . . . 0.0 111.084 172.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.17 -22.58 4.42 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.632 -1.622 . . . . 0.0 113.204 166.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.9 mt -110.35 -9.19 14.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 123.992 0.807 . . . . 0.0 110.018 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.2 14.57 50.96 Favored Glycine 0 N--CA 1.497 2.733 0 O-C-N 124.145 0.903 . . . . 0.0 112.714 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.2 168.12 13.51 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.041 0.495 . . . . 0.0 111.11 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.0 m -147.5 66.67 1.12 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.249 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -163.67 -155.35 0.31 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.074 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.2 26.37 2.17 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -85.69 46.77 1.35 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.999 -1.1 . . . . 0.0 110.145 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.461 ' HG2' HD21 ' A' ' 37' ' ' LEU . 34.3 mt-10 -66.81 -26.88 67.15 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.819 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.96 18.38 13.45 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.78 -172.719 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -130.33 73.14 81.55 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 123.899 0.749 . . . . 0.0 110.309 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HG3' ' H ' ' A' ' 76' ' ' TYR . 3.6 Cg_exo -60.85 -4.96 4.04 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.56 2.174 . . . . 0.0 113.536 174.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.83 -39.42 69.77 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.62 0.575 . . . . 0.0 110.895 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.8 -33.05 16.67 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.094 0.871 . . . . 0.0 109.793 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 mt -77.37 125.5 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.54 -78.62 1.32 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -92.56 120.47 33.04 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 113.335 -1.433 . . . . 0.0 110.006 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 2.2 mp -105.9 123.78 48.52 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.088 172.862 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.98 122.41 35.31 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 168.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.68 171.34 32.45 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.015 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.02 150.28 21.07 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.25 -0.975 . . . . 0.0 109.871 176.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.543 ' ND2' HD11 ' A' ' 30' ' ' LEU . 4.4 m120 -120.14 77.21 1.23 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.102 174.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -52.94 -36.13 59.42 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.942 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -53.28 -50.38 64.98 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.264 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.0 p -89.54 4.74 48.3 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.574 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.45 35.21 50.49 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 124.383 1.052 . . . . 0.0 111.483 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -138.65 -175.85 4.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 154.2 37.46 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.384 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.42 -162.82 34.03 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.774 -1.203 . . . . 0.0 112.55 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.82 161.24 13.84 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.079 -1.06 . . . . 0.0 109.711 176.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.481 ' CE1' HD23 ' A' ' 30' ' ' LEU . 34.4 p90 -162.1 142.18 7.65 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.434 175.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.71 155.33 64.03 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 121.547 1.498 . . . . 0.0 111.89 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.46 -12.43 64.93 Favored Glycine 0 N--CA 1.5 2.937 0 O-C-N 123.915 0.759 . . . . 0.0 112.494 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.51 3.62 18.14 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.507 0.323 . . . . 0.0 110.823 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -121.1 -2.16 9.7 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.165 0.916 . . . . 0.0 110.572 -176.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 m -128.08 -177.64 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 124.175 0.922 . . . . 0.0 110.067 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -150.16 113.78 4.99 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.846 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.409 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 28.4 t80 -46.95 142.59 3.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 123.551 0.532 . . . . 0.0 110.388 172.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 pt -118.6 -55.37 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 123.948 0.78 . . . . 0.0 110.409 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.26 147.16 15.73 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.023 -1.084 . . . . 0.0 110.695 -165.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 128.79 46.84 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 112.904 -1.648 . . . . 0.0 110.019 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -68.06 159.72 30.28 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.338 174.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -79.46 68.8 5.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.045 0.84 . . . . 0.0 109.98 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 4' ' ' GLU . 2.4 mt -140.54 1.36 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.907 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.412 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -90.65 -50.46 0.34 Allowed Pre-proline 0 N--CA 1.498 1.964 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.513 170.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 83' ' ' SER . 1.7 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 CA-C-O 116.153 -1.686 . . . . 0.0 111.244 -174.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 4.5 t 60.74 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.214 -0.993 . . . . 0.0 112.168 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 25.8 mtt -141.42 -46.92 0.38 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.478 -175.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.34 139.11 1.66 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.451 0.469 . . . . 0.0 110.299 -177.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.03 117.46 15.84 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.33 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' H ' ' HE2' ' A' ' 81' ' ' LYS . 6.6 mt-10 -88.93 -42.53 11.76 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.89 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.78 -144.66 34.21 Favored Glycine 0 N--CA 1.495 2.614 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.176 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -89.82 168.75 11.83 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 124.239 0.611 . . . . 0.0 109.694 158.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -147.59 165.26 30.91 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.27 1.033 . . . . 0.0 112.698 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -146.19 148.66 32.76 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 112.404 -2.18 . . . . 0.0 106.896 -174.579 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -117.64 113.8 22.45 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.82 103.95 0.07 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.401 1.063 . . . . 0.0 110.723 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.33 -31.48 69.96 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.824 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.93 141.9 38.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.133 0.895 . . . . 0.0 109.845 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.67 112.87 5.03 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.396 174.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -113.5 133.12 55.4 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -89.89 156.52 18.41 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.322 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -88.84 147.17 24.54 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.927 -175.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -122.67 -7.03 8.57 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.299 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -139.01 159.25 42.59 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.731 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.9 -21.16 66.43 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.364 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.99 -23.35 33.36 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.907 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -94.77 146.21 24.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.263 0.977 . . . . 0.0 109.979 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -111.98 176.69 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 124.775 1.297 . . . . 0.0 110.3 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -86.2 106.22 17.14 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.683 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.56 125.37 35.6 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.46 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.78 -173.12 2.18 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.728 1.267 . . . . 0.0 109.256 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.6 mt -74.13 145.72 44.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.69 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.47 10.88 4.63 Favored Glycine 0 N--CA 1.503 3.119 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.206 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.18 127.17 30.58 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.297 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.71 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 mp -104.56 142.84 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 CA-C-O 121.307 0.575 . . . . 0.0 109.46 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.71 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.4 mp -126.82 150.37 49.21 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.028 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.2 m -128.84 149.62 50.67 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 123.956 0.785 . . . . 0.0 110.62 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -120.63 -156.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 O-C-N 123.551 0.532 . . . . 0.0 109.728 179.148 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.599 ' H ' HD22 ' A' ' 33' ' ' ASN . 0.9 OUTLIER -63.01 -157.21 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 171.034 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -138.17 -19.8 1.11 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.03 33.71 0.09 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.5 p -145.81 64.15 1.24 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 113.767 -1.216 . . . . 0.0 108.351 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 43' ' ' SER . 1.2 mt -50.49 -26.32 5.02 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 112.92 -1.945 . . . . 0.0 113.438 169.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.95 -9.25 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.037 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -45.07 -30.48 1.1 Allowed 'General case' 0 N--CA 1.503 2.204 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.178 169.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.4 mt -117.86 -7.31 10.95 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.012 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.93 18.85 57.33 Favored Glycine 0 N--CA 1.495 2.624 0 O-C-N 123.952 0.782 . . . . 0.0 111.352 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -91.29 167.67 12.14 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.585 -0.808 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.466 ' O ' HD13 ' A' ' 37' ' ' LEU . 14.8 m -109.08 170.31 8.13 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.299 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.52 155.11 20.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.753 175.74 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.13 2.38 31.58 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 124.288 0.992 . . . . 0.0 111.89 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -138.78 2.79 2.21 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 123.981 0.46 . . . . 0.0 111.943 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -57.36 -17.96 15.04 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 124.127 0.892 . . . . 0.0 112.462 174.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.21 -2.84 26.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.532 1.145 . . . . 0.0 111.859 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -119.96 79.15 24.84 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 123.97 0.794 . . . . 0.0 111.283 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.83 -13.7 23.68 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.784 1.656 . . . . 0.0 112.744 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -64.11 -38.1 89.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.093 0.871 . . . . 0.0 111.488 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -90.12 -28.09 19.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.931 0.769 . . . . 0.0 110.912 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 mt -74.09 141.47 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 123.866 0.729 . . . . 0.0 109.577 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.43 -92.82 1.15 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -93.23 120.39 33.47 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.603 -1.299 . . . . 0.0 109.679 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.0 mp -100.44 125.38 46.73 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.604 171.213 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -95.99 118.23 32.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.739 0.65 . . . . 0.0 109.729 171.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.01 -179.36 18.95 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -124.42 125.19 43.87 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -96.42 91.99 6.09 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.434 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -52.41 -35.04 50.99 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.021 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.7 m -51.25 -36.98 44.59 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.514 1.134 . . . . 0.0 112.096 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 64.5 p -115.74 2.6 13.7 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.952 0.782 . . . . 0.0 110.064 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.9 18.69 57.58 Favored Glycine 0 N--CA 1.493 2.483 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.746 -174.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -110.02 153.65 24.3 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' CD ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -137.74 146.72 44.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.665 1.228 . . . . 0.0 109.479 -175.78 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.89 -163.04 31.07 Favored Glycine 0 N--CA 1.491 2.314 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.18 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.3 151.15 26.96 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.066 -1.067 . . . . 0.0 109.587 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 26.7 p90 -147.68 144.38 19.17 Favored Pre-proline 0 N--CA 1.493 1.715 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.365 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.29 153.83 71.84 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.745 1.63 . . . . 0.0 111.34 174.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.27 53.17 2.47 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.3 t -134.46 -23.25 1.66 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -105.15 26.75 8.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.141 0.901 . . . . 0.0 110.63 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.46 166.85 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.595 -173.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -144.91 118.8 9.3 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.103 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -48.46 130.62 16.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.05 0.844 . . . . 0.0 110.464 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.491 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.2 pt -135.87 -62.39 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 123.907 0.754 . . . . 0.0 111.426 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.491 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -93.81 159.68 23.91 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 -176.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -127.06 160.33 31.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.758 0.917 . . . . 0.0 110.478 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -27.13 147.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 125.223 1.577 . . . . 0.0 114.555 166.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HE2' ' H ' ' A' ' 4' ' ' GLU . 18.4 mttm -63.2 -12.68 30.08 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.893 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 18.3 mt -99.98 141.45 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 124.166 0.916 . . . . 0.0 108.949 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.76 163.99 41.51 Favored Pre-proline 0 N--CA 1.497 1.917 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.879 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.218 0 CA-C-O 116.404 -1.582 . . . . 0.0 111.744 177.126 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 1.1 p 60.95 154.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 124.837 0.963 . . . . 0.0 113.049 -171.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.0 mtt -104.82 9.49 34.84 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.172 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 p -146.37 172.61 13.24 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 120.97 0.414 . . . . 0.0 111.358 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.58 172.28 12.31 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.292 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -92.87 -71.19 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.724 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.47 -134.6 10.74 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 124.64 1.213 . . . . 0.0 110.153 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -97.73 161.53 13.71 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.531 ' HB3' HD11 ' A' ' 77' ' ' ILE . 30.1 mt-30 -139.4 159.1 42.95 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.506 -173.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -142.68 125.15 15.68 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.1 -1.863 . . . . 0.0 107.601 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -89.61 118.46 29.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.629 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.63 152.48 0.33 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.927 0.767 . . . . 0.0 112.788 170.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -113.29 -44.81 3.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.512 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.34 151.99 41.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.06 0.85 . . . . 0.0 110.799 -175.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.01 116.37 7.76 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.257 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.2 t80 -117.99 138.1 52.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.125 0.891 . . . . 0.0 108.895 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.02 146.4 25.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.297 0.998 . . . . 0.0 109.921 174.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 164.53 14.94 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.176 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.62 -25.24 0.77 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.074 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -108.03 149.68 28.12 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.101 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.56 -12.25 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.531 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -81.76 -40.27 22.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 123.903 0.752 . . . . 0.0 111.187 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.77 156.22 19.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.114 0.884 . . . . 0.0 111.265 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.41 174.43 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.666 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -75.05 131.47 40.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.766 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 14' ' ' TYR . 97.0 mt -121.56 127.46 50.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.587 1.179 . . . . 0.0 109.179 -177.148 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.74 -173.62 2.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.268 0.98 . . . . 0.0 108.904 -175.672 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 26' ' ' LEU . 3.1 mp -83.12 156.53 23.23 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.423 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.12 0.03 1.0 Allowed Glycine 0 N--CA 1.5 2.955 0 O-C-N 123.872 0.732 . . . . 0.0 113.201 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.69 106.29 1.45 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 30' ' ' LEU . 5.6 mt -90.64 132.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.743 174.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.634 HD11 HD22 ' A' ' 60' ' ' ASN . 10.5 mp -108.52 151.52 25.98 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.064 -1.88 . . . . 0.0 109.013 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.8 m -129.43 147.43 51.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 123.842 0.714 . . . . 0.0 109.845 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.431 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -119.59 -147.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 123.807 0.692 . . . . 0.0 109.265 -178.199 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.431 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -97.77 158.12 15.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 123.419 0.449 . . . . 0.0 110.033 178.061 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -85.41 -27.27 25.89 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.033 -173.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.48 32.99 0.41 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -175.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -152.29 49.08 0.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -60.0 -30.78 69.37 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.094 171.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 38' ' ' VAL . 14.5 t -46.02 -8.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 114.195 -1.366 . . . . 0.0 114.351 167.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -32.6 -36.46 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.273 0.983 . . . . 0.0 112.283 169.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.4 mt -92.72 -34.71 13.82 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.457 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.05 9.96 4.93 Favored Glycine 0 N--CA 1.499 2.838 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.361 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.11 167.18 22.33 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.968 -0.616 . . . . 0.0 110.213 -174.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.38 6.81 0.67 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.841 0.829 . . . . 0.0 112.392 172.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -177.19 106.65 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.356 -1.747 . . . . 0.0 108.08 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.25 -6.02 0.32 Allowed Glycine 0 N--CA 1.497 2.728 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 46.15 91.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.064 0.935 . . . . 0.0 111.246 -172.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.61 -14.14 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 113.407 -1.724 . . . . 0.0 113.349 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -86.96 -37.86 17.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -102.31 102.97 27.94 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.999 0.812 . . . . 0.0 111.325 174.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -68.6 -17.99 42.92 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.641 2.227 . . . . 0.0 114.092 167.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.53 -31.67 68.14 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.657 0.598 . . . . 0.0 112.246 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.32 -21.89 21.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.831 0.707 . . . . 0.0 111.376 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.12 146.91 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -91.56 1.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -90.19 131.04 36.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.425 -1.388 . . . . 0.0 109.032 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -108.46 126.82 53.32 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.506 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.6 t30 -100.94 124.23 46.33 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.77 -166.18 16.67 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -140.17 150.19 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.634 HD22 HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -114.23 99.87 7.93 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.274 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.81 -21.49 66.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.3 m -46.05 -37.42 6.7 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.812 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.61 2.46 6.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.849 1.343 . . . . 0.0 108.877 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.64 36.87 73.33 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.614 -176.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -109.51 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.51 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 156.05 40.99 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.767 0.794 . . . . 0.0 111.699 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.66 -153.05 23.3 Favored Glycine 0 N--CA 1.489 2.197 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.032 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.71 153.94 24.57 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -173.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.6 p90 -151.36 140.77 13.95 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.912 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HB2' HG22 ' A' ' 72' ' ' THR . 1.3 Cg_endo -65.15 150.39 87.74 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.53 1.486 . . . . 0.0 110.708 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.29 48.72 4.08 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 70' ' ' PRO . 7.6 t -141.21 16.39 2.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.105 0.532 . . . . 0.0 111.616 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -136.05 -4.08 2.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 123.751 0.657 . . . . 0.0 111.847 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.98 -169.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 123.932 0.77 . . . . 0.0 109.13 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.71 113.58 5.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 172.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 25.2 t80 -48.27 142.97 4.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.442 171.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.5 pt -122.24 -53.5 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 123.926 0.766 . . . . 0.0 111.688 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.84 146.63 15.79 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.478 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 119.58 23.21 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.311 -1.444 . . . . 0.0 109.988 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -177.84 162.32 1.69 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.383 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -66.91 84.82 0.12 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.978 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.4 mt -89.92 130.01 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.659 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.77 161.45 46.19 Favored Pre-proline 0 N--CA 1.5 2.059 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.032 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.185 0 C-N-CA 121.739 1.626 . . . . 0.0 111.566 175.93 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 29.7 m -58.79 -21.48 56.19 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 174.476 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 5.5 ttm -60.16 133.25 55.91 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 123.619 0.574 . . . . 0.0 111.574 174.312 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.36 109.18 0.17 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 124.513 1.133 . . . . 0.0 108.766 -178.263 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.78 -160.91 0.21 Allowed 'General case' 0 N--CA 1.504 2.235 0 O-C-N 123.987 0.804 . . . . 0.0 112.806 -179.276 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -128.12 -68.24 0.78 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.455 176.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.98 -135.09 8.68 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -177.558 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.9 158.32 15.48 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.872 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.685 ' HB3' HD11 ' A' ' 77' ' ' ILE . 21.9 mt-30 -133.01 165.3 25.04 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.145 0.974 . . . . 0.0 111.857 -177.712 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -136.64 128.42 29.05 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.883 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -89.31 114.69 26.11 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.627 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.89 122.53 4.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.362 1.039 . . . . 0.0 111.99 171.288 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.27 -41.37 34.19 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.677 -178.365 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.11 160.62 39.53 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 124.21 0.944 . . . . 0.0 110.376 -177.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.47 127.8 33.76 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.496 173.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.457 ' CD2' HD12 ' A' ' 24' ' ' LEU . 16.4 t80 -126.56 130.48 50.63 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.367 1.042 . . . . 0.0 109.042 173.34 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -90.29 153.88 20.13 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 169.349 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.62 171.9 9.34 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.101 0.876 . . . . 0.0 109.864 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.44 -10.01 1.24 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.094 177.222 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -132.84 154.58 50.19 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.357 -176.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.2 -19.15 62.83 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.55 174.382 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -71.89 -31.17 66.15 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.045 176.492 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.77 152.06 23.02 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 124.23 0.956 . . . . 0.0 110.317 -177.721 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pt -115.46 173.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.834 176.477 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -74.22 134.05 42.7 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.265 -1.788 . . . . 0.0 108.866 -176.387 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.457 HD12 ' CD2' ' A' ' 14' ' ' TYR . 87.4 mt -126.63 136.63 52.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.279 0.987 . . . . 0.0 110.026 -177.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 173.08 11.9 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.699 -173.976 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -67.55 158.02 32.99 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.228 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.3 -10.0 1.49 Allowed Glycine 0 N--CA 1.5 2.909 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.886 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.32 133.15 50.79 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.174 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.17 116.23 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.47 129.94 45.69 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 -168.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.2 m -103.91 146.97 27.89 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 124.006 0.816 . . . . 0.0 110.619 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.1 t -121.03 -149.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 124.52 1.138 . . . . 0.0 108.365 179.435 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.631 ' H ' HG12 ' A' ' 32' ' ' VAL . 4.2 m-80 -82.74 175.91 9.75 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.409 0.443 . . . . 0.0 111.228 176.836 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -112.32 -28.86 7.75 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.616 1.198 . . . . 0.0 110.883 -175.385 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.89 40.29 0.39 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -177.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 t -147.2 66.7 1.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.932 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -52.4 -26.1 11.65 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 112.202 -2.272 . . . . 0.0 112.457 170.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.5 t -66.17 -9.26 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 123.949 0.781 . . . . 0.0 112.705 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' C ' HD12 ' A' ' 40' ' ' LEU . . . -46.96 -34.85 5.9 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 124.378 1.049 . . . . 0.0 111.578 167.885 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 40' ' ' LEU . 9.3 mp -104.03 -4.93 22.67 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 124.108 0.88 . . . . 0.0 111.161 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.49 16.41 71.18 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 123.963 0.79 . . . . 0.0 112.452 -174.615 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -77.18 146.58 36.97 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.058 -0.571 . . . . 0.0 111.391 -177.747 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.8 m -138.42 33.92 2.28 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 124.093 0.871 . . . . 0.0 109.62 -174.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -123.88 -92.59 0.52 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.379 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.24 14.9 0.12 Allowed Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.466 -166.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -61.36 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 O-C-N 123.964 0.449 . . . . 0.0 110.719 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 45.71 39.41 5.09 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.909 0.861 . . . . 0.0 112.908 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -158.95 -22.75 0.07 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.35 -173.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 84.99 37.78 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 124.006 0.816 . . . . 0.0 109.395 175.61 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.555 ' HA ' HD12 ' A' ' 53' ' ' ILE . 5.0 Cg_exo -56.28 -23.0 43.59 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.444 2.096 . . . . 0.0 111.997 173.257 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.42 -45.63 76.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.657 1.223 . . . . 0.0 110.837 -175.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.01 -26.52 20.29 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 124.113 0.883 . . . . 0.0 111.102 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' A' ' 50' ' ' PRO . 62.4 mt -64.66 153.73 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 123.72 0.638 . . . . 0.0 109.857 176.635 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.17 -101.42 1.03 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 178.668 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -92.18 147.25 23.08 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.497 -0.851 . . . . 0.0 110.382 -177.609 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 67.4 mt -117.46 120.22 37.46 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 113.831 -1.531 . . . . 0.0 107.829 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.25 123.16 42.19 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 124.221 0.951 . . . . 0.0 109.732 173.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.07 -173.19 31.49 Favored Glycine 0 N--CA 1.499 2.871 0 O-C-N 124.066 0.853 . . . . 0.0 111.71 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.73 128.7 49.96 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.025 -174.337 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -94.06 62.19 3.03 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 124.445 1.09 . . . . 0.0 109.625 175.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -42.71 -33.9 0.81 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 114.467 -1.242 . . . . 0.0 114.179 173.155 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.9 p -55.08 -50.26 69.6 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 123.598 0.561 . . . . 0.0 112.028 177.218 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -89.83 1.89 55.62 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.059 0.85 . . . . 0.0 111.06 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.99 33.25 86.75 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -131.44 165.32 23.79 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -150.43 156.04 40.71 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 123.571 0.545 . . . . 0.0 110.551 177.163 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.68 -154.14 20.32 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.457 176.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.04 150.78 26.71 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 56' ' ' LEU . 12.8 p90 -154.95 139.43 11.66 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 124.171 0.919 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.95 161.17 19.59 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.126 1.884 . . . . 0.0 112.86 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.08 22.28 32.71 Favored Glycine 0 N--CA 1.495 2.593 0 O-C-N 124.206 0.941 . . . . 0.0 111.871 -176.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.42 -47.4 4.69 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 117.444 0.622 . . . . 0.0 112.65 -174.737 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -94.02 40.34 1.08 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.499 -171.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.39 152.05 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.484 -174.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -131.96 111.82 11.87 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.432 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 75.8 t80 -54.78 122.57 11.03 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.306 174.779 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.685 HD11 ' HB3' ' A' ' 7' ' ' GLN . 0.9 OUTLIER -94.42 -49.6 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 124.113 0.883 . . . . 0.0 110.783 -176.905 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.97 -168.45 41.55 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.912 -1.137 . . . . 0.0 112.696 175.235 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 140.3 51.85 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 113.41 -1.395 . . . . 0.0 109.973 175.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -114.54 37.79 3.3 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.685 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -131.95 -72.05 0.54 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.122 177.439 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 82' ' ' ILE . 3.8 tp -89.7 100.97 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.777 -171.655 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.499 ' H ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -150.09 -57.12 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.08 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.174 -176.73 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 83' ' ' SER . 1.1 Cg_endo . . . . . 0 N--CA 1.489 1.223 0 CA-C-O 116.36 -1.6 . . . . 0.0 111.08 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 33.7 t -61.69 -49.38 76.71 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.682 -0.759 . . . . 0.0 111.31 175.295 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 0.0 OUTLIER 64.24 149.69 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 O-C-N 124.152 0.908 . . . . 0.0 112.13 -173.095 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.51 143.7 23.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.544 173.008 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.14 -140.63 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.284 -1.326 . . . . 0.0 109.304 -176.482 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -126.3 39.53 3.92 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 122.022 0.915 . . . . 0.0 111.66 -174.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.84 -144.64 7.74 Favored Glycine 0 N--CA 1.495 2.594 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.501 176.684 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -98.34 150.81 21.18 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -174.66 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -128.9 164.03 23.99 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 122.849 1.309 . . . . 0.0 113.832 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -141.12 154.7 46.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 111.398 -2.637 . . . . 0.0 107.338 -174.654 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -125.73 121.21 32.74 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.54 126.06 16.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 124.121 0.888 . . . . 0.0 110.935 168.771 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.38 -33.12 23.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.874 0.734 . . . . 0.0 111.017 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.88 157.59 44.26 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.928 0.767 . . . . 0.0 110.346 -174.514 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.89 116.95 19.53 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.26 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' CD2' HD12 ' A' ' 24' ' ' LEU . 5.3 t80 -121.19 133.78 55.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.449 1.093 . . . . 0.0 108.725 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.6 164.57 14.7 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.495 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -89.06 142.36 27.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.616 0.572 . . . . 0.0 109.803 -177.443 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.44 -12.45 5.0 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.96 177.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.91 143.12 51.37 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.336 178.546 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.98 -34.54 76.34 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.083 -178.846 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.69 -35.41 80.69 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.404 177.467 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -88.35 162.09 16.75 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.177 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.64 174.83 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.278 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.79 148.56 42.38 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.936 -177.147 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 14' ' ' TYR . 92.8 mt -133.24 141.28 47.95 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.093 0.87 . . . . 0.0 110.538 178.043 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.78 165.67 26.82 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.532 -171.31 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.7 mt -65.74 151.69 46.02 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.336 174.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.32 -9.4 4.33 Favored Glycine 0 N--CA 1.501 2.995 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.03 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -69.02 132.46 46.68 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.439 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mt -121.05 138.74 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 124.343 1.027 . . . . 0.0 108.629 176.158 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.438 HD23 ' CE1' ' A' ' 69' ' ' PHE . 10.9 mp -107.48 150.21 27.06 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 112.972 -1.922 . . . . 0.0 108.138 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 m -127.5 153.81 45.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.632 0.583 . . . . 0.0 109.992 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -131.29 175.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -176.508 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.49 ' CB ' ' HB3' ' A' ' 36' ' ' SER . 1.8 t-20 -72.39 164.0 27.07 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.794 0.807 . . . . 0.0 110.338 -178.15 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -61.87 -20.45 63.72 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.514 174.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.29 31.06 1.57 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 -175.427 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB3' ' CB ' ' A' ' 33' ' ' ASN . 7.7 p -73.63 8.07 2.08 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 178.807 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.78 -42.22 88.49 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 117.834 -1.546 . . . . 0.0 110.0 160.455 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.7 t -82.0 -9.49 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.967 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.74 -37.17 1.67 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 123.933 0.771 . . . . 0.0 110.281 170.341 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mt -115.45 -0.4 13.12 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.609 -174.184 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.65 33.63 86.66 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 123.819 0.699 . . . . 0.0 113.143 -172.445 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.36 150.12 40.46 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 114.5 -0.85 . . . . 0.0 111.273 -173.68 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -89.4 -152.39 0.24 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.377 175.611 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -40.63 132.6 2.14 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 167.23 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 165.49 103.9 0.17 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -168.79 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.73 -0.81 0.49 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 124.656 0.856 . . . . 0.0 112.211 174.684 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 70.94 4.63 5.15 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.909 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.71 23.32 9.54 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.393 -169.64 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.68 68.65 81.85 Favored Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.674 -176.138 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HG3' ' H ' ' A' ' 76' ' ' TYR . 5.5 Cg_exo -59.23 -23.91 71.7 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.46 2.107 . . . . 0.0 111.73 174.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -59.31 -49.17 78.84 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.285 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -90.09 -35.19 15.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 123.832 0.708 . . . . 0.0 110.909 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.4 mt -64.1 129.86 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 123.943 0.777 . . . . 0.0 109.64 172.122 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.46 -87.41 1.27 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -175.85 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -98.23 124.87 43.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.609 -1.296 . . . . 0.0 108.144 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.582 ' H ' HD23 ' A' ' 56' ' ' LEU . 1.4 pt? -132.65 144.67 50.5 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 173.686 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 11.9 t30 -92.87 147.84 22.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.594 1.184 . . . . 0.0 108.867 -176.066 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.86 154.13 25.25 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 175.604 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.46 122.49 32.7 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.062 -1.069 . . . . 0.0 108.487 176.376 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -96.47 69.66 2.61 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.977 0.894 . . . . 0.0 111.168 177.005 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -52.31 -26.76 12.96 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 113.754 -1.567 . . . . 0.0 112.458 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.4 p -51.67 -51.72 53.64 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.037 0.836 . . . . 0.0 112.782 174.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.6 p -91.6 2.28 56.56 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.228 176.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.86 30.37 77.81 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.615 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -129.34 178.32 6.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 124.506 0.768 . . . . 0.0 109.508 -178.44 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -144.51 147.66 33.52 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.506 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.17 -163.01 28.54 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 118.79 -1.671 . . . . 0.0 113.847 166.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.69 152.74 19.32 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 113.17 -1.515 . . . . 0.0 108.98 -178.192 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.438 ' CE1' HD23 ' A' ' 30' ' ' LEU . 24.4 p90 -154.36 152.74 26.88 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 123.654 0.596 . . . . 0.0 109.803 175.215 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -65.66 165.25 23.67 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 122.32 2.013 . . . . 0.0 112.007 176.494 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.55 -2.35 67.71 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 123.987 0.804 . . . . 0.0 111.57 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -96.34 -34.13 11.69 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.507 0.67 . . . . 0.0 109.833 -166.689 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -90.95 6.11 45.99 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.567 -1.652 . . . . 0.0 111.529 -174.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.34 -177.75 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 124.208 0.942 . . . . 0.0 109.046 -178.429 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.34 115.95 5.51 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.576 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' TYR . . . . . 0.404 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 32.2 t80 -49.4 128.91 18.03 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 166.182 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.67 -54.72 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 124.131 0.894 . . . . 0.0 109.721 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.94 171.92 36.36 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.681 -1.724 . . . . 0.0 110.502 -170.484 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.37 146.27 27.41 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.732 -1.234 . . . . 0.0 109.404 168.673 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -78.15 100.92 6.79 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.065 166.505 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.23 95.33 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.464 176.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.461 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -99.98 140.94 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.921 177.165 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.55 163.15 45.21 Favored Pre-proline 0 N--CA 1.498 1.963 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.754 -177.517 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 C-N-CA 121.887 1.725 . . . . 0.0 112.301 176.285 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.9 OUTLIER -75.02 136.21 41.25 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 124.128 0.546 . . . . 0.0 110.895 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.2 ptp -87.76 60.72 6.08 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.936 0.874 . . . . 0.0 110.868 -176.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -165.23 142.95 6.03 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.986 -172.676 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.77 -1.29 0.09 Allowed 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.394 177.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.22 82.34 0.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 124.485 1.116 . . . . 0.0 108.772 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -141.8 -151.31 5.51 Favored Glycine 0 N--CA 1.497 2.717 0 CA-C-N 112.528 -2.124 . . . . 0.0 111.083 -178.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.72 154.96 17.59 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -136.73 162.01 34.38 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.848 0.833 . . . . 0.0 110.991 -169.31 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -129.64 170.75 13.4 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.587 -1.642 . . . . 0.0 107.341 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -133.89 116.65 15.87 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.477 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.14 112.03 0.98 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.301 1.0 . . . . 0.0 110.013 174.52 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.4 tp -70.07 -38.49 75.75 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.514 -177.594 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.61 170.83 15.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 124.582 1.176 . . . . 0.0 109.981 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.22 123.2 28.27 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.529 175.199 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CD2' HD12 ' A' ' 24' ' ' LEU . 8.5 t80 -118.83 134.25 55.29 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -89.74 159.12 17.23 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.047 175.635 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -88.3 141.09 28.83 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -176.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -121.32 -8.65 9.16 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.644 178.224 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -136.67 146.62 46.14 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.611 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -60.41 -31.01 69.98 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.166 174.549 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.58 -32.75 73.8 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.3 178.431 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.36 161.1 14.53 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.304 1.002 . . . . 0.0 110.107 177.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 pt -116.94 174.86 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 124.349 1.031 . . . . 0.0 111.545 176.298 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.52 141.95 46.73 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.125 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.5 HD12 ' CD2' ' A' ' 14' ' ' TYR . 18.0 mt -131.38 135.17 46.98 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.968 0.792 . . . . 0.0 111.534 178.279 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.31 176.52 8.62 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.247 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mp -72.47 154.53 40.81 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.937 -177.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.69 -5.57 2.33 Favored Glycine 0 N--CA 1.5 2.931 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.896 -176.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.64 101.13 0.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.233 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.95 135.96 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 124.274 0.984 . . . . 0.0 110.099 173.118 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 69' ' ' PHE . 11.1 mp -111.2 157.03 20.56 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.968 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.5 m -133.37 150.8 51.81 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.768 0.668 . . . . 0.0 110.407 -176.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.4 t -128.31 -151.93 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 123.841 0.713 . . . . 0.0 109.151 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.588 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.8 m-80 -87.18 -173.66 4.52 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.869 178.059 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -133.76 -41.05 0.85 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.504 -173.152 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.28 22.84 3.52 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 t -143.14 61.02 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.513 HD21 ' OE1' ' A' ' 47' ' ' GLU . 4.6 mt -51.72 -18.73 1.31 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 112.717 -2.038 . . . . 0.0 113.206 167.73 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.0 -23.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 124.488 1.117 . . . . 0.0 113.563 176.851 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.451 ' O ' HD23 ' A' ' 40' ' ' LEU . . . -40.7 -28.59 0.08 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 112.516 -2.129 . . . . 0.0 112.316 168.149 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 39' ' ' ALA . 26.0 mt -125.96 -7.61 6.63 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.518 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.44 36.45 30.22 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -178.816 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.79 176.48 5.15 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 112.731 -1.734 . . . . 0.0 109.675 -172.451 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.4 t -132.52 142.02 49.01 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.623 175.965 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.04 117.73 4.29 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.023 173.392 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.76 -43.55 0.06 OUTLIER Glycine 0 N--CA 1.494 2.511 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.613 -179.205 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -150.13 69.12 1.0 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.38 -1.41 . . . . 0.0 108.509 -167.72 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.513 ' OE1' HD21 ' A' ' 37' ' ' LEU . 14.6 mt-10 -100.54 56.99 0.91 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.606 172.619 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.45 -0.84 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.596 178.568 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -123.0 77.78 50.81 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 123.93 0.769 . . . . 0.0 109.557 -176.834 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.43 -18.83 15.73 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.888 2.392 . . . . 0.0 112.7 175.583 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -53.97 -42.62 69.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.087 0.867 . . . . 0.0 111.806 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -89.8 -29.6 18.53 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.1 0.875 . . . . 0.0 110.926 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 mt -73.54 136.7 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.82 -87.08 1.31 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -172.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -102.75 131.22 49.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.309 -1.445 . . . . 0.0 109.051 -178.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -114.5 138.31 50.76 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.233 173.958 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 -108.29 124.33 50.15 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 173.221 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -151.14 176.87 29.46 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 120.079 -1.058 . . . . 0.0 112.006 177.829 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -110.52 131.24 55.22 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.149 -1.025 . . . . 0.0 109.275 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -103.43 102.82 12.75 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.682 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.11 -36.31 72.72 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.284 177.775 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.4 m -56.63 -28.49 60.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.494 1.121 . . . . 0.0 111.996 -177.502 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -116.9 -2.96 11.69 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.645 -176.602 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.15 19.81 32.95 Favored Glycine 0 N--CA 1.497 2.748 0 O-C-N 124.405 1.066 . . . . 0.0 111.37 -172.751 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.98 165.78 13.31 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -172.088 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.16 149.8 40.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.006 0.816 . . . . 0.0 109.68 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.72 -145.19 6.66 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.456 173.569 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.39 153.67 30.62 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.145 -1.027 . . . . 0.0 108.29 -173.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 31.1 p90 -157.01 143.55 13.26 Favored Pre-proline 0 N--CA 1.493 1.699 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.751 178.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.08 157.87 46.86 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 122.111 1.874 . . . . 0.0 112.043 176.064 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.94 43.62 1.92 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.92 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -134.0 -26.38 1.52 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 178.066 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -93.21 2.4 56.67 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.463 -177.945 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.42 -176.44 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 124.306 1.004 . . . . 0.0 109.227 -177.468 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -150.27 115.15 5.31 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.716 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -48.36 122.26 5.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.142 0.901 . . . . 0.0 109.343 171.138 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.97 -51.1 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.039 177.485 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -166.16 159.84 33.21 Favored Glycine 0 N--CA 1.485 1.911 0 C-N-CA 118.814 -1.66 . . . . 0.0 110.688 -178.868 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.478 ' H ' ' CD ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -129.54 124.55 34.17 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.866 -2.167 . . . . 0.0 105.957 173.962 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -57.53 141.47 47.69 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.25 169.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -50.91 109.16 0.29 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.118 0.886 . . . . 0.0 110.649 171.974 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.589 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -88.66 -6.92 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.129 173.54 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.32 157.5 47.48 Favored Pre-proline 0 N--CA 1.503 2.207 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -175.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.491 1.338 0 C-N-CA 122.314 2.01 . . . . 0.0 111.732 -179.513 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 55.3 p -65.82 -37.6 86.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.451 178.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 19.3 mmt -73.25 110.39 7.5 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.833 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.48 169.13 23.64 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.37 -175.398 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.82 95.55 9.91 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.781 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.22 21.96 3.46 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.03 -178.808 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.93 -160.71 0.1 OUTLIER Glycine 0 N--CA 1.495 2.589 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.547 167.619 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -89.44 177.75 6.49 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -163.494 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -144.43 159.56 42.53 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 117.413 -1.715 . . . . 0.0 113.67 -174.535 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -146.31 143.96 29.49 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 112.345 -2.207 . . . . 0.0 107.439 -172.406 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -118.57 112.96 20.55 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -174.606 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.17 121.67 3.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.302 1.001 . . . . 0.0 109.983 175.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -79.8 -68.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.205 176.791 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.41 171.79 7.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.382 1.052 . . . . 0.0 109.924 -177.012 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.43 121.12 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.38 175.539 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD2' HD12 ' A' ' 24' ' ' LEU . 12.9 t80 -124.87 129.33 50.19 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.237 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -89.82 -170.33 2.77 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -88.33 144.89 26.13 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.039 175.221 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.39 -15.7 9.06 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.802 173.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -150.18 147.48 27.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.553 1.158 . . . . 0.0 108.796 -178.601 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.11 -11.31 0.67 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.033 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 18' ' ' ARG . 1.3 mm-40 -81.37 -44.68 17.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 124.212 0.945 . . . . 0.0 111.261 177.661 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.75 165.47 18.85 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.855 0.722 . . . . 0.0 109.334 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 177.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 122.507 1.146 . . . . 0.0 110.85 177.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -82.23 113.11 19.83 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 111.927 -2.397 . . . . 0.0 106.781 -178.323 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' A' ' 14' ' ' TYR . 61.6 mt -103.76 143.19 33.13 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.422 0.629 . . . . 0.0 111.769 179.288 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 172.15 15.72 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.271 -176.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.613 HD12 ' H ' ' A' ' 26' ' ' LEU . 6.5 mp -64.84 155.75 33.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.016 -177.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.19 -12.96 2.89 Favored Glycine 0 N--CA 1.504 3.187 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.476 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -76.58 113.89 14.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.205 0.591 . . . . 0.0 109.609 -175.737 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -96.91 149.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.246 0.546 . . . . 0.0 109.885 179.658 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.518 HD23 ' CE1' ' A' ' 69' ' ' PHE . 10.1 mp -124.47 145.91 49.25 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.228 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 m -127.1 125.63 41.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.165 0.916 . . . . 0.0 109.616 -177.351 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 33' ' ' ASN . 6.4 t -95.85 -124.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.951 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.411 ' N ' HG12 ' A' ' 32' ' ' VAL . 74.9 m-80 -140.03 -173.84 3.76 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -171.127 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 pttm -116.13 5.55 13.8 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.436 173.272 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.19 -12.25 11.49 Favored Glycine 0 N--CA 1.495 2.599 0 CA-C-O 118.941 -0.922 . . . . 0.0 112.88 178.198 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p 77.45 41.96 0.13 Allowed 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.463 1.125 . . . . 0.0 109.811 165.793 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mt 81.45 -15.31 0.73 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 111.554 -2.566 . . . . 0.0 110.337 177.081 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.91 -20.3 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.543 169.66 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.51 -22.1 19.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.533 167.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.448 HD21 ' H ' ' A' ' 57' ' ' ASN . 9.3 mt -114.46 0.52 14.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.052 0.845 . . . . 0.0 110.939 -179.047 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.6 16.67 80.56 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.842 -170.149 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -91.59 155.08 18.62 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 97.6 p -137.74 7.48 2.75 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.022 0.915 . . . . 0.0 113.235 176.207 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -176.31 104.07 0.07 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.944 -1.935 . . . . 0.0 107.256 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.15 -14.47 0.03 OUTLIER Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.561 170.443 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 59.02 99.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.682 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.52 -17.62 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 168.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 -11.89 55.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.1 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 82.37 48.52 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 124.219 0.949 . . . . 0.0 108.587 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.23 -10.68 26.77 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.118 1.879 . . . . 0.0 113.021 173.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.89 -36.73 79.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.719 0.637 . . . . 0.0 111.608 -176.037 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -91.4 -29.98 16.76 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.279 -176.217 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -71.6 149.82 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.222 177.07 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.4 -95.31 1.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -98.8 126.22 44.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.826 0.956 . . . . 0.0 110.061 -175.836 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.7 mp -98.29 145.09 27.01 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.429 174.252 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.448 ' H ' HD21 ' A' ' 40' ' ' LEU . 1.4 m120 -104.54 125.92 51.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.2 0.937 . . . . 0.0 108.664 169.879 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.7 160.39 27.95 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.382 173.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.76 122.24 31.97 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.124 -1.038 . . . . 0.0 109.7 172.458 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -92.44 64.76 4.37 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.674 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -52.61 -31.2 35.27 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.006 -178.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.445 HG21 ' H ' ' A' ' 29' ' ' ILE . 37.6 p -53.89 -48.28 70.27 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.116 0.885 . . . . 0.0 111.49 179.142 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -89.74 -5.47 56.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.03 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.44 24.98 64.26 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 177.773 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -129.28 179.34 5.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.506 0.768 . . . . 0.0 109.144 -175.407 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -147.14 151.67 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.453 179.012 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.68 -161.08 33.2 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.2 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.96 162.18 15.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -170.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.518 ' CE1' HD23 ' A' ' 30' ' ' LEU . 23.4 p90 -160.65 148.47 12.69 Favored Pre-proline 0 N--CA 1.496 1.845 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.12 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.85 150.03 89.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.698 1.598 . . . . 0.0 111.209 177.568 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.04 48.09 2.22 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 175.23 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -146.71 8.16 0.98 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.819 0.364 . . . . 0.0 111.565 174.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.05 9.34 9.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.967 0.792 . . . . 0.0 111.473 -178.603 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 -171.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 124.016 0.823 . . . . 0.0 109.702 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HB2' HD23 ' A' ' 11' ' ' LEU . 10.0 tt0 -150.15 102.36 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.179 175.014 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -41.99 136.32 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.496 170.214 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.3 pt -139.57 -67.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 124.005 0.816 . . . . 0.0 110.604 -177.741 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.486 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -89.86 159.02 27.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -173.01 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -171.18 133.0 0.84 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.88 -168.007 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.1 mttm 54.23 112.63 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 112.097 -2.32 . . . . 0.0 113.229 169.402 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp 43.11 37.9 1.35 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.761 -175.644 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.459 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -88.99 123.65 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 118.424 -1.31 . . . . 0.0 109.527 -171.769 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.16 163.95 23.18 Favored Pre-proline 0 N--CA 1.503 2.177 0 CA-C-N 112.849 -1.978 . . . . 0.0 108.919 -171.775 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 C-N-CA 121.779 1.653 . . . . 0.0 111.918 175.731 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 55.3 p -65.82 -37.6 86.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.451 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 19.3 mmt -73.25 110.39 7.5 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.833 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.48 169.13 23.64 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.37 -175.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.82 95.55 9.91 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.781 -177.327 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.22 21.96 3.46 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.03 -178.808 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.93 -160.71 0.1 OUTLIER Glycine 0 N--CA 1.495 2.589 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.547 167.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -89.44 177.75 6.49 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -163.494 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -144.43 159.56 42.53 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 117.413 -1.715 . . . . 0.0 113.67 -174.535 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -146.31 143.96 29.49 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 112.345 -2.207 . . . . 0.0 107.439 -172.406 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -118.57 112.96 20.55 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -174.606 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.17 121.67 3.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.302 1.001 . . . . 0.0 109.983 175.071 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -79.8 -68.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.205 176.791 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.41 171.79 7.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.382 1.052 . . . . 0.0 109.924 -177.012 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.43 121.12 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.38 175.539 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD2' HD12 ' A' ' 24' ' ' LEU . 12.9 t80 -124.87 129.33 50.19 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.237 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -89.82 -170.33 2.77 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.69 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -88.33 144.89 26.13 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.039 175.221 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.39 -15.7 9.06 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.802 173.987 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -150.18 147.48 27.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.553 1.158 . . . . 0.0 108.796 -178.601 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.11 -11.31 0.67 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.033 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 18' ' ' ARG . 1.3 mm-40 -81.37 -44.68 17.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 124.212 0.945 . . . . 0.0 111.261 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.75 165.47 18.85 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.855 0.722 . . . . 0.0 109.334 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 177.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 122.507 1.146 . . . . 0.0 110.85 177.707 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -82.23 113.11 19.83 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 111.927 -2.397 . . . . 0.0 106.781 -178.323 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' A' ' 14' ' ' TYR . 61.6 mt -103.76 143.19 33.13 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.422 0.629 . . . . 0.0 111.769 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 172.15 15.72 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.271 -176.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.613 HD12 ' H ' ' A' ' 26' ' ' LEU . 6.5 mp -64.84 155.75 33.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.016 -177.457 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.19 -12.96 2.89 Favored Glycine 0 N--CA 1.504 3.187 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.476 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -76.58 113.89 14.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.205 0.591 . . . . 0.0 109.609 -175.737 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -96.91 149.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.246 0.546 . . . . 0.0 109.885 179.658 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.518 HD23 ' CE1' ' A' ' 69' ' ' PHE . 10.1 mp -124.47 145.91 49.25 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.228 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 m -127.1 125.63 41.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.165 0.916 . . . . 0.0 109.616 -177.351 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 33' ' ' ASN . 6.4 t -95.85 -124.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.951 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.411 ' N ' HG12 ' A' ' 32' ' ' VAL . 74.9 m-80 -140.03 -173.84 3.76 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -171.127 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 pttm -116.13 5.55 13.8 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.436 173.272 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.19 -12.25 11.49 Favored Glycine 0 N--CA 1.495 2.599 0 CA-C-O 118.941 -0.922 . . . . 0.0 112.88 178.198 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p 77.45 41.96 0.13 Allowed 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.463 1.125 . . . . 0.0 109.811 165.793 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mt 81.45 -15.31 0.73 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 111.554 -2.566 . . . . 0.0 110.337 177.081 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.91 -20.3 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.543 169.66 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.51 -22.1 19.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.533 167.26 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.448 HD21 ' H ' ' A' ' 57' ' ' ASN . 9.3 mt -114.46 0.52 14.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.052 0.845 . . . . 0.0 110.939 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.6 16.67 80.56 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.842 -170.149 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -91.59 155.08 18.62 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 97.6 p -137.74 7.48 2.75 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.022 0.915 . . . . 0.0 113.235 176.207 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -176.31 104.07 0.07 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.944 -1.935 . . . . 0.0 107.256 -175.235 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.15 -14.47 0.03 OUTLIER Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.561 170.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 59.02 99.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.52 -17.62 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 168.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 -11.89 55.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.1 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 82.37 48.52 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 124.219 0.949 . . . . 0.0 108.587 -177.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.23 -10.68 26.77 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.118 1.879 . . . . 0.0 113.021 173.596 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.89 -36.73 79.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.719 0.637 . . . . 0.0 111.608 -176.037 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -91.4 -29.98 16.76 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.279 -176.217 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -71.6 149.82 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.222 177.07 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.4 -95.31 1.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 177.232 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -98.8 126.22 44.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.826 0.956 . . . . 0.0 110.061 -175.836 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.7 mp -98.29 145.09 27.01 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.429 174.252 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.448 ' H ' HD21 ' A' ' 40' ' ' LEU . 1.4 m120 -104.54 125.92 51.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.2 0.937 . . . . 0.0 108.664 169.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.7 160.39 27.95 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.382 173.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.76 122.24 31.97 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.124 -1.038 . . . . 0.0 109.7 172.458 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -92.44 64.76 4.37 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.674 176.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -52.61 -31.2 35.27 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.006 -178.012 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.445 HG21 ' H ' ' A' ' 29' ' ' ILE . 37.6 p -53.89 -48.28 70.27 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.116 0.885 . . . . 0.0 111.49 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -89.74 -5.47 56.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.03 177.163 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.44 24.98 64.26 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 177.773 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -129.28 179.34 5.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.506 0.768 . . . . 0.0 109.144 -175.407 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -147.14 151.67 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.453 179.012 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.68 -161.08 33.2 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.2 176.8 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.96 162.18 15.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -170.866 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' PHE . . . . . 0.518 ' CE1' HD23 ' A' ' 30' ' ' LEU . 23.4 p90 -160.65 148.47 12.69 Favored Pre-proline 0 N--CA 1.496 1.845 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.12 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.85 150.03 89.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.698 1.598 . . . . 0.0 111.209 177.568 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.04 48.09 2.22 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -146.71 8.16 0.98 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.819 0.364 . . . . 0.0 111.565 174.842 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.05 9.34 9.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.967 0.792 . . . . 0.0 111.473 -178.603 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 -171.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 124.016 0.823 . . . . 0.0 109.702 -173.043 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HB2' HD23 ' A' ' 11' ' ' LEU . 10.0 tt0 -150.15 102.36 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.179 175.014 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -41.99 136.32 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.496 170.214 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.3 pt -139.57 -67.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 124.005 0.816 . . . . 0.0 110.604 -177.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.486 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -89.86 159.02 27.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -173.01 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -171.18 133.0 0.84 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.88 -168.007 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.1 mttm 54.23 112.63 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 112.097 -2.32 . . . . 0.0 113.229 169.402 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp 43.11 37.9 1.35 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.761 -175.644 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.459 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -88.99 123.65 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 118.424 -1.31 . . . . 0.0 109.527 -171.769 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.16 163.95 23.18 Favored Pre-proline 0 N--CA 1.503 2.177 0 CA-C-N 112.849 -1.978 . . . . 0.0 108.919 -171.775 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 C-N-CA 121.779 1.653 . . . . 0.0 111.918 175.731 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' B SER . . . . . . . . . . . . . 5.4 t -155.81 146.31 21.88 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.017 0.481 . . . . 0.0 110.084 -179.011 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 1' C MET . . . . . . . . . . . . . 11.6 tpt 55.97 79.44 0.17 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 124.216 0.947 . . . . 0.0 111.572 176.309 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 p -157.65 74.16 0.73 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.886 -175.173 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.4 107.18 14.87 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.17 176.024 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -89.75 -12.86 38.11 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.818 177.685 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.95 -112.6 0.27 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 177.69 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -111.19 159.68 17.65 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.831 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.547 ' HB3' HD11 ' A' ' 77' ' ' ILE . 70.0 mt-30 -133.38 160.31 37.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 124.038 0.836 . . . . 0.0 111.602 -177.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -138.35 162.04 35.4 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.078 -1.874 . . . . 0.0 108.05 -177.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -125.87 112.9 16.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.293 0.996 . . . . 0.0 108.738 -179.35 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.41 108.93 0.43 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.321 170.315 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.68 -14.41 32.3 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.15 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.38 141.46 41.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.308 1.005 . . . . 0.0 110.544 -179.176 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.59 115.32 17.26 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.182 171.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -125.96 136.15 52.67 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 124.323 1.015 . . . . 0.0 109.101 176.909 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -89.79 163.3 15.11 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.074 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -89.02 140.6 29.27 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.851 0.719 . . . . 0.0 109.514 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -89.74 -25.34 21.2 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.994 -179.356 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -150.2 162.22 40.88 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.363 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -52.52 -14.89 0.55 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.137 -1.392 . . . . 0.0 114.609 173.893 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -75.94 -42.8 47.63 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 123.61 0.569 . . . . 0.0 110.767 177.822 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.35 146.48 24.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.02 0.825 . . . . 0.0 110.161 177.418 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -99.03 173.14 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.058 175.832 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.36 140.6 37.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.644 -177.176 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -125.86 138.91 53.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.497 1.123 . . . . 0.0 109.277 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.04 -155.14 0.67 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.043 -171.911 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.8 mt -106.4 144.29 33.29 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.706 0.629 . . . . 0.0 111.12 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.09 6.6 5.71 Favored Glycine 0 N--CA 1.503 3.11 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.667 178.322 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.89 144.25 54.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 123.93 0.429 . . . . 0.0 110.498 173.728 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.618 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.3 mp -108.9 146.79 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 124.569 1.168 . . . . 0.0 107.933 -177.761 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.618 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.4 mp -128.57 129.04 45.4 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.747 172.021 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 97.0 m -106.5 152.32 23.82 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 124.269 0.981 . . . . 0.0 109.273 -178.919 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -131.67 -173.45 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 124.079 0.862 . . . . 0.0 109.115 -179.133 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -80.76 160.82 24.78 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.7 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -55.41 -33.03 63.17 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.57 175.899 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -127.65 40.99 1.65 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 106.389 -2.685 . . . . 0.0 106.389 -177.202 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -16.6 41.23 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.575 -1.312 . . . . 0.0 111.811 -177.983 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 mt -57.12 -47.72 80.42 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.451 -0.9 . . . . 0.0 108.765 172.238 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.6 t -74.02 -10.66 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.499 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.89 -30.08 9.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.106 0.879 . . . . 0.0 110.158 176.122 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 40' ' ' LEU . 3.0 mm? -103.57 -36.94 7.75 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.765 -179.526 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.84 18.66 3.17 Favored Glycine 0 N--CA 1.493 2.479 0 O-C-N 125.755 1.909 . . . . 0.0 113.279 -174.699 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -69.05 174.94 4.07 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.334 0.588 . . . . 0.0 111.637 176.001 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.5 p -123.29 -178.05 3.88 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.884 176.56 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -56.36 104.12 0.13 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.434 1.084 . . . . 0.0 111.331 174.67 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.88 -110.11 0.94 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -178.008 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' GLN . . . . . 0.447 ' C ' ' H ' ' A' ' 48' ' ' ALA . 0.6 OUTLIER -155.73 89.11 1.15 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.622 1.201 . . . . 0.0 109.865 -172.951 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.6 16.73 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.578 172.59 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 46' ' ' GLN . . . -103.99 -14.15 16.06 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.288 -178.444 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -112.04 94.46 25.48 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 124.197 0.936 . . . . 0.0 108.942 173.961 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.67 -20.9 53.03 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.266 1.977 . . . . 0.0 112.768 166.937 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -59.16 -36.6 75.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.898 0.749 . . . . 0.0 111.951 -175.014 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.75 -31.83 17.26 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 123.856 0.723 . . . . 0.0 109.241 -176.612 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.73 146.17 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 124.123 0.889 . . . . 0.0 110.144 175.324 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.84 -99.69 1.1 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.978 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -89.79 131.94 35.48 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.416 -0.892 . . . . 0.0 110.01 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -102.04 156.26 17.65 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.855 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 t30 -134.21 121.5 21.44 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.549 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.9 -162.38 17.1 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -176.773 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.73 130.01 31.38 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -172.821 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -93.63 68.1 3.98 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.182 -1.826 . . . . 0.0 108.856 174.346 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -43.05 -29.54 0.36 Allowed 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 114.538 -1.21 . . . . 0.0 114.023 175.709 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.489 HG21 ' H ' ' A' ' 29' ' ' ILE . 82.8 p -45.85 -51.02 13.67 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.426 1.079 . . . . 0.0 112.328 178.11 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -106.44 0.26 24.65 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.986 174.982 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.43 37.81 53.22 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 175.333 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -109.3 135.75 49.87 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.227 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -120.99 125.36 47.17 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 123.811 0.694 . . . . 0.0 110.469 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.77 -147.21 8.0 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 119.521 -1.323 . . . . 0.0 114.094 176.777 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.19 164.39 12.91 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 113.782 -1.209 . . . . 0.0 108.898 -177.01 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -163.83 140.87 5.54 Favored Pre-proline 0 N--CA 1.494 1.728 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.614 175.726 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' PRO . . . . . 0.408 ' HB2' HG22 ' A' ' 72' ' ' THR . 2.4 Cg_endo -59.7 155.96 40.1 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.389 2.06 . . . . 0.0 112.305 -177.694 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.86 47.95 1.83 Allowed Glycine 0 N--CA 1.497 2.704 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.704 179.547 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.689 HG23 ' CD1' ' A' ' 73' ' ' TYR . 5.5 t -147.27 -22.85 0.39 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 179.222 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' TYR . . . . . 0.689 ' CD1' HG23 ' A' ' 72' ' ' THR . 10.7 m-30 -89.89 -12.26 39.48 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 123.973 0.795 . . . . 0.0 110.488 -178.261 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.4 m -105.67 -173.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.291 -176.022 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.29 114.32 5.09 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.706 175.433 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -55.69 124.95 19.13 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.932 177.066 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.2 pt -98.97 -52.9 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 123.934 0.771 . . . . 0.0 110.421 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.1 163.64 32.92 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.643 -175.545 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 79' ' ' ARG . . . . . 0.548 ' HD2' ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -123.56 150.29 44.23 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.588 -1.306 . . . . 0.0 110.808 163.884 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -162.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.95 172.341 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -86.9 70.92 10.36 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 173.422 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.8 tt -89.82 138.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 121.728 0.775 . . . . 0.0 112.564 162.455 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.34 164.91 22.09 Favored Pre-proline 0 N--CA 1.502 2.136 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.417 -178.398 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.487 1.124 0 C-N-CA 122.015 1.81 . . . . 0.0 112.319 170.804 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.115 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.531 ' HB3' HD11 ' A' ' 77' ' ' ILE . 30.1 mt-30 -139.4 159.1 42.95 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.506 -173.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -142.68 125.15 15.68 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.1 -1.863 . . . . 0.0 107.601 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -89.61 118.46 29.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.629 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.63 152.48 0.33 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.927 0.767 . . . . 0.0 112.788 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -113.29 -44.81 3.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.512 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.34 151.99 41.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.06 0.85 . . . . 0.0 110.799 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.01 116.37 7.76 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.257 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.2 t80 -117.99 138.1 52.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.125 0.891 . . . . 0.0 108.895 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.02 146.4 25.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.297 0.998 . . . . 0.0 109.921 174.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 164.53 14.94 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.176 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.62 -25.24 0.77 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.074 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -108.03 149.68 28.12 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.101 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.56 -12.25 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.531 170.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -81.76 -40.27 22.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 123.903 0.752 . . . . 0.0 111.187 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.77 156.22 19.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.114 0.884 . . . . 0.0 111.265 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.41 174.43 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.666 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -75.05 131.47 40.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.766 -174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 14' ' ' TYR . 97.0 mt -121.56 127.46 50.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.587 1.179 . . . . 0.0 109.179 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.74 -173.62 2.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.268 0.98 . . . . 0.0 108.904 -175.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 26' ' ' LEU . 3.1 mp -83.12 156.53 23.23 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.423 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.12 0.03 1.0 Allowed Glycine 0 N--CA 1.5 2.955 0 O-C-N 123.872 0.732 . . . . 0.0 113.201 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.69 106.29 1.45 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 30' ' ' LEU . 5.6 mt -90.64 132.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.743 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.634 HD11 HD22 ' A' ' 60' ' ' ASN . 10.5 mp -108.52 151.52 25.98 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.064 -1.88 . . . . 0.0 109.013 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.8 m -129.43 147.43 51.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 123.842 0.714 . . . . 0.0 109.845 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.431 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -119.59 -147.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 123.807 0.692 . . . . 0.0 109.265 -178.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.431 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 O-C-N 123.419 0.449 . . . . 0.0 110.033 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.244 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -86.96 -37.86 17.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -102.31 102.97 27.94 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.999 0.812 . . . . 0.0 111.325 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -68.6 -17.99 42.92 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.641 2.227 . . . . 0.0 114.092 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.53 -31.67 68.14 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.657 0.598 . . . . 0.0 112.246 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.32 -21.89 21.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.831 0.707 . . . . 0.0 111.376 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.12 146.91 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -91.56 1.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -90.19 131.04 36.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.425 -1.388 . . . . 0.0 109.032 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -108.46 126.82 53.32 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.94 124.23 46.33 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.77 -166.18 16.67 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -140.17 150.19 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.634 HD22 HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -114.23 99.87 7.93 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.274 -177.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.81 -21.49 66.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.3 m -46.05 -37.42 6.7 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.812 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.61 2.46 6.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.849 1.343 . . . . 0.0 108.877 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.64 36.87 73.33 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.614 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -109.51 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.51 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 156.05 40.99 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.767 0.794 . . . . 0.0 111.699 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.66 -153.05 23.3 Favored Glycine 0 N--CA 1.489 2.197 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.032 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.71 153.94 24.57 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.6 p90 -151.36 140.77 13.95 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.912 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HB2' HG22 ' A' ' 72' ' ' THR . 1.3 Cg_endo -65.15 150.39 87.74 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.53 1.486 . . . . 0.0 110.708 175.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.29 48.72 4.08 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 70' ' ' PRO . 7.6 t -141.21 16.39 2.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.105 0.532 . . . . 0.0 111.616 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -136.05 -4.08 2.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 123.751 0.657 . . . . 0.0 111.847 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.98 -169.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 123.932 0.77 . . . . 0.0 109.13 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.71 113.58 5.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 25.2 t80 -48.27 142.97 4.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.442 171.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.5 pt -122.24 -53.5 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 123.926 0.766 . . . . 0.0 111.688 176.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.84 146.63 15.79 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.478 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-N 113.311 -1.444 . . . . 0.0 109.988 177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.502 2.151 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -125.09 161.29 27.11 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.563 1.164 . . . . 0.0 113.673 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -139.3 154.68 47.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.167 -2.288 . . . . 0.0 106.711 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 -123.33 121.54 36.08 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.93 145.75 12.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.266 0.979 . . . . 0.0 111.433 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tp -107.4 -41.36 5.1 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.839 -176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.93 152.55 43.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.264 0.977 . . . . 0.0 110.242 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.21 123.04 18.49 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.577 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.419 ' CD1' HD12 ' A' ' 24' ' ' LEU . 4.0 t80 -123.09 136.8 54.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.504 1.127 . . . . 0.0 109.076 174.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -94.61 151.7 19.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 124.294 0.996 . . . . 0.0 109.32 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.49 131.39 35.55 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 123.921 0.763 . . . . 0.0 110.311 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -110.1 -11.22 14.63 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 124.183 0.927 . . . . 0.0 110.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -120.6 146.26 46.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.327 1.017 . . . . 0.0 109.424 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.38 -19.12 63.08 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.758 172.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.3 -19.81 38.7 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.099 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.38 164.67 12.01 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 123.874 0.734 . . . . 0.0 110.757 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 pt -124.58 168.86 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.556 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.52 136.24 40.6 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.494 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.419 HD12 ' CD1' ' A' ' 14' ' ' TYR . 90.7 mt -125.94 135.16 51.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.206 0.941 . . . . 0.0 110.674 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -175.86 3.95 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.43 -173.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mt -84.74 158.31 20.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 123.534 0.521 . . . . 0.0 110.781 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.0 -6.15 1.06 Allowed Glycine 0 N--CA 1.503 3.157 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.676 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.97 110.57 11.71 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -176.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.441 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.2 mt -93.96 138.65 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.856 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 30' ' ' LEU . 9.8 mp -105.75 148.32 27.6 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.702 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 m -126.7 147.34 49.96 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 124.033 0.833 . . . . 0.0 109.177 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -120.37 -154.99 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.454 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.52 172.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 . . . . . 0 N--CA 1.502 2.168 0 CA-C-O 121.253 0.549 . . . . 0.0 109.993 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -176.9 -22.85 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.31 80.63 29.02 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 123.885 0.741 . . . . 0.0 109.113 177.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.15 -22.51 40.27 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.872 2.381 . . . . 0.0 111.938 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -50.16 -41.41 49.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.766 1.292 . . . . 0.0 112.238 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -93.63 -29.32 15.51 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 123.87 0.731 . . . . 0.0 111.463 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.8 mt -64.72 146.33 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.739 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.37 -96.5 1.07 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -98.32 128.58 44.81 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.246 -0.977 . . . . 0.0 110.35 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.5 mp -107.18 136.26 47.31 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -104.97 125.7 51.24 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.04 -164.67 13.55 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -137.27 147.04 45.43 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.131 -0.534 . . . . 0.0 110.749 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -101.1 100.31 10.87 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.9 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -54.51 -39.26 67.43 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 123.743 0.652 . . . . 0.0 111.97 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 96.9 m -52.22 -42.03 63.23 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 124.222 0.951 . . . . 0.0 112.142 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 p -105.28 0.35 27.05 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.343 1.027 . . . . 0.0 110.598 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.96 24.04 13.09 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 124.155 0.91 . . . . 0.0 112.667 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.53 166.48 12.5 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -174.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.7 ttm-85 -148.1 125.64 11.72 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.33 -162.83 26.66 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.978 -1.106 . . . . 0.0 111.173 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.93 153.79 21.48 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.696 -0.752 . . . . 0.0 109.15 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 34.9 p90 -151.24 147.83 21.28 Favored Pre-proline 0 N--CA 1.493 1.695 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.684 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.19 156.28 60.28 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.424 2.083 . . . . 0.0 112.0 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.01 44.2 1.84 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.6 t -134.43 -17.31 2.04 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.656 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.78 0.87 39.59 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.265 0.978 . . . . 0.0 111.696 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.92 -179.0 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 123.756 0.66 . . . . 0.0 109.459 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -149.18 106.53 3.62 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.046 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.475 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 77.6 t80 -43.65 128.44 5.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.097 169.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 pt -126.2 -58.26 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 124.019 0.824 . . . . 0.0 111.419 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.63 156.38 20.99 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -162.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 CA-C-O 121.914 0.864 . . . . 0.0 112.152 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.432 ' HB3' HD11 ' A' ' 77' ' ' ILE . 6.4 mt-30 -128.44 162.07 28.02 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.234 1.016 . . . . 0.0 112.488 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.42 165.32 27.76 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 112.416 -2.174 . . . . 0.0 107.835 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -128.03 115.13 18.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.949 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.48 116.4 3.07 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 123.889 0.743 . . . . 0.0 111.175 173.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tp -76.91 -33.1 57.78 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.949 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -141.25 143.02 33.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 124.296 0.997 . . . . 0.0 109.853 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.18 104.3 0.57 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.083 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.408 ' HD2' HD12 ' A' ' 24' ' ' LEU . 76.2 t80 -101.21 130.57 47.35 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -89.48 163.77 15.1 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 138.64 31.25 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -131.31 -19.33 2.79 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.74 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -123.64 151.26 43.22 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.864 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -63.19 -20.26 65.26 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.286 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -26.97 21.18 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.725 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.39 153.42 20.87 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.376 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -121.22 -173.67 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 124.511 1.132 . . . . 0.0 111.097 -179.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . 0.412 ' H ' HG22 ' A' ' 22' ' ' ILE . 3.5 m-20 -87.47 120.53 28.87 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 112.533 -2.121 . . . . 0.0 107.678 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.408 HD12 ' HD2' ' A' ' 14' ' ' TYR . 5.2 mt -117.37 119.99 36.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.159 0.912 . . . . 0.0 108.916 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.95 -170.36 1.78 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 124.561 1.163 . . . . 0.0 109.523 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.1 mt -84.99 156.1 21.29 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.478 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.99 9.16 2.68 Favored Glycine 0 N--CA 1.502 3.085 0 O-C-N 124.101 0.875 . . . . 0.0 113.074 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' CG ' HG21 ' A' ' 62' ' ' THR . 3.4 m-20 -71.45 125.17 26.33 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mp -96.37 146.91 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 124.198 0.936 . . . . 0.0 109.021 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.599 HD23 ' CE1' ' A' ' 69' ' ' PHE . 7.3 mp -115.46 161.53 18.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 112.442 -2.163 . . . . 0.0 110.911 174.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.6 m -131.31 153.95 49.05 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.748 1.28 . . . . 0.0 108.329 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.658 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.1 t -130.03 -150.5 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.658 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 O-C-N 123.583 0.552 . . . . 0.0 110.889 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 N--CA 1.503 2.196 0 CA-C-O 121.167 0.508 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.48 0.57 0.2 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.006 -173.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -128.93 69.7 80.83 Favored Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 123.606 0.566 . . . . 0.0 111.266 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.93 -4.87 4.04 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.639 2.226 . . . . 0.0 113.67 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.51 -45.5 53.46 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 123.732 0.645 . . . . 0.0 110.756 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -92.47 -28.94 16.51 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 124.057 0.848 . . . . 0.0 111.141 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.7 mt -65.02 143.37 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 123.766 0.666 . . . . 0.0 109.741 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.42 -99.91 1.05 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -89.62 144.59 25.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.492 0.76 . . . . 0.0 110.467 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.2 mp -122.5 130.1 52.69 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.329 170.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.516 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -91.27 121.69 33.24 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.38 177.7 25.48 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 120.048 -1.072 . . . . 0.0 113.008 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.69 123.63 45.99 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 113.559 -1.32 . . . . 0.0 109.226 174.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.414 HD21 ' HB ' ' A' ' 62' ' ' THR . 10.9 t30 -89.47 80.78 6.67 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.42 1.105 . . . . 0.0 108.506 170.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -49.48 -24.95 2.28 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.961 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.429 HG21 ' CG ' ' A' ' 28' ' ' ASP . 18.1 m -53.13 -41.55 65.18 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.19 0.931 . . . . 0.0 112.075 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.8 p -119.41 6.3 11.13 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.428 1.08 . . . . 0.0 109.161 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.87 60.12 8.57 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 124.283 0.989 . . . . 0.0 111.12 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -139.74 160.67 39.35 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.406 0.709 . . . . 0.0 109.999 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -116.25 140.28 49.48 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.96 -155.5 17.34 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.343 -1.408 . . . . 0.0 111.994 164.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.22 166.43 10.64 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.695 -1.252 . . . . 0.0 110.151 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.599 ' CE1' HD23 ' A' ' 30' ' ' LEU . 21.9 p90 -161.89 145.59 9.43 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.889 170.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.24 154.12 75.39 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.233 1.955 . . . . 0.0 113.169 173.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.21 -16.82 63.91 Favored Glycine 0 N--CA 1.499 2.873 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.265 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.4 p -75.8 -14.11 60.3 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 122.245 0.218 . . . . 0.0 111.522 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.28 3.61 35.64 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 123.998 0.811 . . . . 0.0 111.658 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.89 -178.6 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 123.878 0.736 . . . . 0.0 109.237 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -147.79 111.35 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -51.28 140.92 15.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 123.753 0.658 . . . . 0.0 109.603 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.1 pt -118.99 -56.47 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 124.431 1.082 . . . . 0.0 110.472 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.04 147.74 17.17 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.705 -1.236 . . . . 0.0 111.151 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.693 0 CA-C-N 112.856 -1.672 . . . . 0.0 109.128 173.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.512 2.652 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.586 ' HB3' HD11 ' A' ' 77' ' ' ILE . 26.1 mt-30 -128.98 168.49 15.94 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.376 1.084 . . . . 0.0 111.705 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -143.51 123.15 13.29 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 112.275 -2.239 . . . . 0.0 105.563 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -89.39 122.04 32.23 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.76 146.28 10.77 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 123.642 0.589 . . . . 0.0 110.734 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 tp -114.92 -28.79 6.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 124.115 0.884 . . . . 0.0 110.43 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 156.77 48.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 123.954 0.784 . . . . 0.0 110.831 -174.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.39 103.57 16.24 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.596 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.549 ' HD2' HD12 ' A' ' 24' ' ' LEU . 10.4 t80 -110.55 133.26 53.46 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -89.43 158.69 17.63 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 139.68 30.24 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.591 -0.843 . . . . 0.0 110.173 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -128.99 -13.6 4.54 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.192 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.78 140.87 36.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 124.217 0.948 . . . . 0.0 109.322 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.84 -21.84 3.22 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.379 -1.282 . . . . 0.0 114.044 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -59.48 -57.76 11.58 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.799 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -83.29 174.05 11.06 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.053 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.0 pt -129.48 177.05 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 124.267 0.979 . . . . 0.0 111.674 175.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.83 136.75 47.14 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.473 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.549 HD12 ' HD2' ' A' ' 14' ' ' TYR . 15.5 mt -126.38 133.19 51.38 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 123.973 0.795 . . . . 0.0 111.159 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.485 ' NE2' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -145.26 170.65 15.88 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.343 1.027 . . . . 0.0 110.695 -176.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mt -66.8 151.09 48.15 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 123.481 0.488 . . . . 0.0 110.413 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.9 -9.83 3.51 Favored Glycine 0 N--CA 1.501 2.976 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.036 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.86 108.05 7.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.539 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -89.8 152.34 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 115.437 -0.802 . . . . 0.0 108.882 176.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.539 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.2 mp -129.19 127.54 41.54 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.6 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.9 m -107.23 140.28 40.35 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.394 1.058 . . . . 0.0 108.961 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.5 -136.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 124.443 1.089 . . . . 0.0 108.725 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 N--CA 1.489 1.485 0 O-C-N 123.871 0.732 . . . . 0.0 109.441 -176.853 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.511 2.598 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.18 10.25 20.07 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.472 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -129.0 77.46 77.9 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.25 -18.22 50.93 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.411 2.074 . . . . 0.0 112.828 170.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -53.42 -41.47 66.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.125 0.891 . . . . 0.0 111.901 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.61 -26.36 20.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.053 0.846 . . . . 0.0 110.689 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 22.3 mt -79.97 139.17 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 123.961 0.788 . . . . 0.0 109.287 -176.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -93.06 1.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -95.92 120.25 35.87 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 113.708 -1.246 . . . . 0.0 109.169 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.9 mp -96.76 136.26 37.56 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 170.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -98.63 123.44 42.82 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.33 -178.39 27.84 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -133.8 144.12 48.8 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.762 0.33 . . . . 0.0 111.18 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.471 ' ND2' ' H ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -102.24 98.52 8.65 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.166 175.013 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -57.75 -29.21 64.6 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.343 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.0 m -53.05 -43.51 66.72 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 123.905 0.753 . . . . 0.0 112.143 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.485 HG21 ' NE2' ' A' ' 25' ' ' HIS . 22.3 p -102.64 -4.1 25.66 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 124.274 0.984 . . . . 0.0 110.187 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.14 28.4 61.29 Favored Glycine 0 N--CA 1.493 2.435 0 O-C-N 124.149 0.906 . . . . 0.0 111.926 -172.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 2.5 mm-40 -104.17 155.72 18.48 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -143.11 137.57 29.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.065 0.853 . . . . 0.0 110.186 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.32 -155.06 21.73 Favored Glycine 0 N--CA 1.492 2.399 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.429 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.81 153.26 22.74 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.233 -0.983 . . . . 0.0 108.866 -174.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 32.9 p90 -147.95 148.86 31.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.799 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.14 158.12 41.08 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.985 1.79 . . . . 0.0 111.92 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.99 53.6 0.63 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -151.38 -15.89 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.049 0.499 . . . . 0.0 112.108 174.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -94.87 -4.81 46.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 123.977 0.798 . . . . 0.0 112.324 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.4 m -109.64 -166.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 123.954 0.784 . . . . 0.0 109.253 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.28 113.15 5.11 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -48.75 128.34 15.27 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.783 165.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.5 pt -114.7 -84.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 124.36 1.038 . . . . 0.0 110.4 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.83 161.13 13.1 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -171.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.5 2.068 0 CA-C-O 121.939 0.876 . . . . 0.0 112.635 -177.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -126.16 163.26 23.51 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.21 0.943 . . . . 0.0 111.363 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -139.1 160.12 40.55 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.543 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -126.63 118.72 25.38 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -174.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.83 130.77 38.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.857 0.723 . . . . 0.0 110.73 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -85.38 -45.89 11.46 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.226 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -143.23 156.67 44.8 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.395 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.17 111.68 1.82 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.442 173.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.466 ' CD2' HD12 ' A' ' 24' ' ' LEU . 6.3 t80 -120.93 133.39 55.28 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.973 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -90.1 161.75 15.64 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -89.68 147.55 23.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.839 0.712 . . . . 0.0 111.548 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -117.62 -4.53 11.22 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.3 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -146.57 148.84 32.55 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -52.68 -22.59 5.32 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.076 172.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -69.66 -45.56 68.13 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.235 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.38 158.18 16.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 123.965 0.791 . . . . 0.0 109.005 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 pt -115.16 170.68 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 124.185 0.928 . . . . 0.0 111.792 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.71 136.61 38.2 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.257 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.466 HD12 ' CD2' ' A' ' 14' ' ' TYR . 88.5 mt -125.46 133.37 52.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.345 1.028 . . . . 0.0 109.917 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.57 -167.88 1.59 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.686 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -89.22 157.98 18.04 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.627 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 58.7 1.71 0.92 Allowed Glycine 0 N--CA 1.505 3.244 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.39 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.28 108.54 9.29 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.77 -0.715 . . . . 0.0 110.972 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.525 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.4 tp -90.51 149.65 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.033 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 29' ' ' ILE . 10.0 mp -119.07 151.85 37.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.3 m -132.89 146.52 51.87 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.015 0.822 . . . . 0.0 109.627 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.5 t -128.95 -157.39 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.644 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.708 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.782 174.368 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 . . . . . 0 N--CA 1.501 2.088 0 CA-C-O 121.084 0.469 . . . . 0.0 110.452 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -164.35 -11.35 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.361 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' H ' ' H ' ' A' ' 48' ' ' ALA . 18.9 mttp -122.25 82.39 45.39 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 124.502 1.126 . . . . 0.0 109.344 177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -52.8 -20.0 12.02 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.589 2.193 . . . . 0.0 112.054 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.77 -43.17 80.55 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.936 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.01 -29.11 18.64 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 123.632 0.582 . . . . 0.0 111.485 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 mt -66.25 145.4 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.49 -73.29 1.27 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -127.95 133.75 49.25 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.561 -1.82 . . . . 0.0 107.932 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.66 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -127.2 144.46 51.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.176 0.922 . . . . 0.0 109.172 174.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -89.47 145.58 25.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.633 1.208 . . . . 0.0 107.839 -179.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.81 179.7 42.6 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 173.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -128.91 142.12 51.05 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.886 -0.657 . . . . 0.0 109.808 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.03 82.73 1.75 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 125.176 1.547 . . . . 0.0 109.528 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -27.1 49.28 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.776 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.0 m -52.12 -42.68 63.5 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 123.924 0.765 . . . . 0.0 111.562 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -109.12 -3.51 17.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.799 1.312 . . . . 0.0 109.758 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.77 65.7 2.91 Favored Glycine 0 N--CA 1.493 2.447 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.049 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -137.23 162.05 34.54 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.314 0.655 . . . . 0.0 110.247 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -148.15 131.04 16.14 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.383 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.46 -163.42 36.59 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.506 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -102.87 152.44 21.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.488 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 41.2 p90 -148.02 152.27 39.72 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.413 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -66.6 151.23 83.24 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.071 1.847 . . . . 0.0 112.24 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.36 19.79 29.94 Favored Glycine 0 N--CA 1.496 2.697 0 O-C-N 124.093 0.871 . . . . 0.0 112.006 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.83 -35.18 6.24 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.311 0.577 . . . . 0.0 110.911 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -90.21 8.37 33.45 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.479 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.2 m -125.87 179.42 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 123.628 0.58 . . . . 0.0 110.263 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -150.06 106.41 3.49 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.713 0.768 . . . . 0.0 110.262 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 80.0 t80 -44.64 126.16 5.34 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.244 -1.343 . . . . 0.0 111.253 167.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.407 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -115.13 -62.25 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 123.969 0.793 . . . . 0.0 110.889 -177.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.407 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -139.94 161.5 26.32 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -161.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 . . . . . 0 N--CA 1.486 1.362 0 CA-C-N 113.583 -1.308 . . . . 0.0 109.139 -171.555 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.02 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.509 ' HB3' HD11 ' A' ' 77' ' ' ILE . 30.9 mt-30 -134.11 158.92 42.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.006 0.817 . . . . 0.0 111.589 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -138.58 138.62 38.1 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.811 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -94.47 121.88 36.46 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.115 0.884 . . . . 0.0 109.894 171.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.84 119.87 6.94 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.848 167.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.02 -57.89 3.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.603 0.564 . . . . 0.0 109.889 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.97 156.98 25.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.38 1.05 . . . . 0.0 109.919 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.92 134.3 51.74 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.985 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -132.71 128.47 37.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 124.361 1.038 . . . . 0.0 110.208 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -89.58 168.25 12.3 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.662 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 145.95 25.06 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.311 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.87 -3.62 8.65 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.481 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -143.42 145.05 32.31 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.024 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.47 -15.14 2.42 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 114.981 -1.008 . . . . 0.0 113.29 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -74.64 -46.47 37.99 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.558 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 152.31 22.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.083 0.864 . . . . 0.0 109.893 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.59 -170.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 124.472 1.108 . . . . 0.0 109.577 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -95.19 106.34 18.35 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.52 -1.673 . . . . 0.0 108.715 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 24' ' ' LEU . 1.8 mm? -88.98 143.14 27.06 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.646 172.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.422 ' NE2' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -135.52 -173.19 3.28 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.21 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mt -78.25 150.92 33.32 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.019 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.07 -3.47 1.61 Allowed Glycine 0 N--CA 1.506 3.347 0 O-C-N 123.413 0.446 . . . . 0.0 113.588 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.26 116.48 8.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 123.928 0.428 . . . . 0.0 109.95 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.502 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.0 mt -102.3 139.12 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.768 0.794 . . . . 0.0 110.019 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.502 HD12 ' C ' ' A' ' 29' ' ' ILE . 10.2 mp -117.67 162.19 18.45 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 112.909 -1.951 . . . . 0.0 109.454 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.85 147.68 49.95 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 124.036 0.835 . . . . 0.0 108.833 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -121.7 -169.24 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 123.53 0.519 . . . . 0.0 109.829 178.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.503 ' H ' HG12 ' A' ' 32' ' ' VAL . 3.6 m-80 . . . . . 0 N--CA 1.496 1.829 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.285 178.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 121.368 0.604 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.07 1.2 28.75 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.91 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -124.77 79.39 63.66 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 53' ' ' ILE . 1.5 Cg_endo -62.51 -31.08 80.39 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.814 1.676 . . . . 0.0 111.404 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.93 -39.25 39.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.538 1.149 . . . . 0.0 112.129 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -90.0 -31.95 16.98 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.126 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 50' ' ' PRO . 61.7 mt -65.93 151.74 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 123.852 0.72 . . . . 0.0 110.452 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.5 -102.78 1.08 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -91.0 140.3 29.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.417 0.716 . . . . 0.0 110.885 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.9 mt -107.05 135.69 48.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.19 124.15 48.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 124.195 0.934 . . . . 0.0 108.778 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.27 -170.63 33.22 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.317 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -94.72 146.47 24.15 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.24 -0.98 . . . . 0.0 110.082 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.87 64.63 0.81 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.042 -1.436 . . . . 0.0 108.693 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -56.93 -23.9 48.6 Favored 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.755 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.6 m -53.44 -34.73 58.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.849 0.718 . . . . 0.0 111.594 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.422 HG21 ' NE2' ' A' ' 25' ' ' HIS . 39.1 p -108.89 -5.17 16.28 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.771 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.2 40.67 49.28 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -143.59 176.38 9.25 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -147.25 147.35 30.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 123.924 0.765 . . . . 0.0 109.168 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.87 -153.67 13.64 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.269 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.2 149.71 29.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -151.2 142.82 15.65 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.258 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.12 157.98 15.93 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.459 2.106 . . . . 0.0 112.874 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.2 28.57 14.04 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 124.39 1.056 . . . . 0.0 113.508 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.9 t -133.81 -3.03 2.91 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 117.202 0.501 . . . . 0.0 110.725 -170.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.504 ' OH ' HD12 ' A' ' 24' ' ' LEU . 1.7 p90 -121.33 -6.43 9.34 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 123.918 0.761 . . . . 0.0 111.275 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.486 HG13 ' CE1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -97.48 178.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 124.139 0.899 . . . . 0.0 109.508 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -149.34 104.85 3.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -47.05 142.93 3.3 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.636 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.7 pt -122.97 -51.71 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 124.313 1.008 . . . . 0.0 111.958 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.33 146.41 13.9 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.978 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 . . . . . 0 N--CA 1.496 1.866 0 CA-C-N 113.485 -1.357 . . . . 0.0 111.102 179.401 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.19 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -128.74 160.85 31.24 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.406 1.098 . . . . 0.0 112.394 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -148.93 118.92 7.14 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 112.542 -2.117 . . . . 0.0 105.288 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.01 124.21 38.93 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.37 114.25 1.74 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.005 0.816 . . . . 0.0 110.429 174.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 tp -78.5 -31.87 47.9 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.366 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.74 144.14 37.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.436 1.085 . . . . 0.0 108.889 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -64.3 108.65 1.65 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.159 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.44 ' CD2' HD13 ' A' ' 24' ' ' LEU . 17.8 t80 -113.75 136.99 52.25 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -89.7 -178.5 5.54 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -89.93 122.56 33.07 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.327 171.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -90.06 -7.77 53.07 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.945 0.778 . . . . 0.0 110.727 172.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -144.73 150.65 37.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 124.028 0.83 . . . . 0.0 109.648 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.62 -15.65 3.18 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.18 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.48 -41.29 27.8 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.931 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.33 168.24 18.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 123.691 0.619 . . . . 0.0 111.428 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.56 -164.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 124.144 0.902 . . . . 0.0 109.827 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -100.43 108.04 19.93 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.683 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 24' ' ' LEU . 5.3 mp -92.63 123.08 35.66 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 113.529 -1.668 . . . . 0.0 109.71 173.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.03 167.32 11.88 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.687 170.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mt -53.8 150.4 7.51 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.024 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.06 -14.05 3.03 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 114.969 -1.014 . . . . 0.0 114.345 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.87 117.35 6.25 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tp -94.73 148.65 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 123.915 0.759 . . . . 0.0 109.152 171.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.567 HD23 ' CE1' ' A' ' 69' ' ' PHE . 8.3 mp -121.98 135.27 54.84 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.5 m -122.04 140.2 52.78 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 124.143 0.902 . . . . 0.0 108.687 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.63 -175.45 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.865 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.973 -173.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.5 2.027 0 CA-C-O 121.459 0.647 . . . . 0.0 112.038 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.6 -6.35 53.45 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.909 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.53 86.97 35.51 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.68 -6.1 10.03 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.721 2.281 . . . . 0.0 113.75 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -65.97 -35.8 81.59 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.485 0.491 . . . . 0.0 111.947 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -89.2 -28.16 20.16 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 123.678 0.611 . . . . 0.0 110.537 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.0 mt -80.3 141.3 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.8 -84.46 1.34 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -91.49 125.15 36.14 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 113.032 -1.584 . . . . 0.0 110.16 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.3 mp -102.68 131.17 49.66 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 168.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.96 122.31 40.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 168.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.89 -175.31 22.7 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.973 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -120.28 133.53 55.45 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.816 -0.692 . . . . 0.0 110.182 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -99.18 82.83 2.77 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 124.501 1.126 . . . . 0.0 109.132 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -48.05 -28.51 2.88 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.274 172.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 m -55.93 -49.16 74.25 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.022 0.826 . . . . 0.0 111.075 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 p -95.3 0.01 53.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.306 1.004 . . . . 0.0 110.303 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.95 45.56 96.34 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.455 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.85 174.39 10.7 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.358 0.681 . . . . 0.0 109.933 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -145.0 144.24 30.93 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.91 -175.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.28 -158.16 20.44 Favored Glycine 0 N--CA 1.493 2.484 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.749 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.15 168.96 8.99 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.736 -1.232 . . . . 0.0 110.289 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.567 ' CE1' HD23 ' A' ' 30' ' ' LEU . 17.7 p90 -164.16 144.7 6.6 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.912 170.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.8 160.47 40.62 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 121.975 1.783 . . . . 0.0 112.109 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.64 54.65 1.24 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.2 t -137.37 -29.84 0.87 Allowed 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -91.58 -6.05 53.01 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.396 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.19 167.69 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.599 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -139.06 127.05 22.33 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -49.86 144.07 6.89 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.403 167.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.77 -54.99 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 124.026 0.828 . . . . 0.0 111.107 175.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.86 152.76 23.68 Favored Glycine 0 N--CA 1.496 2.668 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.353 -165.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.869 0 O-C-N 124.486 0.756 . . . . 0.0 111.759 -179.113 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.51 2.571 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.513 ' HB3' HD11 ' A' ' 77' ' ' ILE . 23.6 mt-30 -150.0 162.0 41.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.184 0.992 . . . . 0.0 111.815 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -131.8 140.0 49.06 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.126 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -90.97 124.51 35.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.79 0.681 . . . . 0.0 110.084 161.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.43 121.55 9.23 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.809 0.693 . . . . 0.0 111.258 165.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.35 -67.98 0.82 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.228 0.955 . . . . 0.0 109.627 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -94.59 137.26 33.92 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.367 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -68.55 91.2 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 124.13 0.894 . . . . 0.0 110.515 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.442 ' CD2' HD12 ' A' ' 24' ' ' LEU . 9.1 t80 -92.98 133.05 36.51 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.954 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -90.31 163.15 14.85 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.365 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -89.0 115.97 26.95 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.437 0.637 . . . . 0.0 111.611 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -89.08 -14.44 36.3 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.942 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.54 155.49 43.7 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.843 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -63.37 -26.21 68.65 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.852 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.08 -28.4 69.05 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.511 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.25 152.35 25.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.54 1.15 . . . . 0.0 110.812 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 pt -113.03 176.12 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.002 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -69.96 137.4 51.44 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.084 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 14' ' ' TYR . 67.6 mt -126.99 90.41 3.15 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.5 166.3 10.53 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.751 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mt -64.92 162.13 17.05 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.28 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.41 -11.33 13.25 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.498 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.69 133.7 39.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.398 0.705 . . . . 0.0 109.587 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.65 143.73 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.963 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.2 mp -106.32 139.51 40.7 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.67 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.2 m -112.1 144.82 40.83 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 123.871 0.732 . . . . 0.0 110.508 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.68 173.51 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 123.951 0.782 . . . . 0.0 110.686 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 3.7 t30 . . . . . 0 N--CA 1.502 2.128 0 CA-C-N 114.409 -1.269 . . . . 0.0 114.106 175.869 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 . . . . . 0 N--CA 1.504 2.272 0 CA-C-O 122.61 1.195 . . . . 0.0 113.856 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.87 -7.77 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 113.208 -1.815 . . . . 0.0 111.221 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -124.26 75.2 60.48 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 124.113 0.883 . . . . 0.0 111.388 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.2 -11.54 10.74 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.221 1.947 . . . . 0.0 113.56 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -65.95 -40.64 91.51 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.089 0.868 . . . . 0.0 111.543 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -91.38 -21.33 21.05 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 123.769 0.668 . . . . 0.0 112.002 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.4 mt -82.77 145.83 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.29 -88.16 1.24 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -89.76 145.26 25.32 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 113.608 -1.296 . . . . 0.0 109.9 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.2 mp -124.04 125.46 44.57 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.405 166.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.94 119.28 32.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 123.891 0.744 . . . . 0.0 109.079 168.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.13 -165.31 10.62 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 171.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.8 134.99 34.15 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -96.77 76.08 2.77 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -43.16 -33.23 0.86 Allowed 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 113.97 -1.468 . . . . 0.0 112.929 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.5 m -55.21 -49.59 71.56 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 124.208 0.943 . . . . 0.0 111.336 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.4 p -93.37 -4.34 51.67 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.148 0.905 . . . . 0.0 110.888 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.85 60.07 8.67 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 123.884 0.74 . . . . 0.0 111.329 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.58 154.56 45.51 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.343 0.672 . . . . 0.0 109.314 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -127.87 135.21 49.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.328 1.017 . . . . 0.0 108.446 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.92 -168.68 39.12 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.18 -1.486 . . . . 0.0 112.69 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -108.02 165.76 11.23 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.149 -1.525 . . . . 0.0 109.181 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.6 p90 -160.03 143.23 10.23 Favored Pre-proline 0 N--CA 1.494 1.725 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.379 175.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HB2' HG22 ' A' ' 72' ' ' THR . 2.5 Cg_endo -65.76 155.54 68.69 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.967 1.778 . . . . 0.0 110.937 172.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.05 49.64 3.58 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 70' ' ' PRO . 8.0 t -129.97 -28.84 2.14 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -96.82 13.53 28.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 124.193 0.933 . . . . 0.0 111.537 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.28 178.71 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 114.67 -1.15 . . . . 0.0 107.926 -170.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -150.63 116.63 5.59 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -51.58 127.3 19.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 123.856 0.722 . . . . 0.0 109.883 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.0 OUTLIER -101.66 -55.99 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 124.598 1.187 . . . . 0.0 109.757 177.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.95 161.83 35.37 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 118.643 -1.741 . . . . 0.0 112.237 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.7 0 CA-C-N 112.117 -2.042 . . . . 0.0 110.486 175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER . . . . . 0 N--CA 1.509 2.504 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -128.03 163.12 25.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 124.641 1.213 . . . . 0.0 111.839 -168.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -140.59 124.22 17.05 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 112.3 -2.227 . . . . 0.0 105.68 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -91.89 124.66 36.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.1 118.5 5.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 124.162 0.914 . . . . 0.0 110.692 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -60.75 2.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 124.02 0.825 . . . . 0.0 109.213 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.31 168.94 9.31 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.309 1.006 . . . . 0.0 110.228 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.7 123.88 30.88 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.349 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -121.97 138.91 54.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.45 172.52 8.94 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.515 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -89.74 144.52 25.9 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.136 172.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -134.44 -9.54 2.51 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.683 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -141.0 146.65 37.54 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.997 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.8 -17.58 9.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.461 1.101 . . . . 0.0 113.318 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -71.34 -51.07 26.29 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.383 -1.281 . . . . 0.0 111.693 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.41 153.31 21.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.135 0.897 . . . . 0.0 109.606 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pt -114.39 174.59 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 124.378 1.049 . . . . 0.0 110.93 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.75 130.17 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.719 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.66 124.33 44.96 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.579 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 172.75 11.61 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.835 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.95 150.56 48.45 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.028 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.66 -10.27 18.82 Favored Glycine 0 N--CA 1.5 2.909 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.431 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.02 110.14 1.49 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.538 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 tp -90.2 155.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.8 mp -129.23 143.69 50.95 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.184 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.8 m -128.18 143.0 51.01 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.08 -125.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.435 ' O ' ' CE2' ' A' ' 6' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.114 0 CA-C-N 118.234 0.47 . . . . 0.0 111.136 -170.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 . . . . . 0 N--CA 1.512 2.629 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -162.56 -6.1 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.04 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -128.13 76.25 78.0 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 123.917 0.761 . . . . 0.0 110.048 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.93 -16.07 19.2 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.294 1.996 . . . . 0.0 113.514 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -59.7 -47.04 87.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 123.926 0.766 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -89.72 -31.61 17.38 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 123.957 0.785 . . . . 0.0 110.033 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.1 mt -66.49 143.63 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 123.803 0.689 . . . . 0.0 109.643 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.45 -97.78 1.07 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -93.48 135.99 34.19 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.239 -0.981 . . . . 0.0 109.834 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.4 mp -117.58 147.68 42.6 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.796 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.29 130.32 56.47 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.349 1.03 . . . . 0.0 108.223 176.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.44 169.96 36.34 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.55 -1.309 . . . . 0.0 112.999 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -90.73 141.1 29.15 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.17 -1.015 . . . . 0.0 109.102 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -105.49 72.56 0.98 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.442 1.089 . . . . 0.0 109.933 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -44.3 -33.78 1.72 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.291 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 m -51.72 -47.73 63.87 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 124.115 0.884 . . . . 0.0 111.975 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.8 -4.66 23.3 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.849 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.48 47.67 85.18 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -119.05 178.34 4.54 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.154 -1.023 . . . . 0.0 109.61 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -150.12 136.47 18.89 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.56 -153.89 13.54 Favored Glycine 0 N--CA 1.5 2.928 0 C-N-CA 118.916 -1.611 . . . . 0.0 113.538 165.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.79 158.29 17.1 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -172.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.5 p90 -159.53 143.84 11.06 Favored Pre-proline 0 N--CA 1.489 1.5 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.788 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.59 154.32 71.78 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.941 1.761 . . . . 0.0 111.539 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.69 19.53 19.75 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 124.128 0.893 . . . . 0.0 112.648 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.54 -32.4 7.71 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.268 0.556 . . . . 0.0 111.237 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -89.62 -0.31 57.43 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.064 -175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.23 -178.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 124.194 0.934 . . . . 0.0 109.283 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -146.61 122.0 10.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.435 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 45.1 t80 -55.0 120.98 7.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 124.034 0.834 . . . . 0.0 108.98 168.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -90.85 -54.98 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.372 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -169.9 157.76 29.47 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.391 -1.385 . . . . 0.0 111.507 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.949 0 CA-C-N 114.52 -0.84 . . . . 0.0 111.608 171.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.184 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.613 ' HB3' HD11 ' A' ' 77' ' ' ILE . 53.2 mt-30 -120.14 159.93 23.9 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.754 0.788 . . . . 0.0 112.593 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -140.13 132.04 27.66 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.235 -1.802 . . . . 0.0 107.433 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -89.76 123.77 34.05 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 170.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.59 126.74 14.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.508 1.13 . . . . 0.0 111.752 164.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 tp -80.45 -36.55 33.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.099 0.874 . . . . 0.0 110.121 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -145.49 165.1 29.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.185 0.928 . . . . 0.0 110.795 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.03 121.16 23.13 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.393 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.403 ' CD2' HD12 ' A' ' 24' ' ' LEU . 27.9 t80 -128.47 128.48 44.46 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.227 0.954 . . . . 0.0 109.423 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.32 159.51 15.23 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.604 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.34 150.21 22.67 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 123.772 0.67 . . . . 0.0 109.928 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -123.73 -9.79 7.83 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.021 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -139.62 153.35 47.33 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.904 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.91 -11.21 7.2 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.392 -1.276 . . . . 0.0 113.355 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -80.45 -35.02 35.5 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.374 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -98.6 177.61 5.26 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 124.158 0.911 . . . . 0.0 111.039 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 pt -141.23 172.75 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.086 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.83 128.76 33.79 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.979 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.403 HD12 ' CD2' ' A' ' 14' ' ' TYR . 85.3 mt -127.78 140.39 52.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.971 0.794 . . . . 0.0 109.998 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.483 ' NE2' HG21 ' A' ' 63' ' ' THR . 0.2 OUTLIER -140.27 -173.5 3.68 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.078 -176.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -75.52 152.48 37.81 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.663 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.36 -7.87 1.72 Allowed Glycine 0 N--CA 1.498 2.82 0 CA-C-N 114.97 -1.014 . . . . 0.0 114.006 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.82 106.52 0.58 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 mt -98.77 126.88 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 172.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.63 158.07 16.96 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 112.56 -2.109 . . . . 0.0 108.539 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.1 m -134.42 147.09 50.38 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -172.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.3 OUTLIER -120.1 -166.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.492 ' H ' HG12 ' A' ' 32' ' ' VAL . 5.0 m120 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 121.998 0.904 . . . . 0.0 111.681 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 113.124 0.787 . . . . 0.0 113.124 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.18 11.3 1.93 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.291 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.15 76.68 78.82 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 123.604 0.565 . . . . 0.0 109.532 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.26 -16.88 56.69 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.119 1.879 . . . . 0.0 112.731 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -67.09 -37.3 83.7 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 123.896 0.747 . . . . 0.0 110.945 -172.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.81 -33.79 16.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 124.184 0.928 . . . . 0.0 110.104 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.9 mt -64.97 149.1 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 124.152 0.908 . . . . 0.0 109.823 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.43 -103.86 1.09 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -89.88 137.5 32.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 124.632 0.842 . . . . 0.0 110.348 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 64.7 mt -106.4 131.65 53.35 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 113.934 -1.484 . . . . 0.0 107.721 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -104.77 117.44 34.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.009 0.818 . . . . 0.0 109.483 175.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.91 172.58 35.11 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.299 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.84 149.3 22.01 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.477 -0.861 . . . . 0.0 109.997 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -124.42 61.1 1.14 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.89 -22.68 5.79 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.064 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -53.01 -50.48 64.14 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.001 0.813 . . . . 0.0 111.084 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.483 HG21 ' NE2' ' A' ' 25' ' ' HIS . 5.4 p -94.2 3.28 55.47 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.476 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.51 29.42 74.77 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -123.9 173.89 7.91 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -150.45 147.48 27.59 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.79 -154.78 19.44 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.092 171.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.37 155.11 16.87 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.661 -0.769 . . . . 0.0 109.364 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 56' ' ' LEU . 11.8 p90 -157.25 142.34 12.28 Favored Pre-proline 0 N--CA 1.498 1.952 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.846 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.69 151.09 49.35 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.253 1.969 . . . . 0.0 111.899 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.25 -4.39 77.62 Favored Glycine 0 N--CA 1.498 2.817 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.436 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.3 t -104.19 1.36 30.56 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 116.801 0.3 . . . . 0.0 111.345 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.35 -9.46 16.76 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 123.747 0.655 . . . . 0.0 111.988 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 m -119.3 -172.12 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 124.134 0.896 . . . . 0.0 108.983 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -150.13 124.47 9.55 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -49.78 131.57 22.03 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 124.116 0.885 . . . . 0.0 109.913 168.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.613 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.2 pt -108.74 -53.68 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 124.359 1.037 . . . . 0.0 109.393 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.73 171.18 40.11 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.424 0 CA-C-N 114.52 -0.84 . . . . 0.0 109.368 177.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.405 ' CZ ' ' O ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER . . . . . 0 N--CA 1.503 2.193 0 CA-C-O 121.466 0.651 . . . . 0.0 111.481 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -133.09 166.08 23.26 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.393 -169.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -139.92 141.39 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -105.66 120.52 41.88 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.341 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.78 114.91 1.57 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.312 1.007 . . . . 0.0 111.596 168.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -63.54 1.36 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.301 176.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -103.62 143.19 33.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.05 0.844 . . . . 0.0 110.26 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.43 118.65 9.7 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 124.4 1.062 . . . . 0.0 111.164 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -129.42 128.32 42.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 124.564 1.165 . . . . 0.0 108.999 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -89.57 171.42 9.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -89.01 136.17 33.16 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -124.68 -7.66 7.38 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.719 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.65 142.81 50.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 124.258 0.974 . . . . 0.0 109.246 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -10.35 1.78 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.537 172.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.53 -37.5 13.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.053 0.845 . . . . 0.0 111.204 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -86.98 145.43 26.51 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 123.833 0.708 . . . . 0.0 110.471 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pt -99.58 -179.88 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 124.067 0.854 . . . . 0.0 111.8 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -79.73 138.9 37.45 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.207 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -126.95 130.03 49.3 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.652 -1.613 . . . . 0.0 108.408 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.25 33.31 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.28 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -53.84 149.27 8.97 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.01 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.84 -14.4 10.47 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.375 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.54 117.79 9.23 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.456 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -101.68 148.99 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 123.947 0.779 . . . . 0.0 109.431 167.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.463 HD11 ' ND2' ' A' ' 60' ' ' ASN . 10.6 mp -121.95 154.35 37.29 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.8 m -137.26 145.16 43.21 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 123.471 0.482 . . . . 0.0 109.951 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.477 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.0 t -122.14 -145.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 124.269 0.981 . . . . 0.0 108.487 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.477 ' H ' HG12 ' A' ' 32' ' ' VAL . 5.0 m-80 . . . . . 0 N--CA 1.497 1.88 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 N--CA 1.497 1.913 0 CA-C-O 120.665 0.269 . . . . 0.0 111.038 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.59 5.1 39.07 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.826 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -126.98 76.47 75.89 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 123.767 0.667 . . . . 0.0 109.395 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.25 -3.84 6.88 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.329 2.02 . . . . 0.0 113.732 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -71.36 -43.31 67.16 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.806 0.691 . . . . 0.0 110.985 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.68 -24.68 21.54 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.391 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.74 143.02 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.56 -91.0 1.21 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -94.81 123.43 38.26 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.767 -1.217 . . . . 0.0 110.455 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.4 mp -95.63 172.68 7.91 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.756 171.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -145.17 107.44 4.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -175.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.53 -176.78 23.84 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.513 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 66' ' ' ARG . 6.8 m-85 -106.81 153.27 22.72 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.295 -0.953 . . . . 0.0 110.234 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.463 ' ND2' HD11 ' A' ' 30' ' ' LEU . 8.5 t-20 -123.99 60.77 1.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.849 -1.523 . . . . 0.0 107.486 -177.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -42.86 -36.33 1.46 Allowed 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.954 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 p -49.55 -54.58 17.29 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.514 1.134 . . . . 0.0 113.756 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -93.76 3.21 55.78 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.627 0.58 . . . . 0.0 111.29 172.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.23 17.46 56.05 Favored Glycine 0 N--CA 1.496 2.668 0 O-C-N 123.845 0.715 . . . . 0.0 112.227 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.5 167.94 10.84 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 4.3 ptm180 -150.24 148.82 29.35 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.229 0.538 . . . . 0.0 110.246 175.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.2 -156.41 28.0 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.243 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.93 160.89 15.41 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -169.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 27.8 p90 -159.87 149.93 15.0 Favored Pre-proline 0 N--CA 1.498 1.933 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.499 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.75 146.17 87.9 Favored 'Trans proline' 0 N--CA 1.487 1.103 0 C-N-CA 122.064 1.843 . . . . 0.0 112.03 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.59 7.18 82.55 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 123.83 0.706 . . . . 0.0 112.297 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -23.95 15.57 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 176.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -89.83 -9.62 48.43 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.376 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 m -122.95 -178.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 124.491 1.12 . . . . 0.0 108.334 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -149.61 120.57 7.67 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -48.73 127.62 14.01 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 165.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -94.27 -62.39 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 124.225 0.953 . . . . 0.0 109.442 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.16 158.02 28.81 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -165.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.848 0 CA-C-N 114.206 -0.997 . . . . 0.0 110.726 169.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.128 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -133.1 162.9 30.49 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 124.301 1.001 . . . . 0.0 111.992 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -143.76 135.97 26.75 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.294 -1.776 . . . . 0.0 107.082 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HE ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -102.73 125.17 49.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 124.276 0.985 . . . . 0.0 108.862 178.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.5 149.64 5.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 123.879 0.737 . . . . 0.0 110.873 168.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 tp -121.48 -25.58 5.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 123.974 0.796 . . . . 0.0 111.075 -175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.04 146.78 27.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.038 0.836 . . . . 0.0 110.294 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.39 118.55 6.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.507 1.13 . . . . 0.0 110.55 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.416 ' CD1' HD12 ' A' ' 24' ' ' LEU . 2.9 t80 -120.6 135.98 54.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 124.778 1.299 . . . . 0.0 108.82 174.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -89.81 157.03 18.11 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.406 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -88.58 149.82 23.38 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.84 -19.56 2.6 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.312 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.23 147.25 35.41 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.163 -1.381 . . . . 0.0 110.051 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.81 -21.33 64.32 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.158 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.16 -12.28 57.1 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.69 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.97 147.79 30.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 124.091 0.87 . . . . 0.0 110.849 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.22 -175.26 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.483 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -88.73 129.15 35.6 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.445 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 14' ' ' TYR . 71.5 mt -114.02 135.95 53.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.016 0.822 . . . . 0.0 111.007 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.49 -173.91 3.2 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.089 -176.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -84.92 158.06 20.67 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.687 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.64 -5.27 2.45 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.137 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.86 147.41 51.76 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.476 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.0 tt -132.57 150.14 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 124.101 0.876 . . . . 0.0 111.358 172.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.668 HD11 HD22 ' A' ' 60' ' ' ASN . 9.7 mp -121.77 152.83 39.04 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.149 -176.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.3 m -135.04 149.35 50.11 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.914 0.759 . . . . 0.0 110.449 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.3 t -127.67 -153.99 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 123.959 0.787 . . . . 0.0 109.002 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.578 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.423 -179.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 . . . . . 0 N--CA 1.503 2.181 0 CA-C-O 121.247 0.546 . . . . 0.0 111.607 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.74 -4.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.855 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -126.86 79.27 72.65 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 123.942 0.776 . . . . 0.0 110.499 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.82 -7.96 5.2 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.237 1.958 . . . . 0.0 113.514 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -48.56 45.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.2 -23.21 21.34 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 123.822 0.701 . . . . 0.0 111.024 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.78 143.37 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.26 -99.68 1.04 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -89.99 133.49 34.78 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.376 -0.912 . . . . 0.0 110.343 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -109.28 156.47 19.91 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.414 171.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -131.08 124.65 31.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.32 -179.24 29.47 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.073 -1.06 . . . . 0.0 111.498 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -95.85 126.7 41.28 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.52 -1.34 . . . . 0.0 109.483 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.668 HD22 HD11 ' A' ' 30' ' ' LEU . 23.2 t-20 -90.3 85.02 6.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 124.459 1.099 . . . . 0.0 109.896 173.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -47.48 -32.87 5.61 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.952 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -55.88 -47.01 78.15 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.298 0.999 . . . . 0.0 111.423 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -105.03 5.38 32.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.228 0.955 . . . . 0.0 109.651 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.66 53.72 37.34 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 124.292 0.995 . . . . 0.0 111.42 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -138.93 173.21 11.8 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -172.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -129.11 118.87 23.18 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.45 -171.05 23.83 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 118.953 -1.594 . . . . 0.0 113.224 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -103.25 162.16 13.21 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 113.646 -1.277 . . . . 0.0 109.603 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CE1' HD23 ' A' ' 30' ' ' LEU . 13.0 p90 -159.66 140.86 9.3 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.215 176.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.61 152.44 74.63 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.647 1.564 . . . . 0.0 110.406 176.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.75 26.11 2.83 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.984 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 p -96.57 -51.91 4.14 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.276 0.56 . . . . 0.0 111.729 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -90.48 25.65 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.156 -1.383 . . . . 0.0 110.847 -170.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.47 158.7 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -172.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -138.07 112.48 8.73 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -46.77 116.48 1.34 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.448 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.58 HD13 ' HE ' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -91.83 -56.98 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.522 178.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.49 175.85 38.88 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.459 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 CA-C-N 113.973 -1.114 . . . . 0.0 110.383 -177.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.228 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -128.87 164.1 23.83 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.785 0.803 . . . . 0.0 112.737 -171.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -139.03 133.46 31.69 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 113.414 -1.721 . . . . 0.0 107.926 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -90.65 113.49 25.55 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.37 128.2 30.62 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.136 167.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.01 -71.01 0.75 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.036 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -90.34 145.99 24.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 123.86 0.725 . . . . 0.0 110.045 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.97 125.07 23.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.126 0.891 . . . . 0.0 110.52 177.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.518 ' CD2' HD12 ' A' ' 24' ' ' LEU . 16.5 t80 -127.84 133.15 49.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.41 1.069 . . . . 0.0 109.374 175.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -90.01 160.94 16.1 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.346 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 160.83 16.73 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 123.952 0.783 . . . . 0.0 110.224 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.64 -50.43 4.06 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.899 0.857 . . . . 0.0 110.5 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.518 ' HG3' ' H ' ' A' ' 20' ' ' GLU . 6.8 ptp180 -150.27 -166.04 2.44 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 112.82 -1.991 . . . . 0.0 110.437 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -61.5 2.87 0.15 Allowed 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.518 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 28.5 tt0 -85.07 -36.99 20.83 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 123.246 0.341 . . . . 0.0 110.38 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.13 163.77 18.92 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.669 -174.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.597 HD12 ' H ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -120.25 -175.93 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 124.515 1.134 . . . . 0.0 110.294 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -83.6 129.09 34.96 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 112.612 -2.085 . . . . 0.0 107.474 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.518 HD12 ' CD2' ' A' ' 14' ' ' TYR . 82.4 mt -122.75 133.19 54.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.167 0.917 . . . . 0.0 110.415 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.22 171.32 14.33 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.053 -174.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -72.7 151.22 42.31 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.401 -172.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.89 -12.93 15.25 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.111 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.89 141.73 53.1 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.048 0.499 . . . . 0.0 110.206 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 mt -117.1 141.32 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 124.512 1.133 . . . . 0.0 110.01 172.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 30' ' ' LEU . 8.6 mp -107.43 150.15 27.09 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 112.748 -2.024 . . . . 0.0 109.233 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.4 m -128.22 138.98 52.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.19 0.931 . . . . 0.0 110.753 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.5 t -107.76 -155.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 124.367 1.042 . . . . 0.0 108.887 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.629 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.5 t-20 . . . . . 0 N--CA 1.488 1.449 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.57 173.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 . . . . . 0 N--CA 1.499 1.976 0 CA-C-O 122.109 0.957 . . . . 0.0 112.259 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.04 -18.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.38 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -116.25 87.32 19.47 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 124.234 0.959 . . . . 0.0 108.996 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.77 -6.23 3.22 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.535 2.157 . . . . 0.0 113.407 173.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.87 -39.48 87.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 123.651 0.594 . . . . 0.0 111.062 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -90.31 -19.87 23.57 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.127 0.892 . . . . 0.0 110.057 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mt -96.04 129.73 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 123.914 0.759 . . . . 0.0 109.782 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.62 -78.69 1.33 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -90.96 133.16 35.5 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.273 -1.464 . . . . 0.0 110.252 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.3 mp -120.75 125.44 47.63 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 172.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.414 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.2 t-20 -90.0 120.32 31.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 123.926 0.766 . . . . 0.0 109.559 168.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.91 -163.68 9.6 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.386 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -139.99 123.52 17.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.59 88.45 7.42 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.32 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -53.93 -38.17 64.61 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.199 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -52.02 -47.29 65.08 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.252 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -91.28 -4.82 55.54 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 123.992 0.808 . . . . 0.0 109.836 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.45 36.08 62.81 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 124.325 1.015 . . . . 0.0 111.836 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -135.98 134.37 38.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.231 0.606 . . . . 0.0 110.227 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -89.55 155.45 19.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.341 1.026 . . . . 0.0 109.115 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.86 -161.49 35.2 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.132 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.06 166.33 12.12 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 113.891 -1.154 . . . . 0.0 109.228 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.1 p90 -162.58 140.04 6.27 Favored Pre-proline 0 N--CA 1.496 1.847 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.311 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.458 ' HB2' HG22 ' A' ' 72' ' ' THR . 2.5 Cg_endo -63.14 166.86 13.6 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.875 1.716 . . . . 0.0 112.027 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.15 48.05 1.03 Allowed Glycine 0 N--CA 1.496 2.644 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.599 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.474 HG23 ' CD2' ' A' ' 73' ' ' TYR . 5.0 t -138.39 -28.15 0.85 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.19 0.582 . . . . 0.0 112.507 -177.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.474 ' CD2' HG23 ' A' ' 72' ' ' THR . 68.5 m-85 -90.92 1.62 56.87 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.319 1.012 . . . . 0.0 110.976 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.49 -174.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 124.293 0.996 . . . . 0.0 108.924 -176.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.39 127.97 11.55 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.621 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -60.56 133.5 56.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.685 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.08 -60.57 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 124.339 1.025 . . . . 0.0 110.361 176.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.92 148.0 15.91 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -163.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 CA-C-N 112.803 -1.698 . . . . 0.0 109.734 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -100.29 157.59 16.49 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.523 0.677 . . . . 0.0 110.859 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -143.99 124.97 14.35 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -90.6 120.9 32.06 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.67 121.12 6.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 123.974 0.796 . . . . 0.0 110.773 168.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -74.14 -46.42 42.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.018 0.824 . . . . 0.0 109.558 176.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.84 174.75 10.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.36 1.038 . . . . 0.0 110.152 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.25 133.33 35.99 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.089 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 16' ' ' LYS . 8.9 t80 -120.81 108.5 14.03 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 79.29 2.32 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.938 -171.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 31.3 mmtm -142.53 170.7 15.21 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.487 1.136 . . . . 0.0 111.44 170.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -151.45 60.98 0.89 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.804 -166.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -89.67 159.26 17.21 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -60.84 -17.06 47.73 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.133 0.492 . . . . 0.0 111.156 -176.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -105.12 -29.33 10.45 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.555 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -99.92 165.52 11.51 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 123.652 0.595 . . . . 0.0 111.311 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 pt -138.61 173.37 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.083 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -79.51 131.4 36.03 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.11 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 14' ' ' TYR . 20.6 mt -128.87 137.28 51.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.728 1.267 . . . . 0.0 109.429 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 -179.62 5.55 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.2 mt -63.27 151.1 41.54 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.577 171.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.47 -10.55 6.37 Favored Glycine 0 N--CA 1.496 2.683 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.611 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.17 116.5 4.61 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.142 177.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.522 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -97.6 144.04 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.389 0.614 . . . . 0.0 109.418 174.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 29' ' ' ILE . 9.1 mp -125.22 153.65 42.81 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.063 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.4 m -137.14 132.36 33.89 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 33' ' ' ASN . 90.8 t -105.98 168.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 32' ' ' VAL . 8.6 m120 . . . . . 0 N--CA 1.492 1.631 0 O-C-N 123.902 0.751 . . . . 0.0 112.874 176.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 . . . . . 0 N--CA 1.504 2.248 0 CA-C-O 121.522 0.677 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.36 -5.11 0.23 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.503 -173.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -119.16 85.23 29.53 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 124.471 1.107 . . . . 0.0 109.138 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.14 -2.26 5.51 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.151 2.567 . . . . 0.0 113.687 169.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -73.37 -15.83 61.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 123.684 0.615 . . . . 0.0 111.928 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -125.06 -33.86 2.84 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 123.602 0.564 . . . . 0.0 111.194 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.33 146.26 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 123.92 0.763 . . . . 0.0 110.433 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.28 -94.64 1.1 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -95.43 136.29 35.99 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.286 -0.957 . . . . 0.0 110.584 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.4 mp -115.96 138.23 51.39 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.207 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -107.96 118.83 37.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.89 165.91 30.28 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.453 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.2 143.25 26.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.039 0.494 . . . . 0.0 110.182 176.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -116.09 68.48 0.73 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.135 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -47.05 -31.71 3.51 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 114.123 -1.399 . . . . 0.0 114.088 172.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.9 m -50.37 -49.03 55.45 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.531 1.144 . . . . 0.0 111.187 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.9 p -98.03 -2.74 39.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.25 0.969 . . . . 0.0 110.55 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.62 32.27 81.02 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -122.95 176.35 6.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 124.461 0.742 . . . . 0.0 109.244 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -145.69 145.32 30.84 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.03 0.831 . . . . 0.0 109.114 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.28 -156.19 22.86 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.036 -1.554 . . . . 0.0 113.264 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.74 153.91 19.38 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 35.6 p90 -155.18 141.55 13.14 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 123.619 0.575 . . . . 0.0 109.673 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.82 142.02 67.86 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.828 1.685 . . . . 0.0 111.088 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.67 -22.86 78.76 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 124.012 0.82 . . . . 0.0 111.874 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.4 p -72.45 -6.37 43.15 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.035 -0.082 . . . . 0.0 111.025 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -109.73 -6.35 15.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 123.979 0.799 . . . . 0.0 111.785 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.37 -177.21 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 123.933 0.771 . . . . 0.0 109.028 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HB2' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -146.6 123.18 11.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 124.348 1.03 . . . . 0.0 108.948 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -56.26 127.16 29.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.355 1.034 . . . . 0.0 109.572 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.46 -55.08 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 123.874 0.734 . . . . 0.0 110.897 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -146.97 161.23 28.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 107.139 -2.385 . . . . 0.0 107.139 -164.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.764 0 C-N-CA 119.228 -0.989 . . . . 0.0 112.278 169.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.999 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -133.8 155.88 49.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 123.885 0.741 . . . . 0.0 110.216 -166.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -140.39 125.71 18.81 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.619 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -90.89 126.31 36.01 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.75 126.26 23.36 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.705 0.628 . . . . 0.0 111.317 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.24 -35.77 18.33 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.178 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 146.19 38.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.81 0.694 . . . . 0.0 110.224 -175.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.55 120.91 13.76 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.307 172.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.486 ' CD2' HD12 ' A' ' 24' ' ' LEU . 10.0 t80 -125.79 132.42 52.28 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.082 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -90.16 157.14 17.88 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.94 137.36 32.39 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.788 0.68 . . . . 0.0 109.727 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -119.9 -2.51 10.3 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.69 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HB3' ' H ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -120.02 141.7 49.48 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.145 0.903 . . . . 0.0 109.729 177.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.44 -17.27 62.51 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.923 171.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.53 -31.22 21.39 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.637 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . 0.425 ' H ' ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -85.68 144.58 27.74 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 123.641 0.588 . . . . 0.0 109.49 179.322 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pt -104.67 171.75 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 124.3 1.0 . . . . 0.0 111.332 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.24 149.34 47.56 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.77 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.486 HD12 ' CD2' ' A' ' 14' ' ' TYR . 96.1 mt -135.04 142.15 46.31 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.124 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.1 170.08 17.4 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 28' ' ' ASP . 1.6 mt -70.89 153.5 42.65 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.05 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.41 -7.75 1.27 Allowed Glycine 0 N--CA 1.505 3.234 0 O-C-N 123.537 0.523 . . . . 0.0 113.331 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 26' ' ' LEU . 26.0 t70 -68.95 109.12 3.78 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.526 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.702 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -89.04 149.9 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -176.018 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.702 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.1 mp -130.62 157.2 43.38 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 124.509 1.131 . . . . 0.0 111.041 174.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -136.83 141.5 42.86 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 123.782 0.676 . . . . 0.0 110.949 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.3 t -116.4 -147.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.597 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.852 0 CA-C-O 120.844 0.354 . . . . 0.0 110.735 -175.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.511 2.607 0 CA-C-O 121.858 0.837 . . . . 0.0 111.79 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.0 -12.21 0.1 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.031 -173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -120.23 81.5 29.46 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 123.873 0.733 . . . . 0.0 110.198 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.88 -26.63 68.25 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.216 1.944 . . . . 0.0 112.368 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -47.27 -47.04 25.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.883 1.364 . . . . 0.0 111.501 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.63 -37.06 13.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.383 1.052 . . . . 0.0 110.597 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.9 mt -60.5 143.19 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 123.624 0.578 . . . . 0.0 110.081 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.46 -79.48 1.33 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -169.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -115.09 129.87 56.79 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 112.694 -1.753 . . . . 0.0 109.189 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.605 ' N ' HD23 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -130.19 143.64 50.9 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.92 173.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -90.05 145.05 25.36 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.713 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.97 160.03 30.07 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -113.66 125.35 54.05 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -101.79 88.09 3.3 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.231 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -47.85 -36.85 12.66 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 113.608 -1.633 . . . . 0.0 111.977 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -42.39 98.59 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -90.74 0.81 57.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 123.793 0.683 . . . . 0.0 109.432 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.01 22.87 13.76 Favored Glycine 0 N--CA 1.497 2.72 0 O-C-N 124.459 1.099 . . . . 0.0 112.315 -168.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -121.74 155.67 34.75 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -137.76 150.54 47.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.621 1.201 . . . . 0.0 109.698 -174.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.78 -159.15 30.45 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.011 -1.09 . . . . 0.0 111.216 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.07 144.33 44.77 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -165.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.446 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 33.4 p90 -145.29 151.8 48.74 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 124.375 1.047 . . . . 0.0 108.914 -174.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -66.06 165.74 23.09 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.094 1.863 . . . . 0.0 111.779 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.15 60.4 0.4 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -147.71 -24.91 0.37 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -102.18 15.29 29.57 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 124.08 0.863 . . . . 0.0 111.264 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.5 177.81 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.014 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -148.26 116.3 6.44 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -47.81 143.34 4.1 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.757 165.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.53 -49.1 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 124.371 1.044 . . . . 0.0 111.752 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.84 150.21 22.25 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.333 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? . . . . . 0 N--CA 1.499 1.995 0 CA-C-N 113.833 -1.183 . . . . 0.0 111.97 179.055 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.232 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -123.51 157.94 32.44 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.05 0.929 . . . . 0.0 113.313 -173.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -140.43 121.35 14.55 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 112.397 -2.183 . . . . 0.0 107.486 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.2 ttt-85 -89.82 125.14 35.21 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.17 127.49 32.09 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 124.275 0.985 . . . . 0.0 110.742 171.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tp -92.52 -68.43 0.8 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.074 0.859 . . . . 0.0 109.527 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -98.2 144.52 27.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.028 0.83 . . . . 0.0 109.713 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -62.05 129.31 40.25 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.659 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.447 ' CD2' HD12 ' A' ' 24' ' ' LEU . 19.8 t80 -129.92 133.43 46.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.551 1.157 . . . . 0.0 108.846 175.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -90.01 154.33 19.9 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.971 0.794 . . . . 0.0 109.951 171.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.62 142.08 28.01 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.929 -177.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -89.4 -30.42 18.37 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.682 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -150.35 176.93 10.45 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.49 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.46 -18.39 28.27 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.661 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -69.1 -34.46 75.13 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.137 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.65 153.24 22.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.381 1.051 . . . . 0.0 109.406 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 pt -111.39 173.07 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 124.471 1.107 . . . . 0.0 110.534 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.57 132.91 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.186 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.447 HD12 ' CD2' ' A' ' 14' ' ' TYR . 89.8 mt -121.34 127.02 50.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 124.55 1.156 . . . . 0.0 109.866 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.443 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -132.83 172.7 12.23 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.302 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.07 150.98 44.3 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.156 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.05 -13.86 8.65 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.991 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.19 118.28 6.17 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.568 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.1 tp -96.19 151.09 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.714 0.769 . . . . 0.0 109.295 170.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.4 mp -127.71 150.84 49.6 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.388 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.3 m -132.4 146.99 52.36 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 123.822 0.701 . . . . 0.0 109.443 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.4 t -121.37 -147.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.516 ' H ' HG12 ' A' ' 32' ' ' VAL . 9.9 p-10 . . . . . 0 N--CA 1.493 1.694 0 O-C-N 123.768 0.668 . . . . 0.0 111.773 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.503 2.206 0 N-CA-C 115.78 1.77 . . . . 0.0 115.78 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.87 -22.33 0.07 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.023 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -116.29 81.97 11.25 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 124.23 0.956 . . . . 0.0 110.753 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.92 -8.76 6.48 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.373 2.049 . . . . 0.0 113.264 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -70.0 -37.78 75.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.85 0.719 . . . . 0.0 111.329 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -89.68 -27.82 19.86 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 123.933 0.771 . . . . 0.0 110.779 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.7 mt -76.68 140.78 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 123.923 0.764 . . . . 0.0 109.07 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.71 -91.76 1.2 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -175.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -98.18 123.27 42.16 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.701 -1.25 . . . . 0.0 109.503 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.6 mp -99.95 164.27 12.08 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.256 174.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.4 126.69 24.74 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.36 175.82 33.92 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.247 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -99.59 125.17 45.35 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.87 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -89.63 84.27 6.33 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.22 0.95 . . . . 0.0 109.872 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -56.94 -34.82 68.39 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.116 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.4 m -54.57 -38.63 66.9 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.03 0.831 . . . . 0.0 111.87 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.1 p -99.77 -4.36 30.79 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.808 0.693 . . . . 0.0 111.564 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.92 29.84 76.42 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -136.35 170.41 16.08 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -136.51 150.7 48.8 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.08 0.863 . . . . 0.0 109.251 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.65 -163.69 31.16 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.819 -1.182 . . . . 0.0 111.808 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.95 153.48 22.49 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.513 -0.843 . . . . 0.0 109.552 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.4 p90 -150.89 146.67 19.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.285 -176.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -66.59 150.08 83.98 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 121.787 1.658 . . . . 0.0 110.431 175.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.25 23.59 11.33 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 124.078 0.861 . . . . 0.0 111.971 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.98 -34.67 7.12 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.052 0.453 . . . . 0.0 111.23 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -89.92 14.91 10.93 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.193 -174.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.26 171.69 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.218 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -145.9 123.2 11.58 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -48.97 149.06 2.0 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.974 0.796 . . . . 0.0 109.677 170.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.79 -54.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 124.015 0.822 . . . . 0.0 111.336 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.92 146.23 15.43 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.802 -168.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 CA-C-N 113.138 -1.531 . . . . 0.0 110.839 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.499 2.006 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -145.38 165.57 28.09 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 122.437 1.113 . . . . 0.0 113.121 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -142.91 151.55 41.12 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 112.285 -2.234 . . . . 0.0 107.064 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -119.1 115.47 24.34 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.34 121.21 7.15 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.484 171.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tp -93.79 -43.4 8.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.508 1.13 . . . . 0.0 110.235 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.43 143.54 45.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.578 1.174 . . . . 0.0 110.342 -177.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.88 117.47 20.0 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.304 -1.317 . . . . 0.0 109.787 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.494 ' HD2' HD12 ' A' ' 24' ' ' LEU . 16.8 t80 -120.58 131.24 54.56 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -89.1 156.24 18.95 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.652 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -89.19 132.73 34.72 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.622 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -112.51 -13.9 13.29 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.138 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 -129.42 149.33 51.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 124.417 1.073 . . . . 0.0 110.387 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.07 -12.59 61.82 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.878 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -80.09 -19.78 46.64 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.116 0.885 . . . . 0.0 111.514 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.55 159.71 16.85 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.012 0.82 . . . . 0.0 111.497 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 pt -110.63 176.59 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.844 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -73.16 139.88 46.66 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.897 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.494 HD12 ' HD2' ' A' ' 14' ' ' TYR . 16.1 mt -127.52 127.64 44.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.192 0.933 . . . . 0.0 110.566 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.95 -176.61 4.86 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.92 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -61.64 152.98 29.27 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.807 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.14 -11.57 4.8 Favored Glycine 0 N--CA 1.499 2.836 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.801 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' HG21 ' A' ' 62' ' ' THR . 1.1 m-20 -65.17 95.51 0.18 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -91.2 133.25 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.796 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.3 mp -112.83 146.45 38.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 112.494 -2.139 . . . . 0.0 108.756 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 m -132.14 155.79 47.53 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -138.29 169.8 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -170.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.838 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.776 176.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 N--CA 1.502 2.15 0 N-CA-C 112.591 0.589 . . . . 0.0 112.591 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.18 -4.83 19.11 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 174.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 79.12 46.49 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.15 -19.22 65.84 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 122.072 1.848 . . . . 0.0 112.365 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -57.62 -40.49 79.29 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.151 0.907 . . . . 0.0 112.549 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -89.9 -27.41 19.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 123.757 0.661 . . . . 0.0 109.961 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.9 mt -70.58 148.32 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.492 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.52 -94.82 1.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -89.78 144.68 25.77 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.203 -0.998 . . . . 0.0 110.256 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 55.0 mt -117.76 133.22 56.16 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.029 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.8 117.89 34.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.146 0.904 . . . . 0.0 109.463 175.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.87 175.76 35.06 Favored Glycine 0 N--CA 1.496 2.671 0 O-C-N 124.181 0.925 . . . . 0.0 112.015 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -94.71 150.03 20.63 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.108 -1.046 . . . . 0.0 109.987 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.4 64.13 1.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.372 -1.286 . . . . 0.0 107.959 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.01 -25.48 30.38 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.696 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 28' ' ' ASP . 62.5 m -51.75 -49.35 62.76 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 124.351 1.032 . . . . 0.0 110.914 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -94.61 -3.74 49.04 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 124.331 1.019 . . . . 0.0 111.722 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.06 42.38 77.34 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -141.68 178.38 7.51 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.345 -0.927 . . . . 0.0 108.801 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -147.19 151.69 37.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.97 -153.21 13.32 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 118.895 -1.622 . . . . 0.0 112.38 167.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -104.51 148.78 26.09 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 56' ' ' LEU . 17.0 p90 -153.47 140.29 12.91 Favored Pre-proline 0 N--CA 1.494 1.763 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.423 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.31 160.74 15.61 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.905 1.737 . . . . 0.0 111.949 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.12 35.38 4.6 Favored Glycine 0 N--CA 1.498 2.788 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.177 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.448 HG23 ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.56 -30.52 1.87 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.448 ' CD1' HG23 ' A' ' 72' ' ' THR . 18.0 m-30 -90.24 13.93 13.99 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.926 0.766 . . . . 0.0 110.874 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.08 176.2 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 124.57 1.168 . . . . 0.0 107.918 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -144.77 113.76 6.88 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -45.17 139.4 3.38 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.959 0.787 . . . . 0.0 110.196 168.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.487 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.8 pt -137.02 -66.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 124.597 1.186 . . . . 0.0 109.892 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.487 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -98.22 157.89 20.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 -171.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.495 1.819 0 O-C-N 124.587 0.816 . . . . 0.0 111.485 168.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.504 2.227 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -125.65 161.99 26.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 124.192 0.932 . . . . 0.0 111.591 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -138.44 159.57 41.74 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.821 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -120.2 116.27 25.28 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.54 111.55 0.66 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.896 0.748 . . . . 0.0 110.498 170.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -51.37 40.86 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.639 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.38 151.48 49.3 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.511 1.132 . . . . 0.0 109.874 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -57.31 129.23 40.86 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.692 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.489 ' CD2' HD12 ' A' ' 24' ' ' LEU . 16.8 t80 -130.31 129.71 43.56 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.178 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -89.29 155.7 19.21 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.779 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 146.53 24.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.811 0.694 . . . . 0.0 109.388 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -131.78 -7.12 3.59 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.911 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.03 150.55 50.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 124.163 0.914 . . . . 0.0 109.404 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -65.45 -16.97 64.18 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.707 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -78.58 -25.51 45.31 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.728 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.86 154.91 19.43 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.3 1.0 . . . . 0.0 111.174 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 pt -119.13 177.35 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.775 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.87 135.46 38.85 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.826 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.489 HD12 ' CD2' ' A' ' 14' ' ' TYR . 64.9 mt -128.31 135.04 49.06 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 124.294 0.996 . . . . 0.0 110.188 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.51 -174.47 3.65 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.742 -173.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.99 154.05 25.9 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.207 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.85 -6.36 2.04 Favored Glycine 0 N--CA 1.502 3.04 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.673 -176.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.93 116.99 7.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.5 mt -104.19 138.89 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 124.287 0.992 . . . . 0.0 109.868 173.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.543 HD11 ' ND2' ' A' ' 60' ' ' ASN . 11.0 mp -110.74 158.95 18.08 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.903 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.8 m -130.58 151.2 51.3 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 123.804 0.69 . . . . 0.0 109.495 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.1 t -119.85 -141.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.531 ' H ' HG12 ' A' ' 32' ' ' VAL . 35.7 m120 . . . . . 0 N--CA 1.486 1.375 0 O-C-N 124.11 0.881 . . . . 0.0 109.227 -178.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 121.554 0.692 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.96 18.38 13.45 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.78 -172.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -130.33 73.14 81.55 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 123.899 0.749 . . . . 0.0 110.309 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HG3' ' H ' ' A' ' 76' ' ' TYR . 3.6 Cg_exo -60.85 -4.96 4.04 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.56 2.174 . . . . 0.0 113.536 174.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.83 -39.42 69.77 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.62 0.575 . . . . 0.0 110.895 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.8 -33.05 16.67 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.094 0.871 . . . . 0.0 109.793 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 mt -77.37 125.5 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.54 -78.62 1.32 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -92.56 120.47 33.04 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 113.335 -1.433 . . . . 0.0 110.006 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 2.2 mp -105.9 123.78 48.52 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.088 172.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.98 122.41 35.31 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 168.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.68 171.34 32.45 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.015 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.02 150.28 21.07 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.25 -0.975 . . . . 0.0 109.871 176.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.543 ' ND2' HD11 ' A' ' 30' ' ' LEU . 4.4 m120 -120.14 77.21 1.23 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.102 174.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -52.94 -36.13 59.42 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.942 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -53.28 -50.38 64.98 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.264 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.0 p -89.54 4.74 48.3 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.574 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.45 35.21 50.49 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 124.383 1.052 . . . . 0.0 111.483 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -138.65 -175.85 4.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 154.2 37.46 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.384 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.42 -162.82 34.03 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.774 -1.203 . . . . 0.0 112.55 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.82 161.24 13.84 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.079 -1.06 . . . . 0.0 109.711 176.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.481 ' CE1' HD23 ' A' ' 30' ' ' LEU . 34.4 p90 -162.1 142.18 7.65 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.434 175.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.71 155.33 64.03 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 121.547 1.498 . . . . 0.0 111.89 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.46 -12.43 64.93 Favored Glycine 0 N--CA 1.5 2.937 0 O-C-N 123.915 0.759 . . . . 0.0 112.494 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.51 3.62 18.14 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.507 0.323 . . . . 0.0 110.823 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -121.1 -2.16 9.7 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.165 0.916 . . . . 0.0 110.572 -176.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 m -128.08 -177.64 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 124.175 0.922 . . . . 0.0 110.067 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -150.16 113.78 4.99 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.846 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.409 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 28.4 t80 -46.95 142.59 3.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 123.551 0.532 . . . . 0.0 110.388 172.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 pt -118.6 -55.37 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 123.948 0.78 . . . . 0.0 110.409 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.26 147.16 15.73 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.023 -1.084 . . . . 0.0 110.695 -165.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-N 112.904 -1.648 . . . . 0.0 110.019 176.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.505 2.324 0 N-CA-C 109.694 -0.484 . . . . 0.0 109.694 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -147.59 165.26 30.91 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.27 1.033 . . . . 0.0 112.698 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -146.19 148.66 32.76 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 112.404 -2.18 . . . . 0.0 106.896 -174.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -117.64 113.8 22.45 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.82 103.95 0.07 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.401 1.063 . . . . 0.0 110.723 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.33 -31.48 69.96 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.824 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.93 141.9 38.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.133 0.895 . . . . 0.0 109.845 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.67 112.87 5.03 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.396 174.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -113.5 133.12 55.4 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -89.89 156.52 18.41 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.322 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -88.84 147.17 24.54 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.927 -175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -122.67 -7.03 8.57 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.299 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -139.01 159.25 42.59 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.731 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.9 -21.16 66.43 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.364 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.99 -23.35 33.36 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.907 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -94.77 146.21 24.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.263 0.977 . . . . 0.0 109.979 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -111.98 176.69 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 124.775 1.297 . . . . 0.0 110.3 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -86.2 106.22 17.14 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.683 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.56 125.37 35.6 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.46 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.78 -173.12 2.18 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.728 1.267 . . . . 0.0 109.256 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.6 mt -74.13 145.72 44.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.69 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.47 10.88 4.63 Favored Glycine 0 N--CA 1.503 3.119 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.206 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.18 127.17 30.58 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.297 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.71 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 mp -104.56 142.84 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 CA-C-O 121.307 0.575 . . . . 0.0 109.46 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.71 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.4 mp -126.82 150.37 49.21 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.028 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.2 m -128.84 149.62 50.67 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 123.956 0.785 . . . . 0.0 110.62 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -120.63 -156.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 O-C-N 123.551 0.532 . . . . 0.0 109.728 179.148 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.599 ' H ' HD22 ' A' ' 33' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.502 2.129 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 171.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 112.462 0.542 . . . . 0.0 112.462 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.21 -2.84 26.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.532 1.145 . . . . 0.0 111.859 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -119.96 79.15 24.84 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 123.97 0.794 . . . . 0.0 111.283 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.83 -13.7 23.68 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.784 1.656 . . . . 0.0 112.744 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -64.11 -38.1 89.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.093 0.871 . . . . 0.0 111.488 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -90.12 -28.09 19.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.931 0.769 . . . . 0.0 110.912 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 mt -74.09 141.47 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 123.866 0.729 . . . . 0.0 109.577 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.43 -92.82 1.15 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -93.23 120.39 33.47 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.603 -1.299 . . . . 0.0 109.679 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.0 mp -100.44 125.38 46.73 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.604 171.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -95.99 118.23 32.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.739 0.65 . . . . 0.0 109.729 171.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.01 -179.36 18.95 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -124.42 125.19 43.87 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -96.42 91.99 6.09 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.434 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -52.41 -35.04 50.99 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.021 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.7 m -51.25 -36.98 44.59 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.514 1.134 . . . . 0.0 112.096 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 64.5 p -115.74 2.6 13.7 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.952 0.782 . . . . 0.0 110.064 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.9 18.69 57.58 Favored Glycine 0 N--CA 1.493 2.483 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.746 -174.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -110.02 153.65 24.3 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.417 ' CD ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -137.74 146.72 44.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.665 1.228 . . . . 0.0 109.479 -175.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.89 -163.04 31.07 Favored Glycine 0 N--CA 1.491 2.314 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.18 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.3 151.15 26.96 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.066 -1.067 . . . . 0.0 109.587 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 26.7 p90 -147.68 144.38 19.17 Favored Pre-proline 0 N--CA 1.493 1.715 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.365 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.29 153.83 71.84 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.745 1.63 . . . . 0.0 111.34 174.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.27 53.17 2.47 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.3 t -134.46 -23.25 1.66 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -105.15 26.75 8.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.141 0.901 . . . . 0.0 110.63 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.46 166.85 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.595 -173.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -144.91 118.8 9.3 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.103 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -48.46 130.62 16.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.05 0.844 . . . . 0.0 110.464 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.491 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.2 pt -135.87 -62.39 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 123.907 0.754 . . . . 0.0 111.426 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.491 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -93.81 159.68 23.91 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 -176.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 . . . . . 0 N--CA 1.489 1.523 0 O-C-N 124.758 0.917 . . . . 0.0 110.478 -178.292 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.115 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.531 ' HB3' HD11 ' A' ' 77' ' ' ILE . 30.1 mt-30 -139.4 159.1 42.95 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.506 -173.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -142.68 125.15 15.68 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.1 -1.863 . . . . 0.0 107.601 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -89.61 118.46 29.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.629 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.63 152.48 0.33 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.927 0.767 . . . . 0.0 112.788 170.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -113.29 -44.81 3.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.512 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.34 151.99 41.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.06 0.85 . . . . 0.0 110.799 -175.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.01 116.37 7.76 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.257 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.2 t80 -117.99 138.1 52.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.125 0.891 . . . . 0.0 108.895 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.02 146.4 25.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.297 0.998 . . . . 0.0 109.921 174.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 164.53 14.94 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.176 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.62 -25.24 0.77 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.074 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -108.03 149.68 28.12 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.101 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.56 -12.25 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.531 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -81.76 -40.27 22.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 123.903 0.752 . . . . 0.0 111.187 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.77 156.22 19.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.114 0.884 . . . . 0.0 111.265 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.41 174.43 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.666 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -75.05 131.47 40.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.766 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 14' ' ' TYR . 97.0 mt -121.56 127.46 50.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.587 1.179 . . . . 0.0 109.179 -177.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.74 -173.62 2.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.268 0.98 . . . . 0.0 108.904 -175.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 26' ' ' LEU . 3.1 mp -83.12 156.53 23.23 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.423 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.12 0.03 1.0 Allowed Glycine 0 N--CA 1.5 2.955 0 O-C-N 123.872 0.732 . . . . 0.0 113.201 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.69 106.29 1.45 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 30' ' ' LEU . 5.6 mt -90.64 132.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.743 174.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.634 HD11 HD22 ' A' ' 60' ' ' ASN . 10.5 mp -108.52 151.52 25.98 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.064 -1.88 . . . . 0.0 109.013 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.8 m -129.43 147.43 51.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 123.842 0.714 . . . . 0.0 109.845 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.431 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -119.59 -147.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 123.807 0.692 . . . . 0.0 109.265 -178.199 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.431 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.735 0 O-C-N 123.419 0.449 . . . . 0.0 110.033 178.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.504 2.244 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -86.96 -37.86 17.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -102.31 102.97 27.94 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.999 0.812 . . . . 0.0 111.325 174.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -68.6 -17.99 42.92 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.641 2.227 . . . . 0.0 114.092 167.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.53 -31.67 68.14 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.657 0.598 . . . . 0.0 112.246 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.32 -21.89 21.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.831 0.707 . . . . 0.0 111.376 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.12 146.91 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -91.56 1.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -90.19 131.04 36.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.425 -1.388 . . . . 0.0 109.032 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -108.46 126.82 53.32 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.94 124.23 46.33 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.77 -166.18 16.67 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -140.17 150.19 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.634 HD22 HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -114.23 99.87 7.93 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.274 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.81 -21.49 66.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.3 m -46.05 -37.42 6.7 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.812 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.61 2.46 6.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.849 1.343 . . . . 0.0 108.877 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.64 36.87 73.33 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.614 -176.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -109.51 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.51 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 156.05 40.99 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.767 0.794 . . . . 0.0 111.699 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.66 -153.05 23.3 Favored Glycine 0 N--CA 1.489 2.197 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.032 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.71 153.94 24.57 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -173.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.6 p90 -151.36 140.77 13.95 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.912 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HB2' HG22 ' A' ' 72' ' ' THR . 1.3 Cg_endo -65.15 150.39 87.74 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.53 1.486 . . . . 0.0 110.708 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.29 48.72 4.08 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 70' ' ' PRO . 7.6 t -141.21 16.39 2.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.105 0.532 . . . . 0.0 111.616 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -136.05 -4.08 2.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 123.751 0.657 . . . . 0.0 111.847 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.98 -169.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 123.932 0.77 . . . . 0.0 109.13 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.71 113.58 5.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 172.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 25.2 t80 -48.27 142.97 4.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.442 171.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.5 pt -122.24 -53.5 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 123.926 0.766 . . . . 0.0 111.688 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.84 146.63 15.79 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.478 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 CA-C-N 113.311 -1.444 . . . . 0.0 109.988 177.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.503 2.188 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.685 ' HB3' HD11 ' A' ' 77' ' ' ILE . 4.6 mt-30 -133.01 165.3 25.04 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.145 0.974 . . . . 0.0 111.857 -177.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -136.64 128.42 29.05 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.883 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -89.31 114.69 26.11 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.89 122.53 4.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.362 1.039 . . . . 0.0 111.99 171.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.27 -41.37 34.19 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.677 -178.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.11 160.62 39.53 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 124.21 0.944 . . . . 0.0 110.376 -177.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.47 127.8 33.76 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.496 173.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.457 ' CD2' HD12 ' A' ' 24' ' ' LEU . 16.4 t80 -126.56 130.48 50.63 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.367 1.042 . . . . 0.0 109.042 173.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -90.29 153.88 20.13 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 169.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.62 171.9 9.34 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.101 0.876 . . . . 0.0 109.864 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.44 -10.01 1.24 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.094 177.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -132.84 154.58 50.19 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.357 -176.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.2 -19.15 62.83 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.55 174.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -71.89 -31.17 66.15 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.045 176.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.77 152.06 23.02 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 124.23 0.956 . . . . 0.0 110.317 -177.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pt -115.46 173.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.834 176.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -74.22 134.05 42.7 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.265 -1.788 . . . . 0.0 108.866 -176.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.457 HD12 ' CD2' ' A' ' 14' ' ' TYR . 87.4 mt -126.63 136.63 52.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.279 0.987 . . . . 0.0 110.026 -177.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 173.08 11.9 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.699 -173.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -67.55 158.02 32.99 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.228 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.3 -10.0 1.49 Allowed Glycine 0 N--CA 1.5 2.909 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.886 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.32 133.15 50.79 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.17 116.23 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.47 129.94 45.69 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 -168.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.2 m -103.91 146.97 27.89 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 124.006 0.816 . . . . 0.0 110.619 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.1 t -121.03 -149.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 124.52 1.138 . . . . 0.0 108.365 179.435 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.631 ' H ' HG12 ' A' ' 32' ' ' VAL . 4.2 m-80 . . . . . 0 N--CA 1.496 1.832 0 O-C-N 123.409 0.443 . . . . 0.0 111.228 176.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 . . . . . 0 N--CA 1.507 2.404 0 CA-C-O 121.909 0.861 . . . . 0.0 112.908 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -158.95 -22.75 0.07 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.35 -173.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 84.99 37.78 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 124.006 0.816 . . . . 0.0 109.395 175.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.555 ' HA ' HD12 ' A' ' 53' ' ' ILE . 5.0 Cg_exo -56.28 -23.0 43.59 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.444 2.096 . . . . 0.0 111.997 173.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.42 -45.63 76.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.657 1.223 . . . . 0.0 110.837 -175.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.01 -26.52 20.29 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 124.113 0.883 . . . . 0.0 111.102 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' A' ' 50' ' ' PRO . 62.4 mt -64.66 153.73 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 123.72 0.638 . . . . 0.0 109.857 176.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.17 -101.42 1.03 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 178.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -92.18 147.25 23.08 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.497 -0.851 . . . . 0.0 110.382 -177.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 67.4 mt -117.46 120.22 37.46 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 113.831 -1.531 . . . . 0.0 107.829 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.25 123.16 42.19 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 124.221 0.951 . . . . 0.0 109.732 173.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.07 -173.19 31.49 Favored Glycine 0 N--CA 1.499 2.871 0 O-C-N 124.066 0.853 . . . . 0.0 111.71 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.73 128.7 49.96 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.025 -174.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -94.06 62.19 3.03 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 124.445 1.09 . . . . 0.0 109.625 175.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -42.71 -33.9 0.81 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 114.467 -1.242 . . . . 0.0 114.179 173.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.9 p -55.08 -50.26 69.6 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 123.598 0.561 . . . . 0.0 112.028 177.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -89.83 1.89 55.62 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.059 0.85 . . . . 0.0 111.06 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.99 33.25 86.75 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -131.44 165.32 23.79 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -150.43 156.04 40.71 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 123.571 0.545 . . . . 0.0 110.551 177.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.68 -154.14 20.32 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.457 176.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.04 150.78 26.71 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 56' ' ' LEU . 12.8 p90 -154.95 139.43 11.66 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 124.171 0.919 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.95 161.17 19.59 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.126 1.884 . . . . 0.0 112.86 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.08 22.28 32.71 Favored Glycine 0 N--CA 1.495 2.593 0 O-C-N 124.206 0.941 . . . . 0.0 111.871 -176.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.42 -47.4 4.69 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 117.444 0.622 . . . . 0.0 112.65 -174.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -94.02 40.34 1.08 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.499 -171.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.39 152.05 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.484 -174.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -131.96 111.82 11.87 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.432 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 75.8 t80 -54.78 122.57 11.03 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.306 174.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.685 HD11 ' HB3' ' A' ' 7' ' ' GLN . 0.9 OUTLIER -94.42 -49.6 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 124.113 0.883 . . . . 0.0 110.783 -176.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.97 -168.45 41.55 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.912 -1.137 . . . . 0.0 112.696 175.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.498 1.974 0 CA-C-N 113.41 -1.395 . . . . 0.0 109.973 175.837 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.504 2.261 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -128.9 164.03 23.99 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 122.849 1.309 . . . . 0.0 113.832 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -141.12 154.7 46.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 111.398 -2.637 . . . . 0.0 107.338 -174.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -125.73 121.21 32.74 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.54 126.06 16.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 124.121 0.888 . . . . 0.0 110.935 168.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.38 -33.12 23.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.874 0.734 . . . . 0.0 111.017 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.88 157.59 44.26 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.928 0.767 . . . . 0.0 110.346 -174.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.89 116.95 19.53 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.26 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.458 ' CD2' HD12 ' A' ' 24' ' ' LEU . 5.3 t80 -121.19 133.78 55.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.449 1.093 . . . . 0.0 108.725 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.6 164.57 14.7 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -89.06 142.36 27.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.616 0.572 . . . . 0.0 109.803 -177.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.44 -12.45 5.0 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.96 177.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.91 143.12 51.37 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.336 178.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.98 -34.54 76.34 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.083 -178.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.69 -35.41 80.69 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.404 177.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -88.35 162.09 16.75 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.177 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.64 174.83 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.278 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.79 148.56 42.38 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.936 -177.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 14' ' ' TYR . 92.8 mt -133.24 141.28 47.95 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.093 0.87 . . . . 0.0 110.538 178.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.78 165.67 26.82 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.532 -171.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.7 mt -65.74 151.69 46.02 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.336 174.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.32 -9.4 4.33 Favored Glycine 0 N--CA 1.501 2.995 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.03 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -69.02 132.46 46.68 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mt -121.05 138.74 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 124.343 1.027 . . . . 0.0 108.629 176.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.438 HD23 ' CE1' ' A' ' 69' ' ' PHE . 10.9 mp -107.48 150.21 27.06 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 112.972 -1.922 . . . . 0.0 108.138 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 m -127.5 153.81 45.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.632 0.583 . . . . 0.0 109.992 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -131.29 175.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -176.508 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 . . . . . 0 N--CA 1.497 1.905 0 CA-C-O 121.794 0.807 . . . . 0.0 110.338 -178.15 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 . . . . . 0 N--CA 1.502 2.147 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.71 23.32 9.54 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.393 -169.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.68 68.65 81.85 Favored Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.674 -176.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HG3' ' H ' ' A' ' 76' ' ' TYR . 5.5 Cg_exo -59.23 -23.91 71.7 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.46 2.107 . . . . 0.0 111.73 174.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -59.31 -49.17 78.84 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.285 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -90.09 -35.19 15.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 123.832 0.708 . . . . 0.0 110.909 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.4 mt -64.1 129.86 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 123.943 0.777 . . . . 0.0 109.64 172.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.46 -87.41 1.27 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -175.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -98.23 124.87 43.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.609 -1.296 . . . . 0.0 108.144 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.582 ' H ' HD23 ' A' ' 56' ' ' LEU . 1.4 pt? -132.65 144.67 50.5 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 173.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -92.87 147.84 22.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.594 1.184 . . . . 0.0 108.867 -176.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.86 154.13 25.25 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 175.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.46 122.49 32.7 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.062 -1.069 . . . . 0.0 108.487 176.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -96.47 69.66 2.61 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.977 0.894 . . . . 0.0 111.168 177.005 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -52.31 -26.76 12.96 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 113.754 -1.567 . . . . 0.0 112.458 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.4 p -51.67 -51.72 53.64 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.037 0.836 . . . . 0.0 112.782 174.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.6 p -91.6 2.28 56.56 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.228 176.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.86 30.37 77.81 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -129.34 178.32 6.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 124.506 0.768 . . . . 0.0 109.508 -178.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -144.51 147.66 33.52 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.17 -163.01 28.54 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 118.79 -1.671 . . . . 0.0 113.847 166.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.69 152.74 19.32 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 113.17 -1.515 . . . . 0.0 108.98 -178.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.438 ' CE1' HD23 ' A' ' 30' ' ' LEU . 24.4 p90 -154.36 152.74 26.88 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 123.654 0.596 . . . . 0.0 109.803 175.215 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -65.66 165.25 23.67 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 122.32 2.013 . . . . 0.0 112.007 176.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.55 -2.35 67.71 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 123.987 0.804 . . . . 0.0 111.57 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -96.34 -34.13 11.69 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.507 0.67 . . . . 0.0 109.833 -166.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -90.95 6.11 45.99 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.567 -1.652 . . . . 0.0 111.529 -174.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.34 -177.75 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 124.208 0.942 . . . . 0.0 109.046 -178.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.34 115.95 5.51 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . 0.404 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 32.2 t80 -49.4 128.91 18.03 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 166.182 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.67 -54.72 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 124.131 0.894 . . . . 0.0 109.721 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.94 171.92 36.36 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.681 -1.724 . . . . 0.0 110.502 -170.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.395 0 CA-C-N 113.732 -1.234 . . . . 0.0 109.404 168.673 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.502 2.171 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -136.73 162.01 34.38 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.848 0.833 . . . . 0.0 110.991 -169.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -129.64 170.75 13.4 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.587 -1.642 . . . . 0.0 107.341 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -133.89 116.65 15.87 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.14 112.03 0.98 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.301 1.0 . . . . 0.0 110.013 174.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.4 tp -70.07 -38.49 75.75 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.514 -177.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.61 170.83 15.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 124.582 1.176 . . . . 0.0 109.981 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.22 123.2 28.27 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.529 175.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CD2' HD12 ' A' ' 24' ' ' LEU . 8.5 t80 -118.83 134.25 55.29 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -89.74 159.12 17.23 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.047 175.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -88.3 141.09 28.83 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -176.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -121.32 -8.65 9.16 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.644 178.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -136.67 146.62 46.14 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -60.41 -31.01 69.98 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.166 174.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.58 -32.75 73.8 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.3 178.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.36 161.1 14.53 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.304 1.002 . . . . 0.0 110.107 177.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 pt -116.94 174.86 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 124.349 1.031 . . . . 0.0 111.545 176.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.52 141.95 46.73 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.125 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.5 HD12 ' CD2' ' A' ' 14' ' ' TYR . 18.0 mt -131.38 135.17 46.98 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.968 0.792 . . . . 0.0 111.534 178.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.31 176.52 8.62 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mp -72.47 154.53 40.81 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.937 -177.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.69 -5.57 2.33 Favored Glycine 0 N--CA 1.5 2.931 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.896 -176.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.64 101.13 0.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.233 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.95 135.96 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 124.274 0.984 . . . . 0.0 110.099 173.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 69' ' ' PHE . 11.1 mp -111.2 157.03 20.56 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.968 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.5 m -133.37 150.8 51.81 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.768 0.668 . . . . 0.0 110.407 -176.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.4 t -128.31 -151.93 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 123.841 0.713 . . . . 0.0 109.151 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.588 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.8 m-80 . . . . . 0 N--CA 1.493 1.717 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.869 178.059 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 . . . . . 0 N--CA 1.499 1.985 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.45 -0.84 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.596 178.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -123.0 77.78 50.81 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 123.93 0.769 . . . . 0.0 109.557 -176.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.43 -18.83 15.73 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.888 2.392 . . . . 0.0 112.7 175.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -53.97 -42.62 69.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.087 0.867 . . . . 0.0 111.806 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -89.8 -29.6 18.53 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.1 0.875 . . . . 0.0 110.926 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 mt -73.54 136.7 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.82 -87.08 1.31 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -172.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -102.75 131.22 49.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.309 -1.445 . . . . 0.0 109.051 -178.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -114.5 138.31 50.76 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.233 173.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -108.29 124.33 50.15 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 173.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -151.14 176.87 29.46 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 120.079 -1.058 . . . . 0.0 112.006 177.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -110.52 131.24 55.22 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.149 -1.025 . . . . 0.0 109.275 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -103.43 102.82 12.75 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.682 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.11 -36.31 72.72 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.284 177.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.4 m -56.63 -28.49 60.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.494 1.121 . . . . 0.0 111.996 -177.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -116.9 -2.96 11.69 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.645 -176.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.15 19.81 32.95 Favored Glycine 0 N--CA 1.497 2.748 0 O-C-N 124.405 1.066 . . . . 0.0 111.37 -172.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.98 165.78 13.31 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -172.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.16 149.8 40.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.006 0.816 . . . . 0.0 109.68 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.72 -145.19 6.66 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.456 173.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.39 153.67 30.62 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.145 -1.027 . . . . 0.0 108.29 -173.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 31.1 p90 -157.01 143.55 13.26 Favored Pre-proline 0 N--CA 1.493 1.699 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.751 178.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.08 157.87 46.86 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 122.111 1.874 . . . . 0.0 112.043 176.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.94 43.62 1.92 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -134.0 -26.38 1.52 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 178.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -93.21 2.4 56.67 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.463 -177.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.42 -176.44 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 124.306 1.004 . . . . 0.0 109.227 -177.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -150.27 115.15 5.31 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -48.36 122.26 5.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.142 0.901 . . . . 0.0 109.343 171.138 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.97 -51.1 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.039 177.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -166.16 159.84 33.21 Favored Glycine 0 N--CA 1.485 1.911 0 C-N-CA 118.814 -1.66 . . . . 0.0 110.688 -178.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.478 ' H ' ' CD ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--N 1.302 -1.473 0 CA-C-N 111.866 -2.167 . . . . 0.0 105.957 173.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.104 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -144.43 159.56 42.53 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 117.413 -1.715 . . . . 0.0 113.67 -174.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -146.31 143.96 29.49 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 112.345 -2.207 . . . . 0.0 107.439 -172.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -118.57 112.96 20.55 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -174.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.17 121.67 3.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.302 1.001 . . . . 0.0 109.983 175.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -79.8 -68.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.205 176.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.41 171.79 7.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.382 1.052 . . . . 0.0 109.924 -177.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.43 121.12 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.38 175.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD2' HD12 ' A' ' 24' ' ' LEU . 12.9 t80 -124.87 129.33 50.19 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -89.82 -170.33 2.77 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -88.33 144.89 26.13 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.039 175.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.39 -15.7 9.06 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.802 173.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -150.18 147.48 27.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.553 1.158 . . . . 0.0 108.796 -178.601 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.11 -11.31 0.67 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.033 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 18' ' ' ARG . 1.3 mm-40 -81.37 -44.68 17.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 124.212 0.945 . . . . 0.0 111.261 177.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.75 165.47 18.85 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.855 0.722 . . . . 0.0 109.334 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 177.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 122.507 1.146 . . . . 0.0 110.85 177.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -82.23 113.11 19.83 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 111.927 -2.397 . . . . 0.0 106.781 -178.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' A' ' 14' ' ' TYR . 61.6 mt -103.76 143.19 33.13 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.422 0.629 . . . . 0.0 111.769 179.288 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 172.15 15.72 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.271 -176.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.613 HD12 ' H ' ' A' ' 26' ' ' LEU . 6.5 mp -64.84 155.75 33.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.016 -177.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.19 -12.96 2.89 Favored Glycine 0 N--CA 1.504 3.187 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.476 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -76.58 113.89 14.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.205 0.591 . . . . 0.0 109.609 -175.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -96.91 149.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.246 0.546 . . . . 0.0 109.885 179.658 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.518 HD23 ' CE1' ' A' ' 69' ' ' PHE . 10.1 mp -124.47 145.91 49.25 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.228 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 m -127.1 125.63 41.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.165 0.916 . . . . 0.0 109.616 -177.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 33' ' ' ASN . 6.4 t -95.85 -124.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.411 ' N ' HG12 ' A' ' 32' ' ' VAL . 74.9 m-80 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -171.127 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.506 2.338 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 -11.89 55.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 82.37 48.52 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 124.219 0.949 . . . . 0.0 108.587 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.23 -10.68 26.77 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.118 1.879 . . . . 0.0 113.021 173.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.89 -36.73 79.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.719 0.637 . . . . 0.0 111.608 -176.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -91.4 -29.98 16.76 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.279 -176.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -71.6 149.82 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.222 177.07 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.4 -95.31 1.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -98.8 126.22 44.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.826 0.956 . . . . 0.0 110.061 -175.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.7 mp -98.29 145.09 27.01 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.429 174.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.54 125.92 51.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.2 0.937 . . . . 0.0 108.664 169.879 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.7 160.39 27.95 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.382 173.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.76 122.24 31.97 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.124 -1.038 . . . . 0.0 109.7 172.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -92.44 64.76 4.37 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.674 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -52.61 -31.2 35.27 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.006 -178.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.445 HG21 ' H ' ' A' ' 29' ' ' ILE . 37.6 p -53.89 -48.28 70.27 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.116 0.885 . . . . 0.0 111.49 179.142 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -89.74 -5.47 56.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.03 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.44 24.98 64.26 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 177.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -129.28 179.34 5.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.506 0.768 . . . . 0.0 109.144 -175.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -147.14 151.67 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.453 179.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.68 -161.08 33.2 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.2 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.96 162.18 15.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -170.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.518 ' CE1' HD23 ' A' ' 30' ' ' LEU . 23.4 p90 -160.65 148.47 12.69 Favored Pre-proline 0 N--CA 1.496 1.845 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.12 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.85 150.03 89.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.698 1.598 . . . . 0.0 111.209 177.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.04 48.09 2.22 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 175.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -146.71 8.16 0.98 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.819 0.364 . . . . 0.0 111.565 174.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.05 9.34 9.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.967 0.792 . . . . 0.0 111.473 -178.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 -171.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 124.016 0.823 . . . . 0.0 109.702 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HB2' HD23 ' A' ' 11' ' ' LEU . 10.0 tt0 -150.15 102.36 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.179 175.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -41.99 136.32 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.496 170.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.3 pt -139.57 -67.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 124.005 0.816 . . . . 0.0 110.604 -177.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.486 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -89.86 159.02 27.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -173.01 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? . . . . . 0 N--CA 1.489 1.49 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.88 -168.007 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.501 2.104 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -144.43 159.56 42.53 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 117.413 -1.715 . . . . 0.0 113.67 -174.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -146.31 143.96 29.49 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 112.345 -2.207 . . . . 0.0 107.439 -172.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -118.57 112.96 20.55 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -174.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.17 121.67 3.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.302 1.001 . . . . 0.0 109.983 175.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -79.8 -68.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.205 176.791 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.41 171.79 7.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.382 1.052 . . . . 0.0 109.924 -177.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.43 121.12 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.38 175.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD2' HD12 ' A' ' 24' ' ' LEU . 12.9 t80 -124.87 129.33 50.19 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -89.82 -170.33 2.77 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -88.33 144.89 26.13 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.039 175.221 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.39 -15.7 9.06 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.802 173.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -150.18 147.48 27.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.553 1.158 . . . . 0.0 108.796 -178.601 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.11 -11.31 0.67 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.033 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 18' ' ' ARG . 1.3 mm-40 -81.37 -44.68 17.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 124.212 0.945 . . . . 0.0 111.261 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.75 165.47 18.85 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.855 0.722 . . . . 0.0 109.334 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 177.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 122.507 1.146 . . . . 0.0 110.85 177.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -82.23 113.11 19.83 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 111.927 -2.397 . . . . 0.0 106.781 -178.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' A' ' 14' ' ' TYR . 61.6 mt -103.76 143.19 33.13 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.422 0.629 . . . . 0.0 111.769 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 172.15 15.72 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.271 -176.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.613 HD12 ' H ' ' A' ' 26' ' ' LEU . 6.5 mp -64.84 155.75 33.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.016 -177.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.19 -12.96 2.89 Favored Glycine 0 N--CA 1.504 3.187 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.476 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -76.58 113.89 14.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.205 0.591 . . . . 0.0 109.609 -175.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -96.91 149.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.246 0.546 . . . . 0.0 109.885 179.658 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.518 HD23 ' CE1' ' A' ' 69' ' ' PHE . 10.1 mp -124.47 145.91 49.25 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.228 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 m -127.1 125.63 41.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.165 0.916 . . . . 0.0 109.616 -177.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 33' ' ' ASN . 6.4 t -95.85 -124.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.411 ' N ' HG12 ' A' ' 32' ' ' VAL . 74.9 m-80 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -171.127 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.506 2.338 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 -11.89 55.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 82.37 48.52 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 124.219 0.949 . . . . 0.0 108.587 -177.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.23 -10.68 26.77 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.118 1.879 . . . . 0.0 113.021 173.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.89 -36.73 79.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.719 0.637 . . . . 0.0 111.608 -176.037 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -91.4 -29.98 16.76 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.279 -176.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -71.6 149.82 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.222 177.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.4 -95.31 1.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 177.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -98.8 126.22 44.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.826 0.956 . . . . 0.0 110.061 -175.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.7 mp -98.29 145.09 27.01 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.429 174.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -104.54 125.92 51.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.2 0.937 . . . . 0.0 108.664 169.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.7 160.39 27.95 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.382 173.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.76 122.24 31.97 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.124 -1.038 . . . . 0.0 109.7 172.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -92.44 64.76 4.37 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.674 176.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -52.61 -31.2 35.27 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.006 -178.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.445 HG21 ' H ' ' A' ' 29' ' ' ILE . 37.6 p -53.89 -48.28 70.27 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.116 0.885 . . . . 0.0 111.49 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -89.74 -5.47 56.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.03 177.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.44 24.98 64.26 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 177.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -129.28 179.34 5.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.506 0.768 . . . . 0.0 109.144 -175.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -147.14 151.67 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.453 179.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.68 -161.08 33.2 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.2 176.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.96 162.18 15.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -170.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.518 ' CE1' HD23 ' A' ' 30' ' ' LEU . 23.4 p90 -160.65 148.47 12.69 Favored Pre-proline 0 N--CA 1.496 1.845 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.12 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.85 150.03 89.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.698 1.598 . . . . 0.0 111.209 177.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.04 48.09 2.22 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -146.71 8.16 0.98 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.819 0.364 . . . . 0.0 111.565 174.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.05 9.34 9.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.967 0.792 . . . . 0.0 111.473 -178.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 -171.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 124.016 0.823 . . . . 0.0 109.702 -173.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HB2' HD23 ' A' ' 11' ' ' LEU . 10.0 tt0 -150.15 102.36 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.179 175.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -41.99 136.32 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.496 170.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.3 pt -139.57 -67.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 124.005 0.816 . . . . 0.0 110.604 -177.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.486 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -89.86 159.02 27.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -173.01 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? . . . . . 0 N--CA 1.489 1.49 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.88 -168.007 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.507 2.377 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.547 ' HB3' HD11 ' A' ' 77' ' ' ILE . 70.0 mt-30 -133.38 160.31 37.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 124.038 0.836 . . . . 0.0 111.602 -177.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -138.35 162.04 35.4 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.078 -1.874 . . . . 0.0 108.05 -177.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -125.87 112.9 16.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.293 0.996 . . . . 0.0 108.738 -179.35 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.41 108.93 0.43 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.321 170.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.68 -14.41 32.3 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.15 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.38 141.46 41.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.308 1.005 . . . . 0.0 110.544 -179.176 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.59 115.32 17.26 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.182 171.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -125.96 136.15 52.67 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 124.323 1.015 . . . . 0.0 109.101 176.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -89.79 163.3 15.11 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -89.02 140.6 29.27 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.851 0.719 . . . . 0.0 109.514 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -89.74 -25.34 21.2 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.994 -179.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -150.2 162.22 40.88 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.363 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -52.52 -14.89 0.55 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.137 -1.392 . . . . 0.0 114.609 173.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -75.94 -42.8 47.63 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 123.61 0.569 . . . . 0.0 110.767 177.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.35 146.48 24.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.02 0.825 . . . . 0.0 110.161 177.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -99.03 173.14 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.058 175.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.36 140.6 37.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.644 -177.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -125.86 138.91 53.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.497 1.123 . . . . 0.0 109.277 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.04 -155.14 0.67 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.043 -171.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.8 mt -106.4 144.29 33.29 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.706 0.629 . . . . 0.0 111.12 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.09 6.6 5.71 Favored Glycine 0 N--CA 1.503 3.11 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.667 178.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.89 144.25 54.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 123.93 0.429 . . . . 0.0 110.498 173.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.618 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.3 mp -108.9 146.79 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 124.569 1.168 . . . . 0.0 107.933 -177.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.618 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.4 mp -128.57 129.04 45.4 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.747 172.021 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 97.0 m -106.5 152.32 23.82 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 124.269 0.981 . . . . 0.0 109.273 -178.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -131.67 -173.45 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 124.079 0.862 . . . . 0.0 109.115 -179.133 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.491 1.618 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.7 -178.388 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.503 2.193 0 N-CA-C 113.578 0.955 . . . . 0.0 113.578 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.99 -14.15 16.06 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.288 -178.444 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -112.04 94.46 25.48 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 124.197 0.936 . . . . 0.0 108.942 173.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.67 -20.9 53.03 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.266 1.977 . . . . 0.0 112.768 166.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -59.16 -36.6 75.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.898 0.749 . . . . 0.0 111.951 -175.014 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.75 -31.83 17.26 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 123.856 0.723 . . . . 0.0 109.241 -176.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.73 146.17 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 124.123 0.889 . . . . 0.0 110.144 175.324 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.84 -99.69 1.1 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -89.79 131.94 35.48 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.416 -0.892 . . . . 0.0 110.01 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -102.04 156.26 17.65 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -134.21 121.5 21.44 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.9 -162.38 17.1 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -176.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.73 130.01 31.38 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -172.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -93.63 68.1 3.98 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.182 -1.826 . . . . 0.0 108.856 174.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -43.05 -29.54 0.36 Allowed 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 114.538 -1.21 . . . . 0.0 114.023 175.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.489 HG21 ' H ' ' A' ' 29' ' ' ILE . 82.8 p -45.85 -51.02 13.67 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.426 1.079 . . . . 0.0 112.328 178.11 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -106.44 0.26 24.65 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.986 174.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.43 37.81 53.22 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 175.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -109.3 135.75 49.87 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -120.99 125.36 47.17 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 123.811 0.694 . . . . 0.0 110.469 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.77 -147.21 8.0 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 119.521 -1.323 . . . . 0.0 114.094 176.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.19 164.39 12.91 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 113.782 -1.209 . . . . 0.0 108.898 -177.01 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -163.83 140.87 5.54 Favored Pre-proline 0 N--CA 1.494 1.728 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.614 175.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' PRO . . . . . 0.408 ' HB2' HG22 ' A' ' 72' ' ' THR . 2.4 Cg_endo -59.7 155.96 40.1 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.389 2.06 . . . . 0.0 112.305 -177.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.86 47.95 1.83 Allowed Glycine 0 N--CA 1.497 2.704 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.704 179.547 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.689 HG23 ' CD1' ' A' ' 73' ' ' TYR . 5.5 t -147.27 -22.85 0.39 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 179.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' TYR . . . . . 0.689 ' CD1' HG23 ' A' ' 72' ' ' THR . 10.7 m-30 -89.89 -12.26 39.48 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 123.973 0.795 . . . . 0.0 110.488 -178.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.4 m -105.67 -173.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.291 -176.022 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.29 114.32 5.09 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.706 175.433 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -55.69 124.95 19.13 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.932 177.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.2 pt -98.97 -52.9 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 123.934 0.771 . . . . 0.0 110.421 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.1 163.64 32.92 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.643 -175.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' ARG . . . . . 0.548 ' HD2' ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-N 113.588 -1.306 . . . . 0.0 110.808 163.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.196 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 1.1 p 60.95 154.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 124.837 0.963 . . . . 0.0 113.049 -171.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.0 mtt -104.82 9.49 34.84 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.172 178.73 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 p -146.37 172.61 13.24 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 120.97 0.414 . . . . 0.0 111.358 -179.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.58 172.28 12.31 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.292 173.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -92.87 -71.19 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.724 174.336 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.47 -134.6 10.74 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 124.64 1.213 . . . . 0.0 110.153 -177.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -97.73 161.53 13.71 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.531 ' HB3' HD11 ' A' ' 77' ' ' ILE . 30.1 mt-30 -139.4 159.1 42.95 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.506 -173.432 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -142.68 125.15 15.68 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.1 -1.863 . . . . 0.0 107.601 -176.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -89.61 118.46 29.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.629 178.403 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.63 152.48 0.33 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.927 0.767 . . . . 0.0 112.788 170.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -113.29 -44.81 3.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.512 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.34 151.99 41.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.06 0.85 . . . . 0.0 110.799 -175.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.01 116.37 7.76 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.257 177.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.2 t80 -117.99 138.1 52.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.125 0.891 . . . . 0.0 108.895 178.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.02 146.4 25.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.297 0.998 . . . . 0.0 109.921 174.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 164.53 14.94 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.176 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.62 -25.24 0.77 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.074 -176.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -108.03 149.68 28.12 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.101 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.56 -12.25 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.531 170.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -81.76 -40.27 22.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 123.903 0.752 . . . . 0.0 111.187 174.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.77 156.22 19.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.114 0.884 . . . . 0.0 111.265 -176.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.41 174.43 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.666 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -75.05 131.47 40.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.766 -174.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 14' ' ' TYR . 97.0 mt -121.56 127.46 50.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.587 1.179 . . . . 0.0 109.179 -177.148 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.74 -173.62 2.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.268 0.98 . . . . 0.0 108.904 -175.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 26' ' ' LEU . 3.1 mp -83.12 156.53 23.23 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.423 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.12 0.03 1.0 Allowed Glycine 0 N--CA 1.5 2.955 0 O-C-N 123.872 0.732 . . . . 0.0 113.201 -177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.69 106.29 1.45 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 30' ' ' LEU . 5.6 mt -90.64 132.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.743 174.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.634 HD11 HD22 ' A' ' 60' ' ' ASN . 10.5 mp -108.52 151.52 25.98 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.064 -1.88 . . . . 0.0 109.013 179.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.8 m -129.43 147.43 51.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 123.842 0.714 . . . . 0.0 109.845 -176.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.431 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -119.59 -147.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 123.807 0.692 . . . . 0.0 109.265 -178.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.431 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -97.77 158.12 15.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 123.419 0.449 . . . . 0.0 110.033 178.061 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -85.41 -27.27 25.89 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.033 -173.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.48 32.99 0.41 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -175.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -152.29 49.08 0.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -60.0 -30.78 69.37 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.094 171.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 38' ' ' VAL . 14.5 t -46.02 -8.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 114.195 -1.366 . . . . 0.0 114.351 167.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -32.6 -36.46 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.273 0.983 . . . . 0.0 112.283 169.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.4 mt -92.72 -34.71 13.82 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.457 -179.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.05 9.96 4.93 Favored Glycine 0 N--CA 1.499 2.838 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.361 -174.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.11 167.18 22.33 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.968 -0.616 . . . . 0.0 110.213 -174.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.38 6.81 0.67 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.841 0.829 . . . . 0.0 112.392 172.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -177.19 106.65 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.356 -1.747 . . . . 0.0 108.08 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.25 -6.02 0.32 Allowed Glycine 0 N--CA 1.497 2.728 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -178.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 46.15 91.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.064 0.935 . . . . 0.0 111.246 -172.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.61 -14.14 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 113.407 -1.724 . . . . 0.0 113.349 177.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -86.96 -37.86 17.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -102.31 102.97 27.94 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.999 0.812 . . . . 0.0 111.325 174.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -68.6 -17.99 42.92 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.641 2.227 . . . . 0.0 114.092 167.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.53 -31.67 68.14 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.657 0.598 . . . . 0.0 112.246 -178.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.32 -21.89 21.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.831 0.707 . . . . 0.0 111.376 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.12 146.91 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -91.56 1.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -90.19 131.04 36.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.425 -1.388 . . . . 0.0 109.032 176.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -108.46 126.82 53.32 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.94 124.23 46.33 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.77 -166.18 16.67 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -140.17 150.19 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.634 HD22 HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -114.23 99.87 7.93 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.274 -177.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.81 -21.49 66.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 178.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.3 m -46.05 -37.42 6.7 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.812 174.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.61 2.46 6.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.849 1.343 . . . . 0.0 108.877 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.64 36.87 73.33 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.614 -176.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -109.51 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.51 178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 156.05 40.99 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.767 0.794 . . . . 0.0 111.699 177.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.66 -153.05 23.3 Favored Glycine 0 N--CA 1.489 2.197 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.032 177.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.71 153.94 24.57 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -173.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.6 p90 -151.36 140.77 13.95 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.912 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HB2' HG22 ' A' ' 72' ' ' THR . 1.3 Cg_endo -65.15 150.39 87.74 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.53 1.486 . . . . 0.0 110.708 175.672 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.29 48.72 4.08 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 70' ' ' PRO . 7.6 t -141.21 16.39 2.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.105 0.532 . . . . 0.0 111.616 -179.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -136.05 -4.08 2.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 123.751 0.657 . . . . 0.0 111.847 179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.98 -169.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 123.932 0.77 . . . . 0.0 109.13 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.71 113.58 5.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 172.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 25.2 t80 -48.27 142.97 4.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.442 171.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.5 pt -122.24 -53.5 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 123.926 0.766 . . . . 0.0 111.688 176.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.84 146.63 15.79 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.478 -175.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 119.58 23.21 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.311 -1.444 . . . . 0.0 109.988 177.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -177.84 162.32 1.69 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.383 178.009 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -66.91 84.82 0.12 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.978 171.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.4 mt -89.92 130.01 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.659 176.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.77 161.45 46.19 Favored Pre-proline 0 N--CA 1.5 2.059 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.032 178.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.185 0 C-N-CA 121.739 1.626 . . . . 0.0 111.566 175.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.358 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 60.1 m -58.41 -19.34 35.32 Favored 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 176.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 26.0 tpp 64.46 43.91 4.35 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-O 121.663 0.744 . . . . 0.0 110.678 177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -154.38 170.12 22.09 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.736 -1.12 . . . . 0.0 109.891 -173.033 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -68.74 153.74 43.23 Favored 'General case' 0 N--CA 1.5 2.043 0 CA-C-N 114.994 -1.003 . . . . 0.0 111.554 176.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -99.55 40.15 1.25 Allowed 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 122.187 0.994 . . . . 0.0 110.584 -176.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 149.69 -162.99 29.25 Favored Glycine 0 N--CA 1.496 2.684 0 CA-C-N 113.6 -1.636 . . . . 0.0 111.648 -175.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -91.33 145.9 24.26 Favored 'General case' 0 N--CA 1.502 2.151 0 CA-C-N 114.44 -0.88 . . . . 0.0 109.621 176.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -125.09 161.29 27.11 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.563 1.164 . . . . 0.0 113.673 -178.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.0 m-85 -139.3 154.68 47.96 Favored 'General case' 0 N--CA 1.489 1.495 0 CA-C-N 112.167 -2.288 . . . . 0.0 106.711 -176.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 17.3 ttt-85 -123.33 121.54 36.08 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.93 145.75 12.17 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.266 0.979 . . . . 0.0 111.433 173.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.8 tp -107.4 -41.36 5.1 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.839 -176.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -141.93 152.55 43.63 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.264 0.977 . . . . 0.0 110.242 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -65.21 123.04 18.49 Favored 'General case' 0 N--CA 1.494 1.752 0 CA-C-N 115.039 -0.982 . . . . 0.0 110.577 174.527 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.419 ' CD1' HD12 ' A' ' 24' ' ' LEU . 4.0 t80 -123.09 136.8 54.95 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.504 1.127 . . . . 0.0 109.076 174.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.9 mttt -94.61 151.7 19.1 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 124.294 0.996 . . . . 0.0 109.32 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.49 131.39 35.55 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 123.921 0.763 . . . . 0.0 110.311 -178.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.9 tt0 -110.1 -11.22 14.63 Favored 'General case' 0 N--CA 1.502 2.134 0 O-C-N 124.183 0.927 . . . . 0.0 110.515 -179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 tpt180 -120.6 146.26 46.54 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.327 1.017 . . . . 0.0 109.424 179.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.38 -19.12 63.08 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 114.523 -1.217 . . . . 0.0 112.758 172.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -82.3 -19.81 38.7 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 114.833 -1.076 . . . . 0.0 111.099 178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -99.38 164.67 12.01 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 123.874 0.734 . . . . 0.0 110.757 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.3 pt -124.58 168.86 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.974 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.556 178.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -75.52 136.24 40.6 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 114.086 -1.416 . . . . 0.0 109.494 -176.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.419 HD12 ' CD1' ' A' ' 14' ' ' TYR . 90.7 mt -125.94 135.16 51.54 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 124.206 0.941 . . . . 0.0 110.674 -177.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.43 -175.86 3.95 Favored 'General case' 0 N--CA 1.499 2.002 0 CA-C-N 114.681 -1.145 . . . . 0.0 108.43 -173.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.5 mt -84.74 158.31 20.78 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 123.534 0.521 . . . . 0.0 110.781 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 65.0 -6.15 1.06 Allowed Glycine 0 N--CA 1.503 3.157 0 CA-C-N 115.774 -0.648 . . . . 0.0 113.676 -178.193 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.97 110.57 11.71 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -176.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.441 ' C ' HD12 ' A' ' 30' ' ' LEU . 4.2 mt -93.96 138.65 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 CA-C-N 114.825 -1.08 . . . . 0.0 109.856 176.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.499 ' N ' HD12 ' A' ' 30' ' ' LEU . 9.8 mp -105.75 148.32 27.6 Favored 'General case' 0 C--N 1.307 -1.279 0 CA-C-N 113.083 -1.871 . . . . 0.0 109.702 178.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 31.6 m -126.7 147.34 49.96 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 124.033 0.833 . . . . 0.0 109.177 177.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.454 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.5 OUTLIER -120.37 -154.99 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.286 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.454 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.6 OUTLIER -82.26 -179.43 7.41 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.123 -0.944 . . . . 0.0 112.52 172.122 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -120.2 -37.67 3.03 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 113.299 -1.773 . . . . 0.0 110.259 -164.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -155.47 41.94 0.58 Allowed Glycine 0 N--CA 1.498 2.824 0 N-CA-C 110.393 -1.083 . . . . 0.0 110.393 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 36.9 p -150.88 69.69 0.97 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 170.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mt -51.77 -22.62 3.75 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 111.792 -2.458 . . . . 0.0 113.705 170.003 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.4 t -61.33 -9.66 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.279 0 CA-C-N 115.532 -0.758 . . . . 0.0 112.351 174.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.67 -25.56 1.84 Allowed 'General case' 0 N--CA 1.502 2.152 0 CA-C-N 115.377 -0.829 . . . . 0.0 112.557 166.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.423 HD21 ' H ' ' A' ' 57' ' ' ASN . 20.9 mt -118.16 -7.37 10.8 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 123.953 0.783 . . . . 0.0 109.42 -176.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.84 25.6 69.09 Favored Glycine 0 N--CA 1.494 2.518 0 O-C-N 124.253 0.971 . . . . 0.0 112.108 -171.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -91.49 153.08 20.04 Favored 'General case' 0 N--CA 1.498 1.96 0 CA-C-N 114.42 -0.89 . . . . 0.0 109.846 -176.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.6 t -149.71 34.25 0.69 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 124.139 0.899 . . . . 0.0 110.588 -177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.5 -55.68 2.68 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.878 -1.056 . . . . 0.0 109.748 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 96.16 9.83 56.63 Favored Glycine 0 N--CA 1.495 2.611 0 O-C-N 124.628 1.205 . . . . 0.0 112.127 -177.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.03 -72.15 0.18 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 120.758 -0.377 . . . . 0.0 110.372 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 49.8 62.54 2.59 Favored 'General case' 0 N--CA 1.502 2.168 0 O-C-N 123.843 0.714 . . . . 0.0 109.993 176.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.475 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -176.9 -22.85 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.231 0 N-CA-C 114.128 1.159 . . . . 0.0 114.128 -176.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -120.31 80.63 29.02 Favored Pre-proline 0 N--CA 1.498 1.941 0 O-C-N 123.885 0.741 . . . . 0.0 109.113 177.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -56.15 -22.51 40.27 Favored 'Trans proline' 0 N--CA 1.491 1.38 0 C-N-CA 122.872 2.381 . . . . 0.0 111.938 176.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -50.16 -41.41 49.09 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 124.766 1.292 . . . . 0.0 112.238 -178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -93.63 -29.32 15.51 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 123.87 0.731 . . . . 0.0 111.463 178.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 27.8 mt -64.72 146.33 13.27 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.1 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.739 178.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.37 -96.5 1.07 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.015 -1.634 . . . . 0.0 109.015 -174.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.7 m95 -98.32 128.58 44.81 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 114.246 -0.977 . . . . 0.0 110.35 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.529 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.5 mp -107.18 136.26 47.31 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 172.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.423 ' H ' HD21 ' A' ' 40' ' ' LEU . 6.1 t-20 -104.97 125.7 51.24 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 175.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.04 -164.67 13.55 Favored Glycine 0 N--CA 1.497 2.703 0 N-CA-C 109.864 -1.294 . . . . 0.0 109.864 173.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -137.27 147.04 45.43 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 115.131 -0.534 . . . . 0.0 110.749 -179.192 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -101.1 100.31 10.87 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.9 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -54.51 -39.26 67.43 Favored 'General case' 0 N--CA 1.502 2.143 0 O-C-N 123.743 0.652 . . . . 0.0 111.97 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 96.9 m -52.22 -42.03 63.23 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 124.222 0.951 . . . . 0.0 112.142 178.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 4.9 p -105.28 0.35 27.05 Favored 'General case' 0 N--CA 1.5 2.074 0 O-C-N 124.343 1.027 . . . . 0.0 110.598 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 51.96 24.04 13.09 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 124.155 0.91 . . . . 0.0 112.667 -172.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.53 166.48 12.5 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -174.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 36.7 ttm-85 -148.1 125.64 11.72 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 -178.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -174.33 -162.83 26.66 Favored Glycine 0 N--CA 1.493 2.448 0 C-N-CA 119.978 -1.106 . . . . 0.0 111.173 171.55 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.93 153.79 21.48 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.696 -0.752 . . . . 0.0 109.15 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 34.9 p90 -151.24 147.83 21.28 Favored Pre-proline 0 N--CA 1.493 1.695 0 CA-C-N 114.725 -1.125 . . . . 0.0 108.684 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -64.19 156.28 60.28 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 C-N-CA 122.424 2.083 . . . . 0.0 112.0 176.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.01 44.2 1.84 Allowed Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.62 -0.992 . . . . 0.0 110.62 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.6 t -134.43 -17.31 2.04 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.784 -0.367 . . . . 0.0 111.656 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -100.78 0.87 39.59 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.265 0.978 . . . . 0.0 111.696 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.3 m -119.92 -179.0 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.175 0 O-C-N 123.756 0.66 . . . . 0.0 109.459 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -149.18 106.53 3.62 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 115.208 -0.906 . . . . 0.0 109.046 -179.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.475 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 77.6 t80 -43.65 128.44 5.24 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.29 -1.323 . . . . 0.0 111.097 169.294 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.4 pt -126.2 -58.26 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 O-C-N 124.019 0.824 . . . . 0.0 111.419 -176.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -128.63 156.38 20.99 Favored Glycine 0 N--CA 1.494 2.562 0 N-CA-C 108.992 -1.643 . . . . 0.0 108.992 -162.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.23 154.34 36.64 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-O 121.914 0.864 . . . . 0.0 112.152 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -62.69 177.15 0.57 Allowed 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 113.065 -1.88 . . . . 0.0 113.093 160.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 30.4 mttp -81.61 28.31 0.41 Allowed 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.373 -1.285 . . . . 0.0 111.466 -174.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.7 tt -90.82 -5.15 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.766 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.1 t -138.25 72.47 45.44 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 123.939 0.774 . . . . 0.0 109.752 -178.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.489 1.262 0 C-N-CA 122.369 2.046 . . . . 0.0 112.205 171.288 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.388 0 N-CA-C 111.266 -0.733 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 11.0 p -157.7 117.59 3.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 123.786 0.345 . . . . 0.0 110.13 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 1.6 mpp? -100.91 156.33 17.44 Favored 'General case' 0 N--CA 1.501 2.078 0 O-C-N 123.925 0.766 . . . . 0.0 109.252 178.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER 59.77 170.33 0.08 Allowed 'General case' 0 N--CA 1.507 2.395 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -172.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -165.28 135.92 3.82 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 115.081 -0.963 . . . . 0.0 110.02 177.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -94.43 92.01 6.93 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-O 121.618 0.723 . . . . 0.0 110.003 174.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 147.78 -169.27 28.62 Favored Glycine 0 N--CA 1.498 2.77 0 CA-C-N 113.974 -1.467 . . . . 0.0 112.076 179.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -95.42 149.58 21.23 Favored 'General case' 0 N--CA 1.507 2.386 0 CA-C-N 114.311 -0.944 . . . . 0.0 108.663 179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.432 ' HB3' HD11 ' A' ' 77' ' ' ILE . 6.4 mt-30 -128.44 162.07 28.02 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 122.234 1.016 . . . . 0.0 112.488 -175.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 52.5 m-85 -140.42 165.32 27.76 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 112.416 -2.174 . . . . 0.0 107.835 -174.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.7 ttt180 -128.03 115.13 18.0 Favored 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 114.69 -1.141 . . . . 0.0 108.949 -176.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.48 116.4 3.07 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 123.889 0.743 . . . . 0.0 111.175 173.249 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.4 tp -76.91 -33.1 57.78 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 115.018 -0.992 . . . . 0.0 110.949 176.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -141.25 143.02 33.9 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 124.296 0.997 . . . . 0.0 109.853 -177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -63.18 104.3 0.57 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 113.927 -1.488 . . . . 0.0 111.083 175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.408 ' HD2' HD12 ' A' ' 24' ' ' LEU . 76.2 t80 -101.21 130.57 47.35 Favored 'General case' 0 N--CA 1.501 2.079 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 -177.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.4 mtmm -89.48 163.77 15.1 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -177.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.59 138.64 31.25 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -178.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -131.31 -19.33 2.79 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.74 -179.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 23.2 ttp180 -123.64 151.26 43.22 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 114.495 -1.229 . . . . 0.0 109.864 -178.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -63.19 -20.26 65.26 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.645 -1.161 . . . . 0.0 112.286 177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.0 -26.97 21.18 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-N 114.272 -1.331 . . . . 0.0 110.725 177.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -89.39 153.42 20.87 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 119.765 -0.774 . . . . 0.0 111.376 177.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.412 HG22 ' H ' ' A' ' 23' ' ' ASP . 0.1 OUTLIER -121.22 -173.67 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 O-C-N 124.511 1.132 . . . . 0.0 111.097 -179.199 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . 0.412 ' H ' HG22 ' A' ' 22' ' ' ILE . 3.5 m-20 -87.47 120.53 28.87 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-N 112.533 -2.121 . . . . 0.0 107.678 -174.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.408 HD12 ' HD2' ' A' ' 14' ' ' TYR . 5.2 mt -117.37 119.99 36.81 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 124.159 0.912 . . . . 0.0 108.916 -176.528 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -102.95 -170.36 1.78 Allowed 'General case' 0 N--CA 1.499 2.022 0 O-C-N 124.561 1.163 . . . . 0.0 109.523 178.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 14.1 mt -84.99 156.1 21.29 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.478 178.169 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 55.99 9.16 2.68 Favored Glycine 0 N--CA 1.502 3.085 0 O-C-N 124.101 0.875 . . . . 0.0 113.074 -178.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' CG ' HG21 ' A' ' 62' ' ' THR . 3.4 m-20 -71.45 125.17 26.33 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.358 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 mp -96.37 146.91 6.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 124.198 0.936 . . . . 0.0 109.021 172.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.599 HD23 ' CE1' ' A' ' 69' ' ' PHE . 7.3 mp -115.46 161.53 18.44 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 112.442 -2.163 . . . . 0.0 110.911 174.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 99.6 m -131.31 153.95 49.05 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 124.748 1.28 . . . . 0.0 108.329 177.394 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.658 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.1 t -130.03 -150.5 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.366 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 174.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.658 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -80.07 178.07 8.49 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 123.583 0.552 . . . . 0.0 110.889 179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.451 ' HB2' HG21 ' A' ' 82' ' ' ILE . 7.9 pttp -120.95 -34.03 3.62 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 115.032 -0.985 . . . . 0.0 111.077 -171.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.12 34.6 0.78 Allowed Glycine 0 N--CA 1.495 2.585 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 178.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 75.5 m -150.07 58.56 0.97 Allowed 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.483 ' C ' HD12 ' A' ' 37' ' ' LEU . 4.5 pp -61.49 -18.94 61.29 Favored 'General case' 0 N--CA 1.501 2.098 0 CA-C-N 113.08 -1.873 . . . . 0.0 113.565 165.184 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.447 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.8 t -56.85 -9.25 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-N 115.305 -0.861 . . . . 0.0 113.084 167.049 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.99 -35.35 0.36 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.908 1.38 . . . . 0.0 111.57 171.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.2 mp -111.52 -15.23 13.56 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.339 1.025 . . . . 0.0 111.916 177.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 88.71 31.19 13.27 Favored Glycine 0 N--CA 1.502 3.055 0 O-C-N 124.167 0.917 . . . . 0.0 112.301 -174.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -55.76 148.8 15.72 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 113.942 -1.129 . . . . 0.0 113.013 174.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.6 t -139.67 37.84 2.01 Favored 'General case' 0 N--CA 1.5 2.032 0 CA-C-N 114.9 -1.045 . . . . 0.0 108.78 -172.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -145.07 -50.58 0.26 Allowed 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.34 179.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 70.74 88.07 0.11 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.725 -0.95 . . . . 0.0 110.725 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 32.3 mm-40 -130.11 -60.93 1.0 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -173.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 47.68 40.5 12.08 Favored 'General case' 0 N--CA 1.503 2.196 0 O-C-N 124.642 1.214 . . . . 0.0 111.915 -177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -154.48 0.57 0.2 Allowed 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.256 -0.884 . . . . 0.0 112.006 -173.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 41.5 mttt -128.93 69.7 80.83 Favored Pre-proline 0 N--CA 1.5 2.073 0 O-C-N 123.606 0.566 . . . . 0.0 111.266 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.93 -4.87 4.04 Favored 'Trans proline' 0 N--CA 1.494 1.524 0 C-N-CA 122.639 2.226 . . . . 0.0 113.67 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -73.51 -45.5 53.46 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 123.732 0.645 . . . . 0.0 110.756 179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 4.1 pt-20 -92.47 -28.94 16.51 Favored 'General case' 0 N--CA 1.501 2.111 0 O-C-N 124.057 0.848 . . . . 0.0 111.141 -175.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 82.7 mt -65.02 143.37 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.957 0 O-C-N 123.766 0.666 . . . . 0.0 109.741 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.42 -99.91 1.05 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.37 -1.492 . . . . 0.0 109.37 -178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 68.8 m95 -89.62 144.59 25.88 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.492 0.76 . . . . 0.0 110.467 178.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.489 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.2 mp -122.5 130.1 52.69 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 114.339 -1.301 . . . . 0.0 108.329 170.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.516 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -91.27 121.69 33.24 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 169.03 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -147.38 177.7 25.48 Favored Glycine 0 N--CA 1.499 2.881 0 C-N-CA 120.048 -1.072 . . . . 0.0 113.008 175.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -101.69 123.63 45.99 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 113.559 -1.32 . . . . 0.0 109.226 174.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.414 HD21 ' HB ' ' A' ' 62' ' ' THR . 10.9 t30 -89.47 80.78 6.67 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-O 122.42 1.105 . . . . 0.0 108.506 170.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -49.48 -24.95 2.28 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.014 -1.903 . . . . 0.0 111.961 175.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.429 HG21 ' CG ' ' A' ' 28' ' ' ASP . 18.1 m -53.13 -41.55 65.18 Favored 'General case' 0 N--CA 1.5 2.058 0 O-C-N 124.19 0.931 . . . . 0.0 112.075 -176.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 76.8 p -119.41 6.3 11.13 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 124.428 1.08 . . . . 0.0 109.161 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.87 60.12 8.57 Favored Glycine 0 N--CA 1.494 2.532 0 O-C-N 124.283 0.989 . . . . 0.0 111.12 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 -139.74 160.67 39.35 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 124.406 0.709 . . . . 0.0 109.999 -176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.9 ttp180 -116.25 140.28 49.48 Favored 'General case' 0 N--CA 1.497 1.878 0 N-CA-C 107.26 -1.385 . . . . 0.0 107.26 -177.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.96 -155.5 17.34 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.343 -1.408 . . . . 0.0 111.994 164.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -107.22 166.43 10.64 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 113.695 -1.252 . . . . 0.0 110.151 178.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.599 ' CE1' HD23 ' A' ' 30' ' ' LEU . 21.9 p90 -161.89 145.59 9.43 Favored Pre-proline 0 N--CA 1.497 1.903 0 CA-C-N 114.914 -1.039 . . . . 0.0 108.889 170.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -66.24 154.12 75.39 Favored 'Trans proline' 0 N--CA 1.49 1.31 0 C-N-CA 122.233 1.955 . . . . 0.0 113.169 173.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.21 -16.82 63.91 Favored Glycine 0 N--CA 1.499 2.873 0 CA-C-N 114.772 -1.104 . . . . 0.0 112.265 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 80.4 p -75.8 -14.11 60.3 Favored 'General case' 0 C--N 1.306 -1.305 0 C-N-CA 122.245 0.218 . . . . 0.0 111.522 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -103.28 3.61 35.64 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 123.998 0.811 . . . . 0.0 111.658 -173.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.7 m -136.89 -178.6 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 123.878 0.736 . . . . 0.0 109.237 -175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -147.79 111.35 4.99 Favored 'General case' 0 N--CA 1.493 1.689 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 -178.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -51.28 140.92 15.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 123.753 0.658 . . . . 0.0 109.603 174.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.432 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.1 pt -118.99 -56.47 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 124.431 1.082 . . . . 0.0 110.472 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.04 147.74 17.17 Favored Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.705 -1.236 . . . . 0.0 111.151 -168.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.96 125.0 32.24 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-N 112.856 -1.672 . . . . 0.0 109.128 173.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 71.7 mttt -78.12 138.16 38.58 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 114.956 -1.02 . . . . 0.0 109.446 173.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -73.69 77.38 1.54 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.714 1.259 . . . . 0.0 109.893 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.451 HG21 ' HB2' ' A' ' 34' ' ' LYS . 43.5 mt -94.63 91.28 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 CA-C-N 114.642 -1.163 . . . . 0.0 108.361 179.235 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -120.72 159.41 48.71 Favored Pre-proline 0 N--CA 1.505 2.288 0 CA-C-N 113.894 -1.503 . . . . 0.0 109.072 -179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.489 1.207 0 C-N-CA 121.825 1.683 . . . . 0.0 111.206 178.487 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.356 0 CA-C-O 121.479 0.489 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 5.3 p -171.74 129.09 0.65 Allowed 'General case' 0 N--CA 1.498 1.97 0 CA-C-N 114.019 -1.091 . . . . 0.0 109.454 -175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 1.7 mmt -56.31 -38.41 71.25 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 124.039 0.837 . . . . 0.0 111.116 174.175 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 t -84.47 -170.39 3.08 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.992 0.808 . . . . 0.0 110.677 178.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.33 150.64 45.61 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.968 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -143.15 91.82 2.32 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 114.668 -1.151 . . . . 0.0 109.447 173.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 82' ' ' ILE . . . -120.08 165.25 13.62 Favored Glycine 0 N--CA 1.497 2.743 0 O-C-N 124.662 1.226 . . . . 0.0 111.3 -178.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -132.92 152.05 51.95 Favored 'General case' 0 N--CA 1.512 2.652 0 N-CA-C 105.966 -1.864 . . . . 0.0 105.966 -152.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.586 ' HB3' HD11 ' A' ' 77' ' ' ILE . 26.1 mt-30 -128.98 168.49 15.94 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.376 1.084 . . . . 0.0 111.705 177.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -143.51 123.15 13.29 Favored 'General case' 0 C--N 1.306 -1.291 0 CA-C-N 112.275 -2.239 . . . . 0.0 105.563 -176.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 11.6 ttt180 -89.39 122.04 32.23 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.56 -1.274 . . . . 0.0 107.56 176.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.76 146.28 10.77 Favored 'General case' 0 N--CA 1.501 2.119 0 O-C-N 123.642 0.589 . . . . 0.0 110.734 171.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.2 tp -114.92 -28.79 6.92 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 124.115 0.884 . . . . 0.0 110.43 179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.21 156.77 48.42 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 123.954 0.784 . . . . 0.0 110.831 -174.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.39 103.57 16.24 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.173 -1.376 . . . . 0.0 108.596 -178.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.549 ' HD2' HD12 ' A' ' 24' ' ' LEU . 10.4 t80 -110.55 133.26 53.46 Favored 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 107.663 -1.236 . . . . 0.0 107.663 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 18.5 mmtp -89.43 158.69 17.63 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -178.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.22 139.68 30.24 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 119.591 -0.843 . . . . 0.0 110.173 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -128.99 -13.6 4.54 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.58 -1.191 . . . . 0.0 110.192 -176.622 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.78 140.87 36.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 124.217 0.948 . . . . 0.0 109.322 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -51.84 -21.84 3.22 Favored 'General case' 0 N--CA 1.5 2.07 0 CA-C-N 114.379 -1.282 . . . . 0.0 114.044 170.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -59.48 -57.76 11.58 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.761 -1.109 . . . . 0.0 110.799 169.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -83.29 174.05 11.06 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.053 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 4.0 pt -129.48 177.05 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 124.267 0.979 . . . . 0.0 111.674 175.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -71.83 136.75 47.14 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-N 113.863 -1.517 . . . . 0.0 109.473 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.549 HD12 ' HD2' ' A' ' 14' ' ' TYR . 15.5 mt -126.38 133.19 51.38 Favored 'General case' 0 N--CA 1.501 2.085 0 O-C-N 123.973 0.795 . . . . 0.0 111.159 179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.485 ' NE2' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -145.26 170.65 15.88 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.343 1.027 . . . . 0.0 110.695 -176.367 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.0 mt -66.8 151.09 48.15 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 123.481 0.488 . . . . 0.0 110.413 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 70.9 -9.83 3.51 Favored Glycine 0 N--CA 1.501 2.976 0 CA-C-N 115.259 -0.882 . . . . 0.0 113.036 179.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -74.86 108.05 7.35 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 178.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.539 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.7 OUTLIER -89.8 152.34 3.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 CA-C-N 115.437 -0.802 . . . . 0.0 108.882 176.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.539 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.2 mp -129.19 127.54 41.54 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 113.663 -1.608 . . . . 0.0 108.6 176.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.9 m -107.23 140.28 40.35 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.394 1.058 . . . . 0.0 108.961 178.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.1 t -103.5 -136.51 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 124.443 1.089 . . . . 0.0 108.725 177.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -109.27 -157.52 0.62 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 123.871 0.732 . . . . 0.0 109.441 -176.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -137.61 -0.69 2.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 124.663 1.227 . . . . 0.0 111.051 -178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -57.69 -50.68 63.31 Favored Glycine 0 N--CA 1.494 2.529 0 N-CA-C 110.342 -1.103 . . . . 0.0 110.342 -179.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 153.65 -53.03 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 O-C-N 126.061 1.683 . . . . 0.0 106.626 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.572 HD12 ' N ' ' A' ' 38' ' ' VAL . 0.5 OUTLIER -176.97 -21.69 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 113.535 -1.666 . . . . 0.0 111.487 -179.648 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.572 ' N ' HD12 ' A' ' 37' ' ' LEU . 5.2 t -65.1 -17.83 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 CA-C-O 121.174 0.511 . . . . 0.0 111.422 173.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.426 ' C ' HD12 ' A' ' 40' ' ' LEU . . . -49.35 -27.86 4.4 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.424 -1.262 . . . . 0.0 112.307 167.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.426 HD12 ' C ' ' A' ' 39' ' ' ALA . 10.3 mp -105.1 -13.18 15.82 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.127 0.892 . . . . 0.0 111.269 177.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 98.4 27.21 8.77 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 124.195 0.935 . . . . 0.0 111.377 -176.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.414 ' CZ ' HG23 ' A' ' 53' ' ' ILE . 4.7 m-85 -95.34 168.59 10.63 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.34 -0.93 . . . . 0.0 111.956 178.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.4 t -147.69 112.13 5.27 Favored 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 113.72 -1.582 . . . . 0.0 107.301 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 32.1 t70 43.27 90.65 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.618 1.199 . . . . 0.0 113.751 -179.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -135.69 -7.41 1.86 Allowed Glycine 0 N--CA 1.495 2.621 0 CA-C-N 113.826 -1.534 . . . . 0.0 111.759 -171.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 36.0 mm-40 51.77 98.18 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 124.043 0.937 . . . . 0.0 110.123 -170.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -45.92 -24.63 0.43 Allowed 'General case' 0 N--CA 1.511 2.598 0 N-CA-C 114.899 1.444 . . . . 0.0 114.899 175.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -88.18 10.25 20.07 Favored 'General case' 0 N--CA 1.503 2.217 0 CA-C-N 115.036 -0.984 . . . . 0.0 113.472 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 13.1 mttp -129.0 77.46 77.9 Favored Pre-proline 0 N--CA 1.499 2.023 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 177.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -60.25 -18.22 50.93 Favored 'Trans proline' 0 N--CA 1.489 1.214 0 C-N-CA 122.411 2.074 . . . . 0.0 112.828 170.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -53.42 -41.47 66.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.125 0.891 . . . . 0.0 111.901 -177.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -89.61 -26.36 20.82 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.053 0.846 . . . . 0.0 110.689 -178.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.414 HG23 ' CZ ' ' A' ' 42' ' ' PHE . 22.3 mt -79.97 139.17 18.64 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 123.961 0.788 . . . . 0.0 109.287 -176.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -93.06 1.16 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.213 -1.555 . . . . 0.0 109.213 -176.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 78.1 m95 -95.92 120.25 35.87 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-N 113.708 -1.246 . . . . 0.0 109.169 -178.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.524 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.9 mp -96.76 136.26 37.56 Favored 'General case' 0 N--CA 1.494 1.736 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 170.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -98.63 123.44 42.82 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.816 -0.809 . . . . 0.0 108.816 170.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.33 -178.39 27.84 Favored Glycine 0 N--CA 1.498 2.813 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 174.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 26.1 p90 -133.8 144.12 48.8 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.762 0.33 . . . . 0.0 111.18 179.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.471 ' ND2' ' H ' ' A' ' 60' ' ' ASN . 0.0 OUTLIER -102.24 98.52 8.65 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.889 -1.05 . . . . 0.0 109.166 175.013 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -57.75 -29.21 64.6 Favored 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.343 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 85.0 m -53.05 -43.51 66.72 Favored 'General case' 0 N--CA 1.503 2.212 0 O-C-N 123.905 0.753 . . . . 0.0 112.143 176.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.485 HG21 ' NE2' ' A' ' 25' ' ' HIS . 22.3 p -102.64 -4.1 25.66 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 124.274 0.984 . . . . 0.0 110.187 178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.14 28.4 61.29 Favored Glycine 0 N--CA 1.493 2.435 0 O-C-N 124.149 0.906 . . . . 0.0 111.926 -172.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.426 ' HB2' ' ND2' ' A' ' 60' ' ' ASN . 2.5 mm-40 -104.17 155.72 18.48 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 -178.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.7 ptp180 -143.11 137.57 29.23 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 124.065 0.853 . . . . 0.0 110.186 179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.32 -155.06 21.73 Favored Glycine 0 N--CA 1.492 2.399 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.429 172.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -106.81 153.26 22.74 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 114.233 -0.983 . . . . 0.0 108.866 -174.32 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.524 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 32.9 p90 -147.95 148.86 31.31 Favored Pre-proline 0 N--CA 1.493 1.676 0 CA-C-N 115.252 -0.885 . . . . 0.0 108.799 177.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.14 158.12 41.08 Favored 'Trans proline' 0 N--CA 1.487 1.114 0 C-N-CA 121.985 1.79 . . . . 0.0 111.92 176.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.99 53.6 0.63 Allowed Glycine 0 N--CA 1.496 2.66 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.4 t -151.38 -15.89 0.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.049 0.499 . . . . 0.0 112.108 174.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.3 m-85 -94.87 -4.81 46.31 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 123.977 0.798 . . . . 0.0 112.324 177.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.4 m -109.64 -166.55 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 123.954 0.784 . . . . 0.0 109.253 -178.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -149.28 113.15 5.11 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 172.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 60.0 t80 -48.75 128.34 15.27 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.939 -1.028 . . . . 0.0 109.783 165.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.586 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.5 pt -114.7 -84.29 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 124.36 1.038 . . . . 0.0 110.4 178.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -109.83 161.13 13.1 Favored Glycine 0 N--CA 1.503 3.108 0 N-CA-C 110.337 -1.105 . . . . 0.0 110.337 -171.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.69 22.03 14.45 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.939 0.876 . . . . 0.0 112.635 -177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -162.18 27.99 0.11 Allowed 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 123.194 1.473 . . . . 0.0 109.273 -174.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -83.5 17.46 2.18 Favored 'General case' 0 N--CA 1.486 1.35 0 CA-C-N 112.041 -2.345 . . . . 0.0 112.318 175.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.539 HG22 ' H ' ' A' ' 5' ' ' GLY . 0.9 OUTLIER -89.25 134.31 28.95 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 N-CA-C 115.066 1.506 . . . . 0.0 115.066 152.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -150.07 166.37 15.34 Favored Pre-proline 0 N--CA 1.511 2.596 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.067 178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.493 1.456 0 C-N-CA 122.043 1.828 . . . . 0.0 112.337 175.112 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 CA-C-O 119.935 -0.37 . . . . 0.0 112.916 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 8.1 t -82.35 -27.59 32.09 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.845 -178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 0.0 OUTLIER 72.47 -31.07 0.22 Allowed 'General case' 0 N--CA 1.508 2.469 0 O-C-N 124.551 1.157 . . . . 0.0 113.145 -173.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 35.3 t -155.36 141.74 18.62 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.98 112.48 10.15 Favored 'General case' 0 N--CA 1.496 1.83 0 C-N-CA 119.366 -0.933 . . . . 0.0 109.249 169.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -131.24 96.86 4.12 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-N 114.476 -1.238 . . . . 0.0 108.601 164.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -64.91 -146.87 0.04 OUTLIER Glycine 0 N--CA 1.494 2.552 0 CA-C-N 113.244 -1.798 . . . . 0.0 112.832 167.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.88 150.76 20.38 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -174.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -126.16 163.26 23.51 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.21 0.943 . . . . 0.0 111.363 -174.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 23.8 m-85 -139.1 160.12 40.55 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.031 -1.44 . . . . 0.0 107.543 -178.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 54.2 ttt180 -126.63 118.72 25.38 Favored 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 107.016 -1.475 . . . . 0.0 107.016 -174.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.83 130.77 38.19 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.857 0.723 . . . . 0.0 110.73 173.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.5 tp -85.38 -45.89 11.46 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.226 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -143.23 156.67 44.8 Favored 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.395 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -61.17 111.68 1.82 Allowed 'General case' 0 N--CA 1.487 1.386 0 CA-C-N 114.025 -1.443 . . . . 0.0 110.442 173.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.466 ' CD2' HD12 ' A' ' 24' ' ' LEU . 6.3 t80 -120.93 133.39 55.28 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 115.144 -0.934 . . . . 0.0 108.973 177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -90.1 161.75 15.64 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -89.68 147.55 23.81 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 123.839 0.712 . . . . 0.0 111.548 175.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -117.62 -4.53 11.22 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.627 -1.17 . . . . 0.0 110.3 179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -146.57 148.84 32.55 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -52.68 -22.59 5.32 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 114.575 -1.193 . . . . 0.0 113.076 172.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 22.3 mm-40 -69.66 -45.56 68.13 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-N 114.056 -1.429 . . . . 0.0 110.235 -179.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -91.38 158.18 16.67 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 123.965 0.791 . . . . 0.0 109.005 -177.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 pt -115.16 170.68 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 124.185 0.928 . . . . 0.0 111.792 -179.009 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -77.71 136.61 38.2 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 113.753 -1.567 . . . . 0.0 109.257 -176.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.466 HD12 ' CD2' ' A' ' 14' ' ' TYR . 88.5 mt -125.46 133.37 52.45 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 124.345 1.028 . . . . 0.0 109.917 -177.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -121.57 -167.88 1.59 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 114.675 -1.148 . . . . 0.0 108.686 -172.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 68.1 mt -89.22 157.98 18.04 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 120.892 -0.323 . . . . 0.0 111.627 176.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 58.7 1.71 0.92 Allowed Glycine 0 N--CA 1.505 3.244 0 CA-C-N 115.895 -0.593 . . . . 0.0 113.39 -178.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.28 108.54 9.29 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.77 -0.715 . . . . 0.0 110.972 -173.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.525 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.4 tp -90.51 149.65 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.775 0 CA-C-N 115.465 -0.788 . . . . 0.0 109.033 -177.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.525 HD12 ' C ' ' A' ' 29' ' ' ILE . 10.0 mp -119.07 151.85 37.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 178.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 93.3 m -132.89 146.52 51.87 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.015 0.822 . . . . 0.0 109.627 175.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.644 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.5 t -128.95 -157.39 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 176.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.644 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.3 OUTLIER -74.31 179.39 4.57 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.782 174.368 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -114.96 -38.88 3.79 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.982 -1.463 . . . . 0.0 109.909 -172.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.57 41.72 0.74 Allowed Glycine 0 N--CA 1.493 2.49 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -175.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.0 t -147.62 69.66 1.15 Allowed 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 105.264 -2.125 . . . . 0.0 105.264 174.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -51.12 -19.34 1.1 Allowed 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 112.243 -2.253 . . . . 0.0 111.788 167.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.3 t -60.78 -17.24 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.117 0 O-C-N 123.797 0.686 . . . . 0.0 111.687 179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -53.29 -20.82 4.66 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 123.947 0.779 . . . . 0.0 112.63 169.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 57' ' ' ASN . 42.3 mt -129.37 5.39 5.21 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -173.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 61.21 30.07 72.9 Favored Glycine 0 N--CA 1.497 2.708 0 CA-C-N 115.323 -0.853 . . . . 0.0 113.04 -170.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -82.81 169.01 16.59 Favored 'General case' 0 N--CA 1.501 2.079 0 CA-C-N 114.325 -0.938 . . . . 0.0 109.86 -170.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 68.3 p -137.59 -157.07 0.74 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 115.316 -0.856 . . . . 0.0 109.99 -179.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -64.66 93.8 0.11 Allowed 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.24 173.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -125.17 -109.17 1.75 Allowed Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.059 -1.616 . . . . 0.0 109.059 176.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -154.53 -38.64 0.09 Allowed 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.354 0.679 . . . . 0.0 110.263 -175.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 54.27 57.32 5.98 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 124.301 1.001 . . . . 0.0 110.452 -177.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.47 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -164.35 -11.35 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.926 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.361 -172.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' H ' ' H ' ' A' ' 48' ' ' ALA . 18.9 mttp -122.25 82.39 45.39 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 124.502 1.126 . . . . 0.0 109.344 177.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 7.6 Cg_exo -52.8 -20.0 12.02 Favored 'Trans proline' 0 N--CA 1.491 1.369 0 C-N-CA 122.589 2.193 . . . . 0.0 112.054 173.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -56.77 -43.17 80.55 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 114.598 -1.183 . . . . 0.0 111.936 178.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -90.01 -29.11 18.64 Favored 'General case' 0 N--CA 1.501 2.107 0 O-C-N 123.632 0.582 . . . . 0.0 111.485 -177.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 15.4 mt -66.25 145.4 13.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 172.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.49 -73.29 1.27 Allowed Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.689 -1.365 . . . . 0.0 109.689 -177.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 44.6 m95 -127.95 133.75 49.25 Favored 'General case' 0 N--CA 1.495 1.796 0 CA-C-N 112.561 -1.82 . . . . 0.0 107.932 177.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.66 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -127.2 144.46 51.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 124.176 0.922 . . . . 0.0 109.172 174.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.514 ' H ' HD22 ' A' ' 40' ' ' LEU . 0.2 OUTLIER -89.47 145.58 25.21 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.633 1.208 . . . . 0.0 107.839 -179.396 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.81 179.7 42.6 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 109.789 -1.324 . . . . 0.0 109.789 173.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -128.91 142.12 51.05 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 114.886 -0.657 . . . . 0.0 109.808 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.03 82.73 1.75 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 125.176 1.547 . . . . 0.0 109.528 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.78 -27.1 49.28 Favored 'General case' 0 N--CA 1.502 2.149 0 CA-C-N 113.805 -1.543 . . . . 0.0 112.776 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 31.0 m -52.12 -42.68 63.5 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 123.924 0.765 . . . . 0.0 111.562 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 12.3 t -109.12 -3.51 17.29 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.799 1.312 . . . . 0.0 109.758 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.77 65.7 2.91 Favored Glycine 0 N--CA 1.493 2.447 0 CA-C-N 115.162 -0.926 . . . . 0.0 111.049 -176.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -137.23 162.05 34.54 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 124.314 0.655 . . . . 0.0 110.247 177.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.3 ptp180 -148.15 131.04 16.14 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.383 177.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.46 -163.42 36.59 Favored Glycine 0 N--CA 1.496 2.689 0 C-N-CA 120.745 -0.741 . . . . 0.0 111.506 172.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -102.87 152.44 21.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -173.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.488 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 41.2 p90 -148.02 152.27 39.72 Favored Pre-proline 0 N--CA 1.492 1.628 0 CA-C-N 114.477 -1.238 . . . . 0.0 109.413 -175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -66.6 151.23 83.24 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 C-N-CA 122.071 1.847 . . . . 0.0 112.24 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.36 19.79 29.94 Favored Glycine 0 N--CA 1.496 2.697 0 O-C-N 124.093 0.871 . . . . 0.0 112.006 177.757 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.83 -35.18 6.24 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.311 0.577 . . . . 0.0 110.911 -178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -90.21 8.37 33.45 Favored 'General case' 0 N--CA 1.5 2.061 0 CA-C-N 114.115 -1.402 . . . . 0.0 111.479 -175.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.2 m -125.87 179.42 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.99 0 O-C-N 123.628 0.58 . . . . 0.0 110.263 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -150.06 106.41 3.49 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 121.713 0.768 . . . . 0.0 110.262 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 80.0 t80 -44.64 126.16 5.34 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.244 -1.343 . . . . 0.0 111.253 167.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.407 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.0 OUTLIER -115.13 -62.25 2.29 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.925 0 O-C-N 123.969 0.793 . . . . 0.0 110.889 -177.881 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.407 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -139.94 161.5 26.32 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 -161.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 2.9 ptt180 -160.75 105.47 1.4 Allowed 'General case' 0 N--CA 1.486 1.362 0 CA-C-N 113.583 -1.308 . . . . 0.0 109.139 -171.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.7 mtpt -72.34 89.51 1.22 Allowed 'General case' 0 N--CA 1.491 1.597 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 170.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 1.1 pttt -53.96 106.13 0.18 Allowed 'General case' 0 N--CA 1.491 1.576 0 CA-C-N 112.34 -2.209 . . . . 0.0 109.012 178.201 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -88.84 15.06 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.052 -174.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.28 150.92 32.82 Favored Pre-proline 0 N--CA 1.492 1.646 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.878 175.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo . . . . . 0 N--CA 1.488 1.172 0 C-N-CA 121.982 1.788 . . . . 0.0 112.068 172.464 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.1 OUTLIER -64.05 135.15 56.17 Favored 'General case' 0 N--CA 1.498 1.956 0 CA-C-N 115.202 -0.499 . . . . 0.0 110.745 173.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.7 mmm -52.96 -27.51 19.38 Favored 'General case' 0 N--CA 1.502 2.17 0 O-C-N 124.278 0.986 . . . . 0.0 111.749 177.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 62.6 p -157.65 140.66 15.12 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 124.113 0.883 . . . . 0.0 108.935 175.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -66.51 179.2 1.06 Allowed 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.687 0.617 . . . . 0.0 111.526 171.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -52.64 -28.48 21.6 Favored 'General case' 0 N--CA 1.503 2.203 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.613 174.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.23 -133.2 37.98 Favored Glycine 0 N--CA 1.495 2.593 0 O-C-N 124.528 1.143 . . . . 0.0 112.753 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.65 159.25 15.04 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 114.433 -0.883 . . . . 0.0 109.699 168.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.509 ' HB3' HD11 ' A' ' 77' ' ' ILE . 30.9 mt-30 -134.11 158.92 42.4 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 124.006 0.817 . . . . 0.0 111.589 -178.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.0 m-85 -138.58 138.62 38.1 Favored 'General case' 0 N--CA 1.497 1.906 0 CA-C-N 114.016 -1.447 . . . . 0.0 108.811 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 4.4 mtp180 -94.47 121.88 36.46 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 124.115 0.884 . . . . 0.0 109.894 171.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.84 119.87 6.94 Favored 'General case' 0 N--CA 1.497 1.897 0 CA-C-N 115.216 -0.902 . . . . 0.0 110.848 167.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.2 tp -73.02 -57.89 3.71 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.603 0.564 . . . . 0.0 109.889 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.97 156.98 25.29 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 124.38 1.05 . . . . 0.0 109.919 -179.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.92 134.3 51.74 Favored 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.985 173.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -132.71 128.47 37.01 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 124.361 1.038 . . . . 0.0 110.208 174.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 tttm -89.58 168.25 12.3 Favored 'General case' 0 N--CA 1.499 1.977 0 C-N-CA 120.451 -0.5 . . . . 0.0 109.662 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 145.95 25.06 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.311 176.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.87 -3.62 8.65 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.481 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.0 tpt180 -143.42 145.05 32.31 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.024 -178.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -55.47 -15.14 2.42 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 114.981 -1.008 . . . . 0.0 113.29 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 24.7 tt0 -74.64 -46.47 37.99 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.328 -0.851 . . . . 0.0 110.558 176.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -87.14 152.31 22.45 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 124.083 0.864 . . . . 0.0 109.893 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -99.59 -170.25 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 124.472 1.108 . . . . 0.0 109.577 177.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -95.19 106.34 18.35 Favored 'General case' 0 N--CA 1.494 1.761 0 CA-C-N 113.52 -1.673 . . . . 0.0 108.715 178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.546 HD22 ' N ' ' A' ' 24' ' ' LEU . 1.8 mm? -88.98 143.14 27.06 Favored 'General case' 0 C--N 1.311 -1.098 0 CA-C-N 115.433 -0.803 . . . . 0.0 112.646 172.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.422 ' NE2' HG21 ' A' ' 63' ' ' THR . 0.0 OUTLIER -135.52 -173.19 3.28 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.21 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 5.3 mt -78.25 150.92 33.32 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.019 178.196 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 64.07 -3.47 1.61 Allowed Glycine 0 N--CA 1.506 3.347 0 O-C-N 123.413 0.446 . . . . 0.0 113.588 -179.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -67.26 116.48 8.09 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 123.928 0.428 . . . . 0.0 109.95 -177.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.502 ' C ' HD12 ' A' ' 30' ' ' LEU . 2.0 mt -102.3 139.12 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.909 0 CA-C-O 121.768 0.794 . . . . 0.0 110.019 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.502 HD12 ' C ' ' A' ' 29' ' ' ILE . 10.2 mp -117.67 162.19 18.45 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 112.909 -1.951 . . . . 0.0 109.454 -179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -134.85 147.68 49.95 Favored 'General case' 0 N--CA 1.502 2.149 0 O-C-N 124.036 0.835 . . . . 0.0 108.833 -175.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.503 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -121.7 -169.24 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.518 0 O-C-N 123.53 0.519 . . . . 0.0 109.829 178.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.503 ' H ' HG12 ' A' ' 32' ' ' VAL . 3.6 m-80 -99.88 136.66 39.47 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.285 178.327 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.97 -38.82 8.04 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 124.706 1.254 . . . . 0.0 110.783 177.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -84.25 -5.74 86.97 Favored Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.978 -1.249 . . . . 0.0 109.978 -179.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 74.8 m -158.47 38.59 0.24 Allowed 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 -169.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.62 ' C ' HD12 ' A' ' 37' ' ' LEU . 0.3 OUTLIER -56.72 -31.21 64.31 Favored 'General case' 0 N--CA 1.504 2.23 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.726 172.21 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.8 t -50.3 -8.91 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.089 0 CA-C-N 114.192 -1.367 . . . . 0.0 113.944 170.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -35.4 -37.22 0.08 Allowed 'General case' 0 N--CA 1.498 1.967 0 CA-C-N 115.07 -0.968 . . . . 0.0 111.792 170.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.432 ' N ' HD12 ' A' ' 40' ' ' LEU . 11.2 mp -96.41 -26.04 15.48 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.593 -1.185 . . . . 0.0 111.864 -178.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 109.75 17.65 9.57 Favored Glycine 0 N--CA 1.497 2.709 0 O-C-N 124.68 1.238 . . . . 0.0 110.978 -176.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -69.29 173.82 5.36 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.57 -0.815 . . . . 0.0 112.207 -179.617 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 36.5 m -140.81 -166.08 2.07 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.35 -1.295 . . . . 0.0 109.253 -178.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -67.27 86.01 0.16 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 124.07 0.856 . . . . 0.0 109.866 174.703 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -120.9 -113.26 2.31 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.258 -1.937 . . . . 0.0 108.258 175.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -157.62 87.25 0.95 Allowed 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 107.058 -1.46 . . . . 0.0 107.058 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.03 -19.37 65.83 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.673 -1.149 . . . . 0.0 110.438 177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.07 1.2 28.75 Favored 'General case' 0 N--CA 1.498 1.928 0 CA-C-N 114.815 -1.084 . . . . 0.0 111.91 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -124.77 79.39 63.66 Favored Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 -174.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.407 ' HA ' HD12 ' A' ' 53' ' ' ILE . 1.5 Cg_endo -62.51 -31.08 80.39 Favored 'Trans proline' 0 N--CA 1.488 1.182 0 C-N-CA 121.814 1.676 . . . . 0.0 111.404 175.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -49.93 -39.25 39.68 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.538 1.149 . . . . 0.0 112.129 -171.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -90.0 -31.95 16.98 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.128 -0.942 . . . . 0.0 110.126 -177.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.407 HD12 ' HA ' ' A' ' 50' ' ' PRO . 61.7 mt -65.93 151.74 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.971 0 O-C-N 123.852 0.72 . . . . 0.0 110.452 176.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.5 -102.78 1.08 Allowed Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.074 -1.611 . . . . 0.0 109.074 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 38.2 m95 -91.0 140.3 29.96 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 124.417 0.716 . . . . 0.0 110.885 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 97.9 mt -107.05 135.69 48.18 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 106.659 -1.608 . . . . 0.0 106.659 178.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.19 124.15 48.41 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 124.195 0.934 . . . . 0.0 108.778 174.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -168.27 -170.63 33.22 Favored Glycine 0 N--CA 1.498 2.821 0 C-N-CA 120.332 -0.937 . . . . 0.0 112.317 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -94.72 146.47 24.15 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-N 114.24 -0.98 . . . . 0.0 110.082 -178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -119.87 64.63 0.81 Allowed 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.042 -1.436 . . . . 0.0 108.693 175.307 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 71.1 mt-10 -56.93 -23.9 48.6 Favored 'General case' 0 N--CA 1.503 2.21 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.755 179.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 90.6 m -53.44 -34.73 58.97 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 123.849 0.718 . . . . 0.0 111.594 177.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.422 HG21 ' NE2' ' A' ' 25' ' ' HIS . 39.1 p -108.89 -5.17 16.28 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.556 -1.202 . . . . 0.0 110.771 177.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.2 40.67 49.28 Favored Glycine 0 N--CA 1.494 2.556 0 N-CA-C 110.983 -0.847 . . . . 0.0 110.983 -178.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -143.59 176.38 9.25 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 10.2 ptm180 -147.25 147.35 30.34 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 123.924 0.765 . . . . 0.0 109.168 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.87 -153.67 13.64 Favored Glycine 0 N--CA 1.497 2.76 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.269 177.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -110.2 149.71 29.71 Favored 'General case' 0 N--CA 1.498 1.968 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -151.2 142.82 15.65 Favored Pre-proline 0 N--CA 1.493 1.687 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.258 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -56.12 157.98 15.93 Favored 'Trans proline' 0 N--CA 1.488 1.168 0 C-N-CA 122.459 2.106 . . . . 0.0 112.874 -176.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.2 28.57 14.04 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 124.39 1.056 . . . . 0.0 113.508 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 14.9 t -133.81 -3.03 2.91 Favored 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 117.202 0.501 . . . . 0.0 110.725 -170.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.504 ' OH ' HD12 ' A' ' 24' ' ' LEU . 1.7 p90 -121.33 -6.43 9.34 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 123.918 0.761 . . . . 0.0 111.275 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.486 HG13 ' CE1' ' A' ' 73' ' ' TYR . 0.0 OUTLIER -97.48 178.33 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 O-C-N 124.139 0.899 . . . . 0.0 109.508 -179.319 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -149.34 104.85 3.42 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 -178.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 28.5 t80 -47.05 142.93 3.3 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.636 172.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.509 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.7 pt -122.97 -51.71 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.861 0 O-C-N 124.313 1.008 . . . . 0.0 111.958 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -156.33 146.41 13.9 Favored Glycine 0 N--CA 1.5 2.942 0 C-N-CA 120.316 -0.945 . . . . 0.0 111.978 -173.241 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 20.0 ptt-85 -127.69 123.23 34.98 Favored 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 113.485 -1.357 . . . . 0.0 111.102 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' O ' HG22 ' A' ' 82' ' ' ILE . 16.3 mttp -112.03 45.28 1.28 Allowed 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.114 -0.948 . . . . 0.0 108.766 177.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.43 ' HG3' ' H ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -45.25 92.9 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 114.677 -1.147 . . . . 0.0 113.049 175.919 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 82' ' ' ILE . 3.0 tp -148.02 107.52 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 CA-C-O 122.3 1.048 . . . . 0.0 113.189 -174.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.401 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -91.55 -47.99 0.34 Allowed Pre-proline 0 N--CA 1.498 1.955 0 CA-C-N 114.123 -1.399 . . . . 0.0 112.098 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.401 ' CD ' ' N ' ' A' ' 83' ' ' SER . 1.5 Cg_endo . . . . . 0 N--CA 1.486 1.072 0 CA-C-O 116.385 -1.589 . . . . 0.0 111.074 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 110.435 -1.066 . . . . 0.0 110.435 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 15.7 m -149.43 -16.98 0.28 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 124.122 0.542 . . . . 0.0 110.91 -178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 4.6 mmt -86.95 -30.83 21.02 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.643 0.589 . . . . 0.0 110.659 -178.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 17.5 t -89.45 114.74 26.26 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 123.796 0.685 . . . . 0.0 110.589 178.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . 0.434 ' HB3' ' CE ' ' A' ' 80' ' ' LYS . . . -170.17 32.95 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.859 0.724 . . . . 0.0 111.981 -178.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -67.3 84.33 0.15 Allowed 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.304 1.05 . . . . 0.0 111.28 -176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 143.83 -162.09 27.76 Favored Glycine 0 N--CA 1.496 2.661 0 CA-C-N 112.566 -2.106 . . . . 0.0 110.125 177.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -98.51 152.34 19.65 Favored 'General case' 0 N--CA 1.503 2.19 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -172.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 90.3 mt-30 -128.74 160.85 31.24 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.406 1.098 . . . . 0.0 112.394 -179.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -148.93 118.92 7.14 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 112.542 -2.117 . . . . 0.0 105.288 -171.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -95.01 124.21 38.93 Favored 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 106.736 -1.579 . . . . 0.0 106.736 -178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.37 114.25 1.74 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 124.005 0.816 . . . . 0.0 110.429 174.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.6 tp -78.5 -31.87 47.9 Favored 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.366 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -139.74 144.14 37.33 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.436 1.085 . . . . 0.0 108.889 -178.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -64.3 108.65 1.65 Allowed 'General case' 0 C--N 1.304 -1.404 0 CA-C-N 114.303 -1.317 . . . . 0.0 111.159 175.497 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.44 ' CD2' HD13 ' A' ' 24' ' ' LEU . 17.8 t80 -113.75 136.99 52.25 Favored 'General case' 0 N--CA 1.499 2.004 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 8.0 mtmm -89.7 -178.5 5.54 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.5 pttp -89.93 122.56 33.07 Favored 'General case' 0 N--CA 1.499 2.004 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.327 171.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 12.2 tt0 -90.06 -7.77 53.07 Favored 'General case' 0 N--CA 1.501 2.116 0 O-C-N 123.945 0.778 . . . . 0.0 110.727 172.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -144.73 150.65 37.64 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 124.028 0.83 . . . . 0.0 109.648 179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -55.62 -15.65 3.18 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 115.331 -0.849 . . . . 0.0 113.18 173.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -79.48 -41.29 27.8 Favored 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.931 174.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -72.33 168.24 18.79 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 123.691 0.619 . . . . 0.0 111.428 175.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.56 -164.58 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.24 0 O-C-N 124.144 0.902 . . . . 0.0 109.827 176.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -100.43 108.04 19.93 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 114.367 -1.288 . . . . 0.0 109.683 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.582 ' N ' HD12 ' A' ' 24' ' ' LEU . 5.3 mp -92.63 123.08 35.66 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 113.529 -1.668 . . . . 0.0 109.71 173.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -119.03 167.32 11.88 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.687 170.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 9.9 mt -53.8 150.4 7.51 Favored 'General case' 0 N--CA 1.5 2.034 0 C-N-CA 120.316 -0.553 . . . . 0.0 111.024 173.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.06 -14.05 3.03 Favored Glycine 0 N--CA 1.497 2.702 0 CA-C-N 114.969 -1.014 . . . . 0.0 114.345 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -62.87 117.35 6.25 Favored 'General case' 0 N--CA 1.502 2.131 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 tp -94.73 148.65 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 123.915 0.759 . . . . 0.0 109.152 171.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.567 HD23 ' CE1' ' A' ' 69' ' ' PHE . 8.3 mp -121.98 135.27 54.84 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 177.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.5 m -122.04 140.2 52.78 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 124.143 0.902 . . . . 0.0 108.687 177.171 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.63 -175.45 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.163 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 -178.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -74.42 176.11 7.08 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.973 -173.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 44.2 pttt -78.23 -20.95 50.71 Favored 'General case' 0 N--CA 1.497 1.921 0 CA-C-N 114.968 -1.014 . . . . 0.0 109.357 177.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.17 33.31 2.1 Favored Glycine 0 N--CA 1.493 2.472 0 N-CA-C 108.567 -1.813 . . . . 0.0 108.567 -175.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.7 1.2 5.62 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 114.689 -0.755 . . . . 0.0 112.229 178.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 mt -63.94 -42.65 97.28 Favored 'General case' 0 N--CA 1.496 1.834 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 167.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.402 ' O ' HG12 ' A' ' 38' ' ' VAL . 21.1 t -81.44 -8.87 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.022 0 CA-C-N 114.758 -1.11 . . . . 0.0 113.11 -177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -39.51 -37.86 0.52 Allowed 'General case' 0 N--CA 1.504 2.227 0 O-C-N 124.094 0.871 . . . . 0.0 109.571 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 tp -97.57 -49.84 4.72 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 113.199 -1.819 . . . . 0.0 107.897 179.05 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.66 39.87 0.75 Allowed Glycine 0 N--CA 1.493 2.483 0 CA-C-N 111.781 -2.463 . . . . 0.0 113.362 -165.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -58.96 167.17 1.71 Allowed 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 112.897 0.702 . . . . 0.0 112.897 166.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 83.7 p -136.88 29.41 2.85 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.453 -177.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -133.58 -160.53 1.06 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.596 -176.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -152.82 3.84 0.35 Allowed Glycine 0 N--CA 1.498 2.809 0 N-CA-C 110.563 -1.015 . . . . 0.0 110.563 -167.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -92.3 55.31 2.52 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 122.037 0.922 . . . . 0.0 109.466 -174.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -66.08 -23.91 66.61 Favored 'General case' 0 N--CA 1.5 2.027 0 CA-C-N 114.511 -1.222 . . . . 0.0 112.038 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.6 -6.35 53.45 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.177 -1.374 . . . . 0.0 110.909 -179.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -119.53 86.97 35.51 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -63.68 -6.1 10.03 Favored 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 122.721 2.281 . . . . 0.0 113.75 169.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 14.9 mt-10 -65.97 -35.8 81.59 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.485 0.491 . . . . 0.0 111.947 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -89.2 -28.16 20.16 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 123.678 0.611 . . . . 0.0 110.537 -177.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 30.0 mt -80.3 141.3 15.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 -179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.8 -84.46 1.34 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.945 -1.662 . . . . 0.0 108.945 176.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.0 m95 -91.49 125.15 36.14 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 113.032 -1.584 . . . . 0.0 110.16 -177.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.3 mp -102.68 131.17 49.66 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 168.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.96 122.31 40.93 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 168.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.89 -175.31 22.7 Favored Glycine 0 N--CA 1.5 2.909 0 C-N-CA 119.774 -1.203 . . . . 0.0 111.973 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.403 ' CD1' ' N ' ' A' ' 59' ' ' TYR . 0.1 OUTLIER -120.28 133.53 55.45 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-N 114.816 -0.692 . . . . 0.0 110.182 179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 55.6 t30 -99.18 82.83 2.77 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 124.501 1.126 . . . . 0.0 109.132 175.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -48.05 -28.51 2.88 Favored 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 114.068 -1.424 . . . . 0.0 112.274 172.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 9.0 m -55.93 -49.16 74.25 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.022 0.826 . . . . 0.0 111.075 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.5 p -95.3 0.01 53.3 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.306 1.004 . . . . 0.0 110.303 178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.95 45.56 96.34 Favored Glycine 0 N--CA 1.494 2.554 0 C-N-CA 120.799 -0.715 . . . . 0.0 111.455 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -142.85 174.39 10.7 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.358 0.681 . . . . 0.0 109.933 -176.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 29.8 ttt-85 -145.0 144.24 30.93 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.787 -1.097 . . . . 0.0 108.91 -175.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -178.28 -158.16 20.44 Favored Glycine 0 N--CA 1.493 2.484 0 CA-C-N 115.032 -0.986 . . . . 0.0 111.749 176.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -109.15 168.96 8.99 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 113.736 -1.232 . . . . 0.0 110.289 176.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.567 ' CE1' HD23 ' A' ' 30' ' ' LEU . 17.7 p90 -164.16 144.7 6.6 Favored Pre-proline 0 N--CA 1.497 1.908 0 CA-C-N 114.816 -1.083 . . . . 0.0 108.912 170.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.8 160.47 40.62 Favored 'Trans proline' 0 N--CA 1.487 1.101 0 C-N-CA 121.975 1.783 . . . . 0.0 112.109 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.64 54.65 1.24 Allowed Glycine 0 N--CA 1.497 2.766 0 N-CA-C 110.064 -1.214 . . . . 0.0 110.064 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.2 t -137.37 -29.84 0.87 Allowed 'General case' 0 N--CA 1.503 2.212 0 N-CA-C 113.988 1.107 . . . . 0.0 113.988 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -91.58 -6.05 53.01 Favored 'General case' 0 N--CA 1.501 2.123 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.396 178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 7.0 m -116.19 167.69 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 CA-C-N 114.604 -1.18 . . . . 0.0 108.599 -177.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -139.06 127.05 22.33 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 175.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 20.7 t80 -49.86 144.07 6.89 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 119.99 -0.684 . . . . 0.0 109.403 167.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -125.77 -54.99 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 124.026 0.828 . . . . 0.0 111.107 175.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.86 152.76 23.68 Favored Glycine 0 N--CA 1.496 2.668 0 C-N-CA 119.594 -1.289 . . . . 0.0 110.353 -165.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.3 149.48 37.89 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 124.486 0.756 . . . . 0.0 111.759 -179.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.434 ' CE ' ' HB3' ' A' ' 3' ' ' ALA . 1.0 OUTLIER -124.07 42.79 3.16 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 174.211 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.4 ttpm? -40.46 110.62 0.16 Allowed 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 113.593 -1.64 . . . . 0.0 112.159 177.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 6.0 tp -133.06 95.05 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-N 114.448 -1.251 . . . . 0.0 109.165 -177.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.42 160.92 26.26 Favored Pre-proline 0 N--CA 1.503 2.194 0 CA-C-N 113.487 -1.688 . . . . 0.0 109.538 177.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.49 1.292 0 C-N-CA 122.124 1.883 . . . . 0.0 112.766 174.626 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 2.743 0 N-CA-C 112.602 -0.199 . . . . 0.0 112.602 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.0 OUTLIER -155.4 147.06 23.11 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 177.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 7.8 ttt -154.46 -46.68 0.09 Allowed 'General case' 0 N--CA 1.501 2.124 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 172.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 12.8 m -139.95 80.2 1.75 Allowed 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.457 1.098 . . . . 0.0 109.437 -174.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -160.68 153.23 20.76 Favored 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.349 175.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -154.3 83.45 1.12 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 124.209 0.943 . . . . 0.0 109.94 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.428 ' HA3' HG22 ' A' ' 82' ' ' ILE . . . 99.44 141.7 12.47 Favored Glycine 0 N--CA 1.495 2.569 0 CA-C-N 113.79 -1.55 . . . . 0.0 112.046 175.488 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -130.52 -178.3 4.72 Favored 'General case' 0 N--CA 1.51 2.571 0 N-CA-C 106.221 -1.77 . . . . 0.0 106.221 -167.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.513 ' HB3' HD11 ' A' ' 77' ' ' ILE . 23.6 mt-30 -150.0 162.0 41.23 Favored 'General case' 0 N--CA 1.493 1.686 0 CA-C-O 122.184 0.992 . . . . 0.0 111.815 -176.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -131.8 140.0 49.06 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-N 112.722 -2.035 . . . . 0.0 106.126 176.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.0 mtp180 -90.97 124.51 35.28 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 123.79 0.681 . . . . 0.0 110.084 161.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.43 121.55 9.23 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.809 0.693 . . . . 0.0 111.258 165.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -92.35 -67.98 0.82 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.228 0.955 . . . . 0.0 109.627 179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -94.59 137.26 33.92 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.367 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -68.55 91.2 0.41 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 124.13 0.894 . . . . 0.0 110.515 175.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.442 ' CD2' HD12 ' A' ' 24' ' ' LEU . 9.1 t80 -92.98 133.05 36.51 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.33 -1.304 . . . . 0.0 108.954 177.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.4 mttp -90.31 163.15 14.85 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.365 177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 pttm -89.0 115.97 26.95 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-O 121.437 0.637 . . . . 0.0 111.611 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -89.08 -14.44 36.3 Favored 'General case' 0 N--CA 1.504 2.265 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.942 -179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.54 155.49 43.7 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.896 -1.047 . . . . 0.0 109.843 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -63.37 -26.21 68.65 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.927 -1.033 . . . . 0.0 112.852 175.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.08 -28.4 69.05 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.484 -1.235 . . . . 0.0 110.511 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -109.25 152.35 25.33 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 124.54 1.15 . . . . 0.0 110.812 -177.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.1 pt -113.03 176.12 1.94 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.002 176.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -69.96 137.4 51.44 Favored 'General case' 0 N--CA 1.497 1.894 0 CA-C-N 114.8 -1.091 . . . . 0.0 108.084 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.442 HD12 ' CD2' ' A' ' 14' ' ' TYR . 67.6 mt -126.99 90.41 3.15 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 176.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.5 166.3 10.53 Favored 'General case' 0 N--CA 1.502 2.17 0 CA-C-N 113.833 -1.53 . . . . 0.0 109.751 178.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.9 mt -64.92 162.13 17.05 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 115.725 -0.67 . . . . 0.0 111.28 -175.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.41 -11.33 13.25 Favored Glycine 0 N--CA 1.5 2.917 0 C-N-CA 120.287 -0.959 . . . . 0.0 111.498 174.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -95.69 133.7 39.46 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.398 0.705 . . . . 0.0 109.587 -179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.8 mt -114.65 143.73 23.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 CA-C-N 114.059 -1.428 . . . . 0.0 108.963 177.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.2 mp -106.32 139.51 40.7 Favored 'General case' 0 N--CA 1.485 1.278 0 CA-C-N 114.163 -1.38 . . . . 0.0 108.67 -179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.42 ' CG2' HG21 ' A' ' 82' ' ' ILE . 23.2 m -112.1 144.82 40.83 Favored 'General case' 0 N--CA 1.505 2.318 0 O-C-N 123.871 0.732 . . . . 0.0 110.508 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -122.68 173.51 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 123.951 0.782 . . . . 0.0 110.686 -174.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.433 ' H ' ' CB ' ' A' ' 36' ' ' SER . 3.7 t30 -80.77 171.34 15.14 Favored 'General case' 0 N--CA 1.502 2.128 0 CA-C-N 114.409 -1.269 . . . . 0.0 114.106 175.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -73.82 -10.44 59.67 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 114.332 -1.304 . . . . 0.0 111.683 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -142.67 28.66 2.16 Favored Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.182 -1.567 . . . . 0.0 109.182 174.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.433 ' CB ' ' H ' ' A' ' 33' ' ' ASN . 0.2 OUTLIER -71.69 -9.19 57.9 Favored 'General case' 0 N--CA 1.486 1.327 0 CA-C-N 114.41 -0.895 . . . . 0.0 111.449 -179.276 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.553 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -75.1 -37.87 61.35 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 175.843 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.474 HG12 ' O ' ' A' ' 38' ' ' VAL . 9.5 t -77.01 -9.37 12.52 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 CA-C-N 113.77 -1.559 . . . . 0.0 114.656 176.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -40.1 -31.98 0.15 Allowed 'General case' 0 N--CA 1.506 2.372 0 O-C-N 124.173 0.92 . . . . 0.0 111.677 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 25.2 mt -94.6 17.27 13.61 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.615 -1.63 . . . . 0.0 111.122 -171.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 53.64 35.26 51.6 Favored Glycine 0 N--CA 1.498 2.786 0 CA-C-N 116.109 -0.496 . . . . 0.0 113.573 -161.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -64.67 174.14 1.91 Allowed 'General case' 0 N--CA 1.5 2.051 0 CA-C-N 114.508 -0.846 . . . . 0.0 112.866 177.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 t -100.35 160.15 14.57 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 114.691 -1.14 . . . . 0.0 109.459 171.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -48.74 98.69 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 114.361 -1.29 . . . . 0.0 111.63 170.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -102.76 -108.2 3.21 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.016 -1.633 . . . . 0.0 109.016 -177.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -163.17 -6.03 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 O-C-N 124.692 0.878 . . . . 0.0 112.009 -174.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 34.76 61.99 0.55 Allowed 'General case' 0 N--CA 1.504 2.272 0 O-C-N 124.666 1.229 . . . . 0.0 113.856 179.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.87 -7.77 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 113.208 -1.815 . . . . 0.0 111.221 -174.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.5 mttm -124.26 75.2 60.48 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 124.113 0.883 . . . . 0.0 111.388 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -58.2 -11.54 10.74 Favored 'Trans proline' 0 N--CA 1.493 1.465 0 C-N-CA 122.221 1.947 . . . . 0.0 113.56 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -65.95 -40.64 91.51 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.089 0.868 . . . . 0.0 111.543 177.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 -91.38 -21.33 21.05 Favored 'General case' 0 N--CA 1.501 2.082 0 O-C-N 123.769 0.668 . . . . 0.0 112.002 -179.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 39.4 mt -82.77 145.83 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.29 -88.16 1.24 Allowed Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.516 -1.433 . . . . 0.0 109.516 -176.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.5 m95 -89.76 145.26 25.32 Favored 'General case' 0 N--CA 1.493 1.684 0 CA-C-N 113.608 -1.296 . . . . 0.0 109.9 178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.2 mp -124.04 125.46 44.57 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.148 -1.387 . . . . 0.0 108.405 166.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -93.94 119.28 32.63 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 123.891 0.744 . . . . 0.0 109.079 168.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -143.13 -165.31 10.62 Favored Glycine 0 N--CA 1.496 2.636 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 171.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.8 134.99 34.15 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 109.427 -0.582 . . . . 0.0 109.427 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.5 t30 -96.77 76.08 2.77 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 175.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.6 mt-10 -43.16 -33.23 0.86 Allowed 'General case' 0 N--CA 1.504 2.235 0 CA-C-N 113.97 -1.468 . . . . 0.0 112.929 170.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 23.5 m -55.21 -49.59 71.56 Favored 'General case' 0 N--CA 1.501 2.095 0 O-C-N 124.208 0.943 . . . . 0.0 111.336 178.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 29.4 p -93.37 -4.34 51.67 Favored 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.148 0.905 . . . . 0.0 110.888 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.85 60.07 8.67 Favored Glycine 0 N--CA 1.494 2.556 0 O-C-N 123.884 0.74 . . . . 0.0 111.329 -175.049 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -141.58 154.56 45.51 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.343 0.672 . . . . 0.0 109.314 -177.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 21.1 mtp180 -127.87 135.21 49.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.328 1.017 . . . . 0.0 108.446 179.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.92 -168.68 39.12 Favored Glycine 0 N--CA 1.491 2.366 0 C-N-CA 119.18 -1.486 . . . . 0.0 112.69 173.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -108.02 165.76 11.23 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 113.149 -1.525 . . . . 0.0 109.181 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.482 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.6 p90 -160.03 143.23 10.23 Favored Pre-proline 0 N--CA 1.494 1.725 0 CA-C-N 115.235 -0.893 . . . . 0.0 109.379 175.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.488 ' HB2' HG22 ' A' ' 72' ' ' THR . 2.5 Cg_endo -65.76 155.54 68.69 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 121.967 1.778 . . . . 0.0 110.937 172.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -89.05 49.64 3.58 Favored Glycine 0 N--CA 1.497 2.72 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 70' ' ' PRO . 8.0 t -129.97 -28.84 2.14 Favored 'General case' 0 N--CA 1.503 2.208 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -96.82 13.53 28.29 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 124.193 0.933 . . . . 0.0 111.537 -177.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.8 m -139.28 178.71 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 114.67 -1.15 . . . . 0.0 107.926 -170.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -150.63 116.63 5.59 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.767 -1.197 . . . . 0.0 107.767 178.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -51.58 127.3 19.92 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 123.856 0.722 . . . . 0.0 109.883 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.513 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.0 OUTLIER -101.66 -55.99 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 124.598 1.187 . . . . 0.0 109.757 177.579 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -165.95 161.83 35.37 Favored Glycine 0 N--CA 1.488 2.145 0 C-N-CA 118.643 -1.741 . . . . 0.0 112.237 -174.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.57 42.56 1.09 Allowed 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 112.117 -2.042 . . . . 0.0 110.486 175.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 12.1 mtmm -64.68 98.48 0.27 Allowed 'General case' 0 N--CA 1.496 1.825 0 CA-C-N 113.778 -1.555 . . . . 0.0 109.202 175.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.98 103.94 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.312 0 CA-C-N 114.372 -1.285 . . . . 0.0 111.788 171.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.428 HG22 ' HA3' ' A' ' 5' ' ' GLY . 8.8 tp -89.44 95.78 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.114 0 CA-C-O 122.377 1.084 . . . . 0.0 110.154 -179.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -147.98 160.5 37.53 Favored Pre-proline 0 N--CA 1.503 2.215 0 CA-C-N 113.269 -1.787 . . . . 0.0 110.127 -177.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.492 1.396 0 C-N-CA 122.46 2.107 . . . . 0.0 112.652 177.881 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.348 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.1 OUTLIER -98.79 -62.46 1.23 Allowed 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -175.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 14.1 mmt -71.83 -7.52 48.81 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.096 -0.956 . . . . 0.0 112.073 177.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 96.2 p -69.06 -167.43 0.11 Allowed 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 174.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 65.72 141.15 0.03 OUTLIER 'General case' 0 N--CA 1.511 2.577 0 N-CA-C 113.782 1.031 . . . . 0.0 113.782 179.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -125.49 79.38 1.81 Allowed 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 -172.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.432 ' H ' HG22 ' A' ' 82' ' ' ILE . . . -131.82 162.05 23.8 Favored Glycine 0 N--CA 1.504 3.177 0 CA-C-N 114.87 -1.059 . . . . 0.0 112.61 -175.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.435 ' CE2' ' O ' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -137.02 145.31 43.94 Favored 'General case' 0 N--CA 1.509 2.504 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 -143.622 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 20.8 mt-30 -128.03 163.12 25.26 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 124.641 1.213 . . . . 0.0 111.839 -168.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 41.2 m-85 -140.59 124.22 17.05 Favored 'General case' 0 N--CA 1.486 1.337 0 CA-C-N 112.3 -2.227 . . . . 0.0 105.68 -175.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -91.89 124.66 36.18 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.219 -1.03 . . . . 0.0 108.219 176.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.1 118.5 5.09 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 124.162 0.914 . . . . 0.0 110.692 171.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.38 -60.75 2.16 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 124.02 0.825 . . . . 0.0 109.213 -175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -113.31 168.94 9.31 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.309 1.006 . . . . 0.0 110.228 176.868 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.7 123.88 30.88 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 113.855 -1.52 . . . . 0.0 108.349 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 8.9 t80 -121.97 138.91 54.24 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 108.325 -0.991 . . . . 0.0 108.325 173.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -89.45 172.52 8.94 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 177.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.515 ' CD ' ' H ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -89.74 144.52 25.9 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.889 -1.05 . . . . 0.0 111.136 172.841 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -134.44 -9.54 2.51 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 114.764 -1.107 . . . . 0.0 109.683 175.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 24.9 ttm180 -141.0 146.65 37.54 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.997 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.8 -17.58 9.71 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 124.461 1.101 . . . . 0.0 113.318 178.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 61.0 mt-10 -71.34 -51.07 26.29 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.383 -1.281 . . . . 0.0 111.693 174.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -88.41 153.31 21.28 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.135 0.897 . . . . 0.0 109.606 -173.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pt -114.39 174.59 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.148 0 O-C-N 124.378 1.049 . . . . 0.0 110.93 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -65.75 130.17 42.32 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 114.892 -1.049 . . . . 0.0 109.719 178.082 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 4.2 mt -120.66 124.33 44.96 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 114.452 -1.249 . . . . 0.0 109.579 177.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.68 172.75 11.61 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.314 -1.312 . . . . 0.0 108.835 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.0 mt -65.95 150.56 48.45 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.028 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 76.66 -10.27 18.82 Favored Glycine 0 N--CA 1.5 2.909 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.431 176.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -62.02 110.14 1.49 Allowed 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 169.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.538 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 tp -90.2 155.89 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 167.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.538 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.8 mp -129.23 143.69 50.95 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 113.704 -1.589 . . . . 0.0 107.184 177.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 89.8 m -128.18 143.0 51.01 Favored 'General case' 0 N--CA 1.503 2.223 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.9 t -110.08 -125.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.62 HD22 ' H ' ' A' ' 34' ' ' LYS . 0.2 OUTLIER -118.94 -173.79 2.57 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 118.234 0.47 . . . . 0.0 111.136 -170.742 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.62 ' H ' HD22 ' A' ' 33' ' ' ASN . 2.0 mttp -112.85 -45.49 3.19 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 123.869 0.73 . . . . 0.0 112.07 -170.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.25 35.91 0.88 Allowed Glycine 0 N--CA 1.497 2.761 0 N-CA-C 109.084 -1.607 . . . . 0.0 109.084 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.7 m -142.35 63.56 1.4 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 105.71 -1.959 . . . . 0.0 105.71 -177.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.9 mt -55.86 -24.99 40.23 Favored 'General case' 0 N--CA 1.504 2.256 0 CA-C-N 113.351 -1.75 . . . . 0.0 112.092 171.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 25.4 t -57.18 -9.8 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 173.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -48.15 -26.9 2.09 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 115.296 -0.866 . . . . 0.0 112.943 167.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.1 mt -117.44 -6.71 11.2 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 124.118 0.886 . . . . 0.0 110.252 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.74 22.53 59.69 Favored Glycine 0 N--CA 1.498 2.797 0 O-C-N 123.954 0.784 . . . . 0.0 112.143 -175.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -80.86 146.93 30.63 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 114.412 -0.894 . . . . 0.0 111.829 -179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -150.18 38.0 0.71 Allowed 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.768 -177.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -119.27 -56.35 2.08 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 114.934 -1.03 . . . . 0.0 110.274 178.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 102.39 58.01 0.78 Allowed Glycine 0 N--CA 1.498 2.794 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 -177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 33.9 mm-40 -94.04 -77.35 0.46 Allowed 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 112.085 -2.057 . . . . 0.0 109.501 177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 35.23 38.46 0.04 OUTLIER 'General case' 0 N--CA 1.512 2.629 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.435 ' HA ' ' CG ' ' A' ' 76' ' ' TYR . . . -162.56 -6.1 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 113.817 -1.538 . . . . 0.0 112.04 -177.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -128.13 76.25 78.0 Favored Pre-proline 0 N--CA 1.501 2.078 0 O-C-N 123.917 0.761 . . . . 0.0 110.048 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.93 -16.07 19.2 Favored 'Trans proline' 0 N--CA 1.49 1.315 0 C-N-CA 122.294 1.996 . . . . 0.0 113.514 175.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -59.7 -47.04 87.23 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 123.926 0.766 . . . . 0.0 111.218 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -89.72 -31.61 17.38 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 123.957 0.785 . . . . 0.0 110.033 -175.093 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 60.1 mt -66.49 143.63 15.43 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.925 0 O-C-N 123.803 0.689 . . . . 0.0 109.643 179.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.45 -97.78 1.07 Allowed Glycine 0 N--CA 1.493 2.467 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -175.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.7 m95 -93.48 135.99 34.19 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 114.239 -0.981 . . . . 0.0 109.834 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.518 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.4 mp -117.58 147.68 42.6 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.77 -1.104 . . . . 0.0 108.796 174.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.29 130.32 56.47 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 124.349 1.03 . . . . 0.0 108.223 176.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -160.44 169.96 36.34 Favored Glycine 0 N--CA 1.497 2.718 0 C-N-CA 119.55 -1.309 . . . . 0.0 112.999 178.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -90.73 141.1 29.15 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 114.17 -1.015 . . . . 0.0 109.102 175.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -105.49 72.56 0.98 Allowed 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.442 1.089 . . . . 0.0 109.933 169.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -44.3 -33.78 1.72 Allowed 'General case' 0 N--CA 1.508 2.432 0 CA-C-N 114.994 -1.003 . . . . 0.0 113.291 176.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.6 m -51.72 -47.73 63.87 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 124.115 0.884 . . . . 0.0 111.975 -177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.8 -4.66 23.3 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.532 -1.213 . . . . 0.0 108.849 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.48 47.67 85.18 Favored Glycine 0 N--CA 1.494 2.533 0 N-CA-C 110.156 -1.178 . . . . 0.0 110.156 -174.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -119.05 178.34 4.54 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.154 -1.023 . . . . 0.0 109.61 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 8.5 ttm180 -150.12 136.47 18.89 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 176.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.56 -153.89 13.54 Favored Glycine 0 N--CA 1.5 2.928 0 C-N-CA 118.916 -1.611 . . . . 0.0 113.538 165.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -106.79 158.29 17.1 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 -172.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.518 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.5 p90 -159.53 143.84 11.06 Favored Pre-proline 0 N--CA 1.489 1.5 0 CA-C-N 114.712 -1.131 . . . . 0.0 108.788 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_endo -68.59 154.32 71.78 Favored 'Trans proline' 0 C--N 1.314 -1.275 0 C-N-CA 121.941 1.761 . . . . 0.0 111.539 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -84.69 19.53 19.75 Favored Glycine 0 N--CA 1.499 2.89 0 O-C-N 124.128 0.893 . . . . 0.0 112.648 179.017 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -107.54 -32.4 7.71 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.268 0.556 . . . . 0.0 111.237 -178.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -89.62 -0.31 57.43 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.048 -1.433 . . . . 0.0 111.064 -175.321 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.7 m -122.23 -178.98 1.78 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 124.194 0.934 . . . . 0.0 109.283 179.774 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -146.61 122.0 10.31 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 172.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.435 ' CG ' ' HA ' ' A' ' 48' ' ' ALA . 45.1 t80 -55.0 120.98 7.72 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 124.034 0.834 . . . . 0.0 108.98 168.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -90.85 -54.98 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.89 0 C-N-CA 119.353 -0.939 . . . . 0.0 110.372 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -169.9 157.76 29.47 Favored Glycine 0 N--CA 1.495 2.605 0 C-N-CA 119.391 -1.385 . . . . 0.0 111.507 -171.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.8 164.4 17.57 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.52 -0.84 . . . . 0.0 111.608 171.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.4 mttp 64.89 22.85 12.55 Favored 'General case' 0 N--CA 1.508 2.462 0 CA-C-O 122.702 1.239 . . . . 0.0 110.297 174.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -93.57 19.21 8.81 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 112.212 -2.267 . . . . 0.0 112.932 176.02 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 82' ' ' ILE . 4.7 tt -88.48 82.98 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.333 0 CA-C-O 123.063 1.411 . . . . 0.0 112.396 156.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.2 p -150.31 69.58 8.92 Favored Pre-proline 0 N--CA 1.498 1.956 0 CA-C-N 113.438 -1.71 . . . . 0.0 110.459 167.471 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.22 0 C-N-CA 121.931 1.754 . . . . 0.0 111.695 173.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 2.519 0 CA-C-O 119.937 -0.369 . . . . 0.0 112.811 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 20.5 t -86.4 -6.35 58.95 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 123.663 0.272 . . . . 0.0 111.428 179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 4.8 mmt -63.36 -72.84 0.13 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 123.665 0.603 . . . . 0.0 110.816 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.52 144.86 0.4 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 123.927 0.767 . . . . 0.0 110.244 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -90.02 -167.86 1.96 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.649 174.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.522 ' O ' HG23 ' A' ' 31' ' ' THR . 5.9 pt-20 -146.04 13.51 1.29 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 123.645 0.59 . . . . 0.0 112.091 -179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 52.12 -131.45 37.45 Favored Glycine 0 N--CA 1.496 2.649 0 CA-C-N 115.281 -0.872 . . . . 0.0 113.271 -176.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -104.24 144.14 32.0 Favored 'General case' 0 N--CA 1.503 2.184 0 CA-C-N 114.194 -1.003 . . . . 0.0 108.671 170.704 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.613 ' HB3' HD11 ' A' ' 77' ' ' ILE . 53.2 mt-30 -120.14 159.93 23.9 Favored 'General case' 0 N--CA 1.5 2.056 0 CA-C-O 121.754 0.788 . . . . 0.0 112.593 -179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 53.7 m-85 -140.13 132.04 27.66 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 113.235 -1.802 . . . . 0.0 107.433 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.6 mtp180 -89.76 123.77 34.05 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 170.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.59 126.74 14.19 Favored 'General case' 0 N--CA 1.501 2.081 0 O-C-N 124.508 1.13 . . . . 0.0 111.752 164.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 5.7 tp -80.45 -36.55 33.42 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 124.099 0.874 . . . . 0.0 110.121 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -145.49 165.1 29.58 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 124.185 0.928 . . . . 0.0 110.795 -175.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -77.03 121.16 23.13 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-N 113.949 -1.478 . . . . 0.0 109.393 179.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.403 ' CD2' HD12 ' A' ' 24' ' ' LEU . 27.9 t80 -128.47 128.48 44.46 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.227 0.954 . . . . 0.0 109.423 178.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.32 159.51 15.23 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.661 -0.699 . . . . 0.0 109.604 173.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.34 150.21 22.67 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 123.772 0.67 . . . . 0.0 109.928 -176.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -123.73 -9.79 7.83 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.021 -179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 16.0 ttm180 -139.62 153.35 47.33 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 115.432 -0.803 . . . . 0.0 109.904 -179.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -60.91 -11.21 7.2 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.392 -1.276 . . . . 0.0 113.355 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -80.45 -35.02 35.5 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.374 178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -98.6 177.61 5.26 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 124.158 0.911 . . . . 0.0 111.039 179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.9 pt -141.23 172.75 10.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-N 113.448 -1.705 . . . . 0.0 110.086 -174.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -78.83 128.76 33.79 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.185 -1.371 . . . . 0.0 108.979 -173.128 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.403 HD12 ' CD2' ' A' ' 14' ' ' TYR . 85.3 mt -127.78 140.39 52.07 Favored 'General case' 0 N--CA 1.5 2.046 0 O-C-N 123.971 0.794 . . . . 0.0 109.998 -173.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.483 ' NE2' HG21 ' A' ' 63' ' ' THR . 0.2 OUTLIER -140.27 -173.5 3.68 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.078 -176.822 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -75.52 152.48 37.81 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.663 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 67.36 -7.87 1.72 Allowed Glycine 0 N--CA 1.498 2.82 0 CA-C-N 114.97 -1.014 . . . . 0.0 114.006 -176.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -60.82 106.52 0.58 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 175.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 mt -98.77 126.88 51.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 N-CA-C 108.169 -1.048 . . . . 0.0 108.169 172.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 10.0 mp -105.63 158.07 16.96 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 112.56 -2.109 . . . . 0.0 108.539 178.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.522 HG23 ' O ' ' A' ' 4' ' ' GLU . 1.1 m -134.42 147.09 50.38 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -172.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.3 OUTLIER -120.1 -166.7 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.508 2.447 0 N-CA-C 109.419 -0.586 . . . . 0.0 109.419 179.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.492 ' H ' HG12 ' A' ' 32' ' ' VAL . 5.0 m120 -85.19 153.61 22.53 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 121.998 0.904 . . . . 0.0 111.681 173.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.37 -54.95 2.81 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 112.993 -1.912 . . . . 0.0 107.625 -179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -100.96 10.46 58.61 Favored Glycine 0 N--CA 1.494 2.533 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.733 -174.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 10.6 t -155.15 39.89 0.42 Allowed 'General case' 0 N--CA 1.493 1.696 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -172.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.639 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -60.4 -32.78 71.65 Favored 'General case' 0 N--CA 1.504 2.248 0 CA-C-N 114.96 -1.018 . . . . 0.0 110.204 170.153 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.421 HG23 ' H ' ' A' ' 38' ' ' VAL . 2.9 t -52.25 -8.3 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.03 0 CA-C-N 113.765 -1.561 . . . . 0.0 113.25 173.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -29.61 -41.01 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 C-N-CA 124.927 1.291 . . . . 0.0 111.813 169.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.1 mt -86.62 -40.45 15.14 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 112.829 -1.987 . . . . 0.0 111.468 -178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 118.48 17.16 5.31 Favored Glycine 0 N--CA 1.494 2.543 0 CA-C-N 113.039 -1.891 . . . . 0.0 110.241 -174.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -67.95 175.18 3.22 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 114.725 -0.738 . . . . 0.0 111.844 179.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.58 150.92 30.68 Favored 'General case' 0 N--CA 1.499 1.987 0 CA-C-N 115.054 -0.976 . . . . 0.0 108.46 175.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -53.05 110.0 0.48 Allowed 'General case' 0 N--CA 1.496 1.866 0 O-C-N 124.385 1.053 . . . . 0.0 111.125 171.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.71 -108.04 0.83 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 108.594 -1.802 . . . . 0.0 108.594 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -153.91 91.08 1.42 Allowed 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.854 -1.535 . . . . 0.0 106.854 -177.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -54.75 -13.72 1.13 Allowed 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 113.835 -1.53 . . . . 0.0 113.124 171.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.18 11.3 1.93 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.555 -0.748 . . . . 0.0 112.291 177.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.15 76.68 78.82 Favored Pre-proline 0 N--CA 1.499 1.986 0 O-C-N 123.604 0.565 . . . . 0.0 109.532 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -65.26 -16.88 56.69 Favored 'Trans proline' 0 N--CA 1.49 1.304 0 C-N-CA 122.119 1.879 . . . . 0.0 112.731 174.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -67.09 -37.3 83.7 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 123.896 0.747 . . . . 0.0 110.945 -172.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -89.81 -33.79 16.39 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 124.184 0.928 . . . . 0.0 110.104 -177.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 70.9 mt -64.97 149.1 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 124.152 0.908 . . . . 0.0 109.823 176.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.43 -103.86 1.09 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.161 -1.576 . . . . 0.0 109.161 179.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 46.6 m95 -89.88 137.5 32.28 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 124.632 0.842 . . . . 0.0 110.348 -177.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 64.7 mt -106.4 131.65 53.35 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 113.934 -1.484 . . . . 0.0 107.721 -177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -104.77 117.44 34.07 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.009 0.818 . . . . 0.0 109.483 175.22 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.91 172.58 35.11 Favored Glycine 0 N--CA 1.498 2.781 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.299 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -90.84 149.3 22.01 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.477 -0.861 . . . . 0.0 109.997 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -124.42 61.1 1.14 Allowed 'General case' 0 N--CA 1.497 1.893 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 175.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -52.89 -22.68 5.79 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.433 -1.258 . . . . 0.0 112.064 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -53.01 -50.48 64.14 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 124.001 0.813 . . . . 0.0 111.084 176.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.483 HG21 ' NE2' ' A' ' 25' ' ' HIS . 5.4 p -94.2 3.28 55.47 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 114.62 -1.173 . . . . 0.0 111.476 175.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.51 29.42 74.77 Favored Glycine 0 N--CA 1.498 2.78 0 N-CA-C 111.108 -0.797 . . . . 0.0 111.108 -177.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.5 mm-40 -123.9 173.89 7.91 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 178.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 18.2 ptp180 -150.45 147.48 27.59 Favored 'General case' 0 N--CA 1.499 2.01 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 173.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.79 -154.78 19.44 Favored Glycine 0 N--CA 1.498 2.769 0 C-N-CA 119.939 -1.124 . . . . 0.0 113.092 171.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.37 155.11 16.87 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.661 -0.769 . . . . 0.0 109.364 177.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.409 ' CZ ' ' HB3' ' A' ' 56' ' ' LEU . 11.8 p90 -157.25 142.34 12.28 Favored Pre-proline 0 N--CA 1.498 1.952 0 CA-C-N 115.123 -0.944 . . . . 0.0 109.846 178.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -56.69 151.09 49.35 Favored 'Trans proline' 0 N--CA 1.491 1.326 0 C-N-CA 122.253 1.969 . . . . 0.0 111.899 -175.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.25 -4.39 77.62 Favored Glycine 0 N--CA 1.498 2.817 0 CA-C-N 115.329 -0.85 . . . . 0.0 112.436 177.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.3 t -104.19 1.36 30.56 Favored 'General case' 0 N--CA 1.502 2.175 0 CA-C-N 116.801 0.3 . . . . 0.0 111.345 -178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -106.35 -9.46 16.76 Favored 'General case' 0 N--CA 1.501 2.113 0 O-C-N 123.747 0.655 . . . . 0.0 111.988 -176.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 m -119.3 -172.12 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 O-C-N 124.134 0.896 . . . . 0.0 108.983 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -150.13 124.47 9.55 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -49.78 131.57 22.03 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 124.116 0.885 . . . . 0.0 109.913 168.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.613 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.2 pt -108.74 -53.68 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 124.359 1.037 . . . . 0.0 109.393 175.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -164.73 171.18 40.11 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 -170.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.97 161.44 40.49 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-N 114.52 -0.84 . . . . 0.0 109.368 177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? -104.7 130.23 52.78 Favored 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.917 -1.038 . . . . 0.0 111.922 164.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 38.5 tttp -78.76 90.27 4.64 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-N 112.7 -2.045 . . . . 0.0 108.846 175.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 tt -145.88 65.43 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 CA-C-N 114.136 -1.393 . . . . 0.0 108.786 177.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 m -142.77 67.92 18.84 Favored Pre-proline 0 N--CA 1.495 1.789 0 CA-C-N 113.519 -1.673 . . . . 0.0 109.838 -178.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.258 0 CA-C-O 116.217 -1.659 . . . . 0.0 111.807 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.371 0 N-CA-C 110.462 -1.055 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 68.5 m -57.02 139.33 52.56 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 124.281 0.636 . . . . 0.0 112.603 176.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 61.6 mtt -76.12 -19.64 58.33 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.551 -1.204 . . . . 0.0 110.792 -179.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t -138.55 175.45 9.55 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 115.366 -0.834 . . . . 0.0 109.865 179.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.59 177.27 4.63 Favored 'General case' 0 N--CA 1.502 2.141 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.612 -178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.74 -67.85 0.78 Allowed 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 168.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 34' ' ' LYS . . . 33.47 146.11 0.0 OUTLIER Glycine 0 N--CA 1.512 3.728 0 N-CA-C 119.086 2.395 . . . . 0.0 119.086 -173.692 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.405 ' CZ ' ' O ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -150.97 149.39 29.54 Favored 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.466 0.651 . . . . 0.0 111.481 -167.609 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -133.09 166.08 23.26 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 113.365 -1.743 . . . . 0.0 109.393 -169.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -139.92 141.39 36.51 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -175.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -105.66 120.52 41.88 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 114.541 -1.208 . . . . 0.0 108.341 176.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.78 114.91 1.57 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 124.312 1.007 . . . . 0.0 111.596 168.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.87 -63.54 1.36 Allowed 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.301 176.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -103.62 143.19 33.09 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 124.05 0.844 . . . . 0.0 110.26 -178.285 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -65.43 118.65 9.7 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 124.4 1.062 . . . . 0.0 111.164 172.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 25.2 t80 -129.42 128.32 42.73 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 124.564 1.165 . . . . 0.0 108.999 178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.2 mttt -89.57 171.42 9.71 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.5 pttp -89.01 136.17 33.16 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 -176.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -124.68 -7.66 7.38 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.719 179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.65 142.81 50.66 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 124.258 0.974 . . . . 0.0 109.246 175.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -58.0 -10.35 1.78 Allowed 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 114.743 -1.117 . . . . 0.0 113.537 172.476 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -90.53 -37.5 13.83 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.053 0.845 . . . . 0.0 111.204 174.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -86.98 145.43 26.51 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 123.833 0.708 . . . . 0.0 110.471 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.2 pt -99.58 -179.88 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 O-C-N 124.067 0.854 . . . . 0.0 111.8 173.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 59.7 m-20 -79.73 138.9 37.45 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.69 -1.141 . . . . 0.0 110.207 177.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -126.95 130.03 49.3 Favored 'General case' 0 N--CA 1.49 1.549 0 CA-C-N 113.652 -1.613 . . . . 0.0 108.408 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -142.84 163.25 33.31 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 114.037 -1.438 . . . . 0.0 108.28 179.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.8 mt -53.84 149.27 8.97 Favored 'General case' 0 N--CA 1.494 1.745 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.01 177.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.84 -14.4 10.47 Favored Glycine 0 N--CA 1.494 2.517 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.375 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.54 117.79 9.23 Favored 'General case' 0 N--CA 1.501 2.092 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.456 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -101.68 148.99 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 O-C-N 123.947 0.779 . . . . 0.0 109.431 167.408 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.463 HD11 ' ND2' ' A' ' 60' ' ' ASN . 10.6 mp -121.95 154.35 37.29 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 107.936 -1.135 . . . . 0.0 107.936 -179.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.8 m -137.26 145.16 43.21 Favored 'General case' 0 N--CA 1.507 2.416 0 O-C-N 123.471 0.482 . . . . 0.0 109.951 -178.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.477 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.0 t -122.14 -145.6 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.203 0 O-C-N 124.269 0.981 . . . . 0.0 108.487 179.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.477 ' H ' HG12 ' A' ' 32' ' ' VAL . 5.0 m-80 -103.64 -167.87 1.43 Allowed 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -175.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.403 ' HA ' ' H ' ' A' ' 5' ' ' GLY . 4.7 pttt -123.14 -52.7 1.85 Allowed 'General case' 0 N--CA 1.499 2.005 0 O-C-N 124.07 0.857 . . . . 0.0 110.649 -169.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -124.08 27.31 5.64 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 176.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 7.6 t -146.38 61.32 1.23 Allowed 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 106.814 -1.551 . . . . 0.0 106.814 -178.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.402 ' HG ' ' H ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -62.04 -6.62 3.06 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 112.539 -2.118 . . . . 0.0 113.639 164.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 3.5 t -64.03 -12.63 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 N-CA-C 112.516 0.561 . . . . 0.0 112.516 169.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -47.48 -24.08 0.76 Allowed 'General case' 0 N--CA 1.508 2.436 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.851 163.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.442 ' CD2' ' H ' ' A' ' 57' ' ' ASN . 4.7 mt -111.42 -20.62 12.16 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.85 -1.068 . . . . 0.0 109.44 -177.007 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.01 11.01 29.02 Favored Glycine 0 N--CA 1.496 2.639 0 O-C-N 124.999 1.437 . . . . 0.0 112.412 -172.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -88.69 162.79 16.09 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 123.842 0.377 . . . . 0.0 110.637 -178.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.6 t -150.42 36.8 0.66 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 123.734 0.647 . . . . 0.0 111.465 -178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -144.88 -96.66 0.1 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.772 -0.649 . . . . 0.0 110.743 178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 164.12 76.38 0.03 OUTLIER Glycine 0 N--CA 1.494 2.511 0 C-N-CA 120.389 -0.91 . . . . 0.0 111.005 -173.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -147.14 31.18 0.93 Allowed 'General case' 0 C--N 1.301 -1.543 0 CA-C-N 112.741 -1.73 . . . . 0.0 110.143 -178.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -77.87 13.07 1.47 Allowed 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 114.563 -1.199 . . . . 0.0 111.038 178.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -102.59 5.1 39.07 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.826 173.283 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.6 mptt -126.98 76.47 75.89 Favored Pre-proline 0 N--CA 1.501 2.116 0 O-C-N 123.767 0.667 . . . . 0.0 109.395 -176.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -64.25 -3.84 6.88 Favored 'Trans proline' 0 N--CA 1.494 1.513 0 C-N-CA 122.329 2.02 . . . . 0.0 113.732 173.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -71.36 -43.31 67.16 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.806 0.691 . . . . 0.0 110.985 -176.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -89.68 -24.68 21.54 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.391 -178.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 52.4 mt -75.74 143.02 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.56 -91.0 1.21 Allowed Glycine 0 N--CA 1.493 2.434 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 178.277 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -94.81 123.43 38.26 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-N 113.767 -1.217 . . . . 0.0 110.455 -177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.4 mp -95.63 172.68 7.91 Favored 'General case' 0 N--CA 1.498 1.947 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.756 171.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.442 ' H ' ' CD2' ' A' ' 40' ' ' LEU . 1.0 OUTLIER -145.17 107.44 4.37 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 107.149 -1.426 . . . . 0.0 107.149 -175.414 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.53 -176.78 23.84 Favored Glycine 0 N--CA 1.497 2.757 0 C-N-CA 120.154 -1.022 . . . . 0.0 111.513 -176.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . 0.412 ' CZ ' ' HD2' ' A' ' 66' ' ' ARG . 6.8 m-85 -106.81 153.27 22.72 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 114.295 -0.953 . . . . 0.0 110.234 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.463 ' ND2' HD11 ' A' ' 30' ' ' LEU . 8.5 t-20 -123.99 60.77 1.11 Allowed 'General case' 0 N--CA 1.494 1.731 0 CA-C-N 113.849 -1.523 . . . . 0.0 107.486 -177.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -42.86 -36.33 1.46 Allowed 'General case' 0 N--CA 1.509 2.503 0 CA-C-N 113.966 -1.47 . . . . 0.0 112.954 178.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.1 p -49.55 -54.58 17.29 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 124.514 1.134 . . . . 0.0 113.756 174.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.0 p -93.76 3.21 55.78 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 123.627 0.58 . . . . 0.0 111.29 172.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 62.23 17.46 56.05 Favored Glycine 0 N--CA 1.496 2.668 0 O-C-N 123.845 0.715 . . . . 0.0 112.227 -174.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -96.5 167.94 10.84 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 -177.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.412 ' HD2' ' CZ ' ' A' ' 59' ' ' TYR . 4.3 ptm180 -150.24 148.82 29.35 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.229 0.538 . . . . 0.0 110.246 175.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 162.2 -156.41 28.0 Favored Glycine 0 N--CA 1.496 2.672 0 CA-C-N 114.676 -1.147 . . . . 0.0 112.243 178.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -107.93 160.89 15.41 Favored 'General case' 0 N--CA 1.498 1.925 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 -169.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.479 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 27.8 p90 -159.87 149.93 15.0 Favored Pre-proline 0 N--CA 1.498 1.933 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.499 -178.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -64.75 146.17 87.9 Favored 'Trans proline' 0 N--CA 1.487 1.103 0 C-N-CA 122.064 1.843 . . . . 0.0 112.03 173.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.59 7.18 82.55 Favored Glycine 0 N--CA 1.498 2.818 0 O-C-N 123.83 0.706 . . . . 0.0 112.297 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -97.99 -23.95 15.57 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 109.994 -0.373 . . . . 0.0 109.994 176.179 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -89.83 -9.62 48.43 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.105 -0.952 . . . . 0.0 110.376 -173.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.9 m -122.95 -178.29 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 124.491 1.12 . . . . 0.0 108.334 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -149.61 120.57 7.67 Favored 'General case' 0 N--CA 1.495 1.797 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 174.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 21.7 t80 -48.73 127.62 14.01 Favored 'General case' 0 N--CA 1.499 2.015 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 165.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -94.27 -62.39 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 124.225 0.953 . . . . 0.0 109.442 175.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.16 158.02 28.81 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 110.58 -1.008 . . . . 0.0 110.58 -165.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.44 49.71 1.73 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 114.206 -0.997 . . . . 0.0 110.726 169.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 24.8 mttm -64.65 101.18 0.44 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 115.207 -0.906 . . . . 0.0 109.834 170.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 6.0 pttp -36.56 137.07 0.31 Allowed 'General case' 0 N--CA 1.505 2.288 0 CA-C-N 113.789 -1.551 . . . . 0.0 112.923 171.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.0 tt -88.53 126.65 41.75 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 CA-C-O 122.78 1.276 . . . . 0.0 112.033 174.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -89.05 162.22 38.46 Favored Pre-proline 0 N--CA 1.502 2.154 0 CA-C-N 113.107 -1.86 . . . . 0.0 109.004 -177.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo . . . . . 0 N--CA 1.489 1.224 0 CA-C-O 116.034 -1.736 . . . . 0.0 112.324 177.086 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.295 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 88.2 p -154.09 141.94 20.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 124.085 0.521 . . . . 0.0 110.194 177.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 1.0 OUTLIER -76.93 -31.61 56.77 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 124.0 0.813 . . . . 0.0 110.142 178.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.59 -169.07 2.01 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 124.375 1.047 . . . . 0.0 109.829 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.97 109.44 2.02 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 115.126 -0.943 . . . . 0.0 109.764 177.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -132.65 -13.8 2.9 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 115.11 -0.95 . . . . 0.0 109.99 179.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.03 -156.13 22.22 Favored Glycine 0 N--CA 1.495 2.616 0 O-C-N 124.268 0.98 . . . . 0.0 111.308 -169.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -92.24 153.61 19.16 Favored 'General case' 0 N--CA 1.502 2.128 0 N-CA-C 108.843 -0.799 . . . . 0.0 108.843 -175.072 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -133.1 162.9 30.49 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 124.301 1.001 . . . . 0.0 111.992 -172.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -143.76 135.97 26.75 Favored 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.294 -1.776 . . . . 0.0 107.082 -174.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.58 ' HE ' HD13 ' A' ' 77' ' ' ILE . 0.0 OUTLIER -102.73 125.17 49.36 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 124.276 0.985 . . . . 0.0 108.862 178.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.5 149.64 5.64 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 123.879 0.737 . . . . 0.0 110.873 168.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 6.4 tp -121.48 -25.58 5.13 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 123.974 0.796 . . . . 0.0 111.075 -175.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -150.04 146.78 27.16 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 124.038 0.836 . . . . 0.0 110.294 177.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -59.39 118.55 6.12 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.507 1.13 . . . . 0.0 110.55 173.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.416 ' CD1' HD12 ' A' ' 24' ' ' LEU . 2.9 t80 -120.6 135.98 54.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 124.778 1.299 . . . . 0.0 108.82 174.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.8 mptp? -89.81 157.03 18.11 Favored 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.955 -1.02 . . . . 0.0 108.406 175.157 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.7 pttm -88.58 149.82 23.38 Favored 'General case' 0 N--CA 1.496 1.872 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 -177.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -131.84 -19.56 2.6 Favored 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.312 179.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.23 147.25 35.41 Favored 'General case' 0 N--CA 1.489 1.508 0 CA-C-N 114.163 -1.381 . . . . 0.0 110.051 177.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.4 mm-40 -68.81 -21.33 64.32 Favored 'General case' 0 N--CA 1.498 1.963 0 CA-C-N 114.184 -1.371 . . . . 0.0 111.158 175.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 19.7 mt-10 -83.16 -12.28 57.1 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 114.048 -1.433 . . . . 0.0 110.69 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -107.97 147.79 30.57 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 124.091 0.87 . . . . 0.0 110.849 177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -107.22 -175.26 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-N 114.552 -1.204 . . . . 0.0 109.483 178.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -88.73 129.15 35.6 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.445 -175.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.416 HD12 ' CD1' ' A' ' 14' ' ' TYR . 71.5 mt -114.02 135.95 53.44 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 124.016 0.822 . . . . 0.0 111.007 -179.39 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.49 -173.91 3.2 Favored 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 114.493 -1.23 . . . . 0.0 109.089 -176.083 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.7 mt -84.92 158.06 20.67 Favored 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.687 178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.64 -5.27 2.45 Favored Glycine 0 N--CA 1.499 2.866 0 CA-C-N 115.565 -0.743 . . . . 0.0 113.137 -177.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -68.86 147.41 51.76 Favored 'General case' 0 N--CA 1.497 1.887 0 N-CA-C 110.135 -0.32 . . . . 0.0 110.135 178.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.476 ' C ' HD12 ' A' ' 30' ' ' LEU . 6.0 tt -132.57 150.14 32.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 124.101 0.876 . . . . 0.0 111.358 172.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.668 HD11 HD22 ' A' ' 60' ' ' ASN . 9.7 mp -121.77 152.83 39.04 Favored 'General case' 0 N--CA 1.497 1.89 0 CA-C-N 114.514 -1.221 . . . . 0.0 108.149 -176.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 50.3 m -135.04 149.35 50.11 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 123.914 0.759 . . . . 0.0 110.449 -176.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.578 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.3 t -127.67 -153.99 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 123.959 0.787 . . . . 0.0 109.002 -179.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.578 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -79.74 178.46 8.15 Favored 'General case' 0 N--CA 1.491 1.615 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.423 -179.276 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.416 ' H ' HD22 ' A' ' 33' ' ' ASN . 0.7 OUTLIER -122.6 11.4 9.84 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 114.575 -1.193 . . . . 0.0 111.424 -173.652 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 158.04 25.08 0.03 OUTLIER Glycine 0 N--CA 1.494 2.539 0 N-CA-C 110.231 -1.148 . . . . 0.0 110.231 176.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.7 m -141.57 65.82 1.37 Allowed 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 106.6 -1.629 . . . . 0.0 106.6 176.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.538 HD12 ' N ' ' A' ' 38' ' ' VAL . 1.1 pp -55.95 -12.53 1.44 Allowed 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 113.179 -1.828 . . . . 0.0 113.638 168.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.538 ' N ' HD12 ' A' ' 37' ' ' LEU . 5.4 t -61.97 -11.07 5.21 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.374 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 171.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.518 ' C ' HD12 ' A' ' 40' ' ' LEU . . . -48.26 -32.69 7.59 Favored 'General case' 0 N--CA 1.493 1.714 0 CA-C-N 114.935 -1.029 . . . . 0.0 111.219 168.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.518 HD12 ' C ' ' A' ' 39' ' ' ALA . 10.1 mp -109.47 -6.36 15.46 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 124.115 0.884 . . . . 0.0 110.763 178.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 81.5 26.32 51.43 Favored Glycine 0 N--CA 1.498 2.829 0 C-N-CA 120.419 -0.896 . . . . 0.0 111.854 -174.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -75.37 155.74 36.15 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.238 -0.981 . . . . 0.0 111.749 -178.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.5 m -90.11 -140.2 0.15 Allowed 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.138 -1.392 . . . . 0.0 107.558 175.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -33.73 -66.13 0.16 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 124.824 1.327 . . . . 0.0 112.306 171.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 58.28 86.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 170.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -62.05 -12.97 21.74 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 114.572 -0.814 . . . . 0.0 110.113 -179.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.436 ' OE1' HD23 ' A' ' 37' ' ' LEU . 16.1 mt-10 47.51 62.83 2.24 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 124.236 0.96 . . . . 0.0 111.607 174.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -171.74 -4.76 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-N 115.475 -0.784 . . . . 0.0 111.855 -174.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 21.8 mttp -126.86 79.27 72.65 Favored Pre-proline 0 N--CA 1.498 1.928 0 O-C-N 123.942 0.776 . . . . 0.0 110.499 -177.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.82 -7.96 5.2 Favored 'Trans proline' 0 N--CA 1.489 1.241 0 C-N-CA 122.237 1.958 . . . . 0.0 113.514 176.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.86 -48.56 45.13 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 -177.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -90.2 -23.21 21.34 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 123.822 0.701 . . . . 0.0 111.024 -175.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 94.4 mt -70.78 143.37 14.6 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.26 -99.68 1.04 Allowed Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -176.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 57.7 m95 -89.99 133.49 34.78 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.376 -0.912 . . . . 0.0 110.343 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.7 mp -109.28 156.47 19.91 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.705 -1.134 . . . . 0.0 109.414 171.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.433 ' H ' HD21 ' A' ' 40' ' ' LEU . 0.4 OUTLIER -131.08 124.65 31.26 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 175.876 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -154.32 -179.24 29.47 Favored Glycine 0 N--CA 1.493 2.493 0 C-N-CA 120.073 -1.06 . . . . 0.0 111.498 174.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -95.85 126.7 41.28 Favored 'General case' 0 N--CA 1.493 1.707 0 CA-C-N 113.52 -1.34 . . . . 0.0 109.483 175.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.668 HD22 HD11 ' A' ' 30' ' ' LEU . 23.2 t-20 -90.3 85.02 6.1 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 124.459 1.099 . . . . 0.0 109.896 173.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -47.48 -32.87 5.61 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 113.796 -1.547 . . . . 0.0 111.952 178.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.1 m -55.88 -47.01 78.15 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.298 0.999 . . . . 0.0 111.423 -176.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.6 p -105.03 5.38 32.5 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 124.228 0.955 . . . . 0.0 109.651 178.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 54.66 53.72 37.34 Favored Glycine 0 N--CA 1.494 2.538 0 O-C-N 124.292 0.995 . . . . 0.0 111.42 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -138.93 173.21 11.8 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 109.411 -0.588 . . . . 0.0 109.411 -172.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 47.7 ttp180 -129.11 118.87 23.18 Favored 'General case' 0 N--CA 1.496 1.827 0 N-CA-C 107.895 -1.15 . . . . 0.0 107.895 -178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -158.45 -171.05 23.83 Favored Glycine 0 N--CA 1.496 2.637 0 C-N-CA 118.953 -1.594 . . . . 0.0 113.224 173.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -103.25 162.16 13.21 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-N 113.646 -1.277 . . . . 0.0 109.603 -178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.548 ' CE1' HD23 ' A' ' 30' ' ' LEU . 13.0 p90 -159.66 140.86 9.3 Favored Pre-proline 0 N--CA 1.494 1.732 0 CA-C-N 114.739 -1.119 . . . . 0.0 109.215 176.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -68.61 152.44 74.63 Favored 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 121.647 1.564 . . . . 0.0 110.406 176.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.75 26.11 2.83 Favored Glycine 0 N--CA 1.501 3.0 0 C-N-CA 120.519 -0.848 . . . . 0.0 112.984 -179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.5 p -96.57 -51.91 4.14 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-O 121.276 0.56 . . . . 0.0 111.729 -176.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -90.48 25.65 2.21 Favored 'General case' 0 N--CA 1.503 2.181 0 CA-C-N 114.156 -1.383 . . . . 0.0 110.847 -170.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -145.47 158.7 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 -172.651 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -138.07 112.48 8.73 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 177.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -46.77 116.48 1.34 Allowed 'General case' 0 N--CA 1.496 1.851 0 CA-C-N 114.97 -1.014 . . . . 0.0 109.448 169.515 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.58 HD13 ' HE ' ' A' ' 9' ' ' ARG . 0.4 OUTLIER -91.83 -56.98 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.432 -0.907 . . . . 0.0 110.522 178.769 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -162.49 175.85 38.88 Favored Glycine 0 N--CA 1.489 2.218 0 C-N-CA 119.294 -1.432 . . . . 0.0 110.459 -168.022 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.92 136.57 17.99 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-N 113.973 -1.114 . . . . 0.0 110.383 -177.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -123.26 53.08 1.34 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.008 -1.451 . . . . 0.0 109.444 174.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -49.24 124.01 8.34 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 112.969 -1.923 . . . . 0.0 109.54 -176.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.6 tp -141.33 147.58 22.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 124.597 1.185 . . . . 0.0 110.161 -178.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.87 162.54 35.37 Favored Pre-proline 0 N--CA 1.504 2.248 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.372 178.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.488 1.182 0 CA-C-O 116.644 -1.482 . . . . 0.0 111.108 175.886 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.5 OUTLIER -150.7 -16.93 0.23 Allowed 'General case' 0 N--CA 1.497 1.901 0 CA-C-N 115.003 -0.598 . . . . 0.0 110.092 -177.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 75.1 mtp -61.62 -31.58 71.67 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 123.871 0.732 . . . . 0.0 111.039 178.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.408 ' HA ' HE22 ' A' ' 7' ' ' GLN . 49.2 m -65.41 144.96 56.73 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 123.845 0.716 . . . . 0.0 111.438 174.207 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.31 -178.27 2.89 Favored 'General case' 0 N--CA 1.496 1.868 0 CA-C-N 114.752 -1.113 . . . . 0.0 110.948 176.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.96 -23.75 48.36 Favored 'General case' 0 N--CA 1.5 2.064 0 CA-C-N 114.323 -1.308 . . . . 0.0 111.574 178.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -98.6 -157.35 29.58 Favored Glycine 0 N--CA 1.493 2.493 0 O-C-N 123.935 0.772 . . . . 0.0 111.208 -177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.72 143.92 31.06 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 114.228 -0.986 . . . . 0.0 109.165 179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.408 HE22 ' HA ' ' A' ' 2' ' ' SER . 5.5 mt-30 -128.87 164.1 23.83 Favored 'General case' 0 N--CA 1.503 2.19 0 CA-C-O 121.785 0.803 . . . . 0.0 112.737 -171.034 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 51.4 m-85 -139.03 133.46 31.69 Favored 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 113.414 -1.721 . . . . 0.0 107.926 -177.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.9 mtp180 -90.65 113.49 25.55 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 173.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.37 128.2 30.62 Favored 'General case' 0 N--CA 1.494 1.739 0 CA-C-N 114.505 -1.225 . . . . 0.0 111.136 167.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -104.01 -71.01 0.75 Allowed 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 114.509 -1.223 . . . . 0.0 109.036 -177.134 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 -90.34 145.99 24.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 123.86 0.725 . . . . 0.0 110.045 -176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.97 125.07 23.73 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 124.126 0.891 . . . . 0.0 110.52 177.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.518 ' CD2' HD12 ' A' ' 24' ' ' LEU . 16.5 t80 -127.84 133.15 49.37 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 124.41 1.069 . . . . 0.0 109.374 175.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.3 mttp -90.01 160.94 16.1 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 114.83 -1.077 . . . . 0.0 108.346 176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.25 160.83 16.73 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 123.952 0.783 . . . . 0.0 110.224 178.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.64 -50.43 4.06 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-O 121.899 0.857 . . . . 0.0 110.5 -179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.518 ' HG3' ' H ' ' A' ' 20' ' ' GLU . 6.8 ptp180 -150.27 -166.04 2.44 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 112.82 -1.991 . . . . 0.0 110.437 -178.331 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -61.5 2.87 0.15 Allowed 'General case' 0 N--CA 1.501 2.094 0 N-CA-C 114.126 1.158 . . . . 0.0 114.126 175.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.518 ' H ' ' HG3' ' A' ' 18' ' ' ARG . 28.5 tt0 -85.07 -36.99 20.83 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 123.246 0.341 . . . . 0.0 110.38 178.275 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.13 163.77 18.92 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.669 -174.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.597 HD12 ' H ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -120.25 -175.93 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 124.515 1.134 . . . . 0.0 110.294 177.465 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -83.6 129.09 34.96 Favored 'General case' 0 N--CA 1.493 1.705 0 CA-C-N 112.612 -2.085 . . . . 0.0 107.474 -175.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.518 HD12 ' CD2' ' A' ' 14' ' ' TYR . 82.4 mt -122.75 133.19 54.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 124.167 0.917 . . . . 0.0 110.415 -175.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -140.22 171.32 14.33 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 114.077 -1.419 . . . . 0.0 109.053 -174.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.759 HD12 ' H ' ' A' ' 26' ' ' LEU . 0.1 OUTLIER -72.7 151.22 42.31 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.401 -172.207 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.89 -12.93 15.25 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.111 176.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.89 141.73 53.1 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 124.048 0.499 . . . . 0.0 110.206 173.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.5 mt -117.1 141.32 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 124.512 1.133 . . . . 0.0 110.01 172.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.479 ' N ' HD12 ' A' ' 30' ' ' LEU . 8.6 mp -107.43 150.15 27.09 Favored 'General case' 0 N--CA 1.487 1.384 0 CA-C-N 112.748 -2.024 . . . . 0.0 109.233 177.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 58.4 m -128.22 138.98 52.69 Favored 'General case' 0 N--CA 1.498 1.95 0 O-C-N 124.19 0.931 . . . . 0.0 110.753 179.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.629 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.5 t -107.76 -155.53 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.993 0 O-C-N 124.367 1.042 . . . . 0.0 108.887 178.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.629 ' H ' HG12 ' A' ' 32' ' ' VAL . 2.5 t-20 -82.61 174.73 10.76 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.57 173.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? -114.3 -26.49 7.98 Favored 'General case' 0 N--CA 1.502 2.157 0 CA-C-N 114.666 -1.152 . . . . 0.0 110.563 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.84 56.46 0.42 Allowed Glycine 0 N--CA 1.491 2.364 0 N-CA-C 108.792 -1.723 . . . . 0.0 108.792 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.5 t -158.52 57.64 0.45 Allowed 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 171.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 12.8 mt -52.01 -26.29 10.4 Favored 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 113.185 -1.825 . . . . 0.0 112.052 166.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.439 ' H ' HG23 ' A' ' 38' ' ' VAL . 3.4 t -57.6 -8.72 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 O-C-N 124.426 1.079 . . . . 0.0 112.944 175.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -34.52 -39.5 0.09 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 124.989 1.431 . . . . 0.0 110.618 170.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 40' ' ' LEU . 19.7 mt -123.81 0.39 8.63 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-N 113.653 -1.612 . . . . 0.0 113.991 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 74.85 34.9 52.05 Favored Glycine 0 N--CA 1.494 2.523 0 N-CA-C 110.406 -1.077 . . . . 0.0 110.406 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -61.15 162.41 7.41 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 113.213 -1.494 . . . . 0.0 112.117 178.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.5 p -119.97 176.09 5.59 Favored 'General case' 0 N--CA 1.502 2.159 0 CA-C-N 114.118 -1.401 . . . . 0.0 109.827 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.5 t70 52.65 -88.22 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.138 0 O-C-N 124.783 1.302 . . . . 0.0 111.194 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 115.87 91.83 1.73 Allowed Glycine 0 N--CA 1.494 2.516 0 O-C-N 123.757 0.661 . . . . 0.0 111.628 -177.787 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.33 -62.05 1.41 Allowed 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 113.686 -1.257 . . . . 0.0 108.857 179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 51.74 82.94 0.06 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 124.592 1.183 . . . . 0.0 112.259 -177.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.04 -18.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 CA-C-N 113.918 -1.492 . . . . 0.0 111.38 -178.312 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 8.9 mptt -116.25 87.32 19.47 Favored Pre-proline 0 N--CA 1.499 1.982 0 O-C-N 124.234 0.959 . . . . 0.0 108.996 -176.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -58.77 -6.23 3.22 Favored 'Trans proline' 0 N--CA 1.495 1.562 0 C-N-CA 122.535 2.157 . . . . 0.0 113.407 173.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -66.87 -39.48 87.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 123.651 0.594 . . . . 0.0 111.062 177.603 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -90.31 -19.87 23.57 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 124.127 0.892 . . . . 0.0 110.057 -178.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 6.3 mt -96.04 129.73 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.933 0 O-C-N 123.914 0.759 . . . . 0.0 109.782 -178.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.62 -78.69 1.33 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.147 -1.181 . . . . 0.0 110.147 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 56.2 m95 -90.96 133.16 35.5 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 113.273 -1.464 . . . . 0.0 110.252 175.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.47 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.3 mp -120.75 125.44 47.63 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 172.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.414 ' O ' HG13 ' A' ' 32' ' ' VAL . 4.2 t-20 -90.0 120.32 31.1 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 123.926 0.766 . . . . 0.0 109.559 168.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.91 -163.68 9.6 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.386 174.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -139.99 123.52 17.17 Favored 'General case' 0 N--CA 1.493 1.685 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.59 88.45 7.42 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-N 114.02 -1.446 . . . . 0.0 110.32 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -53.93 -38.17 64.61 Favored 'General case' 0 N--CA 1.501 2.125 0 CA-C-N 114.602 -1.181 . . . . 0.0 111.199 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 6.6 p -52.02 -47.29 65.08 Favored 'General case' 0 N--CA 1.501 2.088 0 CA-C-N 114.411 -1.268 . . . . 0.0 113.252 175.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.1 p -91.28 -4.82 55.54 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 123.992 0.808 . . . . 0.0 109.836 177.585 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 55.45 36.08 62.81 Favored Glycine 0 N--CA 1.493 2.434 0 O-C-N 124.325 1.015 . . . . 0.0 111.836 -177.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -135.98 134.37 38.52 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 124.231 0.606 . . . . 0.0 110.227 -175.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -89.55 155.45 19.26 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 124.341 1.026 . . . . 0.0 109.115 -179.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 168.86 -161.49 35.2 Favored Glycine 0 N--CA 1.495 2.574 0 C-N-CA 120.082 -1.056 . . . . 0.0 112.132 173.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -116.06 166.33 12.12 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 113.891 -1.154 . . . . 0.0 109.228 -176.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.47 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 23.1 p90 -162.58 140.04 6.27 Favored Pre-proline 0 N--CA 1.496 1.847 0 CA-C-N 115.043 -0.981 . . . . 0.0 109.311 179.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.458 ' HB2' HG22 ' A' ' 72' ' ' THR . 2.5 Cg_endo -63.14 166.86 13.6 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 C-N-CA 121.875 1.716 . . . . 0.0 112.027 173.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -104.15 48.05 1.03 Allowed Glycine 0 N--CA 1.496 2.644 0 CA-C-N 114.99 -1.005 . . . . 0.0 110.599 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.474 HG23 ' CD2' ' A' ' 73' ' ' TYR . 5.0 t -138.39 -28.15 0.85 Allowed 'General case' 0 N--CA 1.499 2.018 0 O-C-N 124.19 0.582 . . . . 0.0 112.507 -177.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.474 ' CD2' HG23 ' A' ' 72' ' ' THR . 68.5 m-85 -90.92 1.62 56.87 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.319 1.012 . . . . 0.0 110.976 -179.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.4 m -128.49 -174.34 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 124.293 0.996 . . . . 0.0 108.924 -176.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -150.39 127.97 11.55 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.177 -0.919 . . . . 0.0 109.621 175.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 22.5 t80 -60.56 133.5 56.16 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 120.023 -0.671 . . . . 0.0 109.685 176.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.2 pt -102.08 -60.57 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 124.339 1.025 . . . . 0.0 110.361 176.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.92 148.0 15.91 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -163.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.436 ' HG2' ' H ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -129.15 128.84 44.25 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-N 112.803 -1.698 . . . . 0.0 109.734 173.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.24 28.12 0.86 Allowed 'General case' 0 N--CA 1.508 2.429 0 CA-C-O 121.749 0.785 . . . . 0.0 111.68 176.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.436 ' H ' ' HG2' ' A' ' 79' ' ' ARG . 37.8 mtpt 47.79 -173.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 113.349 -1.751 . . . . 0.0 113.064 -169.649 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.6 mt -89.47 -8.25 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.327 172.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.08 164.53 43.28 Favored Pre-proline 0 N--CA 1.505 2.299 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 -173.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo . . . . . 0 N--CA 1.488 1.148 0 C-N-CA 121.902 1.734 . . . . 0.0 112.931 169.907 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 N-CA-C 111.69 -0.564 . . . . 0.0 111.69 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 50.6 m -146.63 108.79 4.43 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.214 -0.993 . . . . 0.0 108.765 -175.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 1.1 tpt -164.22 132.05 3.41 Favored 'General case' 0 N--CA 1.499 2.02 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 175.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 t 58.84 -165.95 0.18 Allowed 'General case' 0 N--CA 1.505 2.286 0 O-C-N 123.826 0.704 . . . . 0.0 112.695 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -63.24 99.78 0.2 Allowed 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 121.107 0.479 . . . . 0.0 110.626 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -90.28 82.96 5.94 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.754 173.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -62.7 -134.33 0.01 OUTLIER Glycine 0 N--CA 1.5 2.942 0 CA-C-N 114.599 -1.182 . . . . 0.0 113.282 174.012 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.81 126.5 35.71 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 176.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -100.29 157.59 16.49 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.523 0.677 . . . . 0.0 110.859 -174.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 72.5 m-85 -143.99 124.97 14.35 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 -176.296 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 55.2 ttt180 -90.6 120.9 32.06 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 175.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.67 121.12 6.57 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 123.974 0.796 . . . . 0.0 110.773 168.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.424 HD23 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -74.14 -46.42 42.57 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 124.018 0.824 . . . . 0.0 109.558 176.48 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.84 174.75 10.13 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.36 1.038 . . . . 0.0 110.152 -178.105 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -80.25 133.33 35.99 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 113.986 -1.461 . . . . 0.0 110.089 177.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 16' ' ' LYS . 8.9 t80 -120.81 108.5 14.03 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.12 79.29 2.32 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-N 114.232 -1.349 . . . . 0.0 107.938 -171.765 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 14' ' ' TYR . 31.3 mmtm -142.53 170.7 15.21 Favored 'General case' 0 N--CA 1.499 2.011 0 CA-C-O 122.487 1.136 . . . . 0.0 111.44 170.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -151.45 60.98 0.89 Allowed 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 112.551 -2.113 . . . . 0.0 108.804 -166.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.6 ttt180 -89.67 159.26 17.21 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 176.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -60.84 -17.06 47.73 Favored 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.133 0.492 . . . . 0.0 111.156 -176.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -105.12 -29.33 10.45 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.09 -1.414 . . . . 0.0 110.555 177.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -99.92 165.52 11.51 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 123.652 0.595 . . . . 0.0 111.311 -176.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.3 pt -138.61 173.37 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.083 179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -79.51 131.4 36.03 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 114.029 -1.441 . . . . 0.0 110.11 -175.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.497 HD12 ' CD2' ' A' ' 14' ' ' TYR . 20.6 mt -128.87 137.28 51.36 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 124.728 1.267 . . . . 0.0 109.429 -175.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.37 -179.62 5.55 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 -178.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 12.2 mt -63.27 151.1 41.54 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.577 171.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.47 -10.55 6.37 Favored Glycine 0 N--CA 1.496 2.683 0 CA-C-N 115.19 -0.914 . . . . 0.0 113.611 177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -61.17 116.5 4.61 Favored 'General case' 0 N--CA 1.5 2.069 0 C-N-CA 120.238 -0.585 . . . . 0.0 110.142 177.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.522 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.9 OUTLIER -97.6 144.04 11.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 121.389 0.614 . . . . 0.0 109.418 174.895 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.522 HD12 ' C ' ' A' ' 29' ' ' ILE . 9.1 mp -125.22 153.65 42.81 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.279 -1.328 . . . . 0.0 108.063 -179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.4 m -137.14 132.36 33.89 Favored 'General case' 0 N--CA 1.504 2.271 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.474 HG12 ' N ' ' A' ' 33' ' ' ASN . 90.8 t -105.98 168.72 2.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.133 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 179.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.474 ' N ' HG12 ' A' ' 32' ' ' VAL . 8.6 m120 -58.1 172.18 0.46 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 123.902 0.751 . . . . 0.0 112.874 176.231 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.9 pttm -135.84 95.4 3.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 124.441 2.067 . . . . 0.0 110.026 176.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 105.86 -13.7 45.61 Favored Glycine 0 N--CA 1.504 3.194 0 CA-C-N 111.978 -2.374 . . . . 0.0 111.143 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 5.1 t -111.47 50.96 0.8 Allowed 'General case' 0 N--CA 1.488 1.475 0 N-CA-C 106.078 -1.823 . . . . 0.0 106.078 173.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.551 HD12 ' N ' ' A' ' 38' ' ' VAL . 1.2 pp -58.42 -17.32 19.64 Favored 'General case' 0 N--CA 1.501 2.106 0 CA-C-N 113.985 -1.462 . . . . 0.0 113.327 161.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.551 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.7 t -55.6 -8.83 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.254 0 N-CA-C 113.604 0.964 . . . . 0.0 113.604 167.119 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -34.92 -38.48 0.08 Allowed 'General case' 0 N--CA 1.502 2.137 0 O-C-N 124.421 1.075 . . . . 0.0 111.537 166.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 43.6 mt -124.82 -7.34 7.3 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 113.104 -1.862 . . . . 0.0 111.637 179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 87.22 34.26 10.89 Favored Glycine 0 N--CA 1.496 2.654 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -72.72 161.74 30.37 Favored 'General case' 0 N--CA 1.497 1.9 0 CA-C-N 113.932 -1.134 . . . . 0.0 112.175 177.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 p -112.51 -168.73 1.36 Allowed 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.182 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -74.72 82.56 2.09 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 123.879 0.737 . . . . 0.0 110.339 169.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -96.43 -107.79 2.4 Favored Glycine 0 N--CA 1.494 2.526 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 173.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -140.98 -40.48 0.4 Allowed 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.786 0.933 . . . . 0.0 108.628 -173.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 56.85 38.29 29.35 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 124.645 1.216 . . . . 0.0 111.345 177.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -152.36 -5.11 0.23 Allowed 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.915 -1.039 . . . . 0.0 110.503 -173.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.6 mptp? -119.16 85.23 29.53 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 124.471 1.107 . . . . 0.0 109.138 179.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -65.14 -2.26 5.51 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 123.151 2.567 . . . . 0.0 113.687 169.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -73.37 -15.83 61.36 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 123.684 0.615 . . . . 0.0 111.928 178.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -125.06 -33.86 2.84 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 123.602 0.564 . . . . 0.0 111.194 -175.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 77.4 mt -58.33 146.26 8.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 123.92 0.763 . . . . 0.0 110.433 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.28 -94.64 1.1 Allowed Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 72.7 m95 -95.43 136.29 35.99 Favored 'General case' 0 N--CA 1.494 1.728 0 CA-C-N 114.286 -0.957 . . . . 0.0 110.584 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 3.4 mp -115.96 138.23 51.39 Favored 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.716 -1.129 . . . . 0.0 108.207 173.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -107.96 118.83 37.77 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 176.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -150.89 165.91 30.28 Favored Glycine 0 N--CA 1.497 2.742 0 C-N-CA 120.476 -0.868 . . . . 0.0 111.453 -176.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -89.2 143.25 26.97 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 124.039 0.494 . . . . 0.0 110.182 176.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -116.09 68.48 0.73 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.957 -1.02 . . . . 0.0 109.135 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -47.05 -31.71 3.51 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 114.123 -1.399 . . . . 0.0 114.088 172.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 27.9 m -50.37 -49.03 55.45 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 124.531 1.144 . . . . 0.0 111.187 175.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.9 p -98.03 -2.74 39.6 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 124.25 0.969 . . . . 0.0 110.55 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 66.62 32.27 81.02 Favored Glycine 0 N--CA 1.495 2.612 0 N-CA-C 110.281 -1.128 . . . . 0.0 110.281 -177.037 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -122.95 176.35 6.06 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 124.461 0.742 . . . . 0.0 109.244 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -145.69 145.32 30.84 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.03 0.831 . . . . 0.0 109.114 174.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 174.28 -156.19 22.86 Favored Glycine 0 N--CA 1.492 2.417 0 C-N-CA 119.036 -1.554 . . . . 0.0 113.264 167.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -101.74 153.91 19.38 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 -173.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.472 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 35.6 p90 -155.18 141.55 13.14 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 123.619 0.575 . . . . 0.0 109.673 -178.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -65.82 142.02 67.86 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.828 1.685 . . . . 0.0 111.088 176.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -72.67 -22.86 78.76 Favored Glycine 0 N--CA 1.498 2.807 0 O-C-N 124.012 0.82 . . . . 0.0 111.874 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.4 p -72.45 -6.37 43.15 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-N 116.035 -0.082 . . . . 0.0 111.025 -178.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 6.9 m-85 -109.73 -6.35 15.32 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 123.979 0.799 . . . . 0.0 111.785 -177.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -126.37 -177.21 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 O-C-N 123.933 0.771 . . . . 0.0 109.028 -176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.424 ' HB2' HD23 ' A' ' 11' ' ' LEU . 0.4 OUTLIER -146.6 123.18 11.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 124.348 1.03 . . . . 0.0 108.948 175.511 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -56.26 127.16 29.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 124.355 1.034 . . . . 0.0 109.572 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -111.46 -55.08 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.951 0 O-C-N 123.874 0.734 . . . . 0.0 110.897 -177.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -146.97 161.23 28.42 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 107.139 -2.385 . . . . 0.0 107.139 -164.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -158.43 -175.96 5.63 Favored 'General case' 0 N--CA 1.494 1.764 0 C-N-CA 119.228 -0.989 . . . . 0.0 112.278 169.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -141.03 94.25 2.68 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 113.549 -1.66 . . . . 0.0 107.619 158.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.5 pttm -44.6 144.66 1.04 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 112.475 -2.148 . . . . 0.0 110.875 171.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.821 ' H ' HD12 ' A' ' 82' ' ' ILE . 0.1 OUTLIER -90.95 178.62 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.041 0 O-C-N 123.847 0.717 . . . . 0.0 109.112 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.44 163.38 33.74 Favored Pre-proline 0 N--CA 1.509 2.499 0 CA-C-N 115.683 -0.69 . . . . 0.0 109.716 -178.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo . . . . . 0 N--CA 1.488 1.187 0 C-N-CA 121.709 1.606 . . . . 0.0 112.612 176.457 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.377 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' B SER . . . . . 0.408 ' H ' ' H ' ' A' ' 1' C MET . 0.6 OUTLIER -170.34 -4.21 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.067 0 O-C-N 124.082 0.519 . . . . 0.0 110.801 -175.337 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 1' C MET . . . . . 0.408 ' H ' ' H ' ' A' ' 1' B SER . 0.0 OUTLIER -154.11 88.47 1.24 Allowed 'General case' 0 N--CA 1.494 1.726 0 CA-C-O 121.536 0.684 . . . . 0.0 110.596 -177.135 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 t 60.34 -175.06 0.11 Allowed 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.256 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.2 106.47 5.87 Favored 'General case' 0 N--CA 1.501 2.083 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.335 175.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -99.13 79.38 2.33 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.175 -178.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -150.28 170.06 30.25 Favored Glycine 0 N--CA 1.498 2.832 0 CA-C-N 114.057 -1.429 . . . . 0.0 111.502 -178.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -89.6 146.01 24.86 Favored 'General case' 0 N--CA 1.499 1.999 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 -171.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -133.8 155.88 49.01 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 123.885 0.741 . . . . 0.0 110.216 -166.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -140.39 125.71 18.81 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 113.565 -1.652 . . . . 0.0 107.619 -174.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 36.9 ttt180 -90.89 126.31 36.01 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 178.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.75 126.26 23.36 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 123.705 0.628 . . . . 0.0 111.317 170.878 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 17.2 tp -87.24 -35.77 18.33 Favored 'General case' 0 N--CA 1.499 2.012 0 CA-C-N 115.541 -0.754 . . . . 0.0 111.178 178.542 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -140.21 146.19 38.38 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 123.81 0.694 . . . . 0.0 110.224 -175.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -65.55 120.91 13.76 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.307 172.378 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.486 ' CD2' HD12 ' A' ' 24' ' ' LEU . 10.0 t80 -125.79 132.42 52.28 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 114.475 -1.239 . . . . 0.0 108.082 174.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 35.0 tttm -90.16 157.14 17.88 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 171.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.94 137.36 32.39 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.788 0.68 . . . . 0.0 109.727 -175.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -119.9 -2.51 10.3 Favored 'General case' 0 N--CA 1.497 1.908 0 CA-C-N 114.363 -1.29 . . . . 0.0 109.69 177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.425 ' HB3' ' H ' ' A' ' 21' ' ' ASP . 0.0 OUTLIER -120.02 141.7 49.48 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 124.145 0.903 . . . . 0.0 109.729 177.207 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -63.44 -17.27 62.51 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-N 114.77 -1.104 . . . . 0.0 111.923 171.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -86.53 -31.22 21.39 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.637 175.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . 0.425 ' H ' ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -85.68 144.58 27.74 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 123.641 0.588 . . . . 0.0 109.49 179.322 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.7 pt -104.67 171.75 1.69 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 124.3 1.0 . . . . 0.0 111.332 170.615 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -70.24 149.34 47.56 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-N 114.655 -1.157 . . . . 0.0 110.77 -179.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.486 HD12 ' CD2' ' A' ' 14' ' ' TYR . 96.1 mt -135.04 142.15 46.31 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.124 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -146.1 170.08 17.4 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -172.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.404 ' C ' ' H ' ' A' ' 28' ' ' ASP . 1.6 mt -70.89 153.5 42.65 Favored 'General case' 0 N--CA 1.499 1.981 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.05 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.41 -7.75 1.27 Allowed Glycine 0 N--CA 1.505 3.234 0 O-C-N 123.537 0.523 . . . . 0.0 113.331 -177.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.404 ' H ' ' C ' ' A' ' 26' ' ' LEU . 26.0 t70 -68.95 109.12 3.78 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 115.14 -0.53 . . . . 0.0 110.526 -174.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.702 ' C ' HD12 ' A' ' 30' ' ' LEU . 0.4 OUTLIER -89.04 149.9 3.88 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -176.018 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.702 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.1 mp -130.62 157.2 43.38 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 124.509 1.131 . . . . 0.0 111.041 174.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.1 m -136.83 141.5 42.86 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 123.782 0.676 . . . . 0.0 110.949 -178.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.597 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.3 t -116.4 -147.89 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 -174.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.597 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -90.2 175.82 6.99 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 120.844 0.354 . . . . 0.0 110.735 -175.85 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.8 mttp -100.67 -29.62 12.2 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.859 -177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -170.36 49.87 0.2 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 -175.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.3 t -149.93 64.86 0.98 Allowed 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 107.384 -1.339 . . . . 0.0 107.384 179.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.5 mt -53.02 -30.33 34.86 Favored 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 112.253 -2.249 . . . . 0.0 112.671 169.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -61.05 -8.86 2.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 CA-C-N 114.751 -1.113 . . . . 0.0 112.481 176.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -36.92 -33.95 0.06 Allowed 'General case' 0 N--CA 1.503 2.197 0 O-C-N 124.243 0.964 . . . . 0.0 112.311 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.7 mt -115.32 -16.59 11.46 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 113.729 -1.578 . . . . 0.0 111.778 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 99.99 14.57 33.47 Favored Glycine 0 N--CA 1.498 2.82 0 O-C-N 124.404 1.065 . . . . 0.0 112.167 -174.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 2.8 m-85 -74.99 161.45 29.46 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.134 0.549 . . . . 0.0 111.106 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -149.36 33.93 0.72 Allowed 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.238 -0.892 . . . . 0.0 110.033 -177.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.38 -154.32 0.5 Allowed 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 114.374 -1.284 . . . . 0.0 109.473 177.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -158.93 29.94 0.43 Allowed Glycine 0 N--CA 1.497 2.707 0 N-CA-C 111.378 -0.689 . . . . 0.0 111.378 -174.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -91.53 -79.85 0.36 Allowed 'General case' 0 N--CA 1.498 1.948 0 CA-C-N 114.445 -0.877 . . . . 0.0 111.458 179.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 58.27 39.21 25.87 Favored 'General case' 0 N--CA 1.511 2.607 0 CA-C-O 121.858 0.837 . . . . 0.0 111.79 177.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -156.0 -12.21 0.1 Allowed 'General case' 0 N--CA 1.5 2.045 0 CA-C-N 114.928 -1.033 . . . . 0.0 111.031 -173.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 38.3 mttp -120.23 81.5 29.46 Favored Pre-proline 0 N--CA 1.496 1.858 0 O-C-N 123.873 0.733 . . . . 0.0 110.198 179.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -56.88 -26.63 68.25 Favored 'Trans proline' 0 N--CA 1.489 1.231 0 C-N-CA 122.216 1.944 . . . . 0.0 112.368 174.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -47.27 -47.04 25.12 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 124.883 1.364 . . . . 0.0 111.501 -177.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -91.63 -37.06 13.29 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 124.383 1.052 . . . . 0.0 110.597 -175.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 40.9 mt -60.5 143.19 14.74 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 O-C-N 123.624 0.578 . . . . 0.0 110.081 174.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.46 -79.48 1.33 Allowed Glycine 0 N--CA 1.491 2.359 0 N-CA-C 109.23 -1.548 . . . . 0.0 109.23 -169.228 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -115.09 129.87 56.79 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 112.694 -1.753 . . . . 0.0 109.189 176.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.605 ' N ' HD23 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -130.19 143.64 50.9 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.819 -1.082 . . . . 0.0 109.92 173.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -90.05 145.05 25.36 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 114.413 -1.267 . . . . 0.0 108.713 -177.203 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.97 160.03 30.07 Favored Glycine 0 N--CA 1.497 2.714 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 176.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.1 t80 -113.66 125.35 54.05 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 -177.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 60.9 t30 -101.79 88.09 3.3 Favored 'General case' 0 N--CA 1.489 1.49 0 CA-C-N 113.971 -1.468 . . . . 0.0 111.231 -176.642 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -47.85 -36.85 12.66 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 113.608 -1.633 . . . . 0.0 111.977 -178.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.32 -42.39 98.59 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.0 p -90.74 0.81 57.31 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 123.793 0.683 . . . . 0.0 109.432 175.044 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.01 22.87 13.76 Favored Glycine 0 N--CA 1.497 2.72 0 O-C-N 124.459 1.099 . . . . 0.0 112.315 -168.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -121.74 155.67 34.75 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -172.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.459 ' HD3' ' H ' ' A' ' 66' ' ' ARG . 0.1 OUTLIER -137.76 150.54 47.34 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 124.621 1.201 . . . . 0.0 109.698 -174.391 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.78 -159.15 30.45 Favored Glycine 0 N--CA 1.496 2.67 0 C-N-CA 120.011 -1.09 . . . . 0.0 111.216 177.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -117.07 144.33 44.77 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 -165.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.446 ' CZ ' ' HG ' ' A' ' 56' ' ' LEU . 33.4 p90 -145.29 151.8 48.74 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 124.375 1.047 . . . . 0.0 108.914 -174.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -66.06 165.74 23.09 Favored 'Trans proline' 0 C--N 1.318 -1.057 0 C-N-CA 122.094 1.863 . . . . 0.0 111.779 178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -105.15 60.4 0.4 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 178.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -147.71 -24.91 0.37 Allowed 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 176.022 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -102.18 15.29 29.57 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 124.08 0.863 . . . . 0.0 111.264 -178.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.1 m -130.5 177.81 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.014 -179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.4 tt0 -148.26 116.3 6.44 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 172.223 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 15.5 t80 -47.81 143.34 4.1 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.757 165.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.1 pt -124.53 -49.1 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 124.371 1.044 . . . . 0.0 111.752 179.226 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -149.84 150.21 22.25 Favored Glycine 0 N--CA 1.498 2.83 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.333 -174.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 1.1 ppt_? -124.18 132.93 53.66 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 113.833 -1.183 . . . . 0.0 111.97 179.055 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 30.8 mttm -124.52 40.34 3.76 Favored 'General case' 0 N--CA 1.5 2.034 0 CA-C-N 114.479 -1.237 . . . . 0.0 110.351 177.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 10.2 tptp -71.01 -23.36 62.16 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.612 -1.176 . . . . 0.0 111.679 166.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 12.4 tt -129.37 142.07 44.9 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.126 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.694 176.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.511 ' H ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -149.62 -59.94 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.118 0 CA-C-O 117.722 -1.132 . . . . 0.0 111.161 175.562 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.511 ' HD2' ' H ' ' A' ' 83' ' ' SER . 1.1 Cg_endo . . . . . 0 N--CA 1.49 1.287 0 CA-C-O 116.152 -1.687 . . . . 0.0 112.34 -178.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.277 0 N-CA-C 110.111 -1.196 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 1.2 m 60.95 -170.81 0.15 Allowed 'General case' 0 N--CA 1.505 2.291 0 O-C-N 124.189 0.582 . . . . 0.0 112.254 -176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 0.0 OUTLIER -154.63 -19.59 0.12 Allowed 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.535 177.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.3 p -68.09 160.65 28.51 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 123.373 0.42 . . . . 0.0 111.704 177.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -56.37 119.33 5.85 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.491 1.119 . . . . 0.0 111.861 175.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -138.69 50.4 1.86 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 113.681 -1.599 . . . . 0.0 108.959 -173.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -176.37 -168.37 36.4 Favored Glycine 0 N--CA 1.496 2.698 0 CA-C-N 113.741 -1.572 . . . . 0.0 111.681 176.057 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -89.73 145.72 25.0 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -176.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.0 mt-30 -123.51 157.94 32.44 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-O 122.05 0.929 . . . . 0.0 113.313 -173.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.3 m-85 -140.43 121.35 14.55 Favored 'General case' 0 N--CA 1.489 1.479 0 CA-C-N 112.397 -2.183 . . . . 0.0 107.486 -176.66 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 26.2 ttt-85 -89.82 125.14 35.21 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.17 127.49 32.09 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 124.275 0.985 . . . . 0.0 110.742 171.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 2.5 tp -92.52 -68.43 0.8 Allowed 'General case' 0 N--CA 1.497 1.878 0 O-C-N 124.074 0.859 . . . . 0.0 109.527 -179.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -98.2 144.52 27.56 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 124.028 0.83 . . . . 0.0 109.713 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -62.05 129.31 40.25 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.041 -0.981 . . . . 0.0 110.659 173.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.447 ' CD2' HD12 ' A' ' 24' ' ' LEU . 19.8 t80 -129.92 133.43 46.84 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.551 1.157 . . . . 0.0 108.846 175.823 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 3.4 tppt? -90.01 154.33 19.9 Favored 'General case' 0 N--CA 1.485 1.314 0 O-C-N 123.971 0.794 . . . . 0.0 109.951 171.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -89.62 142.08 28.01 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-N 114.911 -1.041 . . . . 0.0 109.929 -177.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -89.4 -30.42 18.37 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 115.113 -0.948 . . . . 0.0 110.682 -175.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.7 ptt-85 -150.35 176.93 10.45 Favored 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 113.722 -1.581 . . . . 0.0 110.49 -175.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -58.46 -18.39 28.27 Favored 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.652 -1.158 . . . . 0.0 113.661 175.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 53.4 tt0 -69.1 -34.46 75.13 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 115.652 -0.703 . . . . 0.0 111.137 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.65 153.24 22.68 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 124.381 1.051 . . . . 0.0 109.406 179.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.0 pt -111.39 173.07 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.007 0 O-C-N 124.471 1.107 . . . . 0.0 110.534 175.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -73.57 132.91 43.35 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 114.453 -1.249 . . . . 0.0 109.186 -176.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.447 HD12 ' CD2' ' A' ' 14' ' ' TYR . 89.8 mt -121.34 127.02 50.86 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 124.55 1.156 . . . . 0.0 109.866 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.443 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -132.83 172.7 12.23 Favored 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 114.456 -1.247 . . . . 0.0 108.302 -179.231 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 2.3 mp -64.07 150.98 44.3 Favored 'General case' 0 N--CA 1.495 1.801 0 C-N-CA 119.677 -0.809 . . . . 0.0 110.156 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 77.05 -13.86 8.65 Favored Glycine 0 N--CA 1.494 2.501 0 CA-C-N 115.362 -0.835 . . . . 0.0 112.991 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -60.19 118.28 6.17 Favored 'General case' 0 N--CA 1.499 1.99 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 173.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.568 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.1 tp -96.19 151.09 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-O 121.714 0.769 . . . . 0.0 109.295 170.851 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.568 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.4 mp -127.71 150.84 49.6 Favored 'General case' 0 N--CA 1.493 1.694 0 CA-C-N 114.333 -1.303 . . . . 0.0 108.388 177.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 53.3 m -132.4 146.99 52.36 Favored 'General case' 0 N--CA 1.502 2.144 0 O-C-N 123.822 0.701 . . . . 0.0 109.443 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.516 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.4 t -121.37 -147.58 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.25 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.697 HD22 ' H ' ' A' ' 36' ' ' SER . 9.9 p-10 -83.06 -170.68 3.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 123.768 0.668 . . . . 0.0 111.773 176.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.94 -28.12 0.97 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-N 114.64 -1.163 . . . . 0.0 111.693 -170.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -163.98 27.54 0.21 Allowed Glycine 0 N--CA 1.493 2.495 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.697 ' H ' HD22 ' A' ' 33' ' ' ASN . 69.1 m -141.56 62.54 1.45 Allowed 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.443 HD11 ' OE1' ' A' ' 47' ' ' GLU . 3.3 mt -50.92 -23.37 2.8 Favored 'General case' 0 N--CA 1.5 2.065 0 CA-C-N 113.396 -1.729 . . . . 0.0 112.161 172.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.8 t -63.19 -12.97 11.61 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 O-C-N 124.014 0.821 . . . . 0.0 112.331 179.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.66 -29.47 7.41 Favored 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.456 168.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 13.7 mt -106.86 8.95 30.97 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 123.975 0.797 . . . . 0.0 109.754 -173.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 63.22 21.29 63.93 Favored Glycine 0 N--CA 1.496 2.654 0 CA-C-N 114.991 -1.004 . . . . 0.0 113.316 -170.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -80.46 150.55 29.67 Favored 'General case' 0 N--CA 1.496 1.835 0 CA-C-N 114.943 -0.628 . . . . 0.0 110.987 -175.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -140.25 38.11 1.91 Allowed 'General case' 0 N--CA 1.496 1.873 0 O-C-N 124.453 1.096 . . . . 0.0 108.975 -176.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -143.95 -63.84 0.38 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 114.472 -1.24 . . . . 0.0 108.807 177.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 84.14 100.45 0.6 Allowed Glycine 0 N--CA 1.494 2.504 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.375 -171.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -118.93 -46.02 2.55 Favored 'General case' 0 C--N 1.304 -1.381 0 CA-C-N 113.881 -1.16 . . . . 0.0 108.422 174.542 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.443 ' OE1' HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER 23.33 54.57 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 125.774 1.922 . . . . 0.0 115.78 -172.742 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.87 -22.33 0.07 Allowed 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 114.245 -1.343 . . . . 0.0 111.023 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.9 mttm -116.29 81.97 11.25 Favored Pre-proline 0 N--CA 1.497 1.878 0 O-C-N 124.23 0.956 . . . . 0.0 110.753 178.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.92 -8.76 6.48 Favored 'Trans proline' 0 N--CA 1.489 1.26 0 C-N-CA 122.373 2.049 . . . . 0.0 113.264 174.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 -70.0 -37.78 75.78 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 123.85 0.719 . . . . 0.0 111.329 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.9 pt-20 -89.68 -27.82 19.86 Favored 'General case' 0 N--CA 1.501 2.105 0 O-C-N 123.933 0.771 . . . . 0.0 110.779 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.7 mt -76.68 140.78 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 O-C-N 123.923 0.764 . . . . 0.0 109.07 -179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.71 -91.76 1.2 Allowed Glycine 0 N--CA 1.493 2.46 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -175.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 65.7 m95 -98.18 123.27 42.16 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.701 -1.25 . . . . 0.0 109.503 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.6 mp -99.95 164.27 12.08 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.256 174.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -137.4 126.69 24.74 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 175.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -156.36 175.82 33.92 Favored Glycine 0 N--CA 1.496 2.681 0 C-N-CA 120.386 -0.911 . . . . 0.0 111.247 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -99.59 125.17 45.35 Favored 'General case' 0 N--CA 1.495 1.806 0 CA-C-N 114.65 -0.775 . . . . 0.0 109.87 177.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 41.7 t-20 -89.63 84.27 6.33 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.22 0.95 . . . . 0.0 109.872 173.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -56.94 -34.82 68.39 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.116 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 20.4 m -54.57 -38.63 66.9 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 124.03 0.831 . . . . 0.0 111.87 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 40.1 p -99.77 -4.36 30.79 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.808 0.693 . . . . 0.0 111.564 177.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.92 29.84 76.42 Favored Glycine 0 N--CA 1.497 2.762 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -177.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -136.35 170.41 16.08 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 -175.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.3 ptt180 -136.51 150.7 48.8 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.08 0.863 . . . . 0.0 109.251 -177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 179.65 -163.69 31.16 Favored Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.819 -1.182 . . . . 0.0 111.808 171.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -106.95 153.48 22.49 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.513 -0.843 . . . . 0.0 109.552 -178.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.456 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 21.4 p90 -150.89 146.67 19.58 Favored Pre-proline 0 N--CA 1.491 1.578 0 CA-C-N 114.35 -1.296 . . . . 0.0 109.285 -176.329 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -66.59 150.08 83.98 Favored 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 121.787 1.658 . . . . 0.0 110.431 175.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -87.25 23.59 11.33 Favored Glycine 0 N--CA 1.499 2.836 0 O-C-N 124.078 0.861 . . . . 0.0 111.971 179.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -106.98 -34.67 7.12 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.052 0.453 . . . . 0.0 111.23 177.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -89.92 14.91 10.93 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.429 -1.26 . . . . 0.0 111.193 -174.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -140.26 171.69 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 CA-C-N 114.747 -1.115 . . . . 0.0 108.218 -176.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -145.9 123.2 11.58 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 177.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 41.8 t80 -48.97 149.06 2.0 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 123.974 0.796 . . . . 0.0 109.677 170.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.7 pt -131.79 -54.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 124.015 0.822 . . . . 0.0 111.336 178.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -148.92 146.23 15.43 Favored Glycine 0 N--CA 1.494 2.566 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.802 -168.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.63 145.19 51.52 Favored 'General case' 0 N--CA 1.494 1.729 0 CA-C-N 113.138 -1.531 . . . . 0.0 110.839 178.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.72 80.7 1.73 Allowed 'General case' 0 N--CA 1.492 1.669 0 CA-C-N 113.574 -1.648 . . . . 0.0 107.52 171.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.68 127.75 18.9 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 112.659 -2.064 . . . . 0.0 111.411 167.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -89.71 -8.72 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 114.813 -1.085 . . . . 0.0 110.247 178.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.5 t -119.9 85.81 35.04 Favored Pre-proline 0 N--CA 1.496 1.867 0 O-C-N 123.796 0.685 . . . . 0.0 109.774 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_endo . . . . . 0 C--N 1.315 -1.203 0 CA-C-O 115.789 -1.838 . . . . 0.0 112.473 170.318 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.411 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.9 OUTLIER -172.41 -51.56 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 115.078 -0.561 . . . . 0.0 109.626 -174.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.1 ptp -57.34 121.33 9.93 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 124.31 1.006 . . . . 0.0 111.79 -179.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -86.21 136.36 33.21 Favored 'General case' 0 N--CA 1.503 2.175 0 CA-C-N 115.344 -0.843 . . . . 0.0 110.13 -177.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -69.53 122.81 19.79 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 123.916 0.76 . . . . 0.0 110.634 179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.8 mt-10 -94.8 91.72 6.61 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-O 122.111 0.958 . . . . 0.0 109.838 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -103.12 -127.93 6.23 Favored Glycine 0 N--CA 1.493 2.437 0 CA-C-N 112.875 -1.966 . . . . 0.0 109.046 176.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.517 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -98.05 177.76 5.31 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 -174.566 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -145.38 165.57 28.09 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-O 122.437 1.113 . . . . 0.0 113.121 -177.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 84.9 m-85 -142.91 151.55 41.12 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-N 112.285 -2.234 . . . . 0.0 107.064 -176.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 13.6 ttt180 -119.1 115.47 24.34 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 174.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -53.34 121.21 7.15 Favored 'General case' 0 N--CA 1.497 1.911 0 C-N-CA 120.052 -0.659 . . . . 0.0 109.484 171.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.1 tp -93.79 -43.4 8.63 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 124.508 1.13 . . . . 0.0 110.235 176.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -115.43 143.54 45.14 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 124.578 1.174 . . . . 0.0 110.342 -177.083 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.88 117.47 20.0 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-N 114.304 -1.317 . . . . 0.0 109.787 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.494 ' HD2' HD12 ' A' ' 24' ' ' LEU . 16.8 t80 -120.58 131.24 54.56 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 24.6 tttm -89.1 156.24 18.95 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 115.244 -0.889 . . . . 0.0 108.652 175.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -89.19 132.73 34.72 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.994 -0.682 . . . . 0.0 109.622 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -112.51 -13.9 13.29 Favored 'General case' 0 N--CA 1.499 1.992 0 CA-C-N 114.411 -1.268 . . . . 0.0 110.138 176.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 8.5 tpp85 -129.42 149.33 51.25 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 124.417 1.073 . . . . 0.0 110.387 -178.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -69.07 -12.59 61.82 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.122 -1.399 . . . . 0.0 111.878 177.151 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -80.09 -19.78 46.64 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 124.116 0.885 . . . . 0.0 111.514 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.55 159.71 16.85 Favored 'General case' 0 N--CA 1.498 1.974 0 O-C-N 124.012 0.82 . . . . 0.0 111.497 176.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.6 pt -110.63 176.59 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.98 0 CA-C-N 114.169 -1.378 . . . . 0.0 110.844 174.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -73.16 139.88 46.66 Favored 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.823 -1.08 . . . . 0.0 109.897 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.494 HD12 ' HD2' ' A' ' 14' ' ' TYR . 16.1 mt -127.52 127.64 44.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 124.192 0.933 . . . . 0.0 110.566 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.95 -176.61 4.86 Favored 'General case' 0 N--CA 1.497 1.892 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.92 177.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.4 mt -61.64 152.98 29.27 Favored 'General case' 0 N--CA 1.496 1.862 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.807 176.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 73.14 -11.57 4.8 Favored Glycine 0 N--CA 1.499 2.836 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.801 178.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.484 ' HA ' HG21 ' A' ' 62' ' ' THR . 1.1 m-20 -65.17 95.51 0.18 Allowed 'General case' 0 N--CA 1.497 1.897 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 177.422 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -91.2 133.25 33.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.796 170.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.3 mp -112.83 146.45 38.85 Favored 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 112.494 -2.139 . . . . 0.0 108.756 -178.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 m -132.14 155.79 47.53 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 108.485 -0.931 . . . . 0.0 108.485 -174.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -138.29 169.8 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 -170.283 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.14 154.22 42.41 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.776 176.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -60.73 -27.72 68.13 Favored 'General case' 0 N--CA 1.499 1.984 0 C-N-CA 120.168 -0.613 . . . . 0.0 110.977 172.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -121.03 31.56 5.08 Favored Glycine 0 N--CA 1.492 2.414 0 N-CA-C 109.909 -1.276 . . . . 0.0 109.909 178.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.68 -16.71 61.74 Favored 'General case' 0 N--CA 1.487 1.416 0 CA-C-O 119.013 -0.518 . . . . 0.0 111.713 174.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.407 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 2.0 mt -57.07 -34.59 68.43 Favored 'General case' 0 N--CA 1.489 1.508 0 C-N-CA 117.993 -1.483 . . . . 0.0 108.243 175.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.2 t -86.36 -9.16 11.18 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 N-CA-C 113.804 1.039 . . . . 0.0 113.804 178.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.82 -36.73 1.57 Allowed 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.32 0.581 . . . . 0.0 110.709 170.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.8 mt -108.52 -15.9 14.33 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 113.987 -1.461 . . . . 0.0 109.507 -176.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 77.41 38.2 29.44 Favored Glycine 0 N--CA 1.491 2.328 0 O-C-N 124.52 1.137 . . . . 0.0 112.772 -171.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 37' ' ' LEU . 0.4 OUTLIER -58.97 163.65 3.38 Favored 'General case' 0 N--CA 1.504 2.271 0 CA-C-N 114.502 -0.849 . . . . 0.0 112.327 176.008 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 67.1 m -124.66 34.31 5.03 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 114.266 -1.334 . . . . 0.0 109.534 -179.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.1 -165.28 1.01 Allowed 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 114.089 -1.414 . . . . 0.0 108.72 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -166.21 12.05 0.07 OUTLIER Glycine 0 N--CA 1.493 2.495 0 CA-C-N 115.4 -0.818 . . . . 0.0 111.8 -177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.29 79.32 1.72 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-O 122.49 1.138 . . . . 0.0 109.908 179.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -62.37 -4.9 2.07 Favored 'General case' 0 N--CA 1.502 2.15 0 CA-C-N 113.996 -1.457 . . . . 0.0 112.591 171.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -69.18 -4.83 19.11 Favored 'General case' 0 N--CA 1.498 1.933 0 N-CA-C 113.689 0.996 . . . . 0.0 113.689 174.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.5 79.12 46.49 Favored Pre-proline 0 N--CA 1.499 2.022 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 178.846 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -62.15 -19.22 65.84 Favored 'Trans proline' 0 N--CA 1.489 1.245 0 C-N-CA 122.072 1.848 . . . . 0.0 112.365 172.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -57.62 -40.49 79.29 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.151 0.907 . . . . 0.0 112.549 -174.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -89.9 -27.41 19.89 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 123.757 0.661 . . . . 0.0 109.961 -176.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 65.9 mt -70.58 148.32 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.492 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.52 -94.82 1.12 Allowed Glycine 0 N--CA 1.493 2.445 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 54.1 m95 -89.78 144.68 25.77 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 114.203 -0.998 . . . . 0.0 110.256 -177.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.404 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 55.0 mt -117.76 133.22 56.16 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 113.808 -1.542 . . . . 0.0 107.029 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -111.8 117.89 34.05 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 124.146 0.904 . . . . 0.0 109.463 175.488 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.87 175.76 35.06 Favored Glycine 0 N--CA 1.496 2.671 0 O-C-N 124.181 0.925 . . . . 0.0 112.015 -177.587 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -94.71 150.03 20.63 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 114.108 -1.046 . . . . 0.0 109.987 -178.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -125.4 64.13 1.17 Allowed 'General case' 0 N--CA 1.498 1.944 0 CA-C-N 114.372 -1.286 . . . . 0.0 107.959 178.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -55.01 -25.48 30.38 Favored 'General case' 0 N--CA 1.5 2.072 0 CA-C-N 113.893 -1.503 . . . . 0.0 111.696 177.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.484 HG21 ' HA ' ' A' ' 28' ' ' ASP . 62.5 m -51.75 -49.35 62.76 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 124.351 1.032 . . . . 0.0 110.914 175.029 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 24.1 p -94.61 -3.74 49.04 Favored 'General case' 0 N--CA 1.499 1.975 0 O-C-N 124.331 1.019 . . . . 0.0 111.722 177.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 69.06 42.38 77.34 Favored Glycine 0 N--CA 1.496 2.692 0 N-CA-C 109.991 -1.243 . . . . 0.0 109.991 -177.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -141.68 178.38 7.51 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.345 -0.927 . . . . 0.0 108.801 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.8 ptp180 -147.19 151.69 37.16 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 172.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.97 -153.21 13.32 Favored Glycine 0 N--CA 1.496 2.653 0 C-N-CA 118.895 -1.622 . . . . 0.0 112.38 167.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -104.51 148.78 26.09 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 -175.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.404 ' CZ ' ' HB3' ' A' ' 56' ' ' LEU . 17.0 p90 -153.47 140.29 12.91 Favored Pre-proline 0 N--CA 1.494 1.763 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.423 -179.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -58.31 160.74 15.61 Favored 'Trans proline' 0 C--N 1.318 -1.028 0 C-N-CA 121.905 1.737 . . . . 0.0 111.949 -178.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -98.12 35.38 4.6 Favored Glycine 0 N--CA 1.498 2.788 0 CA-C-N 115.026 -0.988 . . . . 0.0 111.177 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.448 HG23 ' CD1' ' A' ' 73' ' ' TYR . 0.5 OUTLIER -130.56 -30.52 1.87 Allowed 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -179.562 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.448 ' CD1' HG23 ' A' ' 72' ' ' THR . 18.0 m-30 -90.24 13.93 13.99 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.926 0.766 . . . . 0.0 110.874 -173.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.3 m -133.08 176.2 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 124.57 1.168 . . . . 0.0 107.918 -171.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -144.77 113.76 6.88 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 175.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 12.0 t80 -45.17 139.4 3.38 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 123.959 0.787 . . . . 0.0 110.196 168.469 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.487 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.8 pt -137.02 -66.12 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 124.597 1.186 . . . . 0.0 109.892 178.529 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.487 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -98.22 157.89 20.53 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 -171.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.43 169.49 8.77 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 124.587 0.816 . . . . 0.0 111.485 168.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.4 ptmt -58.82 -154.46 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.255 -1.338 . . . . 0.0 113.117 160.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.7 pttt -67.97 13.56 0.08 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 115.046 -0.979 . . . . 0.0 113.277 -177.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.07 139.42 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -117.21 167.26 11.2 Favored Pre-proline 0 N--CA 1.501 2.092 0 CA-C-N 114.318 -1.31 . . . . 0.0 108.972 178.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo . . . . . 0 N--CA 1.485 0.984 0 CA-C-O 116.692 -1.462 . . . . 0.0 110.929 168.164 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 111.008 -0.837 . . . . 0.0 111.008 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 36.0 t -158.89 119.82 3.3 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 115.033 -0.584 . . . . 0.0 109.857 -176.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 8.8 ttt 55.08 28.13 10.43 Favored 'General case' 0 N--CA 1.503 2.183 0 O-C-N 124.178 0.924 . . . . 0.0 111.252 178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.8 m -92.72 166.06 12.64 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.527 -1.215 . . . . 0.0 109.866 -177.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -156.54 93.5 1.39 Allowed 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.178 -176.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.415 ' O ' HD12 ' A' ' 82' ' ' ILE . 4.2 mm-40 -75.64 -27.99 58.62 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.009 -177.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -75.67 -169.22 26.36 Favored Glycine 0 N--CA 1.495 2.577 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.619 172.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -95.04 150.46 20.15 Favored 'General case' 0 N--CA 1.504 2.227 0 CA-C-N 113.583 -1.308 . . . . 0.0 108.031 -177.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 39.0 mt-30 -125.65 161.99 26.0 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 124.192 0.932 . . . . 0.0 111.591 -173.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -138.44 159.57 41.74 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 113.478 -1.692 . . . . 0.0 108.821 -175.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 10.2 mtp180 -120.2 116.27 25.28 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.54 111.55 0.66 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.896 0.748 . . . . 0.0 110.498 170.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.89 -51.37 40.86 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 115.486 -0.779 . . . . 0.0 109.639 -178.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -128.38 151.48 49.3 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 124.511 1.132 . . . . 0.0 109.874 -179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -57.31 129.23 40.86 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.692 171.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.489 ' CD2' HD12 ' A' ' 24' ' ' LEU . 16.8 t80 -130.31 129.71 43.56 Favored 'General case' 0 N--CA 1.494 1.771 0 CA-C-N 115.329 -0.851 . . . . 0.0 109.178 175.718 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 10.6 mttm -89.29 155.7 19.21 Favored 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 115.062 -0.972 . . . . 0.0 108.779 174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.33 146.53 24.64 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 123.811 0.694 . . . . 0.0 109.388 -178.42 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -131.78 -7.12 3.59 Favored 'General case' 0 N--CA 1.498 1.953 0 CA-C-N 115.013 -0.994 . . . . 0.0 109.911 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -129.03 150.55 50.39 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 124.163 0.914 . . . . 0.0 109.404 177.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -65.45 -16.97 64.18 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.735 -1.12 . . . . 0.0 111.707 177.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -78.58 -25.51 45.31 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-N 114.676 -1.147 . . . . 0.0 110.728 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.86 154.91 19.43 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.3 1.0 . . . . 0.0 111.174 -178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.4 pt -119.13 177.35 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.3 -1.318 . . . . 0.0 109.775 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -76.87 135.46 38.85 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-N 114.948 -1.023 . . . . 0.0 109.826 -175.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.489 HD12 ' CD2' ' A' ' 14' ' ' TYR . 64.9 mt -128.31 135.04 49.06 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 124.294 0.996 . . . . 0.0 110.188 -177.101 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -135.51 -174.47 3.65 Favored 'General case' 0 N--CA 1.5 2.06 0 CA-C-N 114.739 -1.119 . . . . 0.0 108.742 -173.058 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.8 mp -81.99 154.05 25.9 Favored 'General case' 0 N--CA 1.498 1.961 0 C-N-CA 119.986 -0.686 . . . . 0.0 110.207 -176.037 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.85 -6.36 2.04 Favored Glycine 0 N--CA 1.502 3.04 0 CA-C-N 115.92 -0.582 . . . . 0.0 113.673 -176.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.93 116.99 7.66 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 176.341 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.415 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.5 mt -104.19 138.89 26.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 124.287 0.992 . . . . 0.0 109.868 173.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.543 HD11 ' ND2' ' A' ' 60' ' ' ASN . 11.0 mp -110.74 158.95 18.08 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 112.818 -1.992 . . . . 0.0 108.903 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 94.8 m -130.58 151.2 51.3 Favored 'General case' 0 N--CA 1.5 2.044 0 O-C-N 123.804 0.69 . . . . 0.0 109.495 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.1 t -119.85 -141.23 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.531 ' H ' HG12 ' A' ' 32' ' ' VAL . 35.7 m120 -124.71 174.13 8.09 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 124.11 0.881 . . . . 0.0 109.227 -178.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.8 pttp -89.17 0.74 56.5 Favored 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.297 169.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -54.81 -16.62 7.87 Favored Glycine 0 N--CA 1.498 2.813 0 O-C-N 123.8 0.688 . . . . 0.0 113.397 176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.6 p 74.1 42.03 0.37 Allowed 'General case' 0 N--CA 1.502 2.165 0 CA-C-O 123.4 1.571 . . . . 0.0 110.482 166.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.461 HD21 ' HG2' ' A' ' 47' ' ' GLU . 45.2 mt 78.95 -16.88 0.63 Allowed 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 110.551 -3.022 . . . . 0.0 110.194 177.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 62.1 t -62.86 -22.42 30.37 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.412 0 CA-C-O 121.873 0.844 . . . . 0.0 111.084 172.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -52.17 -22.58 4.42 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 113.632 -1.622 . . . . 0.0 113.204 166.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.9 mt -110.35 -9.19 14.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 123.992 0.807 . . . . 0.0 110.018 -177.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 94.2 14.57 50.96 Favored Glycine 0 N--CA 1.497 2.733 0 O-C-N 124.145 0.903 . . . . 0.0 112.714 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 3.1 m-85 -87.2 168.12 13.51 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.041 0.495 . . . . 0.0 111.11 176.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.0 m -147.5 66.67 1.12 Allowed 'General case' 0 N--CA 1.497 1.878 0 CA-C-N 114.677 -1.147 . . . . 0.0 109.249 -174.696 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.5 t0 -163.67 -155.35 0.31 Allowed 'General case' 0 N--CA 1.496 1.83 0 CA-C-N 114.822 -1.081 . . . . 0.0 110.074 176.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -143.2 26.37 2.17 Favored Glycine 0 N--CA 1.495 2.6 0 N-CA-C 109.994 -1.242 . . . . 0.0 109.994 -177.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 65.3 mt-30 -85.69 46.77 1.35 Allowed 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 113.999 -1.1 . . . . 0.0 110.145 -177.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.461 ' HG2' HD21 ' A' ' 37' ' ' LEU . 34.3 mt-10 -66.81 -26.88 67.15 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 114.878 -1.056 . . . . 0.0 110.819 -177.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -95.96 18.38 13.45 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 113.503 -1.68 . . . . 0.0 110.78 -172.719 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.2 mttt -130.33 73.14 81.55 Favored Pre-proline 0 N--CA 1.496 1.853 0 O-C-N 123.899 0.749 . . . . 0.0 110.309 -177.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.409 ' HG3' ' H ' ' A' ' 76' ' ' TYR . 3.6 Cg_exo -60.85 -4.96 4.04 Favored 'Trans proline' 0 N--CA 1.497 1.683 0 C-N-CA 122.56 2.174 . . . . 0.0 113.536 174.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 12.1 mm-40 -71.83 -39.42 69.77 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 123.62 0.575 . . . . 0.0 110.895 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.8 -33.05 16.67 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 124.094 0.871 . . . . 0.0 109.793 -177.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 10.7 mt -77.37 125.5 37.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 -177.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.54 -78.62 1.32 Allowed Glycine 0 N--CA 1.487 2.085 0 N-CA-C 108.473 -1.851 . . . . 0.0 108.473 -173.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 69.2 m95 -92.56 120.47 33.04 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-N 113.335 -1.433 . . . . 0.0 110.006 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 2.2 mp -105.9 123.78 48.52 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 113.97 -1.468 . . . . 0.0 108.088 172.862 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -92.98 122.41 35.31 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 168.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -153.68 171.34 32.45 Favored Glycine 0 N--CA 1.493 2.437 0 C-N-CA 120.109 -1.043 . . . . 0.0 111.015 177.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -92.02 150.28 21.07 Favored 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 114.25 -0.975 . . . . 0.0 109.871 176.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.543 ' ND2' HD11 ' A' ' 30' ' ' LEU . 4.4 m120 -120.14 77.21 1.23 Allowed 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 114.941 -1.027 . . . . 0.0 109.102 174.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -52.94 -36.13 59.42 Favored 'General case' 0 N--CA 1.499 2.022 0 CA-C-N 114.77 -1.104 . . . . 0.0 110.942 179.399 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.9 p -53.28 -50.38 64.98 Favored 'General case' 0 N--CA 1.499 1.993 0 CA-C-N 115.088 -0.96 . . . . 0.0 113.264 173.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 68.0 p -89.54 4.74 48.3 Favored 'General case' 0 N--CA 1.499 1.996 0 C-N-CA 119.675 -0.81 . . . . 0.0 109.574 -178.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 53.45 35.21 50.49 Favored Glycine 0 N--CA 1.495 2.597 0 O-C-N 124.383 1.052 . . . . 0.0 111.483 -176.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.0 tp10 -138.65 -175.85 4.27 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 -175.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.29 154.2 37.46 Favored 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 115.201 -0.909 . . . . 0.0 109.384 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 173.42 -162.82 34.03 Favored Glycine 0 N--CA 1.493 2.481 0 C-N-CA 119.774 -1.203 . . . . 0.0 112.55 172.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -97.82 161.24 13.84 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.079 -1.06 . . . . 0.0 109.711 176.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.481 ' CE1' HD23 ' A' ' 30' ' ' LEU . 34.4 p90 -162.1 142.18 7.65 Favored Pre-proline 0 N--CA 1.494 1.737 0 CA-C-N 114.954 -1.021 . . . . 0.0 109.434 175.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -63.71 155.33 64.03 Favored 'Trans proline' 0 N--CA 1.488 1.162 0 C-N-CA 121.547 1.498 . . . . 0.0 111.89 176.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -88.46 -12.43 64.93 Favored Glycine 0 N--CA 1.5 2.937 0 O-C-N 123.915 0.759 . . . . 0.0 112.494 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.51 3.62 18.14 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 122.507 0.323 . . . . 0.0 110.823 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 27.7 m-85 -121.1 -2.16 9.7 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.165 0.916 . . . . 0.0 110.572 -176.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 20.1 m -128.08 -177.64 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 O-C-N 124.175 0.922 . . . . 0.0 110.067 -178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.3 tt0 -150.16 113.78 4.99 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 114.817 -1.083 . . . . 0.0 108.846 176.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.409 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 28.4 t80 -46.95 142.59 3.39 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 123.551 0.532 . . . . 0.0 110.388 172.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.6 pt -118.6 -55.37 3.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 O-C-N 123.948 0.78 . . . . 0.0 110.409 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -155.26 147.16 15.73 Favored Glycine 0 N--CA 1.492 2.402 0 C-N-CA 120.023 -1.084 . . . . 0.0 110.695 -165.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.06 128.79 46.84 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 112.904 -1.648 . . . . 0.0 110.019 176.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.8 mmmt -68.06 159.72 30.28 Favored 'General case' 0 N--CA 1.496 1.861 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.338 174.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 13.1 tttp -79.46 68.8 5.58 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 124.045 0.84 . . . . 0.0 109.98 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.415 HD12 ' O ' ' A' ' 4' ' ' GLU . 2.4 mt -140.54 1.36 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.907 178.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.412 ' N ' ' CD ' ' A' ' 84' ' ' PRO . 0.1 OUTLIER -90.65 -50.46 0.34 Allowed Pre-proline 0 N--CA 1.498 1.964 0 CA-C-O 118.298 -0.858 . . . . 0.0 111.513 170.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 83' ' ' SER . 1.7 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 CA-C-O 116.153 -1.686 . . . . 0.0 111.244 -174.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 N-CA-C 111.207 -0.757 . . . . 0.0 111.207 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 4.5 t 60.74 102.6 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 114.214 -0.993 . . . . 0.0 112.168 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 25.8 mtt -141.42 -46.92 0.38 Allowed 'General case' 0 N--CA 1.499 1.984 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.478 -175.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -170.34 139.11 1.66 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 123.451 0.469 . . . . 0.0 110.299 -177.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.03 117.46 15.84 Favored 'General case' 0 N--CA 1.496 1.859 0 CA-C-N 115.109 -0.951 . . . . 0.0 111.33 174.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.407 ' H ' ' HE2' ' A' ' 81' ' ' LYS . 6.6 mt-10 -88.93 -42.53 11.76 Favored 'General case' 0 N--CA 1.498 1.968 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.89 -177.386 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.78 -144.66 34.21 Favored Glycine 0 N--CA 1.495 2.614 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.176 -179.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -89.82 168.75 11.83 Favored 'General case' 0 N--CA 1.505 2.324 0 O-C-N 124.239 0.611 . . . . 0.0 109.694 158.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -147.59 165.26 30.91 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 122.27 1.033 . . . . 0.0 112.698 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -146.19 148.66 32.76 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 112.404 -2.18 . . . . 0.0 106.896 -174.579 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 6.7 ttt180 -117.64 113.8 22.45 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 107.308 -1.367 . . . . 0.0 107.308 -178.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.82 103.95 0.07 Allowed 'General case' 0 N--CA 1.497 1.907 0 O-C-N 124.401 1.063 . . . . 0.0 110.723 174.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 12.8 tp -69.33 -31.48 69.96 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.824 177.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.93 141.9 38.47 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 124.133 0.895 . . . . 0.0 109.845 -179.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -67.67 112.87 5.03 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 114.352 -1.295 . . . . 0.0 109.396 174.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -113.5 133.12 55.4 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.5 mmtt -89.89 156.52 18.41 Favored 'General case' 0 N--CA 1.484 1.237 0 CA-C-N 114.882 -1.054 . . . . 0.0 108.322 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 pttp -88.84 147.17 24.54 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.64 -0.824 . . . . 0.0 108.927 -175.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -122.67 -7.03 8.57 Favored 'General case' 0 N--CA 1.499 1.994 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.299 178.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -139.01 159.25 42.59 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.164 -0.926 . . . . 0.0 109.731 -177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -65.9 -21.16 66.43 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.311 -1.313 . . . . 0.0 112.364 -179.27 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -82.99 -23.35 33.36 Favored 'General case' 0 N--CA 1.498 1.94 0 CA-C-N 114.928 -1.033 . . . . 0.0 110.907 178.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -94.77 146.21 24.34 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 124.263 0.977 . . . . 0.0 109.979 -177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -111.98 176.69 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 124.775 1.297 . . . . 0.0 110.3 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -86.2 106.22 17.14 Favored 'General case' 0 N--CA 1.491 1.582 0 CA-C-N 114.098 -1.41 . . . . 0.0 108.683 -177.394 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 2.5 mp -90.56 125.37 35.6 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 114.884 -1.053 . . . . 0.0 111.46 172.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -109.78 -173.12 2.18 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 124.728 1.267 . . . . 0.0 109.256 177.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.6 mt -74.13 145.72 44.1 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.69 174.695 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 56.47 10.88 4.63 Favored Glycine 0 N--CA 1.503 3.119 0 CA-C-N 115.581 -0.736 . . . . 0.0 113.206 179.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -65.18 127.17 30.58 Favored 'General case' 0 N--CA 1.496 1.829 0 CA-C-N 115.242 -0.479 . . . . 0.0 110.297 171.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.71 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.2 mp -104.56 142.84 17.08 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.232 0 CA-C-O 121.307 0.575 . . . . 0.0 109.46 -178.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.71 HD12 ' C ' ' A' ' 29' ' ' ILE . 7.4 mp -126.82 150.37 49.21 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.028 178.331 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 7.2 m -128.84 149.62 50.67 Favored 'General case' 0 N--CA 1.502 2.158 0 O-C-N 123.956 0.785 . . . . 0.0 110.62 -175.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 33' ' ' ASN . 0.6 OUTLIER -120.63 -156.32 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.509 2.478 0 O-C-N 123.551 0.532 . . . . 0.0 109.728 179.148 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.599 ' H ' HD22 ' A' ' 33' ' ' ASN . 0.9 OUTLIER -63.01 -157.21 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.129 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 171.034 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.8 pttp -138.17 -19.8 1.11 Allowed 'General case' 0 N--CA 1.499 1.996 0 N-CA-C 113.094 0.775 . . . . 0.0 113.094 -176.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -176.03 33.71 0.09 OUTLIER Glycine 0 N--CA 1.497 2.74 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 55.5 p -145.81 64.15 1.24 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 113.767 -1.216 . . . . 0.0 108.351 177.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 43' ' ' SER . 1.2 mt -50.49 -26.32 5.02 Favored 'General case' 0 N--CA 1.502 2.126 0 CA-C-N 112.92 -1.945 . . . . 0.0 113.438 169.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.3 t -59.95 -9.25 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.097 0 CA-C-N 115.367 -0.833 . . . . 0.0 112.037 175.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -45.07 -30.48 1.1 Allowed 'General case' 0 N--CA 1.503 2.204 0 CA-C-N 115.299 -0.864 . . . . 0.0 112.178 169.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.4 mt -117.86 -7.31 10.95 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.012 179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 86.93 18.85 57.33 Favored Glycine 0 N--CA 1.495 2.624 0 O-C-N 123.952 0.782 . . . . 0.0 111.352 -175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -91.29 167.67 12.14 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.585 -0.808 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.466 ' O ' HD13 ' A' ' 37' ' ' LEU . 14.8 m -109.08 170.31 8.13 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 114.54 -1.209 . . . . 0.0 109.299 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -86.52 155.11 20.63 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.753 175.74 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 109.13 2.38 31.58 Favored Glycine 0 N--CA 1.496 2.691 0 O-C-N 124.288 0.992 . . . . 0.0 111.89 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 4.5 pt20 -138.78 2.79 2.21 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 123.981 0.46 . . . . 0.0 111.943 -177.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.402 ' HG3' ' H ' ' A' ' 47' ' ' GLU . 0.0 OUTLIER -57.36 -17.96 15.04 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 124.127 0.892 . . . . 0.0 112.462 174.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -103.21 -2.84 26.59 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 124.532 1.145 . . . . 0.0 111.859 -178.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -119.96 79.15 24.84 Favored Pre-proline 0 N--CA 1.499 1.984 0 O-C-N 123.97 0.794 . . . . 0.0 111.283 -179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -59.83 -13.7 23.68 Favored 'Trans proline' 0 N--CA 1.491 1.346 0 C-N-CA 121.784 1.656 . . . . 0.0 112.744 174.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 8.3 mm-40 -64.11 -38.1 89.86 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 124.093 0.871 . . . . 0.0 111.488 -177.188 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -90.12 -28.09 19.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 123.931 0.769 . . . . 0.0 110.912 -178.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 16.9 mt -74.09 141.47 16.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 123.866 0.729 . . . . 0.0 109.577 179.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.43 -92.82 1.15 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.854 -1.298 . . . . 0.0 109.854 -176.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 76.2 m95 -93.23 120.39 33.47 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 113.603 -1.299 . . . . 0.0 109.679 -179.388 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.505 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.0 mp -100.44 125.38 46.73 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.604 171.213 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 -95.99 118.23 32.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 123.739 0.65 . . . . 0.0 109.729 171.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.01 -179.36 18.95 Favored Glycine 0 N--CA 1.497 2.757 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -124.42 125.19 43.87 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 -176.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 -96.42 91.99 6.09 Favored 'General case' 0 N--CA 1.495 1.819 0 CA-C-N 114.531 -1.213 . . . . 0.0 111.434 176.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 -52.41 -35.04 50.99 Favored 'General case' 0 N--CA 1.499 2.024 0 CA-C-N 113.836 -1.529 . . . . 0.0 112.021 174.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 89.7 m -51.25 -36.98 44.59 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.514 1.134 . . . . 0.0 112.096 -177.372 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 64.5 p -115.74 2.6 13.7 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.952 0.782 . . . . 0.0 110.064 179.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 61.9 18.69 57.58 Favored Glycine 0 N--CA 1.493 2.483 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.746 -174.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -110.02 153.65 24.3 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 -175.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.417 ' CD ' ' N ' ' A' ' 66' ' ' ARG . 0.0 OUTLIER -137.74 146.72 44.02 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 124.665 1.228 . . . . 0.0 109.479 -175.78 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.89 -163.04 31.07 Favored Glycine 0 N--CA 1.491 2.314 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.18 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.3 151.15 26.96 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 114.066 -1.067 . . . . 0.0 109.587 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 26.7 p90 -147.68 144.38 19.17 Favored Pre-proline 0 N--CA 1.493 1.715 0 CA-C-N 114.844 -1.071 . . . . 0.0 109.365 179.895 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -63.29 153.83 71.84 Favored 'Trans proline' 0 N--CA 1.488 1.155 0 C-N-CA 121.745 1.63 . . . . 0.0 111.34 174.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -93.27 53.17 2.47 Favored Glycine 0 N--CA 1.495 2.573 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.3 t -134.46 -23.25 1.66 Allowed 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 112.917 0.71 . . . . 0.0 112.917 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -105.15 26.75 8.94 Favored 'General case' 0 N--CA 1.501 2.099 0 O-C-N 124.141 0.901 . . . . 0.0 110.63 -179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -143.46 166.85 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 CA-C-N 114.673 -1.149 . . . . 0.0 108.595 -173.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -144.91 118.8 9.3 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 114.959 -1.019 . . . . 0.0 109.103 178.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 47.8 t80 -48.46 130.62 16.93 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 124.05 0.844 . . . . 0.0 110.464 173.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.491 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.2 pt -135.87 -62.39 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.969 0 O-C-N 123.907 0.754 . . . . 0.0 111.426 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.491 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -93.81 159.68 23.91 Favored Glycine 0 N--CA 1.487 2.042 0 N-CA-C 107.615 -2.194 . . . . 0.0 107.615 -176.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 5.5 ptt-85 -127.06 160.33 31.47 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.758 0.917 . . . . 0.0 110.478 -178.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 10.4 pttm -27.13 147.88 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 125.223 1.577 . . . . 0.0 114.555 166.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.407 ' HE2' ' H ' ' A' ' 4' ' ' GLU . 18.4 mttm -63.2 -12.68 30.08 Favored 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 113.117 -1.856 . . . . 0.0 110.893 179.321 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 18.3 mt -99.98 141.45 17.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 124.166 0.916 . . . . 0.0 108.949 -175.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -128.76 163.99 41.51 Favored Pre-proline 0 N--CA 1.497 1.917 0 CA-C-N 114.043 -1.435 . . . . 0.0 109.879 178.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo . . . . . 0 N--CA 1.489 1.218 0 CA-C-O 116.404 -1.582 . . . . 0.0 111.744 177.126 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 109.673 -1.371 . . . . 0.0 109.673 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 1.1 p 60.95 154.72 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.139 0 O-C-N 124.837 0.963 . . . . 0.0 113.049 -171.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.0 mtt -104.82 9.49 34.84 Favored 'General case' 0 N--CA 1.497 1.91 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.172 178.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.9 p -146.37 172.61 13.24 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 120.97 0.414 . . . . 0.0 111.358 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -74.58 172.28 12.31 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.821 -1.082 . . . . 0.0 111.292 173.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -92.87 -71.19 0.66 Allowed 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 114.38 -1.282 . . . . 0.0 110.724 174.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 119.47 -134.6 10.74 Favored Glycine 0 N--CA 1.497 2.723 0 O-C-N 124.64 1.213 . . . . 0.0 110.153 -177.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -97.73 161.53 13.71 Favored 'General case' 0 N--CA 1.501 2.115 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -178.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.531 ' HB3' HD11 ' A' ' 77' ' ' ILE . 30.1 mt-30 -139.4 159.1 42.95 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 119.231 -0.987 . . . . 0.0 111.506 -173.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -142.68 125.15 15.68 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.1 -1.863 . . . . 0.0 107.601 -176.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 45.3 ttt180 -89.61 118.46 29.25 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.629 178.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.63 152.48 0.33 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 123.927 0.767 . . . . 0.0 112.788 170.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 3.5 tp -113.29 -44.81 3.2 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 115.112 -0.949 . . . . 0.0 109.512 -177.638 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -143.34 151.99 41.1 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.06 0.85 . . . . 0.0 110.799 -175.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -67.01 116.37 7.76 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.016 -0.993 . . . . 0.0 110.257 177.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.4 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.2 t80 -117.99 138.1 52.41 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 124.125 0.891 . . . . 0.0 108.895 178.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -98.02 146.4 25.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 124.297 0.998 . . . . 0.0 109.921 174.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.2 164.53 14.94 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.176 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -140.62 -25.24 0.77 Allowed 'General case' 0 N--CA 1.5 2.028 0 CA-C-N 115.089 -0.96 . . . . 0.0 110.074 -176.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.1 tpp180 -108.03 149.68 28.12 Favored 'General case' 0 N--CA 1.495 1.787 0 CA-C-N 114.064 -1.426 . . . . 0.0 110.101 177.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -57.56 -12.25 2.62 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 114.647 -1.161 . . . . 0.0 113.531 170.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 63.4 mt-10 -81.76 -40.27 22.92 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 123.903 0.752 . . . . 0.0 111.187 174.413 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -88.77 156.22 19.1 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 124.114 0.884 . . . . 0.0 111.265 -176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -129.41 174.43 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 CA-C-N 114.567 -1.197 . . . . 0.0 110.666 -179.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -75.05 131.47 40.61 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 114.005 -1.452 . . . . 0.0 108.766 -174.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.4 HD12 ' CD1' ' A' ' 14' ' ' TYR . 97.0 mt -121.56 127.46 50.97 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.587 1.179 . . . . 0.0 109.179 -177.148 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . 0.424 ' ND1' ' N ' ' A' ' 25' ' ' HIS . 0.0 OUTLIER -117.74 -173.62 2.47 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 124.268 0.98 . . . . 0.0 108.904 -175.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.446 HD12 ' H ' ' A' ' 26' ' ' LEU . 3.1 mp -83.12 156.53 23.23 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.423 178.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.12 0.03 1.0 Allowed Glycine 0 N--CA 1.5 2.955 0 O-C-N 123.872 0.732 . . . . 0.0 113.201 -177.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -65.69 106.29 1.45 Allowed 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.822 -0.436 . . . . 0.0 109.822 -179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.505 ' C ' HD12 ' A' ' 30' ' ' LEU . 5.6 mt -90.64 132.68 34.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 CA-C-N 114.91 -1.041 . . . . 0.0 109.743 174.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.634 HD11 HD22 ' A' ' 60' ' ' ASN . 10.5 mp -108.52 151.52 25.98 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 113.064 -1.88 . . . . 0.0 109.013 179.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.8 m -129.43 147.43 51.24 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 123.842 0.714 . . . . 0.0 109.845 -176.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.431 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.0 OUTLIER -119.59 -147.8 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 O-C-N 123.807 0.692 . . . . 0.0 109.265 -178.199 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.431 ' H ' HG12 ' A' ' 32' ' ' VAL . 0.9 OUTLIER -97.77 158.12 15.69 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 123.419 0.449 . . . . 0.0 110.033 178.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -85.41 -27.27 25.89 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.033 -173.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -160.48 32.99 0.41 Allowed Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 -175.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 58.0 m -152.29 49.08 0.77 Allowed 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.603 ' O ' HD12 ' A' ' 37' ' ' LEU . 0.2 OUTLIER -60.0 -30.78 69.37 Favored 'General case' 0 N--CA 1.503 2.199 0 CA-C-N 114.24 -1.346 . . . . 0.0 111.094 171.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.406 ' H ' HG23 ' A' ' 38' ' ' VAL . 14.5 t -46.02 -8.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 114.195 -1.366 . . . . 0.0 114.351 167.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -32.6 -36.46 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 124.273 0.983 . . . . 0.0 112.283 169.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 34.4 mt -92.72 -34.71 13.82 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-N 114.065 -1.425 . . . . 0.0 111.457 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 125.05 9.96 4.93 Favored Glycine 0 N--CA 1.499 2.838 0 CA-C-N 113.915 -1.493 . . . . 0.0 111.361 -174.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.9 m-85 -76.11 167.18 22.33 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 114.968 -0.616 . . . . 0.0 110.213 -174.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -149.38 6.81 0.67 Allowed 'General case' 0 N--CA 1.499 1.999 0 CA-C-O 121.841 0.829 . . . . 0.0 112.392 172.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -177.19 106.65 0.06 Allowed 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 113.356 -1.747 . . . . 0.0 108.08 -178.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -147.25 -6.02 0.32 Allowed Glycine 0 N--CA 1.497 2.728 0 N-CA-C 111.011 -0.835 . . . . 0.0 111.011 -178.448 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 46.15 91.34 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 122.064 0.935 . . . . 0.0 111.246 -172.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -47.61 -14.14 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.244 0 CA-C-N 113.407 -1.724 . . . . 0.0 113.349 177.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.415 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -86.96 -37.86 17.18 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 177.445 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 2.8 mtmm -102.31 102.97 27.94 Favored Pre-proline 0 N--CA 1.497 1.911 0 O-C-N 123.999 0.812 . . . . 0.0 111.325 174.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -68.6 -17.99 42.92 Favored 'Trans proline' 0 N--CA 1.491 1.328 0 C-N-CA 122.641 2.227 . . . . 0.0 114.092 167.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 3.4 pt-20 -58.53 -31.67 68.14 Favored 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.657 0.598 . . . . 0.0 112.246 -178.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -90.32 -21.89 21.82 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 123.831 0.707 . . . . 0.0 111.376 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 9.2 mt -86.12 146.91 5.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.59 -91.56 1.2 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.659 -1.377 . . . . 0.0 109.659 -177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 73.5 m95 -90.19 131.04 36.24 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 113.425 -1.388 . . . . 0.0 109.032 176.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -108.46 126.82 53.32 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 168.506 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -100.94 124.23 46.33 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 172.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.77 -166.18 16.67 Favored Glycine 0 N--CA 1.498 2.802 0 N-CA-C 110.287 -1.125 . . . . 0.0 110.287 175.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 25.0 p90 -140.17 150.19 43.9 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.634 HD22 HD11 ' A' ' 30' ' ' LEU . 0.0 OUTLIER -114.23 99.87 7.93 Favored 'General case' 0 N--CA 1.498 1.945 0 CA-C-N 114.311 -1.313 . . . . 0.0 108.274 -177.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -63.81 -21.49 66.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 115.944 -0.571 . . . . 0.0 112.03 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 43.3 m -46.05 -37.42 6.7 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 115.336 -0.847 . . . . 0.0 112.812 174.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.61 2.46 6.83 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 124.849 1.343 . . . . 0.0 108.877 179.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 56.64 36.87 73.33 Favored Glycine 0 N--CA 1.496 2.64 0 C-N-CA 120.39 -0.91 . . . . 0.0 111.614 -176.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 3.2 tp10 -109.51 160.68 16.02 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-N 114.84 -0.68 . . . . 0.0 109.51 178.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.03 156.05 40.99 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.767 0.794 . . . . 0.0 111.699 177.021 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.66 -153.05 23.3 Favored Glycine 0 N--CA 1.489 2.197 0 CA-C-N 113.224 -1.807 . . . . 0.0 110.032 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -110.71 153.94 24.57 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 -173.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 30.6 p90 -151.36 140.77 13.95 Favored Pre-proline 0 N--CA 1.491 1.582 0 CA-C-N 115.32 -0.854 . . . . 0.0 108.912 175.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.49 ' HB2' HG22 ' A' ' 72' ' ' THR . 1.3 Cg_endo -65.15 150.39 87.74 Favored 'Trans proline' 0 C--N 1.316 -1.175 0 C-N-CA 121.53 1.486 . . . . 0.0 110.708 175.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.29 48.72 4.08 Favored Glycine 0 N--CA 1.496 2.669 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 70' ' ' PRO . 7.6 t -141.21 16.39 2.24 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 124.105 0.532 . . . . 0.0 111.616 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 33.5 m-85 -136.05 -4.08 2.2 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 123.751 0.657 . . . . 0.0 111.847 179.473 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 15.6 m -113.98 -169.31 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 123.932 0.77 . . . . 0.0 109.13 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -148.71 113.58 5.42 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 106.449 -1.686 . . . . 0.0 106.449 172.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.415 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 25.2 t80 -48.27 142.97 4.98 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.442 171.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.531 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.5 pt -122.24 -53.5 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.876 0 O-C-N 123.926 0.766 . . . . 0.0 111.688 176.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -150.84 146.63 15.79 Favored Glycine 0 N--CA 1.494 2.51 0 C-N-CA 119.475 -1.345 . . . . 0.0 111.478 -175.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.15 119.58 23.21 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-N 113.311 -1.444 . . . . 0.0 109.988 177.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 5.2 pttt -177.84 162.32 1.69 Allowed 'General case' 0 N--CA 1.497 1.923 0 CA-C-N 114.691 -1.141 . . . . 0.0 110.383 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 4.8 ptmt -66.91 84.82 0.12 Allowed 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 113.758 -1.565 . . . . 0.0 109.978 171.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.4 mt -89.92 130.01 39.9 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 CA-C-N 114.55 -1.205 . . . . 0.0 110.659 176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.77 161.45 46.19 Favored Pre-proline 0 N--CA 1.5 2.059 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.032 178.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.488 1.185 0 C-N-CA 121.739 1.626 . . . . 0.0 111.566 175.93 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 29.7 m -58.79 -21.48 56.19 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 113.045 0.757 . . . . 0.0 113.045 174.476 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 5.5 ttm -60.16 133.25 55.91 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 123.619 0.574 . . . . 0.0 111.574 174.312 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -173.36 109.18 0.17 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 124.513 1.133 . . . . 0.0 108.766 -178.263 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . 56.78 -160.91 0.21 Allowed 'General case' 0 N--CA 1.504 2.235 0 O-C-N 123.987 0.804 . . . . 0.0 112.806 -179.276 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -128.12 -68.24 0.78 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.455 176.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -101.98 -135.09 8.68 Favored Glycine 0 N--CA 1.495 2.614 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -177.558 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -96.9 158.32 15.48 Favored 'General case' 0 N--CA 1.503 2.188 0 N-CA-C 108.316 -0.994 . . . . 0.0 108.316 176.872 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.685 ' HB3' HD11 ' A' ' 77' ' ' ILE . 4.6 mt-30 -133.01 165.3 25.04 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.145 0.974 . . . . 0.0 111.857 -177.712 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -136.64 128.42 29.05 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 112.689 -2.051 . . . . 0.0 107.883 -179.788 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 2.8 mtp-105 -89.31 114.69 26.11 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 175.627 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -46.89 122.53 4.4 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 124.362 1.039 . . . . 0.0 111.99 171.288 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.2 tp -78.27 -41.37 34.19 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-N 115.022 -0.99 . . . . 0.0 110.677 -178.365 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -140.11 160.62 39.53 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 124.21 0.944 . . . . 0.0 110.376 -177.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -71.47 127.8 33.76 Favored 'General case' 0 N--CA 1.496 1.855 0 CA-C-N 114.781 -1.099 . . . . 0.0 110.496 173.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.457 ' CD2' HD12 ' A' ' 24' ' ' LEU . 16.4 t80 -126.56 130.48 50.63 Favored 'General case' 0 N--CA 1.501 2.087 0 O-C-N 124.367 1.042 . . . . 0.0 109.042 173.34 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 32.5 tttt -90.29 153.88 20.13 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 169.349 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.62 171.9 9.34 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.101 0.876 . . . . 0.0 109.864 -179.167 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -139.44 -10.01 1.24 Allowed 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.094 177.222 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 5.6 tpm_? -132.84 154.58 50.19 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 115.113 -0.949 . . . . 0.0 109.357 -176.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -62.2 -19.15 62.83 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.55 174.382 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -71.89 -31.17 66.15 Favored 'General case' 0 N--CA 1.497 1.922 0 CA-C-N 115.016 -0.993 . . . . 0.0 111.045 176.492 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -104.77 152.06 23.02 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 124.23 0.956 . . . . 0.0 110.317 -177.721 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.4 pt -115.46 173.66 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.038 0 CA-C-N 114.394 -1.276 . . . . 0.0 110.834 176.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -74.22 134.05 42.7 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 113.265 -1.788 . . . . 0.0 108.866 -176.387 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.457 HD12 ' CD2' ' A' ' 14' ' ' TYR . 87.4 mt -126.63 136.63 52.75 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 124.279 0.987 . . . . 0.0 110.026 -177.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 173.08 11.9 Favored 'General case' 0 N--CA 1.495 1.775 0 CA-C-N 114.657 -1.156 . . . . 0.0 108.699 -173.976 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.1 mt -67.55 158.02 32.99 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.228 179.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 68.3 -10.0 1.49 Allowed Glycine 0 N--CA 1.5 2.909 0 CA-C-N 115.326 -0.852 . . . . 0.0 114.886 -175.643 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.32 133.15 50.79 Favored 'General case' 0 N--CA 1.499 1.995 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 175.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -128.17 116.23 41.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.198 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 177.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 11.1 mp -99.47 129.94 45.69 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 106.627 -1.619 . . . . 0.0 106.627 -168.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.2 m -103.91 146.97 27.89 Favored 'General case' 0 N--CA 1.511 2.58 0 O-C-N 124.006 0.816 . . . . 0.0 110.619 -178.844 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.631 HG12 ' H ' ' A' ' 33' ' ' ASN . 2.1 t -121.03 -149.03 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 124.52 1.138 . . . . 0.0 108.365 179.435 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.631 ' H ' HG12 ' A' ' 32' ' ' VAL . 4.2 m-80 -82.74 175.91 9.75 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 123.409 0.443 . . . . 0.0 111.228 176.836 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 1.3 ptmt -112.32 -28.86 7.75 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 124.616 1.198 . . . . 0.0 110.883 -175.385 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -161.89 40.29 0.39 Allowed Glycine 0 N--CA 1.494 2.547 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 -177.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 t -147.2 66.7 1.14 Allowed 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 175.932 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -52.4 -26.1 11.65 Favored 'General case' 0 N--CA 1.504 2.233 0 CA-C-N 112.202 -2.272 . . . . 0.0 112.457 170.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 6.5 t -66.17 -9.26 8.3 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.234 0 O-C-N 123.949 0.781 . . . . 0.0 112.705 178.769 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.405 ' C ' HD12 ' A' ' 40' ' ' LEU . . . -46.96 -34.85 5.9 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 124.378 1.049 . . . . 0.0 111.578 167.885 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.49 ' N ' HD12 ' A' ' 40' ' ' LEU . 9.3 mp -104.03 -4.93 22.67 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 124.108 0.88 . . . . 0.0 111.161 -178.719 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 82.49 16.41 71.18 Favored Glycine 0 N--CA 1.499 2.843 0 O-C-N 123.963 0.79 . . . . 0.0 112.452 -174.615 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -77.18 146.58 36.97 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 115.058 -0.571 . . . . 0.0 111.391 -177.747 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 5.8 m -138.42 33.92 2.28 Favored 'General case' 0 N--CA 1.503 2.191 0 O-C-N 124.093 0.871 . . . . 0.0 109.62 -174.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -123.88 -92.59 0.52 Allowed 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.441 -1.254 . . . . 0.0 109.379 179.538 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 148.24 14.9 0.12 Allowed Glycine 0 N--CA 1.496 2.656 0 C-N-CA 120.808 -0.711 . . . . 0.0 113.466 -166.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 16.3 mt-30 -61.36 -84.85 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 O-C-N 123.964 0.449 . . . . 0.0 110.719 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 45.71 39.41 5.09 Favored 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.909 0.861 . . . . 0.0 112.908 179.299 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.432 ' HA ' ' CD2' ' A' ' 76' ' ' TYR . . . -158.95 -22.75 0.07 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-N 115.176 -0.92 . . . . 0.0 112.35 -173.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -120.63 84.99 37.78 Favored Pre-proline 0 N--CA 1.5 2.046 0 O-C-N 124.006 0.816 . . . . 0.0 109.395 175.61 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.555 ' HA ' HD12 ' A' ' 53' ' ' ILE . 5.0 Cg_exo -56.28 -23.0 43.59 Favored 'Trans proline' 0 N--CA 1.49 1.323 0 C-N-CA 122.444 2.096 . . . . 0.0 111.997 173.257 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -55.42 -45.63 76.73 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 124.657 1.223 . . . . 0.0 110.837 -175.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -90.01 -26.52 20.29 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 124.113 0.883 . . . . 0.0 111.102 -177.707 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . 0.555 HD12 ' HA ' ' A' ' 50' ' ' PRO . 62.4 mt -64.66 153.73 7.62 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 O-C-N 123.72 0.638 . . . . 0.0 109.857 176.635 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.17 -101.42 1.03 Allowed Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.239 -1.545 . . . . 0.0 109.239 178.668 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 49.0 m95 -92.18 147.25 23.08 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 114.497 -0.851 . . . . 0.0 110.382 -177.609 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 69' ' ' PHE . 67.4 mt -117.46 120.22 37.46 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 113.831 -1.531 . . . . 0.0 107.829 179.309 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -98.25 123.16 42.19 Favored 'General case' 0 N--CA 1.503 2.187 0 O-C-N 124.221 0.951 . . . . 0.0 109.732 173.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -163.07 -173.19 31.49 Favored Glycine 0 N--CA 1.499 2.871 0 O-C-N 124.066 0.853 . . . . 0.0 111.71 179.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -123.73 128.7 49.96 Favored 'General case' 0 N--CA 1.503 2.221 0 CA-C-N 114.656 -0.772 . . . . 0.0 109.025 -174.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 34.5 t30 -94.06 62.19 3.03 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 124.445 1.09 . . . . 0.0 109.625 175.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -42.71 -33.9 0.81 Allowed 'General case' 0 N--CA 1.507 2.382 0 CA-C-N 114.467 -1.242 . . . . 0.0 114.179 173.155 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 40.9 p -55.08 -50.26 69.6 Favored 'General case' 0 N--CA 1.505 2.301 0 O-C-N 123.598 0.561 . . . . 0.0 112.028 177.218 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 37.6 p -89.83 1.89 55.62 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.059 0.85 . . . . 0.0 111.06 177.491 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 63.99 33.25 86.75 Favored Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.861 -0.896 . . . . 0.0 110.861 179.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -131.44 165.32 23.79 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 2.6 ptm180 -150.43 156.04 40.71 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 123.571 0.545 . . . . 0.0 110.551 177.163 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 172.68 -154.14 20.32 Favored Glycine 0 N--CA 1.495 2.591 0 C-N-CA 120.353 -0.927 . . . . 0.0 112.457 176.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.04 150.78 26.71 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 107.116 -1.439 . . . . 0.0 107.116 178.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.433 ' CZ ' ' HB3' ' A' ' 56' ' ' LEU . 12.8 p90 -154.95 139.43 11.66 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 124.171 0.919 . . . . 0.0 109.591 -179.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -59.95 161.17 19.59 Favored 'Trans proline' 0 N--CA 1.49 1.275 0 C-N-CA 122.126 1.884 . . . . 0.0 112.86 -177.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.08 22.28 32.71 Favored Glycine 0 N--CA 1.495 2.593 0 O-C-N 124.206 0.941 . . . . 0.0 111.871 -176.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -101.42 -47.4 4.69 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 117.444 0.622 . . . . 0.0 112.65 -174.737 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -94.02 40.34 1.08 Allowed 'General case' 0 N--CA 1.509 2.479 0 CA-C-N 114.853 -1.067 . . . . 0.0 110.499 -171.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 m -148.39 152.05 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 CA-C-N 114.145 -1.389 . . . . 0.0 108.484 -174.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 9.6 tt0 -131.96 111.82 11.87 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 177.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.432 ' CD2' ' HA ' ' A' ' 48' ' ' ALA . 75.8 t80 -54.78 122.57 11.03 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.306 174.779 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.685 HD11 ' HB3' ' A' ' 7' ' ' GLN . 0.9 OUTLIER -94.42 -49.6 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.056 0 O-C-N 124.113 0.883 . . . . 0.0 110.783 -176.905 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 171.97 -168.45 41.55 Favored Glycine 0 N--CA 1.496 2.639 0 C-N-CA 119.912 -1.137 . . . . 0.0 112.696 175.235 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.73 140.3 51.85 Favored 'General case' 0 N--CA 1.498 1.974 0 CA-C-N 113.41 -1.395 . . . . 0.0 109.973 175.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -114.54 37.79 3.3 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.685 178.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -131.95 -72.05 0.54 Allowed 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.122 177.439 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.416 HG23 ' O ' ' A' ' 82' ' ' ILE . 3.8 tp -89.7 100.97 11.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-N 114.642 -1.163 . . . . 0.0 109.777 -171.655 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.499 ' H ' ' HD2' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -150.09 -57.12 0.02 OUTLIER Pre-proline 0 N--CA 1.501 2.08 0 CA-C-N 113.808 -1.542 . . . . 0.0 112.174 -176.73 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.499 ' HD2' ' H ' ' A' ' 83' ' ' SER . 1.1 Cg_endo . . . . . 0 N--CA 1.489 1.223 0 CA-C-O 116.36 -1.6 . . . . 0.0 111.08 179.393 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 111.147 -0.781 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 33.7 t -61.69 -49.38 76.71 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 114.682 -0.759 . . . . 0.0 111.31 175.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 0.0 OUTLIER 64.24 149.69 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.154 0 O-C-N 124.152 0.908 . . . . 0.0 112.13 -173.095 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -54.51 143.7 23.45 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 114.986 -1.006 . . . . 0.0 111.544 173.008 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.14 -140.63 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 CA-C-N 114.284 -1.326 . . . . 0.0 109.304 -176.482 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -126.3 39.53 3.92 Favored 'General case' 0 N--CA 1.498 1.957 0 CA-C-O 122.022 0.915 . . . . 0.0 111.66 -174.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 173.84 -144.64 7.74 Favored Glycine 0 N--CA 1.495 2.594 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.501 176.684 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.537 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -98.34 150.81 21.18 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 -174.66 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -128.9 164.03 23.99 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 122.849 1.309 . . . . 0.0 113.832 179.682 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 -141.12 154.7 46.02 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-N 111.398 -2.637 . . . . 0.0 107.338 -174.654 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 37.9 ttt180 -125.73 121.21 32.74 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 -178.754 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.54 126.06 16.36 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 124.121 0.888 . . . . 0.0 110.935 168.771 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.38 -33.12 23.86 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.874 0.734 . . . . 0.0 111.017 176.165 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.88 157.59 44.26 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 123.928 0.767 . . . . 0.0 110.346 -174.514 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -78.89 116.95 19.53 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.947 -1.024 . . . . 0.0 109.26 178.874 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.458 ' CD2' HD12 ' A' ' 24' ' ' LEU . 5.3 t80 -121.19 133.78 55.19 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 124.449 1.093 . . . . 0.0 108.725 179.181 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -89.6 164.57 14.7 Favored 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 177.495 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.9 ptmt -89.06 142.36 27.7 Favored 'General case' 0 N--CA 1.499 2.013 0 O-C-N 123.616 0.572 . . . . 0.0 109.803 -177.443 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -128.44 -12.45 5.0 Favored 'General case' 0 N--CA 1.499 2.016 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.96 177.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.91 143.12 51.37 Favored 'General case' 0 N--CA 1.493 1.708 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.336 178.546 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -61.98 -34.54 76.34 Favored 'General case' 0 N--CA 1.499 1.983 0 CA-C-N 114.065 -1.425 . . . . 0.0 110.083 -178.846 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -65.69 -35.41 80.69 Favored 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 112.817 -1.992 . . . . 0.0 110.404 177.467 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -88.35 162.09 16.75 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 115.02 -0.991 . . . . 0.0 110.177 179.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.64 174.83 8.0 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-N 113.844 -1.525 . . . . 0.0 110.278 179.29 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -73.79 148.56 42.38 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 114.316 -1.311 . . . . 0.0 108.936 -177.147 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.458 HD12 ' CD2' ' A' ' 14' ' ' TYR . 92.8 mt -133.24 141.28 47.95 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 124.093 0.87 . . . . 0.0 110.538 178.043 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -141.78 165.67 26.82 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.532 -171.31 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 7.7 mt -65.74 151.69 46.02 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.336 174.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 71.32 -9.4 4.33 Favored Glycine 0 N--CA 1.501 2.995 0 CA-C-N 115.85 -0.614 . . . . 0.0 113.03 179.384 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 50.4 t0 -69.02 132.46 46.68 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 177.439 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 mt -121.05 138.74 50.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 124.343 1.027 . . . . 0.0 108.629 176.158 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.438 HD23 ' CE1' ' A' ' 69' ' ' PHE . 10.9 mp -107.48 150.21 27.06 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 112.972 -1.922 . . . . 0.0 108.138 178.683 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 9.2 m -127.5 153.81 45.88 Favored 'General case' 0 N--CA 1.503 2.214 0 O-C-N 123.632 0.583 . . . . 0.0 109.992 179.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 6' ' ' TYR . 0.1 OUTLIER -131.29 175.2 11.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.213 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -176.508 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.49 ' CB ' ' HB3' ' A' ' 36' ' ' SER . 1.8 t-20 -72.39 164.0 27.07 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-O 121.794 0.807 . . . . 0.0 110.338 -178.15 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 7.6 ptmm? -61.87 -20.45 63.72 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-N 113.735 -1.575 . . . . 0.0 111.514 174.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -146.29 31.06 1.57 Allowed Glycine 0 N--CA 1.493 2.453 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 -175.427 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.49 ' HB3' ' CB ' ' A' ' 33' ' ' ASN . 7.7 p -73.63 8.07 2.08 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 113.35 0.87 . . . . 0.0 113.35 178.807 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.5 mt -58.78 -42.22 88.49 Favored 'General case' 0 N--CA 1.489 1.51 0 C-N-CA 117.834 -1.546 . . . . 0.0 110.0 160.455 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.7 t -82.0 -9.49 11.83 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.182 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -177.967 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -42.74 -37.17 1.67 Allowed 'General case' 0 N--CA 1.501 2.109 0 O-C-N 123.933 0.771 . . . . 0.0 110.281 170.341 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 8.0 mt -115.45 -0.4 13.12 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.268 -1.333 . . . . 0.0 111.609 -174.184 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 65.65 33.63 86.66 Favored Glycine 0 N--CA 1.497 2.752 0 O-C-N 123.819 0.699 . . . . 0.0 113.143 -172.445 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -62.36 150.12 40.46 Favored 'General case' 0 N--CA 1.503 2.189 0 CA-C-N 114.5 -0.85 . . . . 0.0 111.273 -173.68 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.0 t -89.4 -152.39 0.24 Allowed 'General case' 0 N--CA 1.497 1.884 0 CA-C-N 114.79 -1.096 . . . . 0.0 110.377 175.611 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -40.63 132.6 2.14 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 167.23 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 165.49 103.9 0.17 Allowed Glycine 0 N--CA 1.49 2.282 0 N-CA-C 108.668 -1.773 . . . . 0.0 108.668 -168.79 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -61.73 -0.81 0.49 Allowed 'General case' 0 N--CA 1.501 2.098 0 O-C-N 124.656 0.856 . . . . 0.0 112.211 174.684 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 70.94 4.63 5.15 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 176.909 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -122.71 23.32 9.54 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.393 -169.64 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.68 68.65 81.85 Favored Pre-proline 0 N--CA 1.494 1.747 0 CA-C-N 115.116 -0.947 . . . . 0.0 110.674 -176.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.404 ' HG3' ' H ' ' A' ' 76' ' ' TYR . 5.5 Cg_exo -59.23 -23.91 71.7 Favored 'Trans proline' 0 N--CA 1.488 1.163 0 C-N-CA 122.46 2.107 . . . . 0.0 111.73 174.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 49.9 mt-10 -59.31 -49.17 78.84 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.285 -179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.7 pt-20 -90.09 -35.19 15.59 Favored 'General case' 0 N--CA 1.501 2.121 0 O-C-N 123.832 0.708 . . . . 0.0 110.909 -176.017 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 49.4 mt -64.1 129.86 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 123.943 0.777 . . . . 0.0 109.64 172.122 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.46 -87.41 1.27 Allowed Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 -175.85 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 84.6 m95 -98.23 124.87 43.04 Favored 'General case' 0 N--CA 1.492 1.664 0 CA-C-N 113.609 -1.296 . . . . 0.0 108.144 179.719 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.582 ' H ' HD23 ' A' ' 56' ' ' LEU . 1.4 pt? -132.65 144.67 50.5 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 173.686 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -92.87 147.84 22.51 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.594 1.184 . . . . 0.0 108.867 -176.066 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -157.86 154.13 25.25 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 110.656 -0.978 . . . . 0.0 110.656 175.604 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -89.46 122.49 32.7 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 114.062 -1.069 . . . . 0.0 108.487 176.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -96.47 69.66 2.61 Favored 'General case' 0 N--CA 1.494 1.764 0 CA-C-O 121.977 0.894 . . . . 0.0 111.168 177.005 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -52.31 -26.76 12.96 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 113.754 -1.567 . . . . 0.0 112.458 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 68.4 p -51.67 -51.72 53.64 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 124.037 0.836 . . . . 0.0 112.782 174.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 36.6 p -91.6 2.28 56.56 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 114.831 -1.077 . . . . 0.0 111.228 176.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.86 30.37 77.81 Favored Glycine 0 N--CA 1.495 2.632 0 N-CA-C 110.783 -0.927 . . . . 0.0 110.783 -178.615 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 30.2 mt-10 -129.34 178.32 6.53 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 124.506 0.768 . . . . 0.0 109.508 -178.44 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 4.1 ptt180 -144.51 147.66 33.52 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 178.506 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -177.17 -163.01 28.54 Favored Glycine 0 N--CA 1.493 2.477 0 C-N-CA 118.79 -1.671 . . . . 0.0 113.847 166.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -98.69 152.74 19.32 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 113.17 -1.515 . . . . 0.0 108.98 -178.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.438 ' CE1' HD23 ' A' ' 30' ' ' LEU . 24.4 p90 -154.36 152.74 26.88 Favored Pre-proline 0 N--CA 1.498 1.968 0 O-C-N 123.654 0.596 . . . . 0.0 109.803 175.215 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_endo -65.66 165.25 23.67 Favored 'Trans proline' 0 N--CA 1.488 1.198 0 C-N-CA 122.32 2.013 . . . . 0.0 112.007 176.494 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -92.55 -2.35 67.71 Favored Glycine 0 N--CA 1.494 2.564 0 O-C-N 123.987 0.804 . . . . 0.0 111.57 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -96.34 -34.13 11.69 Favored 'General case' 0 N--CA 1.49 1.551 0 CA-C-O 121.507 0.67 . . . . 0.0 109.833 -166.689 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 44.9 m-85 -90.95 6.11 45.99 Favored 'General case' 0 N--CA 1.497 1.924 0 CA-C-N 113.567 -1.652 . . . . 0.0 111.529 -174.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.4 m -128.34 -177.75 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 124.208 0.942 . . . . 0.0 109.046 -178.429 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.34 115.95 5.51 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . 0.404 ' H ' ' HG3' ' A' ' 50' ' ' PRO . 32.2 t80 -49.4 128.91 18.03 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 166.182 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.3 pt -102.67 -54.72 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.816 0 O-C-N 124.131 0.894 . . . . 0.0 109.721 174.777 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -159.94 171.92 36.36 Favored Glycine 0 N--CA 1.488 2.107 0 C-N-CA 118.681 -1.724 . . . . 0.0 110.502 -170.484 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.37 146.27 27.41 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 113.732 -1.234 . . . . 0.0 109.404 168.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 15.2 ptmt -78.15 100.92 6.79 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 119.035 -1.066 . . . . 0.0 109.065 166.505 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.23 95.33 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.074 0 CA-C-N 113.504 -1.68 . . . . 0.0 112.464 176.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.461 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -99.98 140.94 17.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 114.083 -1.417 . . . . 0.0 109.921 177.165 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.55 163.15 45.21 Favored Pre-proline 0 N--CA 1.498 1.963 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.754 -177.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo . . . . . 0 N--CA 1.489 1.234 0 C-N-CA 121.887 1.725 . . . . 0.0 112.301 176.285 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.321 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 0.9 OUTLIER -75.02 136.21 41.25 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 124.128 0.546 . . . . 0.0 110.895 -179.037 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 2.2 ptp -87.76 60.72 6.08 Favored 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.936 0.874 . . . . 0.0 110.868 -176.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.7 p -165.23 142.95 6.03 Favored 'General case' 0 N--CA 1.5 2.066 0 CA-C-N 114.577 -1.192 . . . . 0.0 110.986 -172.676 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -158.77 -1.29 0.09 Allowed 'General case' 0 N--CA 1.499 2.025 0 CA-C-N 114.372 -1.286 . . . . 0.0 111.394 177.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -68.22 82.34 0.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 124.485 1.116 . . . . 0.0 108.772 -178.2 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -141.8 -151.31 5.51 Favored Glycine 0 N--CA 1.497 2.717 0 CA-C-N 112.528 -2.124 . . . . 0.0 111.083 -178.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -98.72 154.96 17.59 Favored 'General case' 0 N--CA 1.502 2.171 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 -178.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -136.73 162.01 34.38 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 121.848 0.833 . . . . 0.0 110.991 -169.31 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 26.7 m-85 -129.64 170.75 13.4 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-N 113.587 -1.642 . . . . 0.0 107.341 179.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 15.8 ttt180 -133.89 116.65 15.87 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 178.477 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -55.14 112.03 0.98 Allowed 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.301 1.0 . . . . 0.0 110.013 174.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 8.4 tp -70.07 -38.49 75.75 Favored 'General case' 0 N--CA 1.495 1.797 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.514 -177.594 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -137.61 170.83 15.4 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 124.582 1.176 . . . . 0.0 109.981 178.782 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -81.22 123.2 28.27 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-N 114.071 -1.422 . . . . 0.0 110.529 175.199 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.5 ' CD2' HD12 ' A' ' 24' ' ' LEU . 8.5 t80 -118.83 134.25 55.29 Favored 'General case' 0 N--CA 1.5 2.069 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 172.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 21.5 tttt -89.74 159.12 17.23 Favored 'General case' 0 N--CA 1.495 1.818 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.047 175.635 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.5 pttm -88.3 141.09 28.83 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 -176.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 15.1 tt0 -121.32 -8.65 9.16 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.644 178.224 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 4.2 tpt180 -136.67 146.62 46.14 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 178.611 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -60.41 -31.01 69.98 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-N 115.037 -0.983 . . . . 0.0 111.166 174.549 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -62.58 -32.75 73.8 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 113.789 -1.551 . . . . 0.0 110.3 178.431 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -93.36 161.1 14.53 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.304 1.002 . . . . 0.0 110.107 177.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 3.1 pt -116.94 174.86 3.39 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 O-C-N 124.349 1.031 . . . . 0.0 111.545 176.298 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -73.52 141.95 46.73 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 114.268 -1.333 . . . . 0.0 109.125 179.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.5 HD12 ' CD2' ' A' ' 14' ' ' TYR . 18.0 mt -131.38 135.17 46.98 Favored 'General case' 0 N--CA 1.5 2.066 0 O-C-N 123.968 0.792 . . . . 0.0 111.534 178.279 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -138.31 176.52 8.62 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 -177.247 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 mp -72.47 154.53 40.81 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 120.186 -0.605 . . . . 0.0 110.937 -177.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 66.69 -5.57 2.33 Favored Glycine 0 N--CA 1.5 2.931 0 CA-C-N 115.338 -0.846 . . . . 0.0 113.896 -176.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -64.64 101.13 0.43 Allowed 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 174.233 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.9 mt -89.95 135.96 24.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 124.274 0.984 . . . . 0.0 110.099 173.118 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.484 HD23 ' CE1' ' A' ' 69' ' ' PHE . 11.1 mp -111.2 157.03 20.56 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.968 -178.999 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 20.5 m -133.37 150.8 51.81 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 123.768 0.668 . . . . 0.0 110.407 -176.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.588 HG12 ' H ' ' A' ' 33' ' ' ASN . 1.4 t -128.31 -151.93 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.187 0 O-C-N 123.841 0.713 . . . . 0.0 109.151 -179.006 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.588 ' H ' HG12 ' A' ' 32' ' ' VAL . 1.8 m-80 -87.18 -173.66 4.52 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 115.332 -0.849 . . . . 0.0 110.869 178.059 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 17.9 pttm -133.76 -41.05 0.85 Allowed 'General case' 0 N--CA 1.495 1.79 0 CA-C-N 114.378 -1.283 . . . . 0.0 110.504 -173.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -135.28 22.84 3.52 Favored Glycine 0 N--CA 1.494 2.548 0 N-CA-C 109.781 -1.328 . . . . 0.0 109.781 -179.564 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 6.8 t -143.14 61.02 1.41 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 106.664 -1.606 . . . . 0.0 106.664 179.506 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.513 HD21 ' OE1' ' A' ' 47' ' ' GLU . 4.6 mt -51.72 -18.73 1.31 Allowed 'General case' 0 N--CA 1.504 2.263 0 CA-C-N 112.717 -2.038 . . . . 0.0 113.206 167.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.0 -23.63 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.371 0 O-C-N 124.488 1.117 . . . . 0.0 113.563 176.851 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.451 ' O ' HD23 ' A' ' 40' ' ' LEU . . . -40.7 -28.59 0.08 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-N 112.516 -2.129 . . . . 0.0 112.316 168.149 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.451 HD23 ' O ' ' A' ' 39' ' ' ALA . 26.0 mt -125.96 -7.61 6.63 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-N 114.548 -1.206 . . . . 0.0 110.518 178.458 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 78.44 36.45 30.22 Favored Glycine 0 N--CA 1.497 2.724 0 N-CA-C 110.496 -1.042 . . . . 0.0 110.496 -178.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.79 176.48 5.15 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 112.731 -1.734 . . . . 0.0 109.675 -172.451 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 25.4 t -132.52 142.02 49.01 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-N 114.4 -1.273 . . . . 0.0 108.623 175.965 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -57.04 117.73 4.29 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 113.67 -1.604 . . . . 0.0 111.023 173.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -175.76 -43.55 0.06 OUTLIER Glycine 0 N--CA 1.494 2.511 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.613 -179.205 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -150.13 69.12 1.0 Allowed 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 113.38 -1.41 . . . . 0.0 108.509 -167.72 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.513 ' OE1' HD21 ' A' ' 37' ' ' LEU . 14.6 mt-10 -100.54 56.99 0.91 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-N 114.032 -1.44 . . . . 0.0 108.606 172.619 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.45 -0.84 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.173 0 CA-C-N 115.703 -0.681 . . . . 0.0 111.596 178.568 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -123.0 77.78 50.81 Favored Pre-proline 0 N--CA 1.499 1.993 0 O-C-N 123.93 0.769 . . . . 0.0 109.557 -176.834 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -54.43 -18.83 15.73 Favored 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.888 2.392 . . . . 0.0 112.7 175.583 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -53.97 -42.62 69.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.087 0.867 . . . . 0.0 111.806 179.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 5.0 pt-20 -89.8 -29.6 18.53 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 124.1 0.875 . . . . 0.0 110.926 179.871 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 11.9 mt -73.54 136.7 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -178.37 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.82 -87.08 1.31 Allowed Glycine 0 N--CA 1.493 2.456 0 N-CA-C 108.97 -1.652 . . . . 0.0 108.97 -172.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 60.3 m95 -102.75 131.22 49.74 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 113.309 -1.445 . . . . 0.0 109.051 -178.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.52 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.1 mp -114.5 138.31 50.76 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-N 114.406 -1.27 . . . . 0.0 108.233 173.958 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -108.29 124.33 50.15 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 173.221 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -151.14 176.87 29.46 Favored Glycine 0 N--CA 1.496 2.634 0 C-N-CA 120.079 -1.058 . . . . 0.0 112.006 177.829 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -110.52 131.24 55.22 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.149 -1.025 . . . . 0.0 109.275 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 57.6 t-20 -103.43 102.82 12.75 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-N 114.705 -1.134 . . . . 0.0 111.682 -177.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -58.11 -36.31 72.72 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-N 114.059 -1.428 . . . . 0.0 112.284 177.775 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 22.4 m -56.63 -28.49 60.62 Favored 'General case' 0 N--CA 1.501 2.117 0 O-C-N 124.494 1.121 . . . . 0.0 111.996 -177.502 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 13.7 p -116.9 -2.96 11.69 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.645 -176.602 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.15 19.81 32.95 Favored Glycine 0 N--CA 1.497 2.748 0 O-C-N 124.405 1.066 . . . . 0.0 111.37 -172.751 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -117.98 165.78 13.31 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -172.088 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -142.16 149.8 40.23 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.006 0.816 . . . . 0.0 109.68 -178.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 178.72 -145.19 6.66 Favored Glycine 0 N--CA 1.493 2.452 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.456 173.569 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -115.39 153.67 30.62 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-N 114.145 -1.027 . . . . 0.0 108.29 -173.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.52 ' CZ ' ' HB2' ' A' ' 56' ' ' LEU . 31.1 p90 -157.01 143.55 13.26 Favored Pre-proline 0 N--CA 1.493 1.699 0 CA-C-N 114.923 -1.035 . . . . 0.0 109.751 178.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -63.08 157.87 46.86 Favored 'Trans proline' 0 C--N 1.317 -1.121 0 C-N-CA 122.111 1.874 . . . . 0.0 112.043 176.064 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.94 43.62 1.92 Allowed Glycine 0 N--CA 1.495 2.568 0 N-CA-C 110.455 -1.058 . . . . 0.0 110.455 177.92 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.6 t -134.0 -26.38 1.52 Allowed 'General case' 0 N--CA 1.501 2.112 0 N-CA-C 112.5 0.556 . . . . 0.0 112.5 178.066 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -93.21 2.4 56.67 Favored 'General case' 0 N--CA 1.497 1.895 0 CA-C-N 114.76 -1.109 . . . . 0.0 110.463 -177.945 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 26.7 m -122.42 -176.44 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 124.306 1.004 . . . . 0.0 109.227 -177.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -150.27 115.15 5.31 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 176.716 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -48.36 122.26 5.2 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 124.142 0.901 . . . . 0.0 109.343 171.138 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.97 -51.1 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 C-N-CA 120.008 -0.677 . . . . 0.0 110.039 177.485 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -166.16 159.84 33.21 Favored Glycine 0 N--CA 1.485 1.911 0 C-N-CA 118.814 -1.66 . . . . 0.0 110.688 -178.868 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.478 ' H ' ' CD ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -129.54 124.55 34.17 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-N 111.866 -2.167 . . . . 0.0 105.957 173.962 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.0 ptmt -57.53 141.47 47.69 Favored 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.25 169.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.417 ' HG3' ' H ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -50.91 109.16 0.29 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 124.118 0.886 . . . . 0.0 110.649 171.974 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.589 ' O ' HD13 ' A' ' 82' ' ' ILE . 0.0 OUTLIER -88.66 -6.92 10.86 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 CA-C-N 114.427 -1.261 . . . . 0.0 110.129 173.54 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.32 157.5 47.48 Favored Pre-proline 0 N--CA 1.503 2.207 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 -175.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_endo . . . . . 0 N--CA 1.491 1.338 0 C-N-CA 122.314 2.01 . . . . 0.0 111.732 -179.513 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 55.3 p -65.82 -37.6 86.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.451 178.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 19.3 mmt -73.25 110.39 7.5 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.833 179.488 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.48 169.13 23.64 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.37 -175.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.82 95.55 9.91 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.781 -177.327 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.22 21.96 3.46 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.03 -178.808 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.93 -160.71 0.1 OUTLIER Glycine 0 N--CA 1.495 2.589 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.547 167.619 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -89.44 177.75 6.49 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -163.494 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -144.43 159.56 42.53 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 117.413 -1.715 . . . . 0.0 113.67 -174.535 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -146.31 143.96 29.49 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 112.345 -2.207 . . . . 0.0 107.439 -172.406 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -118.57 112.96 20.55 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -174.606 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.17 121.67 3.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.302 1.001 . . . . 0.0 109.983 175.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -79.8 -68.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.205 176.791 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.41 171.79 7.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.382 1.052 . . . . 0.0 109.924 -177.012 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.43 121.12 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.38 175.539 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD2' HD12 ' A' ' 24' ' ' LEU . 12.9 t80 -124.87 129.33 50.19 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.237 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -89.82 -170.33 2.77 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -88.33 144.89 26.13 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.039 175.221 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.39 -15.7 9.06 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.802 173.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -150.18 147.48 27.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.553 1.158 . . . . 0.0 108.796 -178.601 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.11 -11.31 0.67 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.033 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 18' ' ' ARG . 1.3 mm-40 -81.37 -44.68 17.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 124.212 0.945 . . . . 0.0 111.261 177.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.75 165.47 18.85 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.855 0.722 . . . . 0.0 109.334 -178.266 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 177.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 122.507 1.146 . . . . 0.0 110.85 177.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -82.23 113.11 19.83 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 111.927 -2.397 . . . . 0.0 106.781 -178.323 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' A' ' 14' ' ' TYR . 61.6 mt -103.76 143.19 33.13 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.422 0.629 . . . . 0.0 111.769 179.288 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 172.15 15.72 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.271 -176.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.613 HD12 ' H ' ' A' ' 26' ' ' LEU . 6.5 mp -64.84 155.75 33.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.016 -177.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.19 -12.96 2.89 Favored Glycine 0 N--CA 1.504 3.187 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.476 179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -76.58 113.89 14.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.205 0.591 . . . . 0.0 109.609 -175.737 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -96.91 149.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.246 0.546 . . . . 0.0 109.885 179.658 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.518 HD23 ' CE1' ' A' ' 69' ' ' PHE . 10.1 mp -124.47 145.91 49.25 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.228 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 m -127.1 125.63 41.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.165 0.916 . . . . 0.0 109.616 -177.351 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 33' ' ' ASN . 6.4 t -95.85 -124.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.951 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.411 ' N ' HG12 ' A' ' 32' ' ' VAL . 74.9 m-80 -140.03 -173.84 3.76 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -171.127 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 pttm -116.13 5.55 13.8 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.436 173.272 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.19 -12.25 11.49 Favored Glycine 0 N--CA 1.495 2.599 0 CA-C-O 118.941 -0.922 . . . . 0.0 112.88 178.198 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p 77.45 41.96 0.13 Allowed 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.463 1.125 . . . . 0.0 109.811 165.793 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mt 81.45 -15.31 0.73 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 111.554 -2.566 . . . . 0.0 110.337 177.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.91 -20.3 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.543 169.66 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.51 -22.1 19.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.533 167.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.448 HD21 ' H ' ' A' ' 57' ' ' ASN . 9.3 mt -114.46 0.52 14.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.052 0.845 . . . . 0.0 110.939 -179.047 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.6 16.67 80.56 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.842 -170.149 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -91.59 155.08 18.62 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.339 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 97.6 p -137.74 7.48 2.75 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.022 0.915 . . . . 0.0 113.235 176.207 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -176.31 104.07 0.07 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.944 -1.935 . . . . 0.0 107.256 -175.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.15 -14.47 0.03 OUTLIER Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.561 170.443 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.02 99.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.682 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.52 -17.62 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 168.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 -11.89 55.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.1 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 82.37 48.52 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 124.219 0.949 . . . . 0.0 108.587 -177.871 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.23 -10.68 26.77 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.118 1.879 . . . . 0.0 113.021 173.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.89 -36.73 79.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.719 0.637 . . . . 0.0 111.608 -176.037 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -91.4 -29.98 16.76 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.279 -176.217 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -71.6 149.82 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.222 177.07 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.4 -95.31 1.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -98.8 126.22 44.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.826 0.956 . . . . 0.0 110.061 -175.836 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.7 mp -98.29 145.09 27.01 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.429 174.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.448 ' H ' HD21 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -104.54 125.92 51.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.2 0.937 . . . . 0.0 108.664 169.879 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.7 160.39 27.95 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.382 173.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.76 122.24 31.97 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.124 -1.038 . . . . 0.0 109.7 172.458 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -92.44 64.76 4.37 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.674 176.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -52.61 -31.2 35.27 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.006 -178.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.445 HG21 ' H ' ' A' ' 29' ' ' ILE . 37.6 p -53.89 -48.28 70.27 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.116 0.885 . . . . 0.0 111.49 179.142 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -89.74 -5.47 56.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.03 177.163 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.44 24.98 64.26 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 177.773 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -129.28 179.34 5.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.506 0.768 . . . . 0.0 109.144 -175.407 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -147.14 151.67 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.453 179.012 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.68 -161.08 33.2 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.2 176.8 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.96 162.18 15.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -170.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.518 ' CE1' HD23 ' A' ' 30' ' ' LEU . 23.4 p90 -160.65 148.47 12.69 Favored Pre-proline 0 N--CA 1.496 1.845 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.12 179.272 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.85 150.03 89.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.698 1.598 . . . . 0.0 111.209 177.568 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.04 48.09 2.22 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 175.23 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -146.71 8.16 0.98 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.819 0.364 . . . . 0.0 111.565 174.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.05 9.34 9.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.967 0.792 . . . . 0.0 111.473 -178.603 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 -171.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 124.016 0.823 . . . . 0.0 109.702 -173.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HB2' HD23 ' A' ' 11' ' ' LEU . 10.0 tt0 -150.15 102.36 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.179 175.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -41.99 136.32 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.496 170.214 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.3 pt -139.57 -67.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 124.005 0.816 . . . . 0.0 110.604 -177.741 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.486 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -89.86 159.02 27.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -173.01 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -171.18 133.0 0.84 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.88 -168.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.1 mttm 54.23 112.63 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 112.097 -2.32 . . . . 0.0 113.229 169.402 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp 43.11 37.9 1.35 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.761 -175.644 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.459 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -88.99 123.65 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 118.424 -1.31 . . . . 0.0 109.527 -171.769 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.16 163.95 23.18 Favored Pre-proline 0 N--CA 1.503 2.177 0 CA-C-N 112.849 -1.978 . . . . 0.0 108.919 -171.775 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 C-N-CA 121.779 1.653 . . . . 0.0 111.918 175.731 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 N-CA-C 109.936 -1.265 . . . . 0.0 109.936 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 55.3 p -65.82 -37.6 86.68 Favored 'General case' 0 N--CA 1.498 1.951 0 CA-C-N 115.289 -0.456 . . . . 0.0 111.451 178.704 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 19.3 mmt -73.25 110.39 7.5 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.185 -0.916 . . . . 0.0 109.833 179.488 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -160.48 169.13 23.64 Favored 'General case' 0 N--CA 1.502 2.136 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.37 -175.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -91.82 95.55 9.91 Favored 'General case' 0 N--CA 1.495 1.822 0 CA-C-N 114.734 -1.121 . . . . 0.0 110.781 -177.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.22 21.96 3.46 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-N 114.565 -1.198 . . . . 0.0 110.03 -178.808 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.93 -160.71 0.1 OUTLIER Glycine 0 N--CA 1.495 2.589 0 CA-C-N 114.876 -1.056 . . . . 0.0 112.547 167.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.414 ' CD1' ' N ' ' A' ' 6' ' ' TYR . 0.4 OUTLIER -89.44 177.75 6.49 Favored 'General case' 0 N--CA 1.501 2.104 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 -163.494 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 16.9 mt-30 -144.43 159.56 42.53 Favored 'General case' 0 N--CA 1.499 2.016 0 C-N-CA 117.413 -1.715 . . . . 0.0 113.67 -174.535 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 75.3 m-85 -146.31 143.96 29.49 Favored 'General case' 0 N--CA 1.486 1.367 0 CA-C-N 112.345 -2.207 . . . . 0.0 107.439 -172.406 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 34.6 ttt180 -118.57 112.96 20.55 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 -174.606 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.17 121.67 3.94 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 124.302 1.001 . . . . 0.0 109.983 175.071 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 75' ' ' GLU . 0.2 OUTLIER -79.8 -68.43 0.67 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.205 176.791 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.41 171.79 7.19 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.382 1.052 . . . . 0.0 109.924 -177.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -82.43 121.12 26.32 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 114.896 -1.047 . . . . 0.0 110.38 175.539 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.41 ' CD2' HD12 ' A' ' 24' ' ' LEU . 12.9 t80 -124.87 129.33 50.19 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 174.237 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.6 ttpt -89.82 -170.33 2.77 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 -177.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -88.33 144.89 26.13 Favored 'General case' 0 N--CA 1.5 2.03 0 C-N-CA 119.807 -0.757 . . . . 0.0 111.039 175.221 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.6 mm-40 -119.39 -15.7 9.06 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 113.691 -1.595 . . . . 0.0 111.802 173.987 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.435 ' HG2' ' H ' ' A' ' 20' ' ' GLU . 0.2 OUTLIER -150.18 147.48 27.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 124.553 1.158 . . . . 0.0 108.796 -178.601 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -55.11 -11.31 0.67 Allowed 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 113.507 0.928 . . . . 0.0 113.507 175.033 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . 0.435 ' H ' ' HG2' ' A' ' 18' ' ' ARG . 1.3 mm-40 -81.37 -44.68 17.22 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 124.212 0.945 . . . . 0.0 111.261 177.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 2.2 p30 -83.75 165.47 18.85 Favored 'General case' 0 N--CA 1.501 2.101 0 O-C-N 123.855 0.722 . . . . 0.0 109.334 -178.266 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -113.71 177.11 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 CA-C-O 122.507 1.146 . . . . 0.0 110.85 177.707 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -82.23 113.11 19.83 Favored 'General case' 0 N--CA 1.498 1.946 0 CA-C-N 111.927 -2.397 . . . . 0.0 106.781 -178.323 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.41 HD12 ' CD2' ' A' ' 14' ' ' TYR . 61.6 mt -103.76 143.19 33.13 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.422 0.629 . . . . 0.0 111.769 179.288 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -150.08 172.15 15.72 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-N 114.482 -1.235 . . . . 0.0 109.271 -176.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.613 HD12 ' H ' ' A' ' 26' ' ' LEU . 6.5 mp -64.84 155.75 33.03 Favored 'General case' 0 N--CA 1.495 1.777 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.016 -177.457 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 72.19 -12.96 2.89 Favored Glycine 0 N--CA 1.504 3.187 0 CA-C-N 115.973 -0.558 . . . . 0.0 113.476 179.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -76.58 113.89 14.7 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 124.205 0.591 . . . . 0.0 109.609 -175.737 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.509 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.0 OUTLIER -96.91 149.48 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.146 0 CA-C-O 121.246 0.546 . . . . 0.0 109.885 179.658 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.518 HD23 ' CE1' ' A' ' 69' ' ' PHE . 10.1 mp -124.47 145.91 49.25 Favored 'General case' 0 N--CA 1.5 2.026 0 CA-C-N 114.898 -1.046 . . . . 0.0 108.228 179.622 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.9 m -127.1 125.63 41.6 Favored 'General case' 0 N--CA 1.504 2.228 0 O-C-N 124.165 0.916 . . . . 0.0 109.616 -177.351 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 33' ' ' ASN . 6.4 t -95.85 -124.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 -177.951 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.411 ' N ' HG12 ' A' ' 32' ' ' VAL . 74.9 m-80 -140.03 -173.84 3.76 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 -171.127 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 2.5 pttm -116.13 5.55 13.8 Favored 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 113.826 -1.534 . . . . 0.0 109.436 173.272 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -58.19 -12.25 11.49 Favored Glycine 0 N--CA 1.495 2.599 0 CA-C-O 118.941 -0.922 . . . . 0.0 112.88 178.198 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 3.2 p 77.45 41.96 0.13 Allowed 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 122.463 1.125 . . . . 0.0 109.811 165.793 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.1 mt 81.45 -15.31 0.73 Allowed 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 111.554 -2.566 . . . . 0.0 110.337 177.081 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.9 t -63.91 -20.3 26.31 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.179 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.543 169.66 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -55.51 -22.1 19.74 Favored 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 114.225 -1.352 . . . . 0.0 112.533 167.26 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.448 HD21 ' H ' ' A' ' 57' ' ' ASN . 9.3 mt -114.46 0.52 14.07 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.052 0.845 . . . . 0.0 110.939 -179.047 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 76.6 16.67 80.56 Favored Glycine 0 N--CA 1.497 2.714 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.842 -170.149 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 4.2 m-85 -91.59 155.08 18.62 Favored 'General case' 0 N--CA 1.497 1.886 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 179.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 97.6 p -137.74 7.48 2.75 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 122.022 0.915 . . . . 0.0 113.235 176.207 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -176.31 104.07 0.07 Allowed 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 112.944 -1.935 . . . . 0.0 107.256 -175.235 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.15 -14.47 0.03 OUTLIER Glycine 0 N--CA 1.494 2.533 0 C-N-CA 119.375 -1.393 . . . . 0.0 113.561 170.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER 59.02 99.48 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -172.682 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -44.52 -17.62 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 168.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -84.64 -11.89 55.05 Favored 'General case' 0 N--CA 1.502 2.173 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -179.1 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.69 82.37 48.52 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 124.219 0.949 . . . . 0.0 108.587 -177.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -65.23 -10.68 26.77 Favored 'Trans proline' 0 N--CA 1.49 1.271 0 C-N-CA 122.118 1.879 . . . . 0.0 113.021 173.596 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -60.89 -36.73 79.99 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 123.719 0.637 . . . . 0.0 111.608 -176.037 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -91.4 -29.98 16.76 Favored 'General case' 0 N--CA 1.496 1.834 0 CA-C-N 114.804 -1.089 . . . . 0.0 110.279 -176.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 91.3 mt -71.6 149.82 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.862 0 CA-C-N 115.503 -0.771 . . . . 0.0 109.222 177.07 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.4 -95.31 1.1 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.333 -1.507 . . . . 0.0 109.333 177.232 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 71.1 m95 -98.8 126.22 44.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 124.826 0.956 . . . . 0.0 110.061 -175.836 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 69' ' ' PHE . 4.7 mp -98.29 145.09 27.01 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-N 115.054 -0.976 . . . . 0.0 109.429 174.252 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.448 ' H ' HD21 ' A' ' 40' ' ' LEU . 0.9 OUTLIER -104.54 125.92 51.14 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.2 0.937 . . . . 0.0 108.664 169.879 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -144.7 160.39 27.95 Favored Glycine 0 N--CA 1.496 2.672 0 C-N-CA 120.579 -0.819 . . . . 0.0 111.382 173.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -88.76 122.24 31.97 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 114.124 -1.038 . . . . 0.0 109.7 172.458 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.9 t-20 -92.44 64.76 4.37 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-N 114.706 -1.134 . . . . 0.0 109.674 176.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 86.6 mt-10 -52.61 -31.2 35.27 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.006 -178.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.445 HG21 ' H ' ' A' ' 29' ' ' ILE . 37.6 p -53.89 -48.28 70.27 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 124.116 0.885 . . . . 0.0 111.49 179.142 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 38.7 p -89.74 -5.47 56.96 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 114.915 -1.038 . . . . 0.0 111.03 177.163 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 77.44 24.98 64.26 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.604 -0.999 . . . . 0.0 110.604 177.773 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 61.7 mm-40 -129.28 179.34 5.83 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 124.506 0.768 . . . . 0.0 109.144 -175.407 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -147.14 151.67 37.19 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-N 114.802 -1.09 . . . . 0.0 109.453 179.012 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 171.68 -161.08 33.2 Favored Glycine 0 N--CA 1.495 2.57 0 C-N-CA 119.815 -1.183 . . . . 0.0 112.2 176.8 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -111.96 162.18 15.62 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -170.866 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.518 ' CE1' HD23 ' A' ' 30' ' ' LEU . 23.4 p90 -160.65 148.47 12.69 Favored Pre-proline 0 N--CA 1.496 1.845 0 C-N-CA 120.225 -0.59 . . . . 0.0 111.12 179.272 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -62.85 150.03 89.58 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 121.698 1.598 . . . . 0.0 111.209 177.568 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -94.04 48.09 2.22 Favored Glycine 0 N--CA 1.495 2.602 0 N-CA-C 110.517 -1.033 . . . . 0.0 110.517 175.23 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 7.3 t -146.71 8.16 0.98 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 123.819 0.364 . . . . 0.0 111.565 174.842 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -122.05 9.34 9.92 Favored 'General case' 0 N--CA 1.499 2.016 0 O-C-N 123.967 0.792 . . . . 0.0 111.473 -178.603 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 33.0 m -132.2 -171.31 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.911 0 O-C-N 124.016 0.823 . . . . 0.0 109.702 -173.043 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . 0.529 ' HB2' HD23 ' A' ' 11' ' ' LEU . 10.0 tt0 -150.15 102.36 3.08 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.143 -0.935 . . . . 0.0 109.179 175.014 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -41.99 136.32 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 CA-C-N 114.367 -1.288 . . . . 0.0 110.496 170.214 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.486 HG13 ' H ' ' A' ' 78' ' ' GLY . 1.3 pt -139.57 -67.33 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 124.005 0.816 . . . . 0.0 110.604 -177.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.486 ' H ' HG13 ' A' ' 77' ' ' ILE . . . -89.86 159.02 27.6 Favored Glycine 0 N--CA 1.494 2.531 0 N-CA-C 107.479 -2.249 . . . . 0.0 107.479 -173.01 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . . . . . . . . . 4.7 ppt_? -171.18 133.0 0.84 Allowed 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.542 -0.863 . . . . 0.0 111.88 -168.007 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 23.1 mttm 54.23 112.63 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 CA-C-N 112.097 -2.32 . . . . 0.0 113.229 169.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 26.1 mmtp 43.11 37.9 1.35 Allowed 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 114.697 -1.138 . . . . 0.0 113.761 -175.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.459 HD13 ' C ' ' A' ' 82' ' ' ILE . 0.0 OUTLIER -88.99 123.65 41.35 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 C-N-CA 118.424 -1.31 . . . . 0.0 109.527 -171.769 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -149.16 163.95 23.18 Favored Pre-proline 0 N--CA 1.503 2.177 0 CA-C-N 112.849 -1.978 . . . . 0.0 108.919 -171.775 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo . . . . . 0 N--CA 1.489 1.21 0 C-N-CA 121.779 1.653 . . . . 0.0 111.918 175.731 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' A GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.316 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' B SER . . . . . . . . . . . . . 5.4 t -155.81 146.31 21.88 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 124.017 0.481 . . . . 0.0 110.084 -179.011 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 1' C MET . . . . . . . . . . . . . 11.6 tpt 55.97 79.44 0.17 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 124.216 0.947 . . . . 0.0 111.572 176.309 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.2 p -157.65 74.16 0.73 Allowed 'General case' 0 N--CA 1.498 1.957 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.886 -175.173 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.4 107.18 14.87 Favored 'General case' 0 N--CA 1.498 1.93 0 CA-C-N 114.475 -1.239 . . . . 0.0 111.17 176.024 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.1 mt-10 -89.75 -12.86 38.11 Favored 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 115.091 -0.959 . . . . 0.0 110.818 177.685 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -163.95 -112.6 0.27 Allowed Glycine 0 N--CA 1.494 2.506 0 N-CA-C 110.228 -1.149 . . . . 0.0 110.228 177.69 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -111.19 159.68 17.65 Favored 'General case' 0 N--CA 1.507 2.377 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 179.831 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.547 ' HB3' HD11 ' A' ' 77' ' ' ILE . 70.0 mt-30 -133.38 160.31 37.74 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 124.038 0.836 . . . . 0.0 111.602 -177.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' TYR . . . . . . . . . . . . . 60.4 m-85 -138.35 162.04 35.4 Favored 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 113.078 -1.874 . . . . 0.0 108.05 -177.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . . . . . . . . . 5.3 mtp180 -125.87 112.9 16.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 124.293 0.996 . . . . 0.0 108.738 -179.35 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.41 108.93 0.43 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 114.668 -1.151 . . . . 0.0 111.321 170.315 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.5 tp -90.68 -14.41 32.3 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.15 -177.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.38 141.46 41.75 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 124.308 1.005 . . . . 0.0 110.544 -179.176 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -77.59 115.32 17.26 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.182 171.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -125.96 136.15 52.67 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 124.323 1.015 . . . . 0.0 109.101 176.909 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -89.79 163.3 15.11 Favored 'General case' 0 N--CA 1.498 1.945 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 176.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -89.02 140.6 29.27 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 123.851 0.719 . . . . 0.0 109.514 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -89.74 -25.34 21.2 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.994 -179.356 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -150.2 162.22 40.88 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 114.145 -1.389 . . . . 0.0 110.363 -177.828 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -52.52 -14.89 0.55 Allowed 'General case' 0 N--CA 1.499 1.977 0 CA-C-N 114.137 -1.392 . . . . 0.0 114.609 173.893 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -75.94 -42.8 47.63 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 123.61 0.569 . . . . 0.0 110.767 177.822 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -89.35 146.48 24.66 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 124.02 0.825 . . . . 0.0 110.161 177.418 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 2.6 pt -99.03 173.14 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-N 114.813 -1.085 . . . . 0.0 111.058 175.832 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -79.36 140.6 37.43 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 114.023 -1.444 . . . . 0.0 108.644 -177.176 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.0 mt -125.86 138.91 53.83 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 124.497 1.123 . . . . 0.0 109.277 179.303 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -126.04 -155.14 0.67 Allowed 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.043 -171.911 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 8.8 mt -106.4 144.29 33.29 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 123.706 0.629 . . . . 0.0 111.12 175.099 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 60.09 6.6 5.71 Favored Glycine 0 N--CA 1.503 3.11 0 CA-C-N 115.455 -0.793 . . . . 0.0 112.667 178.322 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -68.89 144.25 54.27 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 123.93 0.429 . . . . 0.0 110.498 173.728 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.618 ' C ' HD12 ' A' ' 30' ' ' LEU . 1.3 mp -108.9 146.79 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 124.569 1.168 . . . . 0.0 107.933 -177.761 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.618 HD12 ' C ' ' A' ' 29' ' ' ILE . 6.4 mp -128.57 129.04 45.4 Favored 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.833 -1.53 . . . . 0.0 110.747 172.021 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 97.0 m -106.5 152.32 23.82 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 124.269 0.981 . . . . 0.0 109.273 -178.919 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 6' ' ' TYR . 0.0 OUTLIER -131.67 -173.45 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 124.079 0.862 . . . . 0.0 109.115 -179.133 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -80.76 160.82 24.78 Favored 'General case' 0 N--CA 1.491 1.618 0 CA-C-N 114.677 -1.147 . . . . 0.0 111.7 -178.388 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 8.2 pttm -55.41 -33.03 63.17 Favored 'General case' 0 N--CA 1.501 2.09 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.57 175.899 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -127.65 40.99 1.65 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 106.389 -2.685 . . . . 0.0 106.389 -177.202 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.7 -16.6 41.23 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 113.575 -1.312 . . . . 0.0 111.811 -177.983 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.2 mt -57.12 -47.72 80.42 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 119.451 -0.9 . . . . 0.0 108.765 172.238 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 18.6 t -74.02 -10.66 13.99 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.242 0 N-CA-C 113.208 0.818 . . . . 0.0 113.208 -175.499 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -49.89 -30.08 9.41 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 124.106 0.879 . . . . 0.0 110.158 176.122 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.493 HD13 ' HA ' ' A' ' 40' ' ' LEU . 3.0 mm? -103.57 -36.94 7.75 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.59 -1.186 . . . . 0.0 109.765 -179.526 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 122.84 18.66 3.17 Favored Glycine 0 N--CA 1.493 2.479 0 O-C-N 125.755 1.909 . . . . 0.0 113.279 -174.699 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -69.05 174.94 4.07 Favored 'General case' 0 N--CA 1.503 2.182 0 CA-C-O 121.334 0.588 . . . . 0.0 111.637 176.001 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 34.5 p -123.29 -178.05 3.88 Favored 'General case' 0 N--CA 1.499 1.978 0 CA-C-N 114.178 -1.374 . . . . 0.0 109.884 176.56 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.1 t0 -56.36 104.12 0.13 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 124.434 1.084 . . . . 0.0 111.331 174.67 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -137.88 -110.11 0.94 Allowed Glycine 0 N--CA 1.492 2.374 0 N-CA-C 108.078 -2.009 . . . . 0.0 108.078 -178.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . 0.447 ' C ' ' H ' ' A' ' 48' ' ' ALA . 1.3 pt20 -155.73 89.11 1.15 Allowed 'General case' 0 C--N 1.306 -1.307 0 CA-C-O 122.622 1.201 . . . . 0.0 109.865 -172.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.6 16.73 0.08 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-N 113.82 -1.536 . . . . 0.0 113.578 172.59 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.447 ' H ' ' C ' ' A' ' 46' ' ' GLN . . . -103.99 -14.15 16.06 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.288 -178.444 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.6 mttt -112.04 94.46 25.48 Favored Pre-proline 0 N--CA 1.498 1.926 0 O-C-N 124.197 0.936 . . . . 0.0 108.942 173.961 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.67 -20.9 53.03 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 C-N-CA 122.266 1.977 . . . . 0.0 112.768 166.937 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 15.2 mm-40 -59.16 -36.6 75.56 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 123.898 0.749 . . . . 0.0 111.951 -175.014 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.7 pt-20 -89.75 -31.83 17.26 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 123.856 0.723 . . . . 0.0 109.241 -176.612 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ILE . . . . . . . . . . . . . 69.1 mt -70.73 146.17 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 124.123 0.889 . . . . 0.0 110.144 175.324 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -89.84 -99.69 1.1 Allowed Glycine 0 N--CA 1.493 2.47 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 177.978 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' TRP . . . . . . . . . . . . . 45.9 m95 -89.79 131.94 35.48 Favored 'General case' 0 N--CA 1.496 1.854 0 CA-C-N 114.416 -0.892 . . . . 0.0 110.01 -177.02 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 95.7 mt -102.04 156.26 17.65 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 176.855 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -134.21 121.5 21.44 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 177.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -165.9 -162.38 17.1 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 -176.773 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -136.73 130.01 31.38 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 -172.821 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 59.6 t30 -93.63 68.1 3.98 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 113.182 -1.826 . . . . 0.0 108.856 174.346 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.3 mt-10 -43.05 -29.54 0.36 Allowed 'General case' 0 N--CA 1.505 2.278 0 CA-C-N 114.538 -1.21 . . . . 0.0 114.023 175.709 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.489 HG21 ' H ' ' A' ' 29' ' ' ILE . 82.8 p -45.85 -51.02 13.67 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 124.426 1.079 . . . . 0.0 112.328 178.11 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 1.6 p -106.44 0.26 24.65 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 113.714 -1.585 . . . . 0.0 110.986 174.982 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 73.43 37.81 53.22 Favored Glycine 0 N--CA 1.496 2.694 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 175.333 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -109.3 135.75 49.87 Favored 'General case' 0 N--CA 1.5 2.054 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -175.227 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 30.7 mtm180 -120.99 125.36 47.17 Favored 'General case' 0 N--CA 1.503 2.206 0 O-C-N 123.811 0.694 . . . . 0.0 110.469 -179.64 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 177.77 -147.21 8.0 Favored Glycine 0 N--CA 1.499 2.844 0 C-N-CA 119.521 -1.323 . . . . 0.0 114.094 176.777 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -111.19 164.39 12.91 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 113.782 -1.209 . . . . 0.0 108.898 -177.01 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 7.4 p90 -163.83 140.87 5.54 Favored Pre-proline 0 N--CA 1.494 1.728 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.614 175.726 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' PRO . . . . . 0.408 ' HB2' HG22 ' A' ' 72' ' ' THR . 2.4 Cg_endo -59.7 155.96 40.1 Favored 'Trans proline' 0 N--CA 1.491 1.325 0 C-N-CA 122.389 2.06 . . . . 0.0 112.305 -177.694 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -95.86 47.95 1.83 Allowed Glycine 0 N--CA 1.497 2.704 0 CA-C-N 114.9 -1.046 . . . . 0.0 110.704 179.547 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.689 HG23 ' CD1' ' A' ' 73' ' ' TYR . 5.5 t -147.27 -22.85 0.39 Allowed 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 179.222 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' TYR . . . . . 0.689 ' CD1' HG23 ' A' ' 72' ' ' THR . 10.7 m-30 -89.89 -12.26 39.48 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 123.973 0.795 . . . . 0.0 110.488 -178.261 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.4 m -105.67 -173.64 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 CA-C-N 114.909 -1.041 . . . . 0.0 109.291 -176.022 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -150.29 114.32 5.09 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.706 175.433 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' TYR . . . . . . . . . . . . . 18.7 t80 -55.69 124.95 19.13 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.932 177.066 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.547 HD11 ' HB3' ' A' ' 7' ' ' GLN . 1.2 pt -98.97 -52.9 8.4 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 O-C-N 123.934 0.771 . . . . 0.0 110.421 178.731 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . -158.1 163.64 32.92 Favored Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.6 -1.286 . . . . 0.0 110.643 -175.545 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' ARG . . . . . 0.548 ' HD2' ' H ' ' A' ' 79' ' ' ARG . 0.1 OUTLIER -123.56 150.29 44.23 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.588 -1.306 . . . . 0.0 110.808 163.884 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -62.41 -162.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 114.621 -1.172 . . . . 0.0 111.95 172.341 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 28.5 tttp -86.9 70.92 10.36 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 173.422 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.8 tt -89.82 138.7 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.05 0 CA-C-O 121.728 0.775 . . . . 0.0 112.564 162.455 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.34 164.91 22.09 Favored Pre-proline 0 N--CA 1.502 2.136 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.417 -178.398 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo . . . . . 0 N--CA 1.487 1.124 0 C-N-CA 122.015 1.81 . . . . 0.0 112.319 170.804 . . . . . . . . 0 0 . 1 stop_ save_